10-K
UNITED
STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549
Form 10-K
|
|
|
(Mark One)
|
|
|
þ
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
For the fiscal year ended
December 31, 2008
|
or
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
For the transition period
from to
|
Commission file number
001-15787
MetLife, Inc.
(Exact name of registrant as
specified in its charter)
|
|
|
Delaware
|
|
13-4075851
|
(State or other jurisdiction
of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
200 Park Avenue, New York, N.Y.
|
|
10166-0188
|
(Address of principal
executive offices)
|
|
(Zip Code)
|
(212) 578-2211
(Registrants telephone
number, including area code)
|
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
Title of each class
|
|
Name of each exchange on which registered
|
Common Stock, par value $0.01
|
|
New York Stock Exchange
|
Floating Rate Non-Cumulative Preferred Stock, Series A, par
value $0.01
|
|
New York Stock Exchange
|
6.50% Non-Cumulative Preferred Stock, Series B, par value
$0.01
|
|
New York Stock Exchange
|
5.875% Senior Notes
|
|
New York Stock Exchange
|
5.375% Senior Notes
|
|
Irish Stock Exchange
|
5.25% Senior Notes
|
|
Irish Stock Exchange
|
Securities registered pursuant to Section 12(g) of the
Act: None
Indicate by check mark if the registrant is a well-known
seasoned issuer, as defined in Rule 405 of the Securities
Act. Yes þ No o
Indicate by check mark if the registrant is not required to file
reports pursuant to Section 13 or 15(d) of the
Act. Yes o No þ
Indicate by check mark whether the registrant: (1) has
filed all reports required to be filed by Section 13 or
15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has
been subject to such filing requirements for the past
90 days. Yes þ No o
Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of
Regulation S-K
(§ 229.405 of this chapter) is not contained herein,
and will not be contained, to the best of registrants
knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this
Form 10-K
or any amendment to this
Form 10-K. o
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated
filer, or a smaller reporting company. See the definitions of
large accelerated filer, accelerated
filer and smaller reporting company in
Rule 12b-2
of the Exchange Act. (Check one):
|
|
|
Large accelerated filer
þ
|
|
Accelerated filer
o
|
Non-accelerated filer
o
|
|
Smaller reporting company
o
|
(Do not check if a smaller reporting company)
|
|
|
Indicate by check mark whether the registrant is a shell company
(as defined in
Rule 12b-2
of the Exchange
Act). Yes o No þ
The aggregate market value of the voting and non-voting common
equity held by non-affiliates of the registrant as of
June 30, 2008 was approximately $37 billion. As of
February 20, 2009, 818,081,294 shares of the
registrants common stock were outstanding.
DOCUMENTS
INCORPORATED BY REFERENCE
The information required to be furnished pursuant to part of
Item 10 and Item 11 through Item 14 of
Part III of this
Form 10-K
is set forth in, and is hereby incorporated by reference herein
from, the registrants definitive proxy statement for the
Annual Meeting of Shareholders to be held on April 28,
2009, to be filed by the registrant with the Securities and
Exchange Commission pursuant to Regulation 14A not later
than 120 days after the year ended December 31,
2008.
Note
Regarding Forward-Looking Statements
This Annual Report on
Form 10-K,
including the Managements Discussion and Analysis of
Financial Condition and Results of Operations, may contain or
incorporate by reference information that includes or is based
upon forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995.
Forward-looking statements give expectations or forecasts of
future events. These statements can be identified by the fact
that they do not relate strictly to historical or current facts.
They use words such as anticipate,
estimate, expect, project,
intend, plan, believe and
other words and terms of similar meaning in connection with a
discussion of future operating or financial performance. In
particular, these include statements relating to future actions,
prospective services or products, future performance or results
of current and anticipated services or products, sales efforts,
expenses, the outcome of contingencies such as legal
proceedings, trends in operations and financial results. See
Managements Discussion and Analysis of Financial
Condition and Results of Operations.
Note
Regarding Reliance on Statements in Our Contracts
In reviewing the agreements included as exhibits to this Annual
Report on
Form 10-K,
please remember that they are included to provide you with
information regarding their terms and are not intended to
provide any other factual or disclosure information about
MetLife, Inc., its subsidiaries or the other parties to the
agreements. The agreements contain representations and
warranties by each of the parties to the applicable agreement.
These representations and warranties have been made solely for
the benefit of the other parties to the applicable agreement and:
|
|
|
|
|
should not in all instances be treated as categorical statements
of fact, but rather as a way of allocating the risk to one of
the parties if those statements prove to be inaccurate;
|
|
|
|
have been qualified by disclosures that were made to the other
party in connection with the negotiation of the applicable
agreement, which disclosures are not necessarily reflected in
the agreement;
|
|
|
|
may apply standards of materiality in a way that is different
from what may be viewed as material to investors; and
|
|
|
|
were made only as of the date of the applicable agreement or
such other date or dates as may be specified in the agreement
and are subject to more recent developments.
|
Accordingly, these representations and warranties may not
describe the actual state of affairs as of the date they were
made or at any other time. Additional information about MetLife,
Inc. and its subsidiaries may be found elsewhere in this Annual
Report on
Form 10-K
and MetLife, Inc.s other public filings, which are
available without charge through the SECs website at
www.sec.gov.
2
Part I
As used in this
Form 10-K,
MetLife, the Company, we,
our and us refer to MetLife, Inc., a
Delaware corporation incorporated in 1999 (the Holding
Company), and its subsidiaries, including Metropolitan
Life Insurance Company (MLIC).
We are a leading provider of individual insurance, employee
benefits and financial services with operations throughout the
United States and the regions of Latin America, Europe, and Asia
Pacific. Through our subsidiaries and affiliates, we offer life
insurance, annuities, automobile and homeowners insurance,
retail banking and other financial services to individuals, as
well as group insurance and retirement & savings
products and services to corporations and other institutions.
We are one of the largest insurance and financial services
companies in the United States. Our franchises and brand names
uniquely position us to be the preeminent provider of protection
and savings and investment products in the United States. In
addition, our international operations are focused on markets
where the demand for insurance and savings and investment
products is expected to grow rapidly in the future.
Our well-recognized brand names, leading market positions,
competitive and innovative product offerings and financial
strength and expertise should help drive future growth and
enhance shareholder value, building on a long history of
fairness, honesty and integrity.
Over the course of the next several years, we will pursue the
following specific strategies to achieve our goals:
|
|
|
|
|
Build on widely recognized brand names
|
|
|
|
Capitalize on a large customer base
|
|
|
|
Enhance capital efficiency
|
|
|
|
Expand distribution channels
|
|
|
|
Continue to introduce innovative and competitive products
|
|
|
|
Focus on international operations
|
|
|
|
Maintain balanced focus on asset accumulation and protection
products
|
|
|
|
Manage operating expenses commensurate with revenue growth
|
|
|
|
Further commit to a diverse workplace
|
|
|
|
Capitalize on retirement income needs
|
We are organized into four operating segments: Institutional,
Individual, International and Auto & Home, as well as
Corporate & Other. Revenues derived from any customer,
or from any class of similar products or services, within each
of these segments did not exceed 10% of consolidated revenues in
any of the last three years. Financial information, including
revenues, expenses, income and loss, and total assets by
segment, is provided in Note 22 of the Notes to the
Consolidated Financial Statements.
Overview
2008
Market and Economic Events Impacting Our Business
The U.S. and global financial markets experienced
extraordinary dislocations during 2008, especially in the second
half of the year, producing challenges for our company and the
financial services industry generally. Concerns which had
originally arisen over the value of subprime mortgage loans
backing certain classes of mortgage-backed securities and other
financial products and investment vehicles spread during the
year to the financial services sector as a whole, as investors
questioned the asset quality and capital strength of banks and
other financial institutions that held these investments or were
otherwise exposed to them. Beginning in the summer and
continuing through the end of the year, these concerns in turn
led to a dramatic increase in credit spreads,
3
particularly in the financial sector, and sharp drops in the
market value of a wide range of financial instruments. Concerns
over the creditworthiness of banks and other financial
institutions also led to a severe contraction in lending
activity, both among financial institutions and more generally,
as lenders sought to increase their own liquidity to bolster
their ability to withstand the stresses in the financial markets
and to protect themselves against the loss of credit from other
institutions. Many investors reduced or eliminated their
holdings of asset-backed and corporate securities and purchased
Treasury securities and other securities viewed as offering
greater liquidity and credit quality, while investors in hedge
funds and other collective investment vehicles sought to redeem
their investments, requiring the funds to sell assets to satisfy
redemption requests. During the third quarter and especially the
fourth quarter, trading markets for certain kinds of financial
instruments contracted severely or dried up altogether, further
contributing to price declines, while concerns over the health
of the economy and the possibility of defaults and bankruptcies
also weighed on the value of debt securities. The application of
fair value accounting principles in conditions of a dislocated
market and low levels of liquidity brought into question the
accuracy of fair valuations of certain securities.
As the crisis worsened, a number of significant, well-known
financial institutions failed or required extraordinary
government assistance to keep from failing. Investor concerns
over the financial strength and solvency of financial
institutions and the impact of the credit crisis on the economy
also resulted in sharp declines in equity prices both within the
financial services sector and in the broader stock market,
especially in the last third of the year. The
Standard & Poors 500 Index fell 37% during the
year, with the most dramatic declines occurring in the second
half, and volatility of stock prices reached extraordinarily
high levels. The stock prices of major life insurance companies,
including ours, registered sharp declines, especially in the
fourth quarter, driven by investor concerns over the quality of
their investment assets, exposures to guarantees that protect
the customer against declines in equity markets and their
overall liquidity and financial strength.
Interest rates dropped significantly during the year and the
yield curve grew steeper. The Federal Funds rate fell from 4.25%
at the beginning of 2008 to a range of 0.0% to 0.25% at the end
of 2008, while the yield on ten-year Treasury obligations
decreased from 3.91% at the beginning of the year to 2.25% at
the end of the year.
The financial market stress and concerns over economic weakness
led the United States government and governments around the
world to take unprecedented actions to shore up their economies
and financial markets, including, in the United States, the
reduction of the Federal Funds rate, a series of increasingly
aggressive actions by the Federal Reserve to provide liquidity
and avert failures of major financial institutions, the
enactment of the Emergency Economic Stabilization Act of 2008 in
October and the enactment of the American Recovery and
Reinvestment Act, an economic stimulus bill, in February 2009. A
number of foreign governments also took actions to support their
economies and banking systems, while in Argentina the government
nationalized their private pension system.
The stress in the financial markets and the impact of certain of
these government stimulus measures may result in inflation or
deflation, although at this point the ultimate outcome cannot be
predicted.
During the second half of the year, the value of the dollar
appreciated sharply against the British pound, the Euro, the
Canadian dollar and other foreign currencies relevant to our
operations, including the Mexican peso and the Korean won, while
depreciating substantially against the Japanese yen.
Late in 2008, the National Bureau of Economic Research announced
that the United States economy was in a recession that had
started in December 2007. Globally, economic growth declined
from 5.2% in 2007 to an estimated 3.4% in 2008, and is currently
predicted to fall to 0.5% in 2009. In the United States,
economic growth fell from 2.3% in 2007 to an estimated -0.2% in
2008, and is currently projected to decline to -2.0% in 2009.
Unemployment rose during 2008 from just below 5% at the
beginning of the year to 7.6% at the end of 2008 with
unemployment forecasted to rise to above 8.5% by the end of 2009.
Impact
of 2008 Market and Economic Events on Our Business
The financial market movements and economic events of 2008 had a
significant impact on our results for the year. The impacts of
the credit and equity markets had the most significant impact
with the recession beginning to impact our business fundamentals.
4
Credit Market Impacts. The widening of credit
spreads on corporate debt instruments and concerns over the
quality of assets underlying various mortgage-backed and
asset-backed securities resulted in significant declines in the
market value of many investment assets and a substantial
increase in our gross unrealized losses on investments,
especially in the third and fourth quarters. The conditions of
reduced liquidity that prevailed toward the end of 2008
presented challenges in determining when a decline in the market
price of a security was due to reduced liquidity or an actual
deterioration in creditworthiness of the issuer. As described
below, we recognized impairment charges when we made a
determination that the decline in market value of our
investments was other than temporary. See
Managements Discussion and Analysis of
Financial Condition and Results of Operations
Investments.
Equity Market Impacts. Declines in the equity
markets had a number of significant effects on our results.
First, these declines increased the costs of guaranteed minimum
benefits on certain annuity contracts, which led to increases in
policyholder benefits and claims in our Individual segment and
caused significant losses on embedded derivatives in our
Individual and International segments, which are reflected in
net investment gains and losses as discussed in greater detail
below. We have put in place freestanding derivatives to hedge
our economic exposure to these embedded derivatives. In
addition, equity market declines reduced separate account
values, resulting in a decrease in fee income and an increase in
amortization of deferred policy acquisition costs within our
Individual segment. See Managements
Discussion and Analysis of Financial Condition and Results of
Operations Policyholder Liabilities; Summary of
Critical Accounting Estimates Deferred Policy
Acquisition Costs and Value of Business Acquired; and
Managements Discussion and Analysis of
Financial Condition and Results of Operations
Results of Operations.
Foreign Currency Impacts. The appreciation of
the dollar against other currencies in the second half of 2008,
especially the British pound, the Euro and the Canadian dollar,
had the effect of reducing our liabilities and assets for
obligations denominated in those currencies. The appreciation of
the dollar against the Mexican peso and the Korean won tended to
reduce our equity in and net income from our international
operations when translated back into dollars. In the case of the
Japanese yen, the depreciation of the dollar in the second half
of the year had the effect of increasing our losses on embedded
derivatives associated with certain variable annuities when
translated into dollars. We use derivatives to manage our
exposure to foreign currency exchange rates. See
Managements Discussion and Analysis of
Financial Condition and Results of Operations
Results of Operations Year Ended December 31,
2008 compared with the Year Ended December 31,
2007 The Company Revenues and
Expenses Net Investment Gains and Losses and
Managements Discussion and Analysis of
Financial Condition and Results of Operations
International.
Impact on Net Investment Gains (Losses). We
recognized substantial gains on freestanding derivatives that we
entered into to hedge our exposures to interest rate risk,
foreign currency exchange rate risk and equity price risk. These
derivative gains outweighed the losses on embedded derivatives
related to guaranteed minimum benefits on variable annuities
(which would have been larger if not offset by adjustments due
to the widening of our own credit spread as described below) and
losses on fixed maturity and equity securities (which were
primarily driven by impairments on holdings of financial
institutions) and resulted in significant net investment gains
for the year. See Managements Discussion
and Analysis of Financial Condition and Results of
Operations Results of Operations Year
Ended December 31, 2008 compared with the Year Ended
December 31, 2007 The Company
Revenues and Expenses Net Investment Gains and
Losses.
Impact of Credit Spread Widening and Fair Value
Accounting. The widening of our own credit spread
in the third and fourth quarters had a beneficial effect on our
results, particularly in our Individual and International
segments, by dampening the impact of declines in equity market
prices on the valuation of our embedded derivatives associated
with guarantees on variable annuities. The substantial decreases
in equity prices during the year increased the liability for
guaranteed minimum benefits on variable annuities, which is
reflected as a loss on embedded derivatives in net investment
gains and losses. Because we carry that liability at fair value
under SFAS No. 157, Fair Value Measurements,
(SFAS 157), which we adopted effective
January 1, 2008, we take our own credit spread into account
in determining the fair value. The widening of our own credit
spread during 2008 substantially reduced the amount of the loss
on embedded derivatives. A narrowing of our own credit spread in
the future could result in net investment losses as the
derivative gain is reduced. See
Managements Discussion and Analysis of
Financial Condition and Results of Operations
Results of Operations Year Ended December 31,
5
2008 compared with the Year Ended December 31,
2007 The Company Revenues and
Expenses Net Investment Gains and Losses.
Pension and Postretirement Benefit Plan Obligation
Impacts. The dramatic deterioration in the credit
and equity markets produced significant declines in the market
value of the assets supporting our pension and postretirement
benefit plan obligations, resulting in changes in the funded
status of such plans which will affect our results of operations
in 2009. See Managements Discussion and
Analysis of Financial Condition and Results of
Operations Pensions and Other Postretirement Benefit
Plans.
Goodwill Impacts. In addition to our annual
goodwill impairment tests performed during the third quarter of
2008 based upon data as of June 30, 2008, we performed an
interim goodwill impairment test as of December 31, 2008,
in light of current economic conditions, the sustained low level
of equity markets, declining market capitalizations in the
insurance industry and lower operating earnings projections,
particularly for the Individual segment. Based upon the tests
performed, management concluded no impairment of goodwill had
occurred for any of the Companys reporting units at
December 31, 2008. See Managements
Discussion and Analysis of Financial Condition and Results of
Operations Goodwill.
Impact on Net Investment Income. Investment
yields declined in many asset classes, principally other limited
partnerships (including hedge funds), real estate joint
ventures, cash and short-term investments, and mortgage loans,
causing net investment income to decrease from 2007 levels. Our
results on securities lending were higher than in the prior
year. See Managements Discussion and
Analysis of Financial Condition and Results of
Operations Results of Operations Year
Ended December 31, 2008 compared with the Year Ended
December 31, 2007 The Company
Revenues and Expenses Net Investment Income.
Business Fundamentals and Other
Events. Although financial market factors had the
largest impact on our performance in 2008, some factors not
related to financial market developments also affected our
results. Top-line growth was strong, with particularly large
increases in premiums, fees and other revenues in our
Institutional segment and our International segment. Net
interest margins decreased in our Individual segment and in the
retirement & savings business in our Institutional
segment but increased in the group life business of
Institutional. Less favorable underwriting results than in 2007
affected our Institutional and Individual segments, while the
Auto & Home segment was impacted by increased
catastrophe losses compared to 2007. The effects of pension
reform in Argentina in 2007 and the nationalization of the
Argentine pension business in 2008 affected our International
results. In Corporate & Other, results were affected
by increases in revenues and expenses resulting from the growth
of MetLife Bank, National Association (MetLife Bank
or MetLife Bank, N.A.) and increased expenses
associated with implementation of an enterprise-wide cost
reduction and revenue enhancement initiative, higher corporate
support expenses and increased interest expense. During 2008, we
also completed the split-off of our majority ownership stake in
Reinsurance Group of America, Incorporated. See
Managements Discussion and Analysis of
Financial Condition and Results of Operations
Results of Operations Year Ended December 31,
2008 compared with the Year Ended December 31,
2007 The Company.
Securities Lending Program. As institutional
investors sought greater liquidity during the third and fourth
quarter of 2008 in response to the turbulent credit markets and
financial institution crisis, we systematically reduced the size
of our securities lending program in-line with demand. The drop
in the securities lending volume was more than offset, however,
by an increase in the rates charged for securities lending
transactions. See Managements Discussion
and Analysis of Financial Condition and Results of
Operations Liquidity and Capital Resources.
Liquidity Position. We purposefully enhanced
own liquidity position in the second half of the year by holding
historically high levels of cash, cash equivalents and
short-term investments, which further pressured net investment
income with the substantial decline in short-term interest rates
over the year. To manage liquidity across our businesses we
utilized intersegment transfers of assets rather than selling
assets into the marketplace and we have participated, to a
limited extent, in certain of the government programs. We are
managing our increased levels of liquidity and their impact on
the matching of our assets and liabilities through our well
established asset/liability management processes. For a
comprehensive description of the impact of 2008 events on our
liquidity see Managements Discussion and
Analysis of Financial Condition and Results of
Operations Liquidity and Capital
Resources Extraordinary Market Conditions.
6
Capital Transactions. In the midst of these
extraordinary market conditions, we were able to raise capital
through offerings of common stock and senior debt. In October
2008, we issued 86,250,000 shares of common stock at a
price of $26.50 per share for gross proceeds of
$2.3 billion in order to strengthen our capital position
and increase our cushion against potential realized and
unrealized losses. In August 2008 and February 2009, we
successfully remarketed a total of $2,070 million of
ten-year senior debt, with coupon rates of 6.817% for notes
maturing in August 2018 and 7.717% for notes maturing in
February 2019. The proceeds of both remarketings were used to
satisfy holders obligations to purchase common stock of
the Company under the stock purchase contracts forming part of
our common equity units issued in 2005. See
Managements Discussion and Analysis of
Financial Condition and Results of Operations
Liquidity and Capital Resources.
Ratings. Rating agencies continue to monitor
insurance companies, including ours, as described in
Company Ratings.
Continuing
Effects of Market and Economic Conditions on Our
Business
During 2009, management expects that the United States and
international economies will continue to feel the impact of the
extraordinary economic and financial market movements and events
of 2008, with a continuation of financial market volatility, as
the effects of recession on our business become more pronounced.
More specifically, management anticipates the following impacts
on MetLifes businesses in 2009:
|
|
|
|
|
a modest increase (on a constant exchange rate basis) in
premiums, fees and other revenues in 2009, with mixed results
across MetLifes segments, including (i) lower fee
income from separate accounts businesses, including variable
annuity and life products in the Individual segment; (ii) a
possible decline in payroll-linked revenue from the
Institutional segments group insurance customers;
(iii) a reduction in the demand for certain retirement and
savings products from the International and Institutional
segments; and (iv) as a result of the impact of the
recession on the housing market and the auto industry, a
decrease in premiums from the Auto and Home segment;
|
|
|
|
continued downward pressure on net income across the enterprise,
specifically net investment income, resulting from lower returns
from other limited partnerships, real estate joint ventures and
securities lending and ongoing uncertainty over the direction of
interest rates, together with difficulty predicting the impact
of the financial markets on net investment gains (losses) and
unrealized investment gains (losses), as well as the effects of
MetLifes own credit, as it varies greatly and the exposure
is not hedged;
|
|
|
|
the potential need to establish additional insurance-related
liabilities, both those associated with guarantees (which are
offset to some extent through hedging) and those not; and
|
|
|
|
the possible increase in certain expenses, including those
associated with (i) the Companys Operational
Excellence initiative; (ii) impairments to goodwill,
specifically in the Individual segment; (iii) the
Companys pension-related expense and (iv) DAC
amortization.
|
In response to the challenges presented by the unusual economic
environment, management continues to focus on disciplined
underwriting, pricing and hedging strategies, as well as focused
expense management.
The ongoing financial turbulence and the governmental responses
have affected the competitive environment and may lead to
consolidation within the life insurance industry as well as
further consolidation in the broader financial services
industry. The precise impacts of such events on our business are
difficult to predict.
A more detailed discussion of managements view of the
outlook for 2009 for each of the Companys operating
segments and for Corporate & Other appears in
Managements Discussion and Analysis of
Financial Condition and Results of Operations
Results of Operations Outlook.
Institutional
Our Institutional segment offers a broad range of group
insurance and retirement & savings products and
services to corporations and other institutions and their
respective employees. We have built a leading position in the
U.S. group insurance market through long-standing
relationships with many of the largest corporate employers in
the United States.
7
Group insurance products and services include group life
insurance, non-medical health insurance products and related
administrative services, as well as other benefits and services,
such as employer-sponsored auto and homeowners insurance
provided through the Auto & Home segment and prepaid
legal services plans. Non-medical health insurance is comprised
of products such as accidental death and dismemberment
(AD&D), long-term care (LTC),
short- and long-term disability, individual disability income,
dental insurance, and prepaid legal services. We offer group
insurance products as employer-paid benefits or as voluntary
benefits where all or a portion of the premiums are paid by the
employee. Revenues applicable to these group insurance products
and services were $16 billion and $14 billion, in 2008
and 2007, respectively, representing 31% and 30% of our total
revenues in 2008 and 2007, respectively.
Our retirement & savings products and services include
an array of annuity and investment products, including,
guaranteed interest products and other stable value products,
accumulation and income annuities, and separate account
contracts for the investment management of defined benefit and
defined contribution plan assets. Revenues applicable to our
retirement & savings products were $8 billion in
both 2008 and 2007 representing 16% and 17% of our total
revenues in 2008 and 2007, respectively.
Marketing
and Distribution
Our Institutional segment markets our products and services
through sales forces, comprised of MetLife employees, for both
our group insurance and retirement & savings lines.
We distribute our group insurance products and services through
a sales force that is segmented by the size of the target
customer. Marketing representatives sell either directly to
Corporate & Other institutional customers or through
an intermediary, such as a broker or consultant. Voluntary
products are sold through the same sales channels, as well as by
specialists for these products. Employers have been emphasizing
such voluntary products and, as a result, we have increased our
focus on communicating and marketing to such employees in order
to further foster sales of those products. As of
December 31, 2008, the group insurance sales channels had
357 marketing representatives, which represented a decrease of
10% from 398 marketing representatives as of the end of the
prior year.
Our retirement & savings organization markets
retirement, savings, investment and payout annuity products and
services to sponsors and advisors of benefit plans of all sizes.
These products and services are offered to private and public
pension plans, collective bargaining units, nonprofit
organizations, recipients of structured settlements and the
current and retired members of these and other institutions.
We distribute retirement & savings products and
services through dedicated sales teams and relationship managers
located in 9 offices around the country. In addition, the
retirement & savings organization works with the
distribution channels in the Individual segment and in the group
insurance area to better reach and service customers, brokers,
consultants and other intermediaries.
We have entered into several joint ventures and other
arrangements with third parties to expand the marketing and
distribution opportunities of institutional products and
services. We also seek to sell our institutional products and
services through sponsoring organizations and affinity groups.
For example, we are the provider of LTC products for the
National Long-Term Care Coalition, a group of some of the
nations largest employers. In addition, the Company,
together with John Hancock Financial Services, Inc., a
wholly-owned subsidiary of Manulife Financial Corporation, is a
provider for the Federal Long-Term Care Insurance program. The
program, available to most federal employees and their families,
is the largest employer-sponsored LTC insurance program in the
country based on the number of enrollees. In addition, we also
provide life and dental coverage to federal employees.
Group
Insurance Products and Services
Our group insurance products and services include:
Group Life. Group life insurance products and
services include group term life (both employer-paid basic life
and employee-paid supplemental life), group universal life,
group variable universal life, dependent life and survivor
income benefits. These products and services are offered as
standard products or may be
8
tailored to meet specific customer needs. This category also
includes specialized life insurance products designed
specifically to provide solutions for non-qualified benefit and
retiree benefit funding purposes.
Non-Medical Health. Non-medical health
insurance consists of short- and long-term disability,
individual disability income, critical illness, LTC, dental and
AD&D coverages. As a result of an acquisition in 2008, we
now offer a dental managed care product in select markets. We
also sell administrative services-only arrangements to some
employers.
Other Products and Services. Other products
and services include employer-sponsored auto and homeowners
insurance provided through the Auto & Home segment and
prepaid legal plans.
Retirement &
Savings Products and Services
Our retirement & savings products and services include:
Guaranteed Interest and Stable Value
Products. We offer guaranteed interest contracts
(GICs), including separate account GICs, funding
agreements and similar products.
Accumulation and Income Annuities. We also
sell fixed and variable annuity products, generally in
connection with the termination of pension plans, both
domestically and in the United Kingdom, or the funding of
structured settlements. Annuity products include single premium
buyouts, terminal funding contracts and structured settlement
annuities.
Other Retirement & Savings Products and
Services. Other retirement & savings
products and services include separate account contracts for the
investment management of defined benefit and defined
contribution plan assets on behalf of corporations and other
institutions.
Individual
Our Individual segment offers a wide variety of protection and
asset accumulation products aimed at serving the financial needs
of our customers throughout their entire life cycle. Products
offered by Individual include insurance products, such as
traditional, variable and universal life insurance, and variable
and fixed annuities. In addition, Individual sales
representatives distribute disability insurance and long-term
care (LTC) insurance products offered by our Institutional
segment, investment products such as mutual funds and wealth
advisory services, as well as other products offered by our
other businesses.
Our broadly recognized brand names and strong distribution
channels have allowed us to become the second largest provider
of individual life insurance and annuities in the United States,
with $17 billion of total statutory individual life and
annuity premiums and deposits through September 30, 2008,
the latest period for which OneSource, a database that
aggregates United States insurance company statutory financial
statements, is available. According to research performed by the
Life Insurance Marketing and Research Association
(LIMRA), based on sales through September 30,
2008, we are the sixth largest issuer of individual variable
life insurance in the United States and the fifth largest issuer
of all individual life insurance products in the United States.
In addition, according to research done by LIMRA and based on
new annuity deposits through September 30, 2008, we are the
third largest annuity writer in the United States.
During the period from 2004 to 2008, our first year statutory
deposits for life products increased at a compound annual growth
rate of approximately 1%. Life deposits represented
approximately 28% and 32% of total statutory premiums and
deposits for Individual in 2008 and 2007, respectively. During
the period from 2004 to 2008, the statutory deposits for annuity
products increased at a compound annual growth rate of
approximately 14%. Annuity deposits represented approximately
72% and 68% of total statutory premiums and deposits for
Individual in 2008 and 2007, respectively. Individual had
$15.6 billion and $15.4 billion of total revenues, or
31% and 33% of our total revenues, in 2008 and 2007,
respectively. These premiums, deposits and revenues can and will
fluctuate with market volatility as noted and discussed in the
Risk Factors section of this document.
In 2008 we realigned resources, which did not change our product
reporting groups, into the Life and Protection Solutions
Group, the Retirement and Wealth Strategies
Group, the Individual Distribution group, and
the Strategic Architecture & Business
Performance group. In this new organizational structure,
we will focus
9
even more on the key factors that will ensure continued
success growing markets, profitable products,
diverse distribution and efficient management of our resources.
Marketing
and Distribution
Our Individual segment targets the large middle-income market,
as well as affluent individuals, owners of small businesses and
executives of small- to medium-sized companies. We have also
been successful in selling our products in various
multi-cultural markets.
Life and Protection Solutions products are sold through
MetLifes Individual Distribution organization and also
through various third party organizations utilizing two models.
In the coverage model, wholesalers sell to high net worth
individuals and small- to medium-sized businesses through
independent general agencies, financial advisors, consultants,
brokerage general agencies and other independent marketing
organizations under contractual arrangements. In the point of
sale model, wholesalers sell through financial intermediaries,
including regional broker dealers, brokerage firms, financial
planners and banks.
Retirement and Wealth Strategies products are sold through
MetLifes Individual Distribution organization and also
through various third party organizations such as regional
broker dealers, New York Stock Exchange (NYSE)
brokerage firms, financial planners and banks.
Individual Distribution. The Individual
Distribution organization is comprised of three channels: the
MetLife Distribution Channel, a career agency system, the New
England Financial Distribution Channel, a general agency system,
and MetLife Resources, a career agency system.
MetLife Distribution Channel. The MetLife
Distribution Channel had 6,362 MetLife agents under contract in
98 agencies at December 31, 2008 as compared to 6,243
agents under contract in 98 agencies at December 31, 2007.
The career agency sales force focuses on the large middle-income
and affluent markets, including multi-cultural markets. We
support our efforts in multi-cultural markets through targeted
advertising, specially trained agents and sales literature
written in various languages.
New England Financial Distribution Channel. At
December 31, 2008, the New England Financial Distribution
Channel included 43 general agencies providing support to 2,278
general agents and a network of independent brokers throughout
the United States. The New England Financial Distribution
Channel targets high net worth individuals, owners of small
businesses and executives of small- to medium-sized companies.
MetLife Resources. MetLife Resources, a
focused distribution channel of MetLife, markets retirement,
annuity and other financial products on a national basis through
660 MetLife agents and independent brokers at December 31,
2008. MetLife Resources targets the nonprofit, educational and
healthcare markets.
Discontinued Distribution Channel. MetLife,
Inc. has entered into an agreement to sell Texas Life Insurance
Company (Texas Life in early 2009. At
December 31, 2008, the results of Texas Life are reported
as discontinued operations. Texas Lifes premiums and
deposits were less than 2% of total premiums and deposits for
2008 and 2007.
Products
We offer a wide variety of individual insurance, as well as
annuities and investment-type products, aimed at serving our
customers financial needs throughout their entire life
cycle.
Life and
Protection Solution Products
Our individual insurance products include variable life
products, universal life products, traditional life products,
including whole life and term life, and other individual
products, including individual disability and LTC insurance.
We continually review and update our products. We have
introduced new products and features designed to increase the
competitiveness of our portfolio and the flexibility of our
products to meet the broad range of asset accumulation,
life-cycle protection and distribution needs of our customers.
10
Variable Life. Variable life products provide
insurance coverage through a contract that gives the
policyholder flexibility in investment choices and, depending on
the product, in premium payments and coverage amounts, with
certain guarantees. Most importantly, with variable life
products, premiums and account balances can be directed by the
policyholder into a variety of separate accounts or directed to
the Companys general account. In the separate accounts,
the policyholder bears the entire risk of the investment
results. We collect specified fees for the management of these
various investment accounts and any net return is credited
directly to the policyholders account. In some instances,
third-party money management firms manage investment accounts
that support variable insurance products. With some products, by
maintaining a certain premium level, policyholders may have the
advantage of various guarantees that may protect the death
benefit from adverse investment experience.
Universal Life. Universal life products
provide insurance coverage on the same basis as variable life,
except that premiums, and the resulting accumulated balances,
are allocated only to the Companys general account.
Universal life products may allow the insured to increase or
decrease the amount of death benefit coverage over the term of
the contract and the owner to adjust the frequency and amount of
premium payments. We credit premiums to an account maintained
for the policyholder. Premiums are credited net of specified
expenses and interest, at interest rates we determine, subject
to specified minimums. Specific charges are made against the
policyholders account for the cost of insurance protection
and for expenses. With some products, by maintaining a certain
premium level, policyholders may have the advantage of various
guarantees that may protect the death benefit from adverse
investment experience.
Whole Life. Whole life products provide a
guaranteed benefit upon the death of the insured in return for
the periodic payment of a fixed premium over a predetermined
period. Premium payments may be required for the entire life of
the contract period, to a specified age or period, and may be
level or change in accordance with a predetermined schedule.
Whole life insurance includes policies that provide a
participation feature in the form of dividends. Policyholders
may receive dividends in cash or apply them to increase death
benefits, increase cash values available upon surrender or
reduce the premiums required to maintain the contract in-force.
Because the use of dividends is specified by the policyholder,
this group of products provides significant flexibility to
individuals to tailor the product to suit their specific needs
and circumstances, while at the same time providing guaranteed
benefits.
Term Life. Term life provides a guaranteed
benefit upon the death of the insured for a specified time
period in return for the periodic payment of premiums. Specified
coverage periods range from one year to 30 years, but in no
event are they longer than the period over which premiums are
paid. Death benefits may be level over the period or decreasing.
Decreasing coverage is used principally to provide for loan
repayment in the event of death. Premiums may be guaranteed at a
level amount for the coverage period or may be non-level and
non-guaranteed. Term insurance products are sometimes referred
to as pure protection products, in that there are typically no
savings or investment elements. Term contracts expire without
value at the end of the coverage period when the insured party
is still living.
Other Individual Products. Individual
disability products provide a benefit in the event of the
disability of the insured. In most instances, this benefit is in
the form of monthly income paid until the insured reaches
age 65. In addition to income replacement, the product may
be used to provide for the payment of business overhead expenses
for disabled business owners or mortgage payment protection.
Our LTC insurance provides a fixed benefit for certain costs
associated with nursing home care and other services that may be
provided to individuals unable to perform certain activities of
daily living.
In addition to these products, our Individual segment supports a
group of low face amount life insurance policies, known as
industrial policies that its agents sold until 1964.
Retirement
and Wealth Strategies Products
We offer a variety of individual annuities and investment
products, including variable and fixed annuities, and mutual
funds and securities.
11
Variable Annuities. We offer variable
annuities for both asset accumulation and asset distribution
needs. Variable annuities allow the contractholder to make
deposits into various investment accounts, as determined by the
contractholder. The investment accounts are separate accounts
and risks associated with such investments are borne entirely by
the contractholder. In certain variable annuity products,
contractholders may also choose to allocate all or a portion of
their account to the Companys general account and are
credited with interest at rates we determine, subject to certain
minimums. In addition, contractholders may also elect certain
minimum death benefit and minimum living benefit guarantees for
which additional fees are charged.
Fixed Annuities. Fixed annuities are used for
both asset accumulation and asset distribution needs. Fixed
annuities do not allow the same investment flexibility provided
by variable annuities, but provide guarantees related to the
preservation of principal and interest credited. Deposits made
into deferred annuity contracts are allocated to the
Companys general account and are credited with interest at
rates we determine, subject to certain minimums. Credited
interest rates are guaranteed not to change for certain limited
periods of time, ranging from one to ten years. Fixed income
annuities provide a guaranteed monthly income for a specified
period of years
and/or for
the life of the annuitant.
Mutual Funds and Securities. Through our
broker-dealer affiliates, we offer a full range of mutual funds
and other securities products.
International
International provides life insurance, accident and health
insurance, credit insurance, annuities, endowment and
retirement & savings products to both individuals and
groups. We focus on emerging markets primarily within the Latin
America, Europe and Asia Pacific regions. We operate in
international markets through subsidiaries and joint ventures.
See Risk Factors Fluctuations in Foreign
Currency Exchange Rates and Foreign Securities Markets Could
Negatively Affect Our Profitability, and Risk
Factors Our International Operations Face Political,
Legal, Operational and Other Risks that Could Negatively Affect
Those Operations or Our Profitability, and
Quantitative and Qualitative Disclosures About Market
Risk.
Latin
America
We operate in the Latin America region in the following
countries: Mexico, Chile, Argentina, Brazil and Uruguay. The
operations in Mexico and Chile represented 82% of the total
premiums and fees in this region for the year ended
December 31, 2008. The Mexican operation is the largest
life insurance company in both the individual and group
businesses in Mexico. The Chilean operation is the largest
annuity company in Chile, based on market share. The Chilean
operation also offers individual life insurance and group
insurance products. In 2008, our Argentine pension business,
which was the second largest in the market ceased to exist as a
result of the nationalization of the private pension system by
the Argentine government. We also actively market individual
life insurance, group insurance products and credit life
coverage in Argentina, but the nationalization of the pension
system substantially reduces our presence in Argentina. The
business environment in Argentina has been, and may continue to
be, affected by governmental and legal actions which impact our
results of operations.
Europe
We operate in Europe in the following countries: the United
Kingdom, Belgium, Poland and Ireland. The results of our
operation in India are also included in this region. The
operation in the United Kingdom represented 54% of the total
premiums and fees in this region for the year ended
December 31, 2008. The United Kingdom operation underwrites
risk in its home market and fourteen other countries across
Europe offering credit insurance coverage.
Asia
Pacific
We operate in the Asia Pacific region in the following
countries: South Korea, Taiwan, Australia, Japan, Hong Kong and
China. The activities in the region are primarily focused on
individual business. The operations in South Korea and Taiwan
represented 70% of the total premiums and fees in this region
for the year ended December 31, 2008. The South Korean
operation has significant sales of variable universal life and
annuity products. The
12
Taiwanese operation has significant sales of annuity and
endowment products. In 2007, we completed the sale of our
Australia annuities and pension businesses to a third party. The
Japanese joint venture operation offers fixed and guaranteed
variable annuities and variable life products. We have a quota
share reinsurance agreement with the joint venture in Japan,
whereby we assume 100% of the living and death benefit guarantee
riders associated with the variable annuity business written
after April 2005 by the joint venture. The operating results of
the joint venture operations in Japan and China are reflected in
net investment income and are not consolidated in the financial
results. Also, in 2007 we acquired the remaining 50% interest in
a joint venture in Hong Kong resulting in the joint venture
becoming a consolidated subsidiary.
Auto &
Home
Auto & Home, operating through Metropolitan Property
and Casualty Insurance Company and its subsidiaries
(MPC), offers personal lines property and casualty
insurance directly to employees at their employers
worksite, as well as to individuals through a variety of retail
distribution channels, including independent agents, property
and casualty specialists, direct response marketing and the
agency distribution group. Auto & Home primarily sells
auto insurance, which represented 69% of Auto &
Homes total net earned premiums in 2008, and homeowners
and other insurance, which represented 31% of Auto &
Homes total net earned premiums in 2008.
Products
Auto & Homes insurance products include auto,
homeowners, renters, condominium and dwelling, and other
personal lines.
Auto Coverages. Auto insurance policies
include coverages for private passenger automobiles, utility
automobiles and vans, motorcycles, motor homes, antique or
classic automobiles and trailers. Auto & Home offers
traditional coverages such as liability, uninsured motorist, no
fault or personal injury protection and collision and
comprehensive.
Homeowners and Other Coverages. Homeowners
insurance provides protection for homeowners, renters,
condominium owners and residential landlords against losses
arising out of damage to dwellings and contents from a wide
variety of perils, as well as coverage for liability arising
from ownership or occupancy. Other insurance includes personal
excess liability (protection against losses in excess of amounts
covered by other liability insurance policies), and coverages
for recreational vehicles and boat owners.
Traditional insurance policies for dwellings represent the
majority of Auto & Homes homeowners
policies providing protection for loss on a replacement
cost basis. These policies provide additional coverage for
reasonable, normal living expenses incurred by policyholders
that have been displaced from their homes.
Marketing
and Distribution
Personal lines auto and homeowners insurance products are
directly marketed to employees at their employers
worksite. Auto & Home products are also marketed and
sold to individuals by independent agents, property and casualty
specialists, through a direct response channel and through the
agency distribution group. Current economic conditions have
impacted the ability to sell new policies. Declines in a variety
of economic factors, most notably falling new and existing home
sales as well as declines in auto sales, have reduced the number
of potential shopping points strongly associated with new policy
sales. Sales to employees at their employers worksite was
the only distribution sector to record increased sales during
2008 over those achieved in 2007.
Employer
Worksite Programs
Auto & Home is a leading provider of auto and
homeowners products offered to employees at their
employers worksite. Net earned premiums increased by
$27 million, or 2.6%, to $1.0 billion for the year
ended December 31, 2008 as compared to the prior year. At
December 31, 2008, 2,136 employers offered MetLife
Auto & Home products to their employees.
Institutional marketing representatives market the
Auto & Home program to employers through a variety of
means, including broker referrals and cross-selling to MetLife
group customers. Once permitted by the employer,
13
MetLife commences marketing efforts to employees. Employees who
are interested in the auto and homeowners products can call a
toll-free number to request a quote, to purchase coverage and to
request payroll deduction over the telephone. Auto &
Home has also developed proprietary software that permits an
employee in most states to obtain a quote for auto insurance
through Auto & Homes Internet website.
Retail
Distribution Channels
We market and sell Auto & Home products through
independent agents, property and casualty specialists, a direct
response channel and the agency distribution group. In recent
years, we have increased the number of independent agents
appointed to sell these products.
Agency Distribution Group Career Agency
System. The agency distribution group career
agency system had 1,610 agents at December 31, 2008, that
sold Auto & Home insurance products, representing a 6%
decrease from 1,720 agents in the prior year.
Independent Agencies. At December 31,
2008, Auto & Home maintained contracts with more than
4,580 agencies and brokers, representing a 2% increase of 80
agencies.
Property and Casualty Specialists. At
December 31, 2008, Auto & Home had 500
specialists located in 35 states as compared to 550
specialists located in 37 states in the prior year.
Auto & Homes strategy is to utilize property and
casualty specialists, who are Auto & Home employees,
in geographic markets that are underserved by MetLife career
agents.
Other Distribution Channels. Auto &
Home also utilizes a direct response marketing channel which
permits sales to be generated through sources such as target
mailings, career agent referrals and the Internet.
In 2008, Auto & Homes business was concentrated
in the following states, as measured by net earned premiums: New
York $383 million, or 13%; Massachusetts $304 million,
or 10%; Illinois $205 million, or 7%; Florida
$188 million, or 6%; Connecticut $144 million, or 5%;
and Texas $119 million, or 4%.
Claims
At December 31, 2008, Auto & Homes claims
department included 2,400 employees located in
Auto & Homes Warwick, Rhode Island home office,
nine field claim offices, five in-house counsel offices,
drive-in inspection sites and other sites throughout the United
States. These employees included claim adjusters, appraisers,
attorneys, managers, medical specialists, investigators,
customer service representatives, claim financial analysts and
support staff. Claim adjusters, representing the majority of
employees, investigate, evaluate and settle over 700,000 claims
annually.
Corporate &
Other
Corporate & Other contains the excess capital not
allocated to the business segments, which is invested to
optimize investment spread and to fund company initiatives,
various
start-up
entities, MetLife Bank which includes the 2008 acquisitions of a
residential mortgage originating and servicing business and a
reverse mortgage company, and run-off entities.
Corporate & Other also includes interest expense
related to the majority of our outstanding debt and expenses
associated with certain legal proceedings. The elimination of
all intersegment transactions from activity between segments
occurs within Corporate & Other. In addition,
Corporate & Other contains the restructuring costs of
Operational Excellence, a corporate initiative further described
below.
Operational
Excellence Initiative
As a result of a strategic review which began in 2007, the
Company has initiated an enterprise-wide cost reduction and
revenue enhancement initiative referred to as Operational
Excellence. This initiative is focused on reducing
complexity, leveraging scale, increasing productivity, improving
the effectiveness of the Companys operations as well as
providing a foundation for future growth.
Restructuring costs for Operational Excellence will encompass
costs related to workforce reductions, lease consolidation, and
asset impairments. Operational Excellence restructuring costs
will occur in phases. In 2008, the
14
restructuring charge, primarily related to severance costs
associated with workforce reductions, was $101 million.
Additional restructuring charges including costs associated with
severance and lease and asset impairments are expected to be
incurred in 2009 and 2010. However, the 2009 and 2010 plans are
not sufficiently developed to enable the Company to make an
estimate of such restructuring charges at December 31,
2008. In addition to the restructuring costs, there have been
and will continue to be external consulting costs incurred
throughout the execution of the initiative. The consultants
support our project teams in terms of strategic direction and
implementation. Costs incurred in connection with Operational
Excellence are reflected in Corporate & Other as it is
an enterprise-wide corporate initiative.
The scope and timing of this enterprise-wide initiative could be
impacted by continued adverse economic conditions, capital
market volatility and changes in strategic priorities.
Policyholder
Liabilities
We establish, and carry as liabilities, actuarially determined
amounts that are calculated to meet our policy obligations when
a policy matures or is surrendered, an insured dies or becomes
disabled or upon the occurrence of other covered events, or to
provide for future annuity payments. We compute the amounts for
actuarial liabilities reported in our consolidated financial
statements in conformity with accounting principles generally
accepted in the United States of America (GAAP). For
more details on Policyholder Liabilities see
Managements Discussion and Analysis of
Financial Condition and Results of Operations
Critical Accounting Estimates Liability for Future
Policy Benefits and Managements Discussion and
Analysis of financial Condition and Results of
Operations Insurance Liabilities.
Pursuant to state insurance laws, the Holding Companys
insurance subsidiaries establish statutory reserves, reported as
liabilities, to meet their obligations on their respective
policies. These statutory reserves are established in amounts
sufficient to meet policy and contract obligations, when taken
together with expected future premiums and interest at assumed
rates. Statutory reserves generally differ from actuarial
liabilities for future policy benefits determined using GAAP.
The New York Insurance Law and regulations require certain
MetLife entities to submit to the New York Superintendent of
Insurance (the Superintendent) or other state
insurance departments, with each annual report, an opinion and
memorandum of a qualified actuary that the statutory
reserves and related actuarial amounts recorded in support of
specified policies and contracts, and the assets supporting such
statutory reserves and related actuarial amounts, make adequate
provision for their statutory liabilities with respect to these
obligations. See Regulation
Insurance Regulation Policy and Contract Reserve
Sufficiency Analysis.
Underwriting
and Pricing
Institutional,
Individual and International Insurance Products
Our underwriting for the Institutional, Individual and
International segments generally involves an evaluation of
applications for life, non-medical health,
retirement & savings, products and services by a
professional staff of underwriters and actuaries, who determine
the type and the amount of risk that we are willing to accept.
In addition to the products described above, the International
segment, also offers credit insurance and in a limited number of
countries major medical products to both individual and
institutional customers. We employ detailed underwriting
policies, guidelines and procedures designed to assist the
underwriter to properly assess and quantify risks before issuing
policies to qualified applicants or groups.
Individual underwriting considers not only an applicants
medical history, but also other factors such as financial
profile, foreign travel, vocations and alcohol, drug and tobacco
use. Group underwriting generally evaluates the risk
characteristics of each prospective insured group, although with
certain voluntary products, employees may be underwritten on an
individual basis. We generally perform our own underwriting;
however, certain policies are reviewed by intermediaries under
guidelines established by us. Generally, we are not obligated to
accept any risk or group of risks from, or to issue a policy or
group of policies to, any employer or intermediary. Requests for
coverage are reviewed on their merits and generally a policy is
not issued unless the particular risk or group has been examined
and approved by our underwriters.
15
Our remote underwriting offices, intermediaries as well as our
corporate underwriting office are periodically reviewed via
continuous ongoing internal underwriting audits to maintain
high-standards of underwriting and consistency across the
company. Such offices are also subject to periodic external
audits by reinsurers with whom we do business.
We have established senior level oversight of the underwriting
process that facilitates quality sales and serves the needs of
our customers, while supporting our financial strength and
business objectives. Our goal is to achieve the underwriting,
mortality and morbidity levels reflected in the assumptions in
our product pricing. This is accomplished by determining and
establishing underwriting policies, guidelines, philosophies and
strategies that are competitive and suitable for the customer,
the agent and us.
Individual,
Institutional and International Pricing
Pricing for the Institutional, Individual and International
segments has traditionally reflected our corporate underwriting
standards. Product pricing of insurance products is based on the
expected payout of benefits calculated through the use of
assumptions for mortality, morbidity, expenses, persistency and
investment returns, as well as certain macroeconomic factors,
such as inflation. Investment-oriented products are priced based
on various factors, which may include investment return,
expenses, persistency and optionality. For certain investment
oriented products in the Institutional segment and for
institutional business sold within the International segment,
pricing may include prospective and retrospective experience
rating features. Prospective experience rating involves the
evaluation of past experience for the purpose of determining
future premium rates and all prior year gains and losses are
borne by the Company. Retrospective experience rating also
involves the evaluation of past experience for the purpose of
determining the actual cost of providing insurance for the
customer, however, the contract includes certain features that
allow the Company to recoup certain losses or distribute certain
gains back to the policyholder based on actual prior years
experience.
We continually review our underwriting and pricing guidelines so
that our policies remain competitive and supportive of our
marketing strategies and profitability goals. The current
economic environment, with its volatility and uncertainty in
interest rates, equity markets, asset valuations and
unemployment trends has impacted or will most likely impact the
pricing of our products.
|
|
|
|
|
For the Institutional segment and for the institutional business
sold within the International segment, rates for group life and
group non-medical and health products are based on anticipated
results for the book of business being underwritten. Renewals
are generally re-evaluated annually or biannually and are
re-priced to reflect actual experience on such products.
Retirement & savings type products are priced
frequently and are very responsive to bond yields, and such
prices include additional margin in periods of market
uncertainty. This business is predominantly illiquid, because
policyholders have no contractual rights to cash values and no
options to change the form of the products benefits.
|
|
|
|
For the Individual segment and for individual business sold
within the International segment, pricing of life insurance
products is highly regulated and must be approved by the
individual state regulators where the product is sold. Generally
such products are renewed annually and may include pricing terms
that are guaranteed for a certain period of time. Fixed and
variable annuity products are also highly regulated and approved
by the individual state regulators. Such products generally
include penalties for early withdrawals and policyholder benefit
elections to tailor the form of the products benefits to
the needs of the opting policyholder. The Company periodically
reevaluates the costs associated with such options and will
periodically adjust pricing levels on its guarantees. Further,
the Company from time to time may also reevaluate the type and
level of guarantee features currently being offered.
|
Auto &
Home
Auto & Homes underwriting function has six
principal aspects:
|
|
|
|
|
evaluating potential worksite marketing employer accounts and
independent agencies;
|
|
|
|
establishing guidelines for the binding of risks;
|
16
|
|
|
|
|
reviewing coverage bound by agents;
|
|
|
|
underwriting potential insureds, on a case by case basis,
presented by agents outside the scope of their binding authority;
|
|
|
|
pursuing information necessary in certain cases to enable
Auto & Home to issue a policy within our
guidelines; and
|
|
|
|
ensuring that renewal policies continue to be written at rates
commensurate with risk.
|
Subject to very few exceptions, agents in each of
Auto & Homes distribution channels, as well as
in our Institutional segment, have binding authority for risks
which fall within Auto & Homes published
underwriting guidelines. Risks falling outside the underwriting
guidelines may be submitted for approval to the underwriting
department; alternatively, agents in such a situation may call
the underwriting department to obtain authorization to bind the
risk themselves. In most states, Auto & Home generally
has the right within a specified period (usually the first
60 days) to cancel any policy.
Auto & Home establishes prices for its major lines of
insurance based on its proprietary database, rather than relying
on rating bureaus. Auto & Home determines prices in
part from a number of variables specific to each risk. The
pricing of personal lines insurance products takes into account,
among other things, the expected frequency and severity of
losses, the costs of providing coverage (including the costs of
acquiring policyholders and administering policy benefits and
other administrative and overhead costs), competitive factors
and profit considerations.
The major pricing variables for personal lines insurance include
characteristics of the insured property, such as age, make and
model or construction type, as well as characteristics of the
insureds, such as driving record and loss experience, and the
insureds personal financial management. Auto &
Homes ability to set and change rates is subject to
regulatory oversight.
As a condition of our license to do business in each state,
Auto & Home, like all other automobile insurers, is
required to write or share the cost of private passenger
automobile insurance for higher risk individuals who would
otherwise be unable to obtain such insurance. This
involuntary market, also called the shared
market, is governed by the applicable laws and regulations
of each state, and policies written in this market are generally
written at rates higher than standard rates.
We continually review our underwriting and pricing guidelines so
that our policies remain competitive and supportive of our
marketing strategies and profitability goals. The current
economic environment, with its volatility and uncertainty is not
expected to materially impact the pricing of our products.
Reinsurance
Activity
We cede premiums to reinsurers under various agreements that
cover individual risks, group risks or defined blocks of
business, primarily on a coinsurance, yearly renewable term,
excess or catastrophe excess basis. These reinsurance agreements
spread the risk and minimize the effect of losses. The amount of
each risk retained by us depends on our evaluation of the
specific risk, subject, in certain circumstances, to maximum
limits based on the characteristics of coverages. We also cede
first dollar mortality risk under certain contracts. We obtain
reinsurance when capital requirements and the economic terms of
the reinsurance make it appropriate to do so. We reinsure our
business through a diversified group of reinsurers.
Under the terms of the reinsurance agreements, the reinsurer
agrees to reimburse us for the ceded amount in the event the
claim is paid. However, we remain liable to our policyholders
with respect to ceded reinsurance should any reinsurer be unable
to meet its obligations under these agreements. Since we bear
the risk of nonpayment by one or more of our reinsurers, we
primarily cede reinsurance to well-capitalized, highly rated
reinsurers. We evaluate the financial strength of our reinsurers
by monitoring their ratings and analyzing their financial
statements. We also analyze recent trends in arbitration and
litigation outcomes in disputes, if any, with our reinsurers.
Recoverability of reinsurance recoverable balances are evaluated
based on these analyses. We generally secure large reinsurance
recoverable balances with various forms of collateral, including
irrevocable letters of credit, secured trusts and funds withheld
accounts.
17
Individual
Our life insurance operations participate in reinsurance
activities in order to limit losses, minimize exposure to large
risks, and provide additional capacity for future growth. We
have historically reinsured the mortality risk on new individual
life insurance policies primarily on an excess of retention
basis or a quota share basis. Until 2005, we reinsured up to 90%
of the mortality risk for all new individual life insurance
policies that we wrote through our various franchises. This
practice was initiated by the different franchises for different
products starting at various points in time between 1992 and
2000. During 2005, we changed our retention practices for
certain individual life insurance policies. Amounts reinsured in
prior years remain reinsured under the original reinsurance;
however, under the new retention guidelines, we reinsure up to
90% of the mortality risk in excess of $1 million for most
new individual life insurance policies that we write through our
various franchises and for certain individual life policies the
retention limits remained unchanged. On a case by case basis, we
may retain up to $20 million per life and reinsure 100% of
amounts in excess of our retention limits. We evaluate our
reinsurance programs routinely and may increase or decrease our
retention at any time. In addition, we reinsure a significant
portion of the mortality risk on our individual universal life
policies issued since 1983. Placement of reinsurance is done
primarily on an automatic basis and also on a facultative basis
for risks with specific characteristics.
We also reinsure a portion of the living and death benefit
riders issued in connection with our variable annuities. Under
these reinsurance agreements, we pay a reinsurance premium
generally based on rider fees collected from policyholders and
receive reimbursements for benefits paid or accrued in excess of
account values, subject to certain limitations. We enter into
similar agreements for new or in-force business depending on
market conditions.
In addition to reinsuring mortality risk as described above, we
reinsure other risks, as well as specific coverages. We
routinely reinsure certain classes of risks in order to limit
our exposure to particular travel, avocation and lifestyle
hazards. We have exposure to catastrophes, which could
contribute to significant fluctuations in our results of
operations. We use excess of retention and quota share
reinsurance arrangements to provide greater diversification of
risk and minimize exposure to larger risks.
Institutional
The Institutional segment generally retains most of its risks
and does not significantly utilize reinsurance. We may, on
certain client arrangements, cede particular risks to reinsurers.
Auto &
Home
Auto & Home purchases reinsurance to control our
exposure to large losses (primarily catastrophe losses) and to
protect statutory surplus. Auto & Home cedes to
reinsurers a portion of losses and cedes premiums based upon the
risk and exposure of the policies subject to reinsurance.
To control our exposure to large property and casualty losses,
Auto & Home utilizes property catastrophe, casualty,
and property per risk excess of loss agreements.
Corporate &
Other
We also reinsure through 100% quota-share reinsurance agreements
certain long-term care and workers compensation business
written by MetLife Insurance Company of Connecticut
(MICC), a subsidiary of the Company, prior to our
acquisition of MICC. These run-off businesses have been included
within Corporate & Other since the acquisition of MICC.
18
Reinsurance
Recoverables
Information regarding ceded reinsurance recoverable balances,
included in premiums and other receivables in the consolidated
balance sheet is as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Future policy benefit recoverables
|
|
$
|
8,258
|
|
|
$
|
6,842
|
|
Deposit recoverables
|
|
|
2,258
|
|
|
|
2,616
|
|
Claim recoverables
|
|
|
319
|
|
|
|
271
|
|
All other recoverables
|
|
|
232
|
|
|
|
48
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
11,067
|
|
|
$
|
9,777
|
|
|
|
|
|
|
|
|
|
|
Our five largest reinsurers account for $7,651 million, or
69%, of our total reinsurance recoverable balances of
$11,067 million at December 31, 2008. Of these
reinsurance recoverable balances, $5,194 million were
secured by funds held in trust as collateral and
$209 million were secured through irrevocable letters of
credit issued by various financial institutions. We evaluate the
collectibility of reinsurance recoverable balances as described
previously and at December 31, 2008 allowances for
uncollectible balances were not material.
Regulation
Insurance
Regulation
Metropolitan Life Insurance Company is licensed to transact
insurance business in, and is subject to regulation and
supervision by, all 50 states, the District of Columbia,
Guam, Puerto Rico, Canada, the U.S. Virgin Islands and
Northern Mariana Islands. Each of MetLifes insurance
subsidiaries is licensed and regulated in each U.S. and
international jurisdiction where they conduct insurance
business. The extent of such regulation varies, but most
jurisdictions have laws and regulations governing the financial
aspects of insurers, including standards of solvency, statutory
reserves, reinsurance and capital adequacy, and the business
conduct of insurers. In addition, statutes and regulations
usually require the licensing of insurers and their agents, the
approval of policy forms and certain other related materials
and, for certain lines of insurance, the approval of rates. Such
statutes and regulations also prescribe the permitted types and
concentration of investments. The New York Insurance Law limits
both the amounts of agent compensation throughout the United
States, as well as the sales commissions and certain other
marketing expenses that may be incurred in connection with the
sale of life insurance policies and annuity contracts.
Each insurance subsidiary is required to file reports, generally
including detailed annual financial statements, with insurance
regulatory authorities in each of the jurisdictions in which it
does business, and its operations and accounts are subject to
periodic examination by such authorities. These subsidiaries
must also file, and in many jurisdictions and in some lines of
insurance obtain regulatory approval for, rules, rates and forms
relating to the insurance written in the jurisdictions in which
they operate.
The National Association of Insurance Commissioners
(NAIC) has established a program of accrediting
state insurance departments. NAIC accreditation contemplates
that accredited states will conduct periodic examinations of
insurers domiciled in such states. NAIC-accredited states will
not accept reports of examination of insurers from unaccredited
states, except under limited circumstances. As a direct result,
insurers domiciled in unaccredited states may be subject to
financial examination by accredited states in which they are
licensed, in addition to any examinations conducted by their
domiciliary states. The New York State Department of Insurance
(the Department), MLICs principal insurance
regulator, has not received accreditation. Historically, the
lack of accreditation has resulted from the New York
legislatures failure to adopt certain model NAIC laws,
although legislation enacted by the New York legislature in
2007 may have removed any statutory barriers to the
Department pursuing accreditation. While the Department may seek
to become accredited in the future, it is not certain whether
other impediments to accreditation remain. We do not believe
that the absence of this accreditation will have a significant
impact upon our ability to conduct our insurance businesses.
19
State and federal insurance and securities regulatory
authorities and other state law enforcement agencies and
attorneys general from time to time make inquiries regarding
compliance by the Holding Company and its insurance subsidiaries
with insurance, securities and other laws and regulations
regarding the conduct of our insurance and securities
businesses. We cooperate with such inquiries and take corrective
action when warranted. See Legal Proceedings.
Holding Company Regulation. The Holding
Company and its insurance subsidiaries are subject to regulation
under the insurance holding company laws of various
jurisdictions. The insurance holding company laws and
regulations vary from jurisdiction to jurisdiction, but
generally require a controlled insurance company (insurers that
are subsidiaries of insurance holding companies) to register
with state regulatory authorities and to file with those
authorities certain reports, including information concerning
its capital structure, ownership, financial condition, certain
intercompany transactions and general business operations.
State insurance statutes also typically place restrictions and
limitations on the amount of dividends or other distributions
payable by insurance company subsidiaries to their parent
companies, as well as on transactions between an insurer and its
affiliates. See Managements Discussion and Analysis
of Financial Condition and Results of Operations
Liquidity and Capital Resources The Holding
Company Liquidity and Capital Sources
Dividends. The New York Insurance Law and the regulations
thereunder also restrict the aggregate amount of investments
MLIC may make in non-life insurance subsidiaries, and provide
for detailed periodic reporting on subsidiaries.
Guaranty Associations and Similar
Arrangements. Most of the jurisdictions in which
the Companys insurance subsidiaries are admitted to
transact business require life and property and casualty
insurers doing business within the jurisdiction to participate
in guaranty associations, which are organized to pay certain
contractual insurance benefits owed pursuant to insurance
policies issued by impaired, insolvent or failed insurers. These
associations levy assessments, up to prescribed limits, on all
member insurers in a particular state on the basis of the
proportionate share of the premiums written by member insurers
in the lines of business in which the impaired, insolvent or
failed insurer is engaged. Some states permit member insurers to
recover assessments paid through full or partial premium tax
offsets.
In the past five years, the aggregate assessments levied against
MetLife have not been material. We have established liabilities
for guaranty fund assessments that we consider adequate for
assessments with respect to insurers that are currently subject
to insolvency proceedings. See Managements
Discussion and Analysis of Financial Condition and Results of
Operations Insolvency Assessments.
Statutory Insurance Examination. As part of
their regulatory oversight process, state insurance departments
conduct periodic detailed examinations of the books, records,
accounts, and business practices of insurers domiciled in their
states. State insurance departments also have the authority to
conduct examinations of non-domiciliary insurers that are
licensed in their states. During the three-year period ended
December 31, 2008, MetLife has not received any material
adverse findings resulting from state insurance department
examinations of its insurance subsidiaries conducted during this
three-year period.
Regulatory authorities in a small number of states have had
investigations or inquiries relating to MLICs, New England
Life Insurance Companys (NELICO) or General
American Life Insurance Companys (GALIC) sales
of individual life insurance policies or annuities. Over the
past several years, these and a number of investigations by
other regulatory authorities were resolved for monetary payments
and certain other relief. We may continue to resolve
investigations in a similar manner.
Policy and Contract Reserve Sufficiency
Analysis. Annually, MetLifes
U.S. insurance subsidiaries are required to conduct an
analysis of the sufficiency of all statutory reserves. In each
case, a qualified actuary must submit an opinion which states
that the statutory reserves, when considered in light of the
assets held with respect to such reserves, make good and
sufficient provision for the associated contractual obligations
and related expenses of the insurer. If such an opinion cannot
be provided, the insurer must set up additional reserves by
moving funds from surplus. Since inception of this requirement,
the Companys insurance subsidiaries which are required by
their states of domicile to provide these opinions have provided
such opinions without qualifications.
20
Surplus and Capital. The Companys
U.S. insurance subsidiaries are subject to the supervision
of the regulators in each jurisdiction in which they are
licensed to transact business. Regulators have discretionary
authority, in connection with the continued licensing of these
insurance subsidiaries, to limit or prohibit sales to
policyholders if, in their judgment, the regulators determine
that such insurer has not maintained the minimum surplus or
capital or that the further transaction of business will be
hazardous to policyholders. See Risk-Based
Capital.
Risk-Based Capital
(RBC). Each of the
Companys U.S. insurance subsidiaries is subject to
certain RBC requirements and reports its RBC based on a formula
calculated by applying factors to various asset, premium and
statutory reserve items. The formula takes into account the risk
characteristics of the insurer, including asset risk, insurance
risk, interest rate risk and business risk. The formula is used
as an early warning regulatory tool to identify possible
inadequately capitalized insurers for purposes of initiating
regulatory action, and not as a means to rank insurers
generally. State insurance laws provide insurance regulators the
authority to require various actions by, or take various actions
against, insurers whose RBC ratio does not exceed certain RBC
levels. As of the date of the most recent annual statutory
financial statements filed with insurance regulators, the RBC of
each of these subsidiaries was in excess of each of those RBC
levels. See Managements Discussion and Analysis of
Financial Condition and Results of Operations
Liquidity and Capital Resources The
Company Capital.
The NAIC adopted the Codification of Statutory Accounting
Principles (Codification) in 2001. Codification was
intended to standardize regulatory accounting and reporting to
state insurance departments. However, statutory accounting
principles continue to be established by individual state laws
and permitted practices. The Department has adopted Codification
with certain modifications for the preparation of statutory
financial statements of insurance companies domiciled in New
York. Modifications by the various state insurance departments
may impact the effect of Codification on the statutory capital
and surplus of the Companys insurance subsidiaries.
Regulation of Investments. Each of the
Companys U.S. insurance subsidiaries are subject to
state laws and regulations that require diversification of its
investment portfolios and limit the amount of investments in
certain asset categories, such as below investment grade fixed
income securities, equity real estate, other equity investments,
and derivatives. Failure to comply with these laws and
regulations would cause investments exceeding regulatory
limitations to be treated as non-admitted assets for purposes of
measuring surplus, and, in some instances, would require
divestiture of such non-qualifying investments. We believe that
the investments made by each of the Companys insurance
subsidiaries complied, in all material respects, with such
regulations at December 31, 2008.
Federal Initiatives. Although the federal
government generally does not directly regulate the insurance
business, federal initiatives often have an impact on our
business in a variety of ways. From time to time, federal
measures are proposed which may significantly affect the
insurance business; the potential for this resides primarily in
the tax-writing committees. At the present time, we do not know
of any federal legislative initiatives that, if enacted, would
adversely impact our business, results of operations or
financial condition. These federal measures may have an adverse
impact on our business, results of operations or financial
condition. See Risk Factors There Can be No
Assurance that actions of the U.S. Government, Federal
Reserve Bank of New York and Other Governmental and Regulatory
Bodies for the Purpose of Stabilizing the Financial Markets Will
Achieve the Intended Effect.
Legislative Developments. On August 17,
2006, President Bush signed the Pension Protection Act of 2006
(PPA) into law. This act is considered to be the
most sweeping pension legislation since the adoption of the
Employee Retirement Income Security Act of 1974
(ERISA) on September 2, 1974. The provisions of
the PPA, some of which were effective immediately and some which
become effective through 2012, may, over time, have a
significant impact on demand for pension, retirement savings,
and lifestyle protection products in both the institutional and
retail markets. The impact of the legislation may have a
positive effect on the life insurance and financial services
industries in the future. In the short-term, regulations on a
number of key provisions have either been issued in proposed or
final form. The final default investment regulations were issued
in October 2007. Final regulations were proposed on investment
advice in October 2008 and final regulations on the selection of
annuity providers for defined contribution plans were issued in
October 2008, becoming effective in December 2008. As these
regulations are likely to interact with one another as plan
sponsors evaluate them, we cannot predict whether
21
these regulations will be adopted as proposed, or what impact,
if any, such proposals may have on our business, results of
operations or financial condition.
On December 23, 2008, President Bush signed into law the
Worker, Retiree and Employer Recovery Act which, among other
things, eases the transition to the new funding requirements
contained in the PPA for defined benefit plans.
On February 8, 2006, President Bush signed into law the
Deficit Reduction Act which, among other things, created the
ability for states to implement an LTC partnership program.
States are currently implementing the partnership program. While
implementation has generated an increased level of awareness
regarding the need to fund long-term care, it is still too early
to quantify what effect, if any, this legislation will have on
our LTC business.
We cannot predict what other proposals may be made, what
legislation may be introduced or enacted or the impact of any
such legislation on our business, results of operations and
financial condition.
Governmental
Responses to Extraordinary Market Conditions
U.S. Federal Governmental
Responses. Throughout 2008 and continuing in
2009, Congress, the Federal Reserve Bank of New York, the
U.S. Treasury and other agencies of the Federal government
took a number of increasingly aggressive actions (in addition to
continuing a series of interest rate reductions that began in
the second half of 2007) intended to provide liquidity to
financial institutions and markets, to avert a loss of investor
confidence in particular troubled institutions and to prevent or
contain the spread of the financial crisis. These measures have
included:
|
|
|
|
|
expanding the types of institutions that have access to the
Federal Reserve Bank of New Yorks discount window;
|
|
|
|
providing asset guarantees and emergency loans to particular
distressed companies;
|
|
|
|
a temporary ban on short selling of shares of certain financial
institutions (including, for a period, MetLife);
|
|
|
|
programs intended to reduce the volume of mortgage foreclosures
by modifying the terms of mortgage loans for distressed
borrowers;
|
|
|
|
temporarily guaranteeing money market funds; and
|
|
|
|
programs to support the mortgage-backed securities market and
mortgage lending.
|
In addition to these actions, pursuant to the Emergency Economic
Stabilization Act of 2008 (EESA), enacted in October
2008, the U.S. Treasury has been injecting capital into
selected banking institutions and their holding companies. At
December 31, 2008, $250 billion of the total
$700 billion available under EESA had been dedicated to
making such capital infusions. EESA also authorizes the
U.S. Treasury to purchase up mortgage-backed and other
securities from financial institutions as part of the overall
$700 billion available for the purpose of stabilizing the
financial markets, although at December 31, 2008, the
U.S. Treasury had indicated a general intention not to
acquire mortgage-backed and similar securities. The Federal
government, the Federal Reserve Bank of New York, the Federal
Deposit Insurance Corporation (FDIC) and other
governmental and regulatory bodies have taken or are considering
taking other actions to address the financial crisis. For
example, the Federal Reserve Bank of New York has been making
funds available to commercial and financial companies under a
number of programs, including the Commercial Paper Funding
Facility (the CPFF), and the FDIC has established
the Temporary Liquidity Guarantee Program (the FDIC
Program), as discussed further below.
In February 2009, the Treasury Department outlined a financial
stability plan with additional measures to provide capital
relief to institutions holding troubled assets, including a
capital assistance program for banks that have undergone a
stress test (the Capital Assistance
Program) and a public-private investment fund to purchase
troubled assets from financial institutions. The administration
has also announced its Homeowner Affordability and Stability
Plan, which includes a number of elements intended to reduce the
number of mortgage foreclosures. Further details of this plan
are expected to be announced in March. The U.S. government
may also establish additional programs to improve liquidity in
the financial markets, support asset prices and recapitalize the
financial sector. There can be no assurance as to the form of
any such additional programs or the impact that these additional
22
measures or any existing governmental programs will have on the
financial markets, whether on the levels of volatility currently
being experienced, the levels of lending by financial
institutions, the prices buyers are willing to pay for financial
assets or otherwise. The choices made by the U.S. Treasury
in its distribution of amounts available under the EESA, the
Capital Assistance Program and other programs could have the
effect of supporting some aspects of the financial services
industry more than others or providing advantages to some of our
competitors. See Risk Factors Competitive
Factors May Adversely Affect Our Market Share and
Profitability.
In addition to the various measures to foster liquidity and
recapitalize the banking sector, the Federal government also
passed the American Recovery and Reinvestment Act in February
2009 that provides for nearly $790 billion in additional
federal spending, tax cuts and federal aid intended to spur
economic activity.
MetLife, Inc. and some or all of its affiliates may be eligible
to sell assets to the U.S. Treasury under one or more of
the programs established under EESA, and some of their assets
may be among those the U.S. Treasury or the public-private
investment partnership proposed by the U.S. Treasury offers
to purchase, either directly or through auction. Furthermore, as
a bank holding company, MetLife, Inc. was eligible to apply for
and could be selected to participate in the capital infusion
program established under EESA, pursuant to which the
U.S. Treasury purchases preferred shares of banking
institutions or their holding companies and acquires warrants
for their common shares. If we choose to participate in this
capital infusion program, we will become subject to requirements
and restrictions on our business. Issuing preferred shares and
warrants could dilute the ownership interests of stockholders or
affect our ability to raise capital in other transactions. We
could also become subject to restrictions on the compensation
that we can offer or pay to certain executive employees,
including incentives or performance-based compensation. These
restrictions could hinder or prevent us from attracting and
retaining management with the talent and experience to manage
our business effectively. Limits on our ability to deduct
certain compensation paid to executive employees will also be
imposed. The U.S. Treasury may also impose additional
restrictions in the future, and such restrictions may apply to
institutions receiving government assistance or financial
institutions generally. In January 2009, Congress released the
remaining $350 billion (of the $700 billion)
authorized by the EESA. The stimulus legislation enacted in
February 2009 contains additional restrictions on executive
compensation for companies that have received or will receive
Federal financial assistance under EESA, and Congress could
impose additional requirements and conditions could be imposed
on firms receiving Federal assistance.
Two of our commercial paper programs have been accepted for the
CPFF. The CPFF is intended to improve liquidity in short-term
funding markets by increasing the availability of term
commercial paper funding to issuers and by providing greater
assurance to both issuers and investors that firms will be able
to rollover their maturing commercial paper. MetLife Short Term
Funding LLC, an issuer of commercial paper under a program
supported by funding agreements issued by Metropolitan Life
Insurance Company and MetLife Insurance Company of Connecticut,
was accepted in October 2008 for the CPFF and may issue a
maximum amount of $3.8 billion under the CPFF. At
December 31, 2008, MetLife Short Term Funding LLC had used
$1,650 million of its available capacity under the CPFF,
and such amount was deposited under the related funding
agreements. MetLife Funding, Inc. was accepted in November 2008
for the CPFF and may issue a maximum amount of $1 billion
under the CPFF. No drawdown by MetLife Funding, Inc. has taken
place under this facility as of the date hereof.
MetLife, Inc. and MetLife Bank may issue debt guaranteed by the
FDIC under the FDIC Program. Under the terms of the FDIC
Program, the FDIC will guarantee through June 2012 (or maturity,
if earlier) the payment of certain newly-issued senior unsecured
debt of MetLife, Inc. or MetLife Bank (or any other eligible
affiliate approved to participate by the FDIC) issued prior to
October 31, 2009. We have elected the option of excluding
specified senior unsecured debt maturing after June 30,
2012, from the guarantee before reaching the limits on the
amount of guaranteed debt under the FDIC Program
($398 million for MetLife, Inc. and $178 million for
MetLife Bank, which may issue debt under its limit, as well as
any unused amounts under MetLife, Inc.s limit). In
addition, MetLife Bank has opted out of the component of the
FDIC Program that guarantees non-interest bearing deposit
transaction accounts. As of the date hereof, neither MetLife,
Inc. nor MetLife Bank has issued debt guaranteed under the FDIC
Program. See Managements Discussion and Analysis of
Financial Condition and Results of Operations
Liquidity and Capital Resources Extraordinary Market
Conditions.
23
MetLife Bank has the capacity to borrow from the Federal Reserve
Bank of New Yorks Discount Window and from the Federal
Reserve Bank of New York under the Term Auction Facility. As of
December 31, 2008, MetLife Bank had borrowed
$950 million under the Term Auction Facility.
State Insurance Regulatory Responses. In
January 2009, the NAIC considered, but declined, a number of
reserve and capital relief requests made by the American Council
of Life Insurers, acting on behalf of its member companies.
These requests, if adopted, would have generally resulted in
lower statutory reserve and capital requirements, effective
December 31, 2008, for life insurance companies. However,
notwithstanding the NAICs action on these requests,
insurance companies have the right to approach the insurance
regulator in their respective state of domicile and request
relief. Several MetLife insurance entities requested and were
granted relief, with a beneficial impact on capital as of
December 31, 2008. We understand that various competitors
have also requested and were sometimes granted relief, but we
cannot quantify or project the impact on the competitive
landscape of such relief or any subsequent regulatory relief
that may be granted.
Foreign Governmental Responses. In an effort
to strengthen the financial condition of key financial
institutions or avert their collapse, and to forestall or reduce
the effects of reduced lending activity, a number of foreign
governments have also taken actions similar to some of those
taken by the U.S. Federal government, including injecting
capital into domestic financial institutions in exchange for
ownership stakes. We cannot predict whether these actions will
achieve their intended purpose or how they will impact
competition in the financial services industry.
Broker-Dealer
and Securities Regulation
Some of the Companys subsidiaries and their activities in
offering and selling variable insurance products are subject to
extensive regulation under the federal securities laws
administered by the U.S. Securities and Exchange Commission
(SEC). These subsidiaries issue variable annuity
contracts and variable life insurance policies through separate
accounts that are registered with the SEC as investment
companies under the Investment Company Act of 1940, as amended
(the Investment Company Act). Each registered
separate account is generally divided into sub-accounts, each of
which invests in an underlying mutual fund which is itself a
registered investment company under the Investment Company Act.
In addition, the variable annuity contracts and variable life
insurance policies issued by the separate accounts are
registered with the SEC under the Securities Act of 1933, as
amended (the Securities Act). Other subsidiaries are
registered with the SEC as broker-dealers under the Securities
Exchange Act of 1934, as amended (the Exchange Act),
and are members of, and subject to, regulation by the Financial
Industry Regulatory Authority (FINRA). Further, some
of the Companys subsidiaries are registered as investment
advisers with the SEC under the Investment Advisers Act of 1940,
as amended (the Investment Advisers Act), and are
also registered as investment advisers in various states, as
applicable. Certain variable contract separate accounts
sponsored by the Companys subsidiaries are exempt from
registration, but may be subject to other provisions of the
federal securities laws.
Federal and state securities regulatory authorities and FINRA
from time to time make inquiries and conduct examinations
regarding compliance by the Holding Company and its subsidiaries
with securities and other laws and regulations. We cooperate
with such inquiries and examinations and take corrective action
when warranted.
Federal and state securities laws and regulations are primarily
intended to protect investors in the securities markets and
generally grant regulatory agencies broad rulemaking and
enforcement powers, including the power to limit or restrict the
conduct of business for failure to comply with such laws and
regulations. We may also be subject to similar laws and
regulations in the foreign countries in which we provide
investment advisory services, offer products similar to those
described above, or conduct other activities.
Environmental
Considerations
As an owner and operator of real property, we are subject to
extensive federal, state and local environmental laws and
regulations. Inherent in such ownership and operation is also
the risk that there may be potential environmental liabilities
and costs in connection with any required remediation of such
properties. In addition, we hold equity interests in companies
that could potentially be subject to environmental liabilities.
We routinely have environmental assessments performed with
respect to real estate being acquired for investment and real
property to
24
be acquired through foreclosure. We cannot provide assurance
that unexpected environmental liabilities will not arise.
However, based on information currently available to management,
management believes that any costs associated with compliance
with environmental laws and regulations or any remediation of
such properties will not have a material adverse effect on our
business, results of operations or financial condition.
ERISA
Considerations
We provide products and services to certain employee benefit
plans that are subject to ERISA, or the Internal Revenue Code of
1986, as amended (the Code). As such, our activities
are subject to the restrictions imposed by ERISA and the Code,
including the requirement under ERISA that fiduciaries must
perform their duties solely in the interests of ERISA plan
participants and beneficiaries and the requirement under ERISA
and the Code that fiduciaries may not cause a covered plan to
engage in prohibited transactions with persons who have certain
relationships with respect to such plans. The applicable
provisions of ERISA and the Code are subject to enforcement by
the Department of Labor, the Internal Revenue Service and the
Pension Benefit Guaranty Corporation (PBGC).
In John Hancock Mutual Life Insurance Company v. Harris
Trust and Savings Bank (1993), the U.S. Supreme Court
held that certain assets in excess of amounts necessary to
satisfy guaranteed obligations under a participating group
annuity general account contract are plan assets.
Therefore, these assets are subject to certain fiduciary
obligations under ERISA, which requires fiduciaries to perform
their duties solely in the interest of ERISA plan participants
and beneficiaries. On January 5, 2000, the Secretary of
Labor issued final regulations indicating, in cases where an
insurer has issued a policy backed by the insurers general
account to or for an employee benefit plan, the extent to which
assets of the insurer constitute plan assets for purposes of
ERISA and the Code. The regulations apply only with respect to a
policy issued by an insurer on or before December 31, 1998
(Transition Policy). No person will generally be
liable under ERISA or the Code for conduct occurring prior to
July 5, 2001, where the basis of a claim is that insurance
company general account assets constitute plan assets. An
insurer issuing a new policy that is backed by its general
account and is issued to or for an employee benefit plan after
December 31, 1998 will generally be subject to fiduciary
obligations under ERISA, unless the policy is a guaranteed
benefit policy.
The regulations indicate the requirements that must be met so
that assets supporting a Transition Policy will not be
considered plan assets for purposes of ERISA and the Code. These
requirements include detailed disclosures to be made to the
employee benefits plan and the requirement that the insurer must
permit the policyholder to terminate the policy on 90 day
notice and receive without penalty, at the policyholders
option, either (i) the unallocated accumulated fund balance
(which may be subject to market value adjustment) or (ii) a
book value payment of such amount in annual installments with
interest. We have taken and continue to take steps designed to
ensure compliance with these regulations.
Financial
Holding Company Regulation
Regulatory Agencies. In connection with its
acquisition of a federally-chartered commercial bank, MetLife,
Inc. became a bank holding company and financial holding company
on February 28, 2001. As such, the Holding Company is
subject to regulation under the Bank Holding Company Act of
1956, as amended (the BHC Act), and to inspection,
examination, and supervision by the Board of Governors of the
Federal Reserve Bank of New York System (the FRB).
In addition, the Holding Companys banking subsidiary is
subject to regulation and examination primarily by the Office of
the Comptroller of the Currency (OCC) and
secondarily by the FRB and the FDIC. The Office of Thrift
Supervision has granted our request to suspend processing of our
pending applications to convert MetLife Bank, N.A. from a
national association to a federal savings bank and to convert
MetLife, Inc. from a financial holding company to a savings and
loan holding company.
Financial Holding Company Activities. As a
financial holding company, MetLife, Inc.s activities and
investments are restricted by the BHC Act, as amended by the
Gramm-Leach-Bliley Act of 1999 (the GLB Act), to
those that are financial in nature or
incidental or complementary to such
financial activities. Activities that are financial in nature
include securities underwriting, dealing and market making,
sponsoring mutual funds and investment companies, insurance
underwriting and agency, merchant banking and activities that
the FRB has
25
determined to be closely related to banking. In addition, under
the insurance company investment portfolio provision of the GLB
Act, financial holding companies are authorized to make
investments in other financial and non-financial companies,
through their insurance subsidiaries, that are in the ordinary
course of business and in accordance with state insurance law,
provided the financial holding company does not routinely manage
or operate such companies except as may be necessary to obtain a
reasonable return on investment.
Other Restrictions and Limitations on Bank Holding Companies
and Financial Holding Companies
Capital. MetLife, Inc. and its insured depository
institution subsidiary, MetLife Bank, are subject to risk-based
and leverage capital guidelines issued by the federal banking
regulatory agencies for banks and financial holding companies.
The federal banking regulatory agencies are required by law to
take specific prompt corrective actions with respect to
institutions that do not meet minimum capital standards. At
December 31, 2008, MetLife, Inc. and MetLife Bank were in
compliance with the aforementioned guidelines.
Other Restrictions and Limitations on Bank Holding Companies
and Financial Holding Companies Consumer Protection
Laws. Numerous other federal and state laws also
affect the Holding Companys and MetLife Banks
earnings and activities, including federal and state consumer
protection laws. The GLB Act included consumer privacy
provisions that, among other things, require disclosure of a
financial institutions privacy policy to customers. In
addition, these provisions permit states to adopt more extensive
privacy protections through legislation or regulation.
Other Restrictions and Limitations on Bank Holding Companies
and Financial Holding Companies Change of
Control. Because MetLife, Inc. is a financial
holding company and bank holding company under the federal
banking laws, no person may acquire control of MetLife, Inc.
without the prior approval of the FRB. A change of control is
conclusively presumed upon acquisitions of 25% or more of any
class of voting securities and rebuttably presumed upon
acquisitions of 10% or more of any class of voting securities.
Further, as a result of MetLife, Inc.s ownership of
MetLife Bank, approval from the OCC would be required in
connection with a change of control (generally presumed upon the
acquisition of 10% or more of any class of voting securities) of
MetLife, Inc.
Competition
Our management believes that competition faced by our business
segments is based on a number of factors, including service,
product features, scale, price, financial strength,
claims-paying ratings, credit ratings, ebusiness capabilities
and name recognition. We compete with a large number of other
insurance companies, as well as non-insurance financial services
companies, such as banks, broker-dealers and asset managers, for
individual consumers, employer and other group customers as well
as agents and other distributors of insurance and investment
products. Some of these companies offer a broader array of
products, have more competitive pricing or, with respect to
other insurance companies, have higher claims paying ability
ratings. Many of our insurance products, particularly those
offered by our Institutional segment, are underwritten annually
and, accordingly, there is a risk that group purchasers may be
able to obtain more favorable terms from competitors rather than
renewing coverage with us.
We believe that the turbulence in financial markets that began
in the latter half of 2008, its impact on the capital position
of many competitors, and subsequent actions by regulators and
rating agencies have altered the competitive environment. In
particular, we believe that these factors have highlighted
financial strength as the most significant differentiator from
the perspective of customers and certain distributors. We
believe the Company is well positioned to compete in this
environment. In particular, the Company distributes many of its
individual products through other financial institutions such as
banks and broker dealers. These distribution partners are
currently placing greater emphasis on the financial strength of
the company whose products they sell. In addition, the financial
market turbulence has highlighted the extent of the risk
associated with certain variable annuity products and has led
many companies in our industry to re-examine the pricing and
features of the products they offer. The effects of current
market conditions may also lead to consolidation in the life
insurance industry. Although we cannot predict the ultimate
impact of these conditions, we believe that the strongest
companies will enjoy a competitive advantage as a result of the
current circumstances.
26
We must attract and retain productive sales representatives to
sell our insurance, annuities and investment products. Strong
competition exists among insurance companies for sales
representatives with demonstrated ability. We compete with other
insurance companies for sales representatives primarily on the
basis of our financial position, support services and
compensation and product features. See
Individual Marketing and
Distribution. We continue to undertake several initiatives
to grow our career agency force, while continuing to enhance the
efficiency and production of our existing sales force. We cannot
provide assurance that these initiatives will succeed in
attracting and retaining new agents. Sales of individual
insurance, annuities and investment products and our results of
operations and financial position could be materially adversely
affected if we are unsuccessful in attracting and retaining
agents.
Numerous aspects of our business are subject to regulation.
Legislative and other changes affecting the regulatory
environment can affect our competitive position within the life
insurance industry and within the broader financial services
industry. See Regulation and Risk
Factors Changes in U.S. Federal and State
Securities Laws May Affect Our Operations and Our
Profitability.
Company
Ratings
Insurer financial strength ratings represent the opinions of
rating agencies, including A.M. Best Company
(A.M. Best), Fitch Ratings (Fitch),
Moodys Investors Service (Moodys) and
Standard & Poors Ratings Services
(S&P), regarding the ability of an insurance
company to meet its financial obligations to policyholders and
contract holders. Credit ratings represent the opinions of
rating agencies regarding an issuers ability to repay its
indebtedness.
Rating
Stability Indicators
Rating agencies use an outlook statement of
positive, stable, negative
or developing to indicate a medium- or long-term
trend in credit fundamentals which, if continued, may lead to a
rating change. A rating may have a stable outlook to
indicate that the rating is not expected to change; however, a
stable rating does not preclude a rating agency from
changing a rating at any time, without notice. See Risk
Factors A Downgrade or a Potential Downgrade in Our
Financial Strength or Credit Ratings Could Result in a Loss of
Business and Materially Adversely Affect Our Financial Condition
and Results of Operations.
Rating
Actions
In September and October 2008, A.M. Best, Fitch,
Moodys, and S&P each revised its outlook for the
U.S. life insurance sector to negative from stable. In
January 2009, S&P reiterated its negative outlook on the
U.S. life insurance sector. Management believes that the
rating agencies may heighten the level of scrutiny that they
apply to such institutions, may increase the frequency and scope
of their credit reviews, may request additional information from
the companies that they rate, and may adjust upward the capital
and other requirements employed in the rating agency models for
maintenance of certain ratings levels.
In November 2008, A.M. Best downgraded the insurer
financial strength rating for Texas Life Insurance Company from
A to A−.
At December 31, 2008, A.M. Best, Fitch, Moodys
and S&P each had MetLife and its Subsidiaries insurer
financial strength and credit ratings on stable
outlook; however, (i) on February 9, 2009,
Moodys revised its outlook to negative,
(ii) on February 11, 2009, Fitch revised its outlook
to negative and anticipates completing its review
within the next several weeks and will reflect those results in
the ratings at that time, (iii) on February 20, 2009,
A.M. Best downgraded the credit ratings of MetLife, Inc. and
certain of its subsidiaries with a stable outlook,
and (iv) on February 26, 2009, S&P downgraded the
insurer financial strength and credit ratings of MetLife, Inc.
and certain of its subsidiaries, with a negative
outlook.
Our insurer financial strength ratings and credit ratings as of
the date of this filing are listed in the tables below:
27
Insurer
Financial Strength Ratings
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A.M. Best (1)
|
|
|
Fitch (2)
|
|
|
Moodys (3)
|
|
|
S&P (4)
|
|
|
First MetLife Investors Insurance Company
|
|
|
A+
|
|
|
|
N/R
|
|
|
|
N/R
|
|
|
|
AA−
|
|
General American Life Insurance Company
|
|
|
A+
|
|
|
|
AA
|
|
|
|
Aa2
|
|
|
|
AA−
|
|
MetLife Insurance Company of Connecticut
|
|
|
A+
|
|
|
|
AA
|
|
|
|
Aa2
|
|
|
|
AA−
|
|
MetLife Investors Insurance Company
|
|
|
A+
|
|
|
|
AA
|
|
|
|
Aa2
|
|
|
|
AA−
|
|
MetLife Investors USA Insurance Company
|
|
|
A+
|
|
|
|
AA
|
|
|
|
Aa2
|
|
|
|
AA−
|
|
Metropolitan Casualty Insurance Company
|
|
|
A
|
|
|
|
N/R
|
|
|
|
N/R
|
|
|
|
N/R
|
|
Metropolitan Direct Property and Casualty Insurance Company
|
|
|
A
|
|
|
|
N/R
|
|
|
|
N/R
|
|
|
|
N/R
|
|
Metropolitan General Insurance Company
|
|
|
A
|
|
|
|
N/R
|
|
|
|
N/R
|
|
|
|
N/R
|
|
Metropolitan Group Property & Casualty Insurance
Company
|
|
|
A
|
|
|
|
N/R
|
|
|
|
N/R
|
|
|
|
N/R
|
|
Metropolitan Life Insurance Company
|
|
|
A+
|
|
|
|
AA
|
|
|
|
Aa2
|
|
|
|
AA−
|
|
Metropolitan Lloyds Insurance Company of Texas
|
|
|
A
|
|
|
|
N/R
|
|
|
|
N/R
|
|
|
|
N/R
|
|
Metropolitan Property and Casualty Insurance Company
|
|
|
A
|
|
|
|
N/R
|
|
|
|
N/R
|
|
|
|
N/R
|
|
Metropolitan Tower Life Insurance Company
|
|
|
A+
|
|
|
|
N/R
|
|
|
|
Aa3
|
|
|
|
N/R
|
|
New England Life Insurance Company
|
|
|
A+
|
|
|
|
AA
|
|
|
|
Aa2
|
|
|
|
AA−
|
|
Texas Life Insurance Company
|
|
|
A-
|
|
|
|
N/R
|
|
|
|
N/R
|
|
|
|
N/R
|
|
Credit
Ratings
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A.M. Best (1)
|
|
|
Fitch (2)
|
|
|
Moodys (3)
|
|
|
S&P (4)
|
|
|
General American Life Insurance Company (Surplus Notes)
|
|
|
a
|
|
|
|
N/R
|
|
|
|
A1
|
|
|
|
A
|
|
MetLife Capital Trust IV & X
(Trust Securities)
|
|
|
bbb
|
|
|
|
A−
|
|
|
|
Baa1
|
|
|
|
BBB
|
|
MetLife Funding, Inc. (Commercial Paper)
|
|
|
AMB-1+
|
|
|
|
F1+
|
|
|
|
P-1
|
|
|
|
A-1+
|
|
MetLife Short Term Funding LLC (Commercial Paper)
|
|
|
N/R
|
|
|
|
N/R
|
|
|
|
P-1
|
|
|
|
A-1+
|
|
MetLife, Inc. (Commercial Paper)
|
|
|
AMB-1
|
|
|
|
F1
|
|
|
|
P-1
|
|
|
|
A-2
|
|
MetLife, Inc. (Senior Unsecured Debt)
|
|
|
a−
|
|
|
|
A
|
|
|
|
A2
|
|
|
|
A−
|
|
MetLife, Inc. (Subordinated Debt)
|
|
|
bbb+
|
|
|
|
N/R
|
|
|
|
A3
|
|
|
|
NR
|
|
MetLife, Inc. (Junior Subordinated Debt)
|
|
|
bbb
|
|
|
|
A−
|
|
|
|
Baa1
|
|
|
|
BBB
|
|
MetLife, Inc. (Preferred Stock)
|
|
|
bbb
|
|
|
|
A−
|
|
|
|
Baa1
|
|
|
|
BBB
|
|
MetLife, Inc. (Non-Cumulative Preferred Stock)
|
|
|
bbb
|
|
|
|
A−
|
|
|
|
Baa1
|
|
|
|
BBB−
|
|
Metropolitan Life Insurance Company (Surplus Notes)
|
|
|
a
|
|
|
|
A+
|
|
|
|
A1
|
|
|
|
A
|
|
Metropolitan Life Global Funding I (Senior Secured Debt)
|
|
|
aa−
|
|
|
|
NR
|
|
|
|
Aa2
|
|
|
|
AA−
|
|
MetLife Institutional Funding I, LLC (Senior Secured Debt)
|
|
|
aa−
|
|
|
|
NR
|
|
|
|
Aa2
|
|
|
|
AA−
|
|
|
|
|
(1) |
|
A.M. Best financial strength ratings range from A++
(superior) to S (Suspended). Ratings of
A+ and A are in the superior
and excellent categories, respectively. |
|
|
|
A.M. Bests long-term credit ratings range from
aaa (exceptional) to d (in default). A
+ or − may be appended to ratings
from aa to ccc to indicate relative
position within a category. Ratings of a and
bbb are in the strong and
adequate categories. |
|
|
|
A.M. Bests short-term credit ratings range from
AMB-1+ (strongest) to d (in default). |
|
(2) |
|
Fitch insurer financial strength ratings range from AAA
(exceptionally strong) to C (ceased or interrupted
payments imminent). A + or −
may be appended to ratings from AA to
CCC to indicate relative position within a category.
A rating of AA is in the very strong
category. |
|
|
|
Fitch long-term credit ratings range from AAA (highest
credit quality), to D (default). A
+ or − may be appended to ratings
from AA to CCC to indicate relative
position within a category. Ratings of A and
BBB are in the strong and
adequate categories, respectively. |
28
|
|
|
|
|
Fitch short-term credit ratings range from F1+
(exceptionally strong credit quality) to D (in
default). A rating of F1 is in the
highest credit quality category. |
|
(3) |
|
Moodys insurance financial strength ratings range from
Aaa (exceptional) to C (extremely poor).
A numeric modifier may be appended to ratings from
Aa to Caa to indicate relative position
within a category, with 1 being the highest and 3 being the
lowest. A rating of Aa is in the
excellent category. Moodys long-term credit
ratings range from Aaa (highest quality) to C
(typically in default). A numeric modifier may be appended
to ratings from Aa to Caa to indicate
relative position within a category, with 1 being the highest
and 3 being the lowest. Ratings of A and
Baa are in the upper-medium grade and
medium-grade categories, respectively. |
|
|
|
Moodys short-term credit ratings range from
P-1
(superior) to NP (not prime). |
|
(4) |
|
S&P long-term insurer financial strength ratings range from
AAA (extremely strong) to R (under regulatory
supervision). A + or
may be appended to ratings from AA to
CCC to indicate relative position within a category.
A rating of AA is in the very strong
category. |
|
|
|
S&P long-term credit ratings range from AAA
(extremely strong) to D (payment default). A
+ or may be appended to
ratings from AA to CCC to indicate
relative position within a category. A rating of A
is in the strong category. A rating of
BBB has adequate protection parameters and is
considered investment grade. |
|
|
|
S&P short-term credit ratings range from
A-1+
(extremely strong) to D (payment default). A
rating of
A-1
is in the strong category. |
|
N/R |
|
indicates not rated. |
The foregoing insurer financial strength ratings reflect each
rating agencys opinion of MLIC and the Holding
Companys other insurance subsidiaries financial
characteristics with respect to their ability to pay obligations
under insurance policies and contracts in accordance with their
terms, and are not evaluations directed toward the protection of
investors in the Holding Companys securities. Credit
ratings are opinions of each agency with respect to specific
securities and contractual financial obligations and the
issuers ability and willingness to meet those obligations
when due. Neither insurer financial strength nor credit ratings
are statements of fact nor are they recommendations to purchase,
hold or sell any security, contract or policy. Each rating
should be evaluated independently of any other rating.
A ratings downgrade (or the potential for such a downgrade) of
MLIC or any of the Holding Companys other insurance
subsidiaries could potentially, among other things, increase the
number of policies surrendered and withdrawals by policyholders
of cash values from their policies, adversely affect
relationships with broker-dealers, banks, agents, wholesalers
and other distributors of our products and services, negatively
impact new sales, and adversely affect our ability to compete
and thereby have a material adverse effect on our business,
results of operations and financial condition. See also
Managements Discussion and Analysis of Financial
Condition and Results of Operations Liquidity and
Capital Resources Extraordinary Market
Conditions for a more complete description of the impact
of a ratings downgrade.
Employees
At December 31, 2008, we had approximately
57,000 employees. We believe that our relations with our
employees are satisfactory.
Executive
Officers of the Registrant
Set forth below is information regarding the executive officers
of MetLife, Inc. and MLIC:
C. Robert Henrikson, age 61, has been Chairman,
President and Chief Executive Officer of MetLife, Inc. and MLIC
since April 25, 2006. Previously, he was President and
Chief Executive Officer of MetLife, Inc. and MLIC from
March 1, 2006, President and Chief Operating Officer of
MetLife, Inc. from June 2004, and President of the
U.S. Insurance and Financial Services businesses of
MetLife, Inc. and MLIC from July 2002 to June 2004. He served as
President of Institutional Business of MetLife, Inc. from
September 1999 to July 2002 and President of Institutional
Business of MLIC from May 1999 through June 2002. He was Senior
Executive Vice President,
29
Institutional Business, of MLIC from December 1997 to May 1999,
Executive Vice President, Institutional Business, from January
1996 to December 1997, and Senior Vice President, Pensions, from
January 1991 to January 1995. He is a director of MetLife, Inc.
and MLIC.
Steven A. Kandarian, age 56, has been Executive Vice
President and Chief Investment Officer of MetLife, Inc. and MLIC
since April 2005. Previously, he was the executive director of
the Pension Benefit Guaranty Corporation from 2001 to 2004.
Before joining the Pension Benefit Guaranty Corporation,
Mr. Kandarian was founder and managing partner of Orion
Capital Partners, LP, where he managed a private equity fund
specializing in venture capital and corporate acquisitions for
eight years.
James L. Lipscomb, age 62, has been Executive Vice
President and General Counsel of MetLife, Inc. and MLIC since
July 2003. He was Senior Vice President and Deputy General
Counsel from July 2001 to July 2003. Mr. Lipscomb was
President and Chief Executive Officer of Conning Corporation, a
former subsidiary of MLIC, from March 2000 to July 2001, prior
to which he served in various senior management positions with
MLIC for more than five years.
Maria R. Morris, age 46, has been Executive Vice
President, Technology and Operations, of MetLife, Inc. and MLIC
since January 2008. Previously, she was Executive Vice President
of MLIC from December 2005 to January 2008, Senior Vice
President of MLIC from October 2004 to December 2005, and Vice
President of MLIC from March 1995 to October 2004.
William J. Mullaney, age 49, has been President,
Institutional Business, of MetLife, Inc. and MLIC since January
2007. Previously, he was President of Metropolitan Property and
Casualty Insurance Company from January 2005 to January 2007,
Senior Vice President of Metropolitan Property and Casualty
Insurance Company from July 2002 to December 2004, Senior Vice
President, Institutional Business, of MLIC from August 2001 to
July 2002, and a Vice President of MLIC for more than five
years. He is a director of MetLife Bank, N.A. and MetLife
Insurance Company of Connecticut.
William J. Toppeta, age 60, has been President,
International, of MetLife, Inc. and MLIC since June 2001. He was
President of Client Services and Chief Administrative Officer of
MetLife, Inc. from September 1999 to June 2001 and President of
Client Services and Chief Administrative Officer of MLIC from
May 1999 to June 2001. He was Senior Executive Vice President,
Head of Client Services, of MLIC from March 1999 to May 1999,
Senior Executive Vice President, Individual, from February 1998
to March 1999, Executive Vice President, Individual Business,
from July 1996 to February 1998, Senior Vice President from
October 1995 to July 1996 and President and Chief Executive
Officer of its Canadian Operations from July 1993 to October
1995.
Lisa M. Weber, age 46, has been President,
Individual Business, of MetLife, Inc. and MLIC since June 2004.
Previously, she was Senior Executive Vice President and Chief
Administrative Officer of MetLife, Inc. and MLIC from June 2001
to June 2004. She was Executive Vice President of MetLife, Inc.
and MLIC from December 1999 to June 2001 and was head of Human
Resources of MLIC from March 1998 to December 2003. She was
Senior Vice President of MetLife, Inc. from September 1999 to
November 1999 and Senior Vice President of MLIC from March 1998
to November 1999. Previously, she was Senior Vice President of
Human Resources of PaineWebber Group Incorporated, where she was
employed for ten years. Ms. Weber is a director of MetLife
Bank, N.A. and MetLife Insurance Company of Connecticut.
William J. Wheeler, age 47, has been Executive Vice
President and Chief Financial Officer of MetLife, Inc. and MLIC
since December 2003, prior to which he was a Senior Vice
President of MLIC from 1997 to December 2003. Previously, he was
a Senior Vice President of Donaldson, Lufkin &
Jenrette for more than five years. Mr. Wheeler is a
director of MetLife Bank, N.A.
Trademarks
We have a worldwide trademark portfolio that we consider
important in the marketing of our products and services,
including, among others, the trademark MetLife. We
also have the exclusive license to use the
Peanuts®
characters in the area of financial services and healthcare
benefit services in the United States and internationally under
an advertising and premium agreement with United Feature
Syndicate until December 31, 2012. Furthermore, we also
have a non-exclusive license to use certain Citigroup-owned
trademarks in connection
30
with the marketing, distribution or sale of life insurance and
annuity products under a licensing agreement with Citigroup
until June 30, 2015. We believe that our rights in our
trademarks and under our
Peanuts®
characters license and our Citigroup license are well protected.
Available
Information
MetLife files periodic reports, proxy statements and other
information with the SEC. Such reports, proxy statements and
other information may be obtained by visiting the Public
Reference Room of the SEC at its Headquarters Office,
100 F Street, N.E., Washington D.C. 20549 or by
calling the SEC at 1-202-551-8090 or
1-800-SEC-0330
(Office of Investor Education and Advocacy). In addition, the
SEC maintains an internet website (www.sec.gov) that contains
reports, proxy statements, and other information regarding
issuers that file electronically with the SEC, including
MetLife, Inc.
MetLife makes available, free of charge, on its website
(www.metlife.com) through the Investor Relations page, its
annual reports on
Form 10-K,
quarterly reports on
Form 10-Q,
current reports on
Form 8-K,
and amendments to all those reports, as soon as reasonably
practicable after filing (furnishing) such reports to the SEC.
Other information found on the website is not part of this or
any other report filed with or furnished to the SEC.
Adverse
Capital and Credit Market Conditions May Significantly Affect
Our Ability to Meet Liquidity Needs, Access to Capital and Cost
of Capital
The capital and credit markets have been experiencing extreme
volatility and disruption. At times, the volatility and
disruption have reached unprecedented levels. In some cases, the
markets have exerted downward pressure on availability of
liquidity and credit capacity for certain issuers.
We need liquidity to pay our operating expenses, interest on our
debt and dividends on our capital stock, maintain our securities
lending activities and replace certain maturing liabilities.
Without sufficient liquidity, we will be forced to curtail our
operations, and our business will suffer. The principal sources
of our liquidity are insurance premiums, annuity considerations,
deposit funds, cash flow from our investment portfolio and
assets, consisting mainly of cash or assets that are readily
convertible into cash. Sources of liquidity in normal markets
also include short-term instruments such as repurchase
agreements and commercial paper. Sources of capital in normal
markets include long-term instruments, medium- and long-term
debt, junior subordinated debt securities, capital securities
and equity securities.
In the event current resources do not satisfy our needs, we may
have to seek additional financing. The availability of
additional financing will depend on a variety of factors such as
market conditions, the general availability of credit, the
volume of trading activities, the overall availability of credit
to the financial services industry, our credit ratings and
credit capacity, as well as the possibility that customers or
lenders could develop a negative perception of our long- or
short-term financial prospects if we incur large investment
losses or if the level of our business activity decreased due to
a market downturn. Similarly, our access to funds may be
impaired if regulatory authorities or rating agencies take
negative actions against us. Our internal sources of liquidity
may prove to be insufficient, and in such case, we may not be
able to successfully obtain additional financing on favorable
terms, or at all.
Our liquidity requirements may change. For instance, we have
funding agreements which can be put to us after a period of
notice. The notice requirements vary; however, the shortest
period is 90 days, applicable to approximately
$1 billion of such liabilities at December 31, 2008.
Disruptions, uncertainty or volatility in the capital and credit
markets may also limit our access to capital required to operate
our business, most significantly our insurance operations. Such
market conditions may limit our ability to replace, in a timely
manner, maturing liabilities; satisfy statutory capital
requirements; and access the capital necessary to grow our
business. As such, we may be forced to delay raising capital,
issue different types of capital than we would otherwise, less
effectively deploy such capital, issue shorter tenor securities
than we prefer, or bear an unattractive cost of capital which
could decrease our profitability and significantly reduce our
financial flexibility. Recently our credit spreads have widened
considerably. Our results of operations, financial condition,
31
cash flows and statutory capital position could be materially
adversely affected by disruptions in the financial markets.
Difficult
Conditions in the Global Capital Markets and the Economy
Generally May Materially Adversely Affect Our Business and
Results of Operations and These Conditions May Not Improve in
the Near Future
Our results of operations are materially affected by conditions
in the global capital markets and the economy generally, both in
the United States and elsewhere around the world. The stress
experienced by global capital markets that began in the second
half of 2007 continued and substantially increased during 2008.
Concerns over the availability and cost of credit, the
U.S. mortgage market, geopolitical issues, energy costs,
inflation and a declining real estate market in the United
States contributed to increased volatility and diminished
expectations for the economy and the markets in the near term.
These factors, combined with declining business and consumer
confidence and increased unemployment, have precipitated a
recession. In addition, the fixed-income markets have
experienced a period of extreme volatility which negatively
impacted market liquidity conditions. Initially, the concerns on
the part of market participants were focused on the sub-prime
segment of the mortgage-backed securities market. However, these
concerns expanded to include a broad range of mortgage- and
asset-backed and other fixed income securities, including those
rated investment grade, the U.S. and international credit
and interbank money markets generally, and a wide range of
financial institutions and markets, asset classes and sectors.
Securities that are less liquid are more difficult to value and
have less opportunity for disposal. Domestic and international
equity markets have also experienced heightened volatility and
turmoil, with issuers (such as our company) that have exposure
to the real estate, mortgage and credit markets particularly
affected. These events and continued market upheavals may have
an adverse effect on us, in part because we have a large
investment portfolio and are also dependent upon customer
behavior. Our revenues are likely to decline in such
circumstances and our profit margins could erode. In addition,
in the event of extreme prolonged market events, such as the
global credit crisis, we could incur significant losses. Even in
the absence of a market downturn, we are exposed to substantial
risk of loss due to market volatility. See
Managements Discussion and Analysis of Financial
Condition and Results of Operations Liquidity and
Capital Resources Extraordinary Market
Conditions.
We are a significant writer of variable annuity products. The
account values of these products will be affected by the
downturn in capital markets. Any decrease in account values will
decrease the fees generated by our variable annuity products,
cause the amortization of deferred acquisition costs to
accelerate and may increase the level of reserves we must carry
to support those variable annuities issued with any associated
guarantees.
Factors such as consumer spending, business investment,
government spending, the volatility and strength of the capital
markets, and inflation all affect the business and economic
environment and, ultimately, the amount and profitability of our
business. In an economic downturn characterized by higher
unemployment, lower family income, lower corporate earnings,
lower business investment and lower consumer spending, the
demand for our financial and insurance products could be
adversely affected. In addition, we may experience an elevated
incidence of claims and lapses or surrenders of policies. Our
policyholders may choose to defer paying insurance premiums or
stop paying insurance premiums altogether. Adverse changes in
the economy could affect earnings negatively and could have a
material adverse effect on our business, results of operations
and financial condition. The current crisis has also raised the
possibility of future legislative and regulatory actions in
addition to the recent enactment of the Emergency Economic
Stabilization Act of 2008 (the EESA) that could
further impact our business. We cannot predict whether or when
such actions may occur, or what impact, if any, such actions
could have on our business, results of operations and financial
condition. See There Can be No Assurance that
Actions of the U.S. Government, Federal Reserve Bank of New
York and Other Governmental and Regulatory Bodies for the
Purpose of Stabilizing the Financial Markets Will Achieve the
Intended Effect and Competitive Factors
May Adversely Affect Our Market Share and Profitability.
There
Can be No Assurance that Actions of the U.S. Government, Federal
Reserve Bank of New York and Other Governmental and Regulatory
Bodies for the Purpose of Stabilizing the Financial Markets Will
Achieve the Intended Effect
In response to the financial crises affecting the banking system
and financial markets and going concern threats to investment
banks and other financial institutions, on October 3, 2008,
President Bush signed the EESA into law.
32
Pursuant to the EESA, the U.S. Treasury has the authority
to, among other things, purchase up to $700 billion of
mortgage-backed and other securities from financial institutions
for the purpose of stabilizing the financial markets. At
December 31, 2008, $250 billion of this amount had
been dedicated to making capital infusions to banking
institutions and their holding companies. The Federal
Government, Federal Reserve Bank of New York, the Federal
Deposit Insurance Corporation (FDIC) and other
governmental and regulatory bodies have taken or are considering
taking other actions to address the financial crisis. For
example, the Federal Reserve Bank of New York has been making
funds available to commercial and financial companies under a
number of programs, including the Commercial Paper Funding
Facility and the FDICs Temporary Liquidity Guarantee
Program (the FDIC Program), as discussed further
below, and legislation is pending in Congress that will allow
bankruptcy judges in certain bankruptcy proceedings to alter the
terms of certain mortgages, including reducing the principal
amount of the loan. There can be no assurance as to what impact
such actions will have on the financial markets, whether on the
levels of volatility currently being experienced, the levels of
lending by financial institutions, the prices buyers are willing
to pay for financial assets or otherwise. Continued volatility,
low levels of credit availability and low prices for financial
assets materially and adversely affect our business, financial
condition and results of operations and the trading price of our
common stock. Furthermore, if the mortgage-related legislation
is passed, it could cause loss of principal on certain of our
nonagency prime residential mortgage backed security holdings
and could cause a ratings downgrade in such holdings which, in
turn, would cause an increase in unrealized losses on such
securities. See We Are Exposed to
Significant Financial and Capital Markets Risk Which May
Adversely Affect Our Results of Operations, Financial Condition
and Liquidity, and Our Net Investment Income Can Vary from
Period to Period. Finally, the choices made by the
U.S. Treasury in its distribution of amounts available
under the EESA could have the effect of supporting some parts of
the financial system more than others. See
Competitive Factors May Adversely Affect Our
Market Share and Profitability.
MetLife, Inc. and some or all of its affiliates may be eligible
to sell assets to the U.S. Treasury under one or more of
the programs established under EESA, and some of their assets
may be among those the U.S. Treasury offers to purchase,
either directly or through auction. Furthermore, as a bank
holding company, MetLife, Inc. could be selected to participate
in the U.S. Treasurys capital infusion program,
pursuant to which the U.S. Treasury purchases preferred
shares of banking institutions or their holding companies and
acquires warrants for their common shares. If we choose to
participate in the capital infusion program of the U.S.
Treasury, we will become subject to requirements and
restrictions on our business. Issuing preferred shares and
warrants could dilute the ownership interests of stockholders or
affect our ability to raise capital in other transactions. We
will also become subject to restrictions on the compensation
that we can offer or pay to certain executive employees,
including incentives or performance-based compensation. These
restrictions could hinder or prevent us from attracting and
retaining management with the talent and experience to manage
our business effectively. Limits on our ability to deduct
certain compensation paid to executive employees will also be
imposed. The remaining $350 billion authorized by the EESA
has been made available to the U.S. Treasury. Congress and
the current Administration are considering the imposition of
additional requirements and conditions on the use of these
additional funds. See Managements Discussion and
Analysis of Financial Condition and Results of
Operations Liquidity and Capital
Resources Extraordinary Market Conditions.
On December 5, 2008, MetLife, Inc. elected to continue to
participate in the debt guarantee component of the FDIC Program.
Under the terms of the FDIC Program, the FDIC will guarantee
through June 2012 (or maturity, if earlier) the payment of
certain newly-issued senior unsecured debt of MetLife, Inc. and
any eligible affiliates. We also notified the FDIC that we have
elected the option of excluding specified senior unsecured debt
maturing after June 30, 2012, from the guarantee before
reaching the limits on the amount of guaranteed debt under the
FDIC Program ($398 million for MetLife, Inc. and
$178 million for its affiliate, MetLife Bank, N.A., which
may issue guaranteed debt under its limit, as well as unused
amounts under MetLife, Inc.s limit). In addition, we opted
out of the component of the FDIC Program that guarantees
non-interest bearing deposit transaction accounts. We cannot
predict how the markets may react to these elections or to any
debt issued subject to the terms of the FDIC Program. See
Managements Discussion and Analysis of Financial
Condition and Results of Operations Liquidity and
Capital Resources Extraordinary Market
Conditions.
33
The
Impairment of Other Financial Institutions Could Adversely
Affect Us
We have exposure to many different industries and
counterparties, and routinely execute transactions with
counterparties in the financial services industry, including
brokers and dealers, commercial banks, investment banks, hedge
funds and other investment funds and other institutions. Many of
these transactions expose us to credit risk in the event of
default of our counterparty. In addition, with respect to
secured transactions, our credit risk may be exacerbated when
the collateral held by us cannot be realized or is liquidated at
prices not sufficient to recover the full amount of the loan or
derivative exposure due to us. We also have exposure to these
financial institutions in the form of unsecured debt
instruments, non-redeemable and redeemable preferred securities,
derivative transactions and equity investments. Further,
potential action by governments and regulatory bodies in
response to the financial crisis affecting the global banking
system and financial markets, such as investment,
nationalization and other intervention, could negatively impact
these instruments, securities, transactions and investments.
There can be no assurance that any such losses or impairments to
the carrying value of these assets would not materially and
adversely affect our business and results of operations.
Our
Participation in a Securities Lending Program Subjects Us to
Potential Liquidity and Other Risks
We participate in a securities lending program whereby blocks of
securities, which are included in fixed maturity securities and
short-term investments, are loaned to third parties, primarily
major brokerage firms and commercial banks. We generally require
collateral equal to 102% of the current estimated fair value of
the loaned securities to be obtained at the inception of a loan,
and maintained at a level greater than or equal to 100% for the
duration of the loan. During the extraordinary market events
occurring in the fourth quarter of 2008, we, in limited
instances, accepted collateral less than 102% at the inception
of certain loans, but never less than 100%, of the estimated
fair value of such loaned securities. These loans involved
U.S. Government Treasury Bills which we considered to have
limited variation in their estimated fair value during the term
of the loan. Securities with a cost or amortized cost of
$20.8 billion and $41.1 billion and an estimated fair
value of $22.9 billion and $42.1 billion were on loan
under the program at December 31, 2008 and
December 31, 2007, respectively. Securities loaned under
such transactions may be sold or repledged by the transferee. We
were liable for cash collateral under our control of
$23.3 billion and $43.3 billion at December 31,
2008 and December 31, 2007, respectively.
Returns of loaned securities by the third parties would require
us to return the cash collateral associated with such loaned
securities. In addition, in some cases, the maturity of the
securities held as invested collateral (i.e., securities that we
have purchased with cash received from the third parties) may
exceed the term of the related securities on loan and the
estimated fair value may fall below the amount of cash received
as collateral and invested. If we are required to return
significant amounts of cash collateral on short notice and we
are forced to sell securities to meet the return obligation, we
may have difficulty selling such collateral that is invested in
securities in a timely manner, be forced to sell securities in a
volatile or illiquid market for less than we otherwise would
have been able to realize under normal market conditions, or
both. In addition, under stressful capital market and economic
conditions, such as those conditions we have experienced
recently, liquidity broadly deteriorates, which may further
restrict our ability to sell securities.
Of this $23.3 billion of cash collateral at
December 31, 2008, $5.1 billion was on open terms,
meaning that the related loaned security could be returned to us
on the next business day requiring return of cash collateral and
the following amounts are due within 30 days, and
60 days $14.7 billion and
$3.5 billion, respectively. The estimated fair value of the
securities related to the cash collateral on open at
December 31, 2008 has been reduced to $5.0 billion
from $15.8 billion as of November 30, 2008. Of the
$5.0 billion of estimated fair value of the securities
related to the cash collateral on open at December 31,
2008, $4.4 billion were U.S. Treasury and agency
securities which, if put to us, can be immediately sold to
satisfy the cash requirements. The remainder of the securities
on loan are primarily U.S. Treasury and agency securities,
and very liquid residential mortgage-backed securities. Within
the U.S. Treasury securities on loan, they are primarily
holdings of on-the-run U.S. Treasury securities, the most
liquid U.S. Treasury securities available. If these high
quality securities that are on loan are put back to us, the
proceeds from immediately selling these securities can be used
to satisfy the related cash requirements. The estimated fair
value of the reinvestment portfolio acquired with the cash
collateral was $19.5 billion at December 31, 2008, and
consisted principally of fixed maturity securities (including
residential mortgage-backed, asset-backed, U.S. corporate
and foreign corporate securities). If the on loan securities or
the
34
reinvestment portfolio become less liquid, we have the liquidity
resources of most of our general account available to meet any
potential cash demand when securities are put back to us. See
Managements Discussion and Analysis of Financial
Condition and Results of Operations
Investments Securities Lending.
If we decrease the amount of our securities lending activities
over time, the amount of income generated by these activities
will also likely decline.
We Are
Exposed to Significant Financial and Capital Markets Risk which
May Adversely Affect Our Results of Operations, Financial
Condition and Liquidity, and Our Net Investment Income Can Vary
from Period to Period
We are exposed to significant financial and capital markets
risk, including changes in interest rates, credit spreads,
equity prices, real estate markets, foreign currency exchange
rates, market volatility, the performance of the economy in
general, the performance of the specific obligors included in
our portfolio and other factors outside our control. Our
exposure to interest rate risk relates primarily to the market
price and cash flow variability associated with changes in
interest rates. A rise in interest rates will increase the net
unrealized loss position of our fixed income investment
portfolio and, if long-term interest rates rise dramatically
within a six to twelve month time period, certain of our life
insurance businesses may be exposed to disintermediation risk.
Disintermediation risk refers to the risk that our policyholders
may surrender their contracts in a rising interest rate
environment, requiring us to liquidate fixed income investments
in an unrealized loss position. Due to the long-term nature of
the liabilities associated with certain of our life insurance
businesses, guaranteed benefits on variable annuities, and
structured settlements, sustained declines in long-term interest
rates may subject us to reinvestment risks and increased hedging
costs. In other situations, declines in interest rates may
result in increasing the duration of certain life insurance
liabilities, creating asset liability duration mismatches. Our
investment portfolio also contains interest rate sensitive
instruments, such as fixed income securities, which may be
adversely affected by changes in interest rates from
governmental monetary policies, domestic and international
economic and political conditions and other factors beyond our
control. A rise in interest rates would increase the net
unrealized loss position of our fixed income investment
portfolio, offset by our ability to earn higher rates of return
on funds reinvested. Conversely, a decline in interest rates
would decrease the net unrealized loss position of our fixed
income investment portfolio, offset by lower rates of return on
funds reinvested. Our mitigation efforts with respect to
interest rate risk are primarily focused towards maintaining an
investment portfolio with diversified maturities that has a
weighted average duration that is approximately equal to the
duration of our estimated liability cash flow profile. However,
our estimate of the liability cash flow profile may be
inaccurate and we may be forced to liquidate fixed income
investments prior to maturity at a loss in order to cover the
liability. Although we take measures to manage the economic
risks of investing in a changing interest rate environment, we
may not be able to mitigate the interest rate risk of our fixed
income investments relative to our liabilities. See also
Changes in Market Interest Rates May
Significantly Affect Our Profitability.
Our exposure to credit spreads primarily relates to market price
and cash flow variability associated with changes in credit
spreads. A widening of credit spreads will increase the net
unrealized loss position of the fixed income investment
portfolio, will increase losses associated with credit based
non-qualifying derivatives where we assume credit exposure, and,
if issuer credit spreads increase significantly or for an
extended period of time, would likely result in higher
other-than-temporary impairments. Credit spread tightening will
reduce net investment income associated with new purchases of
fixed maturity securities. In addition, market volatility can
make it difficult to value certain of our securities if trading
becomes less frequent. As such, valuations may include
assumptions or estimates that may have significant period to
period changes which could have a material adverse effect on our
consolidated results of operations or financial condition.
Credit spreads on both corporate and structured securities
widened during 2008, resulting in continuing depressed pricing.
Continuing challenges include continued weakness in the
U.S. real estate market and increased mortgage
delinquencies, investor anxiety over the U.S. economy,
rating agency downgrades of various structured products and
financial issuers, unresolved issues with structured investment
vehicles and monoline financial guarantee insurers, deleveraging
of financial institutions and hedge funds and a serious
dislocation in the inter-bank market. If significant, continued
volatility, changes in interest rates, changes in credit spreads
and defaults, a lack of pricing transparency, market liquidity,
declines in equity prices, and the strengthening or weakening of
foreign currencies against the U.S. dollar, individually or
in tandem, could have a material adverse effect on our
consolidated results of
35
operations, financial condition or cash flows through realized
losses, impairments, and changes in unrealized positions.
Our primary exposure to equity risk relates to the potential for
lower earnings associated with certain of our insurance
businesses, such as variable annuities, where fee income is
earned based upon the estimated fair value of the assets under
management. In addition, certain of our annuity products offer
guaranteed benefits which increase our potential benefit
exposure should equity markets decline. We are also exposed to
interest rate and equity risk based upon the discount rate and
expected long-term rate of return assumptions associated with
our pension and other post-retirement benefit obligations.
Sustained declines in long-term interest rates or equity returns
likely would have a negative effect on the funded status of
these plans.
Our exposure to real estate risk relates to market price and
cash flow variability associated with changes in real estate
markets, default and bankruptcy rates, geographic and sector
concentration as well as illiquidity of real estate investments.
The current economic environment has led to significant
weakening of the residential and commercial real estate markets,
increases in foreclosures, bankruptcies and unsuccessful
development projects as well as limited access to credit. Our
real estate investments, including those held by joint ventures
and real estate funds, may be negatively impacted by weakened
local real estate conditions, such as oversupply, reduced demand
and the availability and creditworthiness of current and
prospective tenants and borrowers. In addition, real estate
investments are relatively illiquid, and could limit our
ability, and that of our joint venture partners and real estate
fund managers, to sell assets to respond to changing economic,
financial and investment conditions. Also, these factors could
impact mortgage and consumer loan fundamentals which are further
discussed under Defaults on Our Mortgage and
Consumer Loans and Volatility in Performance May Adversely
Affect Our Profitability. These factors and others beyond
our control could have a material adverse effect on our
consolidated results of operations, financial condition or cash
flows through net investment income, realized losses and
impairments.
Our primary foreign currency exchange risks are described under
Fluctuations in Foreign Currency Exchange
Rates and Foreign Securities Markets Could Negatively Affect our
Profitability. Significant declines in equity prices,
changes in U.S. interest rates, changes in credit spreads,
and changes in foreign currency exchange rates could have a
material adverse effect on our consolidated results of
operations, financial condition or liquidity. Changes in these
factors, which are significant risks to us, can affect our net
investment income in any period, and such changes can be
substantial.
We invest a portion of our invested assets in leveraged buy-out
funds, hedge funds and other private equity funds reported
within Other Limited Partnerships, many of which make private
equity investments. The amount and timing of net investment
income from such investment funds tends to be uneven as a result
of the performance of the underlying investments, including
private equity investments. The timing of distributions from the
funds, which depends on particular events relating to the
underlying investments, as well as the funds schedules for
making distributions and their needs for cash, can be difficult
to predict. As a result, the amount of net investment income
that we record from these investments can vary substantially
from quarter to quarter. Recent equity, real estate and credit
market volatility have further reduced net investment income and
related yields for these types of investments and we may
continue to experience reduced net investment income due to
continued volatility in the equity, real estate and credit
markets in 2009. In addition, due to the normal lag in the
preparation of and then receipt of periodic financial statements
from other limited partnership interests and real estate joint
ventures and funds, results from late 2008 during periods of
volatility will be reported to us in 2009.
Our
Requirements to Pledge Collateral or Make Payments Related to
Declines in Value of Specified Assets May Adversely Affect Our
Liquidity and Expose Us to Counterparty Credit
Risk
Many of our transactions with financial and other institutions
specify the circumstances under which the parties are required
to pledge collateral related to any decline in the value of the
specified assets. In addition, under the terms of some of our
transactions, we may be required to make payments to our
counterparties related to any decline in the value of the
specified assets. The amount of collateral we may be required to
pledge and the payments we may be required to make under these
agreements may increase under certain circumstances, which could
adversely affect our liquidity.
36
In December 2007, we entered into an agreement with an
unaffiliated financial institution that referenced
$2.5 billion of
35-year
surplus notes issued by MetLife Reinsurance Company of
Charleston (MRC). Based on the decline in the
estimated fair value of MRCs surplus notes, we have
pledged collateral and made payments to the unaffiliated
financial institution. We may in the future be required to
pledge additional collateral or make additional payments to this
unaffiliated financial institution based on any further declines
in the estimated fair value of MRCs surplus notes. Any
collateral pledged by us under the agreement is required to be
held in a segregated account and remains on our balance sheet.
Any payments to the unaffiliated financial institution may
reduce the amount under the agreement on which our interest
payment was due but may not reduce the principal amount of the
surplus notes. Such payments have been accounted for as a
receivable and will not be realized until the termination of the
agreement with the unaffiliated financial institution.
Furthermore, with respect to any such payments, we have
unsecured risk to the unaffiliated financial institution as
these amounts are not required to be held in a third-party
custodial account or segregated from the unaffiliated financial
institutions funds. Such collateral pledged and payments
could have an adverse effect on our liquidity. See
Managements Discussion and Analysis of Financial
Condition and Results of Operations Liquidity and
Capital Resources The Company Liquidity
and Capital Uses Collateral Financing
Arrangements and Note 11 of the Notes to the
Consolidated Financial Statements.
Our
Statutory Reserve Financings May be Subject to Cost Increases
and New Financings May be Subject to Limited Market
Capacity
To support our level premium term life and universal life with
secondary guarantees businesses and MLICs closed block, we
currently utilize capital markets solutions for financing a
portion of our statutory reserve requirements. While we have
financing facilities in place for our previously written
business and have remaining capacity in existing facilities to
support writings through the end of 2009 or later, certain of
these facilities are subject to cost increases upon the
occurrence of specified ratings downgrades of MetLife or are
subject to periodic repricing. Any resulting cost increases
could negatively impact our financial results.
Further, the capacity for these reserve funding structures
available in the current marketplace is limited. If capacity
continues to be limited for a prolonged period of time, our
ability to obtain new funding for these structures may be
hindered, and as a result, our ability to write additional
business in a cost effective manner may be impacted.
Defaults
on Our Mortgage and Consumer Loans and Volatility in Performance
May Adversely Affect Our Profitability
Our mortgage and consumer loans face default risk and are
principally collateralized by commercial, agricultural and
residential properties, as well as automobiles. The carrying
value of mortgage and consumer loans is stated at original cost
net of repayments, amortization of premiums, accretion of
discounts and valuation allowances, except for residential
mortgage loans held-for-sale accounted for under the fair value
option which are carried at estimated fair value, as determined
on a recurring basis and certain commercial and residential
mortgage loans carried at the lower of cost or estimated fair
value, as determined on a nonrecurring basis. We establish
valuation allowances for estimated impairments as of the balance
sheet date. Such valuation allowances are based on the excess
carrying value of the loan over the present value of expected
future cash flows discounted at the loans original
effective interest rate, the value of the loans collateral
if the loan is in the process of foreclosure or otherwise
collateral dependent, or the loans estimated fair value if
the loan is held-for-sale. We also establish allowances for loan
losses when a loss contingency exists for pools of loans with
similar characteristics, such as mortgage loans based on similar
property types or loan to value risk factors. At
December 31, 2008, loans that were either delinquent or in
the process of foreclosure totaled less than 0.5% of our
mortgage and consumer loan investments. The performance of our
mortgage and consumer loan investments, however, may fluctuate
in the future. In addition, substantially all of our mortgage
loans held-for-investment have balloon payment maturities. An
increase in the default rate of our mortgage and consumer loan
investments could have a material adverse effect on our
business, results of operations and financial condition. See
Managements Discussion and Analysis of Financial
Condition and Results of Operations
Investments Mortgage and Consumer Loans.
Further, any geographic or sector concentration of our mortgage
or consumer loans may have adverse effects on our investment
portfolios and consequently on our consolidated results of
operations or financial condition.
37
While we seek to mitigate this risk by having a broadly
diversified portfolio, events or developments that have a
negative effect on any particular geographic region or sector
may have a greater adverse effect on the investment portfolios
to the extent that the portfolios are concentrated. Moreover,
our ability to sell assets relating to such particular groups of
related assets may be limited if other market participants are
seeking to sell at the same time. In addition, legislative
proposals that would allow or require modifications to the terms
of mortgage loans could be enacted. We cannot predict whether
these proposals will be adopted, or what impact, if any, such
proposals or, if enacted, such laws, could have on our business
or investments.
Our
Investments are Reflected Within the Consolidated Financial
Statements Utilizing Different Accounting Basis and Accordingly
We May Not Have Recognized Differences, Which May Be
Significant, Between Cost and Estimated Fair Value in our
Consolidated Financial Statements
Our principal investments are in fixed maturity and equity
securities, trading securities, short-term investments, mortgage
and consumer loans, policy loans, real estate, real estate joint
ventures and other limited partnerships and other invested
assets. The carrying value of such investments is as follows:
|
|
|
|
|
Fixed maturity and equity securities are classified as
available-for-sale, except for trading securities, and are
reported at their estimated fair value. Unrealized investment
gains and losses on these securities are recorded as a separate
component of other comprehensive income (loss), net of
policyholder related amounts and deferred income taxes.
|
|
|
|
Trading securities are recorded at estimated fair value with
subsequent changes in estimated fair value recognized in net
investment income.
|
|
|
|
Short-term investments include investments with remaining
maturities of one year or less, but greater than three months,
at the time of acquisition and are stated at amortized cost,
which approximates estimated fair value.
|
|
|
|
The carrying value of mortgage and consumer loans is stated at
original cost net of repayments, amortization of premiums,
accretion of discounts and valuation allowances, except for
residential mortgage loans held-for-sale accounted for under the
fair value option which are carried at estimated fair value, as
determined on a recurring basis and certain commercial and
residential mortgage loans carried at the lower of cost or
estimated fair value, as determined on a nonrecurring basis.
|
|
|
|
Policy loans are stated at unpaid principal balances.
|
|
|
|
Real estate held-for-investment, including related improvements,
is stated at cost, less accumulated depreciation.
|
|
|
|
Real estate joint ventures and other limited partnership
interests in which we have more than a minor equity interest or
more than a minor influence over the joint ventures or
partnerships operations, but where we do not have a
controlling interest and are not the primary beneficiary, are
carried using the equity method of accounting. We use the cost
method of accounting for investments in real estate joint
ventures and other limited partnership interests in which it has
a minor equity investment and virtually no influence over the
joint ventures or the partnerships operations.
|
|
|
|
Other invested assets consist principally of freestanding
derivatives with positive estimated fair values and leveraged
leases. Freestanding derivatives are carried at estimated fair
value with changes in estimated fair value reflected in income
for both non-qualifying derivatives and derivatives in fair
value hedging relationships. Derivatives in cash flow hedging
relationships are reflected as a separate component of other
comprehensive income (loss). Leveraged leases are recorded net
of non-recourse debt.
|
Investments not carried at estimated fair value in our
consolidated financial statements principally,
mortgage and consumer loans held-for-investment, policy loans,
real estate, real estate joint ventures, other limited
partnerships and leveraged leases may have estimated
fair values which are substantially higher or lower than the
carrying value reflected in our consolidated financial
statements. Each of such asset classes is regularly evaluated
for impairment under the accounting guidance appropriate to the
respective asset class.
38
Our
Valuation of Fixed Maturity, Equity and Trading Securities May
Include Methodologies, Estimations and Assumptions Which Are
Subject to Differing Interpretations and Could Result in Changes
to Investment Valuations that May Materially Adversely Affect
Our Results of Operations or Financial Condition
Fixed maturity, equity, trading securities and short-term
investments which are reported at estimated fair value on the
consolidated balance sheet represent the majority of our total
cash and invested assets. We have categorized these securities
into a three-level hierarchy, based on the priority of the
inputs to the respective valuation technique. The fair value
hierarchy gives the highest priority to quoted prices in active
markets for identical assets or liabilities
(Level 1) and the lowest priority to unobservable
inputs (Level 3). An asset or liabilitys
classification within the fair value hierarchy is based on the
lowest level of significant input to its valuation.
SFAS 157 defines the input levels as follows:
|
|
|
|
Level 1
|
Unadjusted quoted prices in active markets for identical assets
or liabilities. We define active markets based on average
trading volume for equity securities. The size of the bid/ask
spread is used as an indicator of market activity for fixed
maturity securities.
|
|
|
Level 2
|
Quoted prices in markets that are not active or inputs that are
observable either directly or indirectly. Level 2 inputs
include quoted prices for similar assets or liabilities other
than quoted prices in Level 1; quoted prices in markets
that are not active; or other inputs that are observable or can
be derived principally from or corroborated by observable market
data for substantially the full term of the assets or
liabilities.
|
|
|
Level 3
|
Unobservable inputs that are supported by little or no market
activity and are significant to the fair value of the assets or
liabilities. Unobservable inputs reflect the reporting
entitys own assumptions about the assumptions that market
participants would use in pricing the asset or liability.
Level 3 assets and liabilities include financial
instruments whose values are determined using pricing models,
discounted cash flow methodologies, or similar techniques, as
well as instruments for which the determination of fair value
requires significant management judgment or estimation.
|
At December 31, 2008, 11%, 80% and 9% of these securities
represented Level 1, Level 2 and Level 3,
respectively. The Level 1 securities primarily consist of
certain U.S. Treasury and agency fixed maturity securities;
exchange-traded common stock, and certain short-term
investments. The Level 2 assets include fixed maturity
securities priced principally through independent pricing
services using observable inputs. These fixed maturity
securities include most U.S. Treasury and agency securities
as well as the majority of U.S. and foreign corporate
securities, residential mortgage-backed securities, commercial
mortgage-backed securities, state and political subdivision
securities, foreign government securities, and asset-backed
securities. Equity securities classified as Level 2
primarily consist principally of non-redeemable preferred
securities and certain equity securities where market quotes are
available but are not considered actively traded and are priced
by independent pricing services. Management reviews the
valuation methodologies used by the independent pricing services
on an ongoing basis and ensures that any changes to valuation
methodologies are justified. Level 3 assets include fixed
maturity securities priced principally through independent
non-binding broker quotations or market standard valuation
methodologies using inputs that are not market observable or
cannot be derived principally from or corroborated by observable
market data. This level consists of less liquid fixed maturity
securities with very limited trading activity or where less
price transparency exists around the inputs to the valuation
methodologies including: U.S. and foreign corporate
securities including below investment grade private
placements; residential mortgage-backed securities; and asset
backed securities including all of those supported
by sub-prime mortgage loans. Equity securities classified as
Level 3 securities consist principally of common stock of
privately held companies and non-redeemable preferred securities
where there has been very limited trading activity or where less
price transparency exists around the inputs to the valuation.
See Note 24 of the Notes to the Consolidated Financial
Statements for the estimated fair values of these assets and
liabilities by hierarchy level.
Prices provided by independent pricing services and independent
non-binding broker quotations can vary widely even for the same
security.
39
The determination of estimated fair values by management in the
absence of quoted market prices is based on: (i) valuation
methodologies; (ii) securities we deem to be comparable;
and (iii) assumptions deemed appropriate given the
circumstances. The fair value estimates are made at a specific
point in time, based on available market information and
judgments about financial instruments, including estimates of
the timing and amounts of expected future cash flows and the
credit standing of the issuer or counterparty. Factors
considered in estimating fair value include: coupon rate,
maturity, estimated duration, call provisions, sinking fund
requirements, credit rating, industry sector of the issuer, and
quoted market prices of comparable securities. The use of
different methodologies and assumptions may have a material
effect on the estimated fair value amounts.
During periods of market disruption including periods of
significantly rising or high interest rates, rapidly widening
credit spreads or illiquidity, it may be difficult to value
certain of our securities, for example Alt-A and sub-prime
mortgage-backed securities and commercial mortgage-backed
securities, if trading becomes less frequent
and/or
market data becomes less observable. There may be certain asset
classes that were in active markets with significant observable
data that become illiquid due to the current financial
environment. In such cases, more securities may fall to
Level 3 and thus require more subjectivity and management
judgment. As such, valuations may include inputs and assumptions
that are less observable or require greater estimation as well
as valuation methods which are more sophisticated or require
greater estimation thereby resulting in values which may be
greater or less than the value at which the investments may be
ultimately sold. Further, rapidly changing and unprecedented
credit and equity market conditions could materially impact the
valuation of securities as reported within our consolidated
financial statements and the period-to-period changes in value
could vary significantly. Decreases in value may have a material
adverse effect on our results of operations or financial
condition.
Some
of Our Investments Are Relatively Illiquid and Are in Asset
Classes that Have Been Experiencing Significant Market Valuation
Fluctuations
We hold certain investments that may lack liquidity, such as
privately placed fixed maturity securities; mortgage and
consumer loans; policy loans and leveraged leases; equity real
estate, including real estate joint ventures; and other limited
partnership interests. These asset classes represented 33.7% of
the carrying value of our total cash and invested assets at
December 31, 2008. Even some of our very high quality
assets have been more illiquid as a result of the recent
challenging market conditions.
If we require significant amounts of cash on short notice in
excess of normal cash requirements or are required to post or
return collateral in connection with our investment portfolio,
derivatives transactions or securities lending activities, we
may have difficulty selling these investments in a timely
manner, be forced to sell them for less than we otherwise would
have been able to realize, or both.
The reported value of our relatively illiquid types of
investments, our investments in the asset classes described
above and, at times, our high quality, generally liquid asset
classes, do not necessarily reflect the lowest current market
price for the asset. If we were forced to sell certain of our
assets in the current market, there can be no assurance that we
will be able to sell them for the prices at which we have
recorded them and we may be forced to sell them at significantly
lower prices.
The
Determination of the Amount of Allowances and Impairments Taken
on Our Investments is Highly Subjective and Could Materially
Impact Our Results of Operations or Financial
Position
The determination of the amount of allowances and impairments
varies by investment type and is based upon our periodic
evaluation and assessment of known and inherent risks associated
with the respective asset class. Such evaluations and
assessments are revised as conditions change and new information
becomes available. Management updates its evaluations regularly
and reflects changes in allowances and impairments in operations
as such evaluations are revised. There can be no assurance that
our management has accurately assessed the level of impairments
taken and allowances reflected in our consolidated financial
statements. Furthermore, additional impairments may need to be
taken or allowances provided for in the future. Historical
trends may not be indicative of future impairments or allowances.
For example, the cost of our fixed maturity and equity
securities is adjusted for impairments in value deemed to be
other-than-temporary in the period in which the determination is
made. The assessment of whether impairments
40
have occurred is based on managements
case-by-case
evaluation of the underlying reasons for the decline in
estimated fair value. The review of our fixed maturity and
equity securities for impairments includes an analysis of the
total gross unrealized losses by three categories of securities:
(i) securities where the estimated fair value has declined
and remained below cost or amortized cost by less than 20%;
(ii) securities where the estimated fair value has declined
and remained below cost or amortized cost by 20% or more for
less than six months; and (iii) securities where the
estimated fair value has declined and remained below cost or
amortized cost by 20% or more for six months or greater.
Additionally, our management considers a wide range of factors
about the security issuer and uses their best judgment in
evaluating the cause of the decline in the estimated fair value
of the security and in assessing the prospects for near-term
recovery. Inherent in managements evaluation of the
security are assumptions and estimates about the operations of
the issuer and its future earnings potential. Considerations in
the impairment evaluation process include, but are not limited
to: (i) the length of time and the extent to which the
market value has been below cost or amortized cost;
(ii) the potential for impairments of securities when the
issuer is experiencing significant financial difficulties;
(iii) the potential for impairments in an entire industry
sector or sub-sector; (iv) the potential for impairments in
certain economically depressed geographic locations;
(v) the potential for impairments of securities where the
issuer, series of issuers or industry has suffered a
catastrophic type of loss or has exhausted natural resources;
(vi) our ability and intent to hold the security for a
period of time sufficient to allow for the recovery of its value
to an amount equal to or greater than cost or amortized cost;
(vii) unfavorable changes in forecasted cash flows on
mortgage-backed and asset-backed securities; and
(viii) other subjective factors, including concentrations
and information obtained from regulators and rating agencies.
Gross
Unrealized Losses on Fixed Maturity and Equity Securities May be
Realized or Result in Future Impairments, Resulting in a
Reduction in Our Net Income
Fixed maturity and equity securities classified as
available-for-sale, except trading securities, are reported at
their estimated fair value. Unrealized gains or losses on
available-for-sale securities are recognized as a component of
other comprehensive income (loss) and are, therefore, excluded
from net income. Our gross unrealized losses on fixed maturity
and equity securities at December 31, 2008 were
$29.8 billion. The portion of the $29.8 billion of
gross unrealized losses for fixed maturity and equity securities
where the estimated fair value has declined and remained below
amortized cost or cost by 20% or more for six months or greater
was $4.0 billion at December 31, 2008. The accumulated
change in estimated fair value of these available-for-sale
securities is recognized in net income when the gain or loss is
realized upon the sale of the security or in the event that the
decline in estimated fair value is determined to be
other-than-temporary and an impairment charge is taken. Realized
losses or impairments may have a material adverse affect on our
net income in a particular quarterly or annual period.
Changes
in Market Interest Rates May Significantly Affect Our
Profitability
Some of our products, principally traditional whole life
insurance, fixed annuities and guaranteed investment contracts
(GICs), expose us to the risk that changes in
interest rates will reduce our spread, or the
difference between the amounts that we are required to pay under
the contracts in our general account and the rate of return we
are able to earn on general account investments intended to
support obligations under the contracts. Our spread is a key
component of our net income.
As interest rates decrease or remain at low levels, we may be
forced to reinvest proceeds from investments that have matured
or have been prepaid or sold at lower yields, reducing our
investment margin. Moreover, borrowers may prepay or redeem the
fixed-income securities, commercial mortgages and
mortgage-backed securities in our investment portfolio with
greater frequency in order to borrow at lower market rates,
which exacerbates this risk. Lowering interest crediting rates
can help offset decreases in investment margins on some
products. However, our ability to lower these rates could be
limited by competition or contractually guaranteed minimum rates
and may not match the timing or magnitude of changes in asset
yields. As a result, our spread could decrease or potentially
become negative. Our expectation for future spreads is an
important component in the amortization of DAC and VOBA and
significantly lower spreads may cause us to accelerate
amortization, thereby reducing net income in the affected
reporting period. In addition, during periods of declining
interest rates, life insurance and annuity products may be
relatively more attractive investments to consumers, resulting
in increased premium payments on products
41
with flexible premium features, repayment of policy loans and
increased persistency, or a higher percentage of insurance
policies remaining in force from year to year, during a period
when our new investments carry lower returns. A decline in
market interest rates could also reduce our return on
investments that do not support particular policy obligations.
Accordingly, declining interest rates may materially adversely
affect our results of operations, financial position and cash
flows and significantly reduce our profitability.
The sufficiency of our reserves in Taiwan is highly sensitive to
interest rates and other related assumptions. This is due to the
sustained low interest rate environment in Taiwan coupled with
long-term interest rate guarantees of approximately 6% embedded
in the life and health contracts sold prior to 2003 and the lack
of availability of long-duration assets in the Taiwanese capital
markets to match such long-duration liabilities. The key
assumptions utilized include that current Taiwan government bond
yield rates increase from current levels of 1.6% to 2.7% over
the next ten years, mortality and morbidity levels remain
consistent with recent experience and that U.S. dollar
assets make up 35% of total assets backing reserves. Current
reserve adequacy analysis shows that provisions are adequate;
however, adverse changes in key assumptions for interest rates,
exchange rates, and mortality and morbidity levels or lapse
rates could lead to a need to strengthen reserves and therefore
for additional capital.
Increases in market interest rates could also negatively affect
our profitability. In periods of rapidly increasing interest
rates, we may not be able to replace, in a timely manner, the
assets in MetLifes general account with higher yielding
assets needed to fund the higher crediting rates necessary to
keep interest sensitive products competitive. We, therefore, may
have to accept a lower spread and, thus, lower profitability or
face a decline in sales and greater loss of existing contracts
and related assets. In addition, policy loans, surrenders and
withdrawals may tend to increase as policyholders seek
investments with higher perceived returns as interest rates
rise. This process may result in cash outflows requiring that we
sell invested assets at a time when the prices of those assets
are adversely affected by the increase in market interest rates,
which may result in realized investment losses. Unanticipated
withdrawals and terminations may cause us to accelerate the
amortization of DAC and VOBA, which would increase our current
expenses and reduce net income. An increase in market interest
rates could also have a material adverse effect on the value of
our investment portfolio, for example, by decreasing the
estimated fair values of the fixed income securities that
comprise a substantial portion of our investment portfolio.
Consolidation
of Distributors of Insurance Products May Adversely Affect the
Insurance Industry and the Profitability of Our
Business
The insurance industry distributes many of its individual
products through other financial institutions such as banks and
broker-dealers. As capital, credit and equity markets continue
to experience volatility, bank and broker-dealer consolidation
activity may increase and negatively impact the industrys
sales, and such consolidation could increase competition for
access to distributors, result in greater distribution expenses
and impair our ability to market insurance products to our
current customer base or to expand our customer base.
Industry
Trends Could Adversely Affect the Profitability of Our
Businesses
Our business segments continue to be influenced by a variety of
trends that affect the insurance industry, including intense
competition with respect to product features, price,
distribution capability, customer service and information
technology. See Managements Discussion and Analysis
of Financial Condition and Results of Operations
Industry Trends. The impact on our business and on the
life insurance industry generally of the volatility and
instability of the financial markets is difficult to predict,
and our business plans, financial condition and results of
operations may be negatively impacted or affected in other
unexpected ways. In addition, the life insurance industry is
subject to state regulation, and, as complex products are
introduced, regulators may refine capital requirements and
introduce new reserving standards. Furthermore, regulators have
undertaken market and sales practices reviews of several markets
or products, including equity-indexed annuities, variable
annuities and group products. The current market environment may
also lead to changes in regulation that may benefit or
disadvantage us relative to some of our competitors. See
Competitive Factors May Adversely Affect Our
Market Share and Profitability and
Business Competition.
42
A
Decline in Equity Markets or an Increase in Volatility in Equity
Markets May Adversely Affect Sales of Our Investment Products
and Our Profitability
Significant downturns and volatility in equity markets could
have a material adverse effect on our financial condition and
results of operations in three principal ways.
First, equity market downturns and volatility may discourage
purchases of separate account products, such as variable
annuities and variable life insurance that have underlying
mutual funds with returns linked to the performance of the
equity markets and may cause some of our existing customers to
withdraw cash values or reduce investments in those products.
Second, downturns and volatility in equity markets can have a
material adverse effect on the revenues and returns from our
savings and investment products and services. Because these
products and services depend on fees related primarily to the
value of assets under management, a decline in the equity
markets could reduce our revenues by reducing the value of the
investment assets we manage. The retail annuity business in
particular is highly sensitive to equity markets, and a
sustained weakness in the equity markets will decrease revenues
and earnings in variable annuity products.
Third, we provide certain guarantees within some of our products
that protect policyholders against significant downturns in the
equity markets. For example, we offer variable annuity products
with guaranteed features, such as death benefits, withdrawal
benefits, and minimum accumulation and income benefits. In
volatile or declining equity market conditions, we may need to
increase liabilities for future policy benefits and policyholder
account balances, negatively affecting net income.
If Our
Business Does Not Perform Well, We May Be Required to Recognize
an Impairment of Our Goodwill or Other Long-Lived Assets or to
Establish a Valuation Allowance Against the Deferred Income Tax
Asset, Which Could Adversely Affect Our Results of Operations or
Financial Condition
Goodwill represents the excess of the amounts we paid to acquire
subsidiaries and other businesses over the estimated fair value
of their net assets at the date of acquisition. We test goodwill
at least annually for impairment. Impairment testing is
performed based upon estimates of the fair value of the
reporting unit to which the goodwill relates. The
reporting unit is the operating segment or a business one level
below that operating segment if discrete financial information
is prepared and regularly reviewed by management at that level.
The estimated fair value of the reporting unit is impacted by
the performance of the business. The performance of our
businesses may be adversely impacted by prolonged market
declines. If it is determined that the goodwill has been
impaired, MetLife must write down the goodwill by the amount of
the impairment, with a corresponding charge to net income. Such
write downs could have a material adverse effect on our results
of operations or financial position. See
Managements Discussion and Analysis of
Financial Condition and Results of Operations
Summary of Critical Accounting Estimates
Goodwill.
Long-lived assets, including assets such as real estate, also
require impairment testing to determine whether changes in
circumstances indicate that MetLife will be unable to recover
the carrying amount of the asset group through future operations
of that asset group or market conditions that will impact the
value of those assets. Such write downs could have a material
adverse effect on our results of operations or financial
position.
Deferred income tax represents the tax effect of the differences
between the book and tax basis of assets and liabilities.
Deferred tax assets are assessed periodically by management to
determine if they are realizable. Factors in managements
determination include the performance of the business including
the ability to generate future taxable income. If based on
available information, it is more likely than not that the
deferred income tax asset will not be realized then a valuation
allowance must be established with a corresponding charge to net
income. Such charges could have a material adverse effect on our
results of operations or financial position.
Further or continued deterioration of financial market
conditions could result in a decrease in the expected future
earnings of our reporting units, which could lead to an
impairment of some or all of the goodwill associated with them
in future periods. Such deterioration could also result in the
impairment of long-lived assets and the establishment of a
valuation allowance on our deferred income tax assets.
43
Competitive
Factors May Adversely Affect Our Market Share and
Profitability
Our business segments are subject to intense competition. We
believe that this competition is based on a number of factors,
including service, product features, scale, price, financial
strength, claims-paying ratings, credit ratings,
e-business
capabilities and name recognition. We compete with a large
number of other insurers, as well as non-insurance financial
services companies, such as banks, broker-dealers and asset
managers, for individual consumers, employers and other group
customers and agents and other distributors of insurance and
investment products. Some of these companies offer a broader
array of products, have more competitive pricing or, with
respect to other insurers, have higher claims paying ability
ratings. Some may also have greater financial resources with
which to compete. National banks, which may sell annuity
products of life insurers in some circumstances, also have
pre-existing customer bases for financial services products.
Many of our insurance products, particularly those offered by
our Institutional segment, are underwritten annually, and,
accordingly, there is a risk that group purchasers may be able
to obtain more favorable terms from competitors rather than
renewing coverage with us. The effect of competition may, as a
result, adversely affect the persistency of these and other
products, as well as our ability to sell products in the future.
In addition, the investment management and securities brokerage
businesses have relatively few barriers to entry and continually
attract new entrants. Many of our competitors in these
businesses offer a broader array of investment products and
services and are better known than we are as sellers of
annuities and other investment products. See
Business Competition.
Finally, the choices made by the U.S. Treasury in the
administration of EESA and in its distribution of amounts
available thereunder could have the effect of supporting some
parts of the financial system more than others. See
There Can be No Assurance that Actions
of the U.S. Government, Federal Reserve Bank of New York
and Other Governmental and Regulatory Bodies for the Purpose of
Stabilizing the Financial Markets Will Achieve the Intended
Effect.
We May
be Unable to Attract and Retain Sales Representatives for Our
Products
We must attract and retain productive sales representatives to
sell our insurance, annuities and investment products. Strong
competition exists among insurers for sales representatives with
demonstrated ability. In addition, there is competition for
representatives with other types of financial services firms,
such as independent broker-dealers. We compete with other
insurers for sales representatives primarily on the basis of our
financial position, support services and compensation and
product features. We continue to undertake several initiatives
to grow our career agency force while continuing to enhance the
efficiency and production of our existing sales force. We cannot
provide assurance that these initiatives will succeed in
attracting and retaining new agents. Sales of individual
insurance, annuities and investment products and our results of
operations and financial condition could be materially adversely
affected if we are unsuccessful in attracting and retaining
agents. See Business Competition.
Differences
Between Actual Claims Experience and Underwriting and Reserving
Assumptions May Adversely Affect Our Financial
Results
Our earnings significantly depend upon the extent to which our
actual claims experience is consistent with the assumptions we
use in setting prices for our products and establishing
liabilities for future policy benefits and claims. Our
liabilities for future policy benefits and claims are
established based on estimates by actuaries of how much we will
need to pay for future benefits and claims. For life insurance
and annuity products, we calculate these liabilities based on
many assumptions and estimates, including estimated premiums to
be received over the assumed life of the policy, the timing of
the event covered by the insurance policy, the amount of
benefits or claims to be paid and the investment returns on the
assets we purchase with the premiums we receive. We establish
liabilities for property and casualty claims and benefits based
on assumptions and estimates of damages and liabilities
incurred. To the extent that actual claims experience is less
favorable than the underlying assumptions we used in
establishing such liabilities, we could be required to increase
our liabilities.
Due to the nature of the underlying risks and the high degree of
uncertainty associated with the determination of liabilities for
future policy benefits and claims, we cannot determine precisely
the amounts which we will
44
ultimately pay to settle our liabilities. Such amounts may vary
from the estimated amounts, particularly when those payments may
not occur until well into the future. We evaluate our
liabilities periodically based on changes in the assumptions
used to establish the liabilities, as well as our actual
experience. We charge or credit changes in our liabilities to
expenses in the period the liabilities are established or
re-estimated. If the liabilities originally established for
future benefit payments prove inadequate, we must increase them.
Such increases could affect earnings negatively and have a
material adverse effect on our business, results of operations
and financial condition.
Our
Risk Management Policies and Procedures May Leave Us Exposed to
Unidentified or Unanticipated Risk, Which Could Negatively
Affect Our Business
Management of risk requires, among other things, policies and
procedures to record properly and verify a large number of
transactions and events. We have devoted significant resources
to develop our risk management policies and procedures and
expect to continue to do so in the future. Nonetheless, our
policies and procedures may not be comprehensive. Many of our
methods for managing risk and exposures are based upon the use
of observed historical market behavior or statistics based on
historical models. As a result, these methods may not fully
predict future exposures, which can be significantly greater
than our historical measures indicate. Other risk management
methods depend upon the evaluation of information regarding
markets, clients, catastrophe occurrence or other matters that
is publicly available or otherwise accessible to us. This
information may not always be accurate, complete, up-to-date or
properly evaluated. See Quantitative and Qualitative
Disclosures About Market Risk.
Change
in Our Discount Rate, Expected Rate of Return and Expected
Compensation Increase Assumptions for Our Pension and Other
Postretirement Benefit Plans May Result in Increased Expenses
and Reduce Our Profitability
We determine our pension and other postretirement benefit plan
costs based on our best estimates of future plan experience.
These assumptions are reviewed regularly and include discount
rates, expected rates of return on plan assets and expected
increases in compensation levels and expected medical inflation.
Changes in these assumptions may result in increased expenses
and reduce our profitability. See Managements
Discussion and Analysis of Financial Condition and Results of
Operations Pensions and Other Postretirement Benefit
Plans and Note 17 of the Notes to the Consolidated
Financial Statements for details on how changes in these
assumptions would affect plan costs.
Catastrophes
May Adversely Impact Liabilities for Policyholder Claims and
Reinsurance Availability
Our life insurance operations are exposed to the risk of
catastrophic mortality, such as a pandemic or other event that
causes a large number of deaths. Significant influenza pandemics
have occurred three times in the last century, but neither the
likelihood, timing, nor the severity of a future pandemic can be
predicted. The effectiveness of external parties, including
governmental and non-governmental organizations, in combating
the spread and severity of such a pandemic could have a material
impact on the losses experienced by us. In our group insurance
operations, a localized event that affects the workplace of one
or more of our group insurance customers could cause a
significant loss due to mortality or morbidity claims. These
events could cause a material adverse effect on our results of
operations in any period and, depending on their severity, could
also materially and adversely affect our financial condition.
Our Auto & Home business has experienced, and will
likely in the future experience, catastrophe losses that may
have a material adverse impact on the business, results of
operations and financial condition of the Auto & Home
segment. Although Auto & Home makes every effort to
manage our exposure to catastrophic risks through volatility
management and reinsurance programs, these efforts do not
eliminate all risk. Catastrophes can be caused by various
events, including pandemics, hurricanes, windstorms,
earthquakes, hail, tornadoes, explosions, severe winter weather
(including snow, freezing water, ice storms and blizzards),
fires and man-made events such as terrorist attacks.
Historically, substantially all of our catastrophe-related
claims have related to homeowners coverages. However,
catastrophes may also affect other Auto & Home
coverages. Due to their nature, we cannot predict the incidence,
timing and severity of catastrophes. In addition, changing
climate conditions, primarily rising global temperatures, may be
increasing, or may in the future increase, the frequency and
severity of natural catastrophes such as hurricanes.
45
Hurricanes and earthquakes are of particular note for our
homeowners coverages. Areas of major hurricane exposure include
coastal sections of the northeastern United States (including
lower New York, Connecticut, Rhode Island and Massachusetts),
the Gulf Coast (including Alabama, Mississippi, Louisiana and
Texas) and Florida. We also have some earthquake exposure,
primarily along the New Madrid fault line in the central United
States and in the Pacific Northwest.
The extent of losses from a catastrophe is a function of both
the total amount of insured exposure in the area affected by the
event and the severity of the event. Most catastrophes are
restricted to small geographic areas; however, pandemics,
hurricanes, earthquakes and man-made catastrophes may produce
significant damage in larger areas, especially those that are
heavily populated. Claims resulting from natural or man-made
catastrophic events could cause substantial volatility in our
financial results for any fiscal quarter or year and could
materially reduce our profitability or harm our financial
condition. Also, catastrophic events could harm the financial
condition of our reinsurers and thereby increase the probability
of default on reinsurance recoveries. Our ability to write new
business could also be affected. It is possible that increases
in the value, caused by the effects of inflation or other
factors, and geographic concentration of insured property, could
increase the severity of claims from catastrophic events in the
future.
Most of the jurisdictions in which our insurance subsidiaries
are admitted to transact business require life and property and
casualty insurers doing business within the jurisdiction to
participate in guaranty associations, which are organized to pay
contractual benefits owed pursuant to insurance policies issued
by impaired, insolvent or failed insurers. These associations
levy assessments, up to prescribed limits, on all member
insurers in a particular state on the basis of the proportionate
share of the premiums written by member insurers in the lines of
business in which the impaired, insolvent or failed insurer is
engaged. In addition, certain states have government owned or
controlled organizations providing life and property and
casualty insurance to their citizens. The activities of such
organizations could also place additional stress on the adequacy
of guaranty fund assessments. Many of these organizations also
have the power to levy assessments similar to those of the
guaranty associations described above. Some states permit member
insurers to recover assessments paid through full or partial
premium tax offsets. See Business
Regulation Insurance Regulation Guaranty
Associations and Similar Arrangements.
While in the past five years, the aggregate assessments levied
against MetLife have not been material, it is possible that a
large catastrophic event could render such guaranty funds
inadequate and we may be called upon to contribute additional
amounts, which may have a material impact on our financial
condition or results of operations in a particular period. We
have established liabilities for guaranty fund assessments that
we consider adequate for assessments with respect to insurers
that are currently subject to insolvency proceedings, but
additional liabilities may be necessary. See
Managements Discussion and Analysis of Financial
Condition and Results of Operations Insolvency
Assessments.
Consistent with industry practice and accounting standards, we
establish liabilities for claims arising from a catastrophe only
after assessing the probable losses arising from the event. We
cannot be certain that the liabilities we have established will
be adequate to cover actual claim liabilities. From time to
time, states have passed legislation that has the effect of
limiting the ability of insurers to manage risk, such as
legislation restricting an insurers ability to withdraw
from catastrophe-prone areas. While we attempt to limit our
exposure to acceptable levels, subject to restrictions imposed
by insurance regulatory authorities, a catastrophic event or
multiple catastrophic events could have a material adverse
effect on our business, results of operations and financial
condition.
Our ability to manage this risk and the profitability of our
property and casualty and life insurance businesses depends in
part on our ability to obtain catastrophe reinsurance, which may
not be available at commercially acceptable rates in the future.
See Reinsurance May Not Be Available,
Affordable or Adequate to Protect Us Against Losses.
A
Downgrade or a Potential Downgrade in Our Financial Strength or
Credit Ratings Could Result in a Loss of Business and Materially
Adversely Affect Our Financial Condition and Results of
Operations
Financial strength ratings, which various Nationally Recognized
Statistical Rating Organizations (NRSROs) publish as
indicators of an insurance companys ability to meet
contractholder and policyholder
46
obligations, are important to maintaining public confidence in
our products, our ability to market our products and our
competitive position. See Business Company
Ratings Insurer Financial Strength Ratings.
Downgrades in our financial strength ratings could have a
material adverse effect on our financial condition and results
of operations in many ways, including:
|
|
|
|
|
reducing new sales of insurance products, annuities and other
investment products;
|
|
|
|
adversely affecting our relationships with our sales force and
independent sales intermediaries;
|
|
|
|
materially increasing the number or amount of policy surrenders
and withdrawals by contractholders and policyholders;
|
|
|
|
requiring us to reduce prices for many of our products and
services to remain competitive; and
|
|
|
|
adversely affecting our ability to obtain reinsurance at
reasonable prices or at all.
|
In addition to the financial strength ratings of our insurance
subsidiaries, various NRSROs also publish credit ratings for
MetLife, Inc. and several of its subsidiaries. Credit ratings
are indicators of a debt issuers ability to meet the terms
of debt obligations in a timely manner and are important factors
in our overall funding profile and ability to access certain
types of liquidity. See Business Company
Ratings Credit Ratings. Downgrades in our
credit ratings could have a material adverse effect on our
financial condition and results of operations in many ways,
including adversely limiting our access to capital markets,
potentially increasing the cost of debt, and requiring us to
post collateral. A two-notch decrease in the financial strength
ratings of our insurance company subsidiaries would require us
to post less than $200 million of collateral in connection
with derivative collateral arrangements, to which we are a party
and would have allowed holders of $500 million aggregate
account value of our funding agreements to terminate such
funding agreements on 90 days notice.
In view of the difficulties experienced recently by many
financial institutions, including our competitors in the
insurance industry, we believe it is possible that the NRSROs
will heighten the level of scrutiny that they apply to such
institutions, will increase the frequency and scope of their
credit reviews, will request additional information from the
companies that they rate, and may adjust upward the capital and
other requirements employed in the NRSRO models for maintenance
of certain ratings levels. Rating agencies use an outlook
statement of positive, stable,
negative or developing to indicate a
medium- or long-term trend in credit fundamentals which, if
continued, may lead to a ratings change. A rating may have a
stable outlook to indicate that the rating is not
expected to change; however, a stable rating does
not preclude a rating agency from changing a rating at any time,
without notice. Certain rating agencies have recently revised
their outlook on the U.S. life insurance sector, as well as
MetLife, Inc.s and certain of its subsidiaries
insurer financial strength and credit ratings, from
stable to negative. Furthermore, the
insurer financial strength and credit ratings of MetLife, Inc.
and certain of its subsidiaries have also been recently
downgraded. See Business Company
Ratings Rating Actions.
We cannot predict what actions rating agencies may take, or what
actions we may take in response to the actions of rating
agencies, which could adversely affect our business. As with
other companies in the financial services industry, our ratings
could be downgraded at any time and without any notice by any
NRSRO.
An
Inability to Access Our Credit Facilities Could Result in a
Reduction in Our Liquidity and Lead to Downgrades in Our Credit
and Financial Strength Ratings
We have a $2.85 billion five-year revolving credit facility
that matures in June 2012, as well as other facilities which we
enter into in the ordinary course of business. See
Managements Discussion and Analysis of Financial
Condition and Results of Operations Liquidity and
Capital Resources Liquidity and Capital
Sources Credit Facilities and
Committed Facilities.
We rely on our credit facilities as a potential source of
liquidity. The availability of these facilities could be
critical to our credit and financial strength ratings and our
ability to meet our obligations as they come due, particularly
in the current market when alternative sources of credit are
tight. The credit facilities contain certain administrative,
reporting, legal and financial covenants. We must comply with
certain covenants under our credit
47
facilities (including the $2.85 billion five-year revolving
credit facility) that require us to maintain a specified minimum
consolidated net worth.
Our right to make borrowings under these facilities is subject
to the fulfillment of certain important conditions, including
our compliance with all covenants, and our ability to borrow is
also subject to the continued willingness and ability of the
lenders that are parties to the facilities to provide funds. Our
failure to comply with the covenants in the credit facilities or
fulfill the conditions to borrowings, or the failure of lenders
to fund their lending commitments (whether due to insolvency,
illiquidity or other reasons) in the amounts provided for under
the terms of the facilities, would restrict our ability to
access these credit facilities when needed and, consequently,
could have a material adverse effect on our financial condition
and results of operations.
Guarantees
Within Certain of Our Products that Protect Policyholders
Against Significant Downturns in Equity Markets May Decrease Our
Earnings, Increase the Volatility of Our Results if Hedging or
Risk Management Strategies Prove Ineffective, Result in Higher
Hedging Costs, Expose Us to Increased Counterparty Risk and
Result in Our Own Credit Exposure
Certain of our variable annuity products include guaranteed
benefit riders. These include guaranteed death benefits,
guaranteed withdrawal benefits, lifetime withdrawal guarantees,
guaranteed minimum accumulation benefits, and guaranteed minimum
income benefit riders. Periods of significant and sustained
downturns in equity markets, increased equity volatility, or
reduced interest rates could result in an increase in the
valuation of the future policy benefit or policyholder account
balance liabilities associated with such products, resulting in
a reduction to net income. We use reinsurance in combination
with derivative instruments to mitigate the liability exposure
and the volatility of net income associated with these
liabilities, and while we believe that these and other actions
have mitigated the risks related to these benefits, we remain
liable for the guaranteed benefits in the event that reinsurers
or derivative counterparties are unable or unwilling to pay. In
addition, we are subject to the risk that hedging and other
management procedures prove ineffective or that unanticipated
policyholder behavior or mortality, combined with adverse market
events, produces economic losses beyond the scope of the risk
management techniques employed. These, individually or
collectively, may have a material adverse effect on net income,
financial condition or liquidity. We are also subject to the
risk that the cost of hedging these guaranteed minimum benefits
increases, resulting in a reduction to net income. We also must
consider our own credit standing, which is not hedged, in the
valuation of certain of these liabilities. A decrease in our own
credit spread could cause the value of these liabilities to
increase, resulting in a reduction to net income.
If Our
Business Does Not Perform Well or if Actual Experience Versus
Estimates Used in Valuing and Amortizing DAC and VOBA Vary
Significantly, We May Be Required to Accelerate the Amortization
and/or Impair the DAC and VOBA Which Could Adversely Affect Our
Results of Operations or Financial Condition
We incur significant costs in connection with acquiring new and
renewal business. Those costs that vary with and are primarily
related to the production of new and renewal business are
deferred and referred to as DAC. The recovery of DAC is
dependent upon the future profitability of the related business.
The amount of future profit or margin is dependent principally
on investment returns in excess of the amounts credited to
policyholders, mortality, morbidity, persistency, interest
crediting rates, dividends paid to policyholders, expenses to
administer the business, creditworthiness of reinsurance
counterparties and certain economic variables, such as
inflation. Of these factors, we anticipate that investment
returns are most likely to impact the rate of amortization of
such costs. The aforementioned factors enter into
managements estimates of gross profits or margins, which
generally are used to amortize such costs. If the estimates of
gross profits or margins were overstated, then the amortization
of such costs would be accelerated in the period the actual
experience is known and would result in a charge to income.
Significant or sustained equity market declines could result in
an acceleration of amortization of the DAC related to variable
annuity and variable universal life contracts, resulting in a
charge to income. Such adjustments could have a material adverse
effect on our results of operations or financial condition.
VOBA reflects the estimated fair value of in-force contracts in
a life insurance company acquisition and represents the portion
of the purchase price that is allocated to the value of the
right to receive future cash flows from the insurance and
annuity contracts in-force at the acquisition date. VOBA is
based on actuarially determined
48
projections. Actual experience may vary from the projections.
Revisions to estimates result in changes to the amounts expensed
in the reporting period in which the revisions are made and
could result in an impairment and a charge to income. Also, as
VOBA is amortized similarly to DAC, an acceleration of the
amortization of VOBA would occur if the estimates of gross
profits or margins were overstated. Accordingly, the
amortization of such costs would be accelerated in the period in
which the actual experience is known and would result in a
charge to net income. Significant or sustained equity market
declines could result in an acceleration of amortization of the
VOBA related to variable annuity and variable universal life
contracts, resulting in a charge to income. Such adjustments
could have a material adverse effect on our results of
operations or financial condition.
See Managements Discussion and Analysis
of Financial Condition and Results of Operations
Summary of Critical Accounting Estimates Deferred
Policy Acquisition Costs and Value of Business Acquired
for further consideration of DAC and VOBA and the impact of
current market events during 2008.
Defaults,
Downgrades or Other Events Impairing the Value of Our Fixed
Maturity Securities Portfolio May Reduce Our
Earnings
We are subject to the risk that the issuers, or guarantors, of
fixed maturity securities we own may default on principal and
interest payments they owe us. We are also subject to the risk
that the underlying collateral within loan-backed securities,
including mortgage-backed securities, may default on principal
and interest payments causing an adverse change in cash flows
paid to our investment. At December 31, 2008, the fixed
maturity securities of $188.3 billion in our investment
portfolio represented 58.4% of our total cash and invested
assets. The occurrence of a major economic downturn (such as the
current downturn in the economy), acts of corporate malfeasance,
widening risk spreads, or other events that adversely affect the
issuers, guarantors or underlying collateral of these securities
could cause the value of our fixed maturity securities portfolio
and our net income to decline and the default rate of the fixed
maturity securities in our investment portfolio to increase. A
ratings downgrade affecting issuers or guarantors of particular
securities, or similar trends that could worsen the credit
quality of issuers, such as the corporate issuers of securities
in our investment portfolio, could also have a similar effect.
With economic uncertainty, credit quality of issuers or
guarantors could be adversely affected. Similarly, a ratings
downgrade affecting a loan-backed security we hold could
indicate the credit quality of that security has deteriorated.
Any event reducing the value of these securities other than on a
temporary basis could have a material adverse effect on our
business, results of operations and financial condition. Levels
of write down or impairment are impacted by our assessment of
the intent and ability to hold securities which have declined in
value until recovery. If we determine to reposition or realign
portions of the portfolio so as not to hold certain securities
in an unrealized loss position to recovery, then we will incur
an other than temporary impairment charge in the period that the
decision was made not to hold the security to recovery. In
addition, in January, 2009, Moodys revised its loss
projections for U.S. Alt-A residential mortgage-backed
securities (RMBS), and it is anticipated that Moodys will
be downgrading virtually all 2006 and 2007 Alt-A securities to
below investment grade, which will increase the percentage of
our portfolio that will be rated below investment grade.
Fluctuations
in Foreign Currency Exchange Rates and Foreign Securities
Markets Could Negatively Affect Our Profitability
We are exposed to risks associated with fluctuations in foreign
currency exchange rates against the U.S. dollar resulting
from our holdings of
non-U.S. dollar
denominated investments, investments in foreign subsidiaries and
net income from foreign operations. These risks relate to
potential decreases in value and income resulting from a
strengthening or weakening in foreign exchange rates versus the
U.S. dollar. In general, the weakening of foreign
currencies versus the U.S. dollar will adversely affect the
value of our
non-U.S. dollar
denominated investments and our investments in foreign
subsidiaries. Although we use foreign currency swaps and forward
contracts to mitigate foreign currency exchange rate risk, we
cannot provide assurance that these methods will be effective or
that our counterparties will perform their obligations. See
Quantitative and Qualitative Disclosures About Market
Risk.
From time to time, various emerging market countries have
experienced severe economic and financial disruptions, including
significant devaluations of their currencies. Our exposure to
foreign exchange rate risk is exacerbated by our investments in
emerging markets.
49
We have matched substantially all of our foreign currency
liabilities in our foreign subsidiaries with assets denominated
in their respective foreign currency, which limits the effect of
currency exchange rate fluctuation on local operating results;
however, fluctuations in such rates affect the translation of
these results into our consolidated financial statements.
Although we take certain actions to address this risk, foreign
currency exchange rate fluctuation could materially adversely
affect our reported results due to unhedged positions or the
failure of hedges to effectively offset the impact of the
foreign currency exchange rate fluctuation. See
Quantitative and Qualitative Disclosures About Market
Risk.
Our
International Operations Face Political, Legal, Operational and
Other Risks that Could Negatively Affect Those Operations or Our
Profitability
Our international operations face political, legal, operational
and other risks that we do not face in our domestic operations.
We face the risk of discriminatory regulation, nationalization
or expropriation of assets, price controls and exchange controls
or other restrictions that prevent us from transferring funds
from these operations out of the countries in which they operate
or converting local currencies we hold into U.S. dollars or
other currencies. Some of our foreign insurance operations are,
and are likely to continue to be, in emerging markets where
these risks are heightened. See Quantitative and
Qualitative Disclosures About Market Risk. In addition, we
rely on local sales forces in these countries and may encounter
labor problems resulting from workers associations and
trade unions in some countries. In Japan, China and India we
operate with local business partners with the resulting risk of
managing partner relationships to the business objectives. If
our business model is not successful in a particular country, we
may lose all or most of our investment in building and training
the sales force in that country.
We are currently planning to expand our international operations
in markets where we operate and in selected new markets. This
may require considerable management time, as well as
start-up
expenses for market development before any significant revenues
and earnings are generated. Operations in new foreign markets
may achieve low margins or may be unprofitable, and expansion in
existing markets may be affected by local economic and market
conditions. Therefore, as we expand internationally, we may not
achieve expected operating margins and our results of operations
may be negatively impacted.
In recent years, the operating environment in Argentina has been
very challenging. In Argentina, we are principally engaged in
the pension business. In December 2008, the Argentine government
nationalized private pensions and seized the pension funds
investments, eliminating the private pensions business in
Argentina. As a result, we will experience a reduction in the
operations future revenues and cash flows. The Argentine
government now controls all assets which previously were managed
by our Argentine pension operations. Further governmental or
legal actions related to our operations in Argentina could
negatively impact our operations in Argentina and result in
future losses.
See also Changes in Market Interest Rates May
Significantly Affect Our Profitability regarding the
impact of low interest rates on our Taiwanese operations.
Reinsurance
May Not Be Available, Affordable or Adequate to Protect Us
Against Losses
As part of our overall risk management strategy, we purchase
reinsurance for certain risks underwritten by our various
business segments. See Business Reinsurance
Activity. While reinsurance agreements generally bind the
reinsurer for the life of the business reinsured at generally
fixed pricing, market conditions beyond our control determine
the availability and cost of the reinsurance protection for new
business. In certain circumstances, the price of reinsurance for
business already reinsured may also increase. Any decrease in
the amount of reinsurance will increase our risk of loss and any
increase in the cost of reinsurance will, absent a decrease in
the amount of reinsurance, reduce our earnings. Accordingly, we
may be forced to incur additional expenses for reinsurance or
may not be able to obtain sufficient reinsurance on acceptable
terms, which could adversely affect our ability to write future
business or result in the assumption of more risk with respect
to those policies we issue.
50
If the
Counterparties to Our Reinsurance or Indemnification
Arrangements or to the Derivative Instruments We Use to Hedge
Our Business Risks Default or Fail to Perform, We May Be Exposed
to Risks We Had Sought to Mitigate, Which Could Materially
Adversely Affect Our Financial Condition and Results of
Operations
We use reinsurance, indemnification and derivative instruments
to mitigate our risks in various circumstances. In general,
reinsurance does not relieve us of our direct liability to our
policyholders, even when the reinsurer is liable to us.
Accordingly, we bear credit risk with respect to our reinsurers
and indemnitors. We cannot provide assurance that our reinsurers
will pay the reinsurance recoverables owed to us or that
indemnitors will honor their obligations now or in the future or
that they will pay these recoverables on a timely basis. A
reinsurers or indemnitors insolvency, inability or
unwillingness to make payments under the terms of reinsurance
agreements or indemnity agreements with us could have a material
adverse effect on our financial condition and results of
operations.
In addition, we use derivative instruments to hedge various
business risks. We enter into a variety of derivative
instruments, including options, forwards, interest rate, credit
default and currency swaps with a number of counterparties. See
Managements Discussion and Analysis of Financial
Condition and Results of Operations
Investments. If our counterparties fail or refuse to honor
their obligations under these derivative instruments, our hedges
of the related risk will be ineffective. This is a more
pronounced risk to us in view of the recent stresses suffered by
financial institutions. Such failure could have a material
adverse effect on our financial condition and results of
operations.
Our
Insurance Businesses Are Heavily Regulated, and Changes in
Regulation May Reduce Our Profitability and Limit Our
Growth
Our insurance operations are subject to a wide variety of
insurance and other laws and regulations. See
Business Regulation Insurance
Regulation. State insurance laws regulate most aspects of
our U.S. insurance businesses, and our insurance
subsidiaries are regulated by the insurance departments of the
states in which they are domiciled and the states in which they
are licensed. Our
non-U.S. insurance
operations are principally regulated by insurance regulatory
authorities in the jurisdictions in which they are domiciled and
operate.
State laws in the United States grant insurance regulatory
authorities broad administrative powers with respect to, among
other things:
|
|
|
|
|
licensing companies and agents to transact business;
|
|
|
|
calculating the value of assets to determine compliance with
statutory requirements;
|
|
|
|
mandating certain insurance benefits;
|
|
|
|
regulating certain premium rates;
|
|
|
|
reviewing and approving policy forms;
|
|
|
|
regulating unfair trade and claims practices, including through
the imposition of restrictions on marketing and sales practices,
distribution arrangements and payment of inducements;
|
|
|
|
regulating advertising;
|
|
|
|
protecting privacy;
|
|
|
|
establishing statutory capital and reserve requirements and
solvency standards;
|
|
|
|
fixing maximum interest rates on insurance policy loans and
minimum rates for guaranteed crediting rates on life insurance
policies and annuity contracts;
|
|
|
|
approving changes in control of insurance companies;
|
|
|
|
restricting the payment of dividends and other transactions
between affiliates; and
|
|
|
|
regulating the types, amounts and valuation of investments.
|
51
State insurance guaranty associations have the right to assess
insurance companies doing business in their state for funds to
help pay the obligations of insolvent insurance companies to
policyholders and claimants. Because the amount and timing of an
assessment is beyond our control, the liabilities that we have
currently established for these potential liabilities may not be
adequate. See Business Regulation
Insurance Regulation Guaranty Associations and
Similar Arrangements.
State insurance regulators and the NAIC regularly re-examine
existing laws and regulations applicable to insurance companies
and their products. Changes in these laws and regulations, or in
interpretations thereof, are often made for the benefit of the
consumer at the expense of the insurer and, thus, could have a
material adverse effect on our financial condition and results
of operations.
The NAIC and several states legislatures have considered
the need for regulations
and/or laws
to address agent or broker practices that have been the focus of
investigations of broker compensation in the State of New York
and in other jurisdictions. The NAIC adopted a Compensation
Disclosure Amendment to its Producers Licensing Model Act which,
if adopted by the states, would require disclosure by agents or
brokers to customers that insurers will compensate such agents
or brokers for the placement of insurance and documented
acknowledgement of this arrangement in cases where the customer
also compensates the agent or broker. Several states have
enacted laws similar to the NAIC amendment. We cannot predict
how many states may promulgate the NAIC amendment or alternative
regulations or the extent to which these regulations may have a
material adverse impact on our business.
Currently, the U.S. federal government does not directly
regulate the business of insurance. However, federal legislation
and administrative policies in several areas can significantly
and adversely affect insurance companies. These areas include
financial services regulation, securities regulation, pension
regulation, privacy, tort reform legislation and taxation. In
addition, various forms of direct federal regulation of
insurance have been proposed. In view of recent events involving
certain financial institutions and the financial markets, it is
possible that the U.S. federal government will heighten its
oversight of insurers such as us, including possibly through a
federal system of insurance regulation
and/or that
the oversight responsibilities and mandates of existing or newly
created regulatory bodies could change. We cannot predict
whether these or other proposals will be adopted, or what
impact, if any, such proposals or, if enacted, such laws, could
have on our business, financial condition or results of
operations.
Our international operations are subject to regulation in the
jurisdictions in which they operate, which in many ways is
similar to that of the state regulation outlined above. Many of
our customers and independent sales intermediaries also operate
in regulated environments. Changes in the regulations that
affect their operations also may affect our business
relationships with them and their ability to purchase or
distribute our products. Accordingly, these changes could have a
material adverse effect on our financial condition and results
of operations. See Our International
Operations Face Political, Legal, Operational and Other Risks
that Could Negatively Affect Those Operations or Our
Profitability.
Compliance with applicable laws and regulations is time
consuming and personnel-intensive, and changes in these laws and
regulations may materially increase our direct and indirect
compliance and other expenses of doing business, thus having a
material adverse effect on our financial condition and results
of operations.
From time to time, regulators raise issues during examinations
or audits of MetLife, Inc.s subsidiaries that could, if
determined adversely, have a material impact on us. We cannot
predict whether or when regulatory actions may be taken that
could adversely affect our operations. In addition, the
interpretations of regulations by regulators may change and
statutes may be enacted with retroactive impact, particularly in
areas such as accounting or statutory reserve requirements.
We are also subject to other regulations, including banking
regulations, and may in the future become subject to additional
regulations. See Business Regulation.
52
Litigation
and Regulatory Investigations Are Increasingly Common in Our
Businesses and May Result in Significant Financial Losses and
Harm to Our Reputation
We face a significant risk of litigation and regulatory
investigations and actions in the ordinary course of operating
our businesses, including the risk of class action lawsuits. Our
pending legal and regulatory actions include proceedings
specific to us and others generally applicable to business
practices in the industries in which we operate. In connection
with our insurance operations, plaintiffs lawyers may
bring or are bringing class actions and individual suits
alleging, among other things, issues relating to sales or
underwriting practices, claims payments and procedures, product
design, disclosure, administration, denial or delay of benefits
and breaches of fiduciary or other duties to customers.
Plaintiffs in class action and other lawsuits against us may
seek very large or indeterminate amounts, including punitive and
treble damages, and the damages claimed and the amount of any
probable and estimable liability, if any, may remain unknown for
substantial periods of time. See Legal Proceedings
and Note 16 of the Notes to the Consolidated Financial
Statements.
Due to the vagaries of litigation, the outcome of a litigation
matter and the amount or range of potential loss at particular
points in time may be inherently impossible to ascertain with
any degree of certainty. Inherent uncertainties can include how
fact finders will view individually and in their totality
documentary evidence, the credibility and effectiveness of
witnesses testimony, and how trial and appellate courts
will apply the law in the context of the pleadings or evidence
presented, whether by motion practice, or at trial or on appeal.
Disposition valuations are also subject to the uncertainty of
how opposing parties and their counsel will themselves view the
relevant evidence and applicable law.
On a quarterly and annual basis, we review relevant information
with respect to litigation and contingencies to be reflected in
our consolidated financial statements. The review includes
senior legal and financial personnel. Unless stated elsewhere
herein, estimates of possible losses or ranges of loss for
particular matters cannot in the ordinary course be made with a
reasonable degree of certainty. See Legal
Proceedings and Note 16 of the Notes to the
Consolidated Financial Statements. Liabilities are established
when it is probable that a loss has been incurred and the amount
of the loss can be reasonably estimated. Liabilities have been
established for a number of matters noted in Legal
Proceedings and Note 16 of the Notes to the
Consolidated Financial Statements. It is possible that some of
the matters could require us to pay damages or make other
expenditures or establish accruals in amounts that could not be
estimated at December 31, 2008.
MLIC and MetLife, Inc. have been named as defendants in several
lawsuits brought in connection with MLICs demutualization
in 2000. Although most of these lawsuits have been dismissed,
two have been certified as nationwide class action lawsuits.
MLIC and its affiliates also are currently defendants in
numerous lawsuits including class action lawsuits, alleging
improper marketing or sales of individual life insurance
policies, annuities, mutual funds or other products.
In addition, MLIC is a defendant in a large number of lawsuits
seeking compensatory and punitive damages for personal injuries
allegedly caused by exposure to asbestos or asbestos-containing
products. These lawsuits principally have focused on allegations
with respect to certain research, publication and other
activities of one or more of MLICs employees during the
period from the 1920s through approximately the
1950s and have alleged that MLIC learned or should have
learned of certain health risks posed by asbestos and, among
other things, improperly publicized or failed to disclose those
health risks. Additional litigation relating to these matters
may be commenced in the future. The ability of MLIC to estimate
its ultimate asbestos exposure is subject to considerable
uncertainty, and the conditions impacting its liability can be
dynamic and subject to change. The availability of reliable data
is limited and it is difficult to predict with any certainty the
numerous variables that can affect liability estimates,
including the number of future claims, the cost to resolve
claims, the disease mix and severity of disease in pending and
future claims, the impact of the number of new claims filed in a
particular jurisdiction and variations in the law in the
jurisdictions in which claims are filed, the possible impact of
tort reform efforts, the willingness of courts to allow
plaintiffs to pursue claims against MLIC when exposure took
place after the dangers of asbestos exposure were well known,
and the impact of any possible future adverse verdicts and their
amounts. The number of asbestos cases that may be brought or the
aggregate amount of any liability that MLIC may incur, and the
total amount paid in settlements in any given year are uncertain
and may vary significantly from year to year. Accordingly, it is
reasonably possible that our total exposure to asbestos claims
may be materially greater than
53
the liability recorded by us in our consolidated financial
statements and that future charges to income may be necessary.
The potential future charges could be material in the particular
quarterly or annual periods in which they are recorded.
We are also subject to various regulatory inquiries, such as
information requests, subpoenas and books and record
examinations, from state and federal regulators and other
authorities. A substantial legal liability or a significant
regulatory action against us could have a material adverse
effect on our business, financial condition and results of
operations. Moreover, even if we ultimately prevail in the
litigation, regulatory action or investigation, we could suffer
significant reputational harm, which could have a material
adverse effect on our business, financial condition and results
of operations, including our ability to attract new customers,
retain our current customers and recruit and retain employees.
Regulatory inquiries and litigation may cause volatility in the
price of stocks of companies in our industry.
We cannot give assurance that current claims, litigation,
unasserted claims probable of assertion, investigations and
other proceedings against us will not have a material adverse
effect on our business, financial condition or results of
operations. It is also possible that related or unrelated
claims, litigation, unasserted claims probable of assertion,
investigations and proceedings may be commenced in the future,
and we could become subject to further investigations and have
lawsuits filed or enforcement actions initiated against us. In
addition, increased regulatory scrutiny and any resulting
investigations or proceedings could result in new legal actions
and precedents and industry-wide regulations that could
adversely affect our business, financial condition and results
of operations.
Changes
in Accounting Standards Issued by the Financial Accounting
Standards Board or Other Standard-Setting Bodies May Adversely
Affect Our Financial Statements
Our financial statements are subject to the application of GAAP,
which is periodically revised
and/or
expanded. Accordingly, from time to time we are required to
adopt new or revised accounting standards issued by recognized
authoritative bodies, including the Financial Accounting
Standards Board. Market conditions have prompted accounting
standard setters to expose new guidance which further interprets
or seeks to revise accounting pronouncements related to
financial instruments, structures or transactions as well as to
issue new standards expanding disclosures. The impact of
accounting pronouncements that have been issued but not yet
implemented is disclosed in our annual and quarterly reports on
Form 10-K
and
Form 10-Q.
An assessment of proposed standards is not provided as such
proposals are subject to change through the exposure process
and, therefore, the effects on our financial statements cannot
be meaningfully assessed. It is possible that future accounting
standards we are required to adopt could change the current
accounting treatment that we apply to our consolidated financial
statements and that such changes could have a material adverse
effect on our financial condition and results of operations.
Further, the federal government, under the EESA, conducted an
investigation of fair value accounting during the fourth quarter
of 2008 and has granted the SEC the authority to suspend fair
value accounting for any registrant or group of registrants at
its discretion. The impact of such actions on registrants who
apply fair value accounting cannot be readily determined at this
time; however, actions taken by the federal government could
have a material adverse effect on the financial condition and
results of operations of companies, including ours, that apply
fair value accounting.
Changes
in U.S. Federal and State Securities Laws and Regulations May
Affect Our Operations and Our Profitability
Federal and state securities laws and regulations apply to
insurance products that are also securities,
including variable annuity contracts and variable life insurance
policies. As a result, some of MetLife, Inc.s subsidiaries
and their activities in offering and selling variable insurance
contracts and policies are subject to extensive regulation under
these securities laws. These subsidiaries issue variable annuity
contracts and variable life insurance policies through separate
accounts that are registered with the SEC as investment
companies under the Investment Company Act. Each registered
separate account is generally divided into sub-accounts, each of
which invests in an underlying mutual fund which is itself a
registered investment company under the Investment Company Act.
In addition, the variable annuity contracts and variable life
insurance policies issued by the separate accounts are
registered with the SEC under the Securities Act. Other
subsidiaries are registered with the SEC as
54
broker-dealers under the Exchange Act, and are members of, and
subject to, regulation by FINRA. Further, some of our
subsidiaries are registered as investment advisers with the SEC
under the Investment Advisers Act of 1940, and are also
registered as investment advisers in various states, as
applicable.
Federal and state securities laws and regulations are primarily
intended to ensure the integrity of the financial markets and to
protect investors in the securities markets, as well as protect
investment advisory or brokerage clients. These laws and
regulations generally grant regulatory agencies broad rulemaking
and enforcement powers, including the power to limit or restrict
the conduct of business for failure to comply with the
securities laws and regulations. Changes to these laws or
regulations that restrict the conduct of our business could have
a material adverse effect on our financial condition and results
of operations. In particular, changes in the regulations
governing the registration and distribution of variable
insurance products, such as changes in the regulatory standards
for suitability of variable annuity contracts or variable life
insurance policies, could have such a material adverse effect.
Changes
in Tax Laws, Tax Regulations, or Interpretations of Such Laws or
Regulations Could Increase Our Corporate Taxes; Changes in Tax
Laws Could Make Some of Our Products Less Attractive to
Consumers
Changes in tax laws, tax regulations, or interpretations of such
laws or regulations could increase our corporate taxes. Changes
in corporate tax rates could affect the value of deferred tax
assets and deferred tax liabilities. Furthermore, the value of
deferred tax assets could be impacted by future earnings levels.
Changes in tax laws could make some of our products less
attractive to consumers. A shift away from life insurance and
annuity contracts and other tax-deferred products would reduce
our income from sales of these products, as well as the assets
upon which we earn investment income.
We cannot predict whether any tax legislation impacting
corporate taxes or insurance products will be enacted, what the
specific terms of any such legislation will be or whether, if at
all, any legislation would have a material adverse effect on our
financial condition and results of operations.
We May
Need to Fund Deficiencies in Our Closed Block; Assets
Allocated to the Closed Block Benefit Only the Holders of Closed
Block Policies
MLICs plan of reorganization, as amended (the
Plan), required that we establish and operate an
accounting mechanism, known as a closed block, to ensure that
the reasonable dividend expectations of policyholders who own
certain individual insurance policies of MLIC are met. See
Note 9 of the Notes to the Consolidated Financial
Statements. We allocated assets to the closed block in an amount
that will produce cash flows which, together with anticipated
revenue from the policies included in the closed block, are
reasonably expected to be sufficient to support obligations and
liabilities relating to these policies, including, but not
limited to, provisions for the payment of claims and certain
expenses and tax, and to provide for the continuation of the
policyholder dividend scales in effect for 1999, if the
experience underlying such scales continues, and for appropriate
adjustments in such scales if the experience changes. We cannot
provide assurance that the closed block assets, the cash flows
generated by the closed block assets and the anticipated revenue
from the policies included in the closed block will be
sufficient to provide for the benefits guaranteed under these
policies. If they are not sufficient, we must fund the
shortfall. Even if they are sufficient, we may choose, for
competitive reasons, to support policyholder dividend payments
with our general account funds.
The closed block assets, the cash flows generated by the closed
block assets and the anticipated revenue from the policies in
the closed block will benefit only the holders of those
policies. In addition, to the extent that these amounts are
greater than the amounts estimated at the time the closed block
was funded, dividends payable in respect of the policies
included in the closed block may be greater than they would be
in the absence of a closed block. Any excess earnings will be
available for distribution over time only to closed block
policyholders.
55
The
Continued Threat of Terrorism and Ongoing Military Actions May
Adversely Affect the Level of Claim Losses We Incur and the
Value of Our Investment Portfolio
The continued threat of terrorism, both within the United States
and abroad, ongoing military and other actions and heightened
security measures in response to these types of threats may
cause significant volatility in global financial markets and
result in loss of life, property damage, additional disruptions
to commerce and reduced economic activity. Some of the assets in
our investment portfolio may be adversely affected by declines
in the equity markets and reduced economic activity caused by
the continued threat of terrorism. We cannot predict whether,
and the extent to which, companies in which we maintain
investments may suffer losses as a result of financial,
commercial or economic disruptions, or how any such disruptions
might affect the ability of those companies to pay interest or
principal on their securities. The continued threat of terrorism
also could result in increased reinsurance prices and reduced
insurance coverage and potentially cause us to retain more risk
than we otherwise would retain if we were able to obtain
reinsurance at lower prices. Terrorist actions also could
disrupt our operations centers in the United States or abroad.
In addition, the occurrence of terrorist actions could result in
higher claims under our insurance policies than anticipated. See
Difficult Conditions in the Global Capital
Markets and the Economy Generally May Materially Adversely
Affect Our Business and Results of Operations and These
Conditions May Not Improve in the Near Future.
The
Occurrence of Events Unanticipated In Our Disaster Recovery
Systems and Management Continuity Planning Could Impair Our
Ability to Conduct Business Effectively
In the event of a disaster such as a natural catastrophe, an
epidemic, an industrial accident, a blackout, a computer virus,
a terrorist attack or war, unanticipated problems with our
disaster recovery systems could have a material adverse impact
on our ability to conduct business and on our results of
operations and financial position, particularly if those
problems affect our computer-based data processing,
transmission, storage and retrieval systems and destroy valuable
data. We depend heavily upon computer systems to provide
reliable service. Despite our implementation of a variety of
security measures, our computer systems could be subject to
physical and electronic break-ins, and similar disruptions from
unauthorized tampering. In addition, in the event that a
significant number of our managers were unavailable in the event
of a disaster, our ability to effectively conduct business could
be severely compromised. These interruptions also may interfere
with our suppliers ability to provide goods and services
and our employees ability to perform their job
responsibilities.
We
Face Unforeseen Liabilities or Asset Impairments Arising from
Possible Acquisitions and Dispositions of Businesses or
Difficulties Integrating Such Businesses
We have engaged in dispositions and acquisitions of businesses
in the past, and expect to continue to do so in the future.
There could be unforeseen liabilities or asset impairments,
including goodwill impairments, that arise in connection with
the businesses that we may sell or the businesses that we may
acquire in the future. In addition, there may be liabilities or
asset impairments that we fail, or are unable, to discover in
the course of performing due diligence investigations on each
business that we have acquired or may acquire. Furthermore, the
use of our own funds as consideration in any acquisition would
consume capital resources that would no longer be available for
other corporate purposes.
Our ability to achieve certain benefits we anticipate from any
acquisitions of businesses will depend in large part upon our
ability to successfully integrate such businesses in an
efficient and effective manner. We may not be able to integrate
such businesses smoothly or successfully, and the process may
take loner than expected. The integration of operations may
require the dedication of significant management resources,
which may distract managements attention from day-to-day
business. If we are unable to successfully integrate the
operations of such acquired businesses, we may be unable to
realize the benefits we expect to achieve as a result of such
acquisitions and our business and results of operations may be
less than expected.
56
Guarantees
Within Certain of Our Variable Annuity Guarantee Riders that
Protect Policyholders Against Significant Downturns in Equity
Markets May Increase the Volatility of Our Results Related to
the Inclusion of an Own Credit Adjustment in the Estimated Fair
Value of the Liability for These Riders
In determining the valuation of certain variable annuity
guarantee rider liabilities that are carried at estimated fair
value, we must consider our own credit standing, which is not
hedged. A decrease in our own credit spread could cause the
value of these liabilities to increase, resulting in a reduction
to net income. An increase in our own credit spread could cause
the value of these liabilities to decrease, resulting in an
increase to net income. Because this credit adjustment is
determined, at least in part, by taking into consideration
publicly available information relating to our publicly-traded
debt (including related credit default swap spreads), the
overall condition of fixed income markets may impact this
adjustment. The credit premium implied in our publicly-traded
debt instruments may not always necessarily reflect our actual
credit rating or our claims paying ability. Recently, the
fixed-income markets have experienced a period of extreme
volatility which negatively impacted market liquidity and
increased credit spreads. The increase in credit default swap
spreads has at times been even more pronounced than in the fixed
income cash markets. In a broad based market downturn, this
increase in our own credit spread could result in net income
being relatively flat when a deterioration in other market
inputs required for the estimate of fair value would otherwise
result in a significant reduction in net income. The inclusion
of our own credit standing in this case has the effect of muting
the actual net income losses recognized. In subsequent periods,
if our credit spreads improve relative to the overall market, we
could have a reduction of net income in an overall improving
market.
As a
Holding Company, MetLife, Inc. Depends on the Ability of Its
Subsidiaries to Transfer Funds to It to Meet Its Obligations and
Pay Dividends
MetLife, Inc. is a holding company for its insurance and
financial subsidiaries and does not have any significant
operations of its own. Dividends from its subsidiaries and
permitted payments to it under its tax sharing arrangements with
its subsidiaries are its principal sources of cash to meet its
obligations and to pay preferred and common dividends. If the
cash MetLife, Inc. receives from its subsidiaries is
insufficient for it to fund its debt service and other holding
company obligations, MetLife, Inc. may be required to raise cash
through the incurrence of debt, the issuance of additional
equity or the sale of assets.
The payment of dividends and other distributions to MetLife,
Inc. by its insurance subsidiaries is regulated by insurance
laws and regulations. In general, dividends in excess of
prescribed limits require insurance regulatory approval. In
addition, insurance regulators may prohibit the payment of
dividends or other payments by its insurance subsidiaries to
MetLife, Inc. if they determine that the payment could be
adverse to our policyholders or contractholders. See
Business Regulation Insurance
Regulation and Note 18 of the Notes to the
Consolidated Financial Statements and Managements
Discussion and Analysis of Financial Condition and Results of
Operations Liquidity and Capital
Resources The Holding Company Liquidity
and Capital Sources Dividends.
Any payment of interest, dividends, distributions, loans or
advances by our foreign subsidiaries to MetLife, Inc. could be
subject to taxation or other restrictions on dividends or
repatriation of earnings under applicable law, monetary transfer
restrictions and foreign currency exchange regulations in the
jurisdiction in which such foreign subsidiaries operate. See
Our International Operations Face Political,
Legal, Operational and Other Risks That Could Negatively Affect
Those Operations or Our Profitability.
MetLife,
Inc.s Board of Directors May Control the Outcome of
Stockholder Votes on Many Matters Due to the Voting Provisions
of the MetLife Policyholder Trust
Under the Plan, we established the MetLife Policyholder Trust
(the Trust) to hold the shares of MetLife, Inc.
common stock allocated to eligible policyholders not receiving
cash or policy credits under the plan. As of February 20,
2009, 241,743,740 shares, or 29.6%, of the outstanding
shares of MetLife, Inc. common stock, are held in the Trust.
Because of the number of shares held in the Trust and the voting
provisions of the Trust, the Trust may affect the outcome of
matters brought to a stockholder vote.
Except on votes regarding certain fundamental corporate actions
described below, the trustee will vote all of the shares of
common stock held in the Trust in accordance with the
recommendations given by MetLife, Inc.s
57
Board of Directors to its stockholders or, if the board gives no
such recommendations, as directed by the board. As a result of
the voting provisions of the Trust, the Board of Directors may
be able to control votes on matters submitted to a vote of
stockholders, excluding those fundamental corporate actions, so
long as the Trust holds a substantial number of shares of common
stock.
If the vote relates to fundamental corporate actions specified
in the Trust, the trustee will solicit instructions from the
Trust beneficiaries and vote all shares held in the Trust in
proportion to the instructions it receives. These actions
include:
|
|
|
|
|
an election or removal of directors in which a stockholder has
properly nominated one or more candidates in opposition to a
nominee or nominees of MetLife, Inc.s Board of Directors
or a vote on a stockholders proposal to oppose a board
nominee for director, remove a director for cause or fill a
vacancy caused by the removal of a director by stockholders,
subject to certain conditions;
|
|
|
|
a merger or consolidation, a sale, lease or exchange of all or
substantially all of the assets, or a recapitalization or
dissolution, of MetLife, Inc., in each case requiring a vote of
stockholders under applicable Delaware law;
|
|
|
|
any transaction that would result in an exchange or conversion
of shares of common stock held by the Trust for cash, securities
or other property; and
|
|
|
|
any proposal requiring MetLife, Inc.s Board of Directors
to amend or redeem the rights under the stockholder rights plan,
other than a proposal with respect to which we have received
advice of nationally-recognized legal counsel to the effect that
the proposal is not a proper subject for stockholder action
under Delaware law.
|
If a vote concerns any of these fundamental corporate actions,
the trustee will vote all of the shares of common stock held by
the Trust in proportion to the instructions it received, which
will give disproportionate weight to the instructions actually
given by Trust beneficiaries.
State
Laws, Federal Laws, Our Certificate of Incorporation and By-Laws
and Our Stockholder Rights Plan May Delay, Deter or Prevent
Takeovers and Business Combinations that Stockholders Might
Consider in Their Best Interests
State laws and our certificate of incorporation and by-laws may
delay, deter or prevent a takeover attempt that stockholders
might consider in their best interests. For instance, they may
prevent stockholders from receiving the benefit from any premium
over the market price of MetLife, Inc.s common stock
offered by a bidder in a takeover context. Even in the absence
of a takeover attempt, the existence of these provisions may
adversely affect the prevailing market price of MetLife,
Inc.s common stock if they are viewed as discouraging
takeover attempts in the future.
Any person seeking to acquire a controlling interest in us would
face various regulatory obstacles which may delay, deter or
prevent a takeover attempt that stockholders of MetLife, Inc.
might consider in their best interests. First, the insurance
laws and regulations of the various states in which MetLife,
Inc.s insurance subsidiaries are organized may delay or
impede a business combination involving us. State insurance laws
prohibit an entity from acquiring control of an insurance
company without the prior approval of the domestic insurance
regulator. Under most states statutes, an entity is
presumed to have control of an insurance company if it owns,
directly or indirectly, 10% or more of the voting stock of that
insurance company or its parent company. We are also subject to
banking regulations, and may in the future become subject to
additional regulations. In addition, the Investment Company Act
would require approval by the contract owners of our variable
contracts in order to effectuate a change of control of any
affiliated investment adviser to a mutual fund underlying our
variable contracts. Finally, FINRA approval would be necessary
for a change of control of any FINRA registered broker-dealer
that is a direct or indirect subsidiary of MetLife, Inc.
In addition, Section 203 of the Delaware General
Corporation Law may affect the ability of an interested
stockholder to engage in certain business combinations,
including mergers, consolidations or acquisitions of additional
shares, for a period of three years following the time that the
stockholder becomes an interested
58
stockholder. An interested stockholder is
defined to include persons owning, directly or indirectly, 15%
or more of the outstanding voting stock of a corporation.
MetLife, Inc.s certificate of incorporation and by-laws
also contain provisions that may delay, deter or prevent a
takeover attempt that stockholders might consider in their best
interests. These provisions may adversely affect prevailing
market prices for MetLife, Inc.s common stock and include:
classification of MetLife, Inc.s Board of Directors into
three classes; a prohibition on the calling of special meetings
by stockholders; advance notice procedures for the nomination of
candidates to the Board of Directors and stockholder proposals
to be considered at stockholder meetings; and supermajority
voting requirements for the amendment of certain provisions of
the certificate of incorporation and by-laws.
The stockholder rights plan adopted by MetLife, Inc.s
Board of Directors may also have anti-takeover effects. The
stockholder rights plan is designed to protect MetLife,
Inc.s stockholders in the event of unsolicited offers to
acquire us and other coercive takeover tactics which, in the
opinion of MetLife, Inc.s Board of Directors, could impair
its ability to represent stockholder interests. The provisions
of the stockholder rights plan may render an unsolicited
takeover more difficult or less likely to occur or might prevent
such a takeover, even though such takeover may offer MetLife,
Inc.s stockholders the opportunity to sell their stock at
a price above the prevailing market price and may be favored by
a majority of MetLife, Inc.s stockholders.
|
|
Item 1B.
|
Unresolved
Staff Comments
|
MetLife has no unresolved comments from the SEC staff regarding
its periodic or current reports under the Exchange Act.
In December 2006, we signed a lease for 410,000 rentable
square feet of which 100,000 rentable square feet are
available for sublease in Manhattan, New York to be located on
12 floors. The term of the lease commenced during 2008 and will
continue for 21 years. We moved certain operations
(including certain associates working in the Institutional,
Individual and International segments, as well as
Corporate & Other), from Long Island City,
New York, to Manhattan in late 2008, but continue to
maintain an on-going presence in Long Island City. Our lease in
Long Island City, New York, covers 686,000 rentable square
feet, under a long-term lease arrangement. In connection with
the move of certain operations to Manhattan, in late 2008 we
subleased 80,000 rentable square feet to two subtenants,
each of which has met our standards of review with respect to
creditworthiness. Additionally, 180,000 rentable square
feet are available for sublease. As a result of this movement of
operations, and current market conditions, the Company incurred
a lease impairment charge of $38 million.
In November 2006, we sold our Peter Cooper Village and
Stuyvesant Town properties located in Manhattan, New York to a
group led by Tishman Speyer and BlackRock Realty, the real
estate arm of BlackRock, Inc., for $5.4 billion. The gain
of $3.0 billion is included in income from discontinued
operations in the accompanying consolidated statements of income.
In connection with the 2005 sale of the 200 Park Avenue
property, we have retained rights to existing signage and are
leasing space for associates in the property for 20 years
with optional renewal periods through 2205. Associates located
in the 200 Park Avenue office, our headquarters, include those
working in the Institutional and Individual segments.
We continue to own 15 other buildings in the United States that
we use in the operation of our business. These buildings contain
4.2 million rentable square feet and are located in the
following states: Connecticut, Florida, Illinois, Missouri, New
Jersey, New York, Ohio, Oklahoma, Pennsylvania and Rhode Island.
Our computer center in Rensselaer, New York is not owned in fee
but rather is occupied pursuant to a long-term ground lease. We
lease space in 797 other locations throughout the United States,
and these leased facilities consist of 8.7 million rentable
square feet. Approximately 66% of these leases are occupied as
sales offices for the Individual segment, for MetLife Bank
included within Corporate & Other, and the balance for
our other business activities. We also own nine buildings
outside the United States, comprising 300,000 rentable
square feet including one building 192,000 square feet.
condominium unit in Mexico that we use in the operation of our
business. We lease 3.0 million rentable square
59
feet in various locations outside the United States. Management
believes that these properties are suitable and adequate for our
current and anticipated business operations.
We arrange for property and casualty coverage on our properties,
taking into consideration our risk exposures and the cost and
availability of commercial coverages, including deductible loss
levels. In connection with the renewal of those coverages, we
have arranged $700 million of property coverage including
coverage for terrorism on our real estate portfolio through
May 15, 2009, its renewal date.
|
|
Item 3.
|
Legal
Proceedings
|
The Company is a defendant in a large number of litigation
matters. In some of the matters, very large
and/or
indeterminate amounts, including punitive and treble damages,
are sought. Modern pleading practice in the United States
permits considerable variation in the assertion of monetary
damages or other relief. Jurisdictions may permit claimants not
to specify the monetary damages sought or may permit claimants
to state only that the amount sought is sufficient to invoke the
jurisdiction of the trial court. In addition, jurisdictions may
permit plaintiffs to allege monetary damages in amounts well
exceeding reasonably possible verdicts in the jurisdiction for
similar matters. This variability in pleadings, together with
the actual experience of the Company in litigating or resolving
through settlement numerous claims over an extended period of
time, demonstrate to management that the monetary relief which
may be specified in a lawsuit or claim bears little relevance to
its merits or disposition value. Thus, unless stated below, the
specific monetary relief sought is not noted.
Due to the vagaries of litigation, the outcome of a litigation
matter and the amount or range of potential loss at particular
points in time may normally be inherently impossible to
ascertain with any degree of certainty. Inherent uncertainties
can include how fact finders will view individually and in their
totality documentary evidence, the credibility and effectiveness
of witnesses testimony, and how trial and appellate courts
will apply the law in the context of the pleadings or evidence
presented, whether by motion practice, or at trial or on appeal.
Disposition valuations are also subject to the uncertainty of
how opposing parties and their counsel will themselves view the
relevant evidence and applicable law.
On a quarterly and annual basis, the Company reviews relevant
information with respect to litigation and contingencies to be
reflected in the Companys consolidated financial
statements. In 2007, the Company received $39 million upon
the resolution of an indemnification claim associated with the
2000 acquisition of General American Life Insurance Company
(GALIC), and the Company reduced legal liabilities
by $38 million after the settlement of certain cases. The
review includes senior legal and financial personnel. Unless
stated below, estimates of possible losses or ranges of loss for
particular matters cannot in the ordinary course be made with a
reasonable degree of certainty. Liabilities are established when
it is probable that a loss has been incurred and the amount of
the loss can be reasonably estimated. Liabilities have been
established for a number of the matters noted below; in 2007 the
Company increased legal liabilities for pending sales practices,
employment, property and casualty and intellectual property
litigation matters against the Company. It is possible that some
of the matters could require the Company to pay damages or make
other expenditures or establish accruals in amounts that could
not be estimated at December 31, 2008.
Demutualization
Actions
Several lawsuits were brought in 2000 challenging the fairness
of the Plan and the adequacy and accuracy of MLICs
disclosure to policyholders regarding the Plan. The actions
discussed below name as defendants some or all of MLIC, the
Holding Company, and individual directors. MLIC, the Holding
Company, and the individual directors believe they have
meritorious defenses to the plaintiffs claims and are
contesting vigorously all of the plaintiffs claims in
these actions.
Fiala, et al. v. Metropolitan Life Ins. Co., et al. (Sup.
Ct., N.Y. County, filed March 17, 2000). The
plaintiffs in the consolidated state court class action seek
compensatory relief and punitive damages against MLIC, the
Holding Company, and individual directors. The court has
certified a litigation class of present and former policyholders
on plaintiffs claim that defendants violated
section 7312 of the New York Insurance Law. Pursuant to the
courts order, plaintiffs have given notice to the class of
the pendency of this action. Defendants motion for summary
judgment is pending.
60
In re MetLife Demutualization Litig. (E.D.N.Y., filed
April 18, 2000). In this class action
against MLIC and the Holding Company, plaintiffs served a second
consolidated amended complaint in 2004. Plaintiffs assert
violations of the Securities Act of 1933 and the Securities
Exchange Act of 1934 in connection with the Plan, claiming that
the Policyholder Information Booklets failed to disclose certain
material facts and contained certain material misstatements.
They seek rescission and compensatory damages. By orders dated
July 19, 2005 and August 29, 2006, the federal trial
court certified a litigation class of present and former
policyholders. The court has directed the manner and form of
notice to the class, but plaintiffs have not yet distributed the
notice. MLIC and the Holding Company have moved for summary
judgment, and plaintiffs have moved for partial summary
judgment. The court heard oral argument on the parties
motions for summary judgment on September 19, 2008.
Asbestos-Related
Claims
MLIC is and has been a defendant in a large number of
asbestos-related suits filed primarily in state courts. These
suits principally allege that the plaintiff or plaintiffs
suffered personal injury resulting from exposure to asbestos and
seek both actual and punitive damages. MLIC has never engaged in
the business of manufacturing, producing, distributing or
selling asbestos or asbestos-containing products nor has MLIC
issued liability or workers compensation insurance to
companies in the business of manufacturing, producing,
distributing or selling asbestos or asbestos-containing
products. The lawsuits principally have focused on allegations
with respect to certain research, publication and other
activities of one or more of MLICs employees during the
period from the 1920s through approximately the
1950s and allege that MLIC learned or should have learned
of certain health risks posed by asbestos and, among other
things, improperly publicized or failed to disclose those health
risks. MLIC believes that it should not have legal liability in
these cases. The outcome of most asbestos litigation matters,
however, is uncertain and can be impacted by numerous variables,
including differences in legal rulings in various jurisdictions,
the nature of the alleged injury, and factors unrelated to the
ultimate legal merit of the claims asserted against MLIC. MLIC
employs a number of resolution strategies to manage its asbestos
loss exposure, including seeking resolution of pending
litigation by judicial rulings and settling individual or groups
of claims or lawsuits under appropriate circumstances.
Claims asserted against MLIC have included negligence,
intentional tort and conspiracy concerning the health risks
associated with asbestos. MLICs defenses (beyond denial of
certain factual allegations) include that: (i) MLIC owed no
duty to the plaintiffs it had no special
relationship with the plaintiffs and did not manufacture,
produce, distribute or sell the asbestos products that allegedly
injured plaintiffs; (ii) plaintiffs did not rely on any
actions of MLIC; (iii) MLICs conduct was not the
cause of the plaintiffs injuries;
(iv) plaintiffs exposure occurred after the dangers
of asbestos were known; and (v) the applicable time with
respect to filing suit has expired. During the course of the
litigation, certain trial courts have granted motions dismissing
claims against MLIC, while other trial courts have denied
MLICs motions to dismiss. There can be no assurance that
MLIC will receive favorable decisions on motions in the future.
While most cases brought to date have settled, MLIC intends to
continue to defend aggressively against claims based on asbestos
exposure, including defending claims at trials.
The approximate total number of asbestos personal injury claims
pending against MLIC as of the dates indicated, the approximate
number of new claims during the years ended on those dates and
the approximate total settlement payments made to resolve
asbestos personal injury claims at or during those years are set
forth in the following table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions, except number of claims)
|
|
|
Asbestos personal injury claims at year end
|
|
|
74,027
|
|
|
|
79,717
|
|
|
|
87,070
|
|
Number of new claims during the year
|
|
|
5,063
|
|
|
|
7,161
|
|
|
|
7,870
|
|
Settlement payments during the year (1)
|
|
$
|
99.0
|
|
|
$
|
28.2
|
|
|
$
|
35.5
|
|
|
|
|
(1) |
|
Settlement payments represent payments made by MLIC during the
year in connection with settlements made in that year and in
prior years. Amounts do not include MLICs attorneys
fees and expenses and do not reflect amounts received from
insurance carriers. |
61
In 2005, MLIC received approximately 18,500 new claims, ending
the year with a total of approximately 100,250 claims, and paid
approximately $74.3 million for settlements reached in 2005
and prior years. In 2004, MLIC received approximately 23,900 new
claims, ending the year with a total of approximately 108,000
claims, and paid approximately $85.5 million for
settlements reached in 2004 and prior years. In 2003, MLIC
received approximately 58,750 new claims, ending the year with a
total of approximately 111,700 claims, and paid approximately
$84.2 million for settlements reached in 2003 and prior
years. The number of asbestos cases that may be brought, the
aggregate amount of any liability that MLIC may incur, and the
total amount paid in settlements in any given year are uncertain
and may vary significantly from year to year.
The ability of MLIC to estimate its ultimate asbestos exposure
is subject to considerable uncertainty, and the conditions
impacting its liability can be dynamic and subject to change.
The availability of reliable data is limited and it is difficult
to predict with any certainty the numerous variables that can
affect liability estimates, including the number of future
claims, the cost to resolve claims, the disease mix and severity
of disease in pending and future claims, the impact of the
number of new claims filed in a particular jurisdiction and
variations in the law in the jurisdictions in which claims are
filed, the possible impact of tort reform efforts, the
willingness of courts to allow plaintiffs to pursue claims
against MLIC when exposure to asbestos took place after the
dangers of asbestos exposure were well known, and the impact of
any possible future adverse verdicts and their amounts.
The ability to make estimates regarding ultimate asbestos
exposure declines significantly as the estimates relate to years
further in the future. In the Companys judgment, there is
a future point after which losses cease to be probable and
reasonably estimable. It is reasonably possible that the
Companys total exposure to asbestos claims may be
materially greater than the asbestos liability currently accrued
and that future charges to income may be necessary. While the
potential future charges could be material in the particular
quarterly or annual periods in which they are recorded, based on
information currently known by management, management does not
believe any such charges are likely to have a material adverse
effect on the Companys financial position.
During 1998, MLIC paid $878 million in premiums for excess
insurance policies for asbestos-related claims. The excess
insurance policies for asbestos-related claims provided for
recovery of losses up to $1.5 billion in excess of a
$400 million self-insured retention. The Companys
initial option to commute the excess insurance policies for
asbestos-related claims would have arisen at the end of 2008. On
September 29, 2008, MLIC entered into agreements commuting
the excess insurance policies as of September 30, 2008. As
a result of the commutation of the policies, MLIC received cash
and securities totaling $632 million. Of this total, MLIC
received $115 million in fixed maturity securities on
September 26, 2008, $200 million in cash on
October 29, 2008, and $317 million in cash on
January 29, 2009. MLIC recognized a loss on commutation of
the policies in the amount of $35.3 million during 2008.
In the years prior to commutation, the excess insurance policies
for asbestos-related claims were subject to annual and per claim
sublimits. Amounts exceeding the sublimits during 2007, 2006 and
2005 were approximately $16 million, $8 million and
$0, respectively. Amounts were recoverable under the policies
annually with respect to claims paid during the prior calendar
year. Each asbestos-related policy contained an experience fund
and a reference fund that provided for payments to MLIC at the
commutation date if the reference fund was greater than zero at
commutation or pro rata reductions from time to time in the loss
reimbursements to MLIC if the cumulative return on the reference
fund was less than the return specified in the experience fund.
The return in the reference fund was tied to performance of the
S&P 500 Index and the Lehman Brothers Aggregate Bond Index.
A claim with respect to the prior year was made under the excess
insurance policies in each year from 2003 through 2008 for the
amounts paid with respect to asbestos litigation in excess of
the retention. The foregone loss reimbursements were
approximately $62.2 million with respect to claims for the
period of 2002 through 2007. Because the policies were commuted
as of September 30, 2008, there will be no claims under the
policies or forgone loss reimbursements with respect to payments
made in 2008 and thereafter.
The Company believes adequate provision has been made in its
consolidated financial statements for all probable and
reasonably estimable losses for asbestos-related claims.
MLICs recorded asbestos liability is based on its
estimation of the following elements, as informed by the facts
presently known to it, its understanding of current law, and its
past experiences: (i) the probable and reasonably estimable
liability for asbestos claims already asserted against MLIC,
including claims settled but not yet paid; (ii) the
probable and reasonably estimable liability
62
for asbestos claims not yet asserted against MLIC, but which
MLIC believes are reasonably probable of assertion; and
(iii) the legal defense costs associated with the foregoing
claims. Significant assumptions underlying MLICs analysis
of the adequacy of its recorded liability with respect to
asbestos litigation include: (i) the number of future
claims; (ii) the cost to resolve claims; and (iii) the
cost to defend claims.
MLIC reevaluates on a quarterly and annual basis its exposure
from asbestos litigation, including studying its claims
experience, reviewing external literature regarding asbestos
claims experience in the United States, assessing relevant
trends impacting asbestos liability and considering numerous
variables that can affect its asbestos liability exposure on an
overall or per claim basis. These variables include bankruptcies
of other companies involved in asbestos litigation, legislative
and judicial developments, the number of pending claims
involving serious disease, the number of new claims filed
against it and other defendants, and the jurisdictions in which
claims are pending. As previously disclosed, in 2002 MLIC
increased its recorded liability for asbestos-related claims by
$402 million from approximately $820 million to
$1,225 million. Based upon its regular reevaluation of its
exposure from asbestos litigation, MLIC has updated its
liability analysis for asbestos-related claims through
December 31, 2008.
Regulatory
Matters
The Company receives and responds to subpoenas or other
inquiries from state regulators, including state insurance
commissioners; state attorneys general or other state
governmental authorities; federal regulators, including the SEC;
federal governmental authorities, including congressional
committees; and the Financial Industry Regulatory Authority
seeking a broad range of information. The issues involved in
information requests and regulatory matters vary widely. Certain
regulators have requested information and documents regarding
contingent commission payments to brokers, the Companys
awareness of any sham bids for business, bids and
quotes that the Company submitted to potential customers,
incentive agreements entered into with brokers, or compensation
paid to intermediaries. Regulators also have requested
information relating to market timing and late trading of mutual
funds and variable insurance products and, generally, the
marketing of products. The Company has received a subpoena from
the Office of the U.S. Attorney for the Southern District
of California asking for documents regarding the insurance
broker Universal Life Resources. The Company has been
cooperating fully with these inquiries.
Regulatory authorities in a small number of states have had
investigations or inquiries relating to sales of individual life
insurance policies or annuities or other products by MLIC; New
England Mutual Life Insurance Company, New England Life
Insurance Company and New England Securities Corporation
(collectively New England); GALIC; Walnut Street
Securities, Inc. (Walnut Street Securities) and
MetLife Securities, Inc. (MSI). Over the past
several years, these and a number of investigations by other
regulatory authorities were resolved for monetary payments and
certain other relief. The Company may continue to resolve
investigations in a similar manner.
MSI is a defendant in two regulatory matters brought by the
Illinois Department of Securities. In 2005, MSI received a
notice from the Illinois Department of Securities asserting
possible violations of the Illinois Securities Act in connection
with sales of a former affiliates mutual funds. A response
has been submitted and in January 2008, MSI received notice of
the commencement of an administrative action by the Illinois
Department of Securities. In May 2008, MSIs motion to
dismiss the action was denied. In the second matter, in December
2008 MSI received a Notice of Hearing from the Illinois
Department of Securities based upon a complaint alleging that
MSI failed to reasonably supervise one of its former registered
representatives in connection with the sale of variable
annuities to Illinois investors. MSI intends to vigorously
defend against the claims in these matters.
In June 2008, the Environmental Protection Agency issued a
Notice of Violation (NOV) regarding the operations
of the Homer City Generating Station, an electrical generation
facility. The NOV alleges, among other things, that the
electrical generation facility is being operated in violation of
certain federal and state Clean Air Act requirements. Homer City
OL6 LLC, an entity owned by MLIC, is a passive investor with a
minority interest in the electrical generation facility, which
is solely operated by the lessee, EME Homer City Generation L.P.
(EME Homer). Homer City OL6 LLC and EME Homer are
among the respondents identified in the NOV. EME Homer has been
notified of its obligation to indemnify Homer City OL6 LLC and
MLIC for any claims resulting from the NOV and has expressly
acknowledged its obligation to indemnify Homer City OL6 LLC.
63
Other
Litigation
Jacynthe Evoy-Larouche v. Metropolitan Life Ins. Co.
(Que. Super. Ct., filed March 1998). This
putative class action lawsuit involving sales practices claims
is pending against MLIC in Canada. Plaintiff alleges
misrepresentations regarding dividends and future payments for
life insurance policies and seeks unspecified damages.
Travelers Ins. Co., et al. v. Banc of America Securities
LLC (S.D.N.Y., filed December 13, 2001). On
January 6, 2009, after a jury trial, the district
court entered a judgment in favor of The Travelers Insurance
Company, now known as MetLife Insurance Company of Connecticut,
in the amount of approximately $42 million in connection
with securities and common law claims against the defendant. The
defendant has filed a post judgment motion seeking a judgment in
its favor or, in the alternative, a new trial. If this motion is
denied, the defendant will likely file an appeal. As it is
possible that the judgment could be affected during the post
judgment motion practice or upon appeal, and the Company has not
collected any portion of the judgment, the Company has not
recognized any award amount in its consolidated financial
statements.
Shipley v. St. Paul Fire and Marine Ins. Co. and
Metropolitan Property and Casualty Ins. Co. (Ill. Cir. Ct.,
Madison County, filed February 26 and July 2,
2003). Two putative nationwide class actions have
been filed against Metropolitan Property and Casualty Insurance
Company in Illinois. One suit claims breach of contract and
fraud due to the alleged underpayment of medical claims arising
from the use of a purportedly biased provider fee pricing
system. The second suit currently alleges breach of contract
arising from the alleged use of preferred provider organizations
to reduce medical provider fees covered by the medical claims
portion of the insurance policy. Motions for class certification
have been filed and briefed in both cases. A third putative
nationwide class action relating to the payment of medical
providers, Innovative Physical Therapy, Inc. v. MetLife
Auto & Home, et ano (D. N.J., filed November 12,
2007), was filed against Metropolitan Property and Casualty
Insurance Company in federal court in New Jersey. The court
granted the defendants motion to dismiss, and plaintiff
appealed the dismissal. The Company is vigorously defending
against the claims in these matters.
The American Dental Association, et al. v. MetLife Inc., et
al. (S.D. Fla., filed May 19, 2003). The
American Dental Association and three individual providers have
sued the Holding Company, MLIC and other non-affiliated
insurance companies in a putative class action lawsuit. The
plaintiffs purport to represent a nationwide class of
in-network
providers who allege that their claims are being wrongfully
reduced by downcoding, bundling, and the improper use and
programming of software. The complaint alleges federal
racketeering and various state law theories of liability. On
February 10, 2009, the district court granted the
Companys motion to dismiss plaintiffs second amended
complaint, dismissing all of plaintiffs claims except for
breach of contract claims. Plaintiffs have been provided with an
opportunity to re-plead the dismissed claims by
February 26, 2009.
In Re Ins. Brokerage Antitrust Litig. (D. N.J., filed
February 24, 2005). In this multi-district
class action proceeding, plaintiffs complaint alleged that
the Holding Company, MLIC, several non-affiliated insurance
companies and several insurance brokers violated the Racketeer
Influenced and Corrupt Organizations Act (RICO), the
Employee Retirement Income Security Act of 1974
(ERISA), and antitrust laws and committed other
misconduct in the context of providing insurance to employee
benefit plans and to persons who participate in such employee
benefit plans. In August and September 2007 and January 2008,
the court issued orders granting defendants motions to
dismiss with prejudice the federal antitrust, the RICO, and the
ERISA claims. In February 2008, the court dismissed the
remaining state law claims on jurisdictional grounds.
Plaintiffs appeal from the orders dismissing their RICO
and federal antitrust claims is pending with the U.S. Court
of Appeals for the Third Circuit. A putative class action
alleging that the Holding Company and other non-affiliated
defendants violated state laws was transferred to the District
of New Jersey but was not consolidated with other related
actions. Plaintiffs motion to remand this action to state
court in Florida is pending.
MetLife v. Park Avenue Securities, et. al. (FINRA
Arbitration, filed May 2006). MetLife commenced
an action against Park Avenue Securities LLC., a registered
investment adviser and broker-dealer that is an indirect
wholly-owned subsidiary of The Guardian Life Insurance Company
of America, alleging misappropriation of confidential and
proprietary information and use of prohibited methods to solicit
MetLife customers and recruit MetLife financial services
representatives. On February 12, 2009, a Financial Industry
Regulatory Authority
64
(FINRA) arbitration panel awarded MetLife
$21 million in damages, including punitive damages and
attorneys fees. Park Avenue Securities may appeal the award.
Thomas, et al. v. Metropolitan Life Ins. Co., et al. (W.D.
Okla., filed January 31, 2007). A putative
class action complaint was filed against MLIC and MSI.
Plaintiffs assert legal theories of violations of the federal
securities laws and violations of state laws with respect to the
sale of certain proprietary products by the Companys
agency distribution group. Plaintiffs seek rescission,
compensatory damages, interest, punitive damages and
attorneys fees and expenses. In January and May 2008, the
court issued orders granting the defendants motion to
dismiss in part, dismissing all of plaintiffs claims
except for claims under the Investment Advisers Act.
Defendants motion to dismiss claims under the Investment
Advisers Act was denied. The Company will vigorously defend
against the remaining claims in this matter.
Sales Practices Claims. Over the past several
years, MLIC, New England, GALIC, Walnut Street Securities and
MSI have faced numerous claims, including class action lawsuits,
alleging improper marketing or sales of individual life
insurance policies, annuities, mutual funds or other products.
Some of the current cases seek substantial damages, including
punitive and treble damages and attorneys fees. At
December 31, 2008, there were approximately 125 sales
practices litigation matters pending against the Company. The
Company continues to vigorously defend against the claims in
these matters. The Company believes adequate provision has been
made in its consolidated financial statements for all probable
and reasonably estimable losses for sales practices claims
against MLIC, New England, GALIC, MSI and Walnut Street
Securities.
Summary
Putative or certified class action litigation and other
litigation and claims and assessments against the Company, in
addition to those discussed previously and those otherwise
provided for in the Companys consolidated financial
statements, have arisen in the course of the Companys
business, including, but not limited to, in connection with its
activities as an insurer, employer, investor, investment advisor
and taxpayer. Further, state insurance regulatory authorities
and other federal and state authorities regularly make inquiries
and conduct investigations concerning the Companys
compliance with applicable insurance and other laws and
regulations.
It is not possible to predict the ultimate outcome of all
pending investigations and legal proceedings or provide
reasonable ranges of potential losses, except as noted
previously in connection with specific matters. In some of the
matters referred to previously, very large
and/or
indeterminate amounts, including punitive and treble damages,
are sought. Although in light of these considerations it is
possible that an adverse outcome in certain cases could have a
material adverse effect upon the Companys financial
position, based on information currently known by the
Companys management, in its opinion, the outcomes of such
pending investigations and legal proceedings are not likely to
have such an effect. However, given the large
and/or
indeterminate amounts sought in certain of these matters and the
inherent unpredictability of litigation, it is possible that an
adverse outcome in certain matters could, from time to time,
have a material adverse effect on the Companys
consolidated net income or cash flows in particular quarterly or
annual periods.
|
|
Item 4.
|
Submission
of Matters to a Vote of Security Holders
|
No matter was submitted to a vote of security holders during the
fourth quarter of 2008.
65
Part II
|
|
Item 5.
|
Market
for Registrants Common Equity, Related Stockholder Matters
and Issuer Purchases of Equity Securities
|
Issuer
Common Equity
MetLife, Inc.s common stock, par value $0.01 per share,
began trading on the NYSE under the symbol MET on
April 5, 2000.
The following table presents high and low closing prices for the
common stock on the NYSE for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
|
1st Quarter
|
|
|
2nd Quarter
|
|
|
3rd Quarter
|
|
|
4th Quarter
|
|
|
Common Stock Price
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
High
|
|
$
|
61.52
|
|
|
$
|
62.88
|
|
|
$
|
63.00
|
|
|
$
|
48.15
|
|
Low
|
|
$
|
54.62
|
|
|
$
|
52.77
|
|
|
$
|
43.75
|
|
|
$
|
16.48
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
|
1st Quarter
|
|
|
2nd Quarter
|
|
|
3rd Quarter
|
|
|
4th Quarter
|
|
|
Common Stock Price
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
High
|
|
$
|
65.92
|
|
|
$
|
69.04
|
|
|
$
|
69.92
|
|
|
$
|
70.87
|
|
Low
|
|
$
|
59.10
|
|
|
$
|
63.29
|
|
|
$
|
59.62
|
|
|
$
|
60.46
|
|
As of February 20, 2009, there were 88,239 stockholders of
record of common stock.
The table below presents dividend declaration, record and
payment dates, as well as per share and aggregate dividend
amounts, for the common stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend
|
|
Declaration Date
|
|
Record Date
|
|
Payment Date
|
|
|
Per Share
|
|
|
Aggregate
|
|
|
|
|
|
|
|
|
(In millions,
|
|
|
|
|
|
|
|
|
except per share data)
|
|
|
October 28, 2008
|
|
November 10, 2008
|
|
|
December 15, 2008
|
|
|
$
|
0.74
|
|
|
$
|
592
|
|
October 23, 2007
|
|
November 6, 2007
|
|
|
December 14, 2007
|
|
|
$
|
0.74
|
|
|
$
|
541
|
|
Future common stock dividend decisions will be determined by the
Companys Board of Directors after taking into
consideration factors such as our current earnings, expected
medium-term and long-term earnings, financial condition,
regulatory capital position, and applicable governmental
regulations and policies. Furthermore, the payment of dividends
and other distributions to the Company by its insurance
subsidiaries is regulated by insurance laws and regulations. See
Business Regulation Insurance
Regulation, Managements Discussion and
Analysis of Financial Condition and Results of
Operations Liquidity and Capital
Resources The Holding Company Liquidity
and Capital Sources Dividends and Note 18
of the Notes to the Consolidated Financial Statements.
66
Issuer
Purchases of Equity Securities
Purchases of common stock made by or on behalf of the Company or
its affiliates during the quarter ended December 31, 2008
are set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(c) Total Number
|
|
|
(d) Maximum Number
|
|
|
|
|
|
|
|
|
|
of Shares
|
|
|
(or Approximate
|
|
|
|
|
|
|
|
|
|
Purchased as Part
|
|
|
Dollar Value) of
|
|
|
|
(a) Total Number
|
|
|
|
|
|
of Publicly
|
|
|
Shares that May Yet
|
|
|
|
of Shares
|
|
|
(b) Average Price
|
|
|
Announced Plans
|
|
|
Be Purchased Under the
|
|
Period
|
|
Purchased (1)
|
|
|
Paid per Share
|
|
|
or Programs
|
|
|
Plans or Programs (2)
|
|
|
October 1- October 31, 2008
|
|
|
35,629
|
|
|
$
|
34.02
|
|
|
|
|
|
|
$
|
1,260,735,127
|
|
November 1- November 30, 2008
|
|
|
13,386
|
|
|
$
|
30.76
|
|
|
|
|
|
|
$
|
1,260,735,127
|
|
December 1- December 31, 2008
|
|
|
18,433
|
|
|
$
|
35.01
|
|
|
|
|
|
|
$
|
1,260,735,127
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
67,448
|
|
|
$
|
33.64
|
|
|
|
|
|
|
$
|
1,260,735,127
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
During the periods October 1 October 31, 2008,
November 1 November 30, 2008 and December
1 December 31, 2008, separate account
affiliates of the Company purchased 35,629 shares,
13,386 shares and 18,433 shares, respectively, of
common stock on the open market in nondiscretionary transactions
to rebalance index funds. Except as disclosed above, there were
no shares of common stock which were repurchased by the Company
other than through a publicly announced plan or program. |
|
(2) |
|
In April 2008, the Companys Board of Directors authorized
an additional $1 billion common stock repurchase program,
which will begin after the completion of the January 2008
$1 billion common stock repurchase program, of which
$261 million remained outstanding at December 31,
2008. At December 31, 2008, the Company had
$1,261 million remaining under its common stock repurchase
program authorization. Under these authorizations, the Company
may purchase its common stock from the MetLife Policyholder
Trust, in the open market (including pursuant to the terms of a
pre-set trading plan meeting the requirements of
Rule 10b5-1
under the Exchange Act) and in privately negotiated transactions. |
See also Managements Discussion and Analysis of
Financial Condition and Results of Operations
Liquidity and Capital Resources The Holding Company
Liquidity and Capital Uses Share
Repurchases for further information relating to common
stock repurchases.
67
|
|
Item 6.
|
Selected
Financial Data
|
The following selected financial data has been derived from the
Companys audited consolidated financial statements. The
statement of income data for the years ended December 31,
2008, 2007 and 2006, and the balance sheet data at
December 31, 2008 and 2007 have been derived from the
Companys audited financial statements included elsewhere
herein. The statement of income data for the years ended
December 31, 2005 and 2004, and the balance sheet data at
December 31, 2006, 2005 and 2004 have been derived from the
Companys audited financial statements not included herein.
The selected financial data set forth below should be read in
conjunction with Managements Discussion and Analysis
of Financial Condition and Results of Operations and the
consolidated financial statements and related notes included
elsewhere herein. Some previously reported amounts, most notably
discontinued operations discussed in footnote 2, have been
reclassified to conform with the presentation at and for the
year ended December 31, 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
|
(In millions)
|
|
|
Statement of Income Data (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues (2), (3):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
25,914
|
|
|
$
|
22,970
|
|
|
$
|
22,052
|
|
|
$
|
20,979
|
|
|
$
|
18,842
|
|
Universal life and investment-type product policy fees
|
|
|
5,381
|
|
|
|
5,238
|
|
|
|
4,711
|
|
|
|
3,775
|
|
|
|
2,819
|
|
Net investment income
|
|
|
16,296
|
|
|
|
18,063
|
|
|
|
16,247
|
|
|
|
14,064
|
|
|
|
11,627
|
|
Other revenues
|
|
|
1,586
|
|
|
|
1,465
|
|
|
|
1,301
|
|
|
|
1,221
|
|
|
|
1,152
|
|
Net investment gains (losses)
|
|
|
1,812
|
|
|
|
(578
|
)
|
|
|
(1,382
|
)
|
|
|
(112
|
)
|
|
|
114
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
50,989
|
|
|
|
47,158
|
|
|
|
42,929
|
|
|
|
39,927
|
|
|
|
34,554
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses (2), (3):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims
|
|
|
27,437
|
|
|
|
23,783
|
|
|
|
22,869
|
|
|
|
22,236
|
|
|
|
19,907
|
|
Interest credited to policyholder account balances
|
|
|
4,787
|
|
|
|
5,461
|
|
|
|
4,899
|
|
|
|
3,650
|
|
|
|
2,766
|
|
Policyholder dividends
|
|
|
1,751
|
|
|
|
1,723
|
|
|
|
1,698
|
|
|
|
1,678
|
|
|
|
1,664
|
|
Other expenses
|
|
|
11,924
|
|
|
|
10,429
|
|
|
|
9,537
|
|
|
|
8,259
|
|
|
|
6,833
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
45,899
|
|
|
|
41,396
|
|
|
|
39,003
|
|
|
|
35,823
|
|
|
|
31,170
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before provision for income tax
|
|
|
5,090
|
|
|
|
5,762
|
|
|
|
3,926
|
|
|
|
4,104
|
|
|
|
3,384
|
|
Provision for income tax (2)
|
|
|
1,580
|
|
|
|
1,660
|
|
|
|
1,016
|
|
|
|
1,156
|
|
|
|
931
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
3,510
|
|
|
|
4,102
|
|
|
|
2,910
|
|
|
|
2,948
|
|
|
|
2,453
|
|
Income (loss) from discontinued operations, net of income
tax (2)
|
|
|
(301
|
)
|
|
|
215
|
|
|
|
3,383
|
|
|
|
1,766
|
|
|
|
391
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before cumulative effect of a change in accounting, net
of income tax
|
|
|
3,209
|
|
|
|
4,317
|
|
|
|
6,293
|
|
|
|
4,714
|
|
|
|
2,844
|
|
Cumulative effect of a change in accounting, net of income
tax (3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(86
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
3,209
|
|
|
|
4,317
|
|
|
|
6,293
|
|
|
|
4,714
|
|
|
|
2,758
|
|
Preferred stock dividends
|
|
|
125
|
|
|
|
137
|
|
|
|
134
|
|
|
|
63
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common shareholders
|
|
$
|
3,084
|
|
|
$
|
4,180
|
|
|
$
|
6,159
|
|
|
$
|
4,651
|
|
|
$
|
2,758
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
68
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
|
(In millions)
|
|
|
Balance Sheet Data (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General account assets
|
|
$
|
380,839
|
|
|
$
|
399,007
|
|
|
$
|
383,758
|
|
|
$
|
354,857
|
|
|
$
|
271,137
|
|
Separate account assets
|
|
|
120,839
|
|
|
|
160,142
|
|
|
|
144,349
|
|
|
|
127,855
|
|
|
|
86,755
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets (2)
|
|
$
|
501,678
|
|
|
$
|
559,149
|
|
|
$
|
528,107
|
|
|
$
|
482,712
|
|
|
$
|
357,892
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life and health policyholder liabilities (4)
|
|
$
|
286,019
|
|
|
$
|
262,652
|
|
|
$
|
253,284
|
|
|
$
|
244,683
|
|
|
$
|
182,443
|
|
Property and casualty policyholder liabilities (4)
|
|
|
3,126
|
|
|
|
3,324
|
|
|
|
3,453
|
|
|
|
3,490
|
|
|
|
3,180
|
|
Short-term debt
|
|
|
2,659
|
|
|
|
667
|
|
|
|
1,449
|
|
|
|
1,414
|
|
|
|
1,445
|
|
Long-term debt
|
|
|
9,667
|
|
|
|
9,100
|
|
|
|
8,822
|
|
|
|
9,088
|
|
|
|
7,006
|
|
Collateral financing arrangements
|
|
|
5,192
|
|
|
|
4,882
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Junior subordinated debt securities
|
|
|
3,758
|
|
|
|
4,075
|
|
|
|
3,381
|
|
|
|
2,134
|
|
|
|
|
|
Payables for collateral under securities loaned and other
transactions
|
|
|
31,059
|
|
|
|
44,136
|
|
|
|
45,846
|
|
|
|
34,515
|
|
|
|
28,678
|
|
Other
|
|
|
15,625
|
|
|
|
34,992
|
|
|
|
33,725
|
|
|
|
30,432
|
|
|
|
25,561
|
|
Separate account liabilities
|
|
|
120,839
|
|
|
|
160,142
|
|
|
|
144,349
|
|
|
|
127,855
|
|
|
|
86,755
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities (2)
|
|
|
477,944
|
|
|
|
523,970
|
|
|
|
494,309
|
|
|
|
453,611
|
|
|
|
335,068
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, at par value
|
|
|
1
|
|
|
|
1
|
|
|
|
1
|
|
|
|
1
|
|
|
|
|
|
Common stock, at par value
|
|
|
8
|
|
|
|
8
|
|
|
|
8
|
|
|
|
8
|
|
|
|
8
|
|
Additional paid-in capital
|
|
|
15,811
|
|
|
|
17,098
|
|
|
|
17,454
|
|
|
|
17,274
|
|
|
|
15,037
|
|
Retained earnings (5)
|
|
|
22,403
|
|
|
|
19,884
|
|
|
|
16,574
|
|
|
|
10,865
|
|
|
|
6,608
|
|
Treasury stock, at cost
|
|
|
(236
|
)
|
|
|
(2,890
|
)
|
|
|
(1,357
|
)
|
|
|
(959
|
)
|
|
|
(1,785
|
)
|
Accumulated other comprehensive income (loss) (6)
|
|
|
(14,253
|
)
|
|
|
1,078
|
|
|
|
1,118
|
|
|
|
1,912
|
|
|
|
2,956
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
23,734
|
|
|
|
35,179
|
|
|
|
33,798
|
|
|
|
29,101
|
|
|
|
22,824
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity
|
|
$
|
501,678
|
|
|
$
|
559,149
|
|
|
$
|
528,107
|
|
|
$
|
482,712
|
|
|
$
|
357,892
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
69
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
|
(In millions, except per share data)
|
|
|
Other Data (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common shareholders
|
|
$
|
3,084
|
|
|
$
|
4,180
|
|
|
$
|
6,159
|
|
|
$
|
4,651
|
|
|
$
|
2,758
|
|
Return on common equity (7)
|
|
|
11.2%
|
|
|
|
12.9%
|
|
|
|
20.9%
|
|
|
|
18.6%
|
|
|
|
12.5%
|
|
Return on common equity, excluding accumulated other
comprehensive income (loss)
|
|
|
9.1%
|
|
|
|
13.3%
|
|
|
|
22.1%
|
|
|
|
20.7%
|
|
|
|
14.4%
|
|
EPS Data (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from Continuing Operations Available to Common
Shareholders Per Common Share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
4.60
|
|
|
$
|
5.33
|
|
|
$
|
3.65
|
|
|
$
|
3.85
|
|
|
$
|
3.26
|
|
Diluted
|
|
$
|
4.54
|
|
|
$
|
5.20
|
|
|
$
|
3.60
|
|
|
$
|
3.82
|
|
|
$
|
3.24
|
|
Income (Loss) from Discontinued Operations Per
Common Share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
(0.41
|
)
|
|
$
|
0.29
|
|
|
$
|
4.44
|
|
|
$
|
2.36
|
|
|
$
|
0.52
|
|
Diluted
|
|
$
|
(0.40
|
)
|
|
$
|
0.28
|
|
|
$
|
4.39
|
|
|
$
|
2.34
|
|
|
$
|
0.52
|
|
Cumulative Effect of a Change in Accounting Per Common
Share (3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(0.11
|
)
|
Diluted
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(0.11
|
)
|
Net Income Available to Common Shareholders Per Common Share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
4.19
|
|
|
$
|
5.62
|
|
|
$
|
8.09
|
|
|
$
|
6.21
|
|
|
$
|
3.67
|
|
Diluted
|
|
$
|
4.14
|
|
|
$
|
5.48
|
|
|
$
|
7.99
|
|
|
$
|
6.16
|
|
|
$
|
3.65
|
|
Dividends Declared Per Common Share
|
|
$
|
0.74
|
|
|
$
|
0.74
|
|
|
$
|
0.59
|
|
|
$
|
0.52
|
|
|
$
|
0.46
|
|
|
|
|
(1) |
|
On July 1, 2005, the Company completed the acquisition of
The Travelers Insurance Company, excluding certain assets, most
significantly, Primerica, from Citigroup Inc.
(Citigroup), and substantially all of
Citigroups international insurance businesses. The 2005
selected financial data includes total revenues and total
expenses of $966 million and $577 million,
respectively, from the date of the acquisition. |
|
(2) |
|
Discontinued Operations: |
Real
Estate
Income related to real estate sold or classified as
held-for-sale is presented as discontinued operations. The
following information presents the components of income from
discontinued real estate operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
|
(In millions)
|
|
|
Investment income
|
|
$
|
6
|
|
|
$
|
21
|
|
|
$
|
243
|
|
|
$
|
405
|
|
|
$
|
658
|
|
Investment expense
|
|
|
(3
|
)
|
|
|
(9
|
)
|
|
|
(151
|
)
|
|
|
(246
|
)
|
|
|
(392
|
)
|
Net investment gains (losses)
|
|
|
8
|
|
|
|
13
|
|
|
|
4,795
|
|
|
|
2,125
|
|
|
|
146
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
11
|
|
|
|
25
|
|
|
|
4,887
|
|
|
|
2,284
|
|
|
|
412
|
|
Interest expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13
|
|
Provision for income tax
|
|
|
4
|
|
|
|
11
|
|
|
|
1,725
|
|
|
|
812
|
|
|
|
140
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued operations, net of income tax
|
|
$
|
7
|
|
|
$
|
14
|
|
|
$
|
3,162
|
|
|
$
|
1,472
|
|
|
$
|
259
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70
Operations
In the fourth quarter of 2008, the Company entered into an
agreement to sell its wholly-owned subsidiary, Cova, to a third
party to be completed in early 2009. In September 2008, the
Company completed a tax-free split-off of its majority-owned
subsidiary, Reinsurance Group of America, Incorporated
(RGA). In September 2007, September 2005 and January
2005, the Company sold its MetLife Insurance Limited
(MetLife Australia) annuities and pension
businesses, P.T. Sejahtera (MetLife Indonesia)
and SSRM Holdings, Inc. (SSRM), respectively. The
assets, liabilities and operations of Cova, RGA, MetLife
Australia, MetLife Indonesia and SSRM have been reclassified
into discontinued operations for all years presented. The
following tables present these discontinued operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
|
(In millions)
|
|
|
Revenues
|
|
$
|
4,086
|
|
|
$
|
5,932
|
|
|
$
|
5,467
|
|
|
$
|
4,776
|
|
|
$
|
4,492
|
|
Expenses
|
|
|
3,915
|
|
|
|
5,640
|
|
|
|
5,179
|
|
|
|
4,609
|
|
|
|
4,286
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before provision for income tax
|
|
|
171
|
|
|
|
292
|
|
|
|
288
|
|
|
|
167
|
|
|
|
206
|
|
Provision for income tax
|
|
|
57
|
|
|
|
101
|
|
|
|
99
|
|
|
|
60
|
|
|
|
74
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued operations, net of income tax
|
|
|
114
|
|
|
|
191
|
|
|
|
189
|
|
|
|
107
|
|
|
|
132
|
|
Gain (loss) on sale of subsidiaries, net of income tax
|
|
|
(422
|
)
|
|
|
10
|
|
|
|
32
|
|
|
|
187
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from discontinued operations, net of income tax
|
|
$
|
(308
|
)
|
|
$
|
201
|
|
|
$
|
221
|
|
|
$
|
294
|
|
|
$
|
132
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
|
(In millions)
|
|
|
General account assets
|
|
$
|
946
|
|
|
$
|
22,866
|
|
|
$
|
21,918
|
|
|
$
|
20,150
|
|
|
$
|
16,852
|
|
Separate account assets
|
|
|
|
|
|
|
17
|
|
|
|
16
|
|
|
|
14
|
|
|
|
14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
946
|
|
|
$
|
22,883
|
|
|
$
|
21,934
|
|
|
$
|
20,164
|
|
|
$
|
16,866
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life and health policyholder liabilities (4)
|
|
|
721
|
|
|
|
15,780
|
|
|
|
15,557
|
|
|
|
15,109
|
|
|
|
12,210
|
|
Debt
|
|
|
|
|
|
|
528
|
|
|
|
307
|
|
|
|
401
|
|
|
|
425
|
|
Collateral financing arrangements
|
|
|
|
|
|
|
850
|
|
|
|
850
|
|
|
|
|
|
|
|
|
|
Junior subordinated debt securities
|
|
|
|
|
|
|
399
|
|
|
|
399
|
|
|
|
399
|
|
|
|
|
|
Shares subject to mandatory redemption
|
|
|
|
|
|
|
159
|
|
|
|
159
|
|
|
|
159
|
|
|
|
158
|
|
Other
|
|
|
27
|
|
|
|
2,945
|
|
|
|
2,676
|
|
|
|
2,195
|
|
|
|
2,179
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
$
|
748
|
|
|
$
|
20,661
|
|
|
$
|
19,948
|
|
|
$
|
18,263
|
|
|
$
|
14,972
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3) |
|
The cumulative effect of a change in accounting, net of income
tax, of $86 million for the year ended December 31,
2004, resulted from the adoption of
SOP 03-1,
Accounting and Reporting by Insurance Enterprises for Certain
Nontraditional Long-Duration Contracts and for Separate Account
(SOP 03-1). |
|
(4) |
|
Policyholder liabilities include future policy benefits, other
policyholder funds and bank deposits. The life and health
policyholder liabilities also include policyholder account
balances, policyholder dividends payable and the policyholder
dividend obligation. |
|
(5) |
|
The cumulative effect of changes in accounting principles, net
of income tax, of $329 million, which decreased retained
earnings at January 1, 2007, resulted from
$292 million related to the adoption of
SOP 05-1,
Accounting by Insurance Enterprises for Deferred Acquisition
Costs in Connection with Modifications or Exchanges of Insurance
Contracts, and $37 million related to the adoption of
Financial Accounting Standards Board Interpretation No. 48,
Accounting for Uncertainty in Income Taxes An
Interpretation of FASB Statement No. 109. The
cumulative effect of changes in accounting principles, net of
income tax, of $27 million, which increased retained
earnings at January 1, 2008, resulted from the adoption of
SFAS No. 159, The Fair Value Option for Financial
Assets and Financial Liabilities (SFAS 159). |
71
|
|
|
(6) |
|
The cumulative effect of a change in accounting, net of income
tax, of $744 million resulted from the adoption of SFAS
No. 158, Employers Accounting for Defined Benefit
Pension and Other Postretirement Plans, which decreased
accumulated other comprehensive income (loss) at
December 31, 2006. The cumulative effect of a change in
accounting principle, net of income tax, of $10 million
resulted from the adoption of SFAS 159, which decreased
accumulated other comprehensive income (loss) at January 1,
2008. |
|
(7) |
|
Return on common equity is defined as net income available to
common shareholders divided by average common stockholders
equity. |
Item 7. Managements
Discussion and Analysis of Financial Condition and Results of
Operations
For purposes of this discussion, MetLife or the
Company refers to MetLife, Inc., a Delaware
corporation incorporated in 1999 (the Holding
Company), and its subsidiaries, including Metropolitan
Life Insurance Company (MLIC). Following this
summary is a discussion addressing the consolidated results of
operations and financial condition of the Company for the
periods indicated. This discussion should be read in conjunction
with the forward-looking statement information included below,
Risk Factors, Selected Financial Data
and the Companys consolidated financial statements
included elsewhere herein.
This Managements Discussion and Analysis of Financial
Condition and Results of Operations may contain or incorporate
by reference information that includes or is based upon
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements give expectations or forecasts of future events.
These statements can be identified by the fact that they do not
relate strictly to historical or current facts. They use words
such as anticipate, estimate,
expect, project, intend,
plan, believe and other words and terms
of similar meaning in connection with a discussion of future
operating or financial performance. In particular, these include
statements relating to future actions, prospective services or
products, future performance or results of current and
anticipated services or products, sales efforts, expenses, the
outcome of contingencies such as legal proceedings, trends in
operations and financial results.
Any or all forward-looking statements may turn out to be wrong.
They can be affected by inaccurate assumptions or by known or
unknown risks and uncertainties. Many such factors will be
important in determining MetLifes actual future results.
These statements are based on current expectations and the
current economic environment. They involve a number of risks and
uncertainties that are difficult to predict. These statements
are not guarantees of future performance. Actual results could
differ materially from those expressed or implied in the
forward-looking statements. Risks, uncertainties, and other
factors that might cause such differences include the risks,
uncertainties and other factors identified in MetLife,
Inc.s filings with the U.S. Securities and Exchange
Commission (SEC). These factors include:
(i) difficult and adverse conditions in the global and
domestic capital and credit markets; (ii) continued
volatility and further deterioration of the capital and credit
markets, which may affect the Companys ability to seek
financing or access its credit facilities;
(iii) uncertainty about the effectiveness of the
U.S. governments plan to stabilize the financial
system by injecting capital into financial institutions,
purchasing large amounts of illiquid, mortgage-backed and other
securities from financial institutions, or otherwise;
(iv) the impairment of other financial institutions;
(v) potential liquidity and other risks resulting from
MetLifes participation in a securities lending program and
other transactions; (vi) exposure to financial and capital
market risk; (vii) changes in general economic conditions,
including the performance of financial markets and interest
rates, which may affect the Companys ability to raise
capital, generate fee income and market-related revenue and
finance statutory reserve requirements and may require the
Company to pledge collateral or make payments related to
declines in value of specified assets; (viii) defaults on
the Companys mortgage and consumer loans;
(ix) investment losses and defaults, and changes to
investment valuations; (x) impairments of goodwill and
realized losses or market value impairments to illiquid assets;
(xi) unanticipated changes in industry trends;
(xii) heightened competition, including with respect to
pricing, entry of new competitors, consolidation of
distributors, the development of new products by new and
existing competitors and for personnel;
(xiii) discrepancies between actual claims experience and
assumptions used in setting prices for the Companys
products and establishing the liabilities for the Companys
obligations for future policy benefits and claims;
(xiv) discrepancies between actual experience and
assumptions used in establishing liabilities related to other
contingencies or obligations; (xv) ineffectiveness of risk
management policies and procedures, including with respect to
guaranteed benefit riders (which may be affected by fair value
adjustments arising from changes in our
72
own credit spread) on certain of the Companys variable
annuity products; (xvi) increased expenses relating to
pension and post-retirement benefit plans,
(xvii) catastrophe losses; (xviii) changes in
assumptions related to deferred policy acquisition costs
(DAC), value of business acquired (VOBA)
or goodwill; (xix) downgrades in MetLife, Inc.s and
its affiliates claims paying ability, financial strength
or credit ratings; (xx) economic, political, currency and
other risks relating to the Companys international
operations; (xx) availability and effectiveness of
reinsurance or indemnification arrangements,
(xxi) regulatory, legislative or tax changes that may
affect the cost of, or demand for, the Companys products
or services; (xxii) changes in accounting standards,
practices
and/or
policies; (xxiii) adverse results or other consequences
from litigation, arbitration or regulatory investigations;
(xxiv) deterioration in the experience of the closed
block established in connection with the reorganization of
MLIC; (xxv) the effects of business disruption or economic
contraction due to terrorism, other hostilities, or natural
catastrophes; (xxvi) MetLifes ability to identify and
consummate on successful terms any future acquisitions, and to
successfully integrate acquired businesses with minimal
disruption; (xxvii) MetLife, Inc.s primary reliance,
as a holding company, on dividends from its subsidiaries to meet
debt payment obligations and the applicable regulatory
restrictions on the ability of the subsidiaries to pay such
dividends; and (xxviii) other risks and uncertainties
described from time to time in MetLife, Inc.s filings with
the SEC.
MetLife, Inc. does not undertake any obligation to publicly
correct or update any forward-looking statement if MetLife, Inc.
later becomes aware that such statement is not likely to be
achieved. Please consult any further disclosures MetLife, Inc.
makes on related subjects in reports to the SEC.
Executive
Summary
MetLife is a leading provider of individual insurance, employee
benefits and financial services with operations throughout the
United States and the regions of Latin America, Europe, and Asia
Pacific. Through its subsidiaries and affiliates, MetLife offers
life insurance, annuities, automobile and homeowners insurance,
retail banking and other financial services to individuals, as
well as group insurance and retirement & savings
products and services to corporations and other institutions.
Subsequent to the disposition of Reinsurance Group of America,
Incorporated (RGA) and the elimination of the
Reinsurance segment, MetLife is organized into four operating
segments: Institutional, Individual, Auto & Home and
International, as well as Corporate & Other.
Year
Ended December 31, 2008 compared with the Year Ended
December 31, 2007
The Company reported $3,084 million in net income available
to common shareholders and net income per diluted common share
of $4.14 for the year ended December 31, 2008 compared to
$4,180 million in net income available to common
shareholders and net income per diluted common share of $5.48
for the year ended December 31, 2007. Net income available
to common shareholders decreased by $1,096 million, or 26%,
for the year ended December 31, 2008 compared to the prior
year.
The decrease in net income available to common shareholders was
principally due to an increase in losses from discontinued
operations of $516 million. This was primarily the result
of the split-off of substantially all of the Companys
interest in RGA in September 2008 whereby stockholders of the
Company were offered the opportunity to exchange their shares of
MetLife, Inc. common stock for shares of RGA Class B common
stock based upon a pre-determined exchange ratio.
The decrease in net income available to common shareholders was
also driven by an increase in other expenses of
$972 million, net of income tax. The increase in other
expenses was due to:
|
|
|
|
|
Higher DAC amortization in the Individual segment related to
lower expected future gross profits due to separate account
balance decreases resulting from recent market declines, higher
net investment gains primarily due to net derivative gains and
the reduction on expected cumulative earnings of the closed
block partially offset by a reduction in actual earnings of the
closed block and changes in assumptions used to estimate future
gross profits and margins. In addition, there is further offset
in the Institutional segment due to a charge associated with the
adoption of
SOP 05-1
in the prior year.
|
|
|
|
An increase in corporate expenses primarily related to an
enterprise-wide cost reduction and revenue enhancement
initiative. As a result of a strategic review begun in 2007, the
Company launched an enterprise
|
73
|
|
|
|
|
initiative called Operational Excellence. This initiative began
in April 2008 and management expects the initiative to be fully
implemented by December 31, 2010. This initiative is
focused on reducing complexity, leveraging scale, increasing
productivity, improving the effectiveness of the Companys
operations and providing a foundation for future growth. The
Company recognized within Corporate & Other during the
current period an initial accrual for post-employment related
expenses.
|
|
|
|
|
|
Higher legal costs in Corporate & Other principally
driven by costs associated with the commutation of three
asbestos insurance policies and higher expenses in the
Institutional and International segments as well as
Corporate & Other associated with business growth and
higher corporate support expenses.
|
|
|
|
Higher expenses in Corporate & Other relating to
increased compensation, rent, and mortgage loan origination
costs and servicing expenses associated with two acquisitions by
MetLife Bank in 2008.
|
Premiums, fees and other revenues increased by
$2,085 million, net of income tax, across all of the
Companys operating segments but most notably within the
Institutional and International segments due to business growth.
Policyholder benefits and claims and policyholder dividends
increased commensurately by $2,393 million, net of income
tax; however, policyholder benefits and claims were also
adversely impacted by an increase in catastrophe losses in the
Auto & Home segment, a charge within the Institutional
segment resulting from a liability adjustment in the group
annuity business, and business growth.
Net investment losses decreased by $1,554 million, net of
income tax, to a gain of $1,178 million, net of income tax,
for the year ended December 31, 2008 from a loss of
$376 million, net of income tax, for the comparable 2007
period. The decrease in net investment losses is due to an
increase in gains on derivatives partially offset by losses
primarily on fixed maturity and equity securities. Derivative
gains were driven by gains on freestanding derivatives that were
partially offset by losses on embedded derivatives primarily
associated with variable annuity riders. Gains on freestanding
derivatives increased by $4,225 million, net of income tax,
and were primarily driven by: i) gains on certain interest
rate swaps, floors and swaptions which were economic hedges of
certain investment assets and liabilities, ii) gains from
foreign currency derivatives primarily due to the
U.S. dollar strengthening as well as, iii) gains
primarily from equity options, financial futures, and interest
rate swaps hedging the embedded derivatives. The gains on these
equity options, financial futures, and interest rate swaps
substantially offset the change in the underlying embedded
derivative liability that is hedged by these derivatives. Losses
on the embedded derivatives increased by $1,514 million,
net of income tax, and were driven by declining interest rates
and poor equity market performance throughout the year. These
embedded derivative losses include a $1,946 million, net of
income tax, gain resulting from the effect of the widening of
the Companys own credit spread which is required to be
used in the valuation of these variable annuity rider embedded
derivatives under SFAS No. 157, Fair Value
Measurements (SFAS 157), which became
effective January 1, 2008. The remaining change in net
investment losses of $1,157 million, net of income tax, is
principally attributable to an increase in losses on fixed
maturity and equity securities, and, to a lesser degree, an
increase in losses on mortgage and consumer loans and other
limited partnerships offset by an increase in foreign currency
transaction gains. The increase in losses on fixed maturity and
equity securities is primarily attributable to an increase in
impairments associated with financial services industry holdings
which experienced losses as a result of bankruptcies, FDIC
receivership, and Federal government assisted capital infusion
transactions in the third and fourth quarters of 2008. Losses on
fixed maturity and equity securities were also driven by an
increase in credit related impairments on communication and
consumer sector security holdings, losses on asset-backed
securities as well as an increase in losses on fixed maturity
security holdings where the Company either lacked the intent to
hold, or due to extensive credit widening, the Company was
uncertain of its intent to hold these fixed maturity securities
for a period of time sufficient to allow recovery of the market
value decline.
Net investment income decreased by $1,149 million, or 10%,
net of income tax, to $10,592 million for the year ended
December 31, 2008 from $11,741 million for the
comparable 2007 period. Management attributes
$2,042 million, net of income tax, of this change to a
decrease in yields, partially offset by an increase of
$893 million due to growth in average invested assets.
Average invested assets are calculated on a cost basis without
unrealized gains and losses. The decrease in net investment
income attributable to lower yields was primarily due to lower
returns on other limited partnership interests, real estate
joint ventures, short-term investments, fixed maturity
securities, and mortgage loans, partially offset by improved
securities lending results. Management anticipates that
74
the significant volatility in the equity, real estate and credit
markets will continue in 2009 which could continue to impact net
investment income and yields on other limited partnerships and
real estate joint ventures. Net investment income increased due
to an increase in average invested assets, on an amortized cost
basis, primarily within short-term investments, other invested
assets including derivatives, mortgage loans, other limited
partnership interests, and real estate joint ventures.
A decrease in interest credited to policyholder account balances
of $438 million, net of income tax, resulted from a decline
in average crediting rates, which was largely due to the impact
of lower short-term interest rates in the current period, offset
by an increase from growth in the average policyholder account
balance, primarily the result of continued growth in the global
GIC and funding agreement products all of which occurred within
the Institutional segment. There was also a decrease in interest
credited in the International segment as a result of a reduction
in unit-linked policyholder liabilities reflecting the losses of
the trading portfolio backing these liabilities.
Year
Ended December 31, 2007 compared with the Year Ended
December 31, 2006
The Company reported $4,180 million in net income available
to common shareholders and earnings per diluted common share of
$5.48 for the year ended December 31, 2007 compared to
$6,159 million in net income available to common
shareholders and earnings per diluted common share of $7.99 for
the year ended December 31, 2006. Net income available to
common shareholders decreased by $1,979 million, or 32%,
for the year ended December 31, 2007 compared to the 2006
period.
The decrease in net income available to common shareholders was
primarily due to a decrease in income from discontinued
operations of $3,168 million, net of income tax. This
decrease in income from discontinued operations was principally
driven by a gain on the sale of the Peter Cooper Village and
Stuyvesant Town properties in Manhattan, New York, that was
recognized during the year ended December 31, 2006. Also
contributing to the decrease was lower net investment income and
net investment gains (losses) from discontinued operations
related to real estate properties sold or held-for-sale during
the year ended December 31, 2007 as compared to the year
ended December 31, 2006. Lower income from discontinued
operations related to the sale of MetLife Insurance Limited
(MetLife Australia) annuities and pension businesses
to a third party in the third quarter of 2007 and lower income
from discontinued operations related to the sale of SSRM
Holdings, Inc. (SSRM) resulting from a
reduction in additional proceeds from the sale received during
the year ended December 31, 2007 as compared to the year
December 31, 2006. This decrease was partially offset by
higher income from discontinued operations related to RGA, which
was reclassified to discontinued operations in the third quarter
of 2008 as a result of a tax-free split-off. RGAs income
was higher in 2007, primarily due to an increase in premiums,
net of an increase in policyholder benefits and claims, due to
additional in-force business from facultative and automatic
treaties and renewal premiums on existing blocks of business
combined with an increase in net investment income, net of
interest credited to policyholder account balances, due to
higher invested assets. These increases in RGAs income
were offset by an increase in net investment losses resulting
from a decline in the estimated fair value of embedded
derivatives associated with the reinsurance of annuity products
on a funds withheld basis.
The decrease in net income available to common shareholders was
also driven by an increase in other expenses of
$580 million, net of income tax. The increase in other
expenses was primarily due to higher amortization of deferred
policy acquisition costs (DAC) resulting from
business growth, lower net investment losses in the current year
and the net impact of revisions to managements assumption
used to determine estimated gross profits and margins in both
years. In addition, other expenses increased due to higher
compensation, higher interest expense on debt and interest on
tax contingencies, the net impact of revisions to certain
liabilities in both periods, asset write-offs, higher general
spending and expenses related to growth initiatives, partially
offset by lower legal costs and integration costs incurred in
2006.
The net effect of increases in premiums, fees and other revenues
of $1,046 million, net of income tax, across all of the
Companys operating segments and increases in policyholder
benefit and claims and policyholder dividends of
$610 million, net of income tax, was attributable to
overall business growth and increased net income available to
common shareholders.
75
Net investment income increased by $1,180 million, net of
income tax, or 11%, to $11,741 million for the year ended
December 31, 2007 from $10,561 million for the
comparable 2006 period. Management attributes $700 million
of this increase to growth in the average asset base and
$480 million to an increase in yields. Growth in the
average asset base was primarily within fixed maturity
securities, mortgage loans, real estate joint ventures and other
limited partnership interests. Higher yields was primarily due
to higher returns on fixed maturity securities, other limited
partnership interests excluding hedge funds, equity securities
and improved securities lending results, partially offset by
lower returns on real estate joint ventures, cash, cash
equivalents and short-term investments, hedge funds and mortgage
loans.
Net investment losses decreased by $522 million to a loss
of $376 million for the year ended December 31, 2007
from a loss of $898 million for the comparable 2006 period.
The decrease in net investment losses was primarily due to a
reduction of losses on fixed maturity securities resulting
principally from the 2006 portfolio repositioning in a rising
interest rate environment, increased gains from asset-based
foreign currency transactions due to a decline in the
U.S. dollar year over year against several major currencies
and increased gains on equity securities, partially offset by
increased losses from the mark-to-market on derivatives and
reduced gains on real estate and real estate joint ventures.
An increase in interest credited to policyholder account
balances associated with an increase in the average policyholder
account balance decreased net income available to common
shareholders by $365 million, net of income tax.
The remainder of the variance is due to the change in effective
tax rates between periods.
Consolidated
Company Outlook
The marketplace is still reacting and adapting to the unusual
economic events that took place over the past year and
management expects the volatility in the financial markets to
continue in 2009. As a result, management expects a modest
increase, on a constant exchange rate basis, in premiums, fees
and other revenues in 2009, with mixed results across the
various businesses. While the Company continues to gain market
share in a number of product lines, premiums, fees and other
revenues have and may continue to be impacted by the
U.S. and global recession, which may be reflected by, but
is not limited to:
|
|
|
|
|
Lower fee income from separate account businesses, including
variable annuity and life products in Individual Business.
|
|
|
|
A potential reduction in payroll linked revenue from
Institutional group insurance customers.
|
|
|
|
A decline in demand for certain International and Institutional
retirement & savings products.
|
|
|
|
A decrease in Auto & Home premiums resulting from a
depressed housing market and auto industry.
|
With the expectation of the turbulent financial markets
continuing in 2009, management expects continued downward
pressure on net income, specifically net investment income, as
management expects lower returns from other limited
partnerships, real estate joint ventures, and securities
lending. In addition, the resulting impact of the financial
markets on net investment gains (losses) and unrealized
investment gains (losses) can and will vary greatly and
therefore, it is difficult to predict. Also difficult to
determine is the impact of own credit, as it varies
significantly and this exposure is not hedged.
Certain insurance-related liabilities, specifically those
associated with guarantees, are tied to market performance,
which in times of depressed investment markets may require
management to establish additional liabilities. However, many of
the risks associated with these guarantees are hedged. The
turbulent financial markets, sustained over a period of time,
may also necessitate management to strengthen insurance
liabilities that are not associated with guarantees. Management
does not anticipate significant changes in the underlying trends
that drive underwriting results, with the possible exception of
certain trends in the Auto & Home and disability
businesses.
Certain expenses may increase due to initiatives such as
Operational Excellence. Other charges are also possible as the
combination of the downward pressure on net income coupled with
the expectations of the financial markets, may necessitate a
review of goodwill impairment, specifically within the
Individual Business. The unusual
76
financial market conditions will also likely cause an increase
in the Companys pension-related expense and may cause an
increase in DAC amortization.
In response to the challenges presented by the unusual economic
environment, management continues to focus on disciplined
underwriting, pricing, hedging strategies, as well as focused
expense management.
Institutional
Business Outlook
Management expects continued growth in premium, fees, and other
revenues across the majority of the Institutional businesses.
Revenues in many of the businesses can fluctuate based, in part,
on the covered payroll of customers or changes in the amount of
coverage they have purchased for current or former employees. As
a result, in periods of high unemployment, revenue may be
impacted. Revenue may also be negatively impacted as a result of
customers reduction of coverage stemming from benefit plan
changes, the elimination of retiree coverage or customer-related
bankruptcies. Revenues in the retirement & savings
business may experience some pressure as the demand for certain
of these products can decline during periods of volatile credit
and investment markets.
With the expectation of the turbulent financial markets
continuing in 2009, management expects to see lower earnings
resulting from depressed levels of net investment income,
specifically as previously discussed in the consolidated
outlook, which will put downward pressure on earnings from
interest margins in the spread-related businesses. If there is
an extended period of sustained, low long-term market interest
rates, it is possible that strengthening certain long-term
liabilities could be necessary. Management does not expect to
see significant changes in the underlying trends that drive
underwriting results, with the possible exception of the
disability business. Management thinks the level of disability
claims is correlated to the unemployment rate and therefore
underwriting results in this business may be impacted if the
recession continues to deepen and there is a continued rise in
the unemployment rate.
In 2009, management will continue to focus on disciplined
underwriting, pricing and aggressively managing expenses, while
making deliberate investments in certain areas that Management
expects will create long-term growth opportunities. The unusual
financial market conditions previously mentioned, will also
likely cause an increase in the Companys pension-related
expense.
Individual
Business Outlook
Management expects 2009 premium, fees and other revenues to be
down slightly compared to 2008 results. Individual Business
experienced a significant decline in asset-based fees in annuity
and variable life products in the second half of 2008 due to
equity market declines. This depressed level of fee revenue is
expected to continue in 2009. However, Individual Business
experienced a significant increase in fourth quarter 2008 fixed
annuity sales, which management believes was partially the
result of consumers recognizing the strength of MetLifes
guarantees. While management believes fixed annuity sales will
continue to be strong, future sales of all products could be
impacted as the financial services industry adjusts to the
economic environment and as anticipated industry consolidation
occurs.
Management believes the investment and capital markets may
continue to be turbulent in 2009, which would continue to exert
downward pressure on net income, specifically net investment
income as previously discussed in the consolidated outlook.
Certain annuity and life benefit guarantees are tied to market
performance, which in times of depressed investment markets, may
require management to establish additional liabilities. However,
many of the risks associated with these guarantees are hedged.
These pressures might result in potential modifications to
product pricing strategies associated with acceptable returns
for the underlying risks being covered.
Other charges are also possible as the combination of the
downward pressure on net income coupled with the expectations of
the financial markets, may necessitate a review of goodwill
impairment. The unusual financial market conditions will also
likely cause an increase in the Companys pension-related
expense and may cause an increase in DAC amortization.
77
Management believes that its disciplined approach to
underwriting, pricing, hedging and investment strategies will
further strengthen MetLifes industry leadership position
and mitigate the impacts from the ongoing uncertainty in the
investment markets. Additionally, Management continues to focus
on expense management by driving efficiency and productivity
gains within the distribution and home office organizations.
International
Business Outlook
Although management expects that premiums, fees and other
revenues, on a constant exchange rate basis, will continue to
increase across the regions in 2009, there is a risk of lower
product demand as well as higher policy surrenders if the trend
of higher unemployment, decreased individual income levels, and
lower corporate earnings continues in 2009. To address this,
various distribution channels and customer service operations
initiatives are being implemented to expand relationships with
existing distributors, develop new channel outlets and improve
persistency management. In addition, market conditions have and
may continue to cause an increase in the cost of related hedging
programs and may result in a decrease in fee income from lower
assets under management. Furthermore, the responses of
governments and policymakers, in the countries in which the
business operates, to the economic circumstances could have an
unpredictable impact on results. Continued volatility in foreign
currency exchange rates may adversely impact reported premiums,
fees and other revenues as well as net income. Management
continues to evaluate strategies to mitigate this risk.
Management expects continued turbulence in global capital
markets during 2009, which may create downward pressure on net
income, specifically net investment income as previously
discussed in the consolidated outlook.
In the Asia region, certain annuity benefit guarantees are tied
to market performance, which in times of depressed investment
markets, may require management to establish additional
liabilities. This exposure may result in modifications to our
product pricing strategies in order to maintain acceptable
returns for the underwriting risks being covered. The
sufficiency of certain reserves in the Asia region is sensitive
to interest rates and other related assumptions. Adverse changes
in key assumptions for interest rates, exchange rates, mortality
and morbidity levels or lapse rates could lead to a need to
strengthen reserves.
Management continues to take a disciplined approach toward
expense management, however, management will continue to invest
in infrastructure and distribution improvements where such
spending will enhance growth. The unusual financial market
conditions may cause an increase in DAC amortization. Management
believes that the ability to deliver quality risk &
protection and retirement & savings products to the
markets, coupled with the Companys financial strength and
strong risk management expertise, will help achieve continued
growth in this challenging environment.
Management continues to take a disciplined approach toward
expense management. Operational excellence initiatives
undertaken by management in 2008 and planned for 2009 will
create expense efficiencies, however, management will continue
to invest in infrastructure and distribution improvements where
such spending will enhance growth. Management believes that the
ability to deliver quality risk & protection and
retirement & savings products to the markets, coupled
with the Companys financial strength and strong risk
management expertise, will help achieve continued growth in this
challenging environment.
Auto &
Home Outlook
Management expects premiums for the Auto & Home segment to
grow slightly in 2009. The key sales triggers of new and
existing home sales and auto sales dropped precipitously during
2008, contributing to large declines in new Homeowner and Auto
policies written during 2008. However, these declines began to
slow late in 2008. New business sales are expected to rebound
modestly for both Auto and Homeowners, assuming overall economic
conditions improve, particularly as credit availability returns,
and as a combination of various marketing and sales initiatives
have been implemented. Retention ratios are expected to remain
flat, or improve slightly, as specific underwriting initiatives
to control exposures to catastrophe events were completed in the
fourth quarter of 2008. Net premiums written for 2009 are
expected to increase modestly with slightly larger increases in
Auto premiums written and slightly smaller increases in
Homeowners and other. A portion of this increase is expected to
result from increases in exposures with the remaining change
coming from increased average premium per policy.
78
Net investment income is also expected to be slightly lower in
2009, as previously discussed in the consolidated outlook, and
cash from operations and maturing investments is reinvested at
slightly lower rates. In addition, Management expects the
expense ratio to decline slightly as Management continues to
manage operating expenses.
Underwriting margins for both Auto and Homeowners are expected
to remain under pressure as some carriers have been willing to
accept higher combined ratios in an attempt to grow written
premium. Auto results benefited primarily from lower severities
during 2008. A reduction in miles driven, initially tied to
higher gasoline prices and later in the year to the general
economic slowdown, contributed to these improvements. A
continuation of the trend towards lower frequencies is expected
for 2009 with higher severities expected to more than offset the
gains from frequencies. Management believes this will result in
a slightly higher loss and loss adjusting expense ratio for
2009, compared to the same ratio for 2008, excluding prior year
loss development. Homeowner margins for 2008, excluding
catastrophes, were impacted by higher claims frequencies,
primarily related to greater non-catastrophe weather-related
losses, offset by lower severities. In 2009, a return to more
normal weather patterns is expected and management believes will
result in lower frequencies in 2009 partially offset by higher
severities, resulting in a small expected drop in the Homeowner
loss and loss adjusting ratio, excluding catastrophes, as
compared to 2008. The unusual financial market conditions,
previously discussed, will also likely cause an increase in the
Companys pension-related expense. Management continues to
aggressively look for ways to control costs in all other areas
so it may maintain an appropriate expense ratio.
Corporate &
Other Outlook
Management believes the investment and capital markets may
continue to be turbulent in 2009, which would continue to exert
downward pressure on net investment income, as previously
discussed in the consolidated outlook, and earnings on excess
surplus equity. Management expects that investment income could
be adversely impacted by a continuation of increased liquidity
levels due to the uncertain operating environment and lack of
suitable investment opportunities Current liquidity levels may
position us to take advantage of any economic recovery,
mitigating the impact that these levels have on net investment
income.
Management does not expect a significant increase in interest
expense. A portion of the Companys debt has a variable
interest rate and the associated interest expense will fluctuate
with market rates. However, this expense has a corresponding
investment that is also tied to variable rates and therefore,
generally should minimize the impact to net income. In addition,
settlements for asbestos claims and other potential legal claims
may have an adverse impact on net income.
Management expects that the MetLife Bank acquisitions completed
in 2008 will be accretive to 2009 earnings with additional
investment income and higher premiums, fees, and other income,
partially offset with increased interest and operating expenses.
MetLife Bank could be impacted by changes in the residential
loan market.
Acquisitions
and Dispositions
Disposition
of Reinsurance Group of America, Incorporated
On September 12, 2008, the Company completed a tax-free
split-off of its majority-owned subsidiary, RGA. The Company and
RGA entered into a recapitalization and distribution agreement,
pursuant to which the Company agreed to divest substantially all
of its 52% interest in RGA to the Companys stockholders.
The split-off was effected through the following:
|
|
|
|
|
A recapitalization of RGA common stock into two classes of
common stock RGA Class A common stock and RGA
Class B common stock. Pursuant to the terms of the
recapitalization, each outstanding share of RGA common stock,
including the 32,243,539 shares of RGA common stock
beneficially owned by the Company and its subsidiaries, was
reclassified as one share of RGA Class A common stock.
Immediately thereafter, the Company and its subsidiaries
exchanged 29,243,539 shares of its RGA Class A common
stock which represented all of the RGA Class A
common stock beneficially owned by the Company and its
subsidiaries other than 3,000,000 shares of RGA
Class A common stock with RGA for
29,243,539 shares of RGA Class B common stock.
|
79
|
|
|
|
|
An exchange offer, pursuant to which the Company offered to
acquire MetLife common stock from its stockholders in exchange
for all of its 29,243,539 shares of RGA Class B common
stock. The exchange ratio was determined based upon a
ratio as more specifically described in the exchange
offering document of the value of the MetLife and
RGA shares during the
three-day
period prior to the closing of the exchange offer. The
3,000,000 shares of the RGA Class A common stock were
not subject to the tax-free exchange.
|
As a result of completion of the recapitalization and exchange
offer, the Company received from MetLife stockholders
23,093,689 shares of the Companys common stock with a
market value of $1,318 million and, in exchange, delivered
29,243,539 shares of RGAs Class B common stock
with a net book value of $1,716 million. The resulting loss
on disposition, inclusive of transaction costs of
$60 million, was $458 million. The
3,000,000 shares of RGA Class A common stock retained
by the Company are marketable equity securities which do not
constitute significant continuing involvement in the operations
of RGA; accordingly, they have been classified within equity
securities in the consolidated financial statements of the
Company at a cost basis of $157 million which is equivalent
to the net book value of the shares. The cost basis will be
adjusted to estimated fair value at each subsequent reporting
date. The Company has agreed to dispose of the remaining shares
of RGA within the next five years. In connection with the
Companys agreement to dispose of the remaining shares, the
Company also recognized, in its provision for income tax on
continuing operations, a deferred tax liability of
$16 million which represents the difference between the
book and taxable basis of the remaining investment in RGA.
The impact of the disposition of the Companys investment
in RGA is reflected in the Companys consolidated financial
statements as discontinued operations. The disposition of RGA
results in the elimination of the Companys Reinsurance
segment. The Reinsurance segment was comprised of the results of
RGA, which at disposition became discontinued operations of
Corporate & Other, and the interest on economic
capital, which has been reclassified to the continuing
operations of Corporate & Other.
Disposition
of Texas Life Insurance Company
MetLife, Inc. has entered into an agreement to sell Cova
Corporation, the parent company of Texas Life Insurance Company
in early 2009. As a result of the sale agreement, the Company
recognized gains from discontinued operations of
$37 million, net of income tax, in the fourth quarter of
2008. The gain was comprised of recognition of tax benefits of
$65 million relating to the excess of outside tax basis of
Cova over its financial reporting basis offset by other than
temporary impairments of $28 million, net of income tax,
relating to Covas investments. The Company has
reclassified the assets and liabilities of Cova as held-for-sale
and its operations into discontinued operations for all periods
presented in the consolidated financial statements.
2008
Acquisitions
During 2008, the Company made five acquisitions for
$783 million. As a result of these acquisitions,
MetLifes Institutional segment increased its product
offering of dental and vision benefit plans, MetLife Bank within
Corporate & Other entered the mortgage origination and
servicing business and the International segment increased its
presence in Mexico and Brazil. The acquisitions were each
accounted for using the purchase method of accounting, and
accordingly, commenced being included in the operating results
of the Company upon their respective closing dates. Total
consideration paid by the Company for these acquisitions
consisted of $763 million in cash and $20 million in
transaction costs. The net fair value of assets acquired and
liabilities assumed totaled $527 million, resulting in
goodwill of $256 million. Goodwill increased by
$122 million, $73 million and $61 million in the
International segment, Institutional segment and
Corporate & Other, respectively. The goodwill is
deductible for tax purposes. Value of customer relationships
acquired (VOCRA), VOBA and other intangibles
increased by $137 million, $7 million and
$6 million, respectively, as a result of these acquisitions.
Other
Acquisitions and Dispositions
On June 28, 2007, the Company acquired the remaining 50%
interest in a joint venture in Hong Kong, MetLife Fubon Limited
(MetLife Fubon), for $56 million in cash,
resulting in MetLife Fubon becoming a consolidated subsidiary of
the Company. The transaction was treated as a step acquisition,
and at June 30, 2007, total assets and liabilities of
MetLife Fubon of $839 million and $735 million,
respectively, were included in the Companys
80
consolidated balance sheet. The Companys investment for
the initial 50% interest in MetLife Fubon was $48 million.
The Company used the equity method of accounting for such
investment in MetLife Fubon. The Companys share of the
joint ventures results for the six months ended
June 30, 2007, was a loss of $3 million. The fair
value of the assets acquired and the liabilities assumed in the
step acquisition at June 30, 2007, was $427 million
and $371 million, respectively. No additional goodwill was
recorded as a part of the step acquisition. As a result of this
acquisition, additional VOBA and VODA of $45 million and
$5 million, respectively, were recorded and both have a
weighted average amortization period of 16 years. In June
2008, the Company revised the valuation of certain long-term
liabilities, VOBA, and VODA based on new information received.
As a result, the fair value of acquired insurance liabilities
and VOBA were reduced by $5 million and $12 million,
respectively, offset by an increase in VODA of $7 million.
The revised VOBA and VODA have a weighted average amortization
period of 11 years.
On June 1, 2007, the Company completed the sale of its
Bermuda insurance subsidiary, MetLife International Insurance,
Ltd. (MLII), to a third party for $33 million
in cash consideration, resulting in a gain upon disposal of
$3 million, net of income tax. The net assets of MLII at
disposal were $27 million. A liability of $1 million
was recorded with respect to a guarantee provided in connection
with this disposition.
On July 1, 2005, the Company completed the acquisition of
Travelers for $12.1 billion. The acquisition was accounted
for using the purchase method of accounting. The net fair value
of assets acquired and liabilities assumed totaled
$7.8 billion, resulting in goodwill of $4.3 billion.
The initial consideration paid by the Company in 2005 for the
acquisition consisted of $10.9 billion in cash and
22,436,617 shares of the Companys common stock with a
market value of $1.0 billion to Citigroup and
$100 million in other transaction costs. The Company
revised the purchase price as a result of the finalization by
both parties of their review of the June 30, 2005 financial
statements and final resolution as to the interpretation of the
provisions of the acquisition agreement which resulted in a
payment of additional consideration of $115 million by the
Company to Citigroup in 2006.
Industry
Trends
The Companys segments continue to be influenced by a
variety of trends that affect the industry.
Financial and Economic Environment. Our
results of operations are materially affected by conditions in
the global capital markets and the economy generally, both in
the United States and elsewhere around the world. The stress
experienced by global capital markets that began in the second
half of 2007 has continued and substantially increased; since
mid- September 2008, the global financial markets have
experienced unprecedented disruption, adversely affecting the
business environment in general, as well as the financial
services industry, in particular. There is consensus in the
economic community that the U.S. economy is in a recession.
Throughout 2008 and continuing in 2009, Congress, the Federal
Reserve Bank of New York, the U.S. Treasury and other
agencies of the Federal government took a number of increasingly
aggressive actions (in addition to continuing a series of
interest rate reductions that began in the second half of
2007) intended to provide liquidity to financial
institutions and markets, to avert a loss of investor confidence
in particular troubled institutions and to prevent or contain
the spread of the financial crisis. How and to whom the
U.S. Treasury distributes amounts available under the
governmental programs could have the effect of supporting some
aspects of the financial services industry more than others or
provide advantages to some of our competitors. Governments in
many of the foreign markets in which MetLife operates have also
responded to address market imbalances and have taken meaningful
steps intended to restore market confidence. We cannot predict
whether the U.S. or foreign governments will establish
additional governmental programs or the impact any additional
measures or existing programs will have on the financial
markets, whether on the levels of volatility currently being
experienced, the levels of lending by financial institutions the
prices buyers are willing to pay for financial assets or
otherwise. See Business Regulation
Governmental Responses to Extraordinary Market Conditions.
The economic crisis and the resulting recession have had and
will continue to have an adverse effect on the financial results
of companies in the financial services industry, including the
Company. The declining financial markets and economic conditions
have negatively impacted our investment income and the demand
for and the cost and profitability of certain of our products,
including variable annuities and guarantee riders. See
Results of Operations and
Liquidity and Capital Resources
Extraordinary Market Conditions.
81
Demographics. In the coming decade, a key
driver shaping the actions of the life insurance industry will
be the rising income protection, wealth accumulation and needs
of the retiring Baby Boomers. As a result of increasing
longevity, retirees will need to accumulate sufficient savings
to finance retirements that may span 30 or more years. Helping
the Baby Boomers to accumulate assets for retirement and
subsequently to convert these assets into retirement income
represents an opportunity for the life insurance industry.
Life insurers are well positioned to address the Baby
Boomers rapidly increasing need for savings tools and for
income protection. The Company believes that, among life
insurers, those with strong brands, high financial strength
ratings and broad distribution, are best positioned to
capitalize on the opportunity to offer income protection
products to Baby Boomers.
Moreover, the life insurance industrys products and the
needs they are designed to address are complex. The Company
believes that individuals approaching retirement age will need
to seek information to plan for and manage their retirements and
that, in the workplace, as employees take greater responsibility
for their benefit options and retirement planning, they will
need information about their possible individual needs. One of
the challenges for the life insurance industry will be the
delivery of this information in a cost effective manner.
Competitive Pressures. The life insurance
industry remains highly competitive. The product development and
product life-cycles have shortened in many product segments,
leading to more intense competition with respect to product
features. Larger companies have the ability to invest in brand
equity, product development, technology and risk management,
which are among the fundamentals for sustained profitable growth
in the life insurance industry. In addition, several of the
industrys products can be quite homogeneous and subject to
intense price competition. Sufficient scale, financial strength
and financial flexibility are becoming prerequisites for
sustainable growth in the life insurance industry. Larger market
participants tend to have the capacity to invest in additional
distribution capability and the information technology needed to
offer the superior customer service demanded by an increasingly
sophisticated industry client base. We believe that the
turbulence in financial markets that began in the latter half of
2008, its impact on the capital position of many competitors,
and subsequent actions by regulators and rating agencies have
highlighted financial strength as the most significant
differentiator from the perspective of customers and certain
distributors. In addition, the financial market turbulence and
the economic recession have led many companies in our industry
to re-examine the pricing and features of the products they
offer and may lead to consolidation in the life insurance
industry.
Regulatory Changes. The life insurance
industry is regulated at the state level, with some products and
services also subject to federal regulation. As life insurers
introduce new and often more complex products, regulators refine
capital requirements and introduce new reserving standards for
the life insurance industry. Regulations recently adopted or
currently under review can potentially impact the reserve and
capital requirements of the industry. In addition, regulators
have undertaken market and sales practices reviews of several
markets or products, including equity-indexed annuities,
variable annuities and group products. We expect the regulation
of the financial services industry to receive renewed scrutiny
as a result of the disruptions in the financial markets in 2008.
It is possible that significant regulatory reforms could be
implemented. We cannot predict whether any such reforms will be
adopted, the form they will take or their effect upon us. We
also cannot predict how the various government responses to the
current financial and economic difficulties will affect the
financial services and insurance industries or the standing of
particular companies, including our Company, within those
industries.
Pension Plans. On August 17, 2006,
President Bush signed the Pension Protection Act of 2006
(PPA) into law. The PPA is a comprehensive reform of
defined benefit and defined contribution plan rules. The
provisions of the PPA may, over time, have a significant impact
on demand for pension, retirement savings, and lifestyle
protection products in both the institutional and retail
markets. While the impact of the PPA is generally expected to be
positive over time, these changes may have adverse short-term
effects on the Companys business as plan sponsors may
react to these changes in a variety of ways as the new rules and
related regulations begin to take effect. In response to the
current financial and economic environment, President Bush
signed into the law the Worker, Retiree and Employer Recovery
Act (the Employer Recovery Act) in December 2008.
This Act is intended to, among other things, ease the transition
of certain funding requirements of the PPA for defined benefit
plans. The financial and economic environment and the enactment
of the Employer Recovery Act may delay the timing or change the
nature of qualified plan sponsor actions and, in turn, affect
the Companys business.
82
Summary
of Critical Accounting Estimates
The preparation of financial statements in conformity with
accounting principles generally accepted in the United States of
America (GAAP) requires management to adopt
accounting policies and make estimates and assumptions that
affect amounts reported in the consolidated financial
statements. The most critical estimates include those used in
determining:
|
|
|
|
(i)
|
the estimated fair value of investments in the absence of quoted
market values;
|
|
|
(ii)
|
investment impairments;
|
|
|
(iii)
|
the recognition of income on certain investment entities;
|
|
|
(iv)
|
the application of the consolidation rules to certain
investments;
|
|
|
(v)
|
the existence and estimated fair value of embedded derivatives
requiring bifurcation;
|
|
|
(vi)
|
the estimated fair value of and accounting for derivatives;
|
|
|
(vii)
|
the capitalization and amortization of DAC and the establishment
and amortization of VOBA;
|
|
|
(viii)
|
the measurement of goodwill and related impairment, if any;
|
|
|
(ix)
|
the liability for future policyholder benefits;
|
|
|
(x)
|
accounting for income taxes and the valuation of deferred tax
assets;
|
|
|
(xi)
|
accounting for reinsurance transactions;
|
|
|
(xii)
|
accounting for employee benefit plans; and
|
|
|
(xiii)
|
the liability for litigation and regulatory matters.
|
The application of purchase accounting requires the use of
estimation techniques in determining the estimated fair values
of assets acquired and liabilities assumed the most
significant of which relate to the aforementioned critical
estimates. In applying the Companys accounting policies,
management makes subjective and complex judgments that
frequently require estimates about matters that are inherently
uncertain. Many of these policies, estimates and related
judgments are common in the insurance and financial services
industries; others are specific to the Companys businesses
and operations. Actual results could differ from these estimates.
Fair
Value
As described below, certain assets and liabilities are measured
at estimated fair value on the Companys consolidated
balance sheets. In addition, these footnotes to the consolidated
financial statements include disclosures of estimated fair
values. Effective January 1, 2008, the Company adopted
Statement of Financial Accounting Standards (SFAS)
No. 157, Fair Value Measurements
(SFAS 157). SFAS 157 defines fair value as
the price that would be received to sell an asset or paid to
transfer a liability (an exit price) in the principal or most
advantageous market for the asset or liability in an orderly
transaction between market participants on the measurement date.
In many cases, the exit price and the transaction (or entry)
price will be the same at initial recognition. However, in
certain cases, the transaction price may not represent fair
value. Under SFAS 157, fair value of a liability is based
on the amount that would be paid to transfer a liability to a
third party with the same credit standing. SFAS 157
requires that fair value be a market-based measurement in which
the fair value is determined based on a hypothetical transaction
at the measurement date, considered from the perspective of a
market participant. When quoted prices are not used to determine
fair value, SFAS 157 requires consideration of three broad
valuation techniques: (i) the market approach,
(ii) the income approach, and (iii) the cost approach.
The approaches are not new, but SFAS 157 requires that
entities determine the most appropriate valuation technique to
use, given what is being measured and the availability of
sufficient inputs. SFAS 157 prioritizes the inputs to fair
valuation techniques and allows for the use of unobservable
inputs to the extent that observable inputs are not available.
The Company has categorized its assets and liabilities measured
at estimated fair value into a three-level hierarchy, based on
the priority of the inputs to the respective valuation
technique. The fair value hierarchy gives the highest priority
to quoted prices in active markets for identical assets or
liabilities (Level 1) and the lowest priority to
unobservable inputs (Level 3). An asset
83
or liabilitys classification within the fair value
hierarchy is based on the lowest level of significant input to
its valuation. SFAS 157 defines the input levels as follows:
|
|
|
|
Level 1
|
Unadjusted quoted prices in active markets for identical assets
or liabilities. The Company defines active markets based on
average trading volume for equity securities. The size of the
bid/ask spread is used as an indicator of market activity for
fixed maturity securities.
|
|
|
Level 2
|
Quoted prices in markets that are not active or inputs that are
observable either directly or indirectly. Level 2 inputs
include quoted prices for similar assets or liabilities other
than quoted prices in Level 1; quoted prices in markets
that are not active; or other inputs that are observable or can
be derived principally from or corroborated by observable market
data for substantially the full term of the assets or
liabilities.
|
|
|
Level 3
|
Unobservable inputs that are supported by little or no market
activity and are significant to the estimated fair value of the
assets or liabilities. Unobservable inputs reflect the reporting
entitys own assumptions about the assumptions that market
participants would use in pricing the asset or liability.
Level 3 assets and liabilities include financial
instruments whose values are determined using pricing models,
discounted cash flow methodologies, or similar techniques, as
well as instruments for which the determination of estimated
fair value requires significant management judgment or
estimation.
|
The measurement and disclosures under SFAS 157 in the
accompanying financial statements and footnotes exclude certain
items such as nonfinancial assets and nonfinancial liabilities
initially measured at estimated fair value in a business
combination, reporting units measured at estimated fair value in
the first step of a goodwill impairment test and
indefinite-lived intangible assets measured at estimated fair
value for impairment assessment. The effective date for these
items was deferred to January 1, 2009.
Prior to adoption of SFAS 157, estimated fair value was
determined based solely upon the perspective of the reporting
entity. Therefore, methodologies used to determine the estimated
fair value of certain financial instruments prior to
January 1, 2008, while being deemed appropriate under
existing accounting guidance, may not have produced an exit
value as defined in SFAS 157.
Estimated
Fair Values of Investments
The Companys investments in fixed maturity and equity
securities, investments in trading securities, certain
short-term investments, most mortgage loans
held-for-sale,
and mortgage servicing rights (MSRs) are reported at
their estimated fair value. In determining the estimated fair
value of these investments, various methodologies, assumptions
and inputs are utilized, as described further below.
When available, the estimated fair value of securities is based
on quoted prices in active markets that are readily and
regularly obtainable. Generally, these are the most liquid of
the Companys securities holdings and valuation of these
securities does not involve management judgment.
When quoted prices in active markets are not available, the
determination of estimated fair value is based on market
standard valuation methodologies. The market standard valuation
methodologies utilized include: discounted cash flow
methodologies, matrix pricing or other similar techniques. The
assumptions and inputs in applying these market standard
valuation methodologies include, but are not limited to:
interest rates, credit standing of the issuer or counterparty,
industry sector of the issuer, coupon rate, call provisions,
sinking fund requirements, maturity, estimated duration and
managements assumptions regarding liquidity and estimated
future cash flows. Accordingly, the estimated fair values are
based on available market information and managements
judgments about financial instruments.
The significant inputs to the market standard valuation
methodologies for certain types of securities with reasonable
levels of price transparency are inputs that are observable in
the market or can be derived principally from or corroborated by
observable market data. Such observable inputs include
benchmarking prices for similar assets in active, liquid
markets, quoted prices in markets that are not active and
observable yields and spreads in the market.
84
When observable inputs are not available, the market standard
valuation methodologies for determining the estimated fair value
of certain types of securities that trade infrequently, and
therefore have little or no price transparency, rely on inputs
that are significant to the estimated fair value that are not
observable in the market or cannot be derived principally from
or corroborated by observable market data. These unobservable
inputs can be based in large part on management judgment or
estimation, and cannot be supported by reference to market
activity. Even though unobservable, these inputs are based on
assumptions deemed appropriate given the circumstances and
consistent with what other market participants would use when
pricing such securities.
The estimated fair value of residential mortgage loans
held-for-sale
are determined based on observable pricing of residential
mortgage loans
held-for-sale
with similar characteristics, or observable pricing for
securities backed by similar types of loans, adjusted to convert
the securities prices to loan prices. Generally, quoted market
prices are not available. When observable pricing for similar
loans or securities that are backed by similar loans are not
available, the estimated fair values of residential mortgage
loans
held-for-sale
are determined using independent broker quotations, which is
intended to approximate the amounts that would be received from
third parties. Certain other mortgages have also been designated
as
held-for-sale
which are recorded at the lower of amortized cost or estimated
fair value less expected disposition costs determined on an
individual loan basis. For these loans, estimated fair value is
determined using independent broker quotations or, when the loan
is in foreclosure or otherwise determined to be collateral
dependent, the estimated fair value of the underlying collateral
estimated using internal models.
Mortgage servicing rights (MSRs) are measured at
estimated fair value and are either acquired or are generated
from the sale of originated residential mortgage loans where the
servicing rights are retained by the Company. The estimated fair
value of MSRs is principally determined through the use of
internal discounted cash flow models which utilize various
assumptions as to discount rates, loan-prepayments, and
servicing costs. The use of different valuation assumptions and
inputs as well as assumptions relating to the collection of
expected cash flows may have a material effect on MSRs estimated
fair values.
Financial markets are susceptible to severe events evidenced by
rapid depreciation in asset values accompanied by a reduction in
asset liquidity. The Companys ability to sell securities,
or the price ultimately realized for these securities, depends
upon the demand and liquidity in the market and increases the
use of judgment in determining the estimated fair value of
certain securities.
Investment
Impairments
One of the significant estimates related to
available-for-sale
securities is the evaluation of investments for
other-than-temporary
impairments. The assessment of whether impairments have occurred
is based on managements
case-by-case
evaluation of the underlying reasons for the decline in
estimated fair value. The Companys review of its fixed
maturity and equity securities for impairments includes an
analysis of the total gross unrealized losses by three
categories of securities: (i) securities where the
estimated fair value had declined and remained below cost or
amortized cost by less than 20%; (ii) securities where the
estimated fair value had declined and remained below cost or
amortized cost by 20% or more for less than six months; and
(iii) securities where the estimated fair value had
declined and remained below cost or amortized cost by 20% or
more for six months or greater. An extended and severe
unrealized loss position on a fixed maturity security may not
have any impact on the ability of the issuer to service all
scheduled interest and principal payments and the Companys
evaluation of recoverability of all contractual cash flows, as
well as the Companys ability and intent to hold the
security, including holding the security until the earlier of a
recovery in value, or until maturity. In contrast, for certain
equity securities, greater weight and consideration are given by
the Company to a decline in estimated fair value and the
likelihood such estimated fair value decline will recover.
Additionally, management considers a wide range of factors about
the security issuer and uses its best judgment in evaluating the
cause of the decline in the estimated fair value of the security
and in assessing the prospects for near-term recovery. Inherent
in managements evaluation of the security are assumptions
and estimates about the operations of the issuer and its future
earnings potential. Considerations used by the Company in the
impairment evaluation process include, but are not limited to:
|
|
|
|
(i)
|
the length of time and the extent to which the estimated fair
value has been below cost or amortized cost;
|
85
|
|
|
|
(ii)
|
the potential for impairments of securities when the issuer is
experiencing significant financial difficulties;
|
|
|
(iii)
|
the potential for impairments in an entire industry sector or
sub-sector;
|
|
|
(iv)
|
the potential for impairments in certain economically depressed
geographic locations;
|
|
|
(v)
|
the potential for impairments of securities where the issuer,
series of issuers or industry has suffered a catastrophic type
of loss or has exhausted natural resources;
|
|
|
(vi)
|
the Companys ability and intent to hold the security for a
period of time sufficient to allow for the recovery of its value
to an amount equal to or greater than cost or amortized cost;
|
|
|
(vii)
|
unfavorable changes in forecasted cash flows on mortgage-backed
and asset-backed securities; and
|
|
|
(viii)
|
other subjective factors, including concentrations and
information obtained from regulators and rating agencies.
|
The cost of fixed maturity and equity securities is adjusted for
impairments in value deemed to be other-than temporary in the
period in which the determination is made. These impairments are
included within net investment gains (losses) and the cost basis
of the fixed maturity and equity securities is reduced
accordingly. The Company does not change the revised cost basis
for subsequent recoveries in value.
The determination of the amount of allowances and impairments on
other invested asset classes is highly subjective and is based
upon the Companys periodic evaluation and assessment of
known and inherent risks associated with the respective asset
class. Such evaluations and assessments are revised as
conditions change and new information becomes available.
Management updates its evaluations regularly and reflects
changes in allowances and impairments in operations as such
evaluations are revised.
Recognition
of Income on Certain Investment Entities
The recognition of income on certain investments (e.g.
loan-backed securities, including mortgage-backed and
asset-backed securities, certain structured investment
transactions, trading securities, etc.) is dependent upon market
conditions, which could result in prepayments and changes in
amounts to be earned.
Application
of the Consolidation Rules to Certain Investments
Additionally, the Company has invested in certain structured
transactions that are VIEs under Financial Accounting Standards
Board (FASB) Interpretation (FIN)
No. 46(r), Consolidation of Variable Interest
Entities An Interpretation of Accounting Research
Bulletin No. 51 (FIN 46(r)). These
structured transactions include reinsurance trusts, asset-backed
securitizations, trust preferred securities, joint ventures,
limited partnerships and limited liability companies. The
Company is required to consolidate those VIEs for which it is
deemed to be the primary beneficiary. The accounting rules under
FIN 46(r) for the determination of when an entity is a VIE
and when to consolidate a VIE are complex. The determination of
the VIEs primary beneficiary requires an evaluation of the
contractual rights and obligations associated with each party
involved in the entity, an estimate of the entitys
expected losses and expected residual returns and the allocation
of such estimates to each party involved in the entity. FIN
46(r) defines the primary beneficiary as the entity that will
absorb a majority of a VIEs expected losses, receive a
majority of a VIEs expected residual returns if no single
entity absorbs a majority of expected losses, or both.
When determining the primary beneficiary for structured
investment products such as asset-backed securitizations and
collateralized debt obligations, the Company uses historical
default probabilities based on the credit rating of each issuer
and other inputs including maturity dates, industry
classifications and geographic location. Using computational
algorithms, the analysis simulates default scenarios resulting
in a range of expected losses and the probability associated
with each occurrence. For other investment structures such as
trust preferred securities, joint ventures, limited partnerships
and limited liability companies, the Company gains an
understanding of the design of the VIE and generally uses a
qualitative approach to determine if it is the primary
beneficiary. This approach includes an analysis of all
contractual rights and obligations held by all parties including
profit and loss allocations, repayment or residual value
guarantees, put and call options and other derivative
instruments. If the primary beneficiary of a VIE can not be
identified using this qualitative approach, the Company
calculates the
86
expected losses and expected residual returns of the VIE using a
probability-weighted cash flow model. The use of different
methodologies, assumptions and inputs in the determination of
the primary beneficiary could have a material effect on the
amounts presented within the consolidated financial statements.
Derivative
Financial Instruments
The Company enters into freestanding derivative transactions
including swaps, forwards, futures and option contracts. The
Company uses derivatives primarily to manage various risks. The
risks being managed are variability in cash flows or changes in
estimated fair values related to financial instruments and
currency exposure associated with net investments in certain
foreign operations. To a lesser extent, the Company uses credit
derivatives, such as credit default swaps, to synthetically
replicate investment risks and returns which are not readily
available in the cash market.
The estimated fair value of derivatives is determined through
the use of quoted market prices for exchange-traded derivatives
and financial forwards to sell residential mortgage-backed
securities or through the use of pricing models for
over-the-counter
derivatives. The determination of estimated fair value, when
quoted market values are not available, is based on market
standard valuation methodologies and inputs that are assumed to
be consistent with what other market participants would use when
pricing the instruments. Derivative valuations can be affected
by changes in interest rates, foreign currency exchange rates,
financial indices, credit spreads, default risk (including the
counterparties to the contract), volatility, liquidity and
changes in estimates and assumptions used in the pricing models.
The significant inputs to the pricing models for most
over-the-counter
derivatives are inputs that are observable in the market or can
be derived principally from or corroborated by observable market
data. Significant inputs that are observable generally include:
interest rates, foreign currency exchange rates, interest rate
curves, credit curves, and volatility. However, certain
over-the-counter
derivatives may rely on inputs that are significant to the
estimated fair value that are not observable in the market or
cannot be derived principally from or corroborated by observable
market data. Significant inputs that are unobservable generally
include: independent broker quotes, credit correlation
assumptions, references to emerging market currencies, and
inputs that are outside the observable portion of the interest
rate curve, credit curve, volatility, or other relevant market
measure. These unobservable inputs may involve significant
management judgment or estimation. Even though unobservable,
these inputs are based on assumptions deemed appropriate given
the circumstances and consistent with what other market
participants would use when pricing such instruments. Most
inputs for
over-the-counter
derivatives are mid market inputs but, in certain cases, bid
level inputs are used when they are deemed more representative
of exit value. Market liquidity as well as the use of different
methodologies, assumptions and inputs may have a material effect
on the estimated fair values of the Companys derivatives
and could materially affect net income. Also, fluctuations in
the estimated fair value of derivatives which have not been
designated for hedge accounting may result in significant
volatility in net income.
The credit risk of both the counterparty and the Company are
considered in determining the estimated fair value for all
over-the-counter
derivatives after taking into account the effects of netting
agreements and collateral arrangements. Credit risk is monitored
and consideration of any potential credit adjustment is based on
a net exposure by counterparty. This is due to the existence of
netting agreements and collateral arrangements which effectively
serve to mitigate credit risk. The Company values its derivative
positions using the standard swap curve which includes a credit
risk adjustment. This credit risk adjustment is appropriate for
those parties that execute trades at pricing levels consistent
with the standard swap curve. As the Company and its significant
derivative counterparties consistently execute trades at such
pricing levels, additional credit risk adjustments are not
currently required in the valuation process. The need for such
additional credit risk adjustments is monitored by the Company.
The Companys ability to consistently execute at such
pricing levels is in part due to the netting agreements and
collateral arrangements that are in place with all of its
significant derivative counterparties. The evaluation of the
requirement to make an additional credit risk adjustments is
performed by the Company each reporting period.
The accounting for derivatives is complex and interpretations of
the primary accounting standards continue to evolve in practice.
Judgment is applied in determining the availability and
application of hedge accounting designations and the appropriate
accounting treatment under these accounting standards. If it was
determined that
87
hedge accounting designations were not appropriately applied,
reported net income could be materially affected. Differences in
judgment as to the availability and application of hedge
accounting designations and the appropriate accounting treatment
may result in a differing impact on the consolidated financial
statements of the Company from that previously reported.
Assessments of hedge effectiveness and measurements of
ineffectiveness of hedging relationships are also subject to
interpretations and estimations and different interpretations or
estimates may have a material effect on the amount reported in
net income.
Embedded
Derivatives
Embedded derivatives principally include certain variable
annuity riders and certain guaranteed investment contracts with
equity or bond indexed crediting rates. Embedded derivatives are
recorded in the financial statements at estimated fair value
with changes in estimated fair value adjusted through net income.
The Company issues certain variable annuity products with
guaranteed minimum benefit riders. These include guaranteed
minimum withdrawal benefit (GMWB) riders, guaranteed
minimum accumulation benefit (GMAB) riders, and
certain guaranteed minimum income benefit (GMIB)
riders. GMWB, GMAB and certain GMIB riders are embedded
derivatives, which are measured at estimated fair value
separately from the host variable annuity contract, with changes
in estimated fair value reported in net investment gains
(losses).
The estimated fair value for these riders is estimated using the
present value of future benefits minus the present value of
future fees using actuarial and capital market assumptions
related to the projected cash flows over the expected lives of
the contracts. The projections of future benefits and future
fees require capital market and actuarial assumptions including
expectations concerning policyholder behavior. A risk neutral
valuation methodology is used under which the cash flows from
the riders are projected under multiple capital market scenarios
using observable risk free rates. Beginning in 2008, the
valuation of these embedded derivatives now includes an
adjustment for the Companys own credit and risk margins
for non-capital market inputs. The Companys own credit
adjustment is determined taking into consideration publicly
available information relating to the Companys debt as
well as its claims paying ability. Risk margins are established
to capture the non-capital market risks of the instrument which
represent the additional compensation a market participant would
require to assume the risks related to the uncertainties of such
actuarial assumptions as annuitization, premium persistency,
partial withdrawal and surrenders. The establishment of risk
margins requires the use of significant management judgment.
These riders may be more costly than expected in volatile or
declining equity markets. Market conditions including, but not
limited to, changes in interest rates, equity indices, market
volatility and foreign currency exchange rates; changes in the
Companys own credit standing; and variations in actuarial
assumptions regarding policyholder behavior, and risk margins
related to non-capital market inputs may result in significant
fluctuations in the estimated fair value of the riders that
could materially affect net income.
The Company ceded the risk associated with certain of the GMIB
and GMAB riders described in the preceding paragraphs. The value
of the embedded derivatives on the ceded risk is determined
using a methodology consistent with that described previously
for the riders directly written by the Company.
The estimated fair value of the embedded equity and bond indexed
derivatives contained in certain guaranteed investment contracts
is determined using market standard swap valuation models and
observable market inputs, including an adjustment for the
Companys own credit that takes into consideration publicly
available information relating to the Companys debt as
well as its claims paying ability. Changes in equity and bond
indices, interest rates and the Companys credit standing
may result in significant fluctuations in estimated the fair
value of these embedded derivatives that could materially affect
net income.
The accounting for embedded derivatives is complex and
interpretations of the primary accounting standards continue to
evolve in practice. If interpretations change, there is a risk
that features previously not bifurcated may require bifurcation
and reporting at estimated fair value in the consolidated
financial statements and respective changes in estimated fair
value could materially affect net income.
88
Deferred
Policy Acquisition Costs and Value of Business
Acquired
The Company incurs significant costs in connection with
acquiring new and renewal insurance business. Costs that vary
with and relate to the production of new business are deferred
as DAC. Such costs consist principally of commissions and agency
and policy issuance expenses. VOBA is an intangible asset that
reflects the estimated fair value of in-force contracts in a
life insurance company acquisition and represents the portion of
the purchase price that is allocated to the value of the right
to receive future cash flows from the business in-force at the
acquisition date. VOBA is based on actuarially determined
projections, by each block of business, of future policy and
contract charges, premiums, mortality and morbidity, separate
account performance, surrenders, operating expenses, investment
returns and other factors. Actual experience on the purchased
business may vary from these projections. The recovery of DAC
and VOBA is dependent upon the future profitability of the
related business. DAC and VOBA are aggregated in the financial
statements for reporting purposes.
DAC for property and casualty insurance contracts, which is
primarily composed of commissions and certain underwriting
expenses, is amortized on a pro rata basis over the applicable
contract term or reinsurance treaty.
DAC and VOBA on life insurance or investment-type contracts are
amortized in proportion to gross premiums, gross margins or
gross profits, depending on the type of contract as described
below.
The Company amortizes DAC and VOBA related to non-participating
and non-dividend-paying traditional contracts (term insurance,
non-participating whole life insurance, non-medical health
insurance, and traditional group life insurance) over the entire
premium paying period in proportion to the present value of
actual historic and expected future gross premiums. The present
value of expected premiums is based upon the premium requirement
of each policy and assumptions for mortality, morbidity,
persistency, and investment returns at policy issuance, or
policy acquisition, as it relates to VOBA, that include
provisions for adverse deviation and are consistent with the
assumptions used to calculate future policyholder benefit
liabilities. These assumptions are not revised after policy
issuance or acquisition unless the DAC or VOBA balance is deemed
to be unrecoverable from future expected profits. Absent a
premium deficiency, variability in amortization after policy
issuance or acquisition is caused only by variability in premium
volumes.
The Company amortizes DAC and VOBA related to participating,
dividend-paying traditional contracts over the estimated lives
of the contracts in proportion to actual and expected future
gross margins. The amortization includes interest based on rates
in effect at inception or acquisition of the contracts. The
future gross margins are dependent principally on investment
returns, policyholder dividend scales, mortality, persistency,
expenses to administer the business, creditworthiness of
reinsurance counterparties, and certain economic variables, such
as inflation. For participating contracts (dividend paying
traditional contracts within the closed block) future gross
margins are also dependent upon changes in the policyholder
dividend obligation. Of these factors, the Company anticipates
that investment returns, expenses, persistency, and other factor
changes and policyholder dividend scales are reasonably likely
to impact significantly the rate of DAC and VOBA amortization.
Each reporting period, the Company updates the estimated gross
margins with the actual gross margins for that period. When the
actual gross margins change from previously estimated gross
margins, the cumulative DAC and VOBA amortization is
re-estimated and adjusted by a cumulative charge or credit to
current operations. When actual gross margins exceed those
previously estimated, the DAC and VOBA amortization will
increase, resulting in a current period charge to earnings. The
opposite result occurs when the actual gross margins are below
the previously estimated gross margins. Each reporting period,
the Company also updates the actual amount of business in-force,
which impacts expected future gross margins. When expected
future gross margins are below those previously estimated, the
DAC and VOBA amortization will increase, resulting in a current
period charge to earnings. The opposite result occurs when the
expected future gross margins are above the previously estimated
expected future gross margins. Total DAC and VOBA amortization
during a particular period may increase or decrease depending
upon the relative size of the amortization change resulting from
the adjustment to DAC and VOBA for the update of actual gross
margins and the re-estimation of expected future gross margins.
Each period, the Company also reviews the estimated gross
margins for each block of business to determine the
recoverability of DAC and VOBA balances.
The Company amortizes DAC and VOBA related to fixed and variable
universal life contracts and fixed and variable deferred annuity
contracts over the estimated lives of the contracts in
proportion to actual and expected future gross profits. The
amortization includes interest based on rates in effect at
inception or acquisition of the
89
contracts. The amount of future gross profits is dependent
principally upon returns in excess of the amounts credited to
policyholders, mortality, persistency, interest crediting rates,
expenses to administer the business, creditworthiness of
reinsurance counterparties, the effect of any hedges used, and
certain economic variables, such as inflation. Of these factors,
the Company anticipates that investment returns, expenses, and
persistency are reasonably likely to impact significantly the
rate of DAC and VOBA amortization. Each reporting period, the
Company updates the estimated gross profits with the actual
gross profits for that period. When the actual gross profits
change from previously estimated gross profits, the cumulative
DAC and VOBA amortization is re-estimated and adjusted by a
cumulative charge or credit to current operations. When actual
gross profits exceed those previously estimated, the DAC and
VOBA amortization will increase, resulting in a current period
charge to earnings. The opposite result occurs when the actual
gross profits are below the previously estimated gross profits.
Each reporting period, the Company also updates the actual
amount of business remaining in-force, which impacts expected
future gross profits. When expected future gross profits are
below those previously estimated, the DAC and VOBA amortization
will increase, resulting in a current period charge to earnings.
The opposite result occurs when the expected future gross
profits are above the previously estimated expected future gross
profits. Total DAC and VOBA amortization during a particular
period may increase or decrease depending upon the relative size
of the amortization change resulting from the adjustment to DAC
and VOBA for the update of actual gross profits and the
re-estimation of expected future gross profits. Each period, the
Company also reviews the estimated gross profits for each block
of business to determine the recoverability of DAC and VOBA
balances.
Separate account rates of return on variable universal life
contracts and variable deferred annuity contracts affect
in-force account balances on such contracts each reporting
period which can result in significant fluctuations in
amortization of DAC and VOBA. Returns that are higher than the
Companys long-term expectation produce higher account
balances, which increases the Companys future fee
expectations and decreases future benefit payment expectations
on minimum death and living benefit guarantees, resulting in
higher expected future gross profits. The opposite result occurs
when returns are lower than the Companys long-term
expectation. The Companys practice to determine the impact
of gross profits resulting from returns on separate accounts
assumes that long-term appreciation in equity markets is not
changed by short-term market fluctuations, but is only changed
when sustained interim deviations are expected. The Company
monitors these changes and only changes the assumption when its
long-term expectation changes. The effect of an
increase/(decrease) by 100 basis points in the assumed
future rate of return is reasonably likely to result in a
decrease/(increase) in the DAC and VOBA balances of
approximately $110 million with an offset to the
Companys unearned revenue liability of approximately
$20 million for this factor. During 2008, the Company did
not change its long-term expectation of equity market
appreciation.
The Company also reviews periodically other long-term
assumptions underlying the projections of estimated gross
margins and profits. These include investment returns,
policyholder dividend scales, interest crediting rates,
mortality, persistency, and expenses to administer business.
Management annually updates assumptions used in the calculation
of estimated gross margins and profits which may have
significantly changed. If the update of assumptions causes
expected future gross margins and profits to increase, DAC and
VOBA amortization will decrease, resulting in a current period
increase to earnings. The opposite result occurs when the
assumption update causes expected future gross margins and
profits to decrease.
Over the last several years, the Companys most significant
assumption updates resulting in a change to expected future
gross margins and profits and the amortization of DAC and VOBA
have been updated due to revisions to expected future investment
returns, expenses, in-force or persistency assumptions and
policyholder dividends on contracts included within the
Individual segment. During 2008, the amount of net investment
gains (losses) as well as the level of separate account balances
also resulted in significant changes to expected future gross
margins and profits impacting amortization of DAC and VOBA. The
Company expects these assumptions to be the ones most reasonably
likely to cause significant changes in the future. Changes in
these assumptions can be offsetting and the Company is unable to
predict their movement or offsetting impact over time.
Note 5 of the Notes to the Consolidated Financial
Statements provides a rollforward of DAC and VOBA for the
Company for each of the years ended December 31, 2008, 2007
and 2006 as well as a breakdown of DAC and VOBA by segment and
reporting unit at December 31, 2008 and 2007. At
December 31, 2008 and 2007, DAC and VOBA for the Company
was $20.1 billion and $17.8 billion, respectively. A
substantial portion, approximately
90
80%, of the Companys DAC and VOBA is associated with the
Individual segment which had DAC and VOBA of $16.5 billion
and $14.0 billion, respectively, at December 31, 2008
and 2007. Amortization of DAC and VOBA associated with the
variable & universal life and the annuities reporting
units within the Individual segment are significantly impacted
by movements in equity markets. The following chart illustrates
the effect on DAC and VOBA within the Companys Individual
segment of changing each of the respective assumptions as well
as updating estimated gross margins or profits with actual gross
margins or profits during the years ended December 31,
2008, 2007 and 2006. Increases (decreases) in DAC and VOBA
balances, as presented below, result in a corresponding decrease
(increase) in amortization.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Investment return
|
|
$
|
70
|
|
|
$
|
(34
|
)
|
|
$
|
(50
|
)
|
Separate account balances
|
|
|
(708
|
)
|
|
|
8
|
|
|
|
9
|
|
Net investment gain (loss) related
|
|
|
(521
|
)
|
|
|
126
|
|
|
|
233
|
|
Expense
|
|
|
61
|
|
|
|
(53
|
)
|
|
|
45
|
|
In-force/Persistency
|
|
|
(159
|
)
|
|
|
1
|
|
|
|
(34
|
)
|
Policyholder dividends and other
|
|
|
(30
|
)
|
|
|
(39
|
)
|
|
|
(7
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
(1,287
|
)
|
|
$
|
9
|
|
|
$
|
196
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prior to 2008, fluctuations in the amounts presented in the
table above arose principally from normal assumption reviews
during the period. During 2008, there was a significant increase
in DAC and VOBA amortization attributable to the following:
|
|
|
|
|
The decrease in equity markets during the year significantly
lowered separate account balances resulting in a significant
reduction in expected future gross profits on variable universal
life contracts and variable deferred annuity contracts resulting
in an increase of $708 million in DAC and VOBA amortization.
|
|
|
|
Changes in net investment gains (losses) resulted in the
following changes in DAC and VOBA amortization:
|
|
|
|
|
|
Actual gross profits decreased as a result of an increase in
liabilities associated with guarantee obligations on variable
annuities resulting in a reduction of DAC and VOBA amortization
of $1,047 million. This decrease in actual gross profits
was mitigated by freestanding derivative gains associated with
the hedging of such guarantee obligations which resulted in an
increase in actual gross profits and an increase in DAC and VOBA
amortization of $625 million.
|
|
|
|
A change in valuation of guarantee liabilities, resulting from
the adoption of SFAS 157 during 2008, also impacted the
computation of actual gross profits and the related amortization
of DAC and VOBA. The addition of risk margins increased the
guarantee liability valuations, decreased actual gross profits
and decreased amortization by $100 million. Offsetting this
was the addition of own credit to the valuation of guarantee
liabilities. Own credit decreased guarantee liability
valuations, increased actual gross profits and increased
amortization by $739 million. The inclusion of the
Companys own credit in the valuation of these guarantee
liabilities increases the volatility of these valuations,
the related DAC and VOBA amortization, and the net income of the
Company.
|
|
|
|
As more extensively described in Note 9 of the Notes to the
Consolidated Financial Statements, reductions in both actual and
expected cumulative earnings of the closed block resulting from
recent experience in the closed block combined with changes in
expected dividend scales resulted in an increase in closed block
DAC amortization of $195 million, $175 million of
which is related to net investment gains (losses).
|
|
|
|
The remainder of the impact of net investment gains (losses) on
DAC amortization of $129 million was attributable to
numerous immaterial items.
|
|
|
|
|
|
Increases in amortization in 2008 resulting from changes in
assumptions related to in-force/persistency of $159 million
were driven by higher than anticipated mortality and lower than
anticipated premium persistency during the current year.
|
91
The Companys DAC and VOBA balance is also impacted by
unrealized investment gains (losses) and the amount of
amortization which would have been recognized if such gains and
losses had been recognized. The significant increase in
unrealized investment losses at December 31, 2008 resulted
in an increase in DAC and VOBA of $3.4 billion.
Notes 3 and 5 of the Notes to the Consolidated Financial
Statements include the DAC and VOBA offset to unrealized
investment losses.
Goodwill
Goodwill is the excess of cost over the estimated fair value of
net assets acquired. Goodwill is not amortized but is tested for
impairment at least annually or more frequently if events or
circumstances, such as adverse changes in the business climate,
indicate that there may be justification for conducting an
interim test. The Company performs its annual goodwill
impairment testing during the third quarter of each year based
upon data as of the close of the second quarter.
Impairment testing is performed using the fair value approach,
which requires the use of estimates and judgment, at the
reporting unit level. A reporting unit is the
operating segment or a business one level below the operating
segment, if discrete financial information is prepared and
regularly reviewed by management at that level. For purposes of
goodwill impairment testing, a significant portion of goodwill
within Corporate & Other is allocated to reporting
units within the Companys business segments.
For purposes of goodwill impairment testing, if the carrying
value of a reporting units goodwill exceeds its estimated
fair value, there is an indication of impairment and the implied
fair value of the goodwill is determined in the same manner as
the amount of goodwill would be determined in a business
acquisition. The excess of the carrying value of goodwill over
the implied fair value of goodwill is recognized as an
impairment and recorded as a charge against net income.
In performing its goodwill impairment tests, when management
believes meaningful comparable market data are available, the
estimated fair values of the reporting units are determined
using a market multiple approach. When relevant comparables are
not available, the Company uses a discounted cash flow model.
For reporting units which are particularly sensitive to market
assumptions, such as the annuities and variable &
universal life reporting units within the Individual segment,
the Company may corroborate its estimated fair values by using
additional valuation methodologies.
The key inputs, judgments and assumptions necessary in
determining fair value include projected operating earnings,
current book value (with and without accumulated other
comprehensive income), the level of economic capital required to
support the mix of business, long term growth rates, comparative
market multiples, the account value of in-force business,
projections of new and renewal business as well as margins on
such business, the level of interest rates, credit spreads,
equity market levels, and the discount rate management believes
appropriate to the risk associated with the respective reporting
unit. The estimated fair value of the annuity and
variable & universal life reporting units are
particularly sensitive to the equity market levels.
When testing goodwill for impairment, management also considers
the Companys market capitalization in relation to its book
value. Management believes that the overall decrease in the
Companys current market capitalization is not
representative of a long-term decrease in the value of the
underlying reporting units.
Management applies significant judgment when determining the
estimated fair value of the Companys reporting units and
when assessing the relationship of market capitalization to the
estimated fair value of its reporting units and their book
value. The valuation methodologies utilized are subject to key
judgments and assumptions that are sensitive to change.
Estimates of fair value are inherently uncertain and represent
only managements reasonable expectation regarding future
developments. These estimates and the judgments and assumptions
upon which the estimates are based will, in all likelihood,
differ in some respects from actual future results. Declines in
the estimated fair value of the Companys reporting units
could result in goodwill impairments in future periods which
could materially adversely affect the Companys results of
operations or financial position.
Management continues to evaluate current market conditions that
may affect the estimated fair value of the Companys
reporting units to assess whether any goodwill impairment
exists. Continued deteriorating or adverse
92
market conditions for certain reporting units may have a
significant impact on the estimated fair value of these
reporting units and could result in future impairments of
goodwill.
See Managements Discussion and Analysis
of Financial Condition and Results of Operations
Goodwill for further consideration of goodwill
impairment testing during 2008.
Liability
for Future Policy Benefits
The Company establishes liabilities for amounts payable under
insurance policies, including traditional life insurance,
traditional annuities and non-medical health insurance.
Generally, amounts are payable over an extended period of time
and related liabilities are calculated as the present value of
future expected benefits to be paid reduced by the present value
of future expected premiums. Such liabilities are established
based on methods and underlying assumptions in accordance with
GAAP and applicable actuarial standards. Principal assumptions
used in the establishment of liabilities for future policy
benefits are mortality, morbidity, policy lapse, renewal,
retirement, disability incidence, disability terminations,
investment returns, inflation, expenses and other contingent
events as appropriate to the respective product type. These
assumptions are established at the time the policy is issued and
are intended to estimate the experience for the period the
policy benefits are payable. Utilizing these assumptions,
liabilities are established on a block of business basis. If
experience is less favorable than assumptions, additional
liabilities may be required, resulting in a charge to
policyholder benefits and claims.
Future policy benefit liabilities for disabled lives are
estimated using the present value of benefits method and
experience assumptions as to claim terminations, expenses and
interest.
Liabilities for unpaid claims and claim expenses for property
and casualty insurance are included in future policyholder
benefits and represent the amount estimated for claims that have
been reported but not settled and claims incurred but not
reported. Other policyholder funds include claims that have been
reported but not settled and claims incurred but not reported on
life and non-medical health insurance. Liabilities for unpaid
claims are estimated based upon the Companys historical
experience and other actuarial assumptions that consider the
effects of current developments, anticipated trends and risk
management programs, reduced for anticipated salvage and
subrogation. The effects of changes in such estimated
liabilities are included in the results of operations in the
period in which the changes occur.
Future policy benefit liabilities for minimum death and income
benefit guarantees relating to certain annuity contracts and
secondary and paid up guarantees relating to certain life
policies are based on estimates of the expected value of
benefits in excess of the projected account balance and
recognizing the excess ratably over the accumulation period
based on total expected assessments. Liabilities for universal
and variable life secondary guarantees and
paid-up
guarantees are determined by estimating the expected value of
death benefits payable when the account balance is projected to
be zero and recognizing those benefits ratably over the
accumulation period based on total expected assessments. The
assumptions used in estimating these liabilities are consistent
with those used for amortizing DAC, and are thus subject to the
same variability and risk. The assumptions of investment
performance and volatility for variable products are consistent
with historical S&P experience.
The Company periodically reviews its estimates of actuarial
liabilities for future policy benefits and compares them with
its actual experience. Differences between actual experience and
the assumptions used in pricing these policies, guarantees and
riders and in the establishment of the related liabilities
result in variances in profit and could result in losses. The
effects of changes in such estimated liabilities are included in
the results of operations in the period in which the changes
occur.
Income
Taxes
Income taxes represent the net amount of income taxes that the
Company expects to pay to or receive from various taxing
jurisdictions in connection with its operations. The Company
provides for federal, state and foreign income taxes currently
payable, as well as those deferred due to temporary differences
between the financial reporting and tax bases of assets and
liabilities. The Companys accounting for income taxes
represents managements best estimate of various events and
transactions.
93
Deferred tax assets and liabilities resulting from temporary
differences between the financial reporting and tax bases of
assets and liabilities are measured at the balance sheet date
using enacted tax rates expected to apply to taxable income in
the years the temporary differences are expected to reverse. The
realization of deferred tax assets depends upon the existence of
sufficient taxable income within the carryback or carryforward
periods under the tax law in the applicable tax jurisdiction.
Valuation allowances are established when management determines,
based on available information, that it is more likely than not
that deferred income tax assets will not be realized. Factors in
managements determination consider the performance of the
business including the ability to generate capital gains.
Significant judgment is required in determining whether
valuation allowances should be established, as well as the
amount of such allowances. When making such determination,
consideration is given to, among other things, the following:
|
|
|
|
(i)
|
future taxable income exclusive of reversing temporary
differences and carryforwards;
|
|
|
(ii)
|
future reversals of existing taxable temporary differences;
|
|
|
(iii)
|
taxable income in prior carryback years; and
|
|
|
(iv)
|
tax planning strategies.
|
The Company determines whether it is more likely than not that a
tax position will be sustained upon examination by the
appropriate taxing authorities before any part of the benefit is
recorded in the financial statements. A tax position is measured
at the largest amount of benefit that is greater than
50 percent likely of being realized upon settlement. The
Company may be required to change its provision for income taxes
when the ultimate deductibility of certain items is challenged
by taxing authorities or when estimates used in determining
valuation allowances on deferred tax assets significantly
change, or when receipt of new information indicates the need
for adjustment in valuation allowances. Additionally, future
events, such as changes in tax laws, tax regulations, or
interpretations of such laws or regulations, could have an
impact on the provision for income tax and the effective tax
rate. Any such changes could significantly affect the amounts
reported in the consolidated financial statements in the year
these changes occur.
Reinsurance
The Company enters into reinsurance agreements primarily as a
purchaser of reinsurance for its various insurance products and
also as a provider of reinsurance for some insurance products
issued by third parties. Accounting for reinsurance requires
extensive use of assumptions and estimates, particularly related
to the future performance of the underlying business and the
potential impact of counterparty credit risks. The Company
periodically reviews actual and anticipated experience compared
to the aforementioned assumptions used to establish assets and
liabilities relating to ceded and assumed reinsurance and
evaluates the financial strength of counterparties to its
reinsurance agreements using criteria similar to that evaluated
in the security impairment process discussed previously.
Additionally, for each of its reinsurance agreements, the
Company determines if the agreement provides indemnification
against loss or liability relating to insurance risk, in
accordance with applicable accounting standards. The Company
reviews all contractual features, particularly those that may
limit the amount of insurance risk to which the reinsurer is
subject or features that delay the timely reimbursement of
claims. If the Company determines that a reinsurance agreement
does not expose the reinsurer to a reasonable possibility of a
significant loss from insurance risk, the Company records the
agreement using the deposit method of accounting.
Employee
Benefit Plans
Certain subsidiaries of the Holding Company (the
Subsidiaries) sponsor
and/or
administer pension and other postretirement benefit plans
covering employees who meet specified eligibility requirements.
The obligations and expenses associated with these plans require
an extensive use of assumptions such as the discount rate,
expected rate of return on plan assets, rate of future
compensation increases, healthcare cost trend rates, as well as
assumptions regarding participant demographics such as rate and
age of retirements, withdrawal rates and mortality. Management,
in consultation with its external consulting actuarial firm,
determines these assumptions based upon a variety of factors
such as historical performance of the plan and its assets,
currently available market and industry data, and expected
benefit payout streams. The assumptions used may differ
materially from actual results
94
due to, among other factors, changing market and economic
conditions and changes in participant demographics. These
differences may have a significant effect on the Companys
consolidated financial statements and liquidity.
Litigation
Contingencies
The Company is a party to a number of legal actions and is
involved in a number of regulatory investigations. Given the
inherent unpredictability of these matters, it is difficult to
estimate the impact on the Companys financial position.
Liabilities are established when it is probable that a loss has
been incurred and the amount of the loss can be reasonably
estimated. Liabilities related to certain lawsuits, including
the Companys asbestos-related liability, are especially
difficult to estimate due to the limitation of available data
and uncertainty regarding numerous variables that can affect
liability estimates. The data and variables that impact the
assumptions used to estimate the Companys asbestos-related
liability include the number of future claims, the cost to
resolve claims, the disease mix and severity of disease in
pending and future claims, the impact of the number of new
claims filed in a particular jurisdiction and variations in the
law in the jurisdictions in which claims are filed, the possible
impact of tort reform efforts, the willingness of courts to
allow plaintiffs to pursue claims against the Company when
exposure to asbestos took place after the dangers of asbestos
exposure were well known, and the impact of any possible future
adverse verdicts and their amounts. On a quarterly and annual
basis, the Company reviews relevant information with respect to
liabilities for litigation, regulatory investigations and
litigation-related contingencies to be reflected in the
Companys consolidated financial statements. It is possible
that an adverse outcome in certain of the Companys
litigation and regulatory investigations, including
asbestos-related cases, or the use of different assumptions in
the determination of amounts recorded could have a material
effect upon the Companys consolidated net income or cash
flows in particular quarterly or annual periods.
Economic
Capital
Economic capital is an internally developed risk capital model,
the purpose of which is to measure the risk in the business and
to provide a basis upon which capital is deployed. The economic
capital model accounts for the unique and specific nature of the
risks inherent in MetLifes businesses. As a part of the
economic capital process, a portion of net investment income is
credited to the segments based on the level of allocated equity.
This is in contrast to the standardized regulatory risk-based
capital (RBC) formula, which is not as refined in
its risk calculations with respect to the nuances of the
Companys businesses.
95
Results
of Operations
Discussion
of Results
The following table presents consolidated financial information
for the Company for the years indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
25,914
|
|
|
$
|
22,970
|
|
|
$
|
22,052
|
|
Universal life and investment-type product policy fees
|
|
|
5,381
|
|
|
|
5,238
|
|
|
|
4,711
|
|
Net investment income
|
|
|
16,296
|
|
|
|
18,063
|
|
|
|
16,247
|
|
Other revenues
|
|
|
1,586
|
|
|
|
1,465
|
|
|
|
1,301
|
|
Net investment gains (losses)
|
|
|
1,812
|
|
|
|
(578
|
)
|
|
|
(1,382
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
50,989
|
|
|
|
47,158
|
|
|
|
42,929
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims
|
|
|
27,437
|
|
|
|
23,783
|
|
|
|
22,869
|
|
Interest credited to policyholder account balances
|
|
|
4,787
|
|
|
|
5,461
|
|
|
|
4,899
|
|
Policyholder dividends
|
|
|
1,751
|
|
|
|
1,723
|
|
|
|
1,698
|
|
Other expenses
|
|
|
11,924
|
|
|
|
10,429
|
|
|
|
9,537
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
45,899
|
|
|
|
41,396
|
|
|
|
39,003
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before provision for income tax
|
|
|
5,090
|
|
|
|
5,762
|
|
|
|
3,926
|
|
Provision for income tax
|
|
|
1,580
|
|
|
|
1,660
|
|
|
|
1,016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
3,510
|
|
|
|
4,102
|
|
|
|
2,910
|
|
Income (loss) from discontinued operations, net of income tax
|
|
|
(301
|
)
|
|
|
215
|
|
|
|
3,383
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
3,209
|
|
|
|
4,317
|
|
|
|
6,293
|
|
Preferred stock dividends
|
|
|
125
|
|
|
|
137
|
|
|
|
134
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common shareholders
|
|
$
|
3,084
|
|
|
$
|
4,180
|
|
|
$
|
6,159
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year
Ended December 31, 2008 compared with the Year Ended
December 31, 2007 The Company
Income from continuing operations decreased by
$592 million, or 14%, to $3,510 million for the year
ended December 31, 2008 from $4,102 million for the
comparable 2007 period.
The following table provides the change from the prior year in
income from continuing operations by segment:
|
|
|
|
|
|
|
Change
|
|
|
|
(In millions)
|
|
|
Institutional
|
|
$
|
423
|
|
Individual
|
|
|
(711
|
)
|
International
|
|
|
(64
|
)
|
Auto & Home
|
|
|
(161
|
)
|
Corporate & Other
|
|
|
(79
|
)
|
|
|
|
|
|
Total change, net of income tax
|
|
$
|
(592
|
)
|
|
|
|
|
|
The Institutional segments income from continuing
operations increased primarily due to a decrease in net
investment losses and a decrease in policyholder benefits due to
investment losses shared by policyholders. There was also a
decrease in other expenses due in part to lower expenses related
to DAC amortization which is primarily
96
due to the impact of the implementation of
SOP 05-1,
Accounting by Insurance Enterprises for Deferred Acquisition
Costs in Connection with Modifications or Exchanges of Insurance
Contracts
(SOP 05-1)
in the prior year and amortization refinements in the current
year. These increases were offset by lower underwriting results
in retirement & savings, non-medical
health & other, and group life businesses. There was
also a decrease in interest margins within the
retirement & savings and non-medical
health & other businesses, partially offset by an
increase in the group life business.
The Individual segments income from continuing operations
decreased due to higher DAC amortization partially offset by a
decrease in net investment losses due to an increase in gains on
freestanding derivatives partially offset by losses primarily
relating to embedded derivatives and fixed maturity securities
including those resulting from intersegment transfers of
securities. The embedded derivative losses are net of gains
relating to the effect of the widening of the Companys own
credit spread. Income from continuing operations also decreased
due to decreases in interest margins, unfavorable underwriting
results in life products, an increase in interest credited to
policyholder account balances, higher annuity benefits, lower
universal life and investment-type product policy fees combined
with other revenues, and an increase in policyholder dividends.
These decreases were partially offset by a decrease in other
expenses as well as an increase in net investment income on
blocks of business not driven by interest margins.
The International segments decrease in income from
continuing operations was primarily due to a decrease in income
from continuing operations relating to Argentina and Japan. The
decrease in Argentinas income from continuing operations
was due to the negative impact the 2007 pension reform had on
current year income from continuing operations. The decrease was
partially offset by the net impact resulting from the Argentine
nationalization of the private pension system as well as
refinements to certain contingent and insurance liabilities
associated with a Supreme Court ruling. The Companys
earnings from its investment in Japan decreased due to an
increase in losses on embedded derivatives associated with
variable annuity riders, an increase in DAC amortization related
to market performance and the impact of a refinement in
assumptions for the guaranteed annuity business partially offset
by the favorable impact from the utilization of the fair value
option for certain fixed annuities. The Companys results
were also impacted by a decrease in earnings from assumed
reinsurance, offset by an increase in income from hedging
activities associated with Japans guaranteed annuity
benefits. These decreases were offset by an increase in net
investment gains which was due to an increase from gains on
derivatives primarily in Japan partially offset by losses
primarily on fixed maturity investments. There was also an
increase in income from continuing operations relating to Hong
Kong associated with the remaining 50% interest in MetLife Fubon
acquired in the in the second quarter of 2007.
The Auto & Home segments decrease in income from
continuing operations was primarily attributable to an increase
in net investment losses and an increase in policyholder
benefits and claims. The increase in net investment losses was
due to an increase in losses on fixed maturity and equity
securities. The increase in policyholder benefits and claims was
comprised primarily of an increase in catastrophe losses offset
by a decrease in non-catastrophe policyholder benefits and
claims. Offsetting these decreases was an increase in premiums.
Income from continuing operations for Corporate &
Other decreased due to lower net investment income as well as
higher corporate expenses, interest expense, legal costs and
interest credited to policyholder account balances. These
decreases were offset by an increase in net investment gains,
higher other revenues, lower interest on uncertain tax
positions, and lower interest credited to bankholder deposits.
The increase in net investment gains was primarily due to an
elimination of losses which were recognized by other segments,
partially offset by losses on fixed maturity securities and
derivatives.
Revenues
and Expenses
Premiums,
Fees and Other Revenues
Premiums, fees and other revenues increased by
$3,208 million, or 11%, to $32,881 million for the
year ended December 31, 2008 from $29,673 million for
the comparable 2007 period.
97
The following table provides the change from the prior year in
premiums, fees and other revenues by segment:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% of Total
|
|
|
|
$ Change
|
|
|
$ Change
|
|
|
|
(In millions)
|
|
|
|
|
|
Institutional
|
|
$
|
2,705
|
|
|
|
84
|
%
|
Individual
|
|
|
(70
|
)
|
|
|
(2
|
)
|
International
|
|
|
468
|
|
|
|
15
|
|
Auto & Home
|
|
|
|
|
|
|
|
|
Corporate & Other
|
|
|
105
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
Total change
|
|
$
|
3,208
|
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
The Institutional segments increase in premiums, fees and
other revenues was primarily due to increases in the
retirement & savings, non-medical health &
other and group life businesses. The increase in the
retirement & savings business was primarily due to
increases in premiums in the group institutional annuity,
structured settlement and global GIC businesses. The increase in
both group institutional annuity and the structured settlement
businesses were primarily due to higher sales. The increase in
the group institutional annuity business was primarily due to
large domestic sales and the first significant sales in the
United Kingdom business in the current year. The growth in the
non-medical health & other business was largely due to
increases in the dental, disability, accidental
death & dismemberment (AD&D), and
individual disability insurance (IDI) businesses.
The increase in the dental business was primarily due to organic
growth in the business and the impact of an acquisition that
closed in the first quarter of 2008. The increase in group life
business was primarily due to an increase in term life, which
was largely attributable to business growth, partially offset by
a decrease in assumed reinsurance.
The Individual segments decrease in premiums, fees and
other revenues was primarily attributable to decreases in
universal life and investment-type product policy fees and other
revenues. These decreases were due to lower average separate
account balances due to unfavorable equity market performance
during the current year, as well as revisions to
managements assumptions used to determine estimated gross
profits and margins. These decreases were partially offset by
universal life business growth over the prior year.
The International segments increase in premiums, fees and
other revenues was primarily due to business growth in the Latin
America region, as well as the impact of an acquisition in the
Asia Pacific region, and the impact of foreign currency exchange
rates. Chiles premiums, fees and other revenues increased
primarily due to higher annuity sales, as well as higher
institutional premiums from its traditional and bank
distribution channels. Mexicos premiums, fees and other
revenues increased primarily due to growth in its individual and
institutional businesses, as well as the reinstatement of
premiums from prior periods. Hong Kongs increase was due
to the acquisition of the remaining 50% interest in MetLife
Fubon in the second quarter of 2007 and the resulting
consolidation of the operation beginning in the third quarter of
2007. The United Kingdoms premiums, fees and other
revenues increased primarily due to growth in the reinsurance
business as well as the prior year impact of an unearned premium
calculation refinement. South Koreas premiums, fees and
other revenues increased due to growth in its guaranteed annuity
and variable universal life businesses, as well as in its
traditional business. Australias premiums, fees and other
revenues increased primarily due to growth in the institutional
business and an increase in retention levels. These increases in
premiums, fees and other revenues were partially offset by a
decrease in Argentina primarily due to a decrease in premiums in
the pension business, for which pension reform eliminated the
obligation of plan administrators to provide death and
disability coverage effective January 1, 2008.
The Auto & Home segment reflected no change when
compared to the prior year although a slight increase in
premiums was offset by lower other revenues.
The increase in Corporate & Other premiums, fees and
other revenues was primarily related to MetLife Bank loan
origination and servicing fees from acquisitions in 2008 and an
adjustment of surrender values on corporate-owned life insurance
(COLI) policies in the prior year, partially offset
by lower revenue from a prior year resolution of an
indemnification claim associated with the 2000 acquisition of
GALIC.
98
Net
Investment Income
Net investment income decreased by $1,767 million, or 10%,
to $16,296 million for the year ended December 31,
2008 from $18,063 million for the comparable 2007 period.
Management attributes $3,141 million of this change to a
decrease in yields, partially offset by an increase of
$1,374 million due to growth in average invested assets.
Average invested assets are calculated on cost basis without
unrealized gains and losses. The decrease in net investment
income attributable to lower yields was primarily due to lower
returns on other limited partnership interests, real estate
joint ventures, short-term investments, fixed maturity
securities, and mortgage loans, partially offset by improved
securities lending results. Management anticipates that the
significant volatility in the equity, real estate and credit
markets will continue in 2009 which could continue to impact net
investment income and yields on other limited partnership
interests and real estate joint ventures. The decrease in net
investment income attributable to lower yields was partially
offset by increased net investment income attributable to an
increase in average invested assets on an amortized cost basis,
primarily within short-term investments, mortgage loans, other
limited partnership interests, and real estate joint ventures.
Interest
Margin
Interest margin, which represents the difference between
interest earned and interest credited to policyholder account
balances decreased in the Individual segment for the year ended
December 31, 2008 as compared to the prior year. The
decrease in interest margin within the Individual segment was
primarily attributable to a decline in net investment income due
to lower returns on other limited partnership interests, real
estate joint ventures, other invested assets including
derivatives, and short term investments, all of which were
partially offset by higher securities lending results. Interest
margins decreased in the retirement & savings and
non-medical health & other businesses, but increased
within the group life business, all within the Institutional
segment. Interest earned approximates net investment income on
investable assets attributed to the segment with minor
adjustments related to the consolidation of certain separate
accounts and other minor non-policyholder elements. Interest
credited is the amount attributed to insurance products,
recorded in policyholder benefits and claims, and the amount
credited to policyholder account balances for investment-type
products, recorded in interest credited to policyholder account
balances. Interest credited on insurance products reflects the
current period impact of the interest rate assumptions
established at issuance or acquisition. Interest credited to
policyholder account balances is subject to contractual terms,
including some minimum guarantees. This tends to move gradually
over time to reflect market interest rate movements and may
reflect actions by management to respond to competitive
pressures and, therefore, generally does not introduce
volatility in expense.
Net
Investment Gains (Losses)
Net investment losses decreased by $2,390 million to a gain
of $1,812 million for the year ended December 31, 2008
from a loss of $578 million for the comparable 2007 period.
The decrease in net investment losses is due to an increase in
gains on derivatives partially offset by losses primarily on
fixed maturity and equity securities. Derivative gains were
driven by gains on freestanding derivatives that were partially
offset by losses on embedded derivatives primarily associated
with variable annuity riders. Gains on freestanding derivatives
increased by $6,499 million and were primarily driven by:
i) gains on certain interest rate swaps, floors, and
swaptions which were economic hedges of certain investment
assets and liabilities, ii) gains from foreign currency
derivatives primarily due to the U.S. dollar strengthening
as well as, iii) gains primarily from equity options,
financial futures and interest rate swaps hedging the embedded
derivatives. The gains on these equity options, financial
futures, and interest rate swaps substantially offset the change
in the underlying embedded derivative liability that is hedged
by these derivatives. Losses on the embedded derivatives
increased by $2,329 million and were driven by declining
interest rates and poor equity market performance throughout the
year. These embedded derivative losses include a
$2,994 million gain resulting from the effect of the
widening of the Companys own credit spread which is
required to be used in the valuation of these variable annuity
rider embedded derivatives under SFAS 157 which became
effective January 1, 2008. The remaining change in net
investment losses of $1,780 million is principally
attributable to an increase in losses on fixed maturity and
equity securities, and, to a lesser degree, an increase in
losses on mortgage and consumer loans and other limited
partnership interests offset by an increase in foreign currency
transaction gains. The increase in losses on fixed maturity and
equity securities is primarily attributable to
99
an increase in impairments associated with financial services
industry holdings which experienced losses as a result of
bankruptcies, FDIC receivership, and federal government assisted
capital infusion transactions in the third and fourth quarters
of 2008. Losses on fixed maturity and equity securities were
also driven by an increase in credit related impairments on
communication and consumer sector security holdings, losses on
asset-backed securities as well as an increase in losses on
fixed maturity security holdings where the Company either lacked
the intent to hold, or due to extensive credit widening, the
Company was uncertain of its intent to hold these fixed maturity
securities for a period of time sufficient to allow recovery of
the market value decline.
Underwriting
Underwriting results are generally the difference between the
portion of premium and fee income intended to cover mortality,
morbidity or other insurance costs, less claims incurred, and
the change in insurance-related liabilities. Underwriting
results are significantly influenced by mortality, morbidity or
other insurance-related experience trends, as well as the
reinsurance activity related to certain blocks of business.
Consequently, results can fluctuate from year to year.
Underwriting results, including catastrophes, in the
Auto & Home segment were unfavorable for the year
ended December 31, 2008, as the combined ratio, including
catastrophes, increased to 91.2% from 88.4% for the year ended
December 31, 2007. Underwriting results, excluding
catastrophes, in the Auto & Home segment were
favorable for the year ended December 31, 2008, as the
combined ratio, excluding catastrophes, decreased to 83.1% from
86.3% for the year ended December 31, 2007. Underwriting
results were less favorable in the non-medical
health & other, retirement & savings and
group life businesses in the Institutional segment. Underwriting
results were unfavorable in the life products in the Individual
segment.
Other
Expenses
Other expenses increased by $1,495 million, or 14%, to
$11,924 million for the year ended December 31, 2008
from $10,429 million for the comparable 2007 period.
The following table provides the change from the prior year in
other expenses by segment:
|
|
|
|
|
|
|
$ Change
|
|
|
|
(In millions)
|
|
|
Institutional
|
|
$
|
(31
|
)
|
Individual
|
|
|
1,140
|
|
International
|
|
|
(78
|
)
|
Auto & Home
|
|
|
(25
|
)
|
Corporate & Other
|
|
|
489
|
|
|
|
|
|
|
Total change
|
|
$
|
1,495
|
|
|
|
|
|
|
The Institutional segments decrease in other expenses was
principally due to a decrease in DAC amortization primarily due
to a charge associated with the impact of DAC and VOBA
amortization from the implementation of
SOP 05-1
in the prior year and a decrease mainly due to the impact of
amortization refinements in the current year. This decrease was
offset by increases in non-deferrable volume-related expenses
and corporate support expenses. Also offsetting this decrease
was the impact of revisions to certain pension and
postretirement liabilities in the current year.
The Individual segments increase in other expenses
included higher DAC amortization primarily related to lower
expected future gross profits due to separate account balance
decreases resulting from recent market declines, higher net
investment gains primarily due to net derivative gains and the
reduction in expected cumulative earnings of the closed block
partially offset by a reduction in actual earnings of the closed
block and changes in assumptions used to estimate future gross
profits and margins. There was an additional increase due to the
impact of revisions to certain pension and postretirement
liabilities in the current year. The increases in other expenses
were offset by a decrease in nondeferrable volume-related
expenses and by the write-off of a receivable from a
joint-venture partner in the prior year.
100
The International segments decrease in other expenses was
driven mainly by Argentinas prior year pension liability
and the favorable impact of foreign currency exchange rates. The
decrease in Argentinas other expenses was primarily due to
the establishment in the prior year of a liability for pension
servicing obligations due to pension reform, the elimination of
the liability for pension servicing obligations and the
elimination of DAC for the pension business in the current year
as a result of the nationalization of the pension system, as
well as the elimination of contingent liabilities for certain
cases due to recent court decisions related to the pesification
of insurance contracts by the government in 2002. This decrease
was offset primarily by an increase in other expenses in South
Korea, the United Kingdom, and other countries. South
Koreas other expenses increased primarily due to an
increase in DAC amortization related to market performance, as
well as higher spending on advertising and marketing, offset by
a refinement in DAC capitalization. The United Kingdoms
other expenses increased due to business growth as well as lower
DAC amortization in the prior year resulting from calculation
refinements partially offset by foreign currency transaction
gains. Other expenses increased in India, Chile and Mexico
primarily due to growth initiatives. Contributions from the
other countries accounted for the remainder of the change in
other expenses.
The Auto & Home segments decrease in other
expenses was principally as a result of lower commissions,
decrease in surveys and underwriting reports and other
sales-related expenses, partially offset by an unfavorable
change in DAC capitalization, net of amortization.
The increase in other expenses in Corporate & Other
was primarily due to higher MetLife Bank costs, higher
post-employment related costs in the current period associated
with the implementation of an enterprise-wide cost reduction and
revenue enhancement initiative, higher corporate support
expenses including incentive compensation, rent, advertising and
information technology costs. Corporate expenses also increased
from lease impairments for Company use space that is currently
vacant and higher costs from MetLife Foundation contributions,
partially offset by a reduction in deferred compensation
expenses. Interest expense was higher due to issuances of junior
subordinated debt in December 2007 and April 2008 and collateral
financing arrangements in May 2007 and December 2007, partially
offset by rate reductions on variable rate collateral financing
arrangements in 2008, the prepayment of shares subject to
mandatory redemption in October 2007 and the reduction of
commercial paper outstanding. Higher legal costs were
principally driven by costs associated with the commutation of
three asbestos-related excess insurance policies and decreases
in prior year legal liabilities partially offset by current year
decreases resulting from the resolution of certain matters.
These increases were partially offset by a reduction in
decreases in interest credited on bankholder deposits and
interest on uncertain tax positions.
Net
Income
Income tax expense for the year ended December 31, 2008 was
$1,580 million, or 31% of income from continuing operations
before provision for income tax, versus $1,660 million, or
29% of such income, for the comparable 2007 period. The 2008 and
2007 effective tax rates differ from the corporate tax rate of
35% primarily due to the impact of non-taxable investment income
and tax credits for investments in low income housing. In
addition, the decrease in the effective tax rate is primarily
attributable to changes in the ratio of permanent differences to
income before income taxes.
Income (loss) from discontinued operations, net of income tax,
decreased by $516 million to a loss of $301 million
for the year ended December 31, 2008 from income of
$215 million for the comparable 2007 period. The decrease
was primarily the result of the split-off of substantially all
of the Companys interest in RGA in September 2008 whereby
stockholders of the Company were offered the ability to exchange
their MetLife shares for shares of RGA Class B common
stock. This resulted in a loss on disposal of discontinued
operations of $458 million, net of income tax. Income from
discontinued operations related to RGAs operations also
decreased by $54 million, net of income tax, for the year
ended December 31, 2008. During the fourth quarter of 2008,
the Holding Company entered into an agreement to sell its
wholly-owned subsidiary, Cova, which resulted in a gain on
disposal of discontinued operations of $37 million, net of
income tax. Income from discontinued operations related to Cova
also decreased by $14 million, net of income tax, for the
year ended December 31, 2008. As compared to the prior
year, there was a reduction in income from discontinued
operations of $15 million related to the sale of SSRM and
of $5 million related to the sale of MetLife
Australias annuities and pension businesses to a third
party. There was also a decrease in income from discontinued
real estate operations of $7 million.
101
Year
Ended December 31, 2007 compared with the Year Ended
December 31, 2006 The Company
Income
from Continuing Operations
Income from continuing operations increased by
$1,192 million, or 41%, to $4,102 million for the year
ended December 31, 2007 from $2,910 million for the
comparable 2006 period.
The following table provides the 2007 change in income from
continuing operations by segment:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% of Total
|
|
|
|
$ Change
|
|
|
$ Change
|
|
|
|
(In millions)
|
|
|
|
|
|
Institutional
|
|
$
|
317
|
|
|
|
26
|
%
|
Individual
|
|
|
99
|
|
|
|
8
|
|
International
|
|
|
472
|
|
|
|
40
|
|
Auto & Home
|
|
|
20
|
|
|
|
2
|
|
Corporate & Other
|
|
|
284
|
|
|
|
24
|
|
|
|
|
|
|
|
|
|
|
Total change, net of income tax
|
|
$
|
1,192
|
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
The Institutional segments income from continuing
operations increased primarily due to an increase in interest
margins, an increase in underwriting results, lower net
investment losses and the impact of revisions to certain
expenses in both periods, partially offset by higher expenses
due to an increase in non-deferrable volume-related and
corporate support expenses and an increase in DAC amortization
resulting from the implementation of
SOP 05-1
in 2007.
The Individual segments income from continuing operations
increased primarily due to a decrease in net investment losses,
higher fee income from separate account products, higher net
investment income on blocks of business not driven by interest
margins and an increase in interest margins, partially offset by
higher DAC amortization, unfavorable underwriting results in
life products, higher general expenses, the impact of revisions
to certain liabilities in both years, the write-off of a
receivable in 2007, an increase in the closed block-related
policyholder dividend obligation, higher annuity benefits,
increase in policyholder dividends, and an increase in interest
credited to policyholder account balances.
The increase in the International segments income from
continuing operations was primarily attributable to the
following factors:
|
|
|
|
|
An increase in Argentinas income from continuing
operations primarily due to a net reduction of liabilities
resulting from pension reform, a reduction in claim liabilities
resulting from experience reviews in both 2007 and
2006 years, higher premiums resulting from higher pension
contributions attributable to higher participant salaries,
higher net investment income resulting from capital
contributions in 2006, and a smaller increase in market indexed
policyholder liabilities without a corresponding decrease in net
investment income, partially offset by the reduction of cost of
insurance fees as a result of the new pension system reform
regulation, an increase in retention incentives related to
pension reform, as well as lower trading portfolio income.
Argentina also benefited, in both the current and prior years,
from the utilization of tax loss carryforwards against which
valuation allowances had been previously established.
|
|
|
|
Mexicos income from continuing operations increased
primarily due to a decrease in certain policyholder liabilities
caused by a decrease in the unrealized investment results on
invested assets supporting those liabilities relative to 2006,
the favorable impact of experience refunds during the first
quarter of 2007, a reduction in claim liabilities resulting from
experience reviews and the adverse impact in 2006 of an
adjustment for experience refunds in its institutional business,
a year over year decrease in DAC amortization resulting from
managements update of assumptions used to determine
estimated gross profits in both 2006 and 2007, a decrease in
liabilities based on a review of outstanding remittances, and
growth in its institutional and universal life businesses. These
increases in Mexicos income from continuing operations
were partially offset by lower fees resulting from
managements update of assumptions used to determine
estimated gross profits, the favorable impact in 2006 associated
with a large group policy that was not renewed by the
policyholder, a decrease in various one-time revenue items,
|
102
|
|
|
|
|
lower investment yields, the favorable impact in 2006 of
liabilities related to employment matters that were reduced, and
the benefit 2006 from the elimination of liabilities for pending
claims that were determined to be invalid following a review.
|
|
|
|
|
|
Taiwans income from continuing operations increased
primarily driven by an increase due to higher DAC amortization
in 2006 resulting from a loss recognition adjustment and
restructuring costs, partially offset by the favorable impact of
liability refinements in 2006, as well as higher policyholder
liabilities related to loss recognition in 2006.
|
|
|
|
Brazils income from continuing operations increased due to
the unfavorable impact of increases in policyholder liabilities
due to higher than expected mortality on specific blocks of
business and an increase in litigation liabilities in 2006, the
unfavorable impact of the reversal of a tax credit in 2006 as
well as growth of the in-force business.
|
|
|
|
Japans income from continuing operations increased due to
improved hedge results and business growth, partially offset by
the impact of foreign currency transaction losses.
|
|
|
|
Irelands income from continuing operations increased
primarily due to the utilization of net operating losses for
which a valuation allowance had been previously established,
higher investment income, partially offset by higher
start-up
expenses and currency transaction losses.
|
|
|
|
Hong Kongs income from continuing operations increased due
to the acquisition of the remaining 50% interest in MetLife
Fubon and the resulting consolidation of the operation, as well
as business growth.
|
|
|
|
Chiles income from continuing operations increased
primarily due to growth of the in-force business, higher joint
venture income and higher returns on inflation indexed
securities, partially offset by higher compensation,
infrastructure and marketing expenses.
|
|
|
|
Income from continuing operations increased in the United
Kingdom due to a reduction of claim liabilities resulting from
an experience review, offset by an unearned premium calculation
refinement.
|
|
|
|
Australias income from continuing operations increased due
to changes in foreign currency exchange rates and business
growth.
|
|
|
|
These increases in income from continuing operations were
partially offset by a decrease in the home office due to higher
economic capital charges and investment expenses, an increase in
contingent tax expenses in 2007, as well as higher spending due
to growth and initiatives, partially offset by the elimination
of certain intercompany expenses previously charged to the
International segment, and a tax benefit associated with a 2006
income tax expense related to a revision of an estimate.
|
|
|
|
Indias income from continuing operations decreased
primarily due to headcount increases and growth initiatives, as
well as the impact of valuation allowances established against
losses in both years.
|
|
|
|
South Koreas income from continuing operations decreased
due to a favorable impact in 2006 associated with the
implementation of a more refined reserve valuation system, as
well as additional expenses in 2007 associated with growth and
infrastructure initiatives, partially offset by continued growth
and lower DAC amortization, both in the variable universal life
business.
|
The Auto & Home segments income from continuing
operations increased primarily due to an increase in premiums
and other revenues, an increase in net investment income, an
increase in net investment gains and a decrease in other
expenses. These were partially offset by losses related to
higher claim frequencies, higher earned exposures, higher losses
due to severity, an increase in unallocated claims adjusting
expenses and an increase from a reduction in favorable
development of 2006 losses, partially offset by a decrease in
catastrophe losses, which included favorable development of 2006
catastrophe liabilities, all of which are related to
policyholder benefits and claims.
Corporate & Others income from continuing
operations increased primarily due to higher net investment
income, lower net investment losses, lower corporate expenses,
higher other revenues, integration costs incurred in
103
2006, and lower legal costs, partially offset by a decrease in
tax benefits, higher interest expense on debt, higher interest
on uncertain tax positions, and higher interest credited to
bankholder deposits.
Revenues
and Expenses
Premiums,
Fees and Other Revenues
Premiums, fees and other revenues increased by
$1,609 million, or 6%, to $29,673 million for the year
ended December 31, 2007 from $28,064 million for the
comparable 2006 period.
The following table provides the 2007 change in premiums, fees
and other revenues by segment:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% of Total
|
|
|
|
$ Change
|
|
|
$ Change
|
|
|
|
(In millions)
|
|
|
|
|
|
Institutional
|
|
$
|
594
|
|
|
|
36
|
%
|
Individual
|
|
|
365
|
|
|
|
23
|
|
International
|
|
|
560
|
|
|
|
35
|
|
Auto & Home
|
|
|
63
|
|
|
|
4
|
|
Corporate & Other
|
|
|
27
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
Total change
|
|
$
|
1,609
|
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
The growth in the Institutional segment was primarily due to
increases in the non-medical health & other and group
life businesses. The non-medical health & other
business increased primarily due to growth in the dental,
disability, AD&D and IDI businesses. Partially offsetting
these increases is a decrease in the long-term care
(LTC) business, net of a decrease resulting from a
shift to deposit liability-type contracts in 2007, partially
offset by growth in the business. The group life business
increased primarily due to business growth in term life and
increases in COLI and life insurance sold to postretirement
benefit plans. These increases in the non-medical
health & other and group life businesses were
partially offset by a decrease in the retirement &
savings business. The decrease in retirement & savings
was primarily due to a decrease in structured settlement and
pension closeout premiums, partially offset by an increase
across several products.
The growth in the Individual segment was primarily due to higher
fee income from variable life and annuity and investment-type
products and growth in premiums from other life products,
partially offset by a decrease in immediate annuity premiums and
a decline in premiums associated with the Companys closed
block business, in line with expectations.
The growth in the International segment was primarily due to the
following factors:
|
|
|
|
|
An increase in Mexicos premiums, fees and other revenues
due to higher fees and growth in its institutional and universal
life businesses, a decrease in experience refunds during the
first quarter of 2007 on Mexicos institutional business,
as well as the adverse impact in 2006 of an adjustment for
experience refunds on Mexicos institutional business,
offset by lower fees resulting from managements update of
assumptions used to determine estimated gross profits and
various one-time revenue items which benefited both the current
and prior years.
|
|
|
|
Premiums, fees and other revenues increased in Hong Kong
primarily due to the acquisition of the remaining 50% interest
in MetLife Fubon and the resulting consolidation of the
operation as well as business growth.
|
|
|
|
Chiles premiums, fees and other revenues increased
primarily due to higher annuity sales, higher institutional
premiums from its traditional and bank distribution channels,
and the decrease in 2006 resulting from managements
decision not to match aggressive pricing in the marketplace.
|
|
|
|
South Koreas premiums, fees and other revenues increased
primarily due to higher fees from growth in its guaranteed
annuity and variable universal life businesses.
|
|
|
|
Brazils premiums, fees and other revenues increased due to
changes in foreign currency exchange rates and business growth.
|
104
|
|
|
|
|
Premiums, fees and other revenues increased in Japan due to an
increase in reinsurance assumed.
|
|
|
|
Australias premiums, fees and other revenues increased
primarily due to growth in the institutional and reinsurance
business in-force, an increase in retention levels and changes
in foreign currency exchange rates.
|
|
|
|
Argentinas premiums, fees and other revenues increased due
to higher pension contributions resulting from higher
participant salaries and a higher salary threshold subject to
fees and growth in bancassurance, offset by the reduction of
cost of insurance fees as a result of the new pension system
reform regulation.
|
|
|
|
Taiwans and Indias premiums, fees and other revenues
increased primarily due to business growth.
|
These increases in premiums, fees and other revenues were
partially offset by a decrease in the United Kingdom due to an
unearned premium calculation refinement, partially offset by
changes in foreign currency exchange rates.
The growth in the Auto & Home segment was primarily
due to an increase in premiums related to increased exposures,
an increase from various voluntary and involuntary programs, and
an increase resulting from the change in estimate on auto rate
refunds due to a regulatory examination, as well as an increase
in other revenues primarily due to slower than anticipated claim
payments in 2006. These increases were partially offset by a
reduction in average earned premium per policy, and an increase
in catastrophe reinsurance costs.
The increase in Corporate & Other was primarily
related to the resolution of an indemnification claim associated
with the 2000 acquisition of GALIC, partially offset by an
adjustment of surrender values on COLI policies.
Net
Investment Income
Net investment income increased by $1,816 million, or 11%,
to $18,063 million for the year ended December 31,
2007 from $16,247 million for the comparable 2006 period.
Management attributes $1,078 million of this increase to
growth in the average asset base and $738 million to an
increase in yields. The increase in net investment income from
growth in the average asset base was primarily within fixed
maturity securities, mortgage loans, real estate joint ventures
and other limited partnership interests. The increase in net
investment income attributable to higher yields was primarily
due to higher returns on fixed maturity securities, other
limited partnership interests excluding hedge funds, equity
securities and improved securities lending results, partially
offset by lower returns on real estate joint ventures, cash,
cash equivalents and short-term investments, hedge funds and
mortgage loans.
Interest
Margin
Interest margin, which represents the difference between
interest earned and interest credited to policyholder account
balances increased in the Institutional and Individual segments
for the year ended December 31, 2007 as compared to 2006.
Interest earned approximates net investment income on investable
assets attributed to the segment with minor adjustments related
to the consolidation of certain separate accounts and other
minor non-policyholder elements. Interest credited is the amount
attributed to insurance products, recorded in policyholder
benefits and claims, and the amount credited to policyholder
account balances for investment-type products, recorded in
interest credited to policyholder account balances. Interest
credited on insurance products reflects the 2007 impact of the
interest rate assumptions established at issuance or
acquisition. Interest credited to policyholder account balances
is subject to contractual terms, including some minimum
guarantees. This tends to move gradually over time to reflect
market interest rate movements and may reflect actions by
management to respond to competitive pressures and, therefore,
generally does not introduce volatility in expense.
Net
Investment Gains (Losses)
Net investment losses decreased by $804 million to a loss
of $578 million for the year ended December 31, 2007
from a loss of $1,382 million for the comparable 2006
period. The decrease in net investment losses was primarily due
to a reduction of losses on fixed maturity securities resulting
principally from the 2006 portfolio repositioning in a rising
interest rate environment, increased gains from asset-based
foreign currency transactions
105
due to a decline in the U.S. dollar year over year against
several major currencies and increased gains on equity
securities, partially offset by increased losses from the
mark-to-market on derivatives and reduced gains on real estate
and real estate joint ventures.
Underwriting
Underwriting results are generally the difference between the
portion of premium and fee income intended to cover mortality,
morbidity or other insurance costs, less claims incurred, and
the change in insurance-related liabilities. Underwriting
results are significantly influenced by mortality, morbidity or
other insurance-related experience trends, as well as the
reinsurance activity related to certain blocks of business.
Consequently, results can fluctuate from year to year.
Underwriting results, excluding catastrophes, in the
Auto & Home segment were favorable for the year ended
December 31, 2007. Although lower than comparable period of
2006, as the combined ratio, excluding catastrophes, increased
to 86.3% from 82.8% for the year ended December 31, 2006.
Underwriting results were favorable in the non-medical
health & other, group life and retirement &
savings businesses in the Institutional segment. Underwriting
results were unfavorable in the life products in the Individual
segment.
Other
Expenses
Other expenses increased by $892 million, or 9%, to
$10,429 million for the year ended December 31, 2007
from $9,537 million for the comparable 2006 period.
The following table provides the 2007 change in other expenses
by segment:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% of Total
|
|
|
|
$ Change
|
|
|
$ Change
|
|
|
|
(In millions)
|
|
|
|
|
|
Institutional
|
|
$
|
126
|
|
|
|
14
|
%
|
Individual
|
|
|
518
|
|
|
|
58
|
|
International
|
|
|
218
|
|
|
|
25
|
|
Auto & Home
|
|
|
(17
|
)
|
|
|
(2
|
)
|
Corporate & Other
|
|
|
47
|
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
Total change
|
|
$
|
892
|
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
The Institutional segment contributed to the year over year
increase primarily due to an increase in non-deferrable
volume-related and corporate support expenses, higher DAC
amortization associated with the implementation of
SOP 05-1
in 2007, a charge related to the reimbursement of dental claims
in 2007, the establishment of a contingent legal liability in
2007 and the impact of certain revisions in both years. These
increases were partially offset by a benefit related to a
reduction of an allowance for doubtful accounts in 2007, the
impact of a charge for non-deferrable LTC commissions
expense, a charge associated with costs related to the sale of
certain small market record keeping businesses and a charge
associated with a regulatory settlement, all in 2006.
The Individual segment contributed to the year over year
increase in other expenses primarily due to higher DAC
amortization, higher expenses associated with business growth,
information technology and other general expenses, the impact of
revisions to certain liabilities, including pension and
postretirement liabilities and policyholder liabilities in 2006,
and a write-off of a receivable from one of the Companys
joint venture partners in 2007.
The International segment contributed to the year over year
increase in other expenses primarily due to the business growth
commensurate with the increase in revenues discussed above. It
was driven by the following factors:
|
|
|
|
|
Argentinas other expenses increased primarily due to a
liability for servicing obligations that was established as a
result of pension reform, an increase in commissions on
bancassurance business, an increase in retention incentives
related to pension reform, and the impact of managements
update of DAC assumptions as a result of pension reform and
growth, partially offset by a lower increase in liabilities due
to inflation and exchange rate indexing.
|
106
|
|
|
|
|
South Koreas other expenses increased primarily due to the
favorable impact in DAC amortization associated with the
implementation of a more refined reserve valuation system in
2006, additional expenses associated with growth and
infrastructure initiatives, as well as business growth and
higher bank insurance fees, partially offset by a decrease in
DAC amortization.
|
|
|
|
Mexicos other expenses increased due to higher expenses
related to business growth and the favorable impact in 2006 of
liabilities that were reduced, offset by a decrease in DAC
amortization resulting from managements update of
assumptions used to determine estimated gross profits in both
2007 and 2006 and a decrease in liabilities based on a review of
outstanding remittances.
|
|
|
|
Other expenses increased in India primarily due to headcount
increases and growth initiatives, partially offset by the impact
of managements update of assumptions used to determine
estimated gross profits.
|
|
|
|
Other expenses increased in Australia primarily due to business
growth and changes in foreign currency exchange rates.
|
|
|
|
Other expenses increased in Chile primarily due to compensation
costs, infrastructure and marketing programs, and growth
partially offset by a decrease in DAC amortization related to
inflation indexing.
|
|
|
|
Other expenses increased in Hong Kong due to the acquisition of
the remaining 50% interest in MetLife Fubon and the resulting
consolidation of the operation.
|
|
|
|
Irelands other expenses increased due to higher
start-up
costs, as well as foreign currency transaction losses.
|
|
|
|
Brazils other expenses increased due to changes in foreign
currency exchange rates partially offset by an increase in
litigation liabilities in 2006.
|
|
|
|
The United Kingdoms other expenses increased due to
changes in foreign currency exchange rates and higher spending
on business initiatives partially offset by lower DAC
amortization resulting from calculation refinements.
|
|
|
|
These increases in other expenses were partially offset by a
decrease in Taiwans other expenses primarily due to a
one-time increase in DAC amortization in 2006 due to a loss
recognition adjustment resulting from low interest rates related
to product guarantees coupled with high persistency rates on
certain blocks of business, an increase in DAC amortization in
2006 associated with the implementation of a new valuation
system, as well as one-time expenses in 2006 related to the
termination of the agency force, and expense reductions
recognized in 2007 due to the elimination of the agency force.
|
These increases in other expenses were partially offset by a
decrease in the Auto & Home segment primarily related
to lower information technology and advertising costs, partially
offset by minor changes in a variety of expense categories.
Corporate & Other contributed to the year over year
increase in other expenses primarily due to higher interest
expense, higher interest on uncertain tax positions and an
increase in interest credited to bankholder deposits at MetLife
Bank, National Association (MetLife Bank or
MetLife Bank, N.A.), partially offset by lower
corporate support expenses, lower costs from reductions of
MetLife Foundation contributions, integration costs incurred in
2006 and lower legal costs.
Net
Income
Income tax expense for the year ended December 31, 2007 was
$1,660 million, or 29% of income from continuing operations
before provision for income tax, compared with
$1,016 million, or 26% of such income, for the comparable
2006 period. The 2007 and 2006 effective tax rates differ from
the corporate tax rate of 35% primarily due to the impact of
non-taxable investment income and tax credits for investments in
low income housing. In addition, the increase in the effective
rate for FIN 48 liability additions is entirely offset by
an increase in non-taxable investment income. The 2007 period
includes a benefit for decrease in international deferred tax
valuation allowances and the 2006 period included a prior year
benefit for international taxes. Lastly, the 2006 period
included benefit for a provision-to-filed return
adjustment regarding non-taxable investment income.
107
Income from discontinued operations, net of income tax,
decreased by $3,168 million, or 94%, to $215 million
for the year ended December 31, 2007 from
$3,383 million for the comparable 2006 period. The decrease
in income from discontinued operations was primarily due to a
gain of $3 billion, net of income tax, on the sale of the
Peter Cooper Village and Stuyvesant Town properties in
Manhattan, New York, that was recognized during the year ended
December 31, 2006. In addition, there was lower net
investment income and net investment gains (losses) of
$148 million, net of income tax, from discontinued
operations related to real estate properties sold or
held-for-sale during the year ended December 31, 2007 as
compared to the year ended December 31, 2006. Also
contributing to the decrease was lower income from discontinued
operations of $23 million, net of income tax, related to
the sale of MetLife Australias annuities and pension
businesses to a third party in the third quarter of 2007 and
lower income from discontinued operations of $18 million,
net of income tax, related to the sale of SSRM resulting from a
reduction in additional proceeds from the sale received during
the year ended December 31, 2007 as compared to the year
December 31, 2006. This decrease was partially offset by
higher income of $7 million, net of income tax, from
discontinued operations related to RGA, which was reclassified
to discontinued operations in the third quarter of 2008 as a
result of a tax-free split off. RGAs income was higher in
2007, primarily due to an increase in premiums, net of an
increase in policyholder benefits and claims, due to additional
in-force business from facultative and automatic treaties and
renewal premiums on existing blocks of business combined with an
increase in net investment income, net of interest credited to
policyholder account balances, due to higher invested assets.
These increases in RGAs income were offset by an increase
in net investment losses resulting from a decline in the
estimated fair value of embedded derivatives associated with the
reinsurance of annuity products on a funds withheld basis. Also
offsetting the decrease was higher income of $14 million,
net of income tax, from discontinued operations related to Cova,
which was reclassified to discontinued operations in the fourth
quarter of 2008 as a result of the Holding Company entering into
an agreement to sell the wholly-owned subsidiary.
Institutional
The following table presents consolidated financial information
for the Institutional segment for the years indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
14,964
|
|
|
$
|
12,392
|
|
|
$
|
11,867
|
|
Universal life and investment-type product policy fees
|
|
|
886
|
|
|
|
802
|
|
|
|
775
|
|
Net investment income
|
|
|
7,535
|
|
|
|
8,176
|
|
|
|
7,260
|
|
Other revenues
|
|
|
775
|
|
|
|
726
|
|
|
|
684
|
|
Net investment gains (losses)
|
|
|
168
|
|
|
|
(582
|
)
|
|
|
(630
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
24,328
|
|
|
|
21,514
|
|
|
|
19,956
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims
|
|
|
16,525
|
|
|
|
13,805
|
|
|
|
13,368
|
|
Interest credited to policyholder account balances
|
|
|
2,581
|
|
|
|
3,094
|
|
|
|
2,593
|
|
Policyholder dividends
|
|
|
|
|
|
|
|
|
|
|
|
|
Other expenses
|
|
|
2,408
|
|
|
|
2,439
|
|
|
|
2,313
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
21,514
|
|
|
|
19,338
|
|
|
|
18,274
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before provision for income tax
|
|
|
2,814
|
|
|
|
2,176
|
|
|
|
1,682
|
|
Provision for income tax
|
|
|
955
|
|
|
|
740
|
|
|
|
563
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
1,859
|
|
|
|
1,436
|
|
|
|
1,119
|
|
Income from discontinued operations, net of income tax
|
|
|
3
|
|
|
|
13
|
|
|
|
48
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
1,862
|
|
|
$
|
1,449
|
|
|
$
|
1,167
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
108
Year
Ended December 31, 2008 compared with the Year Ended
December 31, 2007 Institutional
Income
from Continuing Operations
Income from continuing operations increased by
$423 million, or 29%, to $1,859 million for the year
ended December 31, 2008 from $1,436 million for the
comparable 2007 period.
Included in this increase in income from continuing operations
was a decrease in net investment losses of $488 million,
net of income tax. The decrease in net investment losses was
primarily due to an increase in gains on derivatives partially
offset by an increase in losses from fixed maturity and equity
securities, including losses resulting from intersegment
transfers of securities. The derivative gains increased by
$1,572 million, net of income tax, and were primarily
driven by interest rate swaps, swaptions, and financial futures
which were economic hedges of certain investment assets and
institutional liabilities. The remaining change in net
investment losses of $1,084 million, net of income tax, is
principally attributable to an increase in losses on fixed
maturity and equity securities, and, to a lesser degree, an
increase in losses on mortgage and consumer loans and other
limited partnership interests offset by an increase in foreign
currency transaction gains. The increase in losses on fixed
maturity and equity securities is primarily attributable to
losses on intersegment transfers of approximately
$650 million, net of income tax, which are eliminated
within Corporate & Other and to an increase in
impairments associated with financial services industry holdings
which experienced losses as a result of bankruptcies, FDIC
receivership, and federal government assisted capital infusion
transactions in the third and fourth quarters of 2008, as well
as other credit related impairments or losses on fixed maturity
securities where the Company did not intend to hold the
securities until recovery in conjunction with overall market
declines occurring throughout the year.
The increase in net investment losses decreased policyholder
benefits and claims by $83 million, net of income tax, the
majority of which relates to policyholder participation in the
performance of the portfolio.
Excluding the impact from net investment gains (losses), income
from continuing operations decreased by $148 million, net
of income tax, compared to the prior year.
Lower underwriting results of $155 million, net of income
tax, compared to the prior year, contributed to the decrease in
income from continuing operations. Management attributed this
decrease primarily to the group life, non-medical health &
other and retirement & savings businesses of
$61 million, $50 million and $47 million, all net
of income tax, respectively. Underwriting results are generally
the difference between the portion of premium and fee income
intended to cover mortality, morbidity, or other insurance costs
less claims incurred, and the change in insurance-related
liabilities. Underwriting results are significantly influenced
by mortality, morbidity, or other insurance-related experience
trends, as well as the reinsurance activity related to certain
blocks of business. During periods of high unemployment,
underwriting results, specifically in the disability businesses,
tend to decrease as incidence levels trend upwards with
unemployment levels and the amount of recoveries decline. In
addition, certain insurance-related liabilities can vary as a
result of the valuation of the assets supporting those
liabilities. As invested assets under perform or lose value, the
related insurance liabilities are increased to reflect the
companys obligation with respect to those products,
specifically certain LTC products. Consequently, underwriting
results can and will fluctuate from period to period.
In addition, a decrease in interest margins of
$127 million, net of income tax, compared to the prior
year, contributed to the decrease in income from continuing
operations. Management attributed this decrease to the
retirement & savings and non-medical
health & other businesses, which contributed
$144 million and $71 million, net of income tax,
respectively. Partially offsetting these decreases was an
increase in the group life business of $88 million, net of
income tax. The decrease in interest margin is primarily
attributable to a decline in net investment income due to lower
returns on other limited partnership interests, real estate
joint ventures, fixed maturity securities, other invested assets
including derivatives, and mortgage loans, partially offset by
improved securities lending results. Management anticipates that
net investment income and the related yields on other limited
partnerships and real estate joint ventures could decline
further, which may reduce net investment income during the
remainder of 2009 due to continued volatility in equity, real
estate, and credit markets and therefore may continue to reduce
interest margins during 2009. Interest margin is the difference
between interest earned and interest credited to policyholder
account balances. Interest earned approximates net investment
income on investable assets attributed to the segment with minor
adjustments related to the consolidation of certain
109
separate accounts and other minor non-policyholder elements.
Interest credited is the amount attributed to insurance
products, recorded in policyholder benefits and claims, and the
amount credited to policyholder account balances for
investment-type products, recorded in interest credited to
policyholder account balances. Interest credited on insurance
products reflects the current period impact of the interest rate
assumptions established at issuance or acquisition. Interest
credited to policyholder account balances is subject to
contractual terms, including some minimum guarantees. This tends
to move in a manner similar to market interest rate movements,
and may reflect actions by management to respond to competitive
pressures and, therefore, generally does not, but it may,
introduce volatility in expense.
Partially offsetting these decreases in income from continuing
operations was a decline in other expenses, due in part to lower
expenses related to DAC amortization of $65 million, net of
income tax, primarily due to the impact of a charge of
$40 million, net of income tax, in the prior year, due to
the impact of the implementation of
SOP 05-1
and a decrease of $12 million, net of income tax, mainly
from amortization refinements in the current year. Partially
offsetting the decline in DAC amortization was the net impact of
revisions to certain assets and liabilities in the prior and
current year of $19 million, net of income tax. The
remaining increase in operating expenses was more than offset by
the remaining increase in premiums, fees, and other revenues. A
portion of premiums, fees and other revenues is intended to
cover the Companys operating expenses or non-insurance
related expenses. As many of those expenses are fixed expenses,
management may not be able to reduce those expenses, in a timely
manner, proportionate with declining revenues that may result
from customer-related bankruptcies, customers reduction of
coverage stemming from plan changes, elimination of retiree
coverage, or a reduction in covered payroll.
Revenues
Total revenues, excluding net investment gains (losses),
increased by $2,064 million, or 9%, to $24,160 million
for the year ended December 31, 2008 from
$22,096 million for the comparable 2007 period.
The increase of $2,705 million in premiums, fees and other
revenues was largely due to increases in the
retirement & savings, non-medical health &
other and group life businesses of $1,451 million,
$749 million and $505 million, respectively.
An increase in the retirement & savings business was
primarily due to increases in premiums in the group
institutional annuity, structured settlement and global GIC
businesses of $1,310 million, $222 million and
$42 million, respectively. The increase in both group
institutional annuity and the structured settlement businesses
were primarily due to higher sales. The increase in the group
institutional annuity business was primarily due to large
domestic sales and the first significant sales in the United
Kingdom business in the current year. The global GIC related
increase was primarily the result of fees earned on the
surrender of a GIC contract. Partially offsetting these
increases was the impact of lower sales in the income annuity
business of $108 million. The remaining increase in the
retirement & savings business was attributed to
business growth across several products. Premiums, fees and
other revenues from retirement & savings products are
significantly influenced by large transactions and the demand
for certain of these products can decline during periods of
volatile credit and investment markets and, as a result, can
fluctuate from period to period.
The growth in the non-medical health & other business
was largely due to increases in the dental, disability,
AD&D, and IDI businesses of $734 million. The increase
in the dental business was primarily due to organic growth in
the business and the impact of an acquisition that closed in the
first quarter of 2008. The increases in the disability,
AD&D, and IDI businesses were primarily due to continued
growth in the business. Partially offsetting these increases was
a decline in the LTC business of $5 million, primarily
attributable to a $74 million decrease, which management
attributed to a shift to deposit liability-type contracts during
the latter part of the prior year. This decline in the LTC
business was almost completely offset by current year growth in
the business. The remaining increase in the non-medical
health & other business was attributed to business
growth across several products.
The increase in group life business of $505 million was
primarily due to a $443 million increase in term life,
which was largely attributable to business growth, partially
offset by a decrease in assumed reinsurance. COLI and universal
life products increased $47 million and $37 million,
respectively. The increase in COLI was largely attributable to
the impact of fees earned on the cancellation of a portion of a
stable value wrap contract of $44 million. In addition,
continued business growth and the impact of higher experience
rated refunds in the prior
110
year contributed to this increase. Partially offsetting these
increases in COLI was the impact of fees earned on a large sale
in the prior year. The increase in universal life products was
primarily attributable to business growth in the current year.
Partially offsetting these increases was a decline in life
insurance sold to postretirement benefit plans of
$21 million, primarily the result of the impact of a large
sale in the prior year. Premiums, fees and other revenues from
group life business can and will fluctuate based, in part, on
the covered payroll of customers. In periods of high
unemployment, revenue may be impacted. Revenue may also be
impacted as a result of customer-related bankruptcies,
customers reduction of coverage stemming from plan changes
or elimination of retiree coverage.
Partially offsetting the increase in premiums, fees and other
revenues was a decrease in net investment income of
$641 million. Management attributed a $1,246 million
decrease in net investment income to a decrease in yields,
primarily due to lower returns on other limited partnership
interests, real estate joint ventures, fixed maturity
securities, other invested assets including derivatives, and
mortgage loans, partially offset by improved securities lending
results. Management anticipates that net investment income and
the related yields on other limited partnership interests and
real estate joint ventures could decline further, which may
reduce net investment income during 2009 due to continued
volatility in equity, real estate, and credit markets. Partially
offsetting this decrease in yields was a $605 million
increase, attributed to growth in average invested assets
calculated on a cost basis without unrealized gains and losses,
primarily within mortgage loans, other limited partnership
interests, other invested assets including derivatives, and real
estate joint ventures.
Expenses
Total expenses increased by $2,176 million, or 11%, to
$21,514 million for the year ended December 31, 2008
from $19,338 million for the comparable 2007 period. The
increase in expenses was primarily attributable to policyholder
benefits and claims of $2,720 million, partially offset by
lower interest credited to policyholder account balances of
$513 million and lower other expenses of $31 million.
The increase in policyholder benefits and claims of
$2,720 million included a $128 million decrease
related to net investment gains (losses). Excluding the decrease
related to net investment gains (losses), policyholder benefits
and claims increased by $2,848 million.
Retirement & savings policyholder benefits
increased $1,616 million, which was primarily attributable
to the group institutional annuity and structured settlement
businesses of $1,448 million and $261 million,
respectively. The increase in the group institutional annuity
business was primarily due to the aforementioned increase in
premiums and charges of $112 million in the current year
due to liability adjustments in this block of business. In
addition, an increase in interest credited on future
policyholder benefits contributed to this increase, which is
consistent with the expectations of an aging block of business.
The increase in structured settlements was largely due to the
aforementioned increase in premiums, an increase in interest
credited on future policyholder benefits and the impact of a
favorable liability refinement in the prior year of
$12 million, partially offset by slightly more favorable
mortality in the current year. Partially offsetting these
increases was a decrease of $90 million in the income
annuity business, primarily attributable to the aforementioned
decrease in premiums, fees and other revenues, partially offset
by an increase in interest credited to future policyholder
benefits.
Non-medical health & others policyholder
benefits and claims increased by $736 million. An increase
of $650 million was largely due to the aforementioned
growth in the dental, disability, AD&D and IDI businesses.
The increase in the disability business was primarily driven by
higher incidence and lower recoveries in the current year. In
addition, LTC increased $87 million, which was primarily
attributable to continued business growth, the impact of a
separate account reserve strengthening, triggered by weaker
investment performance in the current year and an increase in
interest credited on future policyholder benefits. These
increases were partially offset by the aforementioned
$74 million shift to deposit liability-type contracts.
Included in the disability increase was the favorable impact of
a $14 million charge related to certain liability
refinements in the prior year.
Group lifes policyholder benefits and claims increased
$496 million, mostly due to increases in the term life,
universal life and COLI products of $429 million,
$71 million and $22 million, respectively, partially
offset by a decrease of $26 million in life insurance sold
to postretirement benefit plans. The increases in term life and
universal life were primarily due to the aforementioned increase
in premiums, fees and other revenues and included
111
the impact of less favorable mortality experience in the current
year. The current year mortality experience was negatively
impacted by an unusually high number of large claims in the
specialty product areas. An additional component of the term
life increase was the impact of prior year net favorable
liability refinements of $12 million. Partially offsetting
these increases in term life was a decrease in interest credited
on future policyholder benefits, mainly due to lower crediting
rates in the current year. The increase in the COLI business was
primarily due to the aforementioned growth in fee income,
partially offset by favorable mortality in the current year. The
decrease in life insurance sold to postretirement benefit plans
was primarily due to the aforementioned decrease in premiums and
more favorable mortality in the current year.
Management attributed the decrease of $513 million in
interest credited to policyholder account balances to a
$856 million decrease from a decline in average crediting
rates, which was largely due to the impact of lower short-term
interest rates in the current year, partially offset by a
$343 million increase, solely from growth in the average
policyholder account balances, primarily the result of continued
growth in the global GIC and FHLB advances, partially offset by
a decline in funding agreement issuances. Management attributes
the absence of funding agreement issuances in 2008 as a direct
result of the credit markets. Management believes this trend
will continue through the remainder of 2009.
Lower other expenses of $31 million included a decrease in
DAC amortization of $101 million, primarily due to a
$61 million charge associated with the impact of DAC and
VOBA amortization, from the implementation of
SOP 05-1
in the prior year and an $18 million decrease mainly due to
the impact of amortization refinements in the current year. In
addition, the impact of a charge of $14 million relating to
the reimbursement of certain dental claims and a
$15 million charge related to the establishment of a
liability, both in the prior year, contributed to the decrease
in other expenses. Partially offsetting these decreases were
non-deferrable volume related expenses and corporate support
expenses, which increased $40 million. Non-deferrable
volume related expenses include those expenses associated with
information technology, compensation, and direct departmental
spending. Direct departmental spending includes expenses
associated with advertising, consultants, travel, printing and
postage. Also contributing to the increase was a
$29 million charge due to the impact of revisions to
certain pension and postretirement liabilities in the current
year, a $17 million expense resulting from fees incurred
related to the cancellation of a portion of a stable value wrap
contract, and a $13 million unfavorable impact related to a
prior year reduction of an allowance for doubtful accounts.
Year
ended December 31, 2007 compared with the year ended
December 31, 2006 Institutional
Income
from Continuing Operations
Income from continuing operations increased $317 million,
or 28%, to $1,436 million for the year ended
December 31, 2007 from $1,119 million for the
comparable 2006 period.
Included in this increase are higher earnings of
$31 million, net of income tax, from lower net investment
losses. In addition, higher earnings of $11 million, net of
income tax, resulted from an increase in policyholder benefits
and claims related to net investment gains (losses). Excluding
the impact of net investment gains (losses), income from
continuing operations increased by $275 million, net of
income tax, as compared to 2006.
Interest margins increased $230 million, net of income tax,
as compared to 2006. Management attributes this increase to a
$147 million increase in retirement & savings, a
$46 million increase in group life and a $37 million
increase in non-medical health & other, respectively, all
net of income tax. Interest margin is the difference between
interest earned and interest credited to policyholder account
balances. Interest earned approximates net investment income on
investable assets attributed to the segment with minor
adjustments related to the consolidation of certain separate
accounts and other minor non-policyholder elements. Interest
credited is the amount attributed to insurance products,
recorded in policyholder benefits and claims, and the amount
credited to policyholder account balances for investment-type
products, recorded in interest credited to policyholder account
balances. Interest credited on insurance products reflects the
2007 impact of the interest rate assumptions established at
issuance or acquisition. Interest credited to policyholder
account balances is subject to contractual terms, including some
minimum guarantees. This tends to move gradually over time to
reflect market interest rate movements, and may reflect actions
by management to respond to competitive pressures and,
therefore, generally does not introduce volatility in expense.
112
An increase in underwriting results of $90 million, net of
income tax, as compared to 2006, contributed to the increase in
income from continuing operations. Management attributes this
increase primarily to the non-medical health & other,
group life and retirement & savings businesses with
increases of $66 million, $16 million and
$8 million, all net of income tax, respectively.
Underwriting results are generally the difference between the
portion of premium and fee income intended to cover mortality,
morbidity, or other insurance costs less claims incurred, and
the change in insurance-related liabilities. Underwriting
results are significantly influenced by mortality, morbidity, or
other insurance-related experience trends, as well as the
reinsurance activity related to certain blocks of business.
Consequently, results can fluctuate from period to period.
Partially offsetting this increase in income from continuing
operations were higher expenses related to an increase in
non-deferrable volume-related expenses and corporate support
expenses of $72 million, net of income tax, as well as an
increase in DAC amortization of $44 million, net of income
tax, primarily due to a charge of $40 million, net of
income tax, due to the ongoing impact on DAC and VOBA
amortization resulting from the implementation of
SOP 05-1
in 2007. This increase in expense was partially offset by the
impact of certain revisions in both years for a net decrease of
$34 million, net of income tax. The remaining increase in
operating expenses was more than offset by the remaining
increase in premiums, fees, and other revenues.
Revenues
Total revenues, excluding net investment gains (losses),
increased by $1,510 million, or 7%, to $22,096 million
for the year ended December 31, 2007 from
$20,586 million for the comparable 2006 period.
Net investment income increased by $916 million.
Management attributes $744 million of this increase to
growth in the average asset base primarily within mortgage loans
on real estate, fixed maturity securities, real estate joint
ventures, other limited partnership interests, and equity
securities, driven by continued business growth, particularly
growth in the funding agreements and global GIC businesses.
Additionally, management attributes $172 million of this
increase in net investment income to an increase in yields,
primarily due to higher returns on fixed maturity securities,
improved securities lending results, other limited partnership
interests, and equity securities, partially offset by a decline
in yields on real estate and real estate joint ventures and
mortgage loans.
The increase of $594 million in premiums, fees and other
revenues was largely due to increases in the non-medical
health & other business of $483 million,
primarily due to growth in the dental, disability, AD&D and
IDI businesses of $478 million. Partially offsetting these
increases in the non-medical health & other business
is a decline in the LTC business of $7 million, which
includes a $66 million decrease resulting from a shift to
deposit liability-type contracts in 2007. Excluding this shift,
LTC premiums would have increased due to growth in the business.
Group life increased $345 million, which management
primarily attributes to a $262 million increase in term
life, primarily due to growth in the business from new sales and
an increase in reinsurance assumed, partially offset by the
impact of an increase in experience rated refunds. In addition,
COLI and life insurance sold to postretirement benefit plans
increased by $65 million and $30 million,
respectively. The increase in COLI is largely attributable to
fees earned on a large sale in 2007. These increases in group
lifes premiums, fees and other revenues were partially
offset by a decrease of $5 million in the universal life
insurance products. Partially offsetting the increase in
premiums, fees and other revenues was a decline in
retirement & savings premiums, fees and other
revenues of $234 million, primarily from declines of
$158 million and $79 million in structured settlement
and pension closeout premiums, respectively, partially offset by
an increase of $3 million across several products. The
declines in the structured settlement and pension closeout
businesses are predominantly due to the impact of lower sales in
2007. Premiums, fees and other revenues from
retirement & savings products are significantly
influenced by large transactions and, as a result, can fluctuate
from period to period.
Expenses
Total expenses increased by $1,064 million, or 6%, to
$19,338 million for the year ended December 31, 2007
from $18,274 million for the comparable 2006 period.
113
The increase in expenses was attributable to higher interest
credited to policyholder account balances of $501 million,
higher policyholder benefits and claims of $437 million and
an increase in operating expenses of $126 million.
Management attributes the increase of $501 million in
interest credited to policyholder account balances to a
$352 million increase solely from growth in the average
policyholder account balances, primarily resulting from growth
in global GICs and funding agreements within the
retirement & savings business and a $149 million
increase from a rise in average crediting rates, largely due to
the global GIC program, coupled with a rise in short-term
interest rates in 2007.
The increase in policyholder benefits and claims of
$437 million included a $16 million decrease related
to net investment gains (losses). Excluding the decrease related
to net investment gains (losses), policyholder benefits and
claims increased by $453 million. Non-medical
health & others policyholder benefits and claims
increased by $383 million. This increase was largely due to
a $369 million increase in the dental, disability, IDI and
AD&D businesses, resulting from the aforementioned growth
in business. This increase was partially offset by favorable
claim experience in the dental business and favorable morbidity
experience in the disability, IDI and AD&D businesses. This
increase included charges related to certain refinements of
$14 million in 2007 in LTD and the impact of a
$22 million disability liability reduction in 2006, which
contributed to the increase. An increase in LTC of
$14 million is largely attributable to business growth and
an increase in interest credited, partially offset by the
aforementioned $66 million shift to deposit liability-type
contracts and the impact of more favorable claim experience in
2007. Group lifes policyholder benefits and claims
increased by $264 million due mostly to an increase in the
term life business of $245 million, which included the
impact of less favorable mortality in the term life product,
partially offset by the net impact of favorable liability
refinements of $12 million in 2007. An increase of
$29 million in life insurance sold to postretirement plans
and $25 million for other group life products, including
COLI, also contributed to the increase in policyholder benefits
and claims for group life. The increases in term life and life
insurance sold to postretirement benefit plans are commensurate
with the aforementioned premiums increases. These increases were
partially offset by a decline in universal group life products
of $36 million, primarily due to favorable claim
experience. Retirement & savings policyholder
benefits decreased by $194 million, which was largely due
to decreases in the pension closeout and structured settlement
businesses of $98 million and $97 million,
respectively. The decrease in pension closeouts was primarily
due to the aforementioned decrease in premiums and a decrease in
interest credited. The decline in structured settlements was
primarily a result of the aforementioned decline in premiums,
partially offset by an increase in interest credited and less
favorable mortality experience in 2007. In addition, this
decrease included the net impact of favorable liability
refinements in 2007, which contributed a decrease of
$20 million, and the net impact of favorable liability
refinements in 2006 of $57 million, largely related to
business associated with the acquisition of Travelers,
principally in the structured settlement, pension closeout and
general account businesses.
Higher other expenses of $126 million included an increase
in non-deferrable volume-related expenses and corporate support
expenses of $110 million. Non-deferrable volume-related
expenses included those expenses associated with direct
departmental spending, information technology, commissions and
premium taxes. Corporate support expenses included advertising,
corporate overhead and consulting fees. The increase in other
expenses was also attributable to higher DAC amortization of
$67 million, primarily due to a $61 million charge as
a result of the ongoing impact of DAC and VOBA amortization
resulting from the implementation of
SOP 05-1
in 2007. In addition, a charge of $14 million related to
the reimbursement of certain dental claims and a
$15 million charge related to the establishment of a
contingent legal liability in 2007 contributed to the increase
in other expenses. The impact of certain revisions in both years
also contributed to a net increase in other expenses of
$2 million. These increases were partially offset by a
$13 million benefit related to a reduction of an allowance
for doubtful accounts in 2007. Additionally, 2006 included the
impact of a $22 million charge for non-deferrable LTC
commissions expense, a charge of $24 million associated
with costs related to the sale of certain small market
recordkeeping businesses and $24 million related to a
regulatory settlement, which reduced other expenses in 2007.
114
Individual
The following table presents consolidated financial information
for the Individual segment for the years indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
4,481
|
|
|
$
|
4,481
|
|
|
$
|
4,502
|
|
Universal life and investment-type product policy fees
|
|
|
3,400
|
|
|
|
3,441
|
|
|
|
3,131
|
|
Net investment income
|
|
|
6,509
|
|
|
|
7,025
|
|
|
|
6,863
|
|
Other revenues
|
|
|
571
|
|
|
|
600
|
|
|
|
524
|
|
Net investment gains (losses)
|
|
|
665
|
|
|
|
(112
|
)
|
|
|
(591
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
15,626
|
|
|
|
15,435
|
|
|
|
14,429
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims
|
|
|
5,779
|
|
|
|
5,665
|
|
|
|
5,335
|
|
Interest credited to policyholder account balances
|
|
|
2,028
|
|
|
|
2,013
|
|
|
|
2,018
|
|
Policyholder dividends
|
|
|
1,739
|
|
|
|
1,715
|
|
|
|
1,696
|
|
Other expenses
|
|
|
5,143
|
|
|
|
4,003
|
|
|
|
3,485
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
14,689
|
|
|
|
13,396
|
|
|
|
12,534
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before provision for income tax
|
|
|
937
|
|
|
|
2,039
|
|
|
|
1,895
|
|
Provision for income tax
|
|
|
307
|
|
|
|
698
|
|
|
|
653
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
630
|
|
|
|
1,341
|
|
|
|
1,242
|
|
Income (loss) from discontinued operations, net of income tax
|
|
|
(11
|
)
|
|
|
16
|
|
|
|
22
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
619
|
|
|
$
|
1,357
|
|
|
$
|
1,264
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year
Ended December 31, 2008 compared with the Year Ended
December 31, 2007 Individual
Income
from Continuing Operations
Income from continuing operations decreased by
$711 million, or 53%, to $630 million for the year
ended December 31, 2008 from $1,341 million for the
prior year.
Included in this decrease in income from continuing operations
was a decrease in net investment losses of $505 million,
net of income tax. The decrease in net investment losses is due
to an increase in gains on derivatives partially offset by
losses primarily on fixed maturity securities, including losses
resulting from intersegment transfers of securities. Derivative
gains were driven by gains on freestanding derivatives that were
partially offset by losses on embedded derivatives primarily
associated with variable annuity riders. Gains on freestanding
derivatives increased by $2,308 million, net of income tax,
and were primarily driven by: i) gains on certain interest
rate floors and financial futures which were economic hedges of
certain investment assets and liabilities, ii) gains from
foreign currency derivatives primarily due to the
U.S. dollar strengthening as well as, iii) gains
primarily from equity options, financial futures, and interest
rate swaps hedging the embedded derivatives. The gains on these
equity options, financial futures, and interest rate swaps
substantially offset the change in the underlying embedded
derivative liability that is hedged by these derivatives. Losses
on the embedded derivatives increased by $1,023 million,
net of income tax, and were driven by declining interest rates
and poor equity market performance throughout the year. These
embedded derivative losses include an $870 million, net of
income tax, gain resulting from the effect of the widening of
the Companys own credit spread which is required to be
used in the valuation of these variable annuity rider embedded
derivatives under SFAS 157, which became effective
January 1, 2008. The remaining change in net investment
losses of $780 million, net of income tax, is principally
attributable to an increase in losses on fixed maturity
securities and, to a lesser degree, an increase in foreign
115
currency transaction losses on mortgage loans. The increase in
losses on fixed maturity securities is primarily attributable to
losses on intersegment transfers of approximately
$350 million, net of income tax, which are eliminated
within Corporate & Other and to impairments associated
with financial services industry holdings which experienced
losses as a result of bankruptcies, FDIC receivership, and
federal government assisted capital infusion transactions in the
third and fourth quarters of 2008, as well as other credit
related impairments or losses on fixed maturity securities where
the Company did not intend to hold the securities until recovery
in conjunction with overall market declines occurring throughout
the year.
Excluding the impact of net investment gains (losses), income
from continuing operations decreased by $1,216 million, net
of income tax, from the prior year.
The decrease in income from continuing operations for the year
was driven by the following items:
|
|
|
|
|
Higher DAC amortization of $837 million, net of income tax,
related to lower expected future gross profits due to separate
account balance decreases resulting from recent market declines,
higher net investment gains primarily due to net derivative
gains and the reduction in expected cumulative earnings of the
closed block partially offset by a reduction in actual earnings
of the closed block and changes in assumptions used to estimate
future gross profits and margins.
|
|
|
|
A decrease in interest margins of $318 million, net of
income tax. Interest margins relate primarily to the general
account portion of investment-type products. Management
attributed a $279 million decrease to the deferred annuity
business and a $39 million decrease to other
investment-type products, both net of income tax. The decrease
in interest margin was primarily attributable to a decline in
net investment income due to lower returns on other limited
partnership interests, real estate joint ventures, other
invested assets including derivatives, and short term
investments, all of which were partially offset by higher
securities lending results. Interest margin is the difference
between interest earned and interest credited to policyholder
account balances related to the general account on these
businesses. Interest earned approximates net investment income
on invested assets attributed to these businesses with net
adjustments for other non-policyholder elements. Interest
credited approximates the amount recorded in interest credited
to policyholder account balances. Interest credited to
policyholder account balances is subject to contractual terms,
including some minimum guarantees, and may reflect actions by
management to respond to competitive pressures. Interest
credited to policyholder account balances tends to move in a
manner similar to market interest rate movements, subject to any
minimum guarantees and, therefore, generally does not, but it
may introduce volatility in expense.
|
|
|
|
Unfavorable underwriting results in life products of
$68 million, net of income tax. Underwriting results are
generally the difference between the portion of premium and fee
income intended to cover mortality, morbidity or other insurance
costs less claims incurred and the change in insurance-related
liabilities. Underwriting results are significantly influenced
by mortality, morbidity, or other insurance-related experience
trends, as well as the reinsurance activity related to certain
blocks of business. Consequently, results can fluctuate from
year to year.
|
|
|
|
An increase in interest credited to policyholder account
balances of $39 million, net of income tax, due primarily
to lower amortization of the excess interest reserves on
acquired annuity and universal life blocks of business.
|
|
|
|
Higher annuity benefits of $29 million, net of income tax,
primarily due to higher guaranteed annuity benefit costs net of
related hedging results and higher amortization of sales
inducements, partially offset by revisions to policyholder
benefits in both years.
|
|
|
|
Lower universal life and investment-type product policy fees
combined with other revenues of $22 million, net of income
tax, primarily resulting from lower average separate account
balances due to unfavorable equity market performance during the
current year, as well as revisions to managements
assumptions used to determine estimated gross profits and
margins. These decreases were partially offset by universal life
business growth over the prior year.
|
|
|
|
An increase in policyholder dividends of $16 million, net
of income tax, due to growth in the business.
|
116
These aforementioned decreases in income from continuing
operations were partially offset by the following items:
|
|
|
|
|
Lower expenses of $96 million, net of income tax, primarily
due to a decrease in non-deferrable volume related expenses and
a write-off of a receivable from one of the Companys joint
venture partners in the prior year, partially offset by the
impact of revisions to certain pension and post retirement
liabilities in the current year.
|
|
|
|
Higher net investment income on blocks of business not driven by
interest margins of $12 million, net of income tax.
|
The change in effective tax rates between years accounts for the
remainder of the increase in income from continuing operations.
Revenues
Total revenues, excluding net investment gains (losses),
decreased by $586 million, or 4%, to $14,961 million
for the year ended December 31, 2008 from
$15,547 million for the prior year.
Premiums remained flat for the year ended December 31, 2008
compared to the prior year. Premiums were impacted by an
increase in immediate annuity premiums of $23 million and
growth in premiums from other life products of $60 million
driven by increased renewals of traditional life business. These
increases were completely offset by an $83 million decline
in premiums associated with the Companys closed block of
business in line with expectations.
Universal life and investment-type product policy fees combined
with other revenues decreased by $70 million primarily
resulting from lower average separate account balances due to
unfavorable equity market performance during the current year,
as well as revisions to managements assumptions used to
determine estimated gross profits and margins. These decreases
were partially offset by universal life business growth over the
prior year. Policy fees from variable life and annuity and
investment-type products are typically calculated as a
percentage of the average assets in policyholder accounts. The
value of these assets can fluctuate depending on equity
performance.
Net investment income decreased by $516 million. Net
investment income from the general account portion of
investment-type products decreased by $499 million, while
other businesses decreased by $17 million. Management
attributed $566 million of the decrease to a decrease in
yields, primarily due to lower returns on other limited
partnership interests, real estate joint ventures, other
invested assets including derivatives, and short term
investments, all of which were partially offset by higher
securities lending results. Management attributed a
$50 million increase to a higher average asset base across
various investment types. Average invested assets are calculated
on cost basis without unrealized gains and losses.
Expenses
Total expenses increased by $1,293 million, or 10%, to
$14,689 million for the year ended December 31, 2008
from $13,396 million for the prior year.
Policyholder benefits and claims increased by $114 million.
This was primarily due to unfavorable equity market performance
during the current year, which resulted in higher guaranteed
annuity benefit costs net of related hedging results of
$113 million and higher amortization of sales inducements
of $69 million. These increases were partially offset by
$137 million of revisions to policyholder benefits in the
current year. Additionally, unfavorable mortality in the life
products, including the closed block, contributed
$69 million to this increase.
Interest credited to policyholder account balances increased by
$15 million. Interest credited on the general account
portion of investment-type products decreased by
$40 million, while other businesses decreased by
$5 million. Of the $40 million decrease on the general
account portion of investment-type products, management
attributed $68 million to lower crediting rates partially
offset by a $28 million increase due to higher average
general account balances. More than offsetting these decreases
was lower amortization of the excess interest reserves on
acquired annuity and universal life blocks of business of
$60 million primarily driven by lower lapses in the current
year.
117
Policyholder dividends increased by $24 million due to
growth in the business.
Higher other expenses of $1,140 million include higher DAC
amortization of $1,287 million primarily relating to lower
expected future gross profits due to separate account balance
decreases resulting from recent market declines, higher net
investment gains primarily due to net derivative gains and the
reduction in expected cumulative earnings of the closed block
partially offset by a reduction in actual earnings of the closed
block and changes in assumptions used to estimate future gross
profits and margins. This was offset by a decrease in other
expenses of $147 million driven by a $149 million
decrease in non-deferrable volume related expenses, which
include those expenses associated with information technology,
compensation and direct departmental spending. Direct
departmental spending includes expenses associated with
consultants, travel, printing and postage. Additionally, there
was a decrease due to a $24 million write-off of a
receivable from one of the Companys joint venture partners
in the prior year. Partially offsetting these decreases was an
increase of $26 million due to the impact of revisions to
certain pension and post retirement liabilities in the current
year.
Year
Ended December 31, 2007 compared with the Year Ended
December 31, 2006 Individual
Income
from Continuing Operations
Income from continuing operations increased by $99 million,
or 8%, to $1,341 million for the year ended
December 31, 2007 from $1,242 million for the
comparable period in 2006. Included in this increase was a
decrease in net investment losses of $311 million, net of
income tax. Excluding the impact of net investment gains
(losses), income from continuing operations decreased by
$212 million from 2006.
The decrease in income from continuing operations for the year
was driven by the following items:
|
|
|
|
|
Higher DAC amortization of $205 million, net of income tax,
primarily resulting from business growth, lower net investment
losses in 2007 and revisions to managements assumptions
used to determine estimated gross profits and margins.
|
|
|
|
Unfavorable underwriting results in life products of
$151 million, net of income tax. Underwriting results are
generally the difference between the portion of premium and fee
income intended to cover mortality, morbidity or other insurance
costs less claims incurred and the change in insurance-related
liabilities. Underwriting results are significantly influenced
by mortality, morbidity, or other insurance-related experience
trends, as well as the reinsurance activity related to certain
blocks of business. Consequently, results can fluctuate from
year to year.
|
|
|
|
Higher expenses of $132 million, net of income tax. Higher
general expenses, the impact of revisions to certain liabilities
in both years, and the write-off of a receivable from one of the
Companys joint venture partners contributed to the
increase in other expenses.
|
|
|
|
An increase in the closed block-related policyholder dividend
obligation of $75 million, net of income tax, which was
driven by net investment gains.
|
|
|
|
Higher annuity benefits of $24 million, net of income tax,
primarily due to higher amortization of deferred costs,
partially offset by lower costs of guaranteed annuity benefit
riders and related hedging.
|
|
|
|
An increase in policyholder dividends of $12 million, net
of income tax, due to growth in the business.
|
|
|
|
An increase in interest credited to policyholder account
balances of $13 million, net of income tax, due primarily
to lower amortization of the excess interest reserves on
acquired annuity and universal life blocks of business.
|
These aforementioned decreases in income from continuing
operations were partially offset by the following items:
|
|
|
|
|
Higher fee income from separate account products of
$276 million, net of income tax, primarily related to fees
being earned on a higher average account balance resulting from
a combination of growth in the business and overall market
performance.
|
118
|
|
|
|
|
Higher net investment income on blocks of business not driven by
interest margins of $99 million, net of income tax, due to
an increase in yields and growth in the average asset base.
|
|
|
|
An increase in interest margins of $18 million, net of
income tax. Interest margins relate primarily to the general
account portion of investment-type products. Management
attributed a $1 million decrease to the deferred annuity
business offset by a $19 million increase to other
investment-type products, both net of income tax. Interest
margin is the difference between interest earned and interest
credited to policyholder account balances related to the general
account on these businesses. Interest earned approximates net
investment income on invested assets attributed to these
businesses with net adjustments for other non-policyholder
elements. Interest credited approximates the amount recorded in
interest credited to policyholder account balances. Interest
credited to policyholder account balances is subject to
contractual terms, including some minimum guarantees, and may
reflect actions by management to respond to competitive
pressures. Interest credited to policyholder account balances
tends to move in a manner similar to market interest rate
movements, and may reflect actions by management to respond to
competitive pressures and, therefore, generally does not, but it
may, introduce volatility in expense.
|
The change in effective tax rates between years accounts for the
remainder of the decrease in income from continuing operations.
Revenues
Total revenues, excluding net investment gains (losses),
increased by $527 million, or 4%, to $15,547 million
for the year ended December 31, 2007 from
$15,020 million for 2006.
Premiums decreased by $21 million due to a decrease in
immediate annuity premiums of $27 million, and an
$89 million decline in premiums associated with the
Companys closed block of business, in line with
expectations. These decreases were partially offset by growth in
premiums from other life products of $95 million, primarily
driven by increased sales of term life business.
Universal life and investment-type product policy fees combined
with other revenues increased by $386 million due to a
combination of growth in the business and improved overall
market performance, as well as revisions to managements
assumptions used to determine estimated gross profits and
margins. Policy fees from variable life and annuity and
investment-type products are typically calculated as a
percentage of the average assets in policyholder accounts. The
value of these assets can fluctuate depending on equity
performance.
Net investment income increased by $162 million. Net
investment income from the general account portion of
investment-type products and other businesses increased by
$47 million and $115 million, respectively. Management
attributes $109 million of this increase to an increase in
yields, primarily due to higher returns on other limited
partnership interests. Additionally, management attributes
$53 million to growth in the average asset base across
various investment types.
Expenses
Total expenses increased by $862 million, or 7%, to
$13,396 million for the year ended December 31, 2007
from $12,534 million for 2006.
Policyholder benefits and claims increased by $330 million
primarily due to an increase in the closed block-related
policyholder dividend obligation of $115 million which was
primarily driven by net investment gains. Unfavorable mortality
in the life products, as well as revisions to policyholder
benefits in both years, contributed $199 million to this
increase. Included in this increase was $72 million of
unfavorable mortality in the closed block and a prior year net
increase of $15 million in the excess mortality liability
on specific blocks of life insurance policies. Higher
amortization of sales inducements resulting from business growth
and revisions to managements assumptions used to determine
estimated gross profits and margins, partially offset by lower
costs of guaranteed annuity benefit riders and related hedging
increased annuity benefits by $37 million. Partially
offsetting these increases, policyholder benefits and claims
decreased by $21 million commensurate with the decrease in
premiums discussed above.
119
Interest credited to policyholder account balances decreased by
$5 million. Interest credited on the general account
portion of investment-type products and other businesses
decreased by $16 million and $9 million, respectively.
Of the $16 million decrease on the general account portion
of investment-type products, management attributed
$67 million to higher crediting rates, more than offset by
$83 million due to lower average policyholder account
balances. Partially offsetting these decreases was lower
amortization of the excess interest reserves on acquired annuity
and universal life blocks of business of $20 million
primarily driven by lower lapses in 2007.
Policyholder dividends increased by $19 million due to
growth in the business.
Higher other expenses of $518 million include higher DAC
amortization of $315 million resulting from business
growth, lower net investment losses and revisions to
managements assumptions used to determine estimated gross
profits and margins. The remaining increase in other expenses of
$203 million was comprised of $172 million associated
with business growth, information technology and other general
expenses, $7 million due to the impact of revisions to
certain liabilities including pension and postretirement
liabilities and policyholder liabilities in 2006, and
$24 million associated with the write-off of a receivable
from one of the Companys joint venture partners in 2007.
International
The following table presents consolidated financial information
for the International segment for the years indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
3,470
|
|
|
$
|
3,096
|
|
|
$
|
2,722
|
|
Universal life and investment-type product policy fees
|
|
|
1,095
|
|
|
|
995
|
|
|
|
805
|
|
Net investment income
|
|
|
1,249
|
|
|
|
1,247
|
|
|
|
949
|
|
Other revenues
|
|
|
18
|
|
|
|
24
|
|
|
|
28
|
|
Net investment gains (losses)
|
|
|
167
|
|
|
|
56
|
|
|
|
(10
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
5,999
|
|
|
|
5,418
|
|
|
|
4,494
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims
|
|
|
3,166
|
|
|
|
2,460
|
|
|
|
2,411
|
|
Interest credited to policyholder account balances
|
|
|
171
|
|
|
|
354
|
|
|
|
288
|
|
Policyholder dividends
|
|
|
7
|
|
|
|
4
|
|
|
|
(3
|
)
|
Other expenses
|
|
|
1,671
|
|
|
|
1,749
|
|
|
|
1,531
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
5,015
|
|
|
|
4,567
|
|
|
|
4,227
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before provision for income tax
|
|
|
984
|
|
|
|
851
|
|
|
|
267
|
|
Provision for income tax
|
|
|
404
|
|
|
|
207
|
|
|
|
95
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
580
|
|
|
|
644
|
|
|
|
172
|
|
Income (loss) from discontinued operations, net of income tax
|
|
|
|
|
|
|
(9
|
)
|
|
|
28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
580
|
|
|
$
|
635
|
|
|
$
|
200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year
Ended December 31, 2008 compared with the Year Ended
December 31, 2007 International
Income
from Continuing Operations
Income from continuing operations decreased by $64 million,
or 10%, to $580 million for the year ended
December 31, 2008 from $644 million for the prior year.
120
Included in this decrease in income from continuing operations
was an increase in net investment gains of $39 million, net
of income tax. The increase in net investment gains was due to
an increase in gains on derivatives partially offset by losses
primarily on fixed maturity and equity securities. Derivative
gains were driven by gains on freestanding derivatives that were
partially offset by losses on embedded derivatives associated
with assumed risk on variable annuity riders written directly
through the Japan joint venture. Gains on freestanding
derivatives increased by $644 million, net of income tax,
and were primarily driven by gains from equity options,
financial futures, interest rate swaps, and foreign currency
forwards hedging the embedded derivatives. The gains on these
equity options, financial futures, interest rate swaps, and
foreign currency forwards substantially offset the change in the
underlying embedded derivative liability that is hedged by these
derivatives. Losses on the embedded derivatives increased by
$532 million, net of income tax, and were driven by
declining interest rates, poor equity market performance, and
foreign currency fluctuations throughout the year. These
embedded derivative losses include a $1,076 million, net of
income tax, gain resulting from the effect of the widening of
the Companys own credit spread which is required to be
used in the valuation of these variable annuity rider embedded
derivatives under SFAS 157, which became effective
January 1, 2008. The remaining change in net investment
gains of $73 million, net of income tax, is principally
attributable to an increase in impairments on fixed maturity
securities associated with financial services industry holdings
which experienced losses as a result of bankruptcies, FDIC
receivership, and federal government assisted capital infusion
transactions in the third and fourth quarters of 2008 as well as
other credit related impairments or losses on fixed maturity
securities where the Company did not intend to hold the
securities until recovery in conjunction with overall market
declines occurring throughout the year.
Excluding the impact of net investment gains (losses) of
$39 million, net of income tax, and the adverse impact of
changes in foreign exchange rates of $13 million, net of
income tax, income from continuing operations decreased by
$90 million from the prior year.
Income from continuing operations decreased in:
|
|
|
|
|
Argentina by $65 million, net of income tax primarily due
to the negative impact the 2007 Argentine pension reform had on
the 2008 income from continuing operations. These losses were
partially offset by the net impact resulting from the Argentine
nationalization of the private pension system
Nationalization as well as refinements to certain
contingent and insurance liabilities associated with a Supreme
Court ruling. In 2007, pension reform legislation eliminated the
obligation to provide death and disability coverage by the plan
administrators effective January 1, 2008 which created
significant one time gains in the prior year resulting from the
release of death and disability reserves. In addition, the
impact of the 2007 pension reform resulted in a decrease in
premiums for the full year of 2008 partially offset by a
decrease in claims and market-indexed policyholder liabilities.
In December 2008, the Argentine government nationalized the
private pension system and seized the underlying investments.
With this action the Companys pension business in
Argentina ceased to exist. As a result, the Company eliminated
certain assets which included deferred acquisition costs and
deferred tax assets, certain liabilities which included
primarily the liability for future servicing obligations and
incurred severance costs associated with the termination of
employees. The liability for future servicing obligations was
established due to the 2007 pension reform which resulted in the
Company managing significant pension assets for which the
Company would no longer receive any compensation. The
elimination of this liability more than offset the elimination
of assets and the incurred severance costs related to the
Nationalization. In addition to the impact of pension reform and
Nationalization, Argentinas income from continuing
operations was also favorably impacted by changes in contingent
liabilities and the associated future policyholder benefits for
Supreme Court case decisions related to the pesification of
insurance contracts by the government in 2002. Other
developments include the reduction of claim liabilities in the
prior year from an experience review and the favorable impact in
the current year of higher inflation rates on indexed securities
partially offset by higher losses on the trading securities
portfolio. Argentinas results were impacted, in both the
current and prior years, by valuation allowances against
deferred taxes that are released only upon actual payment of
taxes.
|
|
|
|
Japan by $53 million, net of income tax, due to a decrease
of $146 million, net of income tax, in the Companys
earnings from its investment in Japan due to an increase in
losses on embedded derivatives associated with variable annuity
riders, an increase in DAC amortization related to market
performance and the impact of a refinement in assumptions for
the guaranteed annuity business partially offset by the
|
121
|
|
|
|
|
favorable impact from the utilization of the fair value option
for certain fixed annuities, as well as a decrease of
$14 million, net of income tax in earnings from assumed
reinsurance, and an increase of $108 million, net of income
tax, from hedging activities associated with Japans
guaranteed annuity benefits.
|
|
|
|
|
|
The home office by $7 million, net of income tax, primarily
due to higher economic capital charges and lower expenses in the
prior year resulting from the elimination of intercompany
expenses previously charged to the International segment
partially offset by a decrease in accrued tax liabilities.
|
|
|
|
Mexico by $4 million, net of income tax, primarily due to
higher claims experience, an increase in certain policyholder
liabilities caused by lower unrealized investment losses on the
invested assets supporting those liabilities relative to the
prior year, the favorable impact in the prior year of a decrease
in experience refunds on Mexicos institutional business, a
lower increase in litigation liabilities in the prior year,
higher expenses related to business growth and infrastructure
costs, as well as a valuation allowance established against net
operating losses, partially offset by the reinstatement of
premiums from prior years, growth in the individual and
institutional businesses, higher net investment income due to an
increase in invested assets as well as the impact of higher
inflation rates on indexed securities, lower DAC amortization
resulting from managements update of assumptions used to
determine estimated gross profits in both the current and prior
years, and a decrease in liabilities based on a review of
outstanding remittances.
|
|
|
|
Chile by $3 million, net of income tax, primarily due to
higher spending on growth initiatives, as well as higher
commissions and compensation expenses due to business growth
partially offset by higher joint venture income.
|
Partially offsetting these decreases, income from continuing
operations increased in:
|
|
|
|
|
Hong Kong by $18 million, net of income tax, due to the
acquisition of the remaining 50% interest in MetLife Fubon in
the second quarter of 2007 and the resulting consolidation of
the operation beginning in the third quarter of 2007.
|
|
|
|
Ireland by $5 million, net of income tax, due to foreign
currency transaction losses in the prior year and foreign
currency transaction gains in the current year as well as higher
net investment income due to an increase in invested assets,
partially offset by higher expenses related to growth
initiatives and the utilization in the prior year of net
operating losses for which a valuation allowance had been
previously established.
|
|
|
|
Brazil by $4 million, net of income tax, primarily due to
business growth offset by a decrease in claims liabilities in
the prior year from an experience review and higher claim
experience in the current year.
|
|
|
|
Taiwan by $4 million, net of income tax, primarily due to
an increase in invested assets and a refinement in DAC
capitalization as well as business growth partially offset by
the impact in both the current and prior years from refinements
of methodologies related to the estimation of profit emergence
on certain blocks of business.
|
|
|
|
South Korea by $3 million, net of income tax, primarily due
to higher revenues from business growth and higher investment
yields, a reduction in claim liabilities from a refinement in
methodology, as well as a refinement in DAC capitalization,
partially offset by higher claims and operating expenses,
including an increase in DAC amortization related to market
performance.
|
|
|
|
Australia by $3 million, net of income tax, primarily due
to business growth slightly offset by an increase in claim
liabilities based on a review of experience.
|
|
|
|
The United Kingdom by $2 million, net of income tax,
primarily due to business growth.
|
Contributions from the other countries account for the remainder
of the change in income from continuing operations.
Revenues
Total revenues, excluding net investment gains (losses),
increased by $470 million, or 9%, to $5,832 million
for the year ended December 31, 2008 from
$5,362 million for the prior year. Excluding the adverse
impact of
122
changes in foreign currency exchange rates of $135 million,
total revenues increased by $605 million, or 12%, from the
prior year.
Premiums, fees and other revenues increased by
$468 million, or 11%, to $4,583 million for the year
ended December 31, 2008 from $4,115 million for the
prior year. Excluding the adverse impact of changes in foreign
currency exchange rates of $109 million, premiums, fees and
other revenues increased by $577 million, or 14%, from the
prior year.
Premiums, fees and other revenues increased in:
|
|
|
|
|
Chile by $150 million primarily due to higher annuity sales
as well as higher institutional premiums from its traditional
and bank distribution channels.
|
|
|
|
Mexico by $120 million due to growth in its individual and
institutional businesses as well as the reinstatement of
$8 million of premiums from prior years partially offset by
a decrease of $13 million in experience refunds in the
prior year on Mexicos institutional business and a
decrease in fees due to managements update of assumptions
used to determine estimated gross profits in both the current
and prior years.
|
|
|
|
Hong Kong by $77 million primarily due to the acquisition
of the remaining 50% interest in MetLife Fubon in the second
quarter of 2007 and the resulting consolidation of the operation
beginning in the third quarter of 2007 slightly offset by lower
business growth.
|
|
|
|
The United Kingdom by $68 million primarily due to growth
in the reinsurance business as well as the prior year impact of
an unearned premium calculation refinement.
|
|
|
|
South Korea by $68 million due to growth in its guaranteed
annuity and variable universal life businesses as well as in its
traditional business.
|
|
|
|
Australia by $54 million as a result of growth in the
institutional business and an increase in retention levels.
|
|
|
|
India, Brazil, Belgium, and Taiwan by $34 million,
$28 million, $12 million and $3 million,
respectively, due to business growth.
|
|
|
|
The Companys Japan operations by $17 million due to
an increase in fees from assumed reinsurance.
|
Partially offsetting these increases, premiums, fees and other
revenues decreased in Argentina by $60 million primarily
due to a decrease in premiums in the pension business, for which
pension reform eliminated the obligation of plan administrators
to provide death and disability coverage effective
January 1, 2008. The decrease related to the pension
business was partially offset by growth in its institutional and
bancassurance businesses.
Contributions from the other countries account for the remainder
of the change in premiums, fees and other revenues.
Net investment income is relatively flat with an increase of
$2 million to $1,249 million for the year ended
December 31, 2008 from $1,247 million for the prior
year. Excluding the adverse impact of changes in foreign
currency exchange rates of $26 million, net investment
income increased by $28 million, or 2% from the prior year.
Net investment income increased in:
|
|
|
|
|
Chile by $93 million due to the impact of higher inflation
rates on indexed securities, the valuations and returns of which
are linked to inflation rates, an increase in invested assets,
as well as higher joint venture income.
|
|
|
|
Mexico by $75 million due to an increase in invested
assets, the impact of higher inflation rates on indexed
securities, higher short-term yields as well as the lengthening
of the duration of the portfolio.
|
|
|
|
Japan by $20 million due to an increase of
$166 million from hedging activities associated with
Japans guaranteed annuity business partially offset by a
decrease of $146 million, net of income tax, in the
Companys earnings from its investment in Japan due to an
increase in losses on embedded derivatives associated with
variable annuity riders and the impact of a refinement in
assumptions for the guaranteed
|
123
|
|
|
|
|
annuity business partially offset by the favorable impact from
the utilization of the fair value option for certain fixed
annuities.
|
|
|
|
|
|
South Korea and Taiwan by $19 million and $9 million,
respectively, due to increases in invested assets as well as
higher portfolio yields.
|
|
|
|
Argentina by $6 million primarily due to the impact of
higher inflation rates on indexed securities partially offset by
higher losses on the trading securities portfolio.
|
|
|
|
India by $5 million primarily due to increases in invested
assets.
|
Partially offsetting these increases, net investment income
decreased in:
|
|
|
|
|
Hong Kong by $160 million despite the acquisition of the
remaining 50% interest in MetLife Fubon in the second quarter of
2007 and the resulting consolidation of the operation beginning
in the third quarter of 2007, because of the negative investment
income for the year due to the losses on the trading securities
portfolio which supports unit-linked policyholder liabilities.
|
|
|
|
The home office of $24 million primarily due to an increase
in the amount charged for economic capital.
|
|
|
|
Ireland by $21 million primarily due to losses in the
current year on the trading securities portfolio which supports
unit-linked policyholder liabilities, partially offset by an
increase due to higher invested assets resulting from capital
contributions in the prior year.
|
Contributions from the other countries account for the remainder
of the change in net investment income.
Expenses
Total expenses increased by $448 million, or 10%, to
$5,015 million for the year ended December 31, 2008
from $4,567 million for the prior year. Excluding the
negative impact of changes in foreign currency exchange rates of
$120 million, total expenses increased by
$568 million, or 13%, from the prior year.
Policyholder benefits and claims, policyholder dividends and
interest credited to policyholder account balances increased by
$526 million, or 19%, to $3,344 million for the year
ended December 31, 2008 from $2,818 million for the
prior year. Excluding the negative impact of changes in foreign
currency exchange rates of $68 million, policyholder
benefits and claims, policyholder dividends and interest
credited to policyholder account balances increased by
$594 million, or 22%, from the prior year.
Policyholder benefits and claims, policyholder dividends and
interest credited to policyholder account balances increased in:
|
|
|
|
|
Chile by $236 million primarily due to an increase in the
annuity and institutional businesses mentioned above, as well as
an increase in inflation indexed policyholder liabilities.
|
|
|
|
Mexico by $182 million primarily due to increases in
liabilities and other policyholder benefits commensurate with
the growth in premiums discussed above, an increase in certain
policyholder liabilities caused by lower unrealized investment
losses on the invested assets supporting those liabilities
relative to the prior year, and an increase in interest credited
to policyholder account balances commensurate with the growth in
investment income from inflation-indexed assets discussed above.
|
|
|
|
Argentina by $158 million primarily due to the prior year
impact of a release of death and disability liabilities
associated with the pension reform discussed above, a reduction
of claim liabilities in the prior year from an experience review
as well as growth in the institutional and bancassurance
business, offset by a decrease in claims and market-indexed
policyholder liabilities resulting from pension reform, which
eliminated the obligation of plan administrators to provide
death and disability coverage effective January 1, 2008.
|
|
|
|
The Companys Japan operations by $39 million due to
an increase in guarantee reserves from assumed reinsurance.
|
124
|
|
|
|
|
Australia by $38 million due to growth in the institutional
business and an increase in retention levels as well as an
increase in claim liabilities based on a review of experience.
|
|
|
|
South Korea by $31 million primarily due to higher claim
experience and business growth offset by a reduction in claim
liabilities due to a refinement in methodology.
|
|
|
|
The United Kingdom by $16 million due to the reduction in
claim liabilities in the prior year based on a review of
experience as well as higher claims in the current year and
business growth.
|
|
|
|
India by $13 million due to business growth.
|
|
|
|
Brazil by $12 million due to a decrease in claims
liabilities in the prior year from an experience review, higher
claim experience in the current year and business growth offset
by a decrease in interest credited to unit-linked policyholder
liabilities reflecting net losses in the trading portfolio.
|
Partially offsetting these increases in policyholder benefits
and claims, policyholder dividends and interest credited to
policyholder account balances were decreases in:
|
|
|
|
|
Hong Kong by $113 million due to the acquisition of the
remaining 50% interest in MetLife Fubon in the second quarter of
2007 and the resulting consolidation of the operation beginning
in the third quarter of 2007, which includes a decrease in
interest credited as a result of a reduction in unit-linked
policyholder liabilities reflecting the losses of the trading
portfolio backing these liabilities as discussed in the net
investment income section above.
|
|
|
|
Ireland by $22 million primarily due to a decrease in
interest credited as a result of a reduction in unit-linked
policyholder liabilities reflecting the losses of the trading
portfolio backing these liabilities.
|
Contributions from the other countries account for the remainder
of the change in policyholder benefits and claims, policyholder
dividends and interest credited to policyholder account balances.
Other expenses decreased by $78 million, or 4%, to
$1,671 million for the year ended December 31, 2008
from $1,749 million for the prior year. Excluding the
negative impact of changes in foreign currency exchange rates of
$52 million, total expenses decreased by $26 million,
or 2%, from the prior year.
Other expenses decreased in:
|
|
|
|
|
Argentina by $230 million, primarily due to the
establishment in the prior year of a liability for pension
servicing obligations due to pension reform, the elimination of
the liability for pension servicing obligations and the
elimination of DAC for the pension business in the current year
as a result of Nationalization, as well as the elimination of
contingent liabilities for certain cases due to recent Supreme
Court decisions related to the pesification of insurance
contracts by the government in 2002. Partially offsetting these
decreases is an increase in severance costs related to
Nationalization, as well as higher commissions from growth in
the institutional and bancassurance business.
|
|
|
|
Ireland by $12 million due to foreign currency transaction
losses in the prior year and foreign currency transaction gains
in the current year, partially offset by higher expenses related
to growth initiatives.
|
Partially offsetting these decreases, other expenses increased
in:
|
|
|
|
|
South Korea by $50 million due to an increase in DAC
amortization related to market performance as well as higher
spending on advertising and marketing offset by a refinement in
DAC capitalization.
|
|
|
|
The United Kingdom by $50 million due to business growth as
well as lower DAC amortization in the prior year resulting from
calculation refinements, partially offset by foreign currency
transaction gains.
|
|
|
|
India by $28 million primarily due to increased staffing
and growth initiatives.
|
|
|
|
The home office by $12 million primarily due to lower
expenses in the prior year resulting from the elimination of
intercompany expenses previously charged to the International
segment, as well as higher spending on growth and infrastructure
initiatives, partially offset by a decrease in accrued interest
on tax liabilities.
|
125
|
|
|
|
|
Chile by $12 million primarily due to the business growth
discussed above as well as higher commissions and compensation
costs and higher spending on infrastructure and marketing
programs.
|
|
|
|
Mexico by $11 million primarily due to higher expenses
related to business growth and infrastructure costs, a lower
increase in litigation liabilities in the prior year as well as
changes in liabilities based on a review of outstanding
remittances in both the current and prior years, partially
offset by lower DAC amortization resulting from
managements update of assumptions used to determine
estimated gross profits in both the current and prior years.
|
|
|
|
Hong Kong by $11 million due to the acquisition of the
remaining 50% interest in MetLife Fubon in the second quarter of
2007 and the resulting consolidation of the operation beginning
in the third quarter of 2007.
|
|
|
|
Brazil, Belgium and Australia, each increased by
$11 million, and Poland by $7 million primarily due to
higher commissions related to business growth.
|
|
|
|
Taiwan by $5 million due to a refinement in DAC resulting
from a refinement of methodologies related to the estimation of
profit emergence on certain blocks of business as well as growth.
|
Year
Ended December 31, 2007 compared with the Year Ended
December 31, 2006 International
Income
from Continuing Operations
Income from continuing operations increased by
$472 million, or 274%, to $644 million for the year
ended December 31, 2007 from $172 million for 2006.
This increase includes the impact of net investment gains of
$42 million, net of income tax.
Excluding the impact of net investment gains (losses), income
from continuing operations increased by $430 million from
2006.
Income from continuing operations increased in:
|
|
|
|
|
Argentina by $146 million, net of income tax, primarily due
to a net reduction of liabilities by $48 million, net of
income tax, resulting from pension reform. Additionally,
$66 million of a valuation allowance related to a deferred
tax asset established in connection with such pension reform
liabilities was reduced, resulting in a commensurate increase in
income from continuing operations. Under the reform plan, fund
administrators are no longer liable for death and disability
claims of the plan participants; however, administrators retain
the obligation for administering certain existing and future
participants accounts for which they receive no revenue.
Also contributing is the favorable impact of reductions in claim
liabilities resulting from experience reviews in both years,
higher premiums primarily due to higher pension contributions
attributable to higher participant salaries, higher net
investment income resulting from capital contributions in 2006,
and a smaller increase in market indexed policyholder
liabilities without a corresponding decrease in net investment
income, partially offset by the reduction of cost of insurance
fees as a result of the new pension system reform regulation, an
increase in retention incentives related to pension reform, as
well as lower trading portfolio income. Argentina also
benefited, in both years, from the utilization of tax loss
carryforwards against which valuation allowances had previously
been established, and in 2007 from the reduction of valuation
allowances due to expected realizability of deferred tax assets.
|
|
|
|
Mexico by $139 million, net of income tax, primarily due to
a decrease in certain policyholder liabilities caused by a
decrease in the unrealized investment results on invested assets
supporting those liabilities relative to 2006, the favorable
impact of experience refunds during the first quarter of 2007 in
its institutional business, a reduction in claim liabilities
resulting from experience reviews, the adverse impact in 2006 of
an adjustment for experience refunds in its institutional
business, a year over year decrease in DAC amortization as a
result of managements update of assumptions used to
determine estimated gross profits in both years, a decrease in
liabilities based on a review of outstanding remittances, as
well as growth in its institutional and universal life
businesses. These increases were offset by lower fees resulting
from managements update of assumptions used to determine
estimated gross profits, the favorable impact in 2006 associated
with a large group policy that was not renewed by the
policyholder, a decrease in various
|
126
|
|
|
|
|
one-time revenue items, lower investment yields, the favorable
impact in 2006 of liabilities related to employment matters that
were reduced, and the benefit in 2006 from the elimination of
liabilities for pending claims that were determined to be
invalid following a review.
|
|
|
|
|
|
Taiwan by $51 million, net of income tax, primarily due to
an increase in DAC amortization in 2006 due to a loss
recognition adjustment and prior year restructuring costs of
$11 million associated with the termination of the agency
distribution channel, partially offset by the favorable impact
of liability refinements in 2006 and higher policyholder
liabilities related to loss recognition in 2006.
|
|
|
|
Brazil by $37 million, net of income tax, due to the
unfavorable impact of increases in policyholder liabilities due
to higher than expected mortality on specific blocks of business
in 2006, an increase in litigation liabilities in 2006 and the
unfavorable impact of the reversal of a tax credit in 2006, as
well as growth of the in-force business.
|
|
|
|
Ireland by $19 million, net of income tax, primarily due to
the utilization of net operating losses for which a valuation
allowance had been previously established as well as higher
investment income resulting from higher invested assets from a
capital contribution, partially offset by higher
start-up
expenses and currency transaction losses.
|
|
|
|
Japan by $22 million, net of income tax, due to improved
hedge results and business growth, partially offset by the
impact of foreign currency transaction losses.
|
|
|
|
Hong Kong by $9 million, net of income tax, due to the
acquisition of the remaining 50% interest in MetLife Fubon and
the resulting consolidation of the operation, as well as
business growth.
|
|
|
|
Chile by $8 million, net of income tax, primarily due to
continued growth of the in-force business, higher joint venture
income and higher returns on inflation indexed securities,
partially offset by higher compensation, infrastructure and
marketing expenses.
|
|
|
|
The United Kingdom by $3 million, net of income tax, due to
a reduction of claim liabilities resulting from an experience
review, offset by an unearned premium calculation refinement.
|
|
|
|
Australia by $1 million, net of income tax, due to changes
in foreign currency exchange rates offset by higher claims and
business growth.
|
Partially offsetting these increases, income from continuing
operations decreased in:
|
|
|
|
|
The home office by $9 million, net of income tax, due to
higher economic capital charges and investment expenses of
$16 million, net of income tax, a $3 million increase
in contingent tax expenses in 2007, as well as higher spending
on growth and initiatives, partially offset by the elimination
of certain intercompany expenses previously charged to the
International segment and a tax benefit associated with a prior
year income tax expense of $7 million related to a revision
of an estimate.
|
|
|
|
India by $3 million, net of income tax, primarily due to
headcount increases and growth initiatives, as well as the
impact of valuation allowances established against losses in
both years.
|
|
|
|
South Korea by $4 million, net of income tax, due to a
favorable impact in 2006 of $38 million, net of income tax,
in DAC amortization associated with the implementation of a more
refined reserve valuation system, as well as additional expenses
in 2007 associated with growth and infrastructure initiatives,
partially offset by continued growth in its variable universal
life business, lower DAC amortization in the variable universal
life business due to favorable market performance and a lower
increase in claim liabilities.
|
The remainder of the change in income from continuing operations
can be attributed to contributions from the other countries.
Revenues
Total revenues, excluding net investment gains (losses),
increased by $858 million, or 19%, to $5,362 million
for the year ended December 31, 2007 from
$4,504 million for 2006.
127
Premiums, fees and other revenues increased by
$560 million, or 16%, to $4,115 million for the year
ended December 31, 2007 from $3,555 million for 2006.
Premiums, fees and other revenues increased in:
|
|
|
|
|
Mexico by $133 million primarily due to higher fees and
growth in its institutional and universal life businesses, a
decrease of $13 million in experience refunds during the
first quarter of 2007 on Mexicos institutional business,
as well as the adverse impact in 2006 of an adjustment for
experience refunds on Mexicos institutional business.
These increases were offset by lower fees resulting from
managements update of assumptions used to determine
estimated gross profits, and various one-time revenue items for
which 2006 benefited by $16 million and 2007 benefited by
$4 million.
|
|
|
|
Hong Kong by $98 million due to the acquisition of the
remaining 50% interest in MetLife Fubon and the resulting
consolidation of the operation, as well as business growth.
|
|
|
|
Chile by $94 million primarily due to higher annuity sales
resulting from a higher interest rate environment, improved
competitive conditions and an expected rate increase in 2008,
higher institutional premiums from its traditional and bank
distribution channels, as well as the decrease in 2006 resulting
from managements decision not to match aggressive pricing
in the marketplace.
|
|
|
|
South Korea by $90 million primarily due to higher fees
from growth in its guaranteed annuity business and variable
universal life business.
|
|
|
|
Brazil by $35 million primarily due to changes in foreign
currency exchange rates and business growth.
|
|
|
|
The Companys Japan operation by $31 million due to an
increase in reinsurance assumed.
|
|
|
|
Australia by $26 million as a result of growth in the
institutional and reinsurance in-force business, an increase in
retention levels and changes in the foreign currency exchange
rates.
|
|
|
|
Argentina by $21 million primarily due to an increase in
premiums and fees from higher pension contributions resulting
from higher participant salaries and a higher salary threshold
subject to fees and growth in bancassurance, partially offset by
the reduction of cost of insurance fees as a result of the new
pension system reform regulation.
|
|
|
|
Taiwan and India by $21 million and $11 million,
respectively, primarily due to business growth.
|
Partially offsetting these increases, premiums, fees and other
revenues decreased in:
|
|
|
|
|
The United Kingdom by $3 million due to an unearned premium
calculation refinement partially offset by changes in foreign
currency rates.
|
The remainder of the change in premiums, fees and other revenues
can be attributed to contributions from the other countries.
Net investment income increased by $298 million, or 31%, to
$1,247 million for the year ended December 31, 2007
from $949 million for 2006.
Net investment income increased in:
|
|
|
|
|
Chile by $148 million due to the impact of higher inflation
rates on indexed securities, the valuations and returns of which
are linked to inflation rates, higher joint venture income, as
well as an increase in invested assets.
|
|
|
|
Mexico by $46 million due to an increase in invested
assets, partially offset by a decrease in yields, exclusive of
inflation.
|
|
|
|
Hong Kong by $43 million primarily due to the acquisition
of the remaining 50% interest in MetLife Fubon and the resulting
consolidation of the operation.
|
|
|
|
Japan by $19 million due to an increase of $52 million
from hedging activities associated with Japans guaranteed
annuity, offset by a decrease of $33 million, net of income
tax, in the Companys investment in
|
128
|
|
|
|
|
Japan primarily due to an increase in the costs of guaranteed
annuity benefits and the impact of foreign currency transaction
losses, partially offset by business growth.
|
|
|
|
|
|
South Korea and Taiwan by $24 million and $6 million,
respectively, primarily due to increases in invested assets.
|
|
|
|
Brazil by $14 million primarily due to increases in
invested assets as well as changes in foreign currency exchange
rates.
|
|
|
|
Australia by $12 million due to changes in foreign currency
exchange rates, higher yields and increases in invested assets.
|
|
|
|
Ireland by $9 million due to an increase in invested assets
resulting from capital contributions.
|
|
|
|
India by $4 million due to an increase in invested assets,
as well as higher yields.
|
Partially offsetting these increases in net investment income
was a decrease in:
|
|
|
|
|
The home office of $25 million primarily due to an increase
in the amount charged for economic capital and investment
management expenses.
|
|
|
|
Argentina by $7 million primarily due to unfavorable
results in the trading portfolio, partially offset by higher
invested assets resulting from capital contributions in 2006.
Additionally, net investment income in 2006 did not decrease
correspondingly with the decrease in policyholder benefits and
claims discussed below because 2006 did not include interest-
and inflation-indexed assets to support such liabilities.
|
The remainder of the change in net investment income can be
attributed to contributions from the other countries.
Changes in foreign currency exchange rates accounted for a
$106 million increase in total revenues, excluding net
investment gains (losses).
Expenses
Total expenses increased by $340 million, or 8%, to
$4,567 million for the year ended December 31, 2007
from $4,227 million for 2006.
Policyholder benefits and claims, policyholder dividends and
interest credited to policyholder account balances increased by
$122 million, or 5%, to $2,818 million for the year
ended December 31, 2007 from $2,696 million for 2006.
Policyholder benefits and claims, policyholder dividends and
interest credited to policyholder account balances increased in:
|
|
|
|
|
Chile by $221 million primarily due to an increase in
inflation indexed policyholder liabilities as well as growth in
its annuity and institutional businesses.
|
|
|
|
Hong Kong by $119 million due to the acquisition of the
remaining 50% interest in MetLife Fubon and the resulting
consolidation of the operation.
|
|
|
|
Taiwan by $65 million primarily due to a decrease of
$14 million in 2006 from liability refinements associated
with the conversion to a new valuation system, as well as higher
policyholder liabilities related to loss recognition in the
fourth quarter of 2006 and growth in the business.
|
|
|
|
South Korea by $27 million primarily due to business growth
as well as changes in foreign currency exchange rates, partially
offset by a lower increase in claims liabilities resulting from
a change in the reinsurance allowance in 2006.
|
|
|
|
Australia by $23 million due to higher claims, an increase
in retention levels, business growth and changes in foreign
currency exchange rates.
|
129
|
|
|
|
|
India by $4 million due to higher claims and business
growth, partially offset by managements update of
assumptions used to determine estimated gross profits.
|
Partially offsetting these increases in policyholder benefits
and claims, policyholder dividends and interest credited to
policyholder account balances were decreases in:
|
|
|
|
|
Argentina by $250 million primarily due to the elimination
of liabilities for claims and premium deficiencies of
$208 million resulting from pension reform. Under the
reform plan, which is effective January 1, 2008, fund
administrators are no longer liable for new death and disability
claims of the plan participants. Also contributing is a decrease
in interest- and market-indexed policyholder liabilities and the
favorable impact of reductions in claim liabilities resulting
from experience reviews in both the current and prior years.
|
|
|
|
Mexico by $63 million, primarily due to a decrease in
certain policyholder liabilities of $117 million caused by
a decrease in the unrealized investment results on the invested
assets supporting those liabilities relative to 2006 and a
reduction in claim liabilities resulting from experience
reviews, offset by an increase of $10 million due to a
decrease in 2006 of policyholder benefits associated with a
large group policy that was not renewed by the policyholder, an
increase of $6 million due to a benefit in 2006 from the
elimination of liabilities for pending claims that were
determined to be invalid following a review, as well as business
growth.
|
|
|
|
Brazil of $13 million primarily due to the impact in 2006
of increases in policyholder liabilities from higher than
expected mortality on specific blocks of business, partially
offset by changes in foreign currency exchange rates.
|
|
|
|
The United Kingdom by $8 million, due to a reduction of
claim liabilities based on a review of experience.
|
Decreases in other countries accounted for the remainder of the
change.
Other expenses increased by $218 million, or 14%, to
$1,749 million for the year ended December 31, 2007
from $1,531 million for 2006.
Other expenses increased in:
|
|
|
|
|
Argentina by $153 million, primarily due to a liability of
$128 million for servicing obligations that was established
as a result of pension reform. Under the reform plan, which is
effective January 1, 2008, the Company retains the
obligation for administering certain existing and future
participants accounts for which they receive no revenue.
Also contributing is an increase in commissions on bancassurance
business, an increase in retention incentives related to pension
reform, the impact of managements update of DAC
assumptions as a result of pension reform and growth, partially
offset by a lower increase in liabilities due to inflation and
exchange rate indexing.
|
|
|
|
South Korea by $92 million, primarily due to the favorable
impact in 2006 of $60 million in DAC amortization
associated with the implementation of a more refined reserve
valuation system and additional expenses in 2007 associated with
growth and infrastructure initiatives, as well as business
growth and higher bank insurance fees, partially offset by a
decrease in DAC amortization related to market performance.
|
|
|
|
Mexico by $27 million primarily due to higher expenses
related to business growth and the favorable impact in 2006 of
liabilities related to employment matters that were reduced,
offset by a decrease in DAC amortization resulting from
managements update of assumptions used to determine
estimated gross profits in both the current and prior years, and
a decrease in liabilities based on a review of outstanding
remittances.
|
|
|
|
India by $14 million primarily due to headcount increases
and growth initiatives, partially offset by the impact of
managements update of assumptions used to determine
estimated gross profits.
|
|
|
|
Australia by $12 million primarily due to business growth
and changes in foreign currency exchange rates.
|
|
|
|
Chile by $12 million primarily due to higher compensation
costs, higher spending on infrastructure and marketing programs
and growth, partially offset by a decrease in DAC amortization
related to inflation indexing.
|
130
|
|
|
|
|
Hong Kong by $11 million due to the acquisition of the
remaining 50% interest in MetLife Fubon and the resulting
consolidation of the operation.
|
|
|
|
Ireland by $10 million due to additional
start-up
costs, as well as $5 million of foreign currency
transaction losses.
|
|
|
|
Brazil by $9 million primarily due to changes in foreign
currency exchange rates, partially offset by an increase in
litigation liabilities in 2006.
|
|
|
|
The United Kingdom by $2 million due to changes in foreign
currency rates and higher spending on business initiatives,
partially offset by lower DAC amortization resulting from
calculation refinements.
|
Partially offsetting these increases in other expenses were
decreases in:
|
|
|
|
|
Taiwan by $118 million primarily due to a one-time increase
in DAC amortization in 2006 of $77 million due to a loss
recognition adjustment resulting from low interest rates
relative to product guarantees coupled with high persistency
rates on certain blocks of business, an increase in DAC
amortization in 2006 associated with the implementation of a new
valuation system, expenses of $17 million in 2006 related
the termination of the agency distribution channel and expense
reductions recognized in 2007 due to elimination of the agency
distribution channel.
|
|
|
|
The home office of $4 million primarily due to the
elimination of certain intercompany expenses previously charged
to the International Segment, offset by higher spending on
growth and infrastructure initiatives.
|
Decreases in other countries accounted for the remainder of the
change.
Changes in foreign currency exchange rates accounted for a
$105 million increase in total expenses.
Auto &
Home
The following table presents consolidated financial information
for the Auto & Home segment for the years indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
2,971
|
|
|
$
|
2,966
|
|
|
$
|
2,924
|
|
Net investment income
|
|
|
186
|
|
|
|
196
|
|
|
|
177
|
|
Other revenues
|
|
|
38
|
|
|
|
43
|
|
|
|
22
|
|
Net investment gains (losses)
|
|
|
(135
|
)
|
|
|
15
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
3,060
|
|
|
|
3,220
|
|
|
|
3,126
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims
|
|
|
1,919
|
|
|
|
1,807
|
|
|
|
1,717
|
|
Policyholder dividends
|
|
|
5
|
|
|
|
4
|
|
|
|
5
|
|
Other expenses
|
|
|
804
|
|
|
|
829
|
|
|
|
846
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
2,728
|
|
|
|
2,640
|
|
|
|
2,568
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before provision for income tax
|
|
|
332
|
|
|
|
580
|
|
|
|
558
|
|
Provision for income tax
|
|
|
57
|
|
|
|
144
|
|
|
|
142
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
275
|
|
|
$
|
436
|
|
|
$
|
416
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
131
Year
Ended December 31, 2008 compared with the Year Ended
December 31, 2007 Auto &
Home
Net
Income
Net income decreased by $161 million, or 37%, to
$275 million for the year ended December 31, 2008 from
$436 million for the comparable 2007 period.
The decrease in net income was primarily attributable to an
increase in net investment losses of $98 million, net of
income tax, and an increase in policyholder benefits and claims
of $75 million, net of income tax.
The increase in net investment losses is due to an increase in
losses on fixed maturity and equity securities. The increase in
losses on fixed maturity and equity securities is primarily
attributable to an increase in impairments associated with
financial services industry holdings which experienced losses as
a result of bankruptcies, FDIC receivership, and federal
government assisted capital market infusion transactions in the
third and fourth quarters of 2008, as well as other credit
related impairments or losses on fixed maturity and equity
securities where the Company did not intend to hold securities
until recovery in conjunction with overall market declines
occurring throughout the year.
The increase in policyholder benefits and claims of
$75 million, net of income tax, was comprised primarily of
an increase of $134 million, net of income tax, in
catastrophe losses resulting from severe thunderstorms and
tornadoes in the Midwestern and Southern states in the second
quarter of the current year and hurricanes Ike, Gustav and Hanna
in the third quarter of the current year, offset by
$20 million, net of income tax, of additional favorable
development of prior years catastrophe losses and loss
adjustment expenses, primarily from hurricane Katrina. A
decrease in non-catastrophe policyholder benefits and claims
improved net income by $39 million, net of income tax,
resulting from $51 million, net of income tax, of lower
losses due to lower severity in the auto line of business and
$8 million, net of income tax, of additional favorable
development of prior year non-catastrophe losses and
$8 million, net of income tax, in unallocated loss
adjustment expenses, primarily from lower employee costs, offset
by an increase of $23 million, net of income tax, from
higher non-catastrophe claim frequencies primarily in the
homeowners line of business and a $5 million, net of income
tax, increase related to higher earned exposures.
Offsetting this decrease in net income was an increase in
premiums of $3 million, net of income tax, comprised of an
increase of $11 million, net of income tax, related to
increased exposures and an increase of $16 million, net of
income tax, from a decrease in catastrophe reinsurance costs.
Offsetting these increases in premiums was a decrease of
$20 million, net of income tax, related to a reduction in
average earned premium per policy and a decrease of
$4 million, net of income tax, in premiums from various
involuntary programs.
In addition, net investment income decreased by $6 million,
net of income tax, primarily due to a smaller asset base.
Also impacting net income was a decrease of $16 million,
net of income tax, in other expenses and a decrease of
$3 million, net of income tax, in other revenues.
Income taxes contributed $2 million to net income over the
expected amount primarily due to favorable resolution of a prior
year audit. A greater proportion of tax advantaged investment
income resulted in a decline in the segments effective tax
rate.
Revenues
Total revenues, excluding net investment gains (losses),
decreased by $10 million, or 0.3%, to $3,195 million
for the year ended December 31, 2008 from
$3,205 million for the comparable 2007 period.
Premiums increased by $5 million due to an increase of
$14 million related to increased exposures and a decrease
of $25 million in catastrophe reinsurance costs. These
increases in premiums were offset by a decrease of
$28 million related to a reduction in average earned
premium per policy and a decrease of $6 million in premiums
primarily from various involuntary programs.
Net investment income decreased by $10 million primarily
due to a smaller asset base. Other revenues decreased
$5 million primarily related to slower than anticipated
claims payments resulting in slower recognition of deferred
income in 2008 related to a reinsurance contract as compared to
2007 and less income from COLI.
132
Expenses
Total expenses increased by $88 million, or 3%, to
$2,728 million for the year ended December 31, 2008
from $2,640 million for the comparable 2007 period.
Policyholder benefits and claims increased by $112 million
due to an increase of $202 million in catastrophe losses
primarily resulting from severe thunderstorms and tornadoes in
the Midwestern and Southern states in the second quarter of the
current year and hurricanes Ike, Gustav and Hanna in the third
quarter of the current year, offset by $31 million of
additional favorable development of prior years
catastrophe losses and adjusting expenses, primarily from
hurricane Katrina. Non-catastrophe policyholder benefits and
claims decreased $59 million resulting from
$79 million of lower losses due to lower severities,
primarily in the auto line of business, $11 million of
additional favorable development of prior year losses and a
$12 million decrease in unallocated loss adjustment
expenses primarily from lower employee costs, offset by an
increase of $34 million from higher non-catastrophe claim
frequencies, primarily in the homeowners line of business and a
$9 million increase related to earned exposures.
Other expenses decreased by $25 million resulting mainly
from a $21 million decrease in commissions, a
$3 million decrease in surveys and underwriting reports and
a $5 million decrease in other sales related expenses,
offset by a $13 million change in deferred acquisition
costs, all due to a decrease in policy activity, a decrease of
$4 million related to a 2007 charge for structured
settlements and a $5 million decrease from other minor
fluctuations in a number of expense categories. Policyholder
dividends increased by $1 million.
Underwriting results, including catastrophes, in the
Auto & Home segment were unfavorable for the year
ended December 31, 2008 than as compared to the 2007
period, as the combined ratio, including catastrophes, increased
to 91.2% from 88.4% for the year ended December 31, 2007.
Underwriting results, excluding catastrophes, in the
Auto & Home segment were favorable for the year ended
December 31, 2008, as the combined ratio, excluding
catastrophes, decreased to 83.1% from 86.3% for the year ended
December 31, 2007.
Year
Ended December 31, 2007 compared with the Year Ended
December 31, 2006 Auto &
Home
Net
Income
Net income increased by $20 million, or 5%, to
$436 million for the year ended December 31, 2007 from
$416 million for the comparable 2006 period.
The increase in net income was primarily attributable to an
increase in premiums of $28 million, net of income tax. The
increase in premiums was principally due to an increase of
$38 million, net of income tax, related to increased
exposures, an increase of $4 million, net of income tax,
from various voluntary and involuntary programs and an increase
of $4 million, net of income tax, resulting from the change
in estimate on auto rate refunds due to a regulatory
examination. Offsetting these increases was a $14 million,
net of income tax, decrease related to a reduction in average
earned premium per policy and an increase in catastrophe
reinsurance costs of $4 million, net of income tax.
In addition, net investment income increased by
$12 million, net of income tax, due primarily to a
realignment of economic capital and an increase in net
investment income from higher yields, somewhat offset by a lower
asset base. Net investment gains (losses) increased by
$8 million, net of income tax, for the year ended
December 31, 2007 as compared to 2006.
In addition, other revenues increased by $14 million, net
of income tax, due primarily to slower than anticipated claims
payments in 2006 resulting in slower recognition of deferred
income in 2006 related to a reinsurance contract as compared to
2007.
Negatively impacting net income were additional policyholder
benefits and claims of $59 million, net of income tax,
primarily due to $39 million, $20 million, and
$16 million, all net of income tax, of losses related to
higher claim frequencies, higher earned exposures and higher
losses due to severity, respectively. In addition, a
$13 million increase, net of income tax, in unallocated
claims adjusting expenses and an increase of $12 million,
net of income tax, from a reduction in favorable development of
2006 losses negatively impacted net income. Offsetting
133
these increases was a $41 million, net of income tax,
decrease in catastrophe losses, which included favorable
development of 2006 catastrophe liabilities of $10 million,
net of income tax.
In addition, there was a decrease of $1 million, net of
income tax, in policyholder dividends that positively impacted
net income.
Also favorably impacting net income was a reduction of
$11 million, net of income tax, in other expenses related
to lower information technology and advertising costs.
Revenues
Total revenues, excluding net investment gains (losses),
increased by $82 million, or 3%, to $3,205 million for
the year ended December 31, 2007 from $3,123 million
for the comparable 2006 period.
Premiums increased by $42 million due principally to a
$59 million increase in premiums related to increased
exposures, an increase of $5 million from various voluntary
and involuntary programs and an increase in premiums of
$5 million, resulting from the change in estimate on auto
rate refunds due to a regulatory examination. Offsetting these
increases was a $21 million decrease related to a reduction
in average earned premium per policy and an increase in
catastrophe reinsurance costs of $6 million.
Net investment income increased by $19 million due to a
realignment of economic capital and an increase in net
investment income from higher yields, somewhat offset by a lower
asset base.
In addition, other revenues increased $21 million due
primarily to slower than anticipated claims payments resulting
in slower recognition of deferred income in 2006 related to a
reinsurance contract as compared to 2007.
Expenses
Total expenses increased by $72 million, or 3%, to
$2,640 million for the year ended December 31, 2007
from $2,568 million for the comparable 2006 period.
Policyholder benefits and claims increased by $90 million
which was primarily due to an increase of $59 million from
higher claim frequencies, as a result of a return to normal
weather patterns in 2007 compared to the milder weather in 2006
across the majority of the country, and a $25 million and
$30 million increase in losses related to higher severity
and higher earned exposures, respectively. In addition, an
increase of $20 million in unallocated loss adjustment
expenses, primarily resulting from an increase in claims-related
information technology costs, and a $19 million decrease in
favorable development of 2006 losses, representing
$148 million of favorable development for 2007 as compared
to $167 million for the 2006 period, increased policyholder
benefits and claims. Offsetting these increases in losses was a
decrease of $63 million in catastrophe losses, which
includes $15 million of favorable loss development from
2006 catastrophes.
Policyholder dividends decreased by $1 million in 2007 as
compared to 2006.
Other expenses decreased by $17 million primarily related
to lower information technology and advertising costs, partially
offset by minor changes in a variety of expense categories.
Underwriting results, excluding catastrophes, in the
Auto & Home segment were favorable for the year ended
December 31, 2007, although lower than the comparable
period of 2006, as the combined ratio, excluding catastrophes,
increased to 86.3% from 82.8% for the year ended
December 31, 2006.
134
Corporate &
Other
The following table presents consolidated financial information
for Corporate & Other for the years indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
28
|
|
|
$
|
35
|
|
|
$
|
37
|
|
Net investment income
|
|
|
817
|
|
|
|
1,419
|
|
|
|
998
|
|
Other revenues
|
|
|
184
|
|
|
|
72
|
|
|
|
43
|
|
Net investment gains (losses)
|
|
|
947
|
|
|
|
45
|
|
|
|
(154
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
1,976
|
|
|
|
1,571
|
|
|
|
924
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims
|
|
|
48
|
|
|
|
46
|
|
|
|
38
|
|
Interest credited to policyholder account balances
|
|
|
7
|
|
|
|
|
|
|
|
|
|
Other expenses
|
|
|
1,898
|
|
|
|
1,409
|
|
|
|
1,362
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
1,953
|
|
|
|
1,455
|
|
|
|
1,400
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations before provision
(benefit) for income tax
|
|
|
23
|
|
|
|
116
|
|
|
|
(476
|
)
|
Provision for income tax
|
|
|
(143
|
)
|
|
|
(129
|
)
|
|
|
(437
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations
|
|
|
166
|
|
|
|
245
|
|
|
|
(39
|
)
|
Income (loss) from discontinued operations, net of income tax
|
|
|
(293
|
)
|
|
|
195
|
|
|
|
3,285
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
(127
|
)
|
|
|
440
|
|
|
|
3,246
|
|
Preferred stock dividends
|
|
|
125
|
|
|
|
137
|
|
|
|
134
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to common shareholders
|
|
$
|
(252
|
)
|
|
$
|
303
|
|
|
$
|
3,112
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year
Ended December 31, 2008 compared with the Year Ended
December 31, 2007 Corporate &
Other
Income
from Continuing Operations
Income from continuing operations decreased by $79 million,
or 32%, to $166 million for the year ended
December 31, 2008 from $245 million for the prior year.
Included in this decrease in income from continuing operations
is an increase in net investment gains of $586 million, net
of income tax. The increase in net investment gains arises
principally from the elimination of $993 million, net of
income tax, of net investment losses arising from the transfer
of fixed maturity securities between segments. This was
partially offset by increased losses of $263 million, net
of income tax, primarily due to net investment losses on fixed
maturity securities and derivatives, and, to a much lesser
degree, losses on equity securities, mortgage and consumer
loans, and other limited partnership interests which are
partially offset by foreign currency transaction gains
originating within Corporate & Other. The fixed
maturity and equity security losses include losses on sales of
securities and impairments associated with financial services
industry holdings which experienced losses as a result of
bankruptcies, FDIC receivership, and federal government assisted
capital infusion transactions in the third and fourth quarters
of 2008, as well as other credit related impairments or losses
on fixed maturity or equity securities where the Company did not
intend to hold the securities until recovery in conjunction with
overall market declines occurring throughout the year. The
derivative losses were primarily driven by foreign currency
swaps caused by unfavorable interest rate and foreign exchange
movements. The derivative losses were partially offset by
foreign currency transaction gains associated with foreign
denominated long-term debt.
Excluding the impact of net investment gains (losses), income
from continuing operations decreased by $665 million,
compared to the prior year.
135
The decrease in income from continuing operations excluding net
investment gains (losses) was primarily attributable to lower
net investment income, higher corporate expenses, higher
interest expense, higher legal costs and higher interest
credited to policyholder account balances of $391 million
$216 million, $104 million, $46 million and
$5 million, respectively, each of which were net of income
tax. This decrease was partially offset by higher other
revenues, lower interest on uncertain tax positions, and lower
interest credited to bankholder deposits of $73 million,
$27 million and $21 million, respectively, each of
which were net of income tax. Tax benefits decreased by
$17 million over the prior year primarily due to a
$16 million recognition of a deferred tax liability related
to the RGA split-off and $1 million decrease from the
difference of finalizing the Companys 2007 tax return in
2008 when compared to finalizing the Companys 2006 tax
return in 2007 and the actual and the estimated tax rate
allocated to the various segments.
Revenues
Total revenues, excluding net investment gains (losses),
decreased by $497 million, or 33%, to $1,029 million
for the year ended December 31, 2008 from
$1,526 million for the prior year.
This decrease was primarily due to a decrease in net investment
income excluding MetLife Bank of $644 million, mainly due
to reduced yields on other limited partnership interests
including hedge funds and real estate and real estate joint
ventures partially offset by higher securities lending results.
This decrease in yields was partially offset by a higher asset
base related to the investment of proceeds from issuances of
junior subordinated debt in December 2007 and April 2008,
collateral financing arrangements to support statutory reserves
in May 2007 and December 2007, common stock in October 2008, and
funding agreements with FHLB of NY in November 2008 partially
offset by repurchases of outstanding common stock, the
prepayment of shares subject to mandatory redemption in October
2007 and the reduction of commercial paper outstanding. A
fractional repositioning of the portfolio from short-term
investments resulted in higher leveraged lease income. Net
investment income on MetLife Bank increased $42 million
from higher asset base and mortgage loan production primarily
from acquisitions in 2008. Other revenues increased
$112 million primarily related to MetLife Bank loan
origination and servicing fees of $126 million from
acquisitions in 2008, an adjustment in the prior year of
surrender values on COLI policies of $13 million, and
income from counterparties on collateral pledged in 2008 of
$6 million, partially offset by $37 million lower
revenue from a prior year resolution of an indemnification claim
associated with the 2000 acquisition of GALIC. Also included as
a component of total revenues was the elimination of
intersegment amounts which was offset within total expenses.
Expenses
Total expenses increased by $498 million, or 34%, to
$1,953 million for the year ended December 31, 2008
from $1,455 million for the prior year.
Corporate expenses were higher by $333 million primarily
due to higher MetLife Bank costs of $164 million for
compensation, rent, and mortgage loan origination and servicing
expenses primarily related to acquisitions in 2008, higher post
employment related costs of $101 million in the current
year associated with the implementation of an enterprise-wide
cost reduction and revenue enhancement initiative, higher
corporate support expenses of $72 million, which included
incentive compensation, rent, advertising, and information
technology costs. Corporate expenses also increased from lease
impairments of $38 million for company use space that is
currently vacant, and higher costs from MetLife Foundation
contributions of $18 million, partially offset by a
reduction in deferred compensation expenses of $60 million.
Interest expense was higher by $158 million due to the
issuances of junior subordinated debt in December 2007 and April
2008 and collateral financing arrangements in May 2007 and
December 2007, partially offset by rate reductions on variable
rate collateral financing arrangements in 2008, the prepayment
of shares subject to mandatory redemption in October 2007 and
the reduction of commercial paper outstanding. Legal costs were
higher by $72 million primarily due to asbestos insurance
costs of $38 million, which included $35 million for
the commutation of three asbestos-related excess insurance
policies and $3 million for amortization and valuation of
those policies prior to the commutation, $29 million higher
for decreases in prior year legal liabilities partially offset
by current year decreases resulting from the resolution of
certain matters, and an increase in other legal fees of
$5 million. Interest credited to policyholder account
balances was $7 million in the current year as a result of
issuance of funding agreements with FHLB of NY in November
136
2008. Interest on uncertain tax positions was lower by
$41 million as a result of a settlement payment to the IRS
in December 2007 and a decrease in published IRS interest rates.
Interest credited on bankholder deposits decreased by
$33 million at MetLife Bank due to lower interest rates,
partially offset by higher bankholder deposits. Also included as
a component of total expenses was the elimination of
intersegment amounts which were offset within total revenues.
Year
Ended December 31, 2007 compared with the Year Ended
December 31, 2006 Corporate &
Other
Income
from Continuing Operations
Income from continuing operations increased by
$284 million, to a gain of $245 million for the year
ended December 31, 2007 from a loss of $39 million for
2006. Included in this increase were lower net investment losses
of $129 million, net of income tax. Excluding the impact of
net investment gains (losses), income from continuing operations
increased by $155 million.
The increase in income from continuing operations was primarily
attributable to higher net investment income, lower corporate
expenses, higher other revenues, integration costs incurred in
2006, and lower legal cost of $274 million,
$59 million, $19 million, $17 million, and
$7 million, respectively, each of which were net of income
tax. This was partially offset by higher interest expense on
debt, higher interest on uncertain tax positions, and higher
interest credited to bankholder deposits of $86 million,
$23 million, and $3 million respectively, each of
which were net of income tax. Tax benefits decreased by
$102 million over the comparable period in 2006 due to the
Companys implementation of FIN 48, the difference of
finalizing the Companys 2006 tax return in 2007 when
compared to finalizing the Companys 2005 tax return in
2006 and the difference between the actual and the estimated tax
rate allocated to the various segments.
Revenues
Total revenues, excluding net investment gains (losses),
increased by $448 million, or 42%, to $1,526 million
for the year ended December 31, 2007 from
$1,078 million for 2006. This increase was primarily due to
increased net investment income of $421 million, mainly on
fixed maturity securities, driven by a higher asset base related
to the reinvestment of proceeds from the sale of the Peter
Cooper Village and Stuyvesant Town properties during the fourth
quarter of 2006 and the investment of proceeds from issuances of
junior subordinated debt in December 2006 and December 2007 and
collateral financing arrangements to support statutory reserves
in May 2007 and December 2007. Net investment income also
increased on other limited partnerships, real estate and real
estate joint ventures, and mortgage loans. Other revenues
increased by $29 million primarily related to the
resolution of an indemnification claim associated with the 2000
acquisition of GALIC, offset by an adjustment of surrender
values on COLI policies. Also included as a component of total
revenues was the elimination of intersegment amounts which was
offset within total expenses.
Expenses
Total expenses increased by $55 million, or 4%, to
$1,455 million for the year ended December 31, 2007
from $1,400 million for 2006. Interest expense was higher
by $133 million due to the issuances of junior subordinated
debt in December 2006 and December 2007 and collateral financing
arrangements in May 2007 and December 2007, respectively, and
from settlement fees on the prepayment of shares subject to
mandatory redemption in October 2007, partially offset by the
maturity of senior notes in December 2006 and the reduction of
commercial paper outstanding. Interest on uncertain tax
positions was higher by $35 million as a result of an
increase in published Internal Revenue Service interest rates
and a change in the method of estimating interest expense on tax
contingencies associated with the Companys implementation
of FIN 48. As a result of higher interest rates, interest
credited on bank deposits increased by $5 million at
MetLife Bank. Corporate expenses are lower by $90 million
primarily due to lower corporate support expenses of
$67 million, which included advertising,
start-up
costs for new products and information technology costs, and
lower costs from reductions of MetLife Foundation contributions
of $23 million. Integration costs incurred in prior year
were $25 million. Legal costs were lower by
$11 million primarily due to a reduction in 2007 of
$35 million of legal liabilities resulting from the
settlement of certain cases; lower other legal costs of
$3 million partially offset by higher amortization and
valuation of an asbestos insurance
137
recoverable of $27 million. Also included as a component of
total expenses was the elimination of intersegment amounts which
were offset within total revenues.
Liquidity
and Capital Resources
Extraordinary
Market Conditions
Since mid-September 2008, the global financial markets have
experienced unprecedented disruption, adversely affecting the
business environment in general, as well as financial services
companies in particular. The U.S. Government, as well as
governments in many foreign markets in which the Company
operates, have responded to address market imbalances and taken
meaningful steps intended to eventually restore market
confidence. Continuing adverse financial market conditions could
significantly affect the Companys ability to meet
liquidity needs and obtain capital.
Liquidity Management. Based upon the strength
of its franchise, diversification of its businesses and strong
financial fundamentals, management believes that the Company has
ample liquidity and capital resources to meet business
requirements under current market conditions.
Processes for monitoring and managing liquidity risk, including
liquidity stress models, have been enhanced to take into account
the extraordinary market conditions, including the impact on
policyholder and counterparty behavior, the ability to sell
various investment assets and the ability to raise incremental
funding from various sources. Management has taken steps to
strengthen liquidity in light of its assessment of the impact of
market conditions and will continue to monitor the situation
closely. Asset/Liability Management (ALM) needs and
opportunities are also being evaluated and managed in light of
market conditions and, where appropriate, ALM strategies are
adjusted to achieve management goals and objectives. The
Companys short-term liquidity position (cash and cash
equivalents and short term investments, excluding cash
collateral received under the Companys securities lending
program and in connection with derivative instruments that has
been reinvested in cash, cash equivalents, short-term
investments and publicly-traded securities) was
$26.7 billion and $10.9 billion at December 31,
2008 and 2007, respectively. This higher than normal level of
short-term liquidity was accumulated to provide additional
flexibility to address potential variations in cash needs while
credit market conditions remained distressed. In 2009, we
anticipate short-term liquidity will be brought down in a
prudent manner and invested according to the Companys ALM
discipline in appropriate assets over time. There may be
potential implications for earnings if the reinvestment process
occurs over an extended period of time due to challenging market
conditions or asset availability. The asset portfolio will
continue to be defensively positioned in 2009 with an emphasis
on higher credit quality, more liquid asset types. However,
considering the continued, somewhat uncertain credit market
conditions, management plans to continue to maintain a slightly
higher than normal level of short-term liquidity.
During this extraordinary market environment, management is
continuously monitoring and adjusting its liquidity and capital
plans for the Holding Company and its subsidiaries in light of
changing needs and opportunities. The dislocation in the credit
markets has limited the access of financial institutions to
long-term debt and hybrid capital. While, in general, yields on
benchmark U.S. Treasury securities were historically low
during 2008, related spreads on debt instruments, in general,
and those of financial institutions, specifically, were as high
as they have been in MetLifes history as a public company.
Liquidity Needs of the Insurance
Business. With respect to the Companys
insurance businesses, Individual and Institutional segments tend
to behave differently under these extraordinary market
conditions. In the Companys Individual segment, which
includes individual life and annuity products, lapses and
surrenders occur in the normal course of business in many
product areas. These lapses and surrenders have not deviated
materially from management expectations during the financial
crisis. For both fixed and variable annuities, net flows were
positive and lapse rates declined.
Within the Institutional segment, the retirement &
savings business consists of general account values of
$101 billion at December 31, 2008. Approximately,
$97 billion of that amount is comprised of pension
closeouts, other fixed annuity contracts without surrender or
withdrawal options, as well as global GICs that have stated
maturities and cannot be put back to the Company prior to
maturity. As a result, the surrenders or withdrawals are
138
fairly predictable and even during this difficult environment
they have not deviated materially from management expectations.
With regard to Institutionals retirement &
savings liabilities where customers have limited liquidity
rights at December 31, 2008, there were $3 billion of
funding agreements that could be put back to the Company after a
period of notice. While the notice requirements vary, the
shortest is 90 days, and that applies to only
$1 billion of these liabilities. The remainder of the
notice periods are between 6 and 13 months, so even on the
small portion of the portfolio where there is ability to
accelerate withdrawal, the exposure is relatively limited. With
respect to credit ratings downgrade triggers that permit early
termination, less than $1 billion of the
retirement & savings liabilities were subject to such
triggers. In addition, such early terminations payments are
subject to 90 day prior notice. Management controls the
liquidity exposure that can arise from these various product
features.
Securities Lending. The Companys
securities lending business has been affected by the
extraordinary market environment. In this activity, blocks of
securities, which are included in fixed maturity and short-term
investments, are loaned to third parties, primarily major
brokerage firms and commercial banks. The Company generally
requires a minimum of 102% of the current estimated fair value
of the loaned securities to be obtained at inception of a loan,
and maintained at a level greater than or equal to 100% for
duration of the loan. During the extraordinary market events
occurring in the fourth quarter of 2008, the Company, in limited
instances, accepted collateral less than 102% at the inception
of certain loans, but never less than 100%, of the market value
of loaned such loaned securities. These loans involved
U.S. Treasury bills, which are considered to have limited
variation in their market value during the term of the loan.
Securities with a cost or amortized cost of $20.8 billion
and $41.1 billion and an estimated fair value of
$22.9 billion and $42.1 billion were on loan under the
program at December 31, 2008 and 2007, respectively.
Securities loaned under such transactions may be sold or
repledged by the transferee. The Company was liable for cash
collateral under its control of $23.3 billion and
$43.3 billion at December 31, 2008 and 2007,
respectively. Of this $23.3 billion of cash collateral at
December 31, 2008, $5.1 billion was on open terms,
meaning that the related loaned security could be returned to
the Company on the next business day requiring return of cash
collateral and $14.7 billion and $3.5 billion are due
within 30 days and 60 days, respectively. The
estimated fair value of the securities related to the cash
collateral on open at December 31, 2008 has been reduced to
$5.0 billion from $15.8 billion at November 30,
2008. Of the $5.0 billion of estimated fair value of the
securities related to the cash collateral on open at
December 31, 2008, $4.4 billion were
U.S. Treasury and agency securities which, if put to the
Company, could be immediately sold to satisfy the cash
requirements. The remainder of the securities on loan are
primarily U.S. Treasury and agency securities and very
liquid residential mortgage-backed securities. The
U.S. Treasury securities on loan were primarily holdings of
on-the-run
U.S. Treasury securities, the most liquid
U.S. Treasury securities available. If these high quality
securities that were on loan were put back to the Company, the
proceeds from immediately selling these securities could be used
to satisfy the related cash requirements. The estimated fair
value of the reinvestment portfolio acquired with the cash
collateral was $19.5 billion at December 31, 2008, and
consisted principally of fixed maturity securities (including
residential mortgage-backed, asset-backed, U.S. corporate
and foreign corporate securities). If the on loan securities or
the reinvestment portfolio were to become less liquid, the
Company has the liquidity resources of most of its general
account available to meet any potential cash demand when
securities are put back to the Company. Based upon present
market conditions, management anticipates the securities lending
programs will be maintained in the $18 to $25 billion
range. This estimate has been factored into the Companys
liquidity and investment plans. Management plans to continue to
lend securities and believes it has appropriate policies and
guidelines in place to manage this activity at a reduced level
through this extraordinary business environment. See
Investments Securities
Lending.
Internal Asset Transfers. MetLife employs an
internal asset transfer process that allows for the sale of
securities among the business portfolio segments for the
purposes of efficient asset/liability matching. The execution of
the internally transferred assets is permitted when mutually
beneficial to both business segments. The asset is transferred
at estimated fair market value with corresponding gains (losses)
being eliminated in Corporate & Other.
During the fourth quarter of 2008, at a time of severe market
disruption, internal asset transfers were utilized extensively
to preserve economic value for MetLife by transferring assets
across business segments instead of selling them to external
parties at depressed market prices. Securities with an estimated
fair value of $11.3 billion
139
were transferred across business segments in the fourth quarter
of 2008 generating $1.4 billion in net investment losses,
principally within Individual and Institutional, with the offset
in Corporate & Others net investment gains
(losses).
Collateral. The Company does not operate a
financial guarantee or financial products business with
exposures in derivative products that could give rise to
extremely large collateral calls. The Company is a net receiver
of collateral from counterparties under the Companys
current derivative transactions. With respect to derivative
transactions with credit ratings downgrade triggers, a two notch
downgrade would impact the Companys derivative collateral
requirements by less than $200 million at December 31,
2008. As a result, the Company does not have significant
exposure to any credit ratings dependent liquidity factors
resulting from current derivatives positions.
Holding Company. The Holding Company relies
principally on dividends from its subsidiaries to meet its cash
requirements. None of the Holding Company long-term debt is due
before 2011, so there is no near-term roll-over risk. The
Holding Companys commercial paper program, which amounts
to $300 million at December 31, 2008, is kept active
but is not used to fund on-going operating business
requirements. In addition to its other fixed obligations, the
Holding Company has and may be required to pledge further
collateral under collateral support agreements if the estimated
fair value of the related derivatives
and/or
collateral financing arrangements declines. The Holding Company
holds significant liquid assets of $2.7 billion at
December 31, 2008. At December 31, 2008, the Holding
Company had pledged $820 million of liquid assets under
collateral support agreements. See
Investments Assets on Deposit,
Held in Trust and Pledged as Collateral.
Government Programs. The Company is
participating in certain economic stabilization programs
established by various government institutions as described
under The Company Liquidity and Capital
Resources.
Capital. This shift resulted in a relative
increase in the cost of new debt capital and new credit. For
example, in August 2008, MetLife remarketed senior unsecured
debt with a ten-year maturity at a 6.817% coupon. At
December 31, 2008, the average coupon on ten-year senior
unsecured debt of the Holding Company, excluding the debt
remarketed in August 2008, is 5.40%, or 1.40% less than that of
the debt remarketed in August 2008.
MetLife has no floating rate debt, other than that of the
collateral financing arrangements of $5.2 billion which
float based upon
3-month
LIBOR and the proceeds of which are invested in floating rate
assets, and has issued $600 million in a single series of
LIBOR-based preferred stock with a 4% floor. This series
represents a small portion of MetLifes fixed charges. At
current levels, LIBOR would have to increase by 180 basis
points (over 145% increase) to have any impact on the dividend
for these preferred securities.
MetLife amended and restated certain of its credit agreements in
December 2008. These changes included increases in pricing for
these agreements compared to the original rates.
In February 2009, the Holding Company closed the successful
remarketing of the Series B portion of the junior
subordinated debentures underlying the common equity units. The
Series B junior subordinated debentures were modified as
permitted by their terms to be 7.717% senior debt securities,
Series B, due February 15, 2019. See
Subsequent Events. This issuance
reflects a moderate increase in the Companys cost of
borrowing.
As discussed above, market values experienced significant
volatility during the third and fourth quarters of 2008. This
market disruption impacted unrealized gains and losses, which
are included in accumulated other comprehensive income (loss).
To strengthen our capital position and increase our cushion
against potential realized and unrealized losses in October
2008, the Company issued common stock for gross proceeds of
$2.3 billion to be used for general corporate purposes and
potential strategic initiatives.
MetLife has no current plans to raise additional capital.
140
The
Company
Capital
Capital and liquidity represent the financial strength of the
Company and reflect its ability to generate strong cash flows at
the operating companies, borrow funds at competitive rates and
raise additional capital to meet operating and growth needs. To
strengthen its capital position, in October 2008, the Company
issued $2.3 billion of common stock. The Companys
capital structure is managed to maintain a AA
financial strength ratings target.
Statutory Capital and Dividends. Our insurance
subsidiaries have statutory surplus and RBC levels well above
levels to meet current regulatory requirements and levels needed
to support the business risk at an AA financial
strength rating.
RBC requirements are used as minimum capital requirements by the
National Association of Insurance Commissioners
(NAIC) and the state insurance departments to
identify companies that merit further regulatory action. RBC is
based on a formula calculated by applying factors to various
asset, premium and statutory reserve items. The formula takes
into account the risk characteristics of the insurer, including
asset risk, insurance risk, interest rate risk and business risk
and is calculated on an annual basis. The formula is used as an
early warning regulatory tool to identify possible inadequately
capitalized insurers for purposes of initiating regulatory
action, and not as a means to rank insurers generally. These
rules apply to each of the Holding Companys domestic
insurance subsidiaries. State insurance laws provide insurance
regulators the authority to require various actions by, or take
various actions against, insurers whose total adjusted capital
does not exceed certain RBC levels. At the date of the most
recent annual statutory financial statements filed with
insurance regulators, the total adjusted capital of each of
these subsidiaries was in excess of each of those RBC levels.
The amount of dividends that our insurance subsidiaries can pay
to MetLife, Inc. or other parent entities is constrained by the
amount of surplus we hold to maintain our ratings, and to
provide an additional margin for risk protection and for future
investment in our businesses. We proactively take actions to
maintain capital consistent with these ratings objectives, which
may include adjusting dividend amounts and redeploying financial
resources from internal or external sources of capital. Certain
of these activities may require regulatory approval.
Rating Agencies. The rating agencies assign
insurer financial strength ratings to the Companys
domestic life subsidiaries and credit ratings to subsidiaries of
the Company which directly issue or guarantee substantially all
of the Companys senior unsecured obligations. The level
and composition of our regulatory capital at the subsidiary
level and equity capital of the Company are among the many
factors considered in determining the Companys insurer
financial strength and credit ratings. Each agency has its own
capital adequacy evaluation methodology and assessments are
generally based on a combination of factors.
The Companys financial strength ratings targets for its
domestic life insurance companies are AA/Aa2/AA/A+
for S&P, Moodys, Fitch, and A.M. Best. The
Companys long-term senior debt credit rating targets are
A/A2/A/a for S&P, Moodys, Fitch, and
A.M. Best.
In November 2008, A.M. Best downgraded the insurer
financial strength rating for Texas Life Insurance Company from
A to A-.
At December 31, 2008, A.M. Best, Fitch, Moodys
and S&P each had MetLife and its Subsidiaries insurer
financial strength and credit ratings on stable
outlook; however, (i) on February 9, 2009,
Moodys revised its outlook to negative,
(ii) on February 11, 2009, Fitch revised its outlook
to negative and anticipates completing its review
within the next several weeks and will reflect those results in
the ratings at that time, (iii) on February 20, 2009,
A.M. Best downgraded the credit ratings of MetLife, Inc.
and certain of its subsidiaries with a stable outlook, and
(iv) on February 26, 2009, S&P downgraded the
insurer financial strength and credit ratings of MetLife, Inc.
and certain of its subsidiaries, with a substantive
outlook.
In September and October 2008, A.M. Best, Fitch,
Moodys, and S&P each revised its outlook for the
U.S. life insurance sector to negative from stable. In
January 2009, S&P reiterated its negative outlook on the
U.S. life insurance sector. Management believes that the
rating agencies may heighten the level of scrutiny that they
apply to such institutions, may increase the frequency and scope
of their credit reviews, may request additional information
141
from the companies that they rate, and may adjust upward the
capital and other requirements employed in the rating agency
models for maintenance of certain ratings levels.
A downgrade in the credit or financial strength (i.e.,
claims-paying) ratings of the Company or its subsidiaries would
likely impact the cost and availability of unsecured financing
for the Company and its subsidiaries and result in additional
collateral requirements or other required payments under certain
agreements, which are eligible to be satisfied in cash or by
posting securities held by the subsidiaries subject to the
agreements.
Liquidity
Liquidity refers to a companys ability to generate
adequate amounts of cash to meet its needs. The Companys
liquidity position is defined as cash and cash equivalents,
short-term investments and publicly-traded securities excluding
(i) cash collateral received under the Companys
securities lending program that has been reinvested in cash,
cash equivalents, short-term investments and publicly-traded
securities; (ii) cash collateral received from
counterparties in connection with derivative instruments;
(iii) cash, cash equivalents, short-term investments and
publicly-traded securities on deposit with regulatory agencies;
and (iv) securities
held-in-trust
in support of collateral financing arrangements and pledged in
support of debt and funding agreements. The Companys
liquidity position was $139.4 billion and
$163.8 billion at December 31, 2008 and 2007,
respectively.
Liquidity needs are determined from a rolling
12-month
forecast by portfolio and are monitored daily. Asset mix and
maturities are adjusted based on forecast. Cash flow testing and
stress testing provide additional perspectives on liquidity,
which include various scenarios of the potential risk of early
contractholder and policyholder withdrawal. Management believes
that the Company has ample liquidity and capital resources to
meet business requirements and unlikely but reasonably possible
stress scenarios under current market conditions. The Company
includes provisions limiting withdrawal rights on many of its
products, including general account institutional pension
products (generally group annuities, including GICs, and certain
deposit fund liabilities) sold to employee benefit plan
sponsors. Certain of these provisions prevent the customer from
making withdrawals prior to the maturity date of the product.
In the event of significant unanticipated cash requirements
beyond normal liquidity needs, the Company has various
alternatives available depending on market conditions and the
amount and timing of the liquidity need. These options include
cash flows from operations, the sale of liquid assets, global
funding sources and various credit facilities.
Under stressful market and economic conditions, liquidity
broadly deteriorates which could negatively impact the
Companys ability to sell investment assets. If the Company
requires significant amounts of cash on short notice in excess
of normal cash requirements, the Company may have difficulty
selling investment assets in a timely manner, be forced to sell
them for less than the Company otherwise would have been able to
realize, or both. In addition, in the event of such forced sale,
accounting rules require the recognition of a loss and may
require the impairment of other such securities based upon the
Companys ability to hold such securities which, may
negatively impact the Companys financial statements.
In extreme circumstances, all general account assets
other than those which may have been pledged to a specific
purpose within a statutory legal entity are
available to fund obligations of the general account within that
legal entity. A disruption in the financial markets could limit
the Holding Companys access to or cost of liquidity. See
Extraordinary Market Conditions.
Liquidity
and Capital Sources
Cash Flows from Operations. The Companys
principal cash inflows from its insurance activities come from
insurance premiums, annuity considerations and deposit funds. A
primary liquidity concern with respect to these cash inflows is
the risk of early contractholder and policyholder withdrawal.
See Extraordinary Market Conditions and
Liquidity and Capital Uses Contractual
Obligations.
Cash Flows from Investments. The
Companys principal cash inflows from its investment
activities come from repayments of principal, proceeds from
maturities and sales of invested assets and net investment
income. The primary liquidity concerns with respect to these
cash inflows are the risk of default by debtors and market
142
volatilities. The Company closely monitors and manages these
risks through its credit risk management process. During the
latter half of 2008, the Company increased its short-term
liquidity position in response to the extraordinary market
conditions. The Companys short-term liquidity position
defined as cash, cash equivalents and short-term investments
excluding both cash collateral received under the Companys
securities lending program that has been reinvested in cash,
cash equivalents, short-term investments and collateral received
from counterparties in connection with derivative instruments
was $26.7 billion and $10.9 billion at
December 31, 2008 and 2007, respectively. See
Investments Current
Environment.
Liquid Assets. An integral part of the
Companys liquidity management is the amount of liquid
assets it holds. Liquid assets include cash, cash equivalents,
short-term investments and publicly-traded securities excluding
(i) cash collateral received under the Companys
securities lending program that has been reinvested in cash,
cash equivalents, short-term investments and publicly-traded
securities; (ii) cash collateral received from
counterparties in connection with derivative instruments;
(iii) cash, cash equivalents, short-term investments and
securities on deposit with regulatory agencies; and
(iv) securities held in trust in support of collateral
financing arrangements and pledged in support of debt and
funding agreements. At December 31, 2008 and 2007, the
Company had $139.4 billion and $163.8 billion in
liquid assets, respectively. For further discussion of invested
assets on deposit with regulatory agencies, held in trust in
support of collateral financing arrangements and pledged in
support of debt and funding agreements. See
Investments Assets on Deposit,
Held in Trust and Pledged as Collateral.
Global Funding Sources. Liquidity is also
provided by a variety of short-term instruments, including
repurchase agreements and commercial paper. Capital is provided
by a variety of long-term instruments, including medium- and
long-term debt, junior subordinated debt securities, capital
securities and stockholders equity. The diversity of the
Companys funding sources enhances flexibility, limits
dependence on any one source of funds and generally lowers the
cost of funds. See Extraordinary Market Conditions.
During the turbulent market conditions of 2008, the Company has
utilized various means of short-term and long-term financing
including:
|
|
|
|
|
The Company is participating in certain economic stabilization
programs established by various government institutions. The
Federal Reserve Bank of New Yorks Commercial Paper Funding
Facility (CPFF) is intended to improve liquidity in
short-term funding markets by increasing the availability of
term commercial paper funding to issuers and by providing
greater assurance to both issuers and investors that firms will
be able to rollover their maturing commercial paper. MetLife
Short Term Funding LLC, the issuer of commercial paper under a
program supported by funding agreements issued by Metropolitan
Life Insurance Company and MetLife Insurance Company of
Connecticut, was accepted in October 2008 for the CPFF and may
issue a maximum amount of $3.8 billion under the CPFF. At
December 31, 2008, MetLife Short Term Funding LLC had used
$1,650 million of its available capacity under the CPFF,
and such amount was deposited under the related funding
agreements. MetLife Funding, Inc. was accepted in November 2008
for the Federal Reserve Bank of New Yorks CPFF and may
issue a maximum amount of $1 billion under the CPFF. No
drawdown by MetLife Funding, Inc. has taken place under this
facility as of the date hereof. In December 2008, MetLife, Inc.
elected to continue to participate in the debt guarantee
component of the Federal Deposit Insurance Corporations
(FDIC) Temporary Liquidity Guarantee Program (the
FDIC Program). Under the terms of the FDIC Program,
the FDIC will guarantee through June 2012 (or maturity, if
earlier) the payment of certain newly-issued senior unsecured
debt of MetLife, Inc. and any eligible affiliates. The Company
also notified the FDIC that it elected the option of excluding
specified senior unsecured debt maturing after June 30,
2012 from the guarantee before reaching the limits on the amount
of guaranteed debt under the FDIC Program ($398 million for
MetLife, Inc. and $178 million for MetLife Bank, N.A. which
may issue guaranteed debt under its limit, as well as unused
amounts under MetLife, Inc.s limit). The Company opted out
of the component of the FDIC Program that guarantees
non-interest bearing deposit transaction accounts. Management
cannot predict how the markets may react to these elections or
to any debt issued subject to the terms of the FDIC Program.
|
MetLife, Inc. and MetLife Funding, Inc. each have commercial
paper programs. The commercial paper markets have effectively
closed to certain issuers, depending upon their ratings.
Depending on market conditions, we may issue shorter maturities
than we would otherwise like.
143
|
|
|
|
|
MetLife Bank, N.A. has pledged loans and securities with the
Federal Reserve Bank of New York to have the capacity to borrow
at the Discount Window or under the Term Auction Facility. At
December 31, 2008, MetLife Bank had borrowed
$950 million under the Term Auction Facility for various
short-term maturities. In addition, as a member of the Federal
Home Loan Bank of New York (FHLB of NY), MetLife
Bank has entered into repurchase agreements with FHLB of NY on a
short-term and long-term basis, with a total liability for
repurchase agreements with the FHLB of NY of $1.8 billion
at December 31, 2008. Management expects MetLife Bank to
take further advantage of these funding sources in the future.
In addition, the Company had obligations under funding
agreements with the FHLB of NY of $15.2 billion and
$4.6 billion at December 31, 2008 and
December 31, 2007 respectively for MLIC and with the FHLB
of Boston of $526 million and $726 million at
December 31, 2008 and December 31, 2007 respectively
for MICC. The FHLB of Boston had also advanced $300 million
to MICC at December 31, 2008, which is included in
short-term debt. In the current market environment, the Federal
Home Loan Bank system has demonstrated its commitment to provide
funding to its members especially through these stressful market
conditions. Management expects the renewal of these funding
resources. See Note 7 of the Notes to the Consolidated
Financial Statements
|
As described below in Debt Issuances and Other
Borrowings and above in Extraordinary Market
Conditions the Company sold various long-term debt
securities in August 2008 and February 2009 in connection with
the remarketing of the junior subordinated debentures issued in
connection with the common equity units. The Company also issued
common stock in October 2008 as described in Extraordinary
Market Conditions.
At December 31, 2008 and 2007, the Company had outstanding
$2.7 billion and $667 million in short-term debt,
respectively, and $9.7 billion and $9.1 billion in
long-term debt, respectively. At December 31, 2008 and
2007, the Company had outstanding $5.2 billion and
$4.9 billion in collateral financing arrangements,
respectively, and $3.8 billion and $4.1 billion in
junior subordinated debt, respectively. Long-term and short-term
debt includes certain advances from the FHLB of NY.
Debt Issuances and Other Borrowings. In April
2008, MetLife Capital Trust X, a variable interest entity
(VIE) consolidated by the Company, issued
exchangeable surplus trust securities (the 2008
Trust Securities) with a face amount of
$750 million. The 2008 Trust Securities will be
exchanged into a like amount of the Holding Companys
junior subordinated debentures on April 8, 2038, the
scheduled redemption date, mandatory under certain
circumstances, and at any time upon the Holding Company
exercising its option to redeem the securities. The 2008
Trust Securities will be exchanged for junior subordinated
debentures prior to repayment. The final maturity of the
debentures is April 8, 2068. The Holding Company may cause
the redemption of the 2008 Trust Securities or debentures
(i) in whole or in part, at any time on or after
April 8, 2033 at their principal amount plus accrued and
unpaid interest to the date of redemption, or (ii) in
certain circumstances, in whole or in part, prior to
April 8, 2033 at their principal amount plus accrued and
unpaid interest to the date of redemption or, if greater, a
make-whole price. Interest on the 2008 Trust Securities or
debentures is payable semi-annually at a fixed rate of 9.25% up
to, but not including, April 8, 2038, the scheduled
redemption date. In the event the 2008 Trust Securities or
debentures are not redeemed on or before the scheduled
redemption date, interest will accrue at an annual rate of
3-month
LIBOR plus a margin equal to 5.540%, payable quarterly in
arrears. The Holding Company has the right to, and in certain
circumstances the requirement to, defer interest payments on the
2008 Trust Securities or debentures for a period up to ten
years. Interest compounds during such periods of deferral. If
interest is deferred for more than five consecutive years, the
Holding Company may be required to use proceeds from the sale of
its common stock or warrants on common stock to satisfy its
obligation. In connection with the issuance of the 2008
Trust Securities, the Holding Company entered into a
replacement capital covenant (RCC). As a part of the
RCC, the Holding Company agreed that it will not repay, redeem,
or purchase the debentures on or before April 8, 2058,
unless, subject to certain limitations, it has received proceeds
from the sale of specified capital securities. The RCC will
terminate upon the occurrence of certain events, including an
acceleration of the debentures due to the occurrence of an event
of default. The RCC is not intended for the benefit of holders
of the debentures and may not be enforced by them. The RCC is
for the benefit of holders of one or more other designated
series of its indebtedness (which will initially be its
5.70% senior notes due June 15, 2035). The Holding
Company also entered into a replacement capital obligation which
will commence in 2038 and under which the Holding Company must
use
144
reasonable commercial efforts to raise replacement capital
through the issuance of certain qualifying capital securities.
Issuance costs associated with the offering of the 2008
Trust Securities of $8 million have been capitalized,
are included in other assets, and are amortized using the
effective interest method over the period from the issuance date
of the 2008 Trust Securities until their scheduled
redemption. Interest expense on the 2008 Trust Securities
was $51 million for the year ended December 31, 2008.
In December 2007, MetLife Capital Trust IV
(Trust IV), a VIE consolidated by the Company,
issued exchangeable surplus trust securities (the 2007
Trust Securities) with a face amount of
$700 million and a discount of $6 million
($694 million). The 2007 Trust Securities will be
exchanged into a like amount of Holding Company junior
subordinated debentures on December 15, 2037, the scheduled
redemption date; mandatorily under certain circumstances; and at
any time upon the Holding Company exercising its option to
redeem the securities. The 2007 Trust Securities will be
exchanged for junior subordinated debentures prior to repayment.
The final maturity of the debentures is December 15, 2067.
The Holding Company may cause the redemption of the 2007
Trust Securities or debentures (i) in whole or in
part, at any time on or after December 15, 2032 at their
principal amount plus accrued and unpaid interest to the date of
redemption, or (ii) in certain circumstances, in whole or
in part, prior to December 15, 2032 at their principal
amount plus accrued and unpaid interest to the date of
redemption or, if greater, a make-whole price. Interest on the
2007 Trust Securities or debentures is payable
semi-annually at a fixed rate of 7.875% up to, but not
including, December 15, 2037, the scheduled redemption
date. In the event the 2007 Trust Securities or debentures
are not redeemed on or before the scheduled redemption date,
interest will accrue at an annual rate of
3-month
LIBOR plus a margin equal to 3.96%, payable quarterly in
arrears. The Holding Company has the right to, and in certain
circumstances the requirement to, defer interest payments on the
2007 Trust Securities or debentures for a period up to ten
years. Interest compounds during such periods of deferral. If
interest is deferred for more than five consecutive years, the
Holding Company may be required to use proceeds from the sale of
its common stock or warrants on common stock to satisfy its
obligation. In connection with the issuance of the 2007
Trust Securities, the Holding Company entered into a RCC.
As a part of the RCC, the Holding Company agreed that it will
not repay, redeem, or purchase the debentures on or before
December 15, 2057, unless, subject to certain limitations,
it has received proceeds from the sale of specified capital
securities. The RCC will terminate upon the occurrence of
certain events, including an acceleration of the debentures due
to the occurrence of an event of default. The RCC is not
intended for the benefit of holders of the debentures and may
not be enforced by them. The RCC is for the benefit of holders
of one or more other designated series of its indebtedness
(which will initially be its 5.70% senior notes due
June 15, 2035). The Holding Company also entered into a
replacement capital obligation which will commence in 2037 and
under which the Holding Company must use reasonable commercial
efforts to raise replacement capital through the issuance of
certain qualifying capital securities. Issuance costs associated
with the offering of the 2007 Trust Securities of
$10 million have been capitalized, are included in other
assets, and are amortized using the effective interest method
over the period from the issuance date of the 2007
Trust Securities until their scheduled redemption. Interest
expense on the 2007 Trust Securities was $55 million
and $3 million, for the years ended December 31, 2008
and 2007, respectively.
In December 2007, MLIC reinsured a portion of its closed block
liabilities to MetLife Reinsurance Company of Charleston, a
wholly-owned subsidiary of the Company. In connection with this
transaction, MRC issued, to investors placed by an unaffiliated
financial institution, $2.5 billion of 35 year surplus
notes to provide statutory reserve support for the assumed
closed block liabilities. Interest on the surplus notes accrues
at an annual rate of
3-month
LIBOR plus 0.55%, payable quarterly. The ability of MRC to make
interest and principal payments on the surplus notes is
contingent upon South Carolina regulatory approval. At both
December 31, 2008 and 2007, surplus notes outstanding were
$2.5 billion. Simultaneous with the issuance of the surplus
notes, the Holding Company entered into an agreement with the
unaffiliated financial institution, under which the Holding
Company is entitled to the interest paid by MRC on the surplus
notes of
3-month
LIBOR plus 0.55% in exchange for the payment of
3-month
LIBOR plus 1.12%, payable quarterly on such amount as adjusted,
as described below. Under this agreement, the Holding Company
may also be required to pledge collateral or make payments to
the unaffiliated financial institution related to any decline in
the estimated fair value of the surplus notes. Any such payments
would be accounted for as a receivable and included under other
assets on the Companys consolidated financial statements
and would not reduce the principal amount outstanding of the
surplus notes. In addition, the Holding Company may also be
required to make a payment to the unaffiliated financial
institution in connection with any early termination of this
agreement. During the year ended December 31, 2008, the
145
Holding Company paid $800 million to the unaffiliated
financial institution related to a decline in the estimated fair
value of the surplus notes. This payment reduced the amount
under the agreement on which the Holding Companys interest
payment is due but did not reduce the outstanding amount of the
surplus notes. In addition, the Holding Company had pledged
collateral of $230 million to the unaffiliated financial
institution at December 31, 2008. No collateral had been
pledged at December 31, 2007. A majority of the proceeds
from the offering of the surplus notes were placed in trust,
which is consolidated by the Company, to support MRCs
statutory obligations associated with the assumed closed block
liabilities. During 2007 and 2008, the Company deposited
$2.0 billion and $314 million, respectively, into the
trust, from the proceeds of the surplus notes issued in 2007. At
December 31, 2008 and 2007, the estimated fair value of
assets held in trust by the Company was $2.1 billion and
$2.0 billion, respectively. The assets are principally
invested in fixed maturity securities and are presented as such
within the Companys consolidated balance sheet, with the
related income included within net investment income in the
Companys consolidated income statement. Interest on the
collateral financing arrangement is included as a component of
other expenses. Total interest expense was $117 million and
$5 million for the years ended December 31, 2008 and
2007, respectively. See The Holding Company
Liquidity and Capital Uses Support Agreements
for a description of the support arrangement entered into in
connection with this transaction.
In May 2007, the Holding Company and MetLife Reinsurance Company
of South Carolina (MRSC), a wholly-owned subsidiary
of the Company, entered into a
30-year
collateral financing arrangement with an unaffiliated financial
institution that provides up to $3.5 billion of statutory
reserve support for MRSC associated with reinsurance obligations
under intercompany reinsurance agreements. Such statutory
reserves are associated with universal life secondary guarantees
and are required under U.S. Valuation of Life Policies
Model Regulation (commonly referred to as
Regulation A-XXX).
At December 31, 2008 and 2007, $2.7 billion and
$2.4 billion, respectively, had been drawn upon under the
collateral financing arrangement. The collateral financing
arrangement may be extended by agreement of the Holding Company
and the unaffiliated financial institution on each anniversary
of the closing. Proceeds from the collateral financing
arrangement were placed in trust to support MRSCs
statutory obligations associated with the reinsurance of
secondary guarantees. The trust is a VIE which is consolidated
by the Company. The unaffiliated financial institution is
entitled to the return on the investment portfolio held by the
trust. In connection with the collateral financing arrangement,
the Holding Company entered into an agreement with the same
unaffiliated financial institution under which the Holding
Company is entitled to the return on the investment portfolio
held by the trust established in connection with this collateral
financing arrangement in exchange for the payment of a stated
rate of return to the unaffiliated financial institution of
3-month
LIBOR plus 0.70%, payable quarterly. The Holding Company may
also be required to make payments to the unaffiliated financial
institution, for deposit into the trust, related to any decline
in the estimated fair value of the assets held by the trust, as
well as amounts outstanding upon maturity or early termination
of the collateral financing arrangement. For the year ended
December 31, 2008, the Holding Company paid
$320 million to the unaffiliated financial institution as a
result of the decline in the estimated fair value of the assets
in the trust. All of the $320 million was deposited into
the trust. In January 2009, the Holding Company paid an
additional $360 million to the unaffiliated financial
institution as a result of the continued decline in the
estimated fair value of the assets in trust which was also
deposited into the trust. In addition, the Holding Company may
be required to pledge collateral to the unaffiliated financial
institution under this agreement. At December 31, 2008, the
Holding Company had pledged $86 million under the
agreement. No collateral had been pledged under the agreement at
December 31, 2007. At December 31, 2008 and 2007, the
Company held assets in trust with an estimated fair value of
$2.4 billion and $2.3 billion, respectively,
associated with this transaction. The assets are principally
invested in fixed maturity securities and are presented as such
within the Companys consolidated balance sheet, with the
related income included within net investment income in the
Companys consolidated income statement. Interest on the
collateral financing arrangement is included as a component of
other expenses. Transaction costs associated with the collateral
financing arrangement of $5 million have been capitalized,
are included in other assets, and are amortized using the
effective interest method over the period from the issuance of
the collateral financing arrangement to its expiration. Total
interest expense was $107 million and $84 million for
the years ended December 31, 2008 and 2007, respectively.
See The Holding Company Liquidity and Capital
Uses Support Agreements for a description of
the support arrangement entered into in connection with this
transaction.
In December 2006, the Holding Company issued junior subordinated
debentures with a face amount of $1.25 billion. The
debentures are scheduled for redemption on December 15,
2036; the final maturity of the
146
debentures is December 15, 2066. The Holding Company may
redeem the debentures (i) in whole or in part, at any time
on or after December 15, 2031 at their principal amount
plus accrued and unpaid interest to the date of redemption, or
(ii) in certain circumstances, in whole or in part, prior
to December 15, 2031 at their principal amount plus accrued
and unpaid interest to the date of redemption or, if greater, a
make-whole price. Interest is payable semi-annually at a fixed
rate of 6.40% up to, but not including, December 15, 2036,
the scheduled redemption date. In the event the debentures are
not redeemed on or before the scheduled redemption date,
interest will accrue at an annual rate of
3-month
LIBOR plus a margin equal to 2.205%, payable quarterly in
arrears. The Holding Company has the right to, and in certain
circumstances the requirement to, defer interest payments on the
debentures for a period up to ten years. Interest compounds
during such periods of deferral. If interest is deferred for
more than five consecutive years, the Holding Company may be
required to use proceeds from the sale of its common stock or
warrants on common stock to satisfy its obligation. In
connection with the issuance of the debentures, the Holding
Company entered into a RCC. As part of the RCC, the Holding
Company agreed that it will not repay, redeem, or purchase the
debentures on or before December 15, 2056, unless, subject
to certain limitations, it has received proceeds from the sale
of specified capital securities. The RCC will terminate upon the
occurrence of certain events, including an acceleration of the
debentures due to the occurrence of an event of default. The RCC
is not intended for the benefit of holders of the debentures and
may not be enforced by them. The RCC is for the benefit of
holders of one or more other designated series of its
indebtedness (which will initially be its 5.70% senior
notes due June 15, 2035). The Holding Company also entered
into a replacement capital obligation which will commence in
2036 and under which the Holding Company must use reasonable
commercial efforts to raise replacement capital through the
issuance of certain qualifying capital securities. Issuance
costs associated with the offering of the debentures of
$13 million have been capitalized, are included in other
assets, and are amortized using the effective interest method
over the period from the issuance date of the debentures until
their scheduled redemption. Interest expense on the debentures
was $80 million, $80 million and $2 million for
the years ended December 31, 2008, 2007 and 2006,
respectively.
MetLife Bank has entered into several repurchase agreements with
the FHLB of NY whereby MetLife Bank has issued repurchase
agreements in exchange for cash and for which the FHLB of NY has
been granted a blanket lien on MetLife Banks residential
mortgages and mortgage-backed securities to collateralize
MetLife Banks obligations under the repurchase agreements.
The repurchase agreements and the related security agreement
represented by this blanket lien provide that upon any event of
default by MetLife Bank, the FHLB of NYs recovery is
limited to the amount of MetLife Banks liability under the
outstanding repurchase agreements. During the years ended
December 31, 2008, 2007, and 2006, MetLife Bank received
advances totaling $220 million, $390 million and
$260 million, respectively, from the FHLB of NY, which were
included in long-term debt. MetLife Bank also made repayments of
$371 million, $175 million and $117 million to
the FHLB of NY during the years ended December 31, 2008,
2007 and 2006, respectively. In addition, in 2008 following the
acquisition of a mortgage origination and servicing business,
MetLife Bank began a program of taking short-term advances from
the FHLB of NY. The amount of the Companys liability for
repurchase agreements with the FHLB of NY that is included in
long-term debt was $1.1 billion and $1.2 billion at
December 31, 2008 and 2007, respectively and the amount
that is included in short-term debt was $695 million at
December 31, 2008.
MetLife Funding, Inc. (MetLife Funding), a
subsidiary of MLIC, serves as a centralized finance unit for the
Company. Pursuant to a support agreement, MLIC has agreed to
cause MetLife Funding to have a tangible net worth of at least
one dollar. At both December 31, 2008 and 2007, MetLife
Funding had a tangible net worth of $12 million. MetLife
Funding raises cash from various funding sources and uses the
proceeds to extend loans, through MetLife Credit Corp., another
subsidiary of MLIC, to the Holding Company, MLIC and other
affiliates. MetLife Funding manages its funding sources to
enhance the financial flexibility and liquidity of MLIC and
other affiliated companies. At December 31, 2008 and 2007,
MetLife Funding had total outstanding liabilities, including
accrued interest payable, of $414 million and
$358 million, respectively, consisting primarily of
commercial paper.
The Company is participating in certain economic stabilization
programs established by various government institutions,
including the CPFF and the FDIC program, as described above.
Credit Facilities. The Company maintains
committed and unsecured credit facilities aggregating
$3.2 billion at December 31, 2008. When drawn upon,
these facilities bear interest at varying rates in accordance
with the respective agreements as specified below. The
facilities can be used for general corporate purposes and, at
147
December 31, 2008, $2.9 billion of the facilities also
served as
back-up
lines of credit for the Companys commercial paper
programs. Management has no reason to believe that its lending
counterparties are unable to fulfill their respective
contractual obligations.
Total fees associated with these credit facilities were
$17 million, of which $11 million related to deferred
amendment fees for the year ended December 31, 2008.
Information on these credit facilities at December 31, 2008
is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Letter of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit
|
|
|
|
|
|
Unused
|
|
Borrower(s)
|
|
Expiration
|
|
|
Capacity
|
|
|
Issuances
|
|
|
Drawdowns
|
|
|
Commitments
|
|
|
|
|
|
|
(In millions)
|
|
|
MetLife, Inc. and MetLife Funding, Inc.
|
|
|
June 2012 (1
|
)
|
|
$
|
2,850
|
|
|
$
|
2,313
|
|
|
$
|
|
|
|
$
|
537
|
|
MetLife Bank, N.A
|
|
|
July 2009 (2
|
)
|
|
|
300
|
|
|
|
|
|
|
|
100
|
|
|
|
200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
$
|
3,150
|
|
|
$
|
2,313
|
|
|
$
|
100
|
|
|
$
|
737
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
In December 2008, the Holding Company and MetLife Funding, Inc.
entered into an amended and restated $2.85 billion credit
agreement with various financial institutions. The agreement
amended and restated the $3.0 billion credit agreement
entered into in June 2007. Proceeds are available to be used for
general corporate purposes, to support their commercial paper
programs and for the issuance of letters of credit. The Company
limits its commercial paper outstanding relative to the amount
of unused commitments under this facility. All borrowings under
the credit agreement must be repaid by June 2012, except that
letters of credit outstanding upon termination may remain
outstanding until June 2013. The borrowers and the lenders under
this facility may agree to extend the term of all or part of the
facility to no later than June 2014, except that letters of
credit outstanding upon termination may remain outstanding until
June 2015. Fees for this agreement include a 0.25% facility fee,
0.075% fronting fee, a letter of credit fee between 1% and 5%
based on certain market rates and a 0.05% utilization fee, as
applicable, and may vary based on MetLife, Inc.s senior
unsecured ratings. The Holding Company and MetLife Funding, Inc.
incurred amendment costs of $11 million related to the
$2,850 million amended and restated credit agreement, which
have been capitalized and included in other assets. These costs
will be amortized over the term of the agreement. The Holding
Company did not have any deferred financing costs associated
with the original June 2007 credit agreement. |
|
(2) |
|
In July 2008, the facility was increased by $100 million
and its maturity extended for one year to July 2009. Fees for
this agreement include a commitment fee of $10,000 and a margin
of Federal Funds plus 0.11%, as applicable. |
Committed Facilities. The Company maintains
committed facilities aggregating $11.5 billion at
December 31, 2008. When drawn upon, these facilities bear
interest at varying rates in accordance with the respective
agreements as specified below. The facilities are used for
collateral for certain of the Companys insurance
liabilities. Management has no reason to believe that its
lending counterparties are unable to fulfill their contractual
obligations.
148
Total fees associated with these committed facilities were
$35 million, of which $13 million related to deferred
amendment fees for the year ended December 31, 2008.
Information on committed facilities at December 31, 2008 is
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Letter of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit
|
|
|
Unused
|
|
|
Maturity
|
|
Account Party/Borrower(s)
|
|
Expiration
|
|
Capacity
|
|
|
Drawdowns
|
|
|
Issuances
|
|
|
Commitments
|
|
|
(Years)
|
|
|
|
|
|
(In millions)
|
|
|
MetLife, Inc.
|
|
August 2009 (1)
|
|
$
|
500
|
|
|
$
|
|
|
|
$
|
500
|
|
|
$
|
|
|
|
|
|
|
Exeter Reassurance Company Ltd., MetLife, Inc., & Missouri
Reinsurance (Barbados), Inc.
|
|
June 2016 (3)
|
|
|
500
|
|
|
|
|
|
|
|
490
|
|
|
|
10
|
|
|
|
7
|
|
Exeter Reassurance Company Ltd.
|
|
December 2027 (2),(4)
|
|
|
650
|
|
|
|
|
|
|
|
410
|
|
|
|
240
|
|
|
|
19
|
|
MetLife Reinsurance Company of South Carolina &
MetLife, Inc.
|
|
June 2037 (5)
|
|
|
3,500
|
|
|
|
2,692
|
|
|
|
|
|
|
|
808
|
|
|
|
29
|
|
MetLife Reinsurance Company of Vermont & MetLife,
Inc.
|
|
December 2037 (2),(6)
|
|
|
2,896
|
|
|
|
|
|
|
|
1,359
|
|
|
|
1,537
|
|
|
|
29
|
|
MetLife Reinsurance Company of Vermont & MetLife,
Inc.
|
|
September 2038 (2),(7)
|
|
|
3,500
|
|
|
|
|
|
|
|
1,500
|
|
|
|
2,000
|
|
|
|
29
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
$
|
11,546
|
|
|
$
|
2,692
|
|
|
$
|
4,259
|
|
|
$
|
4,595
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
In December 2008, the Holding Company entered into an amended
and restated one year $500 million letter of credit
facility (dated as of August 2008 and amended and restated at
December 31, 2008), with an unaffiliated financial
institution, Exeter Reassurance Company, Ltd.
(Exeter) is a co-applicant under this letter of
credit facility. This letter of credit facility matures in
August 2009, except that letters of credit outstanding upon
termination may remain outstanding until August 2010. Fees for
this agreement include a margin of 2.25% and a utilization fee
of 0.05%, as applicable. The Holding Company incurred amendment
costs of $1.3 million related to the $500 million
amended and restated letter of credit facility, which has been
capitalized and included in other assets. These costs will be
amortized over the term of the agreement. |
|
(2) |
|
The Holding Company is a guarantor under this agreement. |
|
(3) |
|
Letters of credit and replacements or renewals thereof issued
under this facility of $280 million, $10 million and
$200 million are set to expire no later than December 2015,
March 2016 and June 2016, respectively. |
|
(4) |
|
In December 2008, Exeter, as borrower, and the Holding Company,
as guarantor, entered into an amendment of an existing credit
agreement with an unaffiliated financial institution. Issuances
under this facility are set to expire in December 2027. Exeter
incurred amendment costs of $1.6 million related to the
amendment of the existing credit agreement, which have been
capitalized and included in other assets. These costs will be
amortized over the term of the agreement. |
|
(5) |
|
In May 2007, MRSC, a wholly-owned subsidiary of the Company,
terminated the $2.0 billion amended and restated five-year
letter of credit and reimbursement agreement entered into among
the Holding Company, MRSC and various financial institutions on
April 25, 2005. In its place, the Company entered into a
30-year
collateral financing arrangement as described in Note 11 of
the Notes to the Consolidated Financial Statements, which may be
extended by agreement of the Company and the financial
institution on each anniversary of the closing of the facility
for an additional one-year period. At December 31, 2008,
$2.7 billion had been drawn upon under the collateral
financing arrangement. |
|
(6) |
|
In December 2007, Exeter terminated four letters of credit, with
expirations from March 2025 through December 2026, which were
issued under a letter of credit facility with an unaffiliated
financial institution in an aggregate amount of
$1.7 billion. The letters of credit had served as
collateral for Exeters obligations under a reinsurance
agreement that was recaptured by MetLife Investors USA Insurance
Company (MLI-USA) in December 2007. MLI-USA
immediately thereafter entered into a new reinsurance agreement
with MetLife Reinsurance Company of Vermont (MRV).
To collateralize its reinsurance obligations, MRV and the
Holding Company entered into a
30-year,
$2.9 billion letter of credit facility with an unaffiliated
financial institution. |
149
|
|
|
(7) |
|
In September 2008, MRV and the Holding Company entered into a
30-year,
$3.5 billion letter of credit facility with an unaffiliated
financial institution. These letters of credit serve as
collateral for MRVs obligations under a reinsurance
agreement. |
Letters of Credit. At December 31, 2008,
the Company had outstanding $6.6 billion in letters of
credit from various financial institutions of which
$4.3 billion and $2.3 billion were part of committed
and credit facilities, respectively. As commitments associated
with letters of credit and financing arrangements may expire
unused, these amounts do not necessarily reflect the
Companys actual future cash funding requirements.
Covenants. Certain of the Companys debt
instruments, credit facilities and committed facilities contain
various administrative, reporting, legal and financial
covenants. The Company believes it is in compliance with all
covenants at December 31, 2008 and 2007.
Liquidity
and Capital Uses
Debt Repayments. On October 31, 2007, the
Company redeemed $125 million of 8.525% GenAmerica Capital
I Capital Securities which were due to mature on June 30,
2027. As a result of this repayment, the Company recognized
additional interest expense of $10 million.
During the years ended December 31, 2008, 2007 and 2006,
MetLife Bank made repayments of $371 million,
$175 million, and $117 million, respectively, to the
FHLB of NY related to long-term borrowings. During the year
ended December 31, 2008, MetLife Bank made repayments of
$4.6 billion to the FHLB of NY and $650 million to the
Federal Reserve Bank of New York related to short-term
borrowings. See Liquidity and Capital Sources
Debt Issuances and Other Borrowings for further
information.
The Holding Company repaid a $500 million 5.25% senior
note which matured in December 2006.
Insurance Liabilities. The Companys
principal cash outflows primarily relate to the liabilities
associated with its various life insurance, property and
casualty, annuity and group pension products, operating expenses
and income tax, as well as principal and interest on its
outstanding debt obligations. Liabilities arising from its
insurance activities primarily relate to benefit payments under
the aforementioned products, as well as payments for policy
surrenders, withdrawals and loans. See Contractual
Obligations.
Investment and Other. Additional cash outflows
include those related to obligations of securities lending
activities, investments in real estate, limited partnerships and
joint ventures, as well as litigation-related liabilities.
Securities Lending. The Company participates
in a securities lending program whereby blocks of securities,
which are included in fixed maturity and equity securities, are
loaned to third parties, primarily major brokerage firms and
commercial banks. The Company requires collateral equal to 102%
of the current estimated fair value of the loaned securities to
be obtained at the inception of a loan, and maintained at a
level greater than or equal to 100% for the duration of the
loan. During the extraordinary market events occurring in the
fourth quarter of 2008, the Company, in limited instances,
accepted collateral less than 102% at the inception of certain
loans, but never less than 100%, of the estimated fair value of
such loaned securities. These loans involved U.S. Treasury
Bills which are considered to have limited variation in their
estimated fair value during the term of the loan. The Company
was liable for cash collateral under its control of
$23.3 billion and $43.3 billion at December 31,
2008 and 2007, respectively. During the unprecedented market
disruption since mid-September 2008, the demand for securities
loans from the Companys counterparties has decreased. The
volume of securities lending has decreased in line with reduced
demand from counterparties and reduced trading capacity of
certain segments of the fixed income securities market. See
Extraordinary Market Conditions for further
information.
150
Contractual
Obligations
The following table summarizes the Companys major
contractual obligations at December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
More Than
|
|
|
|
|
|
|
|
|
|
|
|
|
|
More Than
|
|
|
Three Years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
One Year and
|
|
|
and Less
|
|
|
|
|
|
|
|
|
|
|
Less Than
|
|
|
Less Than
|
|
|
Than Five
|
|
|
More Than
|
|
Contractual Obligations
|
|
|
Total
|
|
|
One Year
|
|
|
Three Years
|
|
|
Years
|
|
|
Five Years
|
|
|
|
|
|
|
(In millions)
|
|
|
Future policy benefits
|
|
|
(1
|
)
|
|
$
|
316,201
|
|
|
$
|
7,116
|
|
|
$
|
11,013
|
|
|
$
|
11,278
|
|
|
$
|
286,794
|
|
Policyholder account balances
|
|
|
(2
|
)
|
|
|
201,975
|
|
|
|
38,562
|
|
|
|
27,362
|
|
|
|
18,690
|
|
|
|
117,361
|
|
Other policyholder liabilities
|
|
|
(3
|
)
|
|
|
5,890
|
|
|
|
5,890
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term debt
|
|
|
(4
|
)
|
|
|
2,662
|
|
|
|
2,662
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt
|
|
|
(4
|
)
|
|
|
16,703
|
|
|
|
1,072
|
|
|
|
2,232
|
|
|
|
2,091
|
|
|
|
11,308
|
|
Collateral financing arrangements
|
|
|
(4
|
)
|
|
|
8,138
|
|
|
|
122
|
|
|
|
243
|
|
|
|
243
|
|
|
|
7,530
|
|
Junior subordinated debt securities
|
|
|
(4
|
)
|
|
|
9,637
|
|
|
|
1,278
|
|
|
|
409
|
|
|
|
409
|
|
|
|
7,541
|
|
Payables for collateral under securities loaned and other
transactions
|
|
|
(5
|
)
|
|
|
31,059
|
|
|
|
31,059
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commitments to lend funds
|
|
|
(6
|
)
|
|
|
8,196
|
|
|
|
8,011
|
|
|
|
147
|
|
|
|
6
|
|
|
|
32
|
|
Operating leases
|
|
|
(7
|
)
|
|
|
2,141
|
|
|
|
278
|
|
|
|
460
|
|
|
|
323
|
|
|
|
1,080
|
|
Other
|
|
|
(8
|
)
|
|
|
10,515
|
|
|
|
10,161
|
|
|
|
6
|
|
|
|
3
|
|
|
|
345
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
$
|
613,117
|
|
|
$
|
106,211
|
|
|
$
|
41,872
|
|
|
$
|
33,043
|
|
|
$
|
431,991
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Future policyholder benefits include liabilities related to
traditional whole life policies, term life policies, closeout
and other group annuity contracts, structured settlements,
master terminal funding agreements, single premium immediate
annuities, long-term disability policies, individual disability
income policies, LTC policies and property and casualty
contracts. |
|
|
|
Included within future policyholder benefits are contracts where
the Company is currently making payments and will continue to do
so until the occurrence of a specific event such as death, as
well as those where the timing of a portion of the payments has
been determined by the contract. Also included are contracts
where the Company is not currently making payments and will not
make payments until the occurrence of an insurable event, such
as death or illness, or where the occurrence of the payment
triggering event, such as a surrender of a policy or contract,
is outside the control of the Company. The Company has estimated
the timing of the cash flows related to these contracts based on
historical experience as well as its expectation of future
payment patterns. |
|
|
|
Liabilities related to accounting conventions or which are not
contractually due, such as shadow liabilities, excess interest
reserves and property and casualty loss adjustment expenses of
$303 million, have been excluded from amounts presented in
the table above. |
|
|
|
Amounts presented in the table above, excluding those related to
property and casualty contracts, represent the estimated cash
payments for benefits under such contracts including assumptions
related to the receipt of future premiums and assumptions
related to mortality, morbidity, policy lapse, renewal,
retirement, inflation, disability incidence, disability
terminations, policy loans and other contingent events as
appropriate to the respective product type. Payments for case
reserve liabilities and incurred but not reported liabilities
associated with property and casualty contracts of
$1.5 billion have been included using an estimate of the
ultimate amount to be settled under the policies based upon
historical payment patterns. The ultimate amount to be paid
under property and casualty contracts is not determined until
the Company reaches a settlement with the claimant, which may
vary significantly from the liability or contractual obligation
presented above especially as it relates to incurred but not
reported liabilities. All estimated cash payments presented in
the table above are undiscounted as to interest, net of
estimated future premiums on policies currently in-force and
gross of any reinsurance recoverable. The more than five years
category displays estimated payments due for periods extending
for more than 100 years from the present date. |
151
|
|
|
|
|
The sum of the estimated cash flows shown for all years in the
table of $316.2 billion exceeds the liability amount of
$130.6 billion included on the consolidated balance sheet
principally due to the time value of money, which accounts for
at least 80% of the difference, as well as differences in
assumptions, most significantly mortality, between the date the
liabilities were initially established and the current date. |
|
|
|
For the majority of the Companys insurance operations,
estimated contractual obligations for future policy benefits and
policyholder account balance liabilities as presented in the
table above are derived from the annual asset adequacy analysis
used to develop actuarial opinions of statutory reserve adequacy
for state regulatory purposes. These cash flows are materially
representative of the cash flows under generally accepted
accounting principles. |
|
|
|
Actual cash payments to policyholders may differ significantly
from the liabilities as presented in the consolidated balance
sheet and the estimated cash payments as presented in the table
above due to differences between actual experience and the
assumptions used in the establishment of these liabilities and
the estimation of these cash payments. |
|
(2) |
|
Policyholder account balances include liabilities related to
conventional guaranteed investment contracts, guaranteed
investment contracts associated with formal offering programs,
funding agreements, individual and group annuities, total
control accounts, bank deposits, individual and group universal
life, variable universal life and company-owned life insurance. |
|
|
|
Included within policyholder account balances are contracts
where the amount and timing of the payment is essentially fixed
and determinable. These amounts relate to policies where the
Company is currently making payments and will continue to do so,
as well as those where the timing of the payments has been
determined by the contract. Other contracts involve payment
obligations where the timing of future payments is uncertain and
where the Company is not currently making payments and will not
make payments until the occurrence of an insurable event, such
as death, or where the occurrence of the payment triggering
event, such as a surrender of or partial withdrawal on a policy
or deposit contract, is outside the control of the Company. The
Company has estimated the timing of the cash flows related to
these contracts based on historical experience, as well as its
expectation of future payment patterns. |
|
|
|
Excess interest reserves representing purchase accounting
adjustments of $692 million have been excluded from amounts
presented in the table above as they represent an accounting
convention and not a contractual obligation. |
|
|
|
Amounts presented in the table above represent the estimated
cash payments to be made to policyholders undiscounted as to
interest and including assumptions related to the receipt of
future premiums and deposits; withdrawals, including unscheduled
or partial withdrawals; policy lapses; surrender charges;
annuitization; mortality; future interest credited; policy loans
and other contingent events as appropriate to the respective
product type. Such estimated cash payments are also presented
net of estimated future premiums on policies currently in-force
and gross of any reinsurance recoverable. For obligations
denominated in foreign currencies, cash payments have been
estimated using current spot rates. |
|
|
|
The sum of the estimated cash flows shown for all years in the
table of $202.0 billion exceeds the liability amount of
$149.8 billion included on the consolidated balance sheet
principally due to the time value of money, which accounts for
at least 80% of the difference, as well as differences in
assumptions between the date the liabilities were initially
established and the current date. See the comments under
footnote 1 regarding the source and uncertainties associated
with the estimation of the contractual obligations related to
future policyholder benefits and policyholder account balances.
See also Extraordinary Market Conditions. |
|
(3) |
|
Other policyholder liabilities are comprised of other
policyholder funds, policyholder dividends payable and the
policyholder dividend obligation. Amounts included in the table
above related to these liabilities are as follows: |
|
|
|
a. Other policyholder funds includes liabilities for
incurred but not reported claims and claims payable on group
term life, long-term disability, LTC and dental; policyholder
dividends left on deposit and policyholder dividends due and
unpaid related primarily to traditional life and group life and
health; and premiums received in advance. Liabilities related to
unearned revenue of $1.9 billion have been excluded from
the cash payments presented in the table above because they
reflect an accounting convention and not a contractual
obligation. With the exception of policyholder dividends left on
deposit, and those
|
152
|
|
|
|
|
items excluded as noted in the preceding sentence, the
contractual obligation presented in the table above related to
other policyholder funds is equal to the liability reflected in
the consolidated balance sheet. Such amounts are reported in the
less than one year category due to the short-term nature of the
liabilities. Contractual obligations on policyholder dividends
left on deposit are projected based on assumptions of
policyholder withdrawal activity. |
|
|
|
b. Policyholder dividends payable consists of liabilities
related to dividends payable in the following calendar year on
participating policies. As such, the contractual obligation
related to policyholder dividends payable is presented in the
table above in the less than one year category at the amount of
the liability presented in the consolidated balance sheet.
|
|
|
|
c. The nature of the policyholder dividend obligation is
described in Note 9 of the Notes to Consolidated Financial
Statements. Because the exact timing and amount of the ultimate
policyholder dividend obligation is subject to significant
uncertainty and the amount of the policyholder dividend
obligation is based upon a long-term projection of the
performance of the closed block, management has reflected the
obligation at the amount of the liability, if any, presented in
the consolidated balance sheet in the more than five years
category. This was done to reflect the long-duration of the
liability and the uncertainty of the ultimate cash payment.
|
|
(4) |
|
Amounts presented in the table above for short-term debt,
long-term debt, collateral financing arrangements and junior
subordinated debt securities differ from the balances presented
on the consolidated balance sheet as the amounts presented in
the table above do not include premiums or discounts upon
issuance or purchase accounting fair value adjustments. The
amounts presented above also include interest on such
obligations as described below. |
|
|
|
Short-term debt consists of borrowings with original maturities
of less than one year carrying fixed interest rates. The
contractual obligation for short-term debt presented in the
table above represents the amounts due upon maturity plus the
related interest for the period from January 1, 2009
through maturity. |
|
|
|
Long-term debt bears interest at fixed and variable interest
rates through their respective maturity dates. Interest on fixed
rate debt was computed using the stated rate on the obligations
through maturity. Interest on variable rate debt is computed
using prevailing rates at December 31, 2008 and, as such,
does not consider the impact of future rate movements. Long-term
debt also includes payments under capital lease obligations of
$14 million, $5 million, $1 million and
$28 million, in the less than one year, one to three years,
three to five years and more than five years categories,
respectively. |
|
|
|
Collateral financing arrangements bear interest at fixed and
variable interest rates through their respective maturity dates.
Interest on fixed rate debt was computed using the stated rate
on the obligations through maturity. Interest on variable rate
debt is computed using prevailing rates at December 31,
2008 and, as such, does not consider the impact of future rate
movements. Pursuant to these collateral financing arrangements,
the Holding Company may be required to deliver cash or pledge
collateral to the respective unaffiliated financial
institutions. See Holding Company Global
Funding Sources. |
|
|
|
|
|
Junior subordinated debt securities bear interest at fixed
interest rates through their respective redemption dates.
Interest was computed using the stated rates on the obligations
through the scheduled redemption dates as it is the
Companys expectation that the debt will be redeemed at
that time. Inclusion of interest payments on junior subordinated
debt through the final maturity dates would increase the
contractual obligation by $4.6 billion. |
|
(5) |
|
The Company has accepted cash collateral in connection with
securities lending and derivative transactions. As the
securities lending transactions expire within the next year or
the timing of the return of the collateral is uncertain, the
return of the collateral has been included in the less than one
year category in the table above. The Company also holds
non-cash collateral, which is not reflected as a liability in
the consolidated balance sheet, of $1.2 billion at
December 31, 2008. |
|
(6) |
|
The Company commits to lend funds under mortgage loans,
partnerships, bank credit facilities, bridge loans and private
corporate bond investments. In the table above, the timing of
the funding of mortgage loans and private corporate bond
investments is based on the expiration date of the commitment.
As it relates to commitments to lend funds to partnerships and
under bank credit facilities, the Company anticipates that these
amounts could be invested any time over the next five years;
however, as the timing of the fulfillment of the obligation
cannot be predicted, such obligations are presented in the less
than one year category in the table |
153
|
|
|
|
|
above. Commitments to fund bridge loans are short-term
obligations and, as a result, are presented in the less than one
year category in the table above. See
Off-Balance Sheet Arrangements. |
|
(7) |
|
As a lessee, the Company has various operating leases, primarily
for office space. Contractual provisions exist that could
increase or accelerate those leases obligations presented,
including various leases with early buyouts and/or escalation
clauses. However, the impact of any such transactions would not
be material to the Companys financial position or results
of operations. See Off-Balance Sheet
Arrangements. |
|
(8) |
|
Other includes those other liability balances which represent
contractual obligations, as well as other miscellaneous
contractual obligations of $12 million not included
elsewhere in the table above. Other liabilities presented in the
table above are principally comprised of amounts due under
reinsurance arrangements, payables related to securities
purchased but not yet settled, securities sold short, accrued
interest on debt obligations, estimated fair value of derivative
obligations, deferred compensation arrangements, guaranty
liabilities, the estimated fair value of forward stock purchase
contracts, as well as general accruals and accounts payable due
under contractual obligations. If the timing of any of the other
liabilities is sufficiently uncertain, the amounts are included
within the less than one year category. |
|
|
|
The other liabilities presented in the table above differs from
the amount presented in the consolidated balance sheet by
$4.0 billion due primarily to the exclusion of items such
as minority interests, legal liabilities, pension and
postretirement benefit obligations, taxes due other than income
tax, unrecognized tax benefits and related accrued interest,
accrued severance and employee incentive compensation and other
liabilities such as deferred gains and losses. Such items have
been excluded from the table above as they represent accounting
conventions or are not liabilities due under contractual
obligations. |
|
|
|
The net funded status of the Companys pension and other
postretirement liabilities included within other liabilities has
been excluded from the amounts presented in the table above.
Rather, the amounts presented represent the discretionary
contributions of $150 million to be made by the Company to
the pension plan in 2009 and the discretionary contributions of
$120 million, based on the current years expected
gross benefit payments to participants, to be made by the
Company to the postretirement benefit plans during 2009.
Virtually all contributions to the pension and postretirement
benefit plans are made by the insurance subsidiaries of the
Holding Company with little impact on the Holding Companys
cash flows. |
|
|
|
Excluded from the table above are unrecognized tax benefits and
accrued interest of $766 million and $176 million,
respectively, for which the Company cannot reliably determine
the timing of payment. Current income tax payable is also
excluded from the table. |
|
|
|
See also Off-Balance Sheet Arrangements. |
Separate account liabilities are excluded from the table above.
Generally, the separate account owner, rather than the Company,
bears the investment risk of these funds. The separate account
assets are legally segregated and are not subject to the claims
that arise out of any other business of the Company. Net
deposits, net investment income and realized and unrealized
capital gains and losses on the separate accounts are fully
offset by corresponding amounts credited to contractholders
whose liability is reflected with the separate account
liabilities. Separate account liabilities are fully funded by
cash flows from the separate account assets and are set equal to
the estimated fair value of separate account assets as
prescribed by
SOP 03-1.
The Company also enters into agreements to purchase goods and
services in the normal course of business; however, these
purchase obligations are not material to its consolidated
results of operations or financial position at December 31,
2008.
Additionally, the Company has agreements in place for services
it conducts, generally at cost, between subsidiaries relating to
insurance, reinsurance, loans, and capitalization. Intercompany
transactions have appropriately been eliminated in
consolidation. Intercompany transactions among insurance
subsidiaries and affiliates have been approved by the
appropriate departments of insurance as required.
Support Agreements. The Holding Company and
several of its subsidiaries (each, an Obligor) are
parties to various capital support commitments, guarantees and
contingent reinsurance agreements with certain subsidiaries of
the Holding Company and a corporation in which the Holding
Company owns 50% of the equity. Under these arrangements, each
Obligor, with respect to the applicable entity, has agreed to
cause such entity to meet specified
154
capital and surplus levels, has guaranteed certain contractual
obligations or has agreed to provide, upon the occurrence of
certain contingencies, reinsurance for such entitys
insurance liabilities. Management anticipates that to the extent
that these arrangements place significant demands upon the
Company, there will be sufficient liquidity and capital to
enable the Company to meet these demands. See The Holding
Company Liquidity and Capital Uses
Support Agreements.
Litigation. Putative or certified class action
litigation and other litigation, and claims and assessments
against the Company, in addition to those discussed elsewhere
herein and those otherwise provided for in the Companys
consolidated financial statements, have arisen in the course of
the Companys business, including, but not limited to, in
connection with its activities as an insurer, employer,
investor, investment advisor and taxpayer. Further, state
insurance regulatory authorities and other federal and state
authorities regularly make inquiries and conduct investigations
concerning the Companys compliance with applicable
insurance and other laws and regulations.
It is not possible to predict or determine the ultimate outcome
of all pending investigations and legal proceedings or provide
reasonable ranges of potential losses except as noted elsewhere
herein in connection with specific matters. In some of the
matters referred to herein, very large
and/or
indeterminate amounts, including punitive and treble damages,
are sought. Although in light of these considerations, it is
possible that an adverse outcome in certain cases could have a
material adverse effect upon the Companys financial
position, based on information currently known by the
Companys management, in its opinion, the outcome of such
pending investigations and legal proceedings are not likely to
have such an effect. However, given the large
and/or
indeterminate amounts sought in certain of these matters and the
inherent unpredictability of litigation, it is possible that an
adverse outcome in certain matters could, from time to time,
have a material adverse effect on the Companys
consolidated net income or cash flows in particular quarterly or
annual periods.
Fair Value. The estimated fair value of the
Companys fixed maturity securities, equity securities,
trading securities, short-term investments, derivatives, and
embedded derivatives along with their fair value hierarchy, are
described and disclosed in Note 24 of the Notes to the
Consolidated Financial Statements and
Investments.
Unprecedented credit and equity market conditions have resulted
in difficulty in valuing certain asset classes due to inactive
or disorderly markets and less observable market data. See
Extraordinary Market Conditions. Rapidly changing
market conditions and less liquid markets could materially
change the valuation of securities within our consolidated
financial statements and
period-to-period
changes in value could vary significantly. The ultimate value at
which securities may be sold could differ significantly from the
valuations reported within the consolidated financial statements
and could impact our liquidity.
Further, recent events have prompted accounting standard setters
and law makers to study the definition and application of fair
value accounting. It appears likely that further disclosures
regarding the application of, and amounts carried at, fair value
will be required.
See also Quantitative and Qualitative
Disclosures About Market Risk.
Other. Based on managements analysis of
its expected cash inflows from operating activities, the
dividends it receives from subsidiaries, that are permitted to
be paid without prior insurance regulatory approval and its
portfolio of liquid assets and other anticipated cash flows,
management believes there will be sufficient liquidity to enable
the Company to make payments on debt, make cash dividend
payments on its common and preferred stock, pay all operating
expenses, and meet its cash needs. The nature of the
Companys diverse product portfolio and customer base
lessens the likelihood that normal operations will result in any
significant strain on liquidity.
Consolidated Cash Flows. Net cash provided by
operating activities increased by $0.8 billion to
$10.7 billion for the year ended December 31, 2008 as
compared to $9.9 billion for the year ended
December 31, 2007. Cash flows from operations represent net
income earned adjusted for non-cash charges and changes in
operating assets and liabilities. The net cash generated from
operating activities is used to meet the Companys
liquidity needs, such as debt and dividend payments, and
provides cash available for investing activities. Cash flows
from operations are affected by the timing of receipt of
premiums and other revenues as well as the payment of the
Companys insurance liabilities. In 2008 cash flows from
operations includes the impact of the Company entering the
mortgage origination and servicing business.
155
Net cash provided by operating activities increased by
$3.3 billion to $9.9 billion for the year ended
December 31, 2007 as compared to $6.6 billion for the
year ended December 31, 2006 primarily due to higher net
investment income and premiums, fees and other revenues.
Net cash provided by financing activities was $6.2 billion
and $3.9 billion for the years ended December 31, 2008
and 2007, respectively. Accordingly, net cash provided by
financing activities increased by $2.3 billion for the year
ended December 31, 2008 as compared to the prior year. In
2008 the Company reduced securities lending activities in line
with market conditions, which resulted in a decrease of
$20.0 billion in the cash collateral received in connection
with the securities lending program. Partially offsetting this
decrease was a net increase of $15.8 billion in
policyholder account balances, which primarily reflected the
Companys increased level of funding agreements with the
FHLB of NY and with MetLife Short Term Funding LLC, an issuer of
commercial paper (See Extraordinary Market
Conditions and Liquidity and Capital
Sources Global Funding Sources). The Company
also experienced a $6.9 billion increase in cash collateral
received under derivatives transactions, primarily as a result
of the improvement in estimated fair value of the derivatives.
The cash collateral received under derivatives transactions is
invested in cash, cash equivalents and other short-term
investments, which partly explains the major increase in this
category of liquid assets. The Company increased short-term debt
by $2.0 billion in 2008 compared with a decrease of
$0.8 billion in 2007, which primarily reflected new
activity at MetLife Bank, which borrowed $1.0 billion from
the Federal Reserve Bank of New York under the Term Auction
Facility and entered into $0.7 billion of short-term
borrowing from the FHLB of NY in order to fund mortgage
origination activity acquired by the Company in 2008 and provide
a cost effective substitute for cash collateral received in
connection with securities lending. In 2008 the net cash paid
related to collateral financing arrangements was
$0.5 billion resulting from the incurrence of price
returns, which compares to $4.9 billion of cash provided by
collateral financing arrangement transactions completed in 2007,
as market conditions in 2008 reduced the availability and
attractiveness of such financing. In 2008, there was a net
issuance of $0.7 billion of long-term debt and junior
subordinated debentures, compared to a net issuance in 2007 of
$1.1 billion. Finally, in order to strengthen its capital
base, in 2008 the Company reduced its level of common stock
repurchase activity by $0.5 billion compared with 2007 only
repurchasing $1.3 billion of common stock in 2008 as
compared to $1.8 billion in 2007 and issued $3.3 billion of
stock compared with no issuance in 2007. The Company also paid
dividends on the preferred stock and common stock of $0.7
billion which was comparable to the dividends paid in 2007.
Net cash provided by financing activities was $3.9 billion
and $15.4 billion for the years ended December 31,
2007 and 2006, respectively. Accordingly, net cash provided by
financing activities decreased by $11.5 billion for the
year ended December 31, 2007 as compared to the prior year.
Net cash provided by financing activities decreased primarily
because cash collateral received in connection with securities
lending activity and other transactions was a decrease in cash
$1.7 billion lower for the year ended December 31,
2007 as compared to the prior year where cash increased by $11.3
billion due to an expansion of the securities lending program in
2006. In 2007 the Company benefited from a $4.0 billion
increase in cash from the issuance of collateral financing
arrangements as favorable opportunities to execute such
transactions arose. Also in 2007, cash provided by the
Companys debt financing program decreased to $0.2 billion
as compared to $0.8 billion in the prior year from
short-term, long-term and subordinated debt financings as the
mixture and amount of debt was adjusted in line with the
Companys capital structure plans and market opportunities.
In addition, the Company increased the common stock repurchase
program to $1.7 billion in 2007 as compared to the prior
year of $0.5 billion in order to accomplish the Companys
capital structure plans. The Company also paid dividends on its
preferred stock and common stock of $0.7 billion which was
$0.1 billion higher than prior year reflecting the increase
in the common stock dividend. The remaining decrease in cash was
due to slightly lower net flows on policyholder account balances.
Net cash used in investing activities was $2.7 billion and
$10.6 billion for the years ended December 31, 2008
and 2007, respectively. Accordingly, net cash used in investing
activities decreased by $7.9 billion for the year ended
December 31, 2008 as compared to the prior year. The
Company reduced the level of cash available for investing
activities in 2008 in order to significantly increase cash and
cash equivalents as a liquidity cushion in response to the
deterioration in securities markets in 2008. Cash and cash
equivalents increased $13.9 billion at December 31,
2008 compared to the prior year. The net decrease in the amount
of cash used in investing activities was primarily reflected in
a decrease in net purchases of fixed maturity and equity
securities of $15.8 billion and $2.4 billion,
respectively, as well as a decrease in the net purchases of real
estate and real estate joint ventures of
156
$0.5 billion, a decrease in other invested assets of
$0.5 billion and a decrease of $0.5 billion in the net
origination of mortgage and consumer loans. In addition, the
2007 period included the sale of MetLife Australias
annuities and pension businesses of $0.7 billion. These
decreases in net cash used in investing activities were
partially offset by an increase in cash invested in short-term
investments of $11.3 billion due to a repositioning from
other investment classes due to volatile market conditions, an
increase in net purchases of other limited partnership interests
of $0.1 billion and an increase in policy loans of
$0.3 billion. In addition, the 2008 period includes an
increase of $0.4 billion of cash used to purchase
businesses and the decrease of $0.3 billion of cash held by
a subsidiary, which was split-off from the Company.
Net cash used in investing activities was $10.6 billion and
$18.9 billion for the years ended December 31, 2007
and 2006, respectively. Accordingly, net cash used in investing
activities decreased by $8.3 billion for the year ended
December 31, 2007 as compared to prior year. In 2007, cash
available for the purchase of invested assets decreased by
$11.5 billion as a result of the reduction in cash provided
by financing activities discussed above. Also, partially
offsetting this decrease was an increase of $3.3 billion in
net cash provided by operating activities discussed above. The
lower amount of cash available for investing activities resulted
in a decrease in net purchases of fixed maturity securities of
$15.9 billion, other invested assets of $1.4 billion,
and a decrease in net origination of mortgage and consumer loans
of $0.6 billion. This was partially offset by increases in
the net purchases of real estate and real estate joint ventures
of $6.3 billion, equity securities of $1.4 billion and
other limited partnership interests of $0.8 billion. Also,
there was a decrease in cash provided by short-term investments
of $0.5 billion. In addition, the 2007 period includes the
sale of MetLife Australias annuities and pension
businesses and the acquisition of the remaining 50% interest in
MetLife Fubon of $0.7 billion, while the 2006 period
includes additional consideration paid related to purchases of
businesses $0.1 billion.
As it relates to cash flows during 2009, the Company anticipates
it will pay $30 million in dividends on its series A
and series B preferred shares in March 2009 as
announced in February, 2009 and the Company received
$1,035 million in cash in connection with the settlement of
the stock purchase contracts as described more fully in
The Holding Company Liquidity and Capital
Sources Remarketing of Junior Subordinated
Debentures and Settlement of Stock Purchase Contracts.
The
Holding Company
Capital
Restrictions and Limitations on Bank Holding Companies and
Financial Holding Companies
Capital. The Holding Company and its insured
depository institution subsidiary, MetLife Bank, are subject to
risk-based and leverage capital guidelines issued by the federal
banking regulatory agencies for banks and financial holding
companies. The federal banking regulatory agencies are required
by law to take specific prompt corrective actions with respect
to institutions that do not meet minimum capital standards. As
of their most recently filed reports with the federal banking
regulatory agencies, MetLife, Inc. and MetLife Bank met the
minimum capital standards as per federal banking regulatory
agencies with all of MetLife Banks risk-based and leverage
capital ratios meeting the federal banking regulatory
agencies well capitalized standards and all of
MetLife, Inc.s risk-based and leverage capital ratios
meeting the adequately capitalized standards.
157
The following table contains the RBC ratios and the regulatory
requirements for MetLife, Inc., as a bank holding company, and
MetLife Bank:
MetLife,
Inc.
RBC Ratios Bank Holding Company
December 31,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Regulatory
|
|
|
Regulatory
|
|
|
|
|
|
|
|
|
|
Requirements
|
|
|
Requirements
|
|
|
|
2008
|
|
|
2007
|
|
|
Minimum
|
|
|
Well Capitalized
|
|
|
Total RBC Ratio
|
|
|
9.52%
|
|
|
|
9.87%
|
|
|
|
8.00
|
%
|
|
|
10.00
|
%
|
Tier 1 RBC Ratio
|
|
|
9.21%
|
|
|
|
9.56%
|
|
|
|
4.00
|
%
|
|
|
6.00
|
%
|
Tier 1 Leverage Ratio
|
|
|
5.77%
|
|
|
|
5.56%
|
|
|
|
4.00
|
%
|
|
|
n/a
|
|
MetLife
Bank
RBC Ratios Bank
December 31,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Regulatory
|
|
|
Regulatory
|
|
|
|
|
|
|
|
|
|
Requirements
|
|
|
Requirements
|
|
|
|
2008
|
|
|
2007
|
|
|
Minimum
|
|
|
Well Capitalized
|
|
|
Total RBC Ratio
|
|
|
12.32%
|
|
|
|
12.60%
|
|
|
|
8.00
|
%
|
|
|
10.00
|
%
|
Tier 1 RBC Ratio
|
|
|
11.72%
|
|
|
|
12.03%
|
|
|
|
4.00
|
%
|
|
|
6.00
|
%
|
Tier 1 Leverage Ratio
|
|
|
6.51%
|
|
|
|
6.32%
|
|
|
|
4.00
|
%
|
|
|
5.00
|
%
|
Liquidity
and Capital
Liquidity and capital are managed to preserve stable, reliable
and cost-effective sources of cash to meet all current and
future financial obligations and are provided by a variety of
sources, including a portfolio of liquid assets, a diversified
mix of short- and long-term funding sources from the wholesale
financial markets and the ability to borrow through committed
credit facilities. The Holding Company is an active participant
in the global financial markets through which it obtains a
significant amount of funding. These markets, which serve as
cost-effective sources of funds, are critical components of the
Holding Companys liquidity and capital management.
Decisions to access these markets are based upon relative costs,
prospective views of balance sheet growth and a targeted
liquidity profile and capital structure. A disruption in the
financial markets could limit the Holding Companys access
to liquidity. See Extraordinary Market Conditions.
The Holding Companys ability to maintain regular access to
competitively priced wholesale funds is fostered by its current
high credit ratings from the major credit rating agencies.
Management views its capital ratios, credit quality, stable and
diverse earnings streams, diversity of liquidity sources and its
liquidity monitoring procedures as critical to retaining high
credit ratings. See The Company
Capital Rating Agencies.
Liquidity is monitored through the use of internal liquidity
risk metrics, including the composition and level of the liquid
asset portfolio, timing differences in short-term cash flow
obligations, access to the financial markets for capital and
debt transactions and exposure to contingent draws on the
Holding Companys liquidity.
Liquidity
and Capital Sources
Dividends. The primary source of the Holding
Companys liquidity is dividends it receives from its
insurance subsidiaries. The Holding Companys insurance
subsidiaries are subject to regulatory restrictions on the
payment of dividends imposed by the regulators of their
respective domiciles. The dividend limitation for
U.S. insurance subsidiaries is generally based on the
surplus to policyholders as of the immediately preceding
calendar year and statutory net gain from operations for the
immediately preceding calendar year. Statutory accounting
practices, as prescribed by insurance regulators of various
states in which the Company conducts business, differ in certain
respects from accounting principles used in financial statements
prepared in conformity with GAAP. The
158
significant differences relate to the treatment of DAC, certain
deferred income tax, required investment reserves, reserve
calculation assumptions, goodwill and surplus notes. Management
of the Holding Company cannot provide assurances that the
Holding Companys insurance subsidiaries will have
statutory earnings to support payment of dividends to the
Holding Company in an amount sufficient to fund its cash
requirements and pay cash dividends and that the applicable
insurance departments will not disapprove any dividends that
such insurance subsidiaries must submit for approval.
The table below sets forth the dividends permitted to be paid by
the respective insurance subsidiary without insurance regulatory
approval and the respective dividends paid:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2009
|
|
|
2008
|
|
|
2007
|
|
|
|
Permitted
|
|
|
|
|
|
Permitted
|
|
|
|
|
|
Permitted
|
|
|
|
w/o
|
|
|
|
|
|
w/o
|
|
|
|
|
|
w/o
|
|
Company
|
|
Approval (1)
|
|
|
Paid (2)
|
|
|
Approval (3)
|
|
|
Paid (2)
|
|
|
Approval (3)
|
|
|
|
(In millions)
|
|
|
Metropolitan Life Insurance Company
|
|
$
|
552
|
|
|
$
|
1,318
|
(4)
|
|
$
|
1,299
|
|
|
$
|
500
|
|
|
$
|
919
|
|
MetLife Insurance Company of Connecticut
|
|
$
|
714
|
|
|
$
|
500
|
|
|
$
|
1,026
|
|
|
$
|
690
|
(6)
|
|
$
|
690
|
|
Metropolitan Tower Life Insurance Company
|
|
$
|
88
|
|
|
$
|
277
|
(5)
|
|
$
|
113
|
|
|
$
|
|
|
|
$
|
104
|
|
Metropolitan Property and Casualty Insurance Company
|
|
$
|
9
|
|
|
$
|
300
|
|
|
$
|
|
|
|
$
|
400
|
|
|
$
|
16
|
|
|
|
|
(1) |
|
Reflects dividend amounts that may be paid during 2009 without
prior regulatory approval. However, if paid before a specified
date during 2009, some or all of such dividends may require
regulatory approval. |
|
(2) |
|
Includes amounts paid including those requiring regulatory
approval. |
|
(3) |
|
Reflects dividend amounts that could have been paid during the
relevant year without prior regulatory approval. |
|
(4) |
|
Consists of shares of RGA stock distributed by Metropolitan Life
Insurance Company to the Holding Company as an in-kind dividend
of $1,318 million. |
|
(5) |
|
Includes shares of an affiliate distributed to the Holding
Company as an in-kind dividend of $164 million. |
|
(6) |
|
Includes a return of capital of $404 million as approved by
the applicable insurance department, of which $350 million
was paid to the Holding Company. |
In the fourth quarter of 2008, MICC declared and paid an
ordinary dividend of $500 million to the Holding Company.
In the third quarter of 2008, MLIC used its otherwise ordinary
dividend capacity through a non-cash dividend in conjunction
with the RGA split-off as approved by the New York Insurance
Commissioner.
Under New York State Insurance Law, MLIC is permitted, without
prior insurance regulatory clearance, to pay stockholder
dividends to the Holding Company as long as the aggregate amount
of all such dividends in any calendar year does not exceed the
lesser of: (i) 10% of its surplus to policyholders as of
the end of the immediately preceding calendar year; or
(ii) its statutory net gain from operations for the
immediately preceding calendar year (excluding realized capital
gains). MLIC will be permitted to pay a cash dividend to the
Holding Company in excess of the lesser of such two amounts only
if it files notice of its intention to declare such a dividend
and the amount thereof with the Superintendent and the
Superintendent does not disapprove the distribution within
30 days of its filing.
For the year ended December 31, 2008, $235 million in
dividends from other subsidiaries were paid to the Holding
Company. For the year ended December 31, 2007,
$190 million in dividends from other subsidiaries were
paid, of which $176 million were returns of capital, to the
Holding Company.
Liquid Assets. An integral part of the Holding
Companys liquidity management is the amount of liquid
assets it holds. Liquid assets include cash, cash equivalents,
short-term investments and publicly-traded securities. Liquid
assets exclude cash collateral received under the Companys
securities lending program that has been reinvested in cash,
cash equivalents, short-term investments and publicly-traded
securities. At December 31, 2008 and 2007, the Holding
Company had $2.7 billion and $2.3 billion in liquid
assets, respectively. At December 31, 2008, the Holding
Company had pledged $0.8 billion of liquid assets under
collateral support agreements as described in
Investments Assets on Deposit,
Held in Trust and Pledged as Collateral. The Holding
Company did not pledge any liquid assets at December 31,
2007.
159
Global Funding Sources. Liquidity is also
provided by a variety of short-term instruments, including
commercial paper. Capital is provided by a variety of long-term
instruments, including medium- and long-term debt, junior
subordinated debt securities, collateral financing arrangements,
capital securities and stockholders equity. The diversity
of the Holding Companys funding sources enhances funding
flexibility and limits dependence on any one source of funds and
generally lowers the cost of funds. Other sources of the Holding
Companys liquidity include programs for short-and
long-term borrowing, as needed.
During this extraordinary market environment, management is
continuously monitoring and adjusting its liquidity and capital
plans for the Holding Company and its subsidiaries in light of
changing needs and opportunities. The dislocation in the credit
markets has limited the access of financial institutions to
long-term debt and hybrid capital. While, in general, yields on
benchmark U.S. Treasury securities were historically low
during 2008, related spreads on debt instruments, in general,
and those of financial institutions, specifically, were as high
as they have been in our history as a public company.
This shift resulted in a relative increase in the cost of new
debt capital and new credit. For example, in August 2008,
MetLife remarketed senior unsecured debt with a ten-year
maturity at a 6.817% coupon. At December 31, 2008, the
average coupon on ten-year senior unsecured debt of the Holding
Company, excluding the debt remarketed in August 2008 is 5.4%,
or 1.4% less than that of the debt remarketed in August 2008.
MetLife has issued $600 million in a single series of
LIBOR-based preferred stock with a 4% floor. This series
represents a small portion of MetLifes fixed charges. At
current levels, LIBOR would have to increase by 180 basis
points (over 145% increase) to have any impact on the dividend
for these preferred securities.
MetLife amended and restated certain of its credit agreements in
December 2008. These changes included increases in pricing for
these agreements compared to the original rates.
In February 2009, the Holding Company closed the successful
remarketing of the Series B portion of the junior
subordinated debentures underlying the common equity units. The
Series B junior subordinated debentures were modified as
permitted by their terms to be 7.717% senior debt
securities, Series B, due February 15, 2019. See
Subsequent Events. This issuance
reflects a moderate increase in the Companys cost of
borrowing.
MetLife has no current plans to raise additional capital.
The Company is participating in certain economic stabilization
programs established by various government institutions. See
The Company Liquidity and Capital
Sources.
At December 31, 2008 and 2007, the Holding Company had
$300 million and $310 million in short-term debt
outstanding, respectively. At December 31, 2008 and 2007,
the Holding Company had $7.7 billion and $7.0 billion
of unaffiliated long-term debt outstanding, respectively. At
both December 31, 2008 and 2007, the Holding Company had
$500 million of affiliated long-term debt outstanding,
respectively. At December 31, 2008 and 2007, the Holding
Company had $2.3 billion and $3.4 billion of junior
subordinated debt securities outstanding. At December 31,
2008 and 2007, the Holding Company had $2.7 billion and
$2.4 billion in collateral financing arrangements
outstanding, respectively.
In November 2007, the Holding Company filed a shelf registration
statement (the 2007 Registration Statement) with the
SEC, which was automatically effective upon filing, in
accordance with SEC rules which also allow for pay-as-you-go
fees and the ability to add securities by filing automatically
effective amendment for companies, such as the Holding Company,
which qualify as Well-Known Seasoned Issuers. The
2007 Registration Statement registered an unlimited amount of
debt and equity securities and supersedes the shelf registration
statement that the Holding Company filed in April 2005. The
terms of any offering will be established at the time of the
offering.
Debt Issuances. As described more fully in
Remarketing of Junior Subordinated Debentures and
Settlement of Stock Purchase Contracts the Holding Company
sold senior notes in August 2008 and February 2009.
As described more fully in The Company
Liquidity and Capital Sources Debt
Issuances, during April 2008, Trust X issued 2008
Trust Securities with a face amount of $750 million,
and a fixed rate of interest of 9.25% up to, but not including,
April 8, 2038, the scheduled redemption date. The
beneficial interest in Trust X held by the
160
Holding Company is not represented by an investment in
Trust X but rather by a financing agreement between the
Holding Company and Trust X. The assets of Trust X are
$750 million of 8.595% surplus notes of MICC, which are
scheduled to mature April 8, 2038, and rights under the
financing agreement. Under the financing agreement, the Holding
Company has the obligation to make payments
(i) semiannually at a fixed rate of 0.655% of the surplus
notes outstanding and owned by Trust X or if greater
(ii) equal to the difference between the 2008
Trust Securities interest payment and the interest received
by Trust X on the surplus notes. The ability of MICC to
make interest and principal payments on the surplus notes to the
Trust is contingent upon regulatory approval. The 2008
Trust Securities will be exchanged into a like amount of
Holding Company junior subordinated debentures on April 8,
2038, the scheduled redemption date; mandatorily under certain
circumstances; and at any time upon the Holding Company
exercising its option to redeem the securities. The 2008
Trust Securities will be exchanged for junior subordinated
debentures prior to repayment and the Holding Company is
ultimately responsible for repayment of the junior subordinated
debentures. The Holding Companys other rights and
obligations as it relates to the deferral of interest,
redemption, replacement capital obligation and RCC associated
with the issuance of the 2008 Trust Securities are more
fully described in The Company Liquidity and
Capital Sources Debt Issuances.
During December 2007, Trust IV issued 2007
Trust Securities with a face amount of $700 million
and a discount of $6 million ($694 million) and a
fixed rate of interest of 7.875% up to, but not including,
December 15, 2037, the scheduled redemption date. The
beneficial interest of Trust IV held by the Holding Company
is not represented by an investment in Trust IV but rather
by a financing agreement between the Holding Company and
Trust IV. The assets of Trust IV are $700 million
of 7.375% surplus notes of MLIC, which are scheduled to mature
December 15, 2037, and rights under the financing
agreement. Under the financing agreement, the Holding Company
has the obligation to make payments (i) semiannually at a
fixed rate of 0.50% of the surplus notes outstanding and owned
by Trust IV or if greater (ii) equal to the difference
between the 2007 Trust Securities interest payment and the
interest received by Trust IV on the surplus notes. The
ability of MLIC to make interest and principal payments on the
surplus notes to the Holding Company is contingent upon
regulatory approval. The 2007 Trust Securities, will be
exchanged into a like amount of Holding Company junior
subordinated debentures on December 15, 2037, the scheduled
redemption date; mandatorily under certain circumstances; and at
any time upon the Holding Company exercising its option to
redeem the securities. The 2007 Trust Securities will be
exchanged for junior subordinated debentures prior to repayment
and the Holding Company is ultimately responsible for repayment
of the junior subordinated debentures. The Holding
Companys other rights and obligations as it relates to the
deferral of interest, redemption, replacement capital obligation
and RCC associated with the issuance of the
Trust Securities are more fully described in The
Company Liquidity and Capital Sources
Debt Issuances.
As described more fully in The Company
Liquidity and Capital Sources Debt Issuances:
|
|
|
|
|
In December 2007, the Holding Company, in connection with the
collateral financing arrangement associated with MRCs
reinsurance of the closed block liabilities, entered into an
agreement with an unaffiliated financial institution under which
the Holding Company is entitled to the interest paid by MRC on
the surplus notes of
3-month
LIBOR plus 0.55% in exchange for the payment of
3-month
LIBOR plus 1.12%, payable quarterly.
|
Under this agreement, the Holding Company may also be required
to pledge collateral or make payments to the unaffiliated
financial institution related to any decline in the estimated
fair value of the surplus notes and in connection with any early
termination of this agreement. During the year ended
December 31, 2008, the Holding Company paid
$800 million to the unaffiliated financial institution
related to a decline in the estimated fair value of the surplus
notes. This payment reduced the amount under the agreement on
which the Holding Companys interest payment is due but did
not reduce the outstanding amount of the surplus notes. In
addition, the Holding Company had pledged collateral of
$230 million to the unaffiliated financial institution at
December 31, 2008. No collateral was pledged at
December 31, 2007. The Holding Companys net cost of
0.57% has been allocated to MRC. For the year ended
December 31, 2008, this amount was $14 million. For
the year ended December 31, 2007 this amount was immaterial.
|
|
|
|
|
In May 2007, the Holding Company, in connection with the
collateral financing arrangement associated with MRSCs
reinsurance of universal life secondary guarantees, entered into
an agreement with an unaffiliated
|
161
|
|
|
|
|
financial institution under which the Holding Company is
entitled to the return on the investment portfolio held by a
trust established in connection with this collateral financing
arrangement in exchange for the payment of a stated rate of
return to the unaffiliated financial institution of
3-month
LIBOR plus 0.70%, payable quarterly. The Holding Company may
also be required to make payments to the unaffiliated financial
institution, for deposit into the trust, related to any decline
in the fair value of the assets held by the trust, as well as
amounts outstanding upon maturity or early termination of the
collateral financing arrangement. As a result of this agreement,
the Holding Company effectively assumed the $2.4 billion
liability under the collateral financing agreement along with a
beneficial interest in the trust holding the associated assets.
The Holding Company simultaneously contributed to MRSC its
beneficial interest in the trust, along with any return to be
received on the investment portfolio held by the trust. For the
year ended December 31, 2008, the Holding Company paid
$320 million to the unaffiliated financial institution as a
result of the decline in the fair value of the assets in the
trust. All of the $320 million was deposited into the
trust. In January 2009, the Holding Company paid an additional
$360 million to the unaffiliated financial institution as a
result of the continued decline in the fair value of the assets
in trust which was also deposited into the trust. In addition,
the Holding Company may be required to pledge collateral to the
unaffiliated financial institution under this agreement. At
December 31, 2008, the Holding Company had pledged
$86 million under the agreement. No collateral had been
pledged under the agreement as December 31, 2007. Interest
expense incurred by the Holding Company under the collateral
financing arrangement for the years ended December 31, 2008
and 2007 was $107 million and $84 million,
respectively. The allocation of these financing costs to MRSC is
included in other revenues and recorded as an additional
investment in MRSC.
|
In December 2006, the Holding Company issued junior subordinated
debentures with a face amount of $1.25 billion. See
The Company Liquidity and Capital
Sources Debt Issuances for further information.
In September 2006, the Holding Company issued $204 million
of affiliated long-term debt with an interest rate of 6.07%
maturing in 2016.
In March 2006, the Holding Company issued $10 million of
affiliated long-term debt with an interest rate of 5.70%
maturing in 2016.
The following table summarizes the Holding Companys
outstanding senior notes series, excluding any premium or
discount, at December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
Date
|
|
Principal
|
|
|
Interest Rate
|
|
|
Maturity
|
|
|
|
(In millions)
|
|
|
|
|
|
|
|
|
August 2008
|
|
$
|
1,035
|
|
|
|
6.82
|
%
|
|
|
2018
|
|
June 2005
|
|
$
|
1,000
|
|
|
|
5.00
|
%
|
|
|
2015
|
|
June 2005
|
|
$
|
1,000
|
|
|
|
5.70
|
%
|
|
|
2035
|
|
June 2005 (1)
|
|
$
|
585
|
|
|
|
5.25
|
%
|
|
|
2020
|
|
December 2004 (1)
|
|
$
|
512
|
|
|
|
5.38
|
%
|
|
|
2024
|
|
June 2004
|
|
$
|
350
|
|
|
|
5.50
|
%
|
|
|
2014
|
|
June 2004
|
|
$
|
750
|
|
|
|
6.38
|
%
|
|
|
2034
|
|
November 2003
|
|
$
|
500
|
|
|
|
5.00
|
%
|
|
|
2013
|
|
November 2003
|
|
$
|
200
|
|
|
|
5.88
|
%
|
|
|
2033
|
|
December 2002
|
|
$
|
400
|
|
|
|
5.38
|
%
|
|
|
2012
|
|
December 2002
|
|
$
|
600
|
|
|
|
6.50
|
%
|
|
|
2032
|
|
November 2001
|
|
$
|
750
|
|
|
|
6.13
|
%
|
|
|
2011
|
|
|
|
|
(1) |
|
This amount represents the translation of pounds sterling into
U.S. dollars using the noon buying rate on December 31,
2008 of $1.4619 as announced by the Federal Reserve Bank of New
York. |
Credit Facilities. The Holding Company and
MetLife Funding entered into a $2,850 million credit
agreement with various financial institutions, the proceeds of
which are available to be used for general
162
corporate purposes, to support their commercial paper programs
and for the issuance of letters of credit. All borrowings under
the credit agreement must be repaid by June 2012, except that
letters of credit outstanding upon termination may remain
outstanding until June 2013. The borrowers and the lenders under
this facility may agree to extend the term of all or part of the
facility to no later than June 2014, except that letters of
credit outstanding upon termination may remain outstanding until
June 2015. Total fees associated with these credit facilities
were $17 million, of which $11 million related to
deferred amendment fees for the year ended December 31,
2008.
At December 31, 2008, $2.3 billion of letters of
credit have been issued under these unsecured credit facilities
on behalf of the Holding Company.
Management has no reason to believe that its lending
counterparties are unable to fulfill their respective
contractual obligations. See The Company
Liquidity and Capital Sources Credit
Facilities.
Committed Facilities. The Holding Company
maintains committed facilities aggregating $11.5 billion at
December 31, 2008. When drawn upon, these facilities bear
interest at varying rates in accordance with the respective
agreements as specified below. The facilities are used for
collateral for certain of the Companys insurance
liabilities. Management has no reason to believe that its
lending counterparties are unable to fulfill their contractual
obligations. See The Company
Liquidity and Capital Sources Committed
Facilities.
Total fees associated with these committed facilities were
$35 million, of which $13 million related to deferred
amendment fees, for the year ended December 31, 2008.
Information on committed facilities at December 31, 2008 is
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Letter of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit
|
|
|
Unused
|
|
|
Maturity
|
|
Account Party/Borrower(s)
|
|
Expiration
|
|
Capacity
|
|
|
Drawdowns
|
|
|
Issuances
|
|
|
Commitments
|
|
|
(Years)
|
|
|
|
|
|
(In millions)
|
|
|
MetLife, Inc.
|
|
August 2009 (1)
|
|
$
|
500
|
|
|
$
|
|
|
|
$
|
500
|
|
|
$
|
|
|
|
|
|
|
Exeter Reassurance Company Ltd., MetLife, Inc., & Missouri
Reinsurance (Barbados), Inc.
|
|
June 2016 (2)
|
|
|
500
|
|
|
|
|
|
|
|
490
|
|
|
|
10
|
|
|
|
7
|
|
Exeter Reassurance Company Ltd.
|
|
December 2027 (3),(4)
|
|
|
650
|
|
|
|
|
|
|
|
410
|
|
|
|
240
|
|
|
|
19
|
|
MetLife Reinsurance Company of South Carolina &
MetLife, Inc.
|
|
June 2037 (5)
|
|
|
3,500
|
|
|
|
2,692
|
|
|
|
|
|
|
|
808
|
|
|
|
29
|
|
MetLife Reinsurance Company of Vermont & MetLife,
Inc.
|
|
December 2037 (3),(6)
|
|
|
2,896
|
|
|
|
|
|
|
|
1,359
|
|
|
|
1,537
|
|
|
|
29
|
|
MetLife Reinsurance Company of Vermont & MetLife,
Inc.
|
|
September 2038 (3),(7)
|
|
|
3,500
|
|
|
|
|
|
|
|
1,500
|
|
|
|
2,000
|
|
|
|
29
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
$
|
11,546
|
|
|
$
|
2,692
|
|
|
$
|
4,259
|
|
|
$
|
4,595
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
In December 2008, the Holding Company entered into an amended
and restated one year $500 million letter of credit
facility (dated as of August 2008 and amended and restated at
December 31, 2008 with an unaffiliated financial
institution, Exeter Reassurance Company, Ltd. is a co-applicant
under this letter of credit facility. This letter of credit
facility matures in August 2009, except that letters of credit
outstanding upon termination may remain outstanding until August
2010. Fees for this agreement include a margin of 2.25% and a
utilization fee of 0.05%, as applicable. The Holding Company
incurred amendment costs of $1.3 million related to the
$500 million amended and restated letter of credit
facility, which has been capitalized and included in other
assets. These costs will be amortized over the term of the
agreement. |
|
(2) |
|
Letters of credit and replacements or renewals thereof issued
under this facility of $280 million, $10 million and
$200 million are set to expire no later than December 2015,
March 2016 and June 2016, respectively. |
|
(3) |
|
The Holding Company is a guarantor under this agreement. |
|
(4) |
|
In December 2008, Exeter as borrower and the Holding Company as
guarantor entered into an amendment of an existing credit
agreement with an unaffiliated financial institution. Issuances
under this facility are set to expire in December 2027. Exeter
incurred amendment costs of $1.6 million related to the
amendment of the existing |
163
|
|
|
|
|
credit agreement, which have been capitalized and included in
other assets. These costs will be amortized over the term of the
agreement. |
|
(5) |
|
In May 2007, MetLife Reinsurance Company of South Carolina
terminated the $2.0 billion amended and restated five-year
letter of credit and reimbursement agreement entered into among
the Holding Company, MRSC and various financial institutions on
April 25, 2005. In its place, the Company entered into a
30-year
collateral financing arrangement as described in Note 11 of
the Notes to the Consolidated Financial Statements, which may be
extended by agreement of the Company and the financial
institution on each anniversary of the closing of the facility
for an additional one-year period. At December 31, 2008,
$2.7 billion had been drawn upon under the collateral
financing arrangement. |
|
(6) |
|
In December 2007, Exeter Reassurance Company Ltd. terminated
four letters of credit, with expirations from March 2025 through
December 2026, which were issued under a letter of credit
facility with an unaffiliated financial institution in an
aggregate amount of $1.7 billion. The letters of credit had
served as collateral for Exeters obligations under a
reinsurance agreement that was recaptured by MLI-USA in December
2007. MLI-USA immediately thereafter entered into a new
reinsurance agreement with MetLife Reinsurance Company of
Vermont. To collateralize its reinsurance obligations, MRV and
the Holding Company entered into a
30-year,
$2.9 billion letter of credit facility with an unaffiliated
financial institution. |
|
(7) |
|
In September 2008, MRV and the Holding Company entered into a
30-year,
$3.5 billion letter of credit facility with an unaffiliated
financial institution. These letters of credit serve as
collateral for MRVs obligations under a reinsurance
agreement. |
Letters of Credit. At December 31, 2008,
the Holding Company had outstanding $2.8 billion in letters
of credit from various financial institutions, of which
$500 million and $2.3 billion were part of committed
and credit facilities, respectively. As commitments associated
with letters of credit and financing arrangements may expire
unused, these amounts do not necessarily reflect the Holding
Companys actual future cash funding requirements.
Covenants. Certain of the Holding
Companys debt instruments, credit facilities and committed
facilities contain various administrative, reporting, legal and
financial covenants. The Holding Company believes it is in
compliance with all covenants at December 31, 2008 and 2007.
Remarketing of Junior Subordinated Debentures and Settlement
of Stock Purchase Contracts. On August 15,
2008, the Holding Company closed the successful remarketing of
the Series A portion of the junior subordinated debentures
underlying the common equity units. The Series A junior
subordinated debentures were modified as permitted by their
terms to be 6.817% senior debt securities Series A,
due August 15, 2018. The Holding Company did not receive
any proceeds from the remarketing. Most common equity unit
holders chose to have their junior subordinated debentures
remarketed and used the remarketing proceeds to settle their
payment obligations under the applicable stock purchase
contract. For those common equity unit holders that elected not
to participate in the remarketing and elected to use their own
cash to satisfy the payment obligations under the stock purchase
contract, the terms of the debt are the same as the remarketed
debt. The initial settlement of the stock purchase contracts
occurred on August 15, 2008, providing proceeds to the
Holding Company of $1,035 million in exchange for shares of
the Holding Companys common stock. The Holding Company
delivered 20,244,549 shares of its common stock held in
treasury at a value of $1,064 million to settle the stock
purchase contracts.
On February 17, 2009, the Holding Company closed the
successful remarketing of the Series B portion of the
junior subordinated debentures underlying the common equity
units. The Series B junior subordinated debentures were
modified as permitted by their terms to be 7.717% senior
debt securities Series B, due February 15, 2019. The
Holding Company did not receive any proceeds from the
remarketing. Most common equity unit holders chose to have their
junior subordinated debentures remarketed and used the
remarketing proceeds to settle their payment obligations under
the applicable stock purchase contract. For those common equity
unit holders that elected not to participate in the remarketing
and elected to use their own cash to satisfy the payment
obligations under the stock purchase contract, the terms of the
debt are the same as the remarketed debt. The subsequent
settlement of the stock purchase contracts occurred on
February 17, 2009, providing proceeds to the Holding
Company of $1,035 million in exchange for shares of the
Holding Companys common stock. The Holding Company
delivered 24,343,154 shares of its newly issued common
stock to settle the stock purchase contracts. See
Subsequent Events.
164
Common Stock Issuance. On October 8,
2008, the Holding Company issued 86,250,000 shares of its
common stock at a price of $26.50 per share for gross proceeds
of $2.3 billion. Of the shares issued,
75,000,000 shares were issued from treasury stock.
Preferred Stock. During the year ended
December 31, 2008, the Holding Company issued no new
preferred stock. In December 2008, the Holding Company entered
into a replacement capital covenant (the Replacement
Capital Covenant) whereby the Company agreed for the
benefit of holders of one or more series of the Companys
unsecured long-term indebtedness designated from time to time by
the Company in accordance with the terms of the Replacement
Capital Covenant (Covered Debt), that the Company
will not repay, redeem or purchase and will cause its
subsidiaries not to repay, redeem or purchase, on or before the
termination of the Replacement Capital Covenant on
December 31, 2018 (or earlier termination by agreement of
the holders of Covered Debt or when there is no longer any
outstanding series of unsecured long-term indebtedness which
qualifies for designation as Covered Debt), the
Floating Rate Non-Cumulative Preferred Stock, Series A, of
the Company or the 6.500% Non-Cumulative Preferred Stock,
Series B, of the Company, unless such repayment, redemption
or purchase is made from the proceeds of the issuance of certain
replacement capital securities and pursuant to the other terms
and conditions set forth in the Replacement Capital Covenant.
Liquidity
and Capital Uses
The primary uses of liquidity of the Holding Company include
debt service, cash dividends on common and preferred stock,
capital contributions to subsidiaries, payment of general
operating expenses, acquisitions and the repurchase of the
Holding Companys common stock.
Dividends. The table below presents
declaration, record and payment dates, as well as per share and
aggregate dividend amounts, for the common stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend
|
|
Declaration Date
|
|
Record Date
|
|
|
Payment Date
|
|
|
Per Share
|
|
|
Aggregate
|
|
|
|
|
|
|
|
|
|
(In millions, except per share data)
|
|
|
October 28, 2008
|
|
|
November 10, 2008
|
|
|
|
December 15, 2008
|
|
|
$
|
0.74
|
|
|
$
|
592
|
|
October 23, 2007
|
|
|
November 6, 2007
|
|
|
|
December 14, 2007
|
|
|
$
|
0.74
|
|
|
$
|
541
|
|
October 24, 2006
|
|
|
November 6, 2006
|
|
|
|
December 15, 2006
|
|
|
$
|
0.59
|
|
|
$
|
450
|
|
Future common stock dividend decisions will be determined by the
Holding Companys Board of Directors after taking into
consideration factors such as the Companys current
earnings, expected medium- and long-term earnings, financial
condition, regulatory capital position, and applicable
governmental regulations and policies. Furthermore, the payment
of dividends and other distributions to the Holding Company by
its insurance subsidiaries is regulated by insurance laws and
regulations.
165
Information on the declaration, record and payment dates, as
well as per share and aggregate dividend amounts, for the
Companys Floating Rate Non-Cumulative Preferred Stock,
Series A and 6.50% Non-Cumulative Preferred Stock,
Series B is as follows for the years ended
December 31, 2008, 2007 and 2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend
|
|
|
|
|
|
|
|
Series A
|
|
|
Series A
|
|
|
Series B
|
|
|
Series B
|
|
Declaration Date
|
|
Record Date
|
|
Payment Date
|
|
Per Share
|
|
|
Aggregate
|
|
|
Per Share
|
|
|
Aggregate
|
|
|
|
|
|
|
|
(In millions, except per share data)
|
|
|
November 17, 2008
|
|
November 30, 2008
|
|
December 15, 2008
|
|
$
|
0.2527777
|
|
|
$
|
7
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
August 15, 2008
|
|
August 31, 2008
|
|
September 15, 2008
|
|
$
|
0.2555555
|
|
|
$
|
6
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
May 15, 2008
|
|
May 31, 2008
|
|
June 16, 2008
|
|
$
|
0.2555555
|
|
|
$
|
7
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
March 5, 2008
|
|
February 29, 2008
|
|
March 17, 2008
|
|
$
|
0.3785745
|
|
|
$
|
9
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
29
|
|
|
|
|
|
|
$
|
96
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
November 15, 2007
|
|
November 30, 2007
|
|
December 17, 2007
|
|
$
|
0.4230476
|
|
|
$
|
11
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
August 15, 2007
|
|
August 31, 2007
|
|
September 17, 2007
|
|
$
|
0.4063333
|
|
|
$
|
10
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
May 15, 2007
|
|
May 31, 2007
|
|
June 15, 2007
|
|
$
|
0.4060062
|
|
|
$
|
10
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
March 5, 2007
|
|
February 28, 2007
|
|
March 15, 2007
|
|
$
|
0.3975000
|
|
|
$
|
10
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
41
|
|
|
|
|
|
|
$
|
96
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
November 15, 2006
|
|
November 30, 2006
|
|
December 15, 2006
|
|
$
|
0.4038125
|
|
|
$
|
10
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
August 15, 2006
|
|
August 31, 2006
|
|
September 15, 2006
|
|
$
|
0.4043771
|
|
|
$
|
10
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
May 16, 2006
|
|
May 31, 2006
|
|
June 15, 2006
|
|
$
|
0.3775833
|
|
|
$
|
9
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
March 6, 2006
|
|
February 28, 2006
|
|
March 15, 2006
|
|
$
|
0.3432031
|
|
|
$
|
9
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
38
|
|
|
|
|
|
|
$
|
96
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See Subsequent Events.
Affiliated Capital Transactions. During the
years ended December 31, 2008 and 2007, the Holding Company
invested an aggregate of $2.6 billion and
$2.8 billion, respectively, in various subsidiaries. In
February 2009, the Holding Company contributed a total of
$74 million to two of its insurance subsidiaries.
The Holding Company lends funds, as necessary, to its
subsidiaries, some of which are regulated, to meet their capital
requirements. Such loans are included in loans to subsidiaries
and consisted of the following at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
Subsidiaries
|
|
Interest Rate
|
|
Maturity Date
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
(In millions)
|
|
|
Metropolitan Life Insurance Company
|
|
3-month LIBOR + 1.15%
|
|
December 31, 2009
|
|
$
|
700
|
|
|
$
|
700
|
|
Metropolitan Life Insurance Company
|
|
7.13%
|
|
December 15, 2032
|
|
|
400
|
|
|
|
400
|
|
Metropolitan Life Insurance Company
|
|
7.13%
|
|
January 15, 2033
|
|
|
100
|
|
|
|
100
|
|
MetLife Investors USA Insurance Company
|
|
7.35%
|
|
April 1, 2035
|
|
|
|
|
|
|
400
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
$
|
1,200
|
|
|
$
|
1,600
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Repayments. The Holding Company repaid a
$500 million 5.25% senior note which matured in
December 2006.
Share Repurchases. In October 2004, the
Holding Companys Board of Directors authorized a
$1 billion common stock repurchase program. In February
2007, the Holding Companys Board of Directors authorized
an additional $1 billion common stock repurchase program.
In September 2007, the Holding Companys Board of Directors
authorized an additional $1 billion common stock repurchase
program which began after the completion of the $1 billion
common stock repurchase program authorized in February 2007. In
January 2008, the Holding Companys Board of Directors
authorized an additional $1 billion common stock repurchase
program, which began after the completion of the September 2007
program. Under these authorizations, the Holding Company may
purchase its common stock from the MetLife Policyholder Trust,
in the open market (including pursuant to the terms of a pre-set
trading plan meeting the requirements of
Rule 10b5-1
under the Exchange Act and in privately negotiated transactions).
166
In 2006, 2007 and 2008, the Holding Company entered into the
following accelerated common stock repurchase agreements:
|
|
|
|
|
In February 2008, the Holding Company entered into an
accelerated common stock repurchase agreement with a major bank.
Under the agreement, the Holding Company paid the bank
$711 million in cash and the bank delivered an initial
amount of 11,161,550 shares of the Holding Companys
outstanding common stock that the bank borrowed from third
parties. In May 2008, the bank delivered an additional
864,646 shares of the Holding Companys common stock
to the Company resulting in a total of 12,026,196 shares
being repurchased under the agreement. The Holding Company
recorded the shares repurchased as treasury stock.
|
|
|
|
In December 2007, the Holding Company entered into an
accelerated common stock repurchase agreement with a major bank.
Under the terms of the agreement, the Holding Company paid the
bank $450 million in cash in January 2008 in exchange for
6,646,692 shares of its outstanding common stock that the
bank borrowed from third parties. Also, in January 2008, the
bank delivered 1,043,530 additional shares of Holding
Companys common stock to the Holding Company resulting in
a total of 7,690,222 shares being repurchased under the
agreement. At December 31, 2007, the Holding Company
recorded the obligation to pay $450 million to the bank as
a reduction of additional paid-in capital. Upon settlement with
the bank, the Holding Company increased additional paid-in
capital and reduced treasury stock.
|
|
|
|
In November 2007, the Holding Company repurchased
11,559,803 shares of its outstanding common stock at an
initial cost of $750 million under an accelerated common
stock repurchase agreement with a major bank. The bank borrowed
the stock sold to the Holding Company from third parties and
purchased the common stock in the open market to return to such
third parties. Also, in November 2007, the Holding Company
received a cash adjustment of $19 million based on the
trading price of the common stock during the repurchase period,
for a final purchase price of $731 million. The Holding
Company recorded the shares initially repurchased as treasury
stock and recorded the amount received as an adjustment to the
cost of the treasury stock.
|
|
|
|
In March 2007, the Holding Company repurchased
11,895,321 shares of its outstanding common stock at an
aggregate cost of $750 million under an accelerated common
stock repurchase agreement with a major bank. The bank borrowed
the common stock sold to the Holding Company from third parties
and purchased common stock in the open market to return to such
third parties. In June 2007, the Holding Company paid a cash
adjustment of $17 million for a final purchase price of
$767 million. The Holding Company recorded the shares
initially repurchased as treasury stock and recorded the amount
paid as an adjustment to the cost of the treasury stock.
|
|
|
|
In December 2006, the Holding Company repurchased
3,993,024 shares of its outstanding common stock at an
aggregate cost of $232 million under an accelerated common
stock repurchase agreement with a major bank. The bank borrowed
the common stock sold to the Holding Company from third parties
and purchased the common stock in the open market to return to
such third parties. In February 2007, the Holding Company paid a
cash adjustment of $8 million for a final purchase price of
$240 million. The Holding Company recorded the shares
initially repurchased as treasury stock and recorded the amount
paid as an adjustment to the cost of the treasury stock.
|
In connection with the split-off of RGA as described in
Note 2 of the Notes to the Consolidated Financial
Statements, the Company received from MetLife stockholders
23,093,689 shares of the Companys common stock with a
market value of $1,318 million and, in exchange, delivered
29,243,539 shares of RGA Class B common stock with a
net book value of $1,716 million resulting in a loss on
disposition, including transaction costs, of $458 million.
The Company also repurchased 1,550,000 and 3,171,700 shares
through open market purchases for $88 million and
$200 million, respectively, during the years ended
December 31, 2008 and 2007, respectively.
Cumulatively, the Company repurchased 21,266,418, 26,626,824 and
8,608,824 shares of its common stock for
$1,250 million, $1,705 million and $500 million
during the years ended December 31, 2008, 2007 and 2006,
respectively. During the years ended December 31, 2008,
2007 and 2006, 97,515,737, 3,864,894 and 3,056,559 shares
of common stock were issued from treasury stock for
$5,221 million, $172 million and
167
$102 million, respectively. In addition, 11,250,000 new
shares were issued during the year ended December 31, 2008
in connection with the October 2008 common stock offering.
At December 31, 2006, the Company had $216 million
remaining on the October 2004 common stock repurchase program
which was subsequently reduced by $8 million to
$208 million after the February 2007 cash adjustment to the
December 2006 accelerated common stock repurchase agreement. The
February 2007 stock repurchase program authorization was fully
utilized during 2007. At December 31, 2007,
$511 million remained on the Companys September 2007
common stock repurchase program. The $511 million remaining
on the September 2007 common stock repurchase program was
reduced by $450 million to $61 million upon settlement
of the accelerated stock repurchase agreement executed during
December 2007 but for which no settlement occurred until January
2008. Subsequent to the April 2008 authorization, the amount
remaining under these repurchase programs was
$1,261 million.
Future common stock repurchases will be dependent upon several
factors, including the Companys capital position, its
financial strength and credit ratings, general market conditions
and the price of MetLife, Inc.s common stock. The Company
does not intend to make any purchases under the common stock
repurchase program in 2009.
Support Agreements. In October 2007, the
Holding Company, in connection with MRVs reinsurance of
certain universal life and term life insurance risks, committed
to the Vermont Department of Banking, Insurance, Securities and
Health Care Administration to take necessary action to cause
each of the two initial protected cells of MRV to maintain total
adjusted capital equal to or greater than 200% of such protected
cells authorized control level risk-based capital
(RBC), as defined in state insurance statutes. This
transaction is more fully described in Note 10, Long-term
and Short-term Debt, of the Notes to the Consolidated Financial
Statements. See The Company Liquidity and
Capital Sources Committed Facilities.
In December 2007, the Holding Company, in connection with the
collateral financing arrangement associated with MRCs
reinsurance of a portion of the liabilities associated with the
closed block, committed to the South Carolina Department of
Insurance to make capital contributions, if necessary, to MRC so
that MRC may at all times maintain its total adjusted capital at
a level of not less than 200% of the company action
level RBC, as defined in state insurance statutes as in
effect on the date of determination or December 31, 2007,
whichever calculation produces the greater capital requirement,
or as otherwise required by the South Carolina Department of
Insurance. This collateral financing arrangement is more fully
described in Note 11 of the Notes to the Consolidated
Financial Statements. See The Company
Liquidity and Capital Sources Debt
Issuances.
In May 2007, the Holding Company, in connection with the
collateral financing arrangement associated with MRSCs
reinsurance of universal life secondary guarantees, committed to
the South Carolina Department of Insurance to take necessary
action to cause MRSC to maintain total adjusted capital equal to
the greater of $250,000 or 100% of MRSCs authorized
control level RBC, as defined in state insurance statutes.
This collateral financing arrangement is more fully described in
Note 11 of the Notes to the Consolidated Financial
Statements. See The Company Liquidity and
Capital Sources Debt Issuances.
The Holding Company has net worth maintenance agreements with
two of its insurance subsidiaries, MetLife Investors Insurance
Company and First MetLife Investors Insurance Company. Under
these agreements, as subsequently amended, the Holding Company
agreed, without limitation as to the amount, to cause each of
these subsidiaries to have a minimum capital and surplus of
$10 million, total adjusted capital at a level not less
than 150% of the company action level RBC, as defined by
state insurance statutes, and liquidity necessary to enable it
to meet its current obligations on a timely basis.
The Holding Company entered into a net worth maintenance
agreement with Mitsui Sumitomo MetLife Insurance Company Limited
(MSMIC), an investment in Japan of which the Holding
Company owns 50% of the equity. Under the agreement, the Holding
Company agreed, without limitation as to amount, to cause MSMIC
to have the amount of capital and surplus necessary for MSMIC to
maintain a solvency ratio of at least 400%, as calculated in
accordance with the Insurance Business Law of Japan, and to make
such loans to MSMIC as may be necessary to ensure that MSMIC has
sufficient cash or other liquid assets to meet its payment
obligations as they fall due.
168
The Holding Company has guaranteed the obligations of its
subsidiary, Exeter Reassurance Company, Ltd., under a
reinsurance agreement with MSMIC, under which Exeter reinsures
variable annuity business written MSMIC.
Management anticipates that to the extent that these
arrangements place significant demands upon the Holding Company,
there will be sufficient liquidity and capital to enable the
Holding Company to meet these demands.
Based on managements analysis and comparison of its
current and future cash inflows from the dividends it receives
from subsidiaries that are permitted to be paid without prior
insurance regulatory approval, its asset portfolio and other
cash flows and anticipated access to the capital markets,
management believes there will be sufficient liquidity and
capital to enable the Holding Company to make payments on debt,
make cash dividend payments on its common and preferred stock,
contribute capital to its subsidiaries, pay all operating
expenses and meet its cash needs.
Holding Company Cash Flows. Net cash provided
by operating activities, primarily the result of subsidiary
dividends, was similar at $1.2 billion for the years ending
December 31, 2008 and 2007. The net cash generated from
operating activities was used to meet the Holding Companys
liquidity and capital needs such as debt servicing, dividend
payments, capital contributions to subsidiaries, stock buybacks
and acquisitions, as well as other corporate uses.
Net cash provided by operating activities decreased by
$2.7 billion for the year ended December 31, 2007 from
$3.9 billion for the year ended December 31, 2006
primarily due to $3.0 billion lower dividends from
subsidiaries. The 2006 operating activities included
$2.2 billion of extraordinary dividends in conjunction with
the sale of Peter Cooper Village and Stuyvesant Town.
Net cash provided by financing activities was $50 million
for the year ended December 31, 2008 compared to
$2.9 billion of net cash used for the year ended
December 31, 2007. Accordingly, net cash provided by
financing activities increased by $2.9 billion for the year
ended December 31, 2008 compared to the prior year. In
2008 net cash paid related to collateral financing
arrangements was $800 million resulting from the incurrence
of price return payments compared to zero outflows for this
purpose in 2007. Finally, in order to strengthen its capital
base, in 2008 the Holding Company reduced its level of common
stock repurchase activity by $500 million compared to the
prior year and issued $3.3 billion of common stock compared
with zero issuance in 2007.
Net cash used by financing activities was $2.9 billion for
the years ended December 31, 2007, compared to
$239 million of net cash provided for the year ended
December 31, 2006. Accordingly, net cash provided by
financing activities decreased by $3.1 billion for the year
ended December 31, 2007 compared to the prior year
primarily due to increased stock repurchase of $1.2 billion
and a net decrease in debt issuance of $748 million.
Financing activity results are the result of the Holding
Companys debt and equity financing activities, as well as
changes due to the needs of securities lending and collateral
financing arrangements.
Net cash used in investing activities was $1.2 billion for
the year ended December 31, 2008 compared to
$742 million provided for the year ended December 31,
2007. Accordingly, net cash provided by investing activities
decreased by $1.9 billion for the year ended
December 31, 2008 compared to the prior year primarily due
to increases in capital contributions to subsidiaries and
changes in short-term investments.
Net cash provided by investing activities was $742 million
for the year ended December 31, 2007 compared to
$2.8 billion of net cash used for the year ended
December 31, 2006. Accordingly, net cash provided by
investing activities increased by $3.5 billion for the year
ended December 31, 2007 compared to the prior year
primarily due to a decrease in net purchases of fixed maturity
securities. Investing activity results are generally due to the
Holding Companys management of its capital, as well as the
needs of its subsidiaries and any business development
opportunities.
As it relates to cash flows during 2009, the Holding Company
anticipates it will pay $30 million in dividends on its
Series A and Series B preferred shares in March 2009
as announced in February 2009 and the Holding Company received
$1,035 million in cash in connection with the settlement of
the stock purchase contracts as described more fully in
Remarketing of Junior Subordinated Debentures and
Settlement of Stock Purchase Contracts.
169
Subsequent
Events
Dividends
On February 18, 2009, the Companys Board of Directors
announced dividends of $0.25 per share, for a total of
$6 million, on its Series A preferred shares, and
$0.40625 per share, for a total of $24 million, on its
Series B preferred shares, subject to the final
confirmation that it has met the financial tests specified in
the Series A and Series B preferred shares, which the
Company anticipates will be made on or about March 5, 2009,
the earliest date permitted in accordance with the terms of the
securities. Both dividends will be payable March 16, 2009
to shareholders of record as of February 28, 2009.
Remarketing
of Securities and Settlement of Stock Purchase Contracts
Underlying Common Equity Units
On February 17, 2009, the Holding Company closed the
successful remarketing of the Series B portion of the
junior subordinated debentures underlying the common equity
units. The junior subordinated debentures were modified as
permitted by their terms to be 7.717% senior debt
securities Series B, due February 15, 2019. The
Holding Company did not receive any proceeds from the
remarketing. Most common equity unit holders chose to have their
junior subordinated debentures remarketed and used the
remarketing proceeds to settle their payment obligations under
the applicable stock purchase contract. For those common equity
unit holders that elected not to participate in the remarketing
and elected to use their own cash to satisfy the payment
obligations under the stock purchase contract, the terms of the
debt are the same as the remarketed debt.
The subsequent settlement of the stock purchase contracts
occurred on February 17, 2009, providing proceeds to the
Holding Company of $1,035 million in exchange for shares of
the Holding Companys common stock. The Holding Company
delivered 24,343,154 shares of its newly issued common
stock to settle the remaining stock purchase contracts issued as
part of the common equity units sold in June 2005.
Off-Balance
Sheet Arrangements
Commitments
to Fund Partnership Investments
The Company makes commitments to fund partnership investments in
the normal course of business for the purpose of enhancing the
Companys total return on its investment portfolio. The
amounts of these unfunded commitments were $4.5 billion and
$4.2 billion at December 31, 2008 and 2007, respectively.
Once funded, those commitments are classified in the
consolidated balance sheet according to their nature as other
limited partnership interests, real estate joint ventures or
other invested assets. The Company anticipates that these
amounts will be invested in partnerships over the next five
years. There are no other obligations or liabilities arising
from such arrangements that are reasonably likely to become
material.
Mortgage
Loan Commitments
The Company has issued interest rate lock commitments on certain
residential mortgage loan applications totaling
$8.0 billion at December 31, 2008. The Company intends
to sell the majority of these originated residential mortgage
loans. Interest rate lock commitments to fund mortgage loans
that will be held-for-sale are considered derivatives pursuant
to SFAS 133, and their estimated fair value and notional
amounts are included within financial forwards in the
Companys consolidated balance sheets.
The Company also commits to lend funds under certain other
mortgage loan commitments that will be held-for-investment. The
amounts of these mortgage loan commitments were
$2.7 billion and $4.0 billion at December 31,
2008 and 2007, respectively. The purpose of these loans is to
enhance the Companys total return on its investment
portfolio. There are no other obligations or liabilities arising
from such arrangements that are reasonably likely to become
material.
The purpose of the Companys loan program is to enhance the
Companys total return on its investment portfolio. There
are no other obligations or liabilities arising from such
arrangements that are reasonably likely to become material.
170
Commitments
to Fund Bank Credit Facilities, Bridge Loans and Private
Corporate Bond Investments
The Company commits to lend funds under bank credit facilities,
bridge loans and private corporate bond investments. The amounts
of these unfunded commitments were $1.0 billion and
$1.2 billion at December 31, 2008 and 2007,
respectively. The purpose of these commitments and any related
fundings is to enhance the Companys total return on its
investment portfolio. There are no other obligations or
liabilities arising from such arrangements that are reasonably
likely to become material.
Lease
Commitments
The Company, as lessee, has entered into various lease and
sublease agreements for office space, data processing and other
equipment. The Companys commitments under such lease
agreements are included within the contractual obligations
table. See Liquidity and Capital
Resources The Company Liquidity and
Capital Uses Investment and Other.
Credit
Facilities, Committed Facilities and Letters of
Credit
The Company maintains committed and unsecured credit facilities
and letters of credit with various financial institutions. See
Liquidity and Capital Resources
The Company Liquidity and Capital
Sources Credit Facilities,
Committed Facilities and
Letters of Credit for further
descriptions of such arrangements.
Share-Based
Arrangements
In connection with the issuance of common equity units, the
Holding Company issued forward stock purchase contracts under
which the Holding Company delivered 44,587,703 shares of
its common stock in settlements of the stock purchase contracts.
In February 2009, 24,343,154 shares of common stock were
delivered. See Liquidity and Capital
Resources The Company Liquidity and
Capital Sources Remarketing of Securities and
Settlement of Stock Purchase Contracts Underlying Common Equity
Units for further information.
Guarantees
In the normal course of its business, the Company has provided
certain indemnities, guarantees and commitments to third parties
pursuant to which it may be required to make payments now or in
the future. In the context of acquisition, disposition,
investment and other transactions, the Company has provided
indemnities and guarantees, including those related to tax,
environmental and other specific liabilities, and other
indemnities and guarantees that are triggered by, among other
things, breaches of representations, warranties or covenants
provided by the Company. In addition, in the normal course of
business, the Company provides indemnifications to
counterparties in contracts with triggers similar to the
foregoing, as well as for certain other liabilities, such as
third party lawsuits. These obligations are often subject to
time limitations that vary in duration, including contractual
limitations and those that arise by operation of law, such as
applicable statutes of limitation. In some cases, the maximum
potential obligation under the indemnities and guarantees is
subject to a contractual limitation ranging from less than
$1 million to $800 million, with a cumulative maximum
of $1.6 billion, while in other cases such limitations are
not specified or applicable. Since certain of these obligations
are not subject to limitations, the Company does not believe
that it is possible to determine the maximum potential amount
that could become due under these guarantees in the future.
Management believes that it is unlikely the Company will have to
make any material payments under these indemnities, guarantees,
or commitments.
In addition, the Company indemnifies its directors and officers
as provided in its charters and by-laws. Also, the Company
indemnifies its agents for liabilities incurred as a result of
their representation of the Companys interests. Since
these indemnities are generally not subject to limitation with
respect to duration or amount, the Company does not believe that
it is possible to determine the maximum potential amount that
could become due under these indemnities in the future.
The Company has also guaranteed minimum investment returns on
certain international retirement funds in accordance with local
laws. Since these guarantees are not subject to limitation with
respect to duration or amount, the Company does not believe that
it is possible to determine the maximum potential amount that
could become due under these guarantees in the future.
171
During the year ended December 31, 2008, the Company
recorded $7 million of additional liabilities for
guarantees related to certain investment transactions. The term
for these guarantees and their associated liabilities varies,
with a maximum of 18 years. The maximum potential amount of
future payments the Company could be required to pay under these
guarantees is $202 million. During the year ended
December 31, 2008, the Company reduced $7 million of
previously recorded liabilities related to indemnifications
provided in connection with the disposition of real estate
property and other investment transactions. The Companys
recorded liabilities were $6 million at both
December 31, 2008 and 2007 for indemnities, guarantees and
commitments.
In connection with synthetically created investment
transactions, the Company writes credit default swap obligations
that generally require payment of principal outstanding due in
exchange for the referenced credit obligation. If a credit
event, as defined by the contract, occurs the Companys
maximum amount at risk, assuming the value of all referenced
credit obligations is zero, was $1.9 billion at
December 31, 2008. However, the Company believes that any
actual future losses will be significantly lower than this
amount. Additionally, the Company can terminate these contracts
at any time through cash settlement with the counterparty at an
amount equal to the then current estimated fair value of the
credit default swaps. As of December 31, 2008, the Company
would have paid $37 million to terminate all of these
contracts.
Other
Commitments
MetLife Insurance Company of Connecticut is a member of the
Federal Home Loan Bank of Boston (the FHLB of
Boston) and holds $70 million of common stock of the
FHLB of Boston at both December 31, 2008 and 2007, which is
included in equity securities. MICC has also entered into
funding agreements with the FHLB of Boston whereby MICC has
issued such funding agreements in exchange for cash and for
which the FHLB of Boston has been granted a blanket lien on
certain MICC assets, including residential mortgage-backed
securities, to collateralize MICCs obligations under the
funding agreements. MICC maintains control over these pledged
assets, and may use, commingle, encumber or dispose of any
portion of the collateral as long as there is no event of
default and the remaining qualified collateral is sufficient to
satisfy the collateral maintenance level. Upon any event of
default by MICC, the FHLB of Bostons recovery on the
collateral is limited to the amount of MICCs liability to
the FHLB of Boston. The amount of the Companys liability
for funding agreements with the FHLB of Boston was
$526 million and $726 million at December 31,
2008 and 2007, respectively, which is included in policyholder
account balances. In addition, at December 31, 2008, MICC
had advances of $300 million from the FHLB of Boston with
original maturities of less than one year and therefore, such
advances are included in short-term debt. These advances and the
advances on these funding agreements are collateralized by
mortgage-backed securities with estimated fair values of
$1.3 billion and $901 million at December 31,
2008 and 2007, respectively.
Metropolitan Life Insurance Company is a member of the FHLB of
NY and holds $830 million and $339 million of common
stock of the FHLB of NY at December 31, 2008 and 2007,
respectively, which is included in equity securities. MLIC has
also entered into funding agreements with the FHLB of NY whereby
MLIC has issued such funding agreements in exchange for cash and
for which the FHLB of NY has been granted a lien on certain MLIC
assets, including residential mortgage-backed securities to
collateralize MLICs obligations under the funding
agreements. MLIC maintains control over these pledged assets,
and may use, commingle, encumber or dispose of any portion of
the collateral as long as there is no event of default and the
remaining qualified collateral is sufficient to satisfy the
collateral maintenance level. Upon any event of default by MLIC,
the FHLB of NYs recovery on the collateral is limited to
the amount of MLICs liability to the FHLB of NY. The
amount of the Companys liability for funding agreements
with the FHLB of NY was $15.2 billion and $4.6 billion
at December 31, 2008 and 2007, respectively, which is
included in policyholder account balances. The advances on these
agreements are collateralized by mortgage-backed securities with
estimated fair values of $17.8 billion and
$4.8 billion at December 31, 2008 and 2007,
respectively.
MetLife Bank is a member of the FHLB of NY and holds
$89 million and $64 million of common stock of the
FHLB of NY at December 31, 2008 and 2007, respectively,
which is included in equity securities. MetLife Bank has also
entered into repurchase agreements with the FHLB of NY whereby
MetLife Bank has issued repurchase agreements in exchange for
cash and for which the FHLB of NY has been granted a blanket
lien on MetLife Banks residential mortgages and
mortgage-backed securities to collateralize MetLife Banks
obligations under the repurchase agreements. MetLife Bank
maintains control over these pledged assets, and may use,
commingle,
172
encumber or dispose of any portion of the collateral as long as
there is no event of default and the remaining qualified
collateral is sufficient to satisfy the collateral maintenance
level. The repurchase agreements and the related security
agreement represented by this blanket lien provide that upon any
event of default by MetLife Bank, the FHLB of NYs recovery
is limited to the amount of MetLife Banks liability under
the outstanding repurchase agreements. The amount of the
Companys liability for repurchase agreements with the FHLB
of NY was $1.8 billion and $1.2 billion at
December 31, 2008 and 2007, respectively, which is included
in long-term debt and short-term debt depending on the original
tenor of the advance. The advances on these repurchase
agreements are collateralized by residential mortgage-backed
securities and residential mortgage loans with estimated fair
values of $3.1 billion and $1.3 billion at
December 31, 2008 and 2007, respectively.
Collateral
for Securities Lending
The Company has non-cash collateral for securities lending on
deposit from customers, which cannot be sold or repledged, and
which has not been recorded on its consolidated balance sheets.
The amount of this collateral was $279 million and
$40 million at December 31, 2008 and 2007,
respectively.
Goodwill
Goodwill is the excess of cost over the estimated fair value of
net assets acquired. Goodwill is not amortized but is tested for
impairment at least annually or more frequently if events or
circumstances, such as adverse changes in the business climate,
indicate that there may be justification for conducting an
interim test. Impairment testing is performed using the fair
value approach, which requires the use of estimates and
judgment, at the reporting unit level. A reporting
unit is the operating segment or a business one level below the
operating segment, if discrete financial information is prepared
and regularly reviewed by management at that level.
Information regarding changes in goodwill is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Balance at beginning of the period,
|
|
$
|
4,814
|
|
|
$
|
4,801
|
|
|
$
|
4,701
|
|
Acquisitions (1)
|
|
|
256
|
|
|
|
2
|
|
|
|
93
|
|
Other, net (2)
|
|
|
(62
|
)
|
|
|
11
|
|
|
|
7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at the end of the period
|
|
$
|
5,008
|
|
|
$
|
4,814
|
|
|
$
|
4,801
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
See Managements Discussion and Analysis
of Financial Condition and Results of Operations
Acquisitions and Dispositions for a description of
acquisitions and dispositions. |
|
(2) |
|
Consists principally of foreign currency translation adjustments. |
173
Information regarding goodwill by segment and reporting unit is
as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Institutional:
|
|
|
|
|
|
|
|
|
Group life
|
|
$
|
15
|
|
|
$
|
15
|
|
Retirement & savings
|
|
|
887
|
|
|
|
887
|
|
Non-medical health & other
|
|
|
149
|
|
|
|
76
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
1,051
|
|
|
|
978
|
|
|
|
|
|
|
|
|
|
|
Individual:
|
|
|
|
|
|
|
|
|
Traditional life
|
|
|
73
|
|
|
|
73
|
|
Variable & universal life
|
|
|
1,174
|
|
|
|
1,174
|
|
Annuities
|
|
|
1,692
|
|
|
|
1,692
|
|
Other
|
|
|
18
|
|
|
|
18
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
2,957
|
|
|
|
2,957
|
|
|
|
|
|
|
|
|
|
|
International:
|
|
|
|
|
|
|
|
|
Latin America region
|
|
|
184
|
|
|
|
104
|
|
European region
|
|
|
37
|
|
|
|
50
|
|
Asia Pacific region
|
|
|
152
|
|
|
|
159
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
373
|
|
|
|
313
|
|
|
|
|
|
|
|
|
|
|
Auto & Home
|
|
|
157
|
|
|
|
157
|
|
|
|
|
|
|
|
|
|
|
Corporate & Other (1)
|
|
|
470
|
|
|
|
409
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
5,008
|
|
|
$
|
4,814
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The allocation of the goodwill to the reporting units is
performed at the time of the respective acquisition. The
$470 million of goodwill within Corporate & Other
relates to goodwill acquired as a part of the Travelers
acquisition of $405 million, as well as acquisitions by
MetLife Bank which resides within Corporate & Other.
For purposes of goodwill impairment testing at December 31,
2008 and 2007, $405 million of Corporate & Other
goodwill has been attributed to the Individual and Institutional
segment reporting units. The Individual segment was attributed
$210 million, (traditional life
$23 million, variable & universal
life $11 million and annuities
$176 million) and the Institutional segment was attributed
$195 million, (group life $2 million,
retirement & savings $186 million,
and non-medical health & other
$7 million) at both December 31, 2008 and 2007. |
For purposes of goodwill impairment testing, if the carrying
value of a reporting units goodwill exceeds its estimated
fair value, there is an indication of impairment, and the
implied fair value of the goodwill is determined in the same
manner as the amount of goodwill would be determined in a
business acquisition. The excess of the carrying value of
goodwill over the implied fair value of goodwill is recognized
as an impairment and recorded as a charge against net income.
The Company performed its annual goodwill impairment tests
during the third quarter of 2008 based upon data as of
June 30, 2008. Such tests indicated that goodwill was not
impaired as of September 30, 2008. Current economic
conditions, the sustained low level of equity markets, declining
market capitalizations in the insurance industry and lower
operating earnings projections, particularly for the Individual
segment, required management of the Company to consider the
impact of these events on the recoverability of its assets, in
particular its goodwill. Management concluded it was appropriate
to perform an interim goodwill impairment test at
December 31, 2008. Based upon the tests performed
management concluded no impairment of goodwill had occurred for
any of the Companys reporting units at December 31,
2008.
174
In performing its goodwill impairment tests, when management
believes meaningful comparable market data are available, the
estimated fair values of the reporting units are determined
using a market multiple approach. When relevant comparables are
not available, the Company uses a discounted cash flow model.
For reporting units which are particularly sensitive to market
assumptions, such as the annuities and variable &
universal life reporting units within the Individual segment,
the Company may corroborate its estimated fair values by using
additional valuation methodologies.
The key inputs, judgments and assumptions necessary in
determining estimated fair value include projected operating
earnings, current book value (with and without accumulated other
comprehensive income), the level of economic capital required to
support the mix of business, long term growth rates, comparative
market multiples, the account value of our in-force business,
projections of new and renewal business as well as margins on
such business, the level of interest rates, credit spreads,
equity market levels, and the discount rate management believes
appropriate to the risk associated with the respective reporting
unit. The estimated fair value of the annuity and
variable & universal life reporting units are
particularly sensitive to the equity market levels.
When testing goodwill for impairment, management also considers
its market capitalization in relation to its book value.
Management believes that the overall decrease in the
Companys current market capitalization is not
representative of a long-term decrease in the value of the
underlying reporting units.
Management applies significant judgment when determining the
estimated fair value of its reporting units and when assessing
the relationship of its market capitalization to the estimated
fair value of its reporting units and their book value. The
valuation methodologies utilized are subject to key judgments
and assumptions that are sensitive to change. Estimates of fair
value are inherently uncertain and represent only
managements reasonable expectation regarding future
developments. These estimates and the judgments and assumptions
upon which the estimates are based will, in all likelihood,
differ in some respects from actual future results. Declines in
the estimated fair value of the Companys reporting units
could result in goodwill impairments in future periods which
could materially adversely affect the Companys results of
operations or financial position.
Management continues to evaluate current market conditions that
may affect the estimated fair value of the Companys
reporting units to assess whether any goodwill impairment
exists. Continued deteriorating or adverse market conditions for
certain reporting units may have a significant impact on the
estimated fair value of these reporting units and could result
in future impairments of goodwill.
Pensions
and Other Postretirement Benefit Plans
Description
of Plans
Plan
Description Overview
Certain subsidiaries of the Holding Company (the
Subsidiaries) sponsor
and/or
administer various qualified and non-qualified defined benefit
pension plans and other postretirement employee benefit plans
covering employees and sales representatives who meet specified
eligibility requirements. Pension benefits are provided
utilizing either a traditional formula or cash balance formula.
The traditional formula provides benefits based upon years of
credited service and either final average or career average
earnings. The cash balance formula utilizes hypothetical or
notional accounts, which credit participants with benefits equal
to a percentage of eligible pay, as well as earnings credits,
determined annually based upon the average annual rate of
interest on
30-year
U.S. Treasury securities, for each account balance. At
December 31, 2008, the majority of active participants are
accruing benefits under the cash balance formula; however,
approximately 95% of the Subsidiaries obligations result
from benefits calculated with the traditional formula. The
non-qualified pension plans provide supplemental benefits, in
excess of amounts permitted by governmental agencies, to certain
executive level employees.
The Subsidiaries also provide certain postemployment benefits
and certain postretirement medical and life insurance benefits
for retired employees. Employees of the Subsidiaries who were
hired prior to 2003 (or, in certain cases, rehired during or
after 2003) and meet age and service criteria while working
for one of the Subsidiaries, may become eligible for these other
postretirement benefits, at various levels, in accordance with
the applicable plans. Virtually all retirees, or their
beneficiaries, contribute a portion of the total cost of
postretirement medical benefits. Employees hired after 2003 are
not eligible for any employer subsidy for postretirement medical
benefits.
175
Financial
Summary
Statement of Financial Accounting Standards (SFAS)
No. 87, Employers Accounting for Pensions
(SFAS 87), as amended, establishes the
accounting for pension plan obligations. Under SFAS 87, the
projected pension benefit obligation (PBO) is
defined as the actuarial present value of vested and non-vested
pension benefits accrued based on future salary levels. The
accumulated pension benefit obligation (ABO) is the
actuarial present value of vested and non-vested pension
benefits accrued based on current salary levels. The PBO and ABO
of the pension plans are set forth in the following section.
Prior to December 31, 2006, SFAS 87 also required the
recognition of an additional minimum pension liability and an
intangible asset (limited to unrecognized prior service cost) if
the estimated fair value of pension plan assets was less than
the ABO at the measurement date. The excess of the additional
minimum pension liability over the allowable intangible asset
was charged, net of income tax, to accumulated other
comprehensive income (loss). The Companys additional
minimum pension liability was $78 million, and the
intangible asset was $12 million, at December 31,
2005. The excess of the additional minimum pension liability
over the intangible asset of $66 million ($41 million,
net of income tax) was recorded as a reduction of accumulated
other comprehensive income. At December 31, 2006, the
Companys additional minimum pension liability was
$92 million. The additional minimum pension liability of
$59 million, net of income tax of $33 million, was
recorded as a reduction of accumulated other comprehensive
income.
SFAS No. 106, Employers Accounting for
Postretirement Benefits Other than Pensions, as amended,
(SFAS 106), establishes the accounting for
expected postretirement plan benefit obligations
(EPBO) which represents the actuarial present value
of all postretirement benefits expected to be paid after
retirement to employees and their dependents. Unlike the PBO for
pensions, the EPBO is not recorded in the financial statements
but is used in measuring the periodic expense. The accumulated
postretirement plan benefit obligation (APBO)
represents the actuarial present value of future postretirement
benefits attributed to employee services rendered through a
particular date. The APBO is recorded in the financial
statements and is set forth below.
As described more fully in Adoption of New
Accounting Pronouncements, the Company adopted
SFAS No. 158, Employers Accounting for
Defined Benefit Pension and Other Postretirement Plans
an amendment of FASB Statements No. 87,
88, 106, and SFAS No. 132(r)
(SFAS 158), effective December 31,
2006. Upon adoption, the Company was required to recognize in
the consolidated balance sheet the funded status of defined
benefit pension and other postretirement benefit plans. Funded
status is measured as the difference between the estimated fair
value of plan assets and the benefit obligation, which is the
PBO for pension plans and the APBO for other postretirement
benefit plans. The change to recognize funded status eliminated
the additional minimum pension liability provisions of
SFAS 87. In addition, the Company recognized as an
adjustment to accumulated other comprehensive income (loss), net
of income tax, those amounts of actuarial gains and losses,
prior service costs and credits, and the remaining net
transition asset or obligation that had not yet been included in
net periodic benefit cost at the date of adoption. The adoption
of SFAS 158 resulted in a reduction of $744 million,
net of income tax, to accumulated other comprehensive income
(loss), which is included as a component of total consolidated
176
stockholders equity. The following table summarizes the
adjustments to the December 31, 2006 consolidated balance
sheet in order to effect the adoption of SFAS 158:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2006
|
|
|
|
|
|
|
Additional
|
|
|
|
|
|
|
|
|
|
|
|
|
Minimum
|
|
|
|
|
|
|
|
|
|
Pre
|
|
|
Pension
|
|
|
Adoption of
|
|
|
Post
|
|
|
|
SFAS 158
|
|
|
Liability
|
|
|
SFAS 158
|
|
|
SFAS 158
|
|
Balance Sheet Caption
|
|
Adjustments
|
|
|
Adjustment
|
|
|
Adjustment
|
|
|
Adjustments
|
|
|
|
(In millions)
|
|
|
Other assets: Prepaid pension benefit cost
|
|
$
|
1,938
|
|
|
$
|
|
|
|
$
|
(992
|
)
|
|
$
|
946
|
|
Other assets: Intangible asset
|
|
$
|
12
|
|
|
|
(12
|
)
|
|
|
|
|
|
$
|
|
|
Other liabilities: Accrued pension benefit cost
|
|
$
|
(497
|
)
|
|
|
(14
|
)
|
|
|
(66
|
)
|
|
$
|
(577
|
)
|
Other liabilities: Accrued other postretirement benefit plan cost
|
|
$
|
(794
|
)
|
|
|
|
|
|
|
(95
|
)
|
|
$
|
(889
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
|
|
|
|
(26
|
)
|
|
|
(1,153
|
)
|
|
|
|
|
Net liability of subsidiary held-for-sale
|
|
|
|
|
|
|
|
|
|
|
(18
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated other comprehensive income (loss), before income tax:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Defined benefit plans
|
|
$
|
(66
|
)
|
|
|
(26
|
)
|
|
|
(1,171
|
)
|
|
$
|
(1,263
|
)
|
Minority interest
|
|
|
|
|
|
|
|
|
|
|
8
|
|
|
|
|
|
Deferred income tax
|
|
|
|
|
|
|
8
|
|
|
|
419
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated other comprehensive income (loss), net of income tax:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Defined benefit plans
|
|
$
|
(41
|
)
|
|
$
|
(18
|
)
|
|
$
|
(744
|
)
|
|
$
|
(803
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A December 31 measurement date is used for all of the
Subsidiaries defined benefit pension and other
postretirement benefit plans.
The benefit obligations and funded status of the
Subsidiaries defined benefit pension and other
postretirement benefit plans, as determined in accordance with
the applicable provisions described above, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
|
|
|
Other
|
|
|
|
|
|
|
Postretirement
|
|
|
|
Pension Benefits
|
|
|
Benefits
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Benefit obligation at end of year
|
|
$
|
6,041
|
|
|
$
|
5,722
|
|
|
$
|
1,632
|
|
|
$
|
1,599
|
|
Fair value of plan assets at end of year
|
|
|
5,559
|
|
|
|
6,520
|
|
|
|
1,011
|
|
|
|
1,183
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Funded status at end of year
|
|
$
|
(482
|
)
|
|
$
|
798
|
|
|
$
|
(621
|
)
|
|
$
|
(416
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts recognized in the consolidated balance sheet consist of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other assets
|
|
$
|
227
|
|
|
$
|
1,396
|
|
|
$
|
|
|
|
$
|
|
|
Other liabilities
|
|
|
(709
|
)
|
|
|
(598
|
)
|
|
|
(621
|
)
|
|
|
(416
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net amount recognized
|
|
$
|
(482
|
)
|
|
$
|
798
|
|
|
$
|
(621
|
)
|
|
$
|
(416
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated other comprehensive (income) loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net actuarial (gains) losses
|
|
$
|
2,184
|
|
|
$
|
623
|
|
|
$
|
147
|
|
|
$
|
(112
|
)
|
Prior service cost (credit)
|
|
|
45
|
|
|
|
64
|
|
|
|
(157
|
)
|
|
|
(193
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,229
|
|
|
|
687
|
|
|
|
(10
|
)
|
|
|
(305
|
)
|
Deferred income tax and minority interest
|
|
|
(780
|
)
|
|
|
(251
|
)
|
|
|
4
|
|
|
|
109
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,449
|
|
|
$
|
436
|
|
|
$
|
(6
|
)
|
|
$
|
(196
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
177
The aggregate projected benefit obligation and aggregate
estimated fair value of plan assets for the pension plans were
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
Qualified Plans
|
|
|
Non-Qualified Plans
|
|
|
Total
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Aggregate fair value of plan assets (principally Company
contracts)
|
|
$
|
5,559
|
|
|
$
|
6,520
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
5,559
|
|
|
$
|
6,520
|
|
Aggregate projected benefit obligation
|
|
|
5,356
|
|
|
|
5,139
|
|
|
|
685
|
|
|
|
583
|
|
|
|
6,041
|
|
|
|
5,722
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Over (under) funded
|
|
$
|
203
|
|
|
$
|
1,381
|
|
|
$
|
(685
|
)
|
|
$
|
(583
|
)
|
|
$
|
(482
|
)
|
|
$
|
798
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accumulated benefit obligation for all defined benefit
pension plans was $5,620 million and $5,302 million at
December 31, 2008 and 2007, respectively.
Information for pension plans with an accumulated benefit
obligation in excess of plan assets is as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Projected benefit obligation
|
|
$
|
708
|
|
|
$
|
597
|
|
Accumulated benefit obligation
|
|
$
|
590
|
|
|
$
|
517
|
|
Fair value of plan assets
|
|
$
|
|
|
|
$
|
|
|
Information for pension and other postretirement benefit plans
with a projected benefit obligation in excess of plan assets is
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
|
|
|
Other
|
|
|
|
|
|
|
Postretirement
|
|
|
|
Pension Benefits
|
|
|
Benefits
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
Projected benefit obligation
|
|
$
|
712
|
|
|
$
|
602
|
|
|
$
|
1,632
|
|
|
$
|
1,599
|
|
Fair value of plan assets
|
|
$
|
4
|
|
|
$
|
4
|
|
|
$
|
1,011
|
|
|
$
|
1,183
|
|
Pension
and Other Postretirement Benefit Plan Obligations
Pension
Plan Obligations
Obligations, both PBO and ABO, of the defined benefit pension
plans are determined using a variety of actuarial assumptions,
from which actual results may vary. Some of the more significant
of these assumptions include the discount rate used to determine
the present value of future benefit payments, the expected rate
of compensation increases and average expected retirement age.
Assumptions used in determining pension plan obligations were as
follows:
|
|
|
|
|
|
|
December 31,
|
|
|
2008
|
|
2007
|
|
Weighted average discount rate
|
|
6.60%
|
|
6.65%
|
Rate of compensation increase
|
|
3.5% - 7.5%
|
|
3.5% - 8%
|
Average expected retirement age
|
|
63
|
|
63
|
The discount rate is determined annually based on the yield,
measured on a yield to worst basis, of a hypothetical portfolio
constructed of high-quality debt instruments available on the
valuation date, which would provide the necessary future cash
flows to pay the aggregate PBO when due. The yield of this
hypothetical portfolio, constructed of bonds rated AA or better
by Moodys resulted in a discount rate of approximately
6.60% and 6.65% for the defined pension plans at
December 31, 2008 and 2007, respectively.
178
A decrease (increase) in the discount rate increases (decreases)
the PBO. This increase (decrease) to the PBO is amortized into
earnings as an actuarial loss (gain). Based on the
December 31, 2008 PBO, a 25 basis point decrease
(increase) in the discount rate would result in an increase
(decrease) in the PBO of $168 million.
At the end of 2008, total net actuarial losses were
$2,184 million as compared to $623 million in 2007. In
2008, the decrease in discount rate had a nominal effect on the
increase in the actuarial losses. The substantial increase in
net actuarial losses during 2008 occurred due to the substantial
decline in the estimated fair value of plan assets. These losses
will be amortized on a straight-line basis over the average
remaining service period of active employees expected to receive
benefits under the benefit plans. At the end of 2008, the
average remaining service period of active employees was
7.9 years for the pension plans. The increase in net
periodic benefit cost in 2009 associated with the amortization
of these net actuarial losses is described in the respective
section which follows.
As the benefits provided under the defined pension plans are
calculated as a percentage of future earnings, an assumption of
future compensation increases is required to determine the
projected benefit obligation. This assumption is based on a
building block approach that best-estimates future compensation
increases due to inflation, merit and productivity. The future
compensation rate is derived from a Consumer Price Index
(CPI) assumption and through periodic analysis of
historical demographic data conducted. A recent review of these
underlying assumptions demonstrated that the CPI assumption
should be lowered by 50 basis points based on forecasts
from various economic reports. The last review of the historical
data was conducted using salary information through 2006 and the
Company believes that no circumstances have subsequently
occurred that would result in a material change to the future
compensation rate. The 50 basis point change in future
compensation rate caused a decrease in PBO of $62 million.
This rate is reviewed annually.
Other
Postretirement Benefit Plan Obligations
The APBO is determined using a variety of actuarial assumptions,
from which actual results may vary. Some of the more significant
of these assumptions include the discount rate, the healthcare
cost trend rate and the average expected retirement age. The
determination of the discount rate and the average expected
retirement age are substantially consistent with the
determination described previously for the pension plans.
The assumed healthcare cost trend rates used in measuring the
APBO and net periodic benefit cost were as follows:
|
|
|
|
|
|
|
December 31,
|
|
|
2008
|
|
2007
|
|
Pre-Medicare eligible claims
|
|
8.8% down to 5.8% in 2018 and
|
|
8.5% down to 5% in 2014 and
|
|
|
gradually decreasing until 2079
|
|
remaining constant thereafter
|
|
|
reaching the ultimate rate of 4.1%
|
|
|
Medicare eligible claims
|
|
8.8% down to 5.8% in 2018 and
|
|
10.5% down to 5% in 2018 and
|
|
|
gradually decreasing until 2079
|
|
remaining constant thereafter
|
|
|
reaching the ultimate rate of 4.1%
|
|
|
A recent review of the healthcare cost trend assumption
indicated the need for a slight modification in this assumption
as set forth in the table above. This assumption change in our
healthcare cost trend rate increased the APBO by
$62 million. This rate is reviewed annually.
Assumed healthcare cost trend rates may have a significant
effect on the amounts reported for healthcare plans. A
one-percentage point change in assumed healthcare cost trend
rates would have the following effects:
|
|
|
|
|
|
|
|
|
|
|
One Percent
|
|
|
One Percent
|
|
|
|
Increase
|
|
|
Decrease
|
|
|
|
(In millions)
|
|
|
Effect on total of service and interest cost components
|
|
$
|
6
|
|
|
$
|
(6
|
)
|
Effect of accumulated postretirement benefit obligation
|
|
$
|
76
|
|
|
$
|
(86
|
)
|
A decrease (increase) in the discount rate increases (decreases)
the APBO. This increase (decrease) to the APBO is amortized into
earnings as an actuarial loss (gain). Based on the
December 31, 2008 APBO, a 25 basis point decrease
(increase) in the discount rate would result in an increase
(decrease) in the APBO of $44 million.
179
At the end of 2008, total net actuarial losses were
$147 million as compared to net actuarial gains of
$112 million in 2007. In 2008, the decrease in discount
rate had a nominal effect on the increase in the actuarial
losses. The increase in net actuarial losses during 2008
occurred due to the substantial decline in the estimated fair
value of plan assets. These losses will be amortized on a
straight-line basis over the average remaining service period of
active employees expected to receive benefits under the other
postretirement benefit plans. At the end of 2008, the average
remaining service period of active employees was 7.9 years
for the other postretirement benefit plans. The increase in net
periodic benefit cost in 2009 associated with the amortization
of these net actuarial losses is described in the respective
section which follows.
In 2004, the Company adopted the guidance in Financial
Accounting Standards Board (FASB) Staff Position
(FSP)
No. 106-2,
Accounting and Disclosure Requirements Related to the
Medicare Prescription Drug, Improvement and Modernization Act of
2003
(FSP 106-2),
to account for future subsidies to be received under the
Prescription Drug Act. The Company began receiving these
subsidies during 2006. A summary of the reduction to the APBO
and related reduction to the components of net periodic other
postretirement benefit plan cost is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Cumulative reduction in benefit obligation:
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, beginning of year
|
|
$
|
299
|
|
|
$
|
328
|
|
|
$
|
298
|
|
Service cost
|
|
|
5
|
|
|
|
7
|
|
|
|
6
|
|
Interest cost
|
|
|
20
|
|
|
|
19
|
|
|
|
19
|
|
Net actuarial gains (losses)
|
|
|
3
|
|
|
|
(42
|
)
|
|
|
15
|
|
Prescription drug subsidy
|
|
|
(10
|
)
|
|
|
(13
|
)
|
|
|
(10
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, end of year
|
|
$
|
317
|
|
|
$
|
299
|
|
|
$
|
328
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Reduction in net periodic benefit cost:
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost
|
|
$
|
5
|
|
|
$
|
7
|
|
|
$
|
6
|
|
Interest cost
|
|
|
20
|
|
|
|
19
|
|
|
|
19
|
|
Amortization of net actuarial gains (losses)
|
|
|
|
|
|
|
5
|
|
|
|
30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total reduction in net periodic benefit cost
|
|
$
|
25
|
|
|
$
|
31
|
|
|
$
|
55
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Company received subsidies of $12 million and
$10 million for the years ended December 31, 2008 and
2007, respectively.
Pension
and Other Postretirement Benefit Plan Assets
Pension
Plan Assets
Substantially all assets of the pension plans are invested
within group annuity and life insurance contracts issued by the
Subsidiaries. The majority of assets are held in separate
accounts established by the Subsidiaries. The account values of
assets held with the Subsidiaries were $5,502 million and
$6,440 million at December 31, 2008 and 2007,
respectively. The terms of these contracts are consistent in all
material respects with those the Subsidiaries offer to
unaffiliated parties that are similarly situated.
Net assets invested in separate accounts are stated at the
aggregate estimated fair value of units of participation. Such
value reflects accumulated contributions, dividends and realized
and unrealized investment gains or losses apportioned to such
contributions, less withdrawals, distributions, allocable
expenses relating to the purchase, sale and maintenance of the
assets and an allocable part of such separate accounts
investment expenses.
180
Separate account investments in fixed income and equity
securities are generally carried at published market value, or
if published market values are not readily available, at
estimated fair values. Investments in short-term fixed income
securities are generally reflected as cash equivalents and
carried at fair value. Real estate investments, in the form of
real estate investment trusts, are carried at estimated fair
value based on appraisals performed by third-party real estate
appraisal firms, and generally, determined by discounting
projected cash flows over periods of time and at interest rates
deemed appropriate for each investment. Information on the
physical value of the property and the sales prices of
comparable properties is used to corroborate fair value
estimates. Estimated fair value of hedge fund net assets is
generally determined by third-party pricing vendors using quoted
market prices or through the use of pricing models which are
affected by changes in interest rates, foreign currency exchange
rates, financial indices, credit spreads, market supply and
demand, market volatility and liquidity.
The following table summarizes the actual and target
weighted-average allocations of pension plan assets within the
separate accounts:
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
Weighted Average
|
|
|
Weighted Average
|
|
|
Actual Allocation
|
|
|
Target Allocation
|
|
|
2008
|
|
|
2007
|
|
|
2009
|
|
Asset Category
|
|
|
|
|
|
|
|
|
|
|
Equity securities
|
|
|
28
|
%
|
|
|
38
|
%
|
|
25% - 45%
|
Fixed maturity securities
|
|
|
51
|
|
|
|
44
|
|
|
35% - 55%
|
Other (Real estate and alternative investments)
|
|
|
21
|
|
|
|
18
|
|
|
5% - 32%
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Target allocations of assets are determined with the objective
of maximizing returns and minimizing volatility of net assets
through adequate asset diversification. Adjustments are made to
target allocations based on an assessment of the impact of
economic factors and market conditions.
Credit and equity market volatility during 2008 resulted in a
substantial decrease in the estimated fair value of the pension
plans assets at December 31, 2008. This decline in
asset values resulted in a substantial increase in net actuarial
losses at December 31, 2008, as described in the preceding
section on pension plan obligations, and will result in a
significant increase in net periodic pension cost during 2009,
as described in the following section on net periodic benefit
cost.
Other
Postretirement Benefit Plan Assets
Substantially all assets of the other postretirement benefit
plans are invested within life insurance and reserve contracts
issued by the Subsidiaries. The majority of assets are held in
separate accounts established by the Subsidiaries. The account
values of assets held with the Subsidiaries were
$949 million and $1,125 million at December 31,
2008 and 2007, respectively. The terms of these contracts are
consistent in all material respects with those the Subsidiaries
offer to unaffiliated parties that are similarly situated.
The valuation of separate accounts and the investments within
such separate accounts invested in by the other postretirement
benefit plans are similar to that described in the preceding
section on pension plans.
181
The following table summarizes the actual and target
weighted-average allocations of other postretirement benefit
plan assets within the separate accounts:
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
Weighted Average
|
|
|
Weighted Average
|
|
|
Actual Allocation
|
|
|
Target Allocation
|
|
|
2008
|
|
|
2007
|
|
|
2009
|
|
Asset Category
|
|
|
|
|
|
|
|
|
|
|
Equity securities
|
|
|
27
|
%
|
|
|
37
|
%
|
|
30% - 45%
|
Fixed maturity securities
|
|
|
71
|
|
|
|
58
|
|
|
55% - 85%
|
Other (Real estate and alternative investments)
|
|
|
2
|
|
|
|
5
|
|
|
0% - 10%
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Target allocations of assets are determined with the objective
of maximizing returns and minimizing volatility of net assets
through adequate asset diversification. Adjustments are made to
target allocations based on an assessment of the impact of
economic factors and market conditions.
Credit and equity market volatility during 2008 resulted in a
decrease in the estimated fair value of the other postretirement
benefit plans assets at December 31, 2008. This
decline in asset values resulted in an increase in net actuarial
losses at December 31, 2008, as described in the preceding
section on other postretirement benefit plan obligations, and
will result in a significant increase in net periodic other
postretirement benefit plan cost during 2009, as described in
the following section on net periodic benefit cost.
Pension
and Other Postretirement Net Periodic Benefit Cost
Pension
Cost
Net periodic pension cost is comprised of the following:
|
|
|
|
i)
|
Service Cost Service cost is the increase in the
projected pension benefit obligation resulting from benefits
payable to employees of the Subsidiaries on service rendered
during the current year.
|
|
|
ii)
|
Interest Cost on the Liability Interest cost is the
time value adjustment on the projected pension benefit
obligation at the end of each year.
|
|
|
iii)
|
Expected Return on Plan Assets Expected return on
plan assets is the assumed return earned by the accumulated
pension fund assets in a particular year.
|
|
|
iv)
|
Amortization of Prior Service Cost This cost relates
to the increase or decrease to pension benefit cost for service
provided in prior years due to amendments in plans or initiation
of new plans. As the economic benefits of these costs are
realized in the future periods, these costs are amortized to
pension expense over the expected service years of the employees.
|
|
|
v)
|
Amortization of Net Actuarial Gains or Losses
Actuarial gains and losses result from differences between the
actual experience and the expected experience on pension plan
assets or projected pension benefit obligation during a
particular period. These gains and losses are accumulated and,
to the extent they exceed 10% of the greater of the projected
pension benefit obligation or the market-related value of plan
assets, they are amortized into pension expense over the
expected service years of the employees.
|
182
The Subsidiaries recognized pension expense of $65 million
in 2008 as compared to $93 million in 2007 and
$175 million in 2006. The major components of net periodic
pension cost described above were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Service cost
|
|
$
|
164
|
|
|
$
|
162
|
|
|
$
|
159
|
|
Interest cost
|
|
|
379
|
|
|
|
351
|
|
|
|
332
|
|
Expected return on plan assets
|
|
|
(517
|
)
|
|
|
(505
|
)
|
|
|
(452
|
)
|
Amortization of net actuarial (gains) losses
|
|
|
24
|
|
|
|
68
|
|
|
|
128
|
|
Amortization of prior service cost (credit)
|
|
|
15
|
|
|
|
17
|
|
|
|
8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic benefit cost
|
|
$
|
65
|
|
|
$
|
93
|
|
|
$
|
175
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The decrease in expense from 2006 to 2007 was primarily the
result of an increase in the expected return on plan assets and
a decrease in amortization of net actuarial losses resulting
from the $350 million contribution made in 2006. The
increase in the interest cost resulted from the increase in the
discount rate.
The decrease in expense from 2007 to 2008 was primarily the
result of better than anticipated returns on plan assets in
2007, coupled with the increase in the discount rate.
For 2009 pension expense, we anticipate an increase of
approximately $275 million due to poor plan asset
performance as a result of the economic downturn of the
financial markets. The expected increase in expense can be
attributed to lower expected return on assets and increased
amortization of net actuarial losses.
The estimated net actuarial losses and prior service cost for
the defined benefit pension plans that will be amortized from
accumulated other comprehensive income (loss) into net periodic
benefit cost over the next year are $198 million and
$9 million, respectively.
The weighted average discount rate used to calculate the net
periodic pension cost was 6.65%, 6.00% and 5.82% for the years
ended December 31, 2008, 2007 and 2006, respectively.
The weighted average expected rate of return on pension plan
assets used to calculate the net periodic pension cost for the
years ended December 31, 2008, 2007 and 2006 was 8.25%. The
expected rate of return on plan assets is based on anticipated
performance of the various asset sectors in which the plan
invests, weighted by target allocation percentages. Anticipated
future performance is based on long-term historical returns of
the plan assets by sector, adjusted for the Subsidiaries
long-term expectations on the performance of the markets. While
the precise expected return derived using this approach will
fluctuate from year to year, the Subsidiaries policy is to
hold this long-term assumption constant as long as it remains
within reasonable tolerance from the derived rate.
Based on the December 31, 2008 asset balances, a
25 basis point increase (decrease) in the expected rate of
return on plan assets would result in a decrease (increase) in
net periodic benefit cost of $14 million for the pension
plans.
Other
Postretirement Benefit Plan Cost
The net periodic other postretirement benefit plan cost consists
of the following:
|
|
|
|
i)
|
Service Cost Service cost is the increase in the
expected postretirement plan benefit obligation resulting from
benefits payable to employees of the Subsidiaries on service
rendered during the current year.
|
|
|
ii)
|
Interest Cost on the Liability Interest cost is the
time value adjustment on the expected postretirement benefit
obligation at the end of each year.
|
|
|
iii)
|
Expected Return on Plan Assets Expected return on
plan assets is the assumed return earned by the accumulated
other postretirement fund assets in a particular year.
|
183
|
|
|
|
iv)
|
Amortization of Prior Service Cost This cost relates
to the increase or decrease to other postretirement benefit plan
cost for service provided in prior years due to amendments in
plans or initiation of new plans. As the economic benefits of
these costs are realized in the future periods these costs are
amortized to other postretirement benefit expense over the
expected service years of the employees.
|
|
|
v)
|
Amortization of Net Actuarial Gains or Losses
Actuarial gains and losses result from differences between the
actual experience and the expected experience on other
postretirement benefit plan assets or expected postretirement
plan benefit obligation during a particular year. These gains
and losses are accumulated and, to the extent they exceed 10% of
the greater of the accumulated postretirement plan benefit
obligation or the market-related value of plan assets, they are
amortized into other postretirement benefit expense over the
expected service years of the employees.
|
The Subsidiaries recognized no other postretirement benefit
expense in 2008 as compared to $8 million in 2007 and
$58 million in 2006. The major components of net periodic
other postretirement benefit plan cost described above were as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Service cost
|
|
$
|
21
|
|
|
$
|
27
|
|
|
$
|
35
|
|
Interest cost
|
|
|
103
|
|
|
|
103
|
|
|
|
116
|
|
Expected return on plan assets
|
|
|
(86
|
)
|
|
|
(86
|
)
|
|
|
(79
|
)
|
Amortization of net actuarial (gains) losses
|
|
|
(1
|
)
|
|
|
|
|
|
|
22
|
|
Amortization of prior service cost (credit)
|
|
|
(37
|
)
|
|
|
(36
|
)
|
|
|
(36
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic benefit cost
|
|
$
|
|
|
|
$
|
8
|
|
|
$
|
58
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The decrease in benefit cost from 2006 to 2007 primarily
resulted from a change in the Medicare integration methodology
for certain retirees. The decrease in benefit cost from 2007 to
2008 was due to primarily to increases in the discount rate and
better than expected medical trend experience.
For 2009 postretirement benefit expense, we anticipate an
increase of approximately $25 million due to poor plan
asset performance as a result of the economic downturn of the
financial markets. The expected increase in expense can be
attributed to lower expected return on assets and increased
amortization of net actuarial losses.
The estimated net actuarial losses and prior service credit for
the other postretirement benefit plans that will be amortized
from accumulated other comprehensive income (loss) into net
periodic benefit cost over the next year are less than
$10 million and ($36) million, respectively.
The weighted average discount rate used to calculate the net
periodic postretirement cost was 6.65%, 6.00% and 5.82% for the
years ended December 31, 2008, 2007 and 2006, respectively.
The weighted average expected rate of return on plan assets used
to calculate the net other postretirement benefit plan cost for
the years ended December 31, 2008, 2007 and 2006 was 7.33%,
7.47% and 7.42%, respectively. The expected rate of return on
plan assets is based on anticipated performance of the various
asset sectors in which the plan invests, weighted by target
allocation percentages. Anticipated future performance is based
on long-term historical returns of the plan assets by sector,
adjusted for the Subsidiaries long-term expectations on
the performance of the markets. While the precise expected
return derived using this approach will fluctuate from year to
year, the Subsidiaries policy is to hold this long-term
assumption constant as long as it remains within reasonable
tolerance from the derived rate.
Based on the December 31, 2008 asset balances, a
25 basis point increase (decrease) in the expected rate of
return on plan assets would result in a decrease (increase) in
net periodic benefit cost of $3 million for the other
postretirement benefit plans.
184
Funding
and Cash Flows of Pension and Other Postretirement Benefit Plan
Obligations
Pension
Plan Obligations
It is the Subsidiaries practice to make contributions to
the qualified pension plans to comply with minimum funding
requirements of ERISA, as amended. In accordance with such
practice, no contributions were required for the years ended
December 31, 2008 or 2007. No contributions will be
required for 2009. The Subsidiaries made a discretionary
contribution of $300 million to the qualified pension plans
during the year ended December 31, 2008. During the year
ended December 31, 2007, the Subsidiaries did not make any
discretionary contributions to the qualified pension plans. The
Subsidiaries expect to make additional discretionary
contributions of $150 million in 2009.
Benefit payments due under the non-qualified pension plans are
funded from the Subsidiaries general assets as they become
due under the provision of the plans. These payments totaled
$43 million and $48 million for the years ended
December 31, 2008 and 2007, respectively. These benefit
payments are expected to be at approximately the same level in
2009.
Gross pension benefit payments for the next ten years, which
reflect expected future service as appropriate, are expected to
be as follows:
|
|
|
|
|
|
|
Pension
|
|
|
|
Benefits
|
|
|
|
(In millions)
|
|
|
2009
|
|
$
|
384
|
|
2010
|
|
$
|
398
|
|
2011
|
|
$
|
408
|
|
2012
|
|
$
|
424
|
|
2013
|
|
$
|
437
|
|
2014-2018
|
|
$
|
2,416
|
|
Other
Postretirement Benefit Plan Obligations
Other postretirement benefits represent a non-vested,
non-guaranteed obligation of the Subsidiaries and current
regulations do not require specific funding levels for these
benefits. While the Subsidiaries have partially funded such
plans in advance, it has been the Subsidiaries practice to
primarily use their general assets, net of participants
contributions, to pay postretirement medical claims as they come
due in lieu of utilizing plan assets. Total payments equaled
$149 million and $173 million for the years ended
December 31, 2008 and 2007, respectively.
The Subsidiaries expect to make contributions of
$120 million, net of participants contributions,
towards the other postretirement plan obligations in 2009. As
noted previously, the Subsidiaries expect to receive subsidies
under the Prescription Drug Act to partially offset such
payments.
Gross other postretirement benefit payments for the next ten
years, which reflect expected future service where appropriate,
and gross subsidies to be received under the Prescription Drug
Act are expected to be as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prescription
|
|
|
|
|
Gross
|
|
Drug Subsidies
|
|
Net
|
|
|
|
|
(In millions)
|
|
|
|
2009
|
|
$
|
135
|
|
|
$
|
(15
|
)
|
|
$
|
120
|
|
2010
|
|
$
|
140
|
|
|
$
|
(16
|
)
|
|
$
|
124
|
|
2011
|
|
$
|
146
|
|
|
$
|
(16
|
)
|
|
$
|
130
|
|
2012
|
|
$
|
150
|
|
|
$
|
(17
|
)
|
|
$
|
133
|
|
2013
|
|
$
|
154
|
|
|
$
|
(18
|
)
|
|
$
|
136
|
|
2014-2018
|
|
$
|
847
|
|
|
$
|
(107
|
)
|
|
$
|
740
|
|
185
Insolvency
Assessments
Most of the jurisdictions in which the Company is admitted to
transact business require insurers doing business within the
jurisdiction to participate in guaranty associations, which are
organized to pay contractual benefits owed pursuant to insurance
policies issued by impaired, insolvent or failed insurers. These
associations levy assessments, up to prescribed limits, on all
member insurers in a particular state on the basis of the
proportionate share of the premiums written by member insurers
in the lines of business in which the impaired, insolvent or
failed insurer engaged. Some states permit member insurers to
recover assessments paid through full or partial premium tax
offsets. Assets and liabilities held for insolvency assessments
are as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Other Assets:
|
|
|
|
|
|
|
|
|
Premium tax offset for future undiscounted assessments
|
|
$
|
50
|
|
|
$
|
40
|
|
Premium tax offsets currently available for paid assessments
|
|
|
7
|
|
|
|
6
|
|
Receivable for reimbursement of paid assessments (1)
|
|
|
7
|
|
|
|
7
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
64
|
|
|
$
|
53
|
|
|
|
|
|
|
|
|
|
|
Other Liabilities:
|
|
|
|
|
|
|
|
|
Insolvency assessments
|
|
$
|
83
|
|
|
$
|
74
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The Company holds a receivable from the seller of a prior
acquisition in accordance with the purchase agreement. |
Assessments levied against the Company were $2 million,
($1) million and $2 million for the years ended
December 31, 2008, 2007 and 2006, respectively.
Effects
of Inflation
The Company does not believe that inflation has had a material
effect on its consolidated results of operations, except insofar
as inflation may affect interest rates.
Inflation in the United States has remained contained and been
in a general downtrend for an extended period. However, in light
of recent and ongoing aggressive fiscal and monetary stimulus
measures by the U.S. federal government and foreign
governments, it is possible that inflation could increase in the
future. An increase in inflation could affect our business in
several ways. During inflationary periods, the value of fixed
income investments falls which could increase realized and
unrealized losses. Inflation also increases expenses for labor
and other materials, potentially putting pressure on
profitability if such costs can not be passed through in our
product prices. Inflation could also lead to increased costs for
losses and loss adjustment expenses in our Auto & Home
business, which could require us to adjust our pricing to
reflect our expectations for future inflation. If actual
inflation exceeds the expectations we use in pricing our
policies, the profitability of our Auto & Home business
would be adversely affected. Prolonged and elevated inflation
could adversely affect the financial markets and the economy
generally, and dispelling it may require governments to pursue a
restrictive fiscal and monetary policy, which could constrain
overall economic activity, inhibit revenue growth and reduce the
number of attractive investment opportunities.
Adoption
of New Accounting Pronouncements
Fair
Value
Effective January 1, 2008, the Company adopted
SFAS No. 157, Fair Value Measurements.
SFAS 157 which defines fair value, establishes a consistent
framework for measuring fair value, establishes a fair value
hierarchy based on the observability of inputs used to measure
fair value, and requires enhanced disclosures about fair value
measurements and applied the provisions of the statement
prospectively to assets and liabilities measured at fair value.
The adoption of SFAS 157 changed the valuation of certain
freestanding derivatives by moving from a mid to
186
bid pricing convention as it relates to certain volatility
inputs as well as the addition of liquidity adjustments and
adjustments for risks inherent in a particular input or
valuation technique. The adoption of SFAS 157 also changed
the valuation of the Companys embedded derivatives, most
significantly the valuation of embedded derivatives associated
with certain riders on variable annuity contracts. The change in
valuation of embedded derivatives associated with riders on
annuity contracts resulted from the incorporation of risk
margins associated with non capital market inputs and the
inclusion of the Companys own credit standing in their
valuation. At January 1, 2008, the impact of adopting
SFAS 157 on assets and liabilities measured at estimated
fair value was $30 million ($19 million, net of income
tax) and was recognized as a change in estimate in the
accompanying consolidated statement of income where it was
presented in the respective income statement caption to which
the item measured at estimated fair value is presented. There
were no significant changes in estimated fair value of items
measured at fair value and reflected in accumulated other
comprehensive income (loss). The addition of risk margins and
the Companys own credit spread in the valuation of
embedded derivatives associated with annuity contracts may
result in significant volatility in the Companys
consolidated net income in future periods. Note 24 of the
Notes to the Consolidated Financial Statements presents the
estimated fair value of all assets and liabilities required to
be measured at estimated fair value as well as the expanded fair
value disclosures required by SFAS 157.
In February 2007, the FASB issued SFAS No. 159, The
Fair Value Option for Financial Assets and Financial Liabilities
(SFAS 159). SFAS 159 permits entities
the option to measure most financial instruments and certain
other items at fair value at specified election dates and to
recognize related unrealized gains and losses in earnings. The
fair value option is applied on an
instrument-by-instrument
basis upon adoption of the standard, upon the acquisition of an
eligible financial asset, financial liability or firm commitment
or when certain specified reconsideration events occur. The fair
value election is an irrevocable election. Effective
January 1, 2008, the Company elected the fair value option
on fixed maturity and equity securities backing certain pension
products sold in Brazil. Such securities will now be presented
as trading securities in accordance with SFAS 115 on the
consolidated balance sheet with subsequent changes in estimated
fair value recognized in net investment income. Previously,
these securities were accounted for as available-for-sale
securities in accordance with SFAS 115 and unrealized gains
and losses on these securities were recorded as a separate
component of accumulated other comprehensive income (loss). The
Companys insurance joint venture in Japan also elected the
fair value option for certain of its existing single premium
deferred annuities and the assets supporting such liabilities.
The fair value option was elected to achieve improved reporting
of the asset/liability matching associated with these products.
Adoption of SFAS 159 by the Company and its Japanese joint
venture resulted in an increase in retained earnings of
$27 million, net of income tax, at January 1, 2008.
The election of the fair value option resulted in the
reclassification of $10 million, net of income tax, of net
unrealized gains from accumulated other comprehensive income
(loss) to retained earnings on January 1, 2008.
Effective January 1, 2008, the Company adopted FASB Staff
Position (FSP)
No. FAS 157-1,
Application of FASB Statement No. 157 to FASB Statement
No. 13 and Other Accounting Pronouncements That Address
Fair Value Measurements for Purposes of Lease Classification or
Measurement under Statement 13
(FSP 157-1).
FSP 157-1
amends SFAS 157 to provide a scope out exception for lease
classification and measurement under SFAS No. 13,
Accounting for Leases. The Company also adopted FSP
No. FAS 157-2,
Effective Date of FASB Statement No. 157 which
delays the effective date of SFAS 157 for certain
nonfinancial assets and liabilities that are recorded at fair
value on a nonrecurring basis. The effective date is delayed
until January 1, 2009 and impacts balance sheet items
including nonfinancial assets and liabilities in a business
combination and the impairment testing of goodwill and
long-lived assets.
Effective September 30, 2008, the Company adopted FSP
No. FAS 157-3,
Determining the Fair Value of a Financial Asset When the
Market for That Asset is Not Active
(FSP 157-3).
FSP 157-3
provides guidance on how a companys internal cash flow and
discount rate assumptions should be considered in the
measurement of fair value when relevant market data does not
exist, how observable market information in an inactive market
affects fair value measurement and how the use of market quotes
should be considered when assessing the relevance of observable
and unobservable data available to measure fair value. The
adoption of
FSP 157-3
did not have a material impact on the Companys
consolidated financial statements.
.
187
Investments
Effective December 31, 2008, the Company adopted FSP
No. FAS 140-4
and
FIN 46(r)-8,
Disclosures by Public Entities (Enterprises) about Transfers
of Financial Assets and Interests in Variable Interest Entities
(FSP 140-4
and
FIN 46(r)-8).
FSP 140-4
and
FIN 46(r)-8
requires additional qualitative and quantitative disclosures
about a transferors continuing involvement in transferred
financial assets and involvement in VIE. The exact nature of the
additional required VIE disclosures vary and depend on whether
or not the VIE is a qualifying special purpose entity
(QSPE). For VIEs that are QSPEs, the additional
disclosures are only required for a non-transferor sponsor
holding a variable interest or a non-transferor servicer holding
a significant variable interest. For VIEs that are not QSPEs,
the additional disclosures are only required if the Company is
the primary beneficiary, and if not the primary beneficiary,
only if the Company holds a significant variable interest or is
the sponsor. The Company provided all of the material required
disclosures in its consolidated financial statements.
Effective December 31, 2008, the Company adopted FSP
No. Emerging Issues Task Force (EITF)
99-20-1,
Amendments to the Impairment Guidance of EITF Issue
No. 99-20
(FSP
EITF 99-20-1).
FSP
EITF 99-20-1
amends the guidance in EITF Issue
No. 99-20,
Recognition of Interest Income and Impairment on Purchased
Beneficial Interests and Beneficial Interests That Continue to
Be Held by a Transferor in Securitized Financial Assets, to
more closely align the guidance to determine whether an
other-than-temporary impairment has occurred for a beneficial
interest in a securitized financial asset with the guidance in
SFAS 115 for debt securities classified as
available-for-sale or held-to-maturity. The adoption of FSP
EITF 99-20-1
did not have an impact on the Companys consolidated
financial statements.
Derivative
Financial Instruments
Effective December 31, 2008, the Company adopted FSP
No. FAS
133-1 and
FIN 45-4,
Disclosures about Credit Derivatives and Certain
Guarantees An Amendment of FASB Statement
No. 133 and FASB Interpretation No. 45; and
Clarification of the Effective Date of FASB Statement
No. 161
(FSP 133-1
and
FIN 45-4).
FSP 133-1
and
FIN 45-4
amends SFAS No. 133, Accounting for Derivative
Instruments and Hedging Activities
(SFAS 133) to require certain enhanced
disclosures by sellers of credit derivatives by requiring
additional information about the potential adverse effects of
changes in their credit risk, financial performance, and cash
flows. It also amends FIN No. 45, Guarantors
Accounting and Disclosure Requirements for Guarantees, Including
Indirect Guarantees of Indebtedness of Others An
Interpretation of FASB Statements No. 5, 57, and 107 and
Rescission of FASB Interpretation No. 34
(FIN 45), to require an additional
disclosure about the current status of the payment/performance
risk of a guarantee. The Company provided all of the material
required disclosures in its consolidated financial statements.
Effective January 1, 2008, the Company adopted
SFAS 133 Implementation Issue
No. E-23,
Clarification of the Application of the Shortcut Method
(Issue
E-23).
Issue E-23
amended SFAS 133 by permitting interest rate swaps to have
a non-zero fair value at inception when applying the shortcut
method of assessing hedge effectiveness, as long as the
difference between the transaction price (zero) and the fair
value (exit price), as defined by SFAS 157, is solely
attributable to a bid-ask spread. In addition, entities are not
precluded from applying the shortcut method of assessing hedge
effectiveness in a hedging relationship of interest rate risk
involving an interest bearing asset or liability in situations
where the hedged item is not recognized for accounting purposes
until settlement date as long as the period between trade date
and settlement date of the hedged item is consistent with
generally established conventions in the marketplace. The
adoption of Issue
E-23 did not
have an impact on the Companys consolidated financial
statements.
Effective January 1, 2006, the Company adopted
prospectively SFAS No. 155, Accounting for Certain
Hybrid Instruments (SFAS 155).
SFAS 155 amends SFAS 133 and SFAS No. 140,
Accounting for Transfers and Servicing of Financial Assets
and Extinguishments of Liabilities
(SFAS 140). SFAS 155 allows financial
instruments that have embedded derivatives to be accounted for
as a whole, eliminating the need to bifurcate the derivative
from its host, if the holder elects to account for the whole
instrument on a fair value basis. In addition, among other
changes, SFAS 155:
|
|
|
|
(i)
|
clarifies which interest-only strips and principal-only strips
are not subject to the requirements of SFAS 133;
|
188
|
|
|
|
(ii)
|
establishes a requirement to evaluate interests in securitized
financial assets to identify interests that are freestanding
derivatives or that are hybrid financial instruments that
contain an embedded derivative requiring bifurcation;
|
|
|
(iii)
|
clarifies that concentrations of credit risk in the form of
subordination are not embedded derivatives; and
|
|
|
(iv)
|
amends SFAS 140 to eliminate the prohibition on a QSPE from
holding a derivative financial instrument that pertains to a
beneficial interest other than another derivative financial
interest.
|
The adoption of SFAS 155 did not have a material impact on
the Companys consolidated financial statements.
Effective October 1, 2006, the Company adopted
SFAS 133 Implementation Issue No. B40, Embedded
Derivatives: Application of Paragraph 13(b) to Securitized
Interests in Prepayable Financial Assets (Issue
B40). Issue B40 clarifies that a securitized interest in
prepayable financial assets is not subject to the conditions in
paragraph 13(b) of SFAS 133, if it meets both of the
following criteria: (i) the right to accelerate the
settlement if the securitized interest cannot be controlled by
the investor; and (ii) the securitized interest itself does
not contain an embedded derivative (including an interest
rate-related derivative) for which bifurcation would be required
other than an embedded derivative that results solely from the
embedded call options in the underlying financial assets. The
adoption of Issue B40 did not have a material impact on the
Companys consolidated financial statements.
Effective January 1, 2006, the Company adopted
prospectively SFAS 133 Implementation Issue No. B38,
Embedded Derivatives: Evaluation of Net Settlement with
Respect to the Settlement of a Debt Instrument through Exercise
of an Embedded Put Option or Call Option (Issue
B38) and SFAS 133 Implementation Issue No. B39,
Embedded Derivatives: Application of Paragraph 13(b) to
Call Options That Are Exercisable Only by the Debtor
(Issue B39). Issue B38 clarifies that the
potential settlement of a debtors obligation to a creditor
occurring upon exercise of a put or call option meets the net
settlement criteria of SFAS 133. Issue B39 clarifies that
an embedded call option, in which the underlying is an interest
rate or interest rate index, that can accelerate the settlement
of a debt host financial instrument should not be bifurcated and
fair valued if the right to accelerate the settlement can be
exercised only by the debtor (issuer/borrower) and the investor
will recover substantially all of its initial net investment.
The adoption of Issues B38 and B39 did not have a material
impact on the Companys consolidated financial statements.
Income
Taxes
Effective January 1, 2007, the Company adopted FIN 48.
FIN 48 clarifies the accounting for uncertainty in income
tax recognized in a companys financial statements.
FIN 48 requires companies to determine whether it is
more likely than not that a tax position will be
sustained upon examination by the appropriate taxing authorities
before any part of the benefit can be recorded in the financial
statements. It also provides guidance on the recognition,
measurement, and classification of income tax uncertainties,
along with any related interest and penalties. Previously
recorded income tax benefits that no longer meet this standard
are required to be charged to earnings in the period that such
determination is made.
As a result of the implementation of FIN 48, the Company
recognized a $35 million increase in the liability for
unrecognized tax benefits and a $9 million decrease in the
interest liability for unrecognized tax benefits, as well as a
$17 million increase in the liability for unrecognized tax
benefits and a $5 million increase in the interest
liability for unrecognized tax benefits which are included in
liabilities of subsidiaries held-for-sale. The corresponding
reduction to the January 1, 2007 balance of retained
earnings was $37 million, net of $11 million of
minority interest included in liabilities of subsidiaries
held-for-sale. See also Note 15 of the Notes to the
Consolidated Financial Statements.
Insurance
Contracts
Effective January 1, 2007, the Company adopted
SOP 05-1
which provides guidance on accounting by insurance enterprises
for DAC on internal replacements of insurance and investment
contracts other than those specifically described in
SFAS No. 97, Accounting and Reporting by Insurance
Enterprises for Certain Long-Duration Contracts and for Realized
Gains and Losses from the Sale of Investments.
SOP 05-1
defines an internal replacement and is effective for internal
replacements occurring in fiscal years beginning after
December 15, 2006.
189
In addition, in February 2007, the American Institute of
Certified Public Accountants (AICPA) issued related
Technical Practice Aids (TPAs) to provide further
clarification of
SOP 05-1.
The TPAs became effective concurrently with the adoption of
SOP 05-1.
As a result of the adoption of
SOP 05-1
and the related TPAs, if an internal replacement modification
substantially changes a contract, then the DAC is written off
immediately through income and any new deferrable costs
associated with the new replacement are deferred. If a contract
modification does not substantially change the contract, the DAC
amortization on the original contract will continue and any
acquisition costs associated with the related modification are
immediately expensed.
The adoption of
SOP 05-1
and the related TPAs resulted in a reduction to DAC and VOBA on
January 1, 2007 and an acceleration of the amortization
period relating primarily to the Companys group life and
health insurance contracts that contain certain rate reset
provisions. Prior to the adoption of
SOP 05-1,
DAC on such contracts was amortized over the expected renewable
life of the contract. Upon adoption of
SOP 05-1,
DAC on such contracts is to be amortized over the rate reset
period. The impact as of January 1, 2007 was a cumulative
effect adjustment of $292 million, net of income tax of
$161 million, which was recorded as a reduction to retained
earnings.
Defined
Benefit and Other Postretirement Plans
Effective December 31, 2006, the Company adopted
SFAS 158. The pronouncement revises financial reporting
standards for defined benefit pension and other postretirement
plans by requiring the:
|
|
|
|
(i)
|
recognition in the statement of financial position of the funded
status of defined benefit plans measured as the difference
between the estimated fair value of plan assets and the benefit
obligation, which is the projected benefit obligation for
pension plans and the accumulated postretirement benefit
obligation for other postretirement plans;
|
|
|
(ii)
|
recognition as an adjustment to accumulated other comprehensive
income (loss), net of income tax, those amounts of actuarial
gains and losses, prior service costs and credits, and net asset
or obligation at transition that have not yet been included in
net periodic benefit costs as of the end of the year of adoption;
|
|
|
(iii)
|
recognition of subsequent changes in funded status as a
component of other comprehensive income;
|
|
|
(iv)
|
measurement of benefit plan assets and obligations as of the
date of the statement of financial position; and
|
|
|
(v)
|
disclosure of additional information about the effects on the
employers statement of financial position.
|
The adoption of SFAS 158 resulted in a reduction of
$744 million, net of income tax, to accumulated other
comprehensive income, which is included as a component of total
consolidated stockholders equity. As the Companys
measurement date for its pension and other postretirement
benefit plans is already December 31 there was no impact of
adoption due to changes in measurement date. See also
Summary of Significant Accounting Policies and Critical
Accounting Estimates and Note 17 of the Notes to the
Consolidated Financial Statements.
Stock
Compensation Plans
As described previously, effective January 1, 2006, the
Company adopted SFAS 123(r) including supplemental
application guidance issued by the SEC in Staff Accounting
Bulletin (SAB) No. 107, Share-Based
Payment using the modified prospective
transition method. In accordance with the modified prospective
transition method, results for prior periods have not been
restated. SFAS 123(r) requires that the cost of all
stock-based transactions be measured at fair value and
recognized over the period during which a grantee is required to
provide goods or services in exchange for the award. The Company
had previously adopted the fair value method of accounting for
stock-based awards as prescribed by SFAS 123 on a
prospective basis effective January 1, 2003. The Company
did not modify the substantive terms of any existing awards
prior to adoption of SFAS 123(r).
Under the modified prospective transition method, compensation
expense recognized during the year ended December 31, 2006
includes: (a) compensation expense for all stock-based
awards granted prior to, but not yet vested as of
January 1, 2006, based on the grant date fair value
estimated in accordance with the original provisions
190
of SFAS 123, and (b) compensation expense for all
stock-based awards granted beginning January 1, 2006, based
on the grant date fair value estimated in accordance with the
provisions of SFAS 123(r).
The adoption of SFAS 123(r) did not have a significant
impact on the Companys financial position or results of
operations as all stock-based awards accounted for under the
intrinsic value method prescribed by APB 25 had vested prior to
the adoption date and the Company had adopted the fair value
recognition provisions of SFAS 123 on January 1, 2003.
SFAS 123 allowed forfeitures of stock-based awards to be
recognized as a reduction of compensation expense in the period
in which the forfeiture occurred. Upon adoption of
SFAS 123(r), the Company changed its policy and now
incorporates an estimate of future forfeitures into the
determination of compensation expense when recognizing expense
over the requisite service period. The impact of this change in
accounting policy was not significant to the Companys
financial position or results of operations as of the date of
adoption.
Additionally, for awards granted after adoption, the Company
changed its policy from recognizing expense for stock-based
awards over the requisite service period to recognizing such
expense over the shorter of the requisite service period or the
period to attainment of retirement-eligibility. The pro forma
impact of this change in expense recognition policy for
stock-based compensation is detailed in Note 18 of the
Notes to the Consolidated Financial Statements.
Prior to the adoption of SFAS 123(r), the Company presented
tax benefits of deductions resulting from the exercise of stock
options within operating cash flows in the consolidated
statements of cash flows. SFAS 123(r) requires tax benefits
resulting from tax deductions in excess of the compensation cost
recognized for those options be classified and reported as a
financing cash inflow upon adoption of SFAS 123(r).
Other
Pronouncements
Effective January 1, 2008, the Company adopted FSP
No. FIN 39-1,
Amendment of FASB Interpretation No. 39
(FSP 39-1).
FSP 39-1
amends FIN 39, Offsetting of Amounts Related to Certain
Contracts (FIN 39), to permit a reporting
entity to offset fair value amounts recognized for the right to
reclaim cash collateral (a receivable) or the obligation to
return cash collateral (a payable) against fair value amounts
recognized for derivative instruments executed with the same
counterparty under the same master netting arrangement that have
been offset in accordance with FIN 39.
FSP 39-1
also amends FIN 39 for certain terminology modifications.
Upon adoption of
FSP 39-1,
the Company did not change its accounting policy of not
offsetting fair value amounts recognized for derivative
instruments under master netting arrangements. The adoption of
FSP 39-1
did not have an impact on the Companys consolidated
financial statements.
Effective January 1, 2008, the Company adopted
SAB No. 109, Written Loan Commitments Recorded at
Fair Value through Earnings (SAB 109),
which amends SAB No. 105, Application of Accounting
Principles to Loan Commitments. SAB 109 provides
guidance on (i) incorporating expected net future cash
flows when related to the associated servicing of a loan when
measuring fair value; and (ii) broadening the SEC
staffs view that internally-developed intangible assets
should not be recorded as part of the fair value of a derivative
loan commitment or to written loan commitments that are
accounted for at fair value through earnings.
Internally-developed intangible assets are not considered a
component of the related instruments. The adoption of
SAB 109 did not have an impact on the Companys
consolidated financial statements.
Effective January 1, 2008, the Company adopted EITF Issue
No. 07-6,
Accounting for the Sale of Real Estate When the Agreement
Includes a Buy-Sell Clause
(EITF 07-6)
prospectively.
EITF 07-6
addresses whether the existence of a buy-sell arrangement would
preclude partial sales treatment when real estate is sold to a
jointly owned entity.
EITF 07-6
concludes that the existence of a buy-sell clause does not
necessarily preclude partial sale treatment under current
guidance. The adoption of EITF
07-6 did not
have a material impact on the Companys consolidated
financial statements.
Effective January 1, 2007, the Company adopted FSP
No. EITF 00-19-2,
Accounting for Registration Payment Arrangements
(FSP
EITF 00-19-2).
FSP
EITF 00-19-2
specifies that the contingent obligation to make future payments
or otherwise transfer consideration under a registration payment
arrangement should be separately
191
recognized and measured in accordance with SFAS No. 5,
Accounting for Contingencies. The adoption of FSP
EITF 00-19-2
did not have an impact on the Companys consolidated
financial statements.
Effective January 1, 2007, the Company adopted FSP
No. FAS 13-2,
Accounting for a Change or Projected Change in the Timing of
Cash Flows Relating to Income Taxes Generated by a Leveraged
Lease Transaction
(FSP 13-2).
FSP 13-2
amends SFAS No. 13, Accounting for Leases, to
require that a lessor review the projected timing of income tax
cash flows generated by a leveraged lease annually or more
frequently if events or circumstances indicate that a change in
timing has occurred or is projected to occur. In addition,
FSP 13-2
requires that the change in the net investment balance resulting
from the recalculation be recognized as a gain or loss from
continuing operations in the same line item in which leveraged
lease income is recognized in the year in which the assumption
is changed. The adoption of
FSP 13-2
did not have a material impact on the Companys
consolidated financial statements.
Effective January 1, 2007, the Company adopted
SFAS No. 156, Accounting for Servicing of Financial
Assets an amendment of FASB Statement
No. 140 (SFAS 156). Among other
requirements, SFAS 156 requires an entity to recognize a
servicing asset or servicing liability each time it undertakes
an obligation to service a financial asset by entering into a
servicing contract in certain situations. The adoption of
SFAS 156 did not have an impact on the Companys
consolidated financial statements.
Effective November 15, 2006, the Company adopted
SAB No. 108, Considering the Effects of Prior Year
Misstatements when Quantifying Misstatements in Current Year
Financial Statements (SAB 108).
SAB 108 provides guidance on how prior year misstatements
should be considered when quantifying misstatements in current
year financial statements for purposes of assessing materiality.
SAB 108 requires that registrants quantify errors using
both a balance sheet and income statement approach and evaluate
whether either approach results in quantifying a misstatement
that, when relevant quantitative and qualitative factors are
considered, is material. SAB 108 permits companies to
initially apply its provisions by either restating prior
financial statements or recording a cumulative effect adjustment
to the carrying values of assets and liabilities as of
January 1, 2006 with an offsetting adjustment to retained
earnings for errors that were previously deemed immaterial but
are material under the guidance in SAB 108. The adoption of
SAB 108 did not have a material impact on the
Companys consolidated financial statements.
Effective January 1, 2006, the Company adopted
prospectively EITF Issue
No. 05-7,
Accounting for Modifications to Conversion Options Embedded
in Debt Instruments and Related Issues
(EITF 05-7).
EITF 05-7
provides guidance on whether a modification of conversion
options embedded in debt results in an extinguishment of that
debt. In certain situations, companies may change the terms of
an embedded conversion option as part of a debt modification.
The EITF concluded that the change in the fair value of an
embedded conversion option upon modification should be included
in the analysis of EITF Issue
No. 96-19,
Debtors Accounting for a Modification or Exchange of
Debt Instruments, to determine whether a modification or
extinguishment has occurred and that a change in the fair value
of a conversion option should be recognized upon the
modification as a discount (or premium) associated with the
debt, and an increase (or decrease) in additional paid-in
capital. The adoption of
EITF 05-7
did not have a material impact on the Companys
consolidated financial statements.
Effective January 1, 2006, the Company adopted EITF Issue
No. 05-8,
Income Tax Consequences of Issuing Convertible Debt with a
Beneficial Conversion Feature
(EITF 05-8).
EITF 05-8
concludes that: (i) the issuance of convertible debt with a
beneficial conversion feature results in a basis difference that
should be accounted for as a temporary difference; and
(ii) the establishment of the deferred tax liability for
the basis difference should result in an adjustment to
additional paid-in capital.
EITF 05-8
was applied retrospectively for all instruments with a
beneficial conversion feature accounted for in accordance with
EITF Issue
No. 98-5,
Accounting for Convertible Securities with Beneficial
Conversion Features or Contingently Adjustable Conversion
Ratios, and EITF Issue
No. 00-27,
Application of Issue
No. 98-5
to Certain Convertible Instruments. The adoption of
EITF 05-8
did not have a material impact on the Companys
consolidated financial statements.
Effective January 1, 2006, the Company adopted
SFAS No. 154, Accounting Changes and Error
Corrections, a replacement of APB Opinion No. 20 and FASB
Statement No. 3 (SFAS 154).
SFAS 154 requires retrospective application to prior
periods financial statements for a voluntary change in
accounting principle unless it is deemed
192
impracticable. It also requires that a change in the method of
depreciation, amortization, or depletion for long-lived,
non-financial assets be accounted for as a change in accounting
estimate rather than a change in accounting principle. The
adoption of SFAS 154 did not have a material impact on the
Companys consolidated financial statements.
Future
Adoption of New Accounting Pronouncements
Business
Combinations
In December 2007, the FASB issued SFAS No. 141
(revised 2007), Business Combinations A
Replacement of FASB Statement No. 141
(SFAS 141(r)) and SFAS No. 160,
Noncontrolling Interests in Consolidated Financial
Statements An Amendment of ARB No. 51
(SFAS 160). Under SFAS 141(r) and
SFAS 160:
|
|
|
|
|
All business combinations (whether full, partial or
step acquisitions) result in all assets and
liabilities of an acquired business being recorded at fair
value, with limited exceptions.
|
|
|
|
Acquisition costs are generally expensed as incurred;
restructuring costs associated with a business combination are
generally expensed as incurred subsequent to the acquisition
date.
|
|
|
|
The fair value of the purchase price, including the issuance of
equity securities, is determined on the acquisition date.
|
|
|
|
Certain acquired contingent liabilities are recorded at fair
value at the acquisition date and subsequently measured at
either the higher of such amount or the amount determined under
existing guidance for non-acquired contingencies.
|
|
|
|
Changes in deferred tax asset valuation allowances and income
tax uncertainties after the acquisition date generally affect
income tax expense.
|
|
|
|
Noncontrolling interests (formerly known as minority
interests) are valued at fair value at the acquisition
date and are presented as equity rather than liabilities.
|
|
|
|
When control is attained on previously noncontrolling interests,
the previously held equity interests are remeasured at fair
value and a gain or loss is recognized.
|
|
|
|
Purchases or sales of equity interests that do not result in a
change in control are accounted for as equity transactions.
|
|
|
|
When control is lost in a partial disposition, realized gains or
losses are recorded on equity ownership sold and the remaining
ownership interest is remeasured and holding gains or losses are
recognized.
|
The pronouncements are effective for fiscal years beginning on
or after December 15, 2008 and apply prospectively to
business combinations after that date. Presentation and
disclosure requirements related to noncontrolling interests must
be retrospectively applied. The Company will apply the guidance
in SFAS 141(r) prospectively on its accounting for future
acquisitions and does not expect the adoption of SFAS 160
to have a material impact on the Companys consolidated
financial statements.
In November 2008, the FASB ratified the consensus on EITF Issue
No. 08-6,
Equity Method Investment Accounting Considerations
(EITF 08-6).
EITF 08-6
addresses a number of issues associated with the impact that
SFAS 141(r) and SFAS 160 might have on the accounting
for equity method investments, including how an equity method
investment should initially be measured, how it should be tested
for impairment, and how changes in classification from equity
method to cost method should be treated.
EITF 08-6
is effective prospectively for fiscal years beginning on or
after December 15, 2008. The Company does not expect the
adoption of
EITF 08-6
to have a material impact on the Companys consolidated
financial statements.
In November 2008, the FASB ratified the consensus on EITF Issue
No. 08-7,
Accounting for Defensive Intangible Assets
(EITF 08-7).
EITF 08-7
requires that an acquired defensive intangible asset (i.e., an
asset an entity does not intend to actively use, but rather,
intends to prevent others from using) be accounted for as a
separate unit of accounting at time of acquisition, not combined
with the acquirers existing intangible assets. In
addition, the EITF concludes that a defensive intangible asset
may not be considered immediately abandoned following its
193
acquisition or have indefinite life. The Company will apply the
guidance of
EITF 08-7
prospectively to its intangible assets acquired after fiscal
years beginning on or after December 15, 2008.
In April 2008, the FASB issued FSP
No. FAS 142-3,
Determination of the Useful Life of Intangible Assets
(FSP 142-3).
FSP 142-3
amends the factors that should be considered in developing
renewal or extension assumptions used to determine the useful
life of a recognized intangible asset under
SFAS No. 142, Goodwill and Other Intangible Assets
(SFAS 142). This change is intended to
improve the consistency between the useful life of a recognized
intangible asset under SFAS 142 and the period of expected
cash flows used to measure the fair value of the asset under
SFAS 141(r) and other GAAP.
FSP 142-3
is effective for financial statements issued for fiscal years
beginning after December 15, 2008, and interim periods
within those fiscal years. The requirement for determining
useful lives and related disclosures will be applied
prospectively to intangible assets acquired as of, and
subsequent to, the effective date.
Derivative
Financial Instruments
In March 2008, the FASB issued SFAS No. 161,
Disclosures about Derivative Instruments and Hedging
Activities An Amendment of FASB Statement
No. 133 (SFAS 161). SFAS 161
requires enhanced qualitative disclosures about objectives and
strategies for using derivatives, quantitative disclosures about
fair value amounts of and gains and losses on derivative
instruments, and disclosures about credit-risk-related
contingent features in derivative agreements. SFAS 161 is
effective for financial statements issued for fiscal years and
interim periods beginning after November 15, 2008. The
Company will provide all of the material required disclosures in
the appropriate future interim and annual periods.
Other
Pronouncements
In December 2008, the FASB issued FSP
No. FAS 132(r)-1,
Employers Disclosures about Postretirement Benefit Plan
Assets (FSP 132(r)-1). FSP 132(r)-1
amends SFAS No. 132(r), Employers Disclosures
about Pensions and Other Postretirement Benefits to enhance
the transparency surrounding the types of assets and associated
risks in an employers defined benefit pension or other
postretirement plan. The FSP requires an employer to disclose
information about the valuation of plan assets similar to that
required under SFAS 157. FSP 132(r)-1 is effective for
fiscal years ending after December 15, 2009. The Company
will provide all of the material required disclosures in the
appropriate future annual period.
In September 2008, the FASB ratified the consensus on EITF Issue
No. 08-5,
Issuers Accounting for Liabilities Measured at Fair
Value with a Third-Party Credit Enhancement
(EITF 08-5).
EITF 08-5
concludes that an issuer of a liability with a third-party
credit enhancement should not include the effect of the credit
enhancement in the fair value measurement of the liability. In
addition,
EITF 08-5
requires disclosures about the existence of any third-party
credit enhancement related to liabilities that are measured at
fair value.
EITF 08-5
is effective beginning in the first reporting period after
December 15, 2008 and will be applied prospectively, with
the effect of initial application included in the change in fair
value of the liability in the period of adoption. The Company
does not expect the adoption of
EITF 08-5
to have a material impact on the Companys consolidated
financial statements.
In June 2008, the FASB ratified the consensus on EITF Issue
No. 07-5,
Determining Whether an Instrument (or Embedded Feature) Is
Indexed to an Entitys Own Stock
(EITF 07-5).
EITF 07-5
provides a framework for evaluating the terms of a particular
instrument and whether such terms qualify the instrument as
being indexed to an entitys own stock.
EITF 07-5
is effective for financial statements issued for fiscal years
beginning after December 15, 2008 and must be applied by
recording a cumulative effect adjustment to the opening balance
of retained earnings at the date of adoption. The Company does
not expect the adoption of
EITF 07-5
to have a material impact on its consolidated financial
statements.
In February 2008, the FASB issued FSP
No. FAS 140-3,
Accounting for Transfers of Financial Assets and Repurchase
Financing Transactions
(FSP 140-3).
FSP 140-3
provides guidance for evaluating whether to account for a
transfer of a financial asset and repurchase financing as a
single transaction or as two separate transactions.
FSP 140-3
is effective prospectively for financial statements issued for
fiscal years beginning after November 15, 2008. The Company
does not expect the adoption of
FSP 140-3
to have a material impact on its consolidated financial
statements.
194
Investments
Investment Risks. The Companys primary
investment objective is to optimize, net of income tax,
risk-adjusted investment income and risk-adjusted total return
while ensuring that assets and liabilities are managed on a cash
flow and duration basis. The Company is exposed to four primary
sources of investment risk:
|
|
|
|
|
credit risk, relating to the uncertainty associated with the
continued ability of a given obligor to make timely payments of
principal and interest;
|
|
|
|
interest rate risk, relating to the market price and cash flow
variability associated with changes in market interest rates;
|
|
|
|
liquidity risk, relating to the diminished ability to sell
certain investments in times of strained market
conditions; and
|
|
|
|
market valuation risk.
|
The Company manages risk through in-house fundamental analysis
of the underlying obligors, issuers, transaction structures and
real estate properties. The Company also manages credit risk,
market valuation risk and liquidity risk through industry and
issuer diversification and asset allocation. For real estate and
agricultural assets, the Company manages credit risk and market
valuation risk through geographic, property type and product
type diversification and asset allocation. The Company manages
interest rate risk as part of its asset and liability management
strategies; product design, such as the use of market value
adjustment features and surrender charges; and proactive
monitoring and management of certain non-guaranteed elements of
its products, such as the resetting of credited interest and
dividend rates for policies that permit such adjustments. The
Company also uses certain derivative instruments in the
management of credit and interest rate risks.
Current Environment. Concerns over the
availability and cost of credit, the U.S. mortgage market,
geopolitical issues, energy costs, inflation and a declining
real estate market in the United States have contributed to
increased volatility and diminished expectations for the economy
and the financial markets going forward. These factors, combined
with declining business and consumer confidence and increased
unemployment, have precipitated an economic slowdown and with
the National Bureau of Economic Research having announced in the
4th quarter of 2008 an ongoing U.S. recession that
began in December 2007. As a result of the stress experienced by
the global financial markets, the fixed-income markets are
experiencing a period of extreme volatility which has negatively
impacted market liquidity conditions. Initially, the concerns on
the part of market participants were focused on the sub-prime
segment of the mortgage-backed securities market. However, these
concerns have since expanded to include a broad range of
mortgage-backed and asset-backed and other fixed income
securities, including those rated investment grade, the
U.S. and international credit and inter-bank money markets
generally, and a wide range of financial institutions and
markets, asset classes and sectors. Securities that are less
liquid are more difficult to value and have fewer opportunities
for disposal.
As a result of this unprecedented disruption and market
dislocation, we have experienced both volatility in the
valuation of certain investments and decreased liquidity in
certain asset classes and, as such, have experienced an increase
in certain Level 3 investments. As demonstrated in -
Fixed Maturity Securities Available for
Sale Fair Value Hierarchy, during 2008 we have
experienced an increase in certain Level 3 investments
which include less liquid fixed maturity securities and equity
securities with very limited trading activity. Even some of our
very high quality assets have been more illiquid for periods of
time as a result of the recent challenging market conditions.
These market conditions have also lead to an increase in
unrealized losses on fixed maturity and equity securities in
2008, particularly for residential and commercial
mortgage-backed, asset-backed and corporate fixed maturity
securities; and within the Companys financial services
industry fixed maturity and equity securities holdings.
195
Composition
of Investment Portfolio Results
The following table illustrates the net investment income, net
investment gains (losses), annualized yields on average ending
assets and ending carrying value for each of the components of
the Companys investment portfolio at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Fixed Maturity Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
Yield (1)
|
|
|
6.40
|
%
|
|
|
6.42
|
%
|
|
|
6.23
|
%
|
Investment income (2)
|
|
$
|
12,403
|
|
|
$
|
12,425
|
|
|
$
|
11,623
|
|
Investment gains (losses)
|
|
$
|
(1,949
|
)
|
|
$
|
(615
|
)
|
|
$
|
(1,119
|
)
|
Ending carrying value (2)
|
|
$
|
189,197
|
|
|
$
|
233,115
|
|
|
$
|
233,514
|
|
Mortgage and Consumer Loans
|
|
|
|
|
|
|
|
|
|
|
|
|
Yield (1)
|
|
|
6.08
|
%
|
|
|
6.56
|
%
|
|
|
6.60
|
%
|
Investment income (3)
|
|
$
|
2,774
|
|
|
$
|
2,648
|
|
|
$
|
2,365
|
|
Investment gains (losses)
|
|
$
|
(136
|
)
|
|
$
|
3
|
|
|
$
|
(8
|
)
|
Ending carrying value
|
|
$
|
51,364
|
|
|
$
|
46,154
|
|
|
$
|
41,457
|
|
Real Estate and Real Estate Joint Ventures (4)
|
Yield (1)
|
|
|
2.98
|
%
|
|
|
10.29
|
%
|
|
|
11.43
|
%
|
Investment income
|
|
$
|
217
|
|
|
$
|
607
|
|
|
$
|
550
|
|
Investment gains (losses)
|
|
$
|
(10
|
)
|
|
$
|
59
|
|
|
$
|
4,897
|
|
Ending carrying value
|
|
$
|
7,586
|
|
|
$
|
6,767
|
|
|
$
|
4,981
|
|
Policy Loans
|
|
|
|
|
|
|
|
|
|
|
|
|
Yield (1)
|
|
|
6.22
|
%
|
|
|
6.21
|
%
|
|
|
6.02
|
%
|
Investment income
|
|
$
|
601
|
|
|
$
|
572
|
|
|
$
|
547
|
|
Ending carrying value
|
|
$
|
9,802
|
|
|
$
|
9,326
|
|
|
$
|
9,178
|
|
Equity Securities (7)
|
|
|
|
|
|
|
|
|
|
|
|
|
Yield (1)
|
|
|
5.25
|
%
|
|
|
5.14
|
%
|
|
|
3.56
|
%
|
Investment income
|
|
$
|
249
|
|
|
$
|
244
|
|
|
$
|
106
|
|
Investment gains (losses)
|
|
$
|
(257
|
)
|
|
$
|
164
|
|
|
$
|
84
|
|
Ending carrying value
|
|
$
|
3,197
|
|
|
$
|
5,911
|
|
|
$
|
4,929
|
|
Other Limited Partnership Interests (7)
|
|
|
|
|
|
|
|
|
|
|
|
|
Yield (1)
|
|
|
(2.77
|
)%
|
|
|
27.09
|
%
|
|
|
22.42
|
%
|
Investment income (loss)
|
|
$
|
(170
|
)
|
|
$
|
1,309
|
|
|
$
|
945
|
|
Investment gains (losses)
|
|
$
|
(140
|
)
|
|
$
|
16
|
|
|
$
|
1
|
|
Ending carrying value
|
|
$
|
6,039
|
|
|
$
|
6,155
|
|
|
$
|
4,781
|
|
Cash and Short-Term Investments
|
|
|
|
|
|
|
|
|
|
|
|
|
Yield (1)
|
|
|
1.62
|
%
|
|
|
4.91
|
%
|
|
|
5.68
|
%
|
Investment income
|
|
$
|
307
|
|
|
$
|
424
|
|
|
$
|
437
|
|
Investment gains (losses)
|
|
$
|
3
|
|
|
$
|
3
|
|
|
$
|
(2
|
)
|
Ending carrying value
|
|
$
|
38,085
|
|
|
$
|
12,505
|
|
|
$
|
9,472
|
|
Other Invested Assets (5),(6),(8)
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment income
|
|
$
|
383
|
|
|
$
|
526
|
|
|
$
|
447
|
|
Investment gains (losses)
|
|
$
|
4,260
|
|
|
$
|
(474
|
)
|
|
$
|
(736
|
)
|
Ending carrying value
|
|
$
|
17,248
|
|
|
$
|
8,076
|
|
|
$
|
6,524
|
|
Total Investments
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross investment income yield (1)
|
|
|
5.71
|
%
|
|
|
6.88
|
%
|
|
|
6.65
|
%
|
Investment fees and expenses yield
|
|
|
(0.16
|
)%
|
|
|
(0.16
|
)%
|
|
|
(0.15
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Investment Income Yield
|
|
|
5.55
|
%
|
|
|
6.72
|
%
|
|
|
6.50
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross investment income
|
|
$
|
16,764
|
|
|
$
|
18,755
|
|
|
$
|
17,020
|
|
Investment fees and expenses
|
|
|
(460
|
)
|
|
|
(427
|
)
|
|
|
(391
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Investment Income
|
|
$
|
16,304
|
|
|
$
|
18,328
|
|
|
$
|
16,629
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending carrying value
|
|
$
|
322,518
|
|
|
$
|
328,009
|
|
|
$
|
314,836
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross investment gains
|
|
$
|
2,575
|
|
|
$
|
1,386
|
|
|
$
|
5,731
|
|
Gross investment losses (8)
|
|
|
(2,005
|
)
|
|
|
(1,710
|
)
|
|
|
(2,008
|
)
|
Writedowns (8)
|
|
|
(2,042
|
)
|
|
|
(140
|
)
|
|
|
(134
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
$
|
(1,472
|
)
|
|
$
|
(464
|
)
|
|
$
|
3,589
|
|
Derivatives not qualifying for hedge accounting (8),(9)
|
|
|
3,243
|
|
|
|
(380
|
)
|
|
|
(472
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment Gains (Losses)
|
|
$
|
1,771
|
|
|
$
|
(844
|
)
|
|
$
|
3,117
|
|
Investment gains (losses) income tax benefit (provision)
|
|
|
(671
|
)
|
|
|
280
|
|
|
|
(1,114
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment Gains (Losses), Net of Income Tax
|
|
$
|
1,100
|
|
|
$
|
(564
|
)
|
|
$
|
2,003
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
196
|
|
|
(1) |
|
Yields are based on quarterly average asset carrying values,
excluding recognized and unrealized investment gains (losses),
and for yield calculation purposes, average assets exclude
collateral received from counterparties associated with the
Companys securities lending program. |
|
(2) |
|
Fixed maturity securities include $946 million,
$779 million and $759 million at estimated fair value
related to trading securities at December 31, 2008, 2007
and 2006, respectively. Fixed maturity securities include
($193) million, $50 million and $71 million of
investment income (loss) related to trading securities for the
years ended December 31, 2008, 2007 and 2006, respectively. |
|
(3) |
|
Investment income from mortgage and consumer loans includes
prepayment fees. |
|
(4) |
|
Included in net investment income from real estate and real
estate joint ventures is $3 million, $12 million and
$92 million related to discontinued operations for the
years ended December 31, 2008, 2007 and 2006, respectively.
Included in investment gains (losses) from real estate and real
estate joint ventures is $8 million, $13 million and
$4,795 million of gains related to discontinued operations
for the years ended December 31, 2008, 2007 and 2006,
respectively. |
|
(5) |
|
Included in investment income from other invested assets are
scheduled periodic settlement payments on derivative instruments
that do not qualify for hedge accounting under SFAS 133 of
$5 million, $253 million and $290 million for the
years ended December 31, 2008, 2007 and 2006, respectively.
These amounts are excluded from investment gains (losses).
Additionally, excluded from investment gains (losses) is
$44 million, $25 million and $6 million for the
years ended December 31, 2008, 2007 and 2006, respectively,
related to settlement payments on derivatives used to hedge
interest rate and currency risk on policyholder account balances
that do not qualify for hedge accounting. Such amounts are
included within interest credited to policyholder account
balances. |
|
(6) |
|
Other invested assets are principally comprised of free standing
derivatives with positive estimated fair values and leveraged
leases. Freestanding derivatives with negative estimated fair
values are included within other liabilities. As yield is not
considered a meaningful measure of performance for other
invested assets it has been excluded from the table above. |
|
(7) |
|
Certain prior period amounts have been reclassified to conform
to the current period presentation. |
|
(8) |
|
The components of investment gains (losses) for the year ended
December 31, 2008 are shown net of a realized gain under
purchased credit default swaps that offsets losses incurred on
certain fixed maturity securities. |
|
(9) |
|
The caption Derivatives not qualifying for hedge
accounting is comprised of amounts for freestanding
derivatives of $5,893 million, ($59) million, and
($674) million; and embedded derivatives of
($2,650) million, ($321) million, and
$202 million for the years ended December 31, 2008,
2007 and 2006, respectively. |
Year
Ended December 31, 2008 compared with the Year Ended
December 31, 2007
Net investment income decreased by $2,024 million, or 11%,
to $16,304 million for the year ended December 31,
2008 from $18,328 million for the comparable 2007 period.
Excluding the impacts of discontinued operations and periodic
settlement payments on derivatives instruments as described in
notes 4 and 5 of the yield table presented above, net
investment income decreased by $1,767 million, or 10%, to
$16,296 million for the year ended December 31, 2008
from $18,063 million for the comparable 2007 period.
Management attributes $3,141 million of this change to a
decrease in yields, partially offset by an increase of
$1,374 million due to growth in average invested assets.
Average invested assets are calculated on the cost basis without
unrealized gains and losses. The decrease in net investment
income attributable to lower yields was primarily due to lower
returns on other limited partnership interests, real estate
joint ventures, short-term investments, fixed maturity
securities, and mortgage loans partially offset by improved
securities lending results. The reduction in yields associated
with other limited partnership interests were primarily due to
the lack of liquidity and credit in the financial markets as
well as unprecedented investor redemptions in an environment
with steep declines in the public equity and debt markets. The
decrease in real estate joint ventures yields was primarily due
to a slow down in lease and related sales activities in a period
with declining property values as well as fund investment
write-downs. The decrease in short-term investment yields was
primarily attributable to declines in short-term interest rates.
The decrease in the fixed maturity securities yield was
primarily due to lower yields on floating rate securities due to
declines in short-term interest rates and an increased
allocation to lower yielding
197
U.S. Treasuries, partially offset by improved securities
lending results. The decrease in yields associated with our
mortgage loan portfolio was primarily attributable to lower
prepayments on commercial mortgage loans and lower yields on
variable rate loans due to declines in short-term interest
rates. The decrease in net investment income attributable to
lower yields was partially offset by increased net investment
income attributable to an increase in average invested assets on
an amortized cost basis, primarily within short-term
investments, other invested assets including derivatives,
mortgage loans, other limited partnership interests, and real
estate joint ventures.
Management anticipates that the significant volatility in the
equity, credit and real estate markets will continue in 2009
which could continue to impact net investment income and the
related yields on private equity funds, hedge funds and real
estate joint ventures, included within our other limited
partnerships and real estate and real estate joint venture
portfolios. Further, in light of the current market
conditions, liquidity will be reinvested in a prudent manner and
invested according to our ALM discipline in appropriate assets
over time. However, considering the continued, uncertain credit
market conditions, management plans to continue to maintain a
slightly higher than normal level of short-term liquidity. Net
investment income may be adversely affected if the reinvestment
process occurs over an extended period of time due to
challenging market conditions or asset availability.
|
|
|
Year
Ended December 31, 2007 compared with the Year Ended
December 31, 2006
|
Net investment income increased by $1,699 million, or 10%,
to $18,328 million for the year ended December 31,
2007 from $16,629 million for the comparable 2006 period.
Excluding the impacts of discontinued operations and periodic
settlement payments on derivatives instruments as described in
notes 4 and 5 to the yield table presented above, net
investment income increased by $1,816 million, or 11%, to
$18,063 million for the year ended December 31, 2007
from $16,247 million for the comparable 2006 period.
Management attributes $1,078 million of this increase to
growth in the average asset base and $738 million to an
increase in yields. Average invested assets are calculated on
the cost basis without unrealized gains and losses. The increase
in net investment income attributable to higher yields was
primarily due to higher returns on fixed maturity securities,
other limited partnership interests excluding hedge funds,
equity securities and improved securities lending results,
partially offset by lower returns on real estate and real estate
joint ventures, cash and short-term investments, hedge funds and
mortgage loans. The improvement in yields associated with fixed
maturity securities was due primarily to higher bond prepayment
fees related to decreasing interest rates in the second half of
2007 and to a repositioning of the portfolio in 2006 during a
rising interest rate environment. The improvement in yields
associated with other limited partnership interests, excluding
hedge funds, was due primarily to a robust private equity market
resulting in improved returns on equity based funds and
increased distributions on cost basis funds. The increase in
equity securities yields is primarily related to increased
earnings on the non-redeemable preferred securities comprised of
perpetual hybrid securities and higher dividend income on our
common stock holdings. The decrease in real estate and real
estate joint ventures yields was primarily due lower income from
the sale of the Peter Cooper and Stuyvesant Town properties in
fourth quarter 2006 and reinvestment in real estate joint
ventures and development funds with more variable income
streams. The decrease in yields for cash and short-term
investment was primarily attributable to declines in short-term
interest rates in the second half of 2007. The decrease in hedge
fund yields was primarily due to increasing volatility in
private equity markets in the latter half of 2007, driven by
economic uncertainty as reflected in credit and equity markets.
The decrease in yields associated with our mortgage loan
portfolio was primarily attributable to lower prepayments on
commercial mortgage loans as well as new loan production at
lower yields due to the declines in interest rates in the second
half of 2007.
Fixed
Maturity and Equity Securities Available-for-Sale
Fixed maturity securities consisted principally of
publicly-traded and privately placed fixed maturity securities,
and represented 58% and 71% of total cash and invested assets at
December 31, 2008 and 2007, respectively. Based on
estimated fair value, public fixed maturity securities
represented $156.7 billion, or 83%, and
$196.7 billion, or 85%, of total fixed maturity securities
at December 31, 2008 and 2007, respectively. Based on
estimated fair value, private fixed maturity securities
represented $31.6 billion, or 17%, and $35.6 billion,
or 15%, of total fixed maturity securities at December 31,
2008 and 2007, respectively.
198
Valuation of Securities. Management is
responsible for the determination of estimated fair value. The
estimated fair value of publicly-traded fixed maturity, equity
and trading securities as well as short-term investments is
determined by management after considering one of three primary
sources of information: quoted market prices in active markets,
independent pricing services, or independent broker quotations.
The number of quotes obtained varies by instrument and depends
on the liquidity of the particular instrument. Generally
we obtain prices from multiple pricing services to cover all
asset classes and do obtain multiple prices for certain
securities, but ultimately utilize the price with the highest
placement in the fair value hierarchy. Independent pricing
services that value these instruments use market standard
valuation methodologies based on inputs that are market
observable or can be derived principally from or corroborated by
observable market data. Such observable inputs include
benchmarking prices for similar assets in active, liquid
markets, quoted prices in markets that are not active and
observable yields and spreads in the market. The market standard
valuation methodologies utilized include: discounted cash flow
methodologies, matrix pricing or similar techniques. The
assumptions and inputs in applying these market standard
valuation methodologies include, but are not limited to,
interest rates, credit standing of the issuer or counterparty,
industry sector of the issuer, coupon rate, call provisions,
sinking fund requirements, maturity, estimated duration, and
managements assumptions regarding liquidity and estimated
future cash flows. When a price is not available in the active
market or through an independent pricing service, management
will value the security primarily using independent non-binding
broker quotations. Independent non-binding broker quotations
utilize inputs that are not market observable or cannot be
derived principally from or corroborated by observable market
data.
Senior management, independent of the trading and investing
functions, is responsible for the oversight of control systems
and valuation policies, including reviewing and approving new
transaction types and markets, for ensuring that observable
market prices and market-based parameters are used for valuation
wherever possible and for determining that judgmental valuation
adjustments, if any, are based upon established policies and are
applied consistently over time. Management reviews its valuation
methodologies on an ongoing basis and ensures that any changes
to valuation methodologies are justified. The Company gains
assurance on the overall reasonableness and consistent
application of input assumptions, valuation methodologies, and
compliance with accounting standards for fair value
determination through various controls designed to ensure that
the financial assets and financial liabilities are appropriately
valued and represent an exit price. The control systems and
procedures include, but are not limited to, analysis of
portfolio returns to corresponding benchmark returns, comparing
a sample of executed prices of securities sold to the fair value
estimates, comparing fair value estimates to managements
knowledge of the current market, reviewing the bid/ask spreads
to assess activity and ongoing confirmation that independent
pricing services use, wherever possible, market-based parameters
for valuation. Management determines the observability of inputs
used in estimated fair values received from independent pricing
sources or brokers by assessing whether these inputs can be
corroborated by observable market data. The Company also follows
a formal process to challenge any prices received from
independent pricing services that are not considered
representative of fair value. If we conclude that prices
received from independent pricing services are not reflective of
market activity or representative of estimated fair value, we
will seek independent non-binding broker quotes or use an
internally developed valuation to override these prices. Such
overrides are classified as Level 3. Despite the credit
events prevalent in the current dislocated markets and reduced
levels of liquidity at the end of 2008, our internally developed
valuations of current estimated fair value, which reflect our
estimates of liquidity and non performance risks, compared with
pricing received from the independent pricing services, did not
produce material differences for the vast majority of our fixed
maturity securities portfolio. Our estimates of liquidity and
non performance risks are generally based on available market
evidence and on what other market participants would use. In
absence of such evidence, managements best estimate is
used. As a result, we generally continued to use the price
provided by the independent pricing service under our normal
pricing protocol and pricing overrides were not material. As
discussed in the Fair Value Hierarchy below,
during 2008 due to these conditions, we have experienced an
increase in Level 3 securities holdings which include less
liquid fixed maturity and equity securities, some with very
limited trading activity. Even some of our very high quality
invested assets have been more illiquid for periods of time as a
result of the challenging market conditions. The Company uses
the results of this analysis for classifying the estimated fair
value of these instruments in Level 1, 2 or 3. For example,
management will review the estimated fair values received to
determine whether corroborating evidence (i.e., similar
observable positions and actual
199
trades) will support a Level 2 classification in the
estimated fair value hierarchy. Security prices which cannot be
corroborated due to relatively less pricing transparency and
diminished liquidity will be classified as Level 3.
For privately placed fixed maturity securities, the Company
determines the estimated fair value generally through matrix
pricing or discounted cash flow techniques. The discounted cash
flow valuations rely upon the estimated future cash flows of the
security, credit spreads of comparable public securities, and
secondary transactions, as well as taking account of, among
other factors, the credit quality of the issuer and the reduced
liquidity associated with privately placed debt securities.
The Company has reviewed the significance and observability of
inputs used in the valuation methodologies to determine the
appropriate SFAS 157 fair value hierarchy level for each of
its securities. Based on the results of this review and
investment class analyses, each instrument is categorized as
Level 1, 2, or 3 based on the priority of the inputs to the
respective valuation methodologies. While prices for certain
U.S. Treasury and agency fixed maturity securities, certain
foreign government fixed maturity securities, exchange-traded
common stock, and certain short-term money market securities
have been classified into Level 1 because of high volumes
of trading activity and narrow bid/ask spreads, most securities
valued by independent pricing services have been classified into
Level 2 because the significant inputs used in pricing
these securities are market observable or can be corroborated
using market observable information. Most investment grade
privately placed fixed maturity securities have been classified
within Level 2, while most below investment grade or
distressed privately placed fixed maturity securities have been
classified within Level 3. Where estimated fair values are
determined by independent pricing sources or by independent
non-binding broker quotations that utilize inputs that are not
market observable or cannot be derived principally from or
corroborated by observable market data, these instruments have
been classified as Level 3. Use of independent non-binding
broker quotations generally indicates there is a lack of
liquidity or the general lack of transparency in the process to
develop these price estimates causing them to be considered
Level 3.
Ratings. The Securities Valuation Office of
the NAIC evaluates the fixed maturity investments of insurers
for regulatory reporting purposes and assigns securities to one
of six investment categories called NAIC
designations. The NAIC ratings are similar to the rating
agency designations of the Nationally Recognized Statistical
Rating Organizations (NRSROs) for marketable bonds.
NAIC ratings 1 and 2 include bonds generally considered
investment grade (rated Baa3 or higher by
Moodys or rated BBB or higher by
S&P and Fitch), by such rating organizations. NAIC ratings
3 through 6 include bonds generally considered below investment
grade (rated Ba1 or lower by Moodys, or rated
BB+ or lower by S&P and Fitch).
The following table presents the Companys total fixed
maturity securities by NRSRO designation and the equivalent
ratings of the NAIC, as well as the percentage, based on
estimated fair value, that each designation is comprised of at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
December 31, 2007
|
|
|
|
|
|
Cost or
|
|
|
|
|
|
|
|
|
Cost or
|
|
|
|
|
|
|
|
|
|
|
|
Amortized
|
|
|
Estimated
|
|
|
% of
|
|
|
Amortized
|
|
|
Estimated
|
|
|
% of
|
|
NAIC Rating
|
|
Rating Agency Designation (1)
|
|
Cost
|
|
|
Fair Value
|
|
|
Total
|
|
|
Cost
|
|
|
Fair Value
|
|
|
Total
|
|
|
|
|
|
(In millions)
|
|
|
1
|
|
Aaa/Aa/A
|
|
$
|
146,796
|
|
|
$
|
137,125
|
|
|
|
72.9
|
%
|
|
$
|
165,328
|
|
|
$
|
167,761
|
|
|
|
72.2
|
%
|
2
|
|
Baa
|
|
|
45,253
|
|
|
|
38,761
|
|
|
|
20.6
|
|
|
|
46,520
|
|
|
|
47,172
|
|
|
|
20.3
|
|
3
|
|
Ba
|
|
|
10,258
|
|
|
|
7,796
|
|
|
|
4.1
|
|
|
|
10,463
|
|
|
|
10,528
|
|
|
|
4.5
|
|
4
|
|
B
|
|
|
5,915
|
|
|
|
3,779
|
|
|
|
2.0
|
|
|
|
6,583
|
|
|
|
6,435
|
|
|
|
2.8
|
|
5
|
|
Caa and lower
|
|
|
1,192
|
|
|
|
715
|
|
|
|
0.4
|
|
|
|
459
|
|
|
|
428
|
|
|
|
0.2
|
|
6
|
|
In or near default
|
|
|
94
|
|
|
|
75
|
|
|
|
|
|
|
|
1
|
|
|
|
12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
$
|
209,508
|
|
|
$
|
188,251
|
|
|
|
100.0
|
%
|
|
$
|
229,354
|
|
|
$
|
232,336
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Amounts presented are based on rating agency designations.
Comparisons between NAIC ratings and rating agency designations
are published by the NAIC. The rating agency designations are
based on availability and the midpoint of the applicable ratings
among Moodys, S&P and Fitch. If no rating is
available from a rating agency, then the MetLife rating is used. |
200
Below Investment Grade or Non-Rated Fixed Maturity
Securities. The Company held fixed maturity
securities at estimated fair values that were below investment
grade or not rated by an independent rating agency that totaled
$12.4 billion and $17.4 billion at December 31,
2008 and 2007, respectively. These securities had net unrealized
losses of $5,094 million and $103 million at
December 31, 2008 and 2007, respectively.
Non-Income Producing Fixed Maturity
Securities. Non-income producing fixed maturity
securities at estimated fair value were $75 million and
$12 million at December 31, 2008 and 2007,
respectively. Net unrealized gains (losses) associated with
non-income producing fixed maturity securities were
($19) million and $11 million at December 31,
2008 and 2007, respectively.
Fixed Maturity Securities Credit Enhanced by Financial
Guarantee Insurers. At December 31, 2008,
$4.9 billion of the estimated fair value of the
Companys fixed maturity securities were credit enhanced by
financial guarantee insurers of which $2.0 billion,
$2.0 billion and $0.9 billion, are included within
state and political subdivision securities, U.S. corporate
securities, and asset-backed securities, respectively, and 15%
and 68% were guaranteed by financial guarantee insurers who were
Aa and Baa rated, respectively. As described below, all of the
asset-backed securities that are credit enhanced by financial
guarantee insurers are asset-backed securities which are backed
by sub-prime mortgage loans.
Gross Unrealized Gains and Losses. The
following tables present the cost or amortized cost, gross
unrealized gain and loss, estimated fair value of the
Companys fixed maturity and equity securities, and the
percentage that each sector represents by the respective total
holdings at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
Cost or
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortized
|
|
|
Gross Unrealized
|
|
|
Estimated
|
|
|
% of
|
|
|
|
Cost
|
|
|
Gain
|
|
|
Loss
|
|
|
Fair Value
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
U.S. corporate securities
|
|
$
|
72,211
|
|
|
$
|
994
|
|
|
$
|
9,902
|
|
|
$
|
63,303
|
|
|
|
33.6
|
%
|
Residential mortgage-backed securities
|
|
|
39,995
|
|
|
|
753
|
|
|
|
4,720
|
|
|
|
36,028
|
|
|
|
19.2
|
|
Foreign corporate securities
|
|
|
34,798
|
|
|
|
565
|
|
|
|
5,684
|
|
|
|
29,679
|
|
|
|
15.8
|
|
U.S. Treasury/agency securities
|
|
|
17,229
|
|
|
|
4,082
|
|
|
|
1
|
|
|
|
21,310
|
|
|
|
11.3
|
|
Commercial mortgage-backed securities
|
|
|
16,079
|
|
|
|
18
|
|
|
|
3,453
|
|
|
|
12,644
|
|
|
|
6.7
|
|
Asset-backed securities
|
|
|
14,246
|
|
|
|
16
|
|
|
|
3,739
|
|
|
|
10,523
|
|
|
|
5.6
|
|
Foreign government securities
|
|
|
9,474
|
|
|
|
1,056
|
|
|
|
377
|
|
|
|
10,153
|
|
|
|
5.4
|
|
State and political subdivision securities
|
|
|
5,419
|
|
|
|
80
|
|
|
|
942
|
|
|
|
4,557
|
|
|
|
2.4
|
|
Other fixed maturity securities
|
|
|
57
|
|
|
|
|
|
|
|
3
|
|
|
|
54
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities (2),(3)
|
|
$
|
209,508
|
|
|
$
|
7,564
|
|
|
$
|
28,821
|
|
|
$
|
188,251
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
$
|
1,778
|
|
|
$
|
40
|
|
|
$
|
133
|
|
|
$
|
1,685
|
|
|
|
52.7
|
%
|
Non-redeemable preferred stock (2)
|
|
|
2,353
|
|
|
|
4
|
|
|
|
845
|
|
|
|
1,512
|
|
|
|
47.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities (1)
|
|
$
|
4,131
|
|
|
$
|
44
|
|
|
$
|
978
|
|
|
$
|
3,197
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
201
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2007
|
|
|
|
Cost or
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortized
|
|
|
Gross Unrealized
|
|
|
Estimated
|
|
|
% of
|
|
|
|
Cost
|
|
|
Gain
|
|
|
Loss
|
|
|
Fair Value
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
U.S. corporate securities
|
|
$
|
74,310
|
|
|
$
|
1,685
|
|
|
$
|
2,076
|
|
|
$
|
73,919
|
|
|
|
31.8
|
%
|
Residential mortgage-backed securities
|
|
|
54,773
|
|
|
|
598
|
|
|
|
376
|
|
|
|
54,995
|
|
|
|
23.7
|
|
Foreign corporate securities
|
|
|
36,232
|
|
|
|
1,701
|
|
|
|
767
|
|
|
|
37,166
|
|
|
|
16.0
|
|
U.S. Treasury/agency securities
|
|
|
19,723
|
|
|
|
1,482
|
|
|
|
13
|
|
|
|
21,192
|
|
|
|
9.1
|
|
Commercial mortgage-backed securities
|
|
|
16,946
|
|
|
|
241
|
|
|
|
194
|
|
|
|
16,993
|
|
|
|
7.3
|
|
Asset-backed securities
|
|
|
11,048
|
|
|
|
40
|
|
|
|
516
|
|
|
|
10,572
|
|
|
|
4.6
|
|
Foreign government securities
|
|
|
11,645
|
|
|
|
1,350
|
|
|
|
182
|
|
|
|
12,813
|
|
|
|
5.5
|
|
State and political subdivision securities
|
|
|
4,342
|
|
|
|
140
|
|
|
|
114
|
|
|
|
4,368
|
|
|
|
1.9
|
|
Other fixed maturity securities
|
|
|
335
|
|
|
|
13
|
|
|
|
30
|
|
|
|
318
|
|
|
|
0.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities (2),(3)
|
|
$
|
229,354
|
|
|
$
|
7,250
|
|
|
$
|
4,268
|
|
|
$
|
232,336
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
$
|
2,477
|
|
|
$
|
568
|
|
|
$
|
108
|
|
|
$
|
2,937
|
|
|
|
49.7
|
%
|
Non-redeemable preferred stock (2)
|
|
|
3,255
|
|
|
|
60
|
|
|
|
341
|
|
|
|
2,974
|
|
|
|
50.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities (1)
|
|
$
|
5,732
|
|
|
$
|
628
|
|
|
$
|
449
|
|
|
$
|
5,911
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Equity securities primarily consist of investments in common and
preferred stocks and mutual fund interests. Such securities
include common stock of privately held companies with an
estimated fair value of $1.1 billion and $569 million
at December 31, 2008 and 2007, respectively. |
(2) |
|
The Company classifies perpetual securities that have attributes
of both debt and equity as fixed maturity securities if the
security has a punitive interest rate step-up feature as it
believes in most instances this feature will compel the issuer
to redeem the security at the specified call date. Perpetual
securities that do not have a punitive interest rate step-up
feature are classified as non-redeemable preferred stock. Many
of such securities have been issued by non-U.S. financial
institutions that are accorded Tier 1 and Upper Tier 2
capital treatment by their respective regulatory bodies and are
commonly referred to as perpetual hybrid securities.
Perpetual hybrid securities classified as non-redeemable
preferred stock held by the Company at December 31, 2008
and 2007 had an estimated fair value of $1,224 million and
$2,051 million respectively. In addition, the Company held
$288 million and $923 million at estimated fair value,
respectively, at December 31, 2008 and 2007 of other
perpetual hybrid securities, primarily U.S. financial
institutions, also included in non-redeemable preferred stock.
Perpetual hybrid securities held by the Company and included
within fixed maturity securities (primarily within foreign
corporate securities) at December 31, 2008 and 2007 had an
estimated fair value of $2,110 million and
$3,896 million, respectively. In addition, the Company held
$46 million and $57 million at estimated fair values,
respectively, at December 31, 2008 and 2007 of other
perpetual hybrid securities, primarily U.S. financial
institutions, included in fixed maturity securities. |
(3) |
|
At December 31, 2008 and 2007 the Company also held
$2,052 million and $3,432 million at estimated fair
value, respectively, of redeemable preferred stock which have
stated maturity dates which are included within fixed maturity
securities. These securities are primarily issued by
U.S. financial institutions, have cumulative interest
deferral features and are commonly referred to as capital
securities within U.S. corporate securities. |
Concentrations of Credit Risk. The Company is
not exposed to any significant concentrations of credit risk of
any single issuer greater than 10% of the Companys
stockholders in its equity securities portfolio.
The Company is not exposed to any concentrations of credit risk
of any single issuer greater than 10% of the Companys
stockholders equity, other than securities of the
U.S. government and certain U.S. government agencies.
At December 31, 2008 and 2007, the Companys holdings
in U.S. Treasury and agency fixed maturity securities at
estimated fair value were $21.3 billion and
$21.2 billion, respectively. As shown in the sector table
above, at December 31, 2008 the Companys three
largest exposures in its fixed maturity security portfolio were
U.S. corporate fixed maturity securities (33.6%),
residential mortgage-backed securities (19.2%), and foreign
202
corporate securities (15.8%); and at December 31, 2007 were
U.S. corporate fixed maturity securities (31.8%),
residential mortgage-backed securities (23.7%), and foreign
corporate securities (16.0%). Additionally, at December 31,
2008 and 2007, the Company had exposure to fixed maturity
securities backed by sub-prime mortgages with estimated fair
values of $1.1 billion and $2.0 billion, respectively,
and unrealized losses of $730 million and
$198 million, respectively. These securities are classified
within asset-backed securities in the immediately preceding
table.
See also Investments Fixed
Maturity and Equity Securities Available-for-Sale
Corporate Fixed Maturity Securities and
Structured Securities for a description
of concentrations of credit risk related to these asset
subsectors.
At December 31, 2008, the Companys direct investments
in fixed maturity securities and equity securities in Lehman
Brothers Holdings Inc. (Lehman), Washington Mutual,
Inc. (Washington Mutual) and American International
Group, Inc. (AIG) have an aggregate carrying value
(after impairments) of approximately $360 million. In
addition, the Company has made secured loans to affiliates of
Lehman which are fully collateralized. See also
Investments Fixed Maturity
and Equity Securities Available-for-Sale
Impairments.
Fair Value Hierarchy. Fixed maturity
securities and equity securities measured at estimated fair
value on a recurring basis and their corresponding fair value
sources and fair value hierarchy, are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
Fixed Maturity
|
|
|
Equity
|
|
|
|
Securities
|
|
|
Securities
|
|
|
|
(In millions)
|
|
|
Quoted prices in active markets for identical assets
(Level 1)
|
|
$
|
10,414
|
|
|
|
5.5
|
%
|
|
$
|
413
|
|
|
|
12.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Independent pricing source
|
|
|
133,620
|
|
|
|
71.0
|
|
|
|
402
|
|
|
|
12.6
|
|
Internal matrix pricing or discounted cash flow techniques
|
|
|
26,809
|
|
|
|
14.2
|
|
|
|
1,003
|
|
|
|
31.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Significant other observable inputs (Level 2)
|
|
|
160,429
|
|
|
|
85.2
|
|
|
|
1,405
|
|
|
|
44.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Independent pricing source
|
|
|
7,423
|
|
|
|
3.9
|
|
|
|
779
|
|
|
|
24.4
|
|
Internal matrix pricing or discounted cash flow techniques
|
|
|
7,443
|
|
|
|
4.0
|
|
|
|
397
|
|
|
|
12.4
|
|
Independent broker quotations
|
|
|
2,542
|
|
|
|
1.4
|
|
|
|
203
|
|
|
|
6.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Significant unobservable inputs (Level 3)
|
|
|
17,408
|
|
|
|
9.3
|
|
|
|
1,379
|
|
|
|
43.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total estimated fair value
|
|
$
|
188,251
|
|
|
|
100.0
|
%
|
|
$
|
3,197
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
203
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
Fair Value Measurements at Reporting Date Using
|
|
|
|
|
|
|
Quoted Prices
|
|
|
Significant
|
|
|
|
|
|
|
|
|
|
in Active
|
|
|
Other
|
|
|
Significant
|
|
|
|
|
|
|
Markets for
|
|
|
Observable
|
|
|
Unobservable
|
|
|
Total
|
|
|
|
Identical Assets
|
|
|
Inputs
|
|
|
Inputs
|
|
|
Estimated
|
|
|
|
(Level 1)
|
|
|
(Level 2)
|
|
|
(Level 3)
|
|
|
Fair Value
|
|
|
|
(In millions)
|
|
|
Fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. corporate securities
|
|
$
|
|
|
|
$
|
55,805
|
|
|
$
|
7,498
|
|
|
$
|
63,303
|
|
Residential mortgage-backed securities
|
|
|
|
|
|
|
35,433
|
|
|
|
595
|
|
|
|
36,028
|
|
Foreign corporate securities
|
|
|
|
|
|
|
23,735
|
|
|
|
5,944
|
|
|
|
29,679
|
|
U.S. Treasury/agency securities
|
|
|
10,132
|
|
|
|
11,090
|
|
|
|
88
|
|
|
|
21,310
|
|
Commercial mortgage-backed securities
|
|
|
|
|
|
|
12,384
|
|
|
|
260
|
|
|
|
12,644
|
|
Asset-backed securities
|
|
|
|
|
|
|
8,071
|
|
|
|
2,452
|
|
|
|
10,523
|
|
Foreign government securities
|
|
|
282
|
|
|
|
9,463
|
|
|
|
408
|
|
|
|
10,153
|
|
State and political subdivision securities
|
|
|
|
|
|
|
4,434
|
|
|
|
123
|
|
|
|
4,557
|
|
Other fixed maturity securities
|
|
|
|
|
|
|
14
|
|
|
|
40
|
|
|
|
54
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
$
|
10,414
|
|
|
$
|
160,429
|
|
|
$
|
17,408
|
|
|
$
|
188,251
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
$
|
413
|
|
|
$
|
1,167
|
|
|
$
|
105
|
|
|
$
|
1,685
|
|
Non-redeemable preferred stock
|
|
|
|
|
|
|
238
|
|
|
|
1,274
|
|
|
|
1,512
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
$
|
413
|
|
|
$
|
1,405
|
|
|
$
|
1,379
|
|
|
$
|
3,197
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Composition and pricing source for significant Level 3
fixed maturity and equity securities are as follows:
As shown above, the majority of the Level 3 fixed maturity
and equity securities (91%) are concentrated in four of the
sectors shown above, U.S. and foreign corporate securities,
asset-backed securities and non-redeemable preferred securities.
The pricing sources for these sectors are as follows at
December 31, 2008:
Level 3 fixed maturity securities are priced principally
through independent broker quotations or market standard
valuation methodologies using inputs that are not market
observable or cannot be derived principally from or corroborated
by observable market data. Level 3 fixed maturity
securities consists of less liquid fixed maturity securities
with very limited trading activity or where less price
transparency exists around the inputs to the valuation
methodologies including below investment grade private
placements and less liquid investment grade corporate securities
(included in U.S. and foreign corporate securities) and
less liquid asset-backed securities including securities
supported by sub-prime mortgage loans (included in asset-backed
securities). Level 3 non-redeemable preferred securities
include securities with very limited trading activity or where
less price transparency exists around the inputs to the
valuation.
The change in Level 3 fixed maturity securities during the
period was as follows:
During the year ended December 31, 2008, Level 3 fixed
maturity securities decreased by $5,910 million or 25%, due
primarily to increased unrealized losses recognized in other
comprehensive income (loss) and to a lesser extent sales and
settlements in excess of purchases. The increased unrealized
losses in fixed maturity securities were concentrated in
asset-backed securities (including residential mortgage-backed
securities backed by sub-prime mortgage loans), U.S. and
foreign corporate securities and to a lesser extent commercial
mortgage-backed securities due to current market conditions
including less liquidity and increased spreads for such
securities. Net sales and settlements in excess of purchases of
fixed maturity securities were concentrated in asset-backed
securities (including residential mortgage-backed securities
backed by sub-prime mortgage loans) and U.S. and foreign
corporate securities.
204
A rollforward of the fair value measurements for fixed maturity
securities and equity securities measured at estimated fair
value on a recurring basis using significant unobservable
(Level 3) inputs for the year ended December 31,
2008 is as follows:
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
|
December 31, 2008
|
|
|
|
Fixed Maturity
|
|
|
Equity
|
|
|
|
Securities
|
|
|
Securities
|
|
|
|
(In millions)
|
|
|
Balance, December 31, 2007
|
|
$
|
23,326
|
|
|
$
|
2,371
|
|
Impact of SFAS 157 and SFAS 159 adoption
|
|
|
(8
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, beginning of period
|
|
|
23,318
|
|
|
|
2,371
|
|
Total realized/unrealized gains (losses) included in:
|
|
|
|
|
|
|
|
|
Earnings
|
|
|
(881
|
)
|
|
|
(197
|
)
|
Other comprehensive income (loss)
|
|
|
(6,272
|
)
|
|
|
(478
|
)
|
Purchases, sales, issuances and settlements
|
|
|
(596
|
)
|
|
|
(288
|
)
|
Transfer in and/or out of Level 3
|
|
|
1,839
|
|
|
|
(29
|
)
|
|
|
|
|
|
|
|
|
|
Balance, end of period
|
|
$
|
17,408
|
|
|
$
|
1,379
|
|
|
|
|
|
|
|
|
|
|
Transfers in and/or out of Level 3
a) Total gains and losses (in earnings and other
comprehensive income (loss)) are calculated assuming transfers
in (out) of Level 3 occurred at the beginning of the
period. Items transferred in and out in the same period are
excluded from the rollforward.
b) Net transfers in
and/or out
of Level 3 for fixed maturity securities were
$1,839 million for the year ended December 31, 2008
and were comprised of transfers in of $3,522 million and
transfers out of ($1,683) million. Net transfers in
and/or out
of Level 3 for equity securities were ($29) million
for the year ended December 31, 2008 and were comprised of
transfers in of $38 million and transfers out of
($67) million.
c) Included in earnings and other comprehensive income
(loss) in the above table, that were incurred for transfers in
subsequent to their transfer to Level 3 were
($479) million and ($723) million, respectively, for
fixed maturity securities, and ($20) million and
($3) million, respectively, for equity securities, for the
year ended December 31, 2008.
d) Overall, transfers in
and/or out
of Level 3 are attributable to a change in the
observability of inputs. During the year ended December 31,
2008, fixed maturity securities transfers into Level 3 of
$3,522 million resulted primarily from current market
conditions characterized by a lack of trading activity,
decreased liquidity, fixed maturity securities going into
default, and ratings downgrades (e.g. from investment grade to
below investment grade). These current market conditions have
resulted in decreased transparency of valuations, and an
increased use of broker quotations and unobservable inputs to
determine fair value. During the year ended December 31,
2008, fixed maturity securities transfers out of Level 3 of
($1,683) million resulted primarily from increased
transparency of both new issuances that subsequent to issuance
and establishment of trading activity became priced by pricing
services and existing issuances that, over time, the Company was
able to corroborate pricing received from independent pricing
services with observable inputs.
See Summary of Critical Accounting
Estimates Investments for further information
on the estimates and assumptions that affect the amounts
reported above.
205
Net Unrealized Investment Gains (Losses). The
components of net unrealized investment gains (losses), included
in accumulated other comprehensive income (loss), are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Fixed maturity securities
|
|
$
|
(21,246
|
)
|
|
$
|
3,479
|
|
|
$
|
5,075
|
|
Equity securities
|
|
|
(934
|
)
|
|
|
159
|
|
|
|
541
|
|
Derivatives
|
|
|
(2
|
)
|
|
|
(373
|
)
|
|
|
(208
|
)
|
Minority interest
|
|
|
(10
|
)
|
|
|
(150
|
)
|
|
|
(159
|
)
|
Other
|
|
|
53
|
|
|
|
3
|
|
|
|
9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
(22,139
|
)
|
|
|
3,118
|
|
|
|
5,258
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts allocated from:
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance liability loss recognition
|
|
|
42
|
|
|
|
(608
|
)
|
|
|
(1,149
|
)
|
DAC and VOBA
|
|
|
3,025
|
|
|
|
(327
|
)
|
|
|
(189
|
)
|
Policyholder dividend obligation
|
|
|
|
|
|
|
(789
|
)
|
|
|
(1,062
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
3,067
|
|
|
|
(1,724
|
)
|
|
|
(2,400
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred income tax
|
|
|
6,508
|
|
|
|
(423
|
)
|
|
|
(994
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
9,575
|
|
|
|
(2,147
|
)
|
|
|
(3,394
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net unrealized investment gains (losses)
|
|
$
|
(12,564
|
)
|
|
$
|
971
|
|
|
$
|
1,864
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The changes in net unrealized investment gains (losses) are as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Balance, end of prior period
|
|
$
|
971
|
|
|
$
|
1,864
|
|
|
$
|
1,942
|
|
Cumulative effect of change in accounting principles, net of
income tax
|
|
|
(10
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, beginning of period
|
|
|
961
|
|
|
|
1,864
|
|
|
|
1,942
|
|
Unrealized investment gains (losses) during the year
|
|
|
(25,377
|
)
|
|
|
(2,140
|
)
|
|
|
(706
|
)
|
Unrealized investment losses of subsidiaries at the date of
disposal
|
|
|
130
|
|
|
|
|
|
|
|
|
|
Unrealized investment gains (losses) relating to:
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance liability gain (loss) recognition
|
|
|
650
|
|
|
|
541
|
|
|
|
261
|
|
DAC and VOBA
|
|
|
3,370
|
|
|
|
(138
|
)
|
|
|
(110
|
)
|
DAC and VOBA of subsidiaries at date of disposal
|
|
|
(18
|
)
|
|
|
|
|
|
|
|
|
Policyholder dividend obligation
|
|
|
789
|
|
|
|
273
|
|
|
|
430
|
|
Deferred income tax
|
|
|
6,991
|
|
|
|
571
|
|
|
|
47
|
|
Deferred income tax of subsidiaries at date of disposal
|
|
|
(60
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, end of period
|
|
$
|
(12,564
|
)
|
|
$
|
971
|
|
|
$
|
1,864
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in net unrealized investment gains (losses)
|
|
$
|
(13,525
|
)
|
|
$
|
(893
|
)
|
|
$
|
(78
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
206
The following tables present the cost or amortized cost, gross
unrealized loss and number of securities for fixed maturity and
equity securities, where the estimated fair value had declined
and remained below cost or amortized cost by less than 20%, or
20% or more at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
Cost or Amortized Cost
|
|
|
Gross Unrealized Loss
|
|
|
Number of Securities
|
|
|
Less than
|
|
|
20% or
|
|
|
Less than
|
|
|
20% or
|
|
|
Less than
|
|
20% or
|
|
|
20%
|
|
|
more
|
|
|
20%
|
|
|
more
|
|
|
20%
|
|
more
|
|
|
(In millions, except number of securities)
|
|
Fixed Maturity Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less than six months
|
|
$
|
32,658
|
|
|
$
|
48,114
|
|
|
$
|
2,358
|
|
|
$
|
17,191
|
|
|
|
4,566
|
|
|
|
2,827
|
|
Six months or greater but less than nine months
|
|
|
14,975
|
|
|
|
2,180
|
|
|
|
1,313
|
|
|
|
1,109
|
|
|
|
1,314
|
|
|
|
157
|
|
Nine months or greater but less than twelve months
|
|
|
16,372
|
|
|
|
3,700
|
|
|
|
1,830
|
|
|
|
2,072
|
|
|
|
934
|
|
|
|
260
|
|
Twelve months or greater
|
|
|
23,191
|
|
|
|
650
|
|
|
|
2,533
|
|
|
|
415
|
|
|
|
1,809
|
|
|
|
102
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
87,196
|
|
|
$
|
54,644
|
|
|
$
|
8,034
|
|
|
$
|
20,787
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less than six months
|
|
$
|
386
|
|
|
$
|
1,190
|
|
|
$
|
58
|
|
|
$
|
519
|
|
|
|
351
|
|
|
|
551
|
|
Six months or greater but less than nine months
|
|
|
33
|
|
|
|
413
|
|
|
|
6
|
|
|
|
190
|
|
|
|
8
|
|
|
|
32
|
|
Nine months or greater but less than twelve months
|
|
|
3
|
|
|
|
487
|
|
|
|
|
|
|
|
194
|
|
|
|
5
|
|
|
|
15
|
|
Twelve months or greater
|
|
|
171
|
|
|
|
|
|
|
|
11
|
|
|
|
|
|
|
|
20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
593
|
|
|
$
|
2,090
|
|
|
$
|
75
|
|
|
$
|
903
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2007
|
|
|
Cost or Amortized Cost
|
|
|
Gross Unrealized Loss
|
|
|
Number of Securities
|
|
|
Less than
|
|
|
20% or
|
|
|
Less than
|
|
|
20% or
|
|
|
Less than
|
|
20% or
|
|
|
20%
|
|
|
more
|
|
|
20%
|
|
|
more
|
|
|
20%
|
|
more
|
|
|
(In millions, except number of securities)
|
|
Fixed Maturity Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less than six months
|
|
$
|
46,343
|
|
|
$
|
1,375
|
|
|
$
|
1,482
|
|
|
$
|
383
|
|
|
|
4,713
|
|
|
|
148
|
|
Six months or greater but less than nine months
|
|
|
15,833
|
|
|
|
14
|
|
|
|
730
|
|
|
|
4
|
|
|
|
1,028
|
|
|
|
24
|
|
Nine months or greater but less than twelve months
|
|
|
8,529
|
|
|
|
7
|
|
|
|
492
|
|
|
|
2
|
|
|
|
586
|
|
|
|
|
|
Twelve months or greater
|
|
|
29,893
|
|
|
|
50
|
|
|
|
1,162
|
|
|
|
13
|
|
|
|
2,692
|
|
|
|
32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
100,598
|
|
|
$
|
1,446
|
|
|
$
|
3,866
|
|
|
$
|
402
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less than six months
|
|
$
|
1,757
|
|
|
$
|
423
|
|
|
$
|
148
|
|
|
$
|
133
|
|
|
|
1,212
|
|
|
|
417
|
|
Six months or greater but less than nine months
|
|
|
528
|
|
|
|
|
|
|
|
62
|
|
|
|
|
|
|
|
154
|
|
|
|
|
|
Nine months or greater but less than twelve months
|
|
|
439
|
|
|
|
|
|
|
|
54
|
|
|
|
|
|
|
|
62
|
|
|
|
1
|
|
Twelve months or greater
|
|
|
511
|
|
|
|
|
|
|
|
52
|
|
|
|
|
|
|
|
90
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
3,235
|
|
|
$
|
423
|
|
|
$
|
316
|
|
|
$
|
133
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Company performs a regular evaluation, on a
security-by-security
basis, of its investment holdings in accordance with its
impairment policy in order to evaluate whether such securities
are other-than-temporarily impaired. One of the criteria which
the Company considers in its other-than-temporary impairment
analysis is its intent and ability to hold securities for a
period of time sufficient to allow for the recovery of their
value to an amount equal to or greater than cost or amortized
cost. The Companys intent and ability to hold securities
considers broad portfolio management objectives such as
asset/liability duration management, issuer and industry segment
exposures, interest rate views and the overall total return
focus. In following these portfolio management objectives,
changes in facts and circumstances that were present in past
reporting periods may trigger a decision to sell securities that
were held in prior reporting periods. Decisions to sell are
based on current conditions or the Companys need to shift
the portfolio to maintain its portfolio management objectives
including liquidity needs or
207
duration targets on asset/liability managed portfolios. The
Company attempts to anticipate these types of changes and if a
sale decision has been made on an impaired security and that
security is not expected to recover prior to the expected time
of sale, the security will be deemed other-than-temporarily
impaired in the period that the sale decision was made and an
other-than-temporary impairment loss will be recognized. See
Summary of Critical Accounting
Estimates Investments.
At December 31, 2008 and 2007, $8.0 billion and
$3.9 billion, respectively, of unrealized losses related to
fixed maturity securities with an unrealized loss position of
less than 20% of cost or amortized cost, which represented 9%
and 4%, respectively, of the cost or amortized cost of such
securities. At December 31, 2008 and 2007, $75 million
and $316 million, respectively, of unrealized losses
related to equity securities with an unrealized loss position of
less than 20% of cost, which represented 13% and 10%,
respectively, of the cost of such securities.
At December 31, 2008, $20.8 billion and
$903 million of unrealized losses related to fixed maturity
securities and equity securities, respectively, with an
unrealized loss position of 20% or more of cost or amortized
cost, which represented 38% and 43% of the cost or amortized
cost of such fixed maturity securities and equity securities,
respectively. Of such unrealized losses of $20.8 billion
and $903 million, $17.2 billion and $519 million
related to fixed maturity securities and equity securities,
respectively, that were in an unrealized loss position for a
period of less than six months. At December 31, 2007,
$402 million and $133 million of unrealized losses
related to fixed maturity securities and equity securities,
respectively, with an unrealized loss position of 20% or more of
cost or amortized cost, which represented 28% and 31% of the
cost or amortized cost of such fixed maturity securities and
equity securities, respectively. Of such unrealized losses of
$402 million and $133 million, $383 million and
$133 million related to fixed maturity securities and
equity securities, respectively, that were in an unrealized loss
position for a period of less than six months.
The Company held 699 fixed maturity securities and 33 equity
securities, each with a gross unrealized loss at
December 31, 2008 of greater than $10 million. These
699 fixed maturity securities represented 50%, or
$14.5 billion in the aggregate, of the gross unrealized
loss on fixed maturity securities. These 33 equity securities
represented 71%, or $699 million in the aggregate, of the
gross unrealized loss on equity securities. The Company held 23
fixed maturity securities and six equity securities, each with a
gross unrealized loss at December 31, 2007 of greater than
$10 million. These 23 fixed maturity securities represented
8%, or $357 million in the aggregate, of the gross
unrealized loss on fixed maturity securities. These six equity
securities represented 20%, or $90 million in the
aggregate, of the gross unrealized loss on equity securities.
The fixed maturity and equity securities, each with a gross
unrealized loss greater than $10 million, increased
$14.7 billion during the year ended December 31, 2008.
These securities were included in the regular evaluation of
whether such securities are other-than-temporarily impaired.
Based upon the Companys current evaluation of these
securities in accordance with its impairment policy, the cause
of the decline being primarily attributable to a rise in market
yields caused principally by an extensive widening of credit
spreads which resulted from a lack of market liquidity and a
short-term market dislocation versus a long-term deterioration
in credit quality, and the Companys current intent and
ability to hold the fixed maturity and equity securities with
unrealized losses for a period of time sufficient for them to
recover, the Company has concluded that these securities are not
other-than-temporarily impaired.
In the Companys impairment review process, the duration
of, and severity of, an unrealized loss position, such as
unrealized losses of 20% or more for equity securities, which
was $903 million and $133 million at December 31,
2008 and 2007, respectively, is given greater weight and
consideration, than for fixed maturity securities. An extended
and severe unrealized loss position on a fixed maturity security
may not have any impact on the ability of the issuer to service
all scheduled interest and principal payments and the
Companys evaluation of recoverability of all contractual
cash flows, as well as the Companys ability and intent to
hold the security, including holding the security until the
earlier of a recovery in value, or until maturity. In contrast,
for an equity security, greater weight and consideration is
given by the Company to a decline in market value and the
likelihood such market value decline will recover.
Equity securities with an unrealized loss of 20% or more for six
months or greater was $384 million at December 31,
2008, of which, $382 million of the unrealized losses, or
99%, are for non-redeemable preferred securities, of which
$377 million of the unrealized losses, or 99%, are for
investment grade non-redeemable preferred securities. Of the
$377 million of unrealized losses for investment grade
non-redeemable preferred
208
securities, $372 million of the unrealized losses, or 99%,
was comprised of unrealized losses on investment grade financial
services industry non-redeemable preferred securities, of which
85% are rated A or higher.
Equity securities with an unrealized loss of 20% or more for
less than six months was $519 million at December 31,
2008 of which $427 million of the unrealized losses, or
82%, are for non-redeemable preferred securities, of which
$421 million of the unrealized losses, or 98% are for
investment grade non-redeemable preferred securities. Of the
$421 million of unrealized losses for investment grade
non-redeemable preferred securities, $417 million of the
unrealized losses, or 99%, was comprised of unrealized losses on
investment grade financial services industry non-redeemable
preferred securities, of which 81% are rated A or higher.
There were no equity securities with an unrealized loss of 20%
or more for twelve months or greater.
In connection with the equity securities impairment review
process during 2008, the Company evaluated its holdings in
non-redeemable preferred securities, particularly those of
financial services industry companies. The Company considered
several factors including whether there has been any
deterioration in credit of the issuer and the likelihood of
recovery in value of non-redeemable preferred securities with a
severe or an extended unrealized loss. With respect to common
stock holdings, the Company considered the duration and severity
of the securities in an unrealized loss position of 20% or more;
and the duration of the securities in an unrealized loss
position of 20% or less with an extended unrealized loss
position (i.e. 12 months or more).
At December 31, 2008, there are $903 million of equity
securities with an unrealized losses of 20% or more, of which
$809 million of the unrealized losses, or 90%, were for
non-redeemable preferred securities. Through December 31,
2008, $798 million of the unrealized losses of 20% or more,
or 99%, of the non-redeemable preferred securities were
investment grade securities, of which, $789 million of the
unrealized losses of 20% or more, or 99%, are investment grade
financial services industry non-redeemable preferred securities;
and all non-redeemable preferred securities with unrealized
losses of 20% or more, regardless of rating, have not deferred
any dividend payments.
Also, the Company believes the unrealized loss position is not
necessarily predictive of the ultimate performance of these
securities, and with respect to fixed maturity securities, it
has the ability and intent to hold until the earlier of the
recovery in value, or until maturity, and with respect to equity
securities, it has the ability and intent to hold until the
recovery in value.
Future other-than-temporary impairments will depend primarily on
economic fundamentals, issuer performance, changes in collateral
valuation, changes in interest rates, and changes in credit
spreads. If economic fundamentals and other of the above factors
continue to deteriorate, additional other-than-temporary
impairments may be incurred in upcoming quarters. See also
Investments Fixed Maturity and
Equity Securities Available-for-Sale
Impairments.
209
At December 31, 2008 and 2007, the Companys gross
unrealized losses related to its fixed maturity and equity
securities of $29.8 billion and $4.7 billion,
respectively, were concentrated, calculated as a percentage of
gross unrealized loss, as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
Sector:
|
|
|
|
|
|
|
|
|
U.S. corporate securities
|
|
|
33
|
%
|
|
|
44
|
%
|
Foreign corporate securities
|
|
|
19
|
|
|
|
16
|
|
Residential mortgage-backed securities
|
|
|
16
|
|
|
|
8
|
|
Asset-backed securities
|
|
|
13
|
|
|
|
11
|
|
Commercial mortgage-backed securities
|
|
|
11
|
|
|
|
4
|
|
State and political subdivision securities
|
|
|
3
|
|
|
|
2
|
|
Foreign government securities
|
|
|
1
|
|
|
|
4
|
|
Other
|
|
|
4
|
|
|
|
11
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
Industry:
|
|
|
|
|
|
|
|
|
Mortgage-backed
|
|
|
27
|
%
|
|
|
12
|
%
|
Finance
|
|
|
24
|
|
|
|
33
|
|
Asset-backed
|
|
|
13
|
|
|
|
11
|
|
Consumer
|
|
|
11
|
|
|
|
3
|
|
Utility
|
|
|
8
|
|
|
|
8
|
|
Communication
|
|
|
5
|
|
|
|
2
|
|
Industrial
|
|
|
4
|
|
|
|
19
|
|
Foreign government
|
|
|
1
|
|
|
|
4
|
|
Other
|
|
|
7
|
|
|
|
8
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
The components of fixed maturity and equity securities net
investment gains (losses) are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed Maturity Securities
|
|
|
Equity Securities
|
|
|
Total
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Proceeds
|
|
$
|
62,495
|
|
|
$
|
78,001
|
|
|
$
|
86,725
|
|
|
$
|
2,107
|
|
|
$
|
1,112
|
|
|
$
|
845
|
|
|
$
|
64,602
|
|
|
$
|
79,113
|
|
|
$
|
87,570
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross investment gains
|
|
|
858
|
|
|
|
554
|
|
|
|
421
|
|
|
|
436
|
|
|
|
226
|
|
|
|
130
|
|
|
|
1,294
|
|
|
|
780
|
|
|
|
551
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross investment losses
|
|
|
(1,511
|
)
|
|
|
(1,091
|
)
|
|
|
(1,484
|
)
|
|
|
(263
|
)
|
|
|
(43
|
)
|
|
|
(22
|
)
|
|
|
(1,774
|
)
|
|
|
(1,134
|
)
|
|
|
(1,506
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Writedowns
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit-related
|
|
|
(1,138
|
)
|
|
|
(58
|
)
|
|
|
(56
|
)
|
|
|
(90
|
)
|
|
|
(19
|
)
|
|
|
(24
|
)
|
|
|
(1,228
|
)
|
|
|
(77
|
)
|
|
|
(80
|
)
|
Other than credit-related (1)
|
|
|
(158
|
)
|
|
|
(20
|
)
|
|
|
|
|
|
|
(340
|
)
|
|
|
|
|
|
|
|
|
|
|
(498
|
)
|
|
|
(20
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total writedowns
|
|
|
(1,296
|
)
|
|
|
(78
|
)
|
|
|
(56
|
)
|
|
|
(430
|
)
|
|
|
(19
|
)
|
|
|
(24
|
)
|
|
|
(1,726
|
)
|
|
|
(97
|
)
|
|
|
(80
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment gains (losses)
|
|
$
|
(1,949
|
)
|
|
$
|
(615
|
)
|
|
$
|
(1,119
|
)
|
|
$
|
(257
|
)
|
|
$
|
164
|
|
|
$
|
84
|
|
|
$
|
(2,206
|
)
|
|
$
|
(451
|
)
|
|
$
|
(1,035
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Other than credit-related writedowns include items such as
equity securities where the primary reason for the writedown was
the severity and/or the duration of an unrealized loss position
and fixed maturity securities where an interest-rate related
writedown was taken. |
210
Overview of Fixed Maturity and Equity Security Writedowns.
Writedowns of fixed maturity and equity securities were
$1.7 billion, $97 million and $80 million for the
years ended December 31, 2008, 2007 and 2006, respectively.
Writedowns of fixed maturity securities were $1.3 billion,
$78 million and $56 million for the years ended
December 31, 2008, 2007 and 2006, respectively. Writedowns
of equity securities were $430 million, $19 million
and $24 million for the years ended December 31, 2008,
2007 and 2006, respectively.
The Companys credit-related writedowns of fixed maturity
and equity securities were $1.2 billion, $77 million
and $80 million for the years ended December 31, 2008,
2007 and 2006, respectively. The Companys credit-related
writedowns of fixed maturity securities were $1.1 billion,
$58 million and $56 million for the years ended
December 31, 2008, 2007 and 2006, respectively. The
Companys credit-related writedowns of equity securities
were $90 million, $19 million and $24 million for
the years ended December 31, 2008, 2007 and 2006,
respectively. The $90 million of credit-related equity
securities writedowns in 2008 were primarily on non-redeemable
preferred securities.
The Companys three largest impairments totaled
$528 million, $19 million and $33 million for the
years ended December 31, 2008, 2007 and 2006, respectively.
The Company records impairments as investment losses and adjusts
the cost basis of the fixed maturity and equity securities
accordingly. The Company does not change the revised cost basis
for subsequent recoveries in value.
The Company sold or disposed of fixed maturity and equity
securities at a loss that had an estimated fair value of
$29.9 billion, $47.1 billion and $69.2 billion
during the years ended December 31, 2008, 2007 and 2006,
respectively. Gross losses excluding impairments for fixed
maturity and equity securities were $1.8 billion,
$1.1 billion and $1.5 billion for the years ended
December 31, 2008, 2007 and 2006, respectively.
2008 Financial Institutions, Individually
Significant and Trust Preferred Security Impairments.
Of the fixed maturity and equity securities impairments of
$1.7 billion for the year ended December 31, 2008,
$1,014 million were concentrated in the Companys
financial services industry securities holdings and were
comprised of $673 million in impairments on fixed maturity
securities and $341 million in impairments on equity
securities. The circumstances that gave rise to these
impairments were financial restructurings, bankruptcy filings or
difficult underlying operating environments for the entities
concerned. A significant portion of the impairments were
concentrated in three particular financial institutions that
entered bankruptcy, were subject to Federal Deposit Insurance
Corporation (FDIC) receivership or received federal
government capital infusions as described further below:
|
|
|
|
|
Lehman In connection with the filing on
September 15, 2008 by Lehman of a Chapter 11
bankruptcy petition, the Company recorded in 2008, impairments
totaling $372 million (i.e., $329 million fixed
maturity securities and $43 million equity securities) as
follows related to Lehman $256 million of
Lehman senior unsecured debt and subordinated debt,
$73 million of debt instruments issued by a special-purpose
entity backed by Lehman obligations, and $43 million of
Lehman non-redeemable preferred securities. The Company has also
made secured loans to affiliates of Lehman which are fully
collateralized; accordingly, no impairment charge has been
recorded.
|
|
|
|
Washington Mutual In connection with the
September 25, 2008 acquisition of Washington Mutuals
banking operation by JP Morgan Chase & Co. relating to
the FDIC receivership of its bank subsidiaries, which
transaction excluded the assumption of any senior unsecured
debt, subordinated debt, and preferred securities of Washington
Mutual and its bank subsidiaries, the Company recorded
impairments in 2008, totaling $197 million (i.e.,
$125 million fixed maturity securities and $72 million
equity securities) as follows $125 million of
Washington Mutual subordinated debt, $71 million of
Washington Mutual non-redeemable preferred securities, and less
than $1 million of Washington Mutual common stock holdings.
These impairments were partially offset by a $17 million
realized gain on credit default swaps purchased on Washington
Mutual debt.
|
|
|
|
AIG In connection with the September 23,
2008 definitive agreement between AIG and the Federal Reserve
Bank of New York for a two-year revolving credit facility and
issuance of preferred stock that
|
211
|
|
|
|
|
granted 79.9% common stock voting power to the United States
Treasury, the Company recorded impairments on securities for the
year ended December 31, 2008 totaling $37 million
(i.e., $35 million fixed maturity securities and
$2 million equity securities) as follows
$35 million of AIG unsecured subordinated debt holdings,
and $2 million of AIG common stock. Additionally, a
$2 million impairment was recorded on an AIG
affiliate-managed other limited partnership investment for the
year ended December 31, 2008, for a total AIG impairment of
$37 million for the year ended December 31, 2008.
|
Overall, impairments related to these three counterparties
accounted for impairments on fixed maturity and equity
securities of $489 million and $117 million,
respectively, for a total of $606 million for the year
ended December 31, 2008. These three counterparties account
for substantial portion, $489 million, of the financial
institution related fixed maturity security impairments of
$673 million; however, at $117 million, they do not
account for the majority of the financial institution related
equity security impairments of $341 million which are
nearly all related to writedowns of non-redeemable preferred
securities, included in non-redeemable preferred stock.
2008 Impairments Summary of Fixed Maturity
Security Impairments. Overall impairments of fixed maturity
securities were $1.3 billion for the year ended
December 31, 2008. This substantial increase over the prior
year was driven by impairments of: 1) $673 million on
financial services industry fixed maturity security holdings as
described previously; 2) $241 million were on
communication and consumer industries holdings;
3) $164 million on asset-backed (substantially all are
backed by or exposed to sub-prime mortgage loans) and below
investment grade commercial mortgage-backed holdings; and
4) $218 million in fixed maturity security holdings
that the Company either lacked the intent to hold, or due to
extensive credit spread widening, the Company was uncertain of
its intent to hold these fixed maturity securities for a period
of time sufficient to allow for recovery of the market value
decline Overall, $1.1 billion of the impairments were
considered to be credit-related and are included in the
$1.2 billion of credit-related impairments of fixed
maturities and equity securities described previously.
2008 Impairments Summary of Equity Security
Impairments. Equity security impairments recorded in 2008
totaled $430 million. Included within the $430 million
of impairments on equity securities in 2008 are
$341 million related to the financial services industry
holdings, (of which, $90 million related to the financial
services industry non-redeemable preferred securities) and
$89 million across several industries including consumer,
communications, industrial and utility. As described previously,
$117 million of these equity security impairments related
to Lehman, Washington Mutual and AIG. As a result of the
Companys equity securities impairment review process,
which included a review of the duration of, and or the severity
of the unrealized loss position of its equity securities
holdings, additional other-than-temporary impairment charges
totaling $313 million were recorded for the year ended
December 31, 2008. These additional impairments were
principally related to impairments on non-redeemable trust
preferred securities holdings of financial services industry
securities holdings that had either been in an unrealized loss
position for an extended duration (i.e., 12 months or
more), or were in a severe unrealized loss position. In fourth
quarter of 2008, the Company not only considered the severity
and duration of unrealized losses on its non-redeemable
preferred security holdings, but placed greater weight and
emphasis on whether there has been any credit deterioration in
the issuer of these holdings in accordance with recent published
guidance. Overall, $90 million of the impairments were
considered to be credit related and are included in the
$1.2 billion of credit related impairments of fixed
maturity and equity securities described previously.
Future Impairments. Future other-than-temporary
impairments will depend primarily on economic fundamentals,
issuer performance, changes in collateral valuation, changes in
interest rates, and changes in credit spreads. If economic
fundamentals and other of the above factors continue to
deteriorate, additional other-than-temporary impairments may be
incurred in upcoming periods. See also
Investments Fixed Maturity and Equity Securities
Available-for-Sale Net Unrealized Investment Gains
(Losses).
212
Corporate Fixed Maturity Securities. The table
below shows the major industry types that comprise the corporate
fixed maturity holdings at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
Estimated
|
|
|
% of
|
|
|
Estimated
|
|
|
% of
|
|
|
|
Fair Value
|
|
|
Total
|
|
|
Fair Value
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Foreign (1)
|
|
$
|
29,679
|
|
|
|
32.0
|
%
|
|
$
|
37,166
|
|
|
|
33.4
|
%
|
Finance
|
|
|
14,996
|
|
|
|
16.1
|
|
|
|
20,639
|
|
|
|
18.6
|
|
Industrial
|
|
|
13,324
|
|
|
|
14.3
|
|
|
|
15,838
|
|
|
|
14.3
|
|
Consumer
|
|
|
13,122
|
|
|
|
14.1
|
|
|
|
15,793
|
|
|
|
14.2
|
|
Utility
|
|
|
12,434
|
|
|
|
13.4
|
|
|
|
13,206
|
|
|
|
11.9
|
|
Communications
|
|
|
5,714
|
|
|
|
6.1
|
|
|
|
7,679
|
|
|
|
6.9
|
|
Other
|
|
|
3,713
|
|
|
|
4.0
|
|
|
|
764
|
|
|
|
0.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
92,982
|
|
|
|
100.0
|
%
|
|
$
|
111,085
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Includes U.S. dollar-denominated debt obligations of foreign
obligors, and other fixed maturity foreign investments. |
The Company maintains a diversified corporate fixed maturity
portfolio across industries and issuers. The portfolio does not
have exposure to any single issuer in excess of 1% of the total
invested assets of the portfolio. At December 31, 2008 and
2007, the Companys combined holdings in the ten issuers to
which it had the greatest exposure totaled $8.4 billion and
$7.8 billion, respectively, the total of these ten issuers
being less than 3% of the Companys total invested assets
at such dates. The exposure to the largest single issuer of
corporate fixed maturity securities held at December 31,
2008 and 2007 was $1.5 billion and $1.2 billion,
respectively.
The Company has hedged all of its material exposure to foreign
currency risk in its corporate fixed maturity portfolio. In the
Companys international insurance operations, both its
assets and liabilities are generally denominated in local
currencies.
Structured Securities. The following table
shows the types of structured securities the Company held at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
Estimated
|
|
|
% of
|
|
|
Estimated
|
|
|
% of
|
|
|
|
Fair Value
|
|
|
Total
|
|
|
Fair Value
|
|
|
Total
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Collateralized mortgage obligations
|
|
$
|
26,025
|
|
|
|
44.0
|
%
|
|
$
|
36,303
|
|
|
|
44.0
|
%
|
Pass-through securities
|
|
|
10,003
|
|
|
|
16.8
|
|
|
|
18,692
|
|
|
|
22.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total residential mortgage-backed securities
|
|
|
36,028
|
|
|
|
60.8
|
|
|
|
54,995
|
|
|
|
66.6
|
|
Commercial mortgage-backed securities
|
|
|
12,644
|
|
|
|
21.4
|
|
|
|
16,993
|
|
|
|
20.6
|
|
Asset-backed securities
|
|
|
10,523
|
|
|
|
17.8
|
|
|
|
10,572
|
|
|
|
12.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
59,195
|
|
|
|
100.0
|
%
|
|
$
|
82,560
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Collateralized mortgage obligations are a type of
mortgage-backed security that creates separate pools or tranches
of pass-through cash flows for different classes of bondholders
with varying maturities. Pass-through mortgage-backed securities
are a type of asset-backed security that is secured by a
mortgage or collection of mortgages. The monthly mortgage
payments from homeowners pass from the originating bank through
an intermediary, such as a government agency or investment bank,
which collects the payments, and for fee, remits or passes these
payments through to the holders of the pass-through securities.
213
Residential Mortgage-Backed Securities. At
December 31, 2008, the exposures in the Companys
residential mortgage-backed securities portfolio consist of
agency, prime, and alternative residential mortgage loans
(Alt-A) securities of 68%, 23%, and 9% of the total
holdings, respectively. At December 31, 2008 and 2007,
$33.3 billion and $54.7 billion, respectively, or 92%
and 99% respectively, of the residential mortgage-backed
securities were rated Aaa/AAA by Moodys, S&P or
Fitch. The majority of the agency residential mortgage-backed
securities are guaranteed or otherwise supported by the Federal
National Mortgage Association, the Federal Home Loan Mortgage
Corporation or the Government National Mortgage Association.
Prime residential mortgage lending includes the origination of
residential mortgage loans to the most credit-worthy customers
with high quality credit profiles. Alt-A residential mortgage
loans are a classification of mortgage loans where the risk
profile of the borrower falls between prime and sub-prime. At
December 31, 2008 and 2007, the Companys Alt-A
residential mortgage-backed securities exposure was
$3.4 billion and $6.3 billion, respectively, with an
unrealized loss of $1,963 million and $139 million,
respectively. At December 31, 2008 and December 31,
2007, $2.1 billion and $6.3 billion, respectively, or
63% and 99%, respectively, of the Companys Alt-A
residential mortgage-backed securities were rated Aa/AA or
better by Moodys, S&P or Fitch; At December 31,
2008 the Companys Alt-A holdings are distributed as
follows: 23% 2007 vintage year, 25% 2006 vintage year; and 52%
in the 2005 and prior vintage years. Vintage year refers to the
year of origination and not to the year of purchase. In December
2008, certain Alt-A residential mortgage-backed securities
experienced ratings downgrades from investment grade to below
investment grade, contributing to the decrease year over year
cited above in those securities rated Aa/AA or better. In
January 2009 Moodys revised its loss projections for Alt-A
residential mortgage-backed securities, and the Company
anticipates that Moodys will be downgrading virtually all
2006 and 2007 vintage year Alt-A securities to below investment
grade, which will increase the percentage of our Alt-A
residential mortgage-backed securities portfolio that will be
rated below investment grade. Our analysis suggests that
Moodys is applying essentially the same default
methodology to all Alt-A bonds, regardless of the underlying
collateral. The Companys Alt-A portfolio has superior
structure to the overall Alt-A market. The Companys Alt-A
portfolio is 88% fixed rate collateral, has zero exposure to
option ARM mortgages and has only 12% hybrid ARMs. Fixed rate
mortgages have performed better than both option ARMs and hybrid
ARMs. Additionally, 83% of the Companys Alt-A portfolio
has super senior credit enhancement, which typically provides
double the credit enhancement of a standard AAA rated bond.
Based upon the analysis of the Companys exposure to Alt-A
mortgage loans through its investment in asset-backed
securities, the Company continues to expect to receive payments
in accordance with the contractual terms of the securities.
Asset-Backed Securities. The Companys
asset-backed securities are diversified both by sector and by
issuer. At December 31, 2008, the largest exposures in the
Companys asset-backed securities portfolio were credit
card receivables, automobile receivables, student loan
receivables and residential mortgage-backed securities backed by
sub-prime mortgage loans of 49%, 10%, 10% and 10% of the total
holdings, respectively. At December 31, 2008 and 2007, the
Companys holdings in asset-backed securities was
$10.5 billion and $10.6 billion at estimated fair
value. At December 31, 2008 and 2007, $7.9 billion and
$5.7 billion, respectively, or 75% and 54%, respectively,
of total asset-backed securities were rated Aaa/AAA by
Moodys, S&P or Fitch.
The Companys asset-backed securities included in the
structured securities table above include exposure to
residential mortgage-backed securities backed by sub-prime
mortgage loans. Sub-prime mortgage lending is the origination of
residential mortgage loans to customers with weak credit
profiles. The Companys exposure exists through investment
in asset-backed securities which are supported by sub-prime
mortgage loans. The slowing U.S. housing market, greater
use of affordable mortgage products, and relaxed underwriting
standards for some originators of below-prime loans have
recently led to higher delinquency and loss rates, especially
within the 2006 and 2007 vintage year. Vintage year refers to
the year of origination and not to the year of purchase. These
factors have caused a pull-back in market liquidity and
repricing of risk, which has led to an increase in unrealized
losses from December 31, 2007 to December 31, 2008.
Based upon the analysis of the Companys exposure to
sub-prime mortgage loans through its investment in asset-backed
securities, the Company expects to receive payments in
accordance with the contractual terms of the securities.
214
The following table shows the Companys exposure to
asset-backed securities supported by sub-prime mortgage loans by
credit quality and by vintage year:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Below
|
|
|
|
|
|
|
Aaa
|
|
|
Aa
|
|
|
A
|
|
|
Baa
|
|
|
Investment Grade
|
|
|
Total
|
|
|
|
Cost or
|
|
|
|
|
|
Cost or
|
|
|
|
|
|
Cost or
|
|
|
|
|
|
Cost or
|
|
|
|
|
|
Cost or
|
|
|
|
|
|
Cost or
|
|
|
|
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
|
(In millions)
|
|
|
2003 & Prior
|
|
$
|
96
|
|
|
$
|
77
|
|
|
$
|
92
|
|
|
$
|
72
|
|
|
$
|
26
|
|
|
$
|
16
|
|
|
$
|
83
|
|
|
$
|
53
|
|
|
$
|
8
|
|
|
$
|
4
|
|
|
$
|
305
|
|
|
$
|
222
|
|
2004
|
|
|
129
|
|
|
|
70
|
|
|
|
372
|
|
|
|
204
|
|
|
|
5
|
|
|
|
3
|
|
|
|
37
|
|
|
|
28
|
|
|
|
2
|
|
|
|
1
|
|
|
|
545
|
|
|
|
306
|
|
2005
|
|
|
357
|
|
|
|
227
|
|
|
|
186
|
|
|
|
114
|
|
|
|
20
|
|
|
|
11
|
|
|
|
79
|
|
|
|
46
|
|
|
|
4
|
|
|
|
4
|
|
|
|
646
|
|
|
|
402
|
|
2006
|
|
|
146
|
|
|
|
106
|
|
|
|
69
|
|
|
|
30
|
|
|
|
15
|
|
|
|
10
|
|
|
|
26
|
|
|
|
7
|
|
|
|
2
|
|
|
|
2
|
|
|
|
258
|
|
|
|
155
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
78
|
|
|
|
33
|
|
|
|
35
|
|
|
|
21
|
|
|
|
2
|
|
|
|
2
|
|
|
|
3
|
|
|
|
1
|
|
|
|
118
|
|
|
|
57
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
728
|
|
|
$
|
480
|
|
|
$
|
797
|
|
|
$
|
453
|
|
|
$
|
101
|
|
|
$
|
61
|
|
|
$
|
227
|
|
|
$
|
136
|
|
|
$
|
19
|
|
|
$
|
12
|
|
|
$
|
1,872
|
|
|
$
|
1,142
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Below
|
|
|
|
|
|
|
Aaa
|
|
|
Aa
|
|
|
A
|
|
|
Baa
|
|
|
Investment Grade
|
|
|
Total
|
|
|
|
Cost or
|
|
|
|
|
|
Cost or
|
|
|
|
|
|
Cost or
|
|
|
|
|
|
Cost or
|
|
|
|
|
|
Cost or
|
|
|
|
|
|
Cost or
|
|
|
|
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
|
(In millions)
|
|
|
2003 & Prior
|
|
$
|
217
|
|
|
$
|
206
|
|
|
$
|
130
|
|
|
$
|
123
|
|
|
$
|
15
|
|
|
$
|
14
|
|
|
$
|
13
|
|
|
$
|
12
|
|
|
$
|
4
|
|
|
$
|
2
|
|
|
$
|
379
|
|
|
$
|
357
|
|
2004
|
|
|
186
|
|
|
|
169
|
|
|
|
412
|
|
|
|
383
|
|
|
|
11
|
|
|
|
9
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
610
|
|
|
|
561
|
|
2005
|
|
|
509
|
|
|
|
462
|
|
|
|
218
|
|
|
|
197
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
727
|
|
|
|
659
|
|
2006
|
|
|
244
|
|
|
|
223
|
|
|
|
64
|
|
|
|
43
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
308
|
|
|
|
266
|
|
2007
|
|
|
132
|
|
|
|
123
|
|
|
|
17
|
|
|
|
9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
149
|
|
|
|
132
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
1,288
|
|
|
$
|
1,183
|
|
|
$
|
841
|
|
|
$
|
755
|
|
|
$
|
26
|
|
|
$
|
23
|
|
|
$
|
13
|
|
|
$
|
12
|
|
|
$
|
5
|
|
|
$
|
2
|
|
|
$
|
2,173
|
|
|
$
|
1,975
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At December 31, 2008 and 2007, the Company had asset-backed
securities supported by sub-prime mortgage loans with estimated
fair values of $1.1 billion and $2.0 billion,
respectively, and unrealized losses of $730 million and
$198 million, respectively, as outlined in the tables
above. At December 31, 2008, approximately 82% of the
portfolio is rated Aa or better of which 82% was in vintage year
2005 and prior. At December 31, 2007, approximately 98% of
the portfolio was rated Aa or better of which 79% was in vintage
year 2005 and prior. These older vintages benefit from better
underwriting, improved enhancement levels and higher residential
property price appreciation. At December 31, 2008, 37% of
the asset-backed securities backed by sub-prime mortgage loans
have been guaranteed by financial guarantee insurers, of which
19% and 37% were guaranteed by financial guarantee insurers who
were Aa and Baa rated, respectively. At December 31, 2008,
all of the $1.1 billion of asset-backed securities
supported by sub-prime mortgage loans were classified as
Level 3 securities.
Asset-backed securities also include collateralized debt
obligations backed by sub-prime mortgage loans at an aggregate
cost of $20 million with an estimated fair value of
$10 million at December 31, 2008 and an aggregate cost
of $63 million with an estimated fair value of
$47 million at December 31, 2007, which are not
included in the tables above.
Commercial Mortgage-Backed Securities. There
have been disruptions in the commercial mortgage-backed
securities market due to market perceptions that default rates
will increase in part due weakness in commercial real estate
market fundamentals and due in part to relaxed underwriting
standards by some originators of commercial mortgage loans
within the more recent vintage years (i.e. 2006 and later).
These factors have caused a pull-back in market liquidity,
increased spreads and repricing of risk, which has led to an
increase in unrealized losses since third
215
quarter 2008. Based upon the analysis of the Companys
exposure to commercial mortgage-backed securities, the Company
expects to receive payments in accordance with the contractual
terms of the securities.
At December 31, 2008 and 2007, the Companys holdings
in commercial mortgage-backed securities was $12.6 billion
and $17.0 billion, respectively, at estimated fair value.
At December 31, 2008 and 2007, $11.8 billion and
$14.9 billion, respectively, of the estimated fair value,
or 93% and 88%, respectively, of the commercial mortgage-backed
securities were rated Aaa/AAA by Moodys, S&P, or
Fitch. At December 31, 2008, the rating distribution of the
Companys commercial mortgage-backed securities holdings
was as follows: 93% Aaa, 4% Aa, 1% A, 1% Baa, and 1% Ba or
below. At December 31, 2008, 84% of the holdings are in the
2005 and prior vintage years. At December 31, 2008, the
Company had no exposure to CMBX securities and its holdings of
commercial real estate debt obligations securities was
$121 million at estimated fair value. The weighted average
credit enhancement of the Companys commercial
mortgage-backed securities holdings at December 31, 2008
was 26%. This credit enhancement percentage represents the
current weighted average estimated percentage of outstanding
capital structure subordinated to the Companys investment
holding that is available to absorb losses before the security
incurs the first dollar of loss of principal. The credit
protection does not include any equity interest or property
value in excess of outstanding debt.
The following table shows the Companys exposure to
commercial mortgage-backed securities by credit quality and by
vintage year:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Below
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment
|
|
|
|
|
|
|
Aaa
|
|
|
Aa
|
|
|
A
|
|
|
Baa
|
|
|
Grade
|
|
|
Total
|
|
|
|
Cost or
|
|
|
|
|
|
Cost or
|
|
|
|
|
|
Cost or
|
|
|
|
|
|
Cost or
|
|
|
|
|
|
Cost or
|
|
|
|
|
|
Cost or
|
|
|
|
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
|
(In millions)
|
|
|
2003 & Prior
|
|
$
|
5,428
|
|
|
$
|
4,975
|
|
|
$
|
424
|
|
|
$
|
272
|
|
|
$
|
213
|
|
|
$
|
124
|
|
|
$
|
51
|
|
|
$
|
24
|
|
|
$
|
42
|
|
|
$
|
17
|
|
|
$
|
6,158
|
|
|
$
|
5,412
|
|
2004
|
|
|
2,630
|
|
|
|
2,255
|
|
|
|
205
|
|
|
|
100
|
|
|
|
114
|
|
|
|
41
|
|
|
|
47
|
|
|
|
11
|
|
|
|
102
|
|
|
|
50
|
|
|
|
3,098
|
|
|
|
2,457
|
|
2005
|
|
|
3,403
|
|
|
|
2,664
|
|
|
|
187
|
|
|
|
49
|
|
|
|
40
|
|
|
|
13
|
|
|
|
5
|
|
|
|
1
|
|
|
|
18
|
|
|
|
10
|
|
|
|
3,653
|
|
|
|
2,737
|
|
2006
|
|
|
1,825
|
|
|
|
1,348
|
|
|
|
110
|
|
|
|
39
|
|
|
|
25
|
|
|
|
14
|
|
|
|
94
|
|
|
|
36
|
|
|
|
|
|
|
|
|
|
|
|
2,054
|
|
|
|
1,437
|
|
2007
|
|
|
999
|
|
|
|
535
|
|
|
|
43
|
|
|
|
28
|
|
|
|
63
|
|
|
|
28
|
|
|
|
10
|
|
|
|
9
|
|
|
|
|
|
|
|
|
|
|
|
1,115
|
|
|
|
600
|
|
2008
|
|
|
1
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
14,286
|
|
|
$
|
11,778
|
|
|
$
|
969
|
|
|
$
|
488
|
|
|
$
|
455
|
|
|
$
|
220
|
|
|
$
|
207
|
|
|
$
|
81
|
|
|
$
|
162
|
|
|
$
|
77
|
|
|
$
|
16,079
|
|
|
$
|
12,644
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Below
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment
|
|
|
|
|
|
|
Aaa
|
|
|
Aa
|
|
|
A
|
|
|
Baa
|
|
|
Grade
|
|
|
Total
|
|
|
|
Cost or
|
|
|
|
|
|
Cost or
|
|
|
|
|
|
Cost or
|
|
|
|
|
|
Cost or
|
|
|
|
|
|
Cost or
|
|
|
|
|
|
Cost or
|
|
|
|
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
Amortized
|
|
|
Fair
|
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
Cost
|
|
|
Value
|
|
|
|
(In millions)
|
|
|
2003 & Prior
|
|
$
|
5,442
|
|
|
$
|
5,500
|
|
|
$
|
504
|
|
|
$
|
512
|
|
|
$
|
339
|
|
|
$
|
342
|
|
|
$
|
94
|
|
|
$
|
92
|
|
|
$
|
42
|
|
|
$
|
43
|
|
|
$
|
6,421
|
|
|
$
|
6,489
|
|
2004
|
|
|
1,738
|
|
|
|
1,749
|
|
|
|
156
|
|
|
|
148
|
|
|
|
106
|
|
|
|
100
|
|
|
|
47
|
|
|
|
34
|
|
|
|
111
|
|
|
|
101
|
|
|
|
2,158
|
|
|
|
2,132
|
|
2005
|
|
|
3,154
|
|
|
|
3,166
|
|
|
|
212
|
|
|
|
198
|
|
|
|
50
|
|
|
|
48
|
|
|
|
5
|
|
|
|
4
|
|
|
|
76
|
|
|
|
61
|
|
|
|
3,497
|
|
|
|
3,477
|
|
2006
|
|
|
2,767
|
|
|
|
2,813
|
|
|
|
120
|
|
|
|
116
|
|
|
|
34
|
|
|
|
34
|
|
|
|
121
|
|
|
|
118
|
|
|
|
10
|
|
|
|
10
|
|
|
|
3,052
|
|
|
|
3,091
|
|
2007
|
|
|
1,680
|
|
|
|
1,672
|
|
|
|
91
|
|
|
|
87
|
|
|
|
37
|
|
|
|
36
|
|
|
|
10
|
|
|
|
9
|
|
|
|
|
|
|
|
|
|
|
|
1,818
|
|
|
|
1,804
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
14,781
|
|
|
$
|
14,900
|
|
|
$
|
1,083
|
|
|
$
|
1,061
|
|
|
$
|
566
|
|
|
$
|
560
|
|
|
$
|
277
|
|
|
$
|
257
|
|
|
$
|
239
|
|
|
$
|
215
|
|
|
$
|
16,946
|
|
|
$
|
16,993
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities
Lending
The Company participates in securities lending programs whereby
blocks of securities, which are included in fixed maturity
securities, and short-term investments are loaned to third
parties, primarily major brokerage firms
216
and commercial banks. The Company generally requires collateral
equal to 102% of the current estimated fair value of the loaned
securities to be obtained at the inception of a loan, and
maintained at a level greater than or equal to 100% for the
duration of the loan. During the extraordinary market events
occurring in the fourth quarter of 2008, the Company, in limited
instances, accepted collateral less than 102% at the inception
of certain loans, but never less than 100%, of the estimated
fair value of such loaned securities. These loans involved
U.S. Government Treasury Bills which are considered to have
limited variation in their estimated fair value during the term
of the loan. Securities with a cost or amortized cost of
$20.8 billion and $41.1 billion and an estimated fair
value of $22.9 billion and $42.1 billion were on loan
under the program at December 31, 2008 and 2007,
respectively. Securities loaned under such transactions may be
sold or repledged by the transferee. The Company was liable for
cash collateral under its control of $23.3 billion and
$43.3 billion at December 31, 2008 and 2007,
respectively. Of this $23.3 billion of cash collateral at
December 31, 2008, $5.1 billion was on open terms,
meaning that the related loaned security could be returned to
the Company on the next business day requiring return of cash
collateral and $14.7 billion and $3.5 billion,
respectively were due within 30 days and 60 days. The
estimated fair value of the securities related to the cash
collateral on open at December 31, 2008 has been reduced to
$5.0 billion from $15.8 billion as of
November 30, 2008. Of the $5.0 billion of estimated
fair value of the securities related to the cash collateral on
open at December 31, 2008, $4.4 billion were
U.S. Treasury and agency securities which, if put to the
Company, can be immediately sold to satisfy the cash
requirements. The remainder of the securities on loan are
primarily U.S. Treasury and agency securities, and very
liquid residential mortgage-backed securities. Within the
U.S. Treasury securities on loan, they are primarily
holdings of on-the-run U.S. Treasury securities, the most
liquid U.S. Treasury securities available. If these high
quality securities that are on loan are put back to the Company,
the proceeds from immediately selling these securities can be
used to satisfy the related cash requirements. The estimated
fair value of the reinvestment portfolio acquired with the cash
collateral was $19.5 billion at December 31, 2008, and
consisted principally of fixed maturity securities (including
residential mortgage-backed, asset-backed, U.S. corporate
and foreign corporate securities). If the on loan securities or
the reinvestment portfolio become less liquid, the Company has
the liquidity resources of most of its general account available
to meet any potential cash demand when securities are put back
to the Company.
The following table represents, at December 31, 2008, when
the Company may be obligated to return cash collateral received
in connection with its securities lending program. Cash
collateral is required to be returned when the related loaned
security is returned to the Company.
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
Cash Collateral
|
|
|
% of Total
|
|
|
|
(In millions)
|
|
|
|
|
|
Open
|
|
$
|
5,118
|
|
|
|
22.0
|
%
|
Less than thirty days
|
|
|
14,711
|
|
|
|
63.1
|
|
Greater than thirty days to sixty days
|
|
|
3,471
|
|
|
|
14.9
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
23,300
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
Security collateral of $279 million and $40 million on
deposit from counterparties in connection with the securities
lending transactions at December 31, 2008 and 2007,
respectively may not be sold or repledged and is not reflected
in the consolidated financial statements.
Assets
on Deposit, Held in Trust and Pledged as
Collateral
The Company had investment assets on deposit with regulatory
agencies with an estimated fair value of $1.3 billion and
$1.8 billion at December 31, 2008 and 2007,
respectively, consisting primarily of fixed maturity and equity
securities. The Company also held in trust cash and securities,
primarily fixed maturity and equity securities, with an
estimated fair value of $9.3 billion and $5.9 billion
at December 31, 2008 and 2007, respectively, to satisfy
collateral requirements. The Company has also pledged certain
fixed maturity securities in support of the collateral financing
arrangements described in Note 11 of the Notes to the
Consolidated Financial Statements
Liquidity and Capital
Resources The Company Liquidity and
Capital Uses Collateral Financing Arrangements.
The Company has pledged fixed maturity securities and mortgage
loans in support of its debt and funding agreements with the
FHLB of New York and the FHLB of Boston of $22.2 billion
and $7.0 billion at December 31,
217
2008 and 2007, respectively. The Company has also pledged
certain agricultural real estate mortgage loans in connection
with funding agreements with the Federal Agricultural Mortgage
Corporation with a carrying value of $2.9 billion at both
December 31, 2008 and 2007. The Company has also pledged
qualifying mortgage loans and securities in connection with
collateralized borrowings from the Federal Reserve Bank of New
Yorks Term Auction Facility with an estimated fair value
of $1.6 billion at December 31, 2008. The nature of
these Federal Home Loan Bank, and Federal Agricultural Mortgage
Corporation and Federal Reserve Bank of New York arrangements
are described in Notes 7 and 10 of the Notes to
Consolidated Financial Statements.
Certain of the Companys invested assets are pledged as
collateral for various derivative transactions as described in
Composition of Investment Portfolio
Results Derivative Financial Instruments
Credit Risk. Certain of the Companys trading
securities are pledged to secure liabilities associated with
short sale agreements in the trading securities portfolio as
described in the following section.
Trading
Securities
The Company has trading securities portfolios to support
investment strategies that involve the active and frequent
purchase and sale of securities, the execution of short sale
agreements and asset and liability matching strategies for
certain insurance products. Trading securities and short sale
agreement liabilities are recorded at estimated fair value with
subsequent changes in estimated fair value recognized in net
investment income.
At December 31, 2008 and 2007, trading securities at
estimated fair value were $946 million and
$779 million, respectively, and liabilities associated with
the short sale agreements in the trading securities portfolio,
which were included in other liabilities, were $57 million
and $107 million, respectively. The Company had pledged
$346 million and $407 million of its assets, at
estimated fair value, primarily consisting of trading
securities, as collateral to secure the liabilities associated
with the short sale agreements in the trading securities
portfolio at December 31, 2008 and 2007, respectively.
Interest and dividends earned on trading securities in addition
to the net realized and unrealized gains (losses) recognized on
the trading securities and the related short sale agreement
liabilities included within net investment income totaled
($193) million, $50 million and $71 million for
the years ended December 31, 2008, 2007 and 2006,
respectively. Included within unrealized gains (losses) on such
trading securities and short sale agreement liabilities are
changes in estimated fair value of ($174) million,
($4) million and $26 million for the years ended
December 31, 2008, 2007 and 2006, respectively. In 2008,
unrealized losses recognized for trading securities, due to
volatility in the equity and credit markets, were in excess of
interest and dividends earned.
The trading securities measured at estimated fair value on a
recurring basis and their corresponding fair value hierarchy,
are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
Trading
|
|
|
Trading
|
|
|
|
Securities
|
|
|
Liabilities
|
|
|
|
(In millions)
|
|
|
Quoted prices in active markets for identical assets and
liabilities (Level 1)
|
|
$
|
587
|
|
|
|
62
|
%
|
|
$
|
57
|
|
|
|
100
|
%
|
Significant other observable inputs (Level 2)
|
|
|
184
|
|
|
|
19
|
|
|
|
|
|
|
|
|
|
Significant unobservable inputs (Level 3)
|
|
|
175
|
|
|
|
19
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total estimated fair value
|
|
$
|
946
|
|
|
|
100
|
%
|
|
$
|
57
|
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
218
A rollforward of the fair value measurements for trading
securities measured at estimated fair value on a recurring basis
using significant unobservable (Level 3) inputs for
the year ended December 31, 2008 is as follows:
|
|
|
|
|
|
|
Year Ended
|
|
|
|
December 31, 2008
|
|
|
|
(In millions)
|
|
|
Balance, December 31, 2007
|
|
$
|
183
|
|
Impact of SFAS 157 and SFAS 159 adoption
|
|
|
8
|
|
|
|
|
|
|
Balance, beginning of period
|
|
|
191
|
|
Total realized/unrealized gains (losses) included in:
|
|
|
|
|
Earnings
|
|
|
(26
|
)
|
Other comprehensive income (loss)
|
|
|
|
|
Purchases, sales, issuances and settlements
|
|
|
18
|
|
Transfer in and/or out of Level 3
|
|
|
(8
|
)
|
|
|
|
|
|
Balance, end of period
|
|
$
|
175
|
|
|
|
|
|
|
See Summary of Critical Accounting
Estimates Investments for further information
on the estimates and assumptions that affect the amounts
reported above.
Mortgage
and Consumer Loans
The Companys mortgage and consumer loans are principally
collateralized by commercial, agricultural and residential
properties, as well as automobiles. Mortgage and consumer loans
comprised 15.9% and 14.1% of the Companys total cash and
invested assets at December 31, 2008 and 2007,
respectively. The carrying value of mortgage and consumer loans
is stated at original cost net of repayments, amortization of
premiums, accretion of discounts and valuation allowances,
except for residential mortgage loans held-for-sale accounted
for under the fair value option which are carried at estimated
fair value, as determined on a recurring basis and certain
commercial and residential mortgage loans carried at the lower
of cost or estimated fair value, as determined on a nonrecurring
basis. The following table shows the carrying value of the
Companys mortgage and consumer loans by type at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
Carrying
|
|
|
% of
|
|
|
Carrying
|
|
|
% of
|
|
|
|
Value
|
|
|
Total
|
|
|
Value
|
|
|
Total
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
Commercial mortgage loans
|
|
$
|
35,965
|
|
|
|
70.1
|
%
|
|
$
|
34,657
|
|
|
|
75.1
|
%
|
Agricultural mortgage loans
|
|
|
12,234
|
|
|
|
23.8
|
|
|
|
10,452
|
|
|
|
22.6
|
|
Consumer loans
|
|
|
1,153
|
|
|
|
2.2
|
|
|
|
1,040
|
|
|
|
2.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loans held-for-investment
|
|
|
49,352
|
|
|
|
96.1
|
|
|
|
46,149
|
|
|
|
100.0
|
|
Mortgage loans held-for-sale
|
|
|
2,012
|
|
|
|
3.9
|
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
51,364
|
|
|
|
100.0
|
%
|
|
$
|
46,154
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At December 31, 2008, mortgage loans held-for-sale include
$1,975 million of residential mortgage loans held-for-sale
carried under the fair value option. At December 31, 2008
and 2007, mortgage loans held-for-sale also include
$37 million and $5 million, respectively, of
commercial and residential mortgage loans held-for-sale which
are carried at the lower of amortized cost or estimated fair
value.
At December 31, 2008, the Company held $220 million in
mortgage loans which are carried at estimated fair value based
on the value of the underlying collateral or independent broker
quotations, if lower, of which $188 million relate to
impaired mortgage loans held-for-investment and $32 million
to certain mortgage loans held-for-sale. These impaired mortgage
loans were recorded at estimated fair value and represent a
nonrecurring fair value measurement. The estimated fair value is
categorized as Level 3. Included within net investment
gains (losses) for such impaired mortgage loans are net
impairments of $79 million for the year ended
December 31, 2008.
219
Commercial Mortgage Loans By Geographic Region and Property
Type. The Company diversifies its commercial
mortgage loans by both geographic region and property type. The
following table presents the distribution across geographic
regions and property types for commercial mortgage loans
held-for-investment at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
December 31, 2007
|
|
|
|
Carrying
|
|
|
% of
|
|
|
Carrying
|
|
|
% of
|
|
|
|
Value
|
|
|
Total
|
|
|
Value
|
|
|
Total
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
Region
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pacific
|
|
$
|
8,837
|
|
|
|
24.6
|
%
|
|
$
|
8,436
|
|
|
|
24.4
|
%
|
South Atlantic
|
|
|
8,101
|
|
|
|
22.5
|
|
|
|
7,770
|
|
|
|
22.4
|
|
Middle Atlantic
|
|
|
5,931
|
|
|
|
16.5
|
|
|
|
5,042
|
|
|
|
14.5
|
|
International
|
|
|
3,414
|
|
|
|
9.5
|
|
|
|
3,642
|
|
|
|
10.5
|
|
West South Central
|
|
|
3,070
|
|
|
|
8.5
|
|
|
|
2,888
|
|
|
|
8.3
|
|
East North Central
|
|
|
2,591
|
|
|
|
7.2
|
|
|
|
2,866
|
|
|
|
8.3
|
|
New England
|
|
|
1,529
|
|
|
|
4.3
|
|
|
|
1,464
|
|
|
|
4.2
|
|
Mountain
|
|
|
1,052
|
|
|
|
2.9
|
|
|
|
1,002
|
|
|
|
2.9
|
|
West North Central
|
|
|
716
|
|
|
|
2.0
|
|
|
|
974
|
|
|
|
2.8
|
|
East South Central
|
|
|
468
|
|
|
|
1.3
|
|
|
|
481
|
|
|
|
1.4
|
|
Other
|
|
|
256
|
|
|
|
0.7
|
|
|
|
92
|
|
|
|
0.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
35,965
|
|
|
|
100.0
|
%
|
|
$
|
34,657
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property Type
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Office
|
|
$
|
15,307
|
|
|
|
42.6
|
%
|
|
$
|
15,216
|
|
|
|
43.9
|
%
|
Retail
|
|
|
8,038
|
|
|
|
22.3
|
|
|
|
7,334
|
|
|
|
21.1
|
|
Apartments
|
|
|
4,113
|
|
|
|
11.4
|
|
|
|
4,368
|
|
|
|
12.6
|
|
Hotel
|
|
|
3,078
|
|
|
|
8.6
|
|
|
|
3,258
|
|
|
|
9.4
|
|
Industrial
|
|
|
2,901
|
|
|
|
8.1
|
|
|
|
2,622
|
|
|
|
7.6
|
|
Other
|
|
|
2,528
|
|
|
|
7.0
|
|
|
|
1,859
|
|
|
|
5.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
35,965
|
|
|
|
100.0
|
%
|
|
$
|
34,657
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restructured, Potentially Delinquent, Delinquent or Under
Foreclosure. The Company monitors its mortgage
loan investments on an ongoing basis, including reviewing loans
that are restructured, potentially delinquent, delinquent or
under foreclosure. These loan classifications are consistent
with those used in industry practice.
The Company defines restructured mortgage loans as loans in
which the Company, for economic or legal reasons related to the
debtors financial difficulties, grants a concession to the
debtor that it would not otherwise consider. The Company defines
potentially delinquent loans as loans that, in managements
opinion, have a high probability of becoming delinquent. The
Company defines delinquent mortgage loans, consistent with
industry practice, as loans in which two or more interest or
principal payments are past due. The Company defines mortgage
loans under foreclosure as loans in which foreclosure
proceedings have formally commenced.
The Company reviews all mortgage loans on an ongoing basis.
These reviews may include an analysis of the property financial
statements and rent roll, lease rollover analysis, property
inspections, market analysis and tenant creditworthiness.
The Company records valuation allowances for certain of the
loans that it deems impaired. The Companys valuation
allowances are established both on a loan specific basis for
those loans where a property or market specific risk has been
identified that could likely result in a future default, as well
as for pools of loans with similar high risk characteristics
where a property specific or market risk has not been
identified. Loan specific valuation allowances are established
for the excess carrying value of the mortgage loan over the
present value of expected future cash
220
flows discounted at the loans original effective interest
rate, the value of the loans collateral, or the
loans estimated fair value if the loan is being sold.
Valuation allowances for pools of loans are established based on
property types and loan to value risk factors. The Company
records valuation allowances as investment losses. The Company
records subsequent adjustments to allowances as investment gains
(losses).
Recent economic events causing deteriorating market conditions,
low levels of liquidity and credit spread widening have all
adversely impacted the mortgage and consumer loan markets. As a
result, commercial real estate, agricultural and residential
loan market fundamentals have weakened. The Company expects
continued pressure on these fundamentals, including but not
limited to declining rent growth, increased vacancies, rising
delinquencies and declining property values. These deteriorating
factors have been considered in the Companys ongoing,
systematic and comprehensive review of the mortgage and consumer
loan portfolios, resulting in higher writedown amounts and
valuation allowances for 2008.
The following table presents the amortized cost and valuation
allowance for commercial mortgage loans held-for-investment
distributed by loan classification at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
December 31, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
% of
|
|
|
|
|
|
|
|
|
|
|
|
% of
|
|
|
|
Amortized
|
|
|
% of
|
|
|
Valuation
|
|
|
Amortized
|
|
|
Amortized
|
|
|
% of
|
|
|
Valuation
|
|
|
Amortized
|
|
|
|
Cost (1)
|
|
|
Total
|
|
|
Allowance
|
|
|
Cost
|
|
|
Cost (1)
|
|
|
Total
|
|
|
Allowance
|
|
|
Cost
|
|
|
|
(In millions)
|
|
|
Performing
|
|
$
|
36,192
|
|
|
|
100.0
|
%
|
|
$
|
232
|
|
|
|
0.6
|
%
|
|
|
$
|
34,820
|
|
|
|
100.0
|
%
|
|
$
|
167
|
|
|
|
0.5
|
%
|
|
Restructured
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
%
|
|
Potentially delinquent
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
%
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
%
|
|
Delinquent or under foreclosure
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
%
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
36,197
|
|
|
|
100.0
|
%
|
|
$
|
232
|
|
|
|
0.6
|
%
|
|
|
$
|
34,824
|
|
|
|
100.0
|
%
|
|
$
|
167
|
|
|
|
0.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Amortized cost is equal to carrying value before valuation
allowances. |
The following table presents the changes in valuation allowances
for commercial mortgage loans held-for-investment for the:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Balance, beginning of period
|
|
$
|
167
|
|
|
$
|
153
|
|
|
|
147
|
|
Additions
|
|
|
145
|
|
|
|
68
|
|
|
|
25
|
|
Deductions
|
|
|
(80
|
)
|
|
|
(54
|
)
|
|
|
(19
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, end of period
|
|
$
|
232
|
|
|
$
|
167
|
|
|
$
|
153
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agricultural Mortgage Loans. The Company
diversifies its agricultural mortgage loans held-for-investment
by both geographic region and product type.
Of the $12.2 billion of agricultural mortgage loans
outstanding at December 31, 2008, 56% were subject to rate
resets prior to maturity. A substantial portion of these loans
has been successfully renegotiated and remain outstanding to
maturity. The process and policies for monitoring the
agricultural mortgage loans and classifying them by performance
status are generally the same as those for the commercial loans.
221
The following table presents the amortized cost and valuation
allowances for agricultural mortgage loans held-for-investment
distributed by loan classification at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
December 31, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
% of
|
|
|
|
|
|
|
|
|
|
|
|
% of
|
|
|
|
Amortized
|
|
|
% of
|
|
|
Valuation
|
|
|
Amortized
|
|
|
Amortized
|
|
|
% of
|
|
|
Valuation
|
|
|
Amortized
|
|
|
|
Cost (1)
|
|
|
Total
|
|
|
Allowance
|
|
|
Cost
|
|
|
Cost (1)
|
|
|
Total
|
|
|
Allowance
|
|
|
Cost
|
|
|
|
(In millions)
|
|
|
Performing
|
|
$
|
12,054
|
|
|
|
98.0
|
%
|
|
$
|
16
|
|
|
|
0.1
|
%
|
|
|
$
|
10,409
|
|
|
|
99.4
|
%
|
|
$
|
12
|
|
|
|
0.1
|
%
|
|
Restructured
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
%
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
%
|
|
Potentially delinquent
|
|
|
133
|
|
|
|
1.1
|
|
|
|
18
|
|
|
|
13.5
|
%
|
|
|
|
46
|
|
|
|
0.4
|
|
|
|
4
|
|
|
|
8.7
|
%
|
|
Delinquent or under foreclosure
|
|
|
107
|
|
|
|
0.9
|
|
|
|
27
|
|
|
|
25.2
|
%
|
|
|
|
19
|
|
|
|
0.2
|
|
|
|
8
|
|
|
|
42.1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
12,295
|
|
|
|
100.0
|
%
|
|
$
|
61
|
|
|
|
0.5
|
%
|
|
|
$
|
10,476
|
|
|
|
100.0
|
%
|
|
$
|
24
|
|
|
|
0.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Amortized cost is equal to carrying value before valuation
allowances. |
The following table presents the changes in valuation allowances
for agricultural mortgage loans held-for-investment for the:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Balance, beginning of period
|
|
$
|
24
|
|
|
$
|
18
|
|
|
$
|
11
|
|
Additions
|
|
|
49
|
|
|
|
8
|
|
|
|
10
|
|
Deductions
|
|
|
(12
|
)
|
|
|
(2
|
)
|
|
|
(3
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, end of period
|
|
$
|
61
|
|
|
$
|
24
|
|
|
$
|
18
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumer Loans. Consumer loans consist of
residential mortgages and auto loans held-for-investment.
The following table presents the amortized cost and valuation
allowances for consumer loans held-for-investment distributed by
loan classification at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
December 31, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
% of
|
|
|
|
|
|
|
|
|
|
|
|
% of
|
|
|
|
Amortized
|
|
|
% of
|
|
|
Valuation
|
|
|
Amortized
|
|
|
Amortized
|
|
|
% of
|
|
|
Valuation
|
|
|
Amortized
|
|
|
|
Cost (1)
|
|
|
Total
|
|
|
Allowance
|
|
|
Cost
|
|
|
Cost (1)
|
|
|
Total
|
|
|
Allowance
|
|
|
Cost
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
Performing
|
|
$
|
1,116
|
|
|
|
95.8
|
%
|
|
$
|
11
|
|
|
|
1.0
|
%
|
|
|
$
|
1,001
|
|
|
|
95.7
|
%
|
|
$
|
5
|
|
|
|
0.5
|
%
|
|
Restructured
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
%
|
|
Potentially delinquent
|
|
|
17
|
|
|
|
1.5
|
|
|
|
|
|
|
|
|
%
|
|
|
|
19
|
|
|
|
1.8
|
|
|
|
|
|
|
|
|
%
|
|
Delinquent or under foreclosure
|
|
|
31
|
|
|
|
2.7
|
|
|
|
|
|
|
|
|
%
|
|
|
|
26
|
|
|
|
2.5
|
|
|
|
1
|
|
|
|
4.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
1,164
|
|
|
|
100.0
|
%
|
|
$
|
11
|
|
|
|
0.9
|
%
|
|
|
$
|
1,046
|
|
|
|
100.0
|
%
|
|
$
|
6
|
|
|
|
0.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Amortized cost is equal to carrying value before valuation
allowances. |
222
The following table presents the changes in valuation allowances
for consumer loans held-for-investment for the:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Balance, beginning of period
|
|
$
|
6
|
|
|
$
|
11
|
|
|
$
|
14
|
|
Additions
|
|
|
6
|
|
|
|
|
|
|
|
1
|
|
Deductions
|
|
|
(1
|
)
|
|
|
(5
|
)
|
|
|
(4
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, end of period
|
|
$
|
11
|
|
|
$
|
6
|
|
|
$
|
11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Real
Estate Holdings
The Companys real estate holdings consist of commercial
properties located primarily in the United States. At
December 31, 2008 and 2007, the carrying value of the
Companys real estate, real estate joint ventures and real
estate held-for-sale was $7.6 billion and
$6.8 billion, respectively, or 2.4% and 2.1%, respectively,
of total cash and invested assets. The carrying value of real
estate is stated at depreciated cost net of impairments and
valuation allowances. The carrying value of real estate joint
ventures is stated at the Companys equity in the real
estate joint ventures net of impairments and valuation
allowances.
The following table presents the carrying value of the
Companys real estate holdings at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
Carrying
|
|
|
% of
|
|
|
Carrying
|
|
|
% of
|
|
Type
|
|
Value
|
|
|
Total
|
|
|
Value
|
|
|
Total
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
Real estate
|
|
$
|
4,061
|
|
|
|
53.5
|
%
|
|
$
|
3,954
|
|
|
|
58.4
|
%
|
Real estate joint ventures
|
|
|
3,522
|
|
|
|
46.5
|
|
|
|
2,771
|
|
|
|
41.0
|
|
Foreclosed real estate
|
|
|
2
|
|
|
|
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,585
|
|
|
|
100.0
|
|
|
|
6,728
|
|
|
|
99.4
|
|
Real estate held-for-sale
|
|
|
1
|
|
|
|
|
|
|
|
39
|
|
|
|
0.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total real estate holdings
|
|
$
|
7,586
|
|
|
|
100.0
|
%
|
|
$
|
6,767
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Company diversifies its real estate holdings by both
geographic region and property type to reduce risk of
concentration. The Companys real estate holdings are
primarily located in the United States. At December 31,
2008, 22%, 13%, 11% and 8% of the Companys real estate
holdings were located in California, Florida, New York and
Texas, respectively. Property type diversification is shown in
the table below.
223
Real estate holdings were categorized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
Amount
|
|
|
Percent
|
|
|
Amount
|
|
|
Percent
|
|
|
|
(In millions)
|
|
|
Office
|
|
$
|
3,489
|
|
|
|
46
|
%
|
|
$
|
3,480
|
|
|
|
51
|
%
|
Apartments
|
|
|
1,602
|
|
|
|
21
|
|
|
|
1,148
|
|
|
|
17
|
|
Real estate investment funds
|
|
|
1,080
|
|
|
|
14
|
|
|
|
950
|
|
|
|
14
|
|
Industrial
|
|
|
483
|
|
|
|
7
|
|
|
|
443
|
|
|
|
7
|
|
Retail
|
|
|
472
|
|
|
|
6
|
|
|
|
455
|
|
|
|
7
|
|
Hotel
|
|
|
180
|
|
|
|
3
|
|
|
|
60
|
|
|
|
1
|
|
Land
|
|
|
155
|
|
|
|
2
|
|
|
|
125
|
|
|
|
2
|
|
Agriculture
|
|
|
24
|
|
|
|
|
|
|
|
29
|
|
|
|
|
|
Other
|
|
|
101
|
|
|
|
1
|
|
|
|
77
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total real estate holdings
|
|
$
|
7,586
|
|
|
|
100
|
%
|
|
$
|
6,767
|
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Companys carrying value of real estate held-for-sale
of $1 million and $39 million at December 31,
2008 and 2007, respectively, have been reduced by impairments of
$1 million at both December 31, 2008 and 2007,
respectively.
The Company records real estate acquired upon foreclosure of
commercial and agricultural mortgage loans at the lower of
estimated fair value or the carrying value of the mortgage loan
at the date of foreclosure.
Net investment income from real estate joint ventures and funds
within the real estate and real estate joint venture caption
represents distributions from investees accounted for under the
cost method and equity in earnings from investees accounted for
under the equity method. For the years ended December 31,
2008, 2007 and 2006, net investment income from real estate and
real estate joint ventures was $581 million,
$950 million and $777 million, respectively. Net
investment income from real estate and real estate joint
ventures decreased by $369 million for the year ended 2008
due to volatility in the real estate markets. Management
anticipates that the significant volatility in the real estate
markets will continue in 2009 which could continue to impact net
investment income and the related yields on real estate and real
estate joint ventures. For equity method real estate joint
ventures and funds, the Company reports the equity in earnings
based on the availability of financial statements and other
periodic financial information that are substantially the same
as financial statements. Accordingly, those financial statements
are reviewed on a lag basis after the close of the joint
ventures or funds financial reporting periods, and
the Company records the equity in earnings, generally on a one
reporting period lag. In addition, due to the lag in reporting
of the joint ventures and funds results to the
Company, volatility in the equity and credit markets experienced
in late 2008, is expected to unfavorably impact net investment
income in 2009, as those results are reported to the Company.
Other
Limited Partnership Interests
The carrying value of other limited partnership interests (which
primarily represent ownership interests in pooled investment
funds that principally make private equity investments in
companies in the United States and overseas) was
$6.0 billion and $6.2 billion at December 31,
2008 and 2007, respectively. Included within other limited
partnership interests at December 31, 2008 and 2007 are
$1.3 billion and $1.6 billion, respectively, of hedge
funds. The Company uses the equity method of accounting for
investments in limited partnership interests in which it has
more than a minor interest, has influence over the
partnerships operating and financial policies, but does
not have a controlling interest and is not the primary
beneficiary. The Company uses the cost method for minor interest
investments and when it has virtually no influence over the
partnerships operating and financial policies. For equity
method limited partnership interests, the Company reports the
equity in earnings based on the availability of financial
statements and other periodic financial information that are
substantially the same as financial statements. Accordingly,
those financial statements are reviewed on a lag basis after the
close of the partnerships financial reporting periods, and
the Company records the equity in earnings, generally on a one
reporting period lag. In
224
addition, due to the lag in reporting of the partnerships
results to the Company, volatility in the equity and credit
markets experienced in late 2008, is expected to unfavorably
impact net investment income in 2009, as those results are
reported to the Company. The Companys investments in other
limited partnership interests represented 1.9% and 1.9% of cash
and invested assets at December 31, 2008 and 2007,
respectively.
For the years ended December 31, 2008, 2007 and 2006, net
investment income (loss) from other limited partnership
interests was ($170) million, $1,309 million and
$945 million, respectively. Net investment income from
other limited partnership interests, including hedge funds,
decreased by $1,479 million for the year ended 2008, due to
volatility in the equity and credit markets. Management
anticipates that the significant volatility in the equity and
credit markets will continue in 2009 which could continue to
impact net investment income and the related yields on other
limited partnership interests. In addition, due to the lag in
reporting of the partnership results to the Company, volatility
in the equity and credit markets incurred in late 2008, is
expected to unfavorably impact net investment income in 2009, as
those results are reported to the Company.
At December 31, 2008, the Company held $137 million in
cost basis other limited partnership interests which were
impaired during the year ended December 31, 2008 based on
the underlying limited partnership financial statements.
Consistent with equity securities, greater weight and
consideration is given in the other limited partnership
interests impairment review process, to the severity and
duration of unrealized losses on such other limited partnership
interests holdings. These other limited partnership interests
were recorded at estimated fair value and represent a
nonrecurring fair value measurement. The estimated fair value
was categorized as Level 3. Included within net investment
gains (losses) for such other limited partnerships are
impairments of $105 million for the year ended
December 31, 2008.
Other
Invested Assets
The following table presents the carrying value of the
Companys other invested assets at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
Carrying
|
|
|
% of
|
|
|
Carrying
|
|
|
% of
|
|
Type
|
|
Value
|
|
|
Total
|
|
|
Value
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Freestanding derivatives with positive fair values
|
|
$
|
12,306
|
|
|
|
71.3
|
%
|
|
$
|
4,036
|
|
|
|
50.0
|
%
|
Leveraged leases, net of non-recourse debt
|
|
|
2,146
|
|
|
|
12.4
|
|
|
|
2,059
|
|
|
|
25.5
|
|
Joint venture investments
|
|
|
751
|
|
|
|
4.4
|
|
|
|
622
|
|
|
|
7.7
|
|
Tax credit partnerships
|
|
|
503
|
|
|
|
2.9
|
|
|
|
|
|
|
|
|
|
Funding agreements
|
|
|
394
|
|
|
|
2.3
|
|
|
|
383
|
|
|
|
4.7
|
|
Mortgage servicing rights
|
|
|
191
|
|
|
|
1.1
|
|
|
|
|
|
|
|
|
|
Funds withheld
|
|
|
62
|
|
|
|
0.4
|
|
|
|
80
|
|
|
|
1.0
|
|
Other
|
|
|
895
|
|
|
|
5.2
|
|
|
|
896
|
|
|
|
11.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
17,248
|
|
|
|
100.0
|
%
|
|
$
|
8,076
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See Derivative Financial Instruments
regarding the freestanding derivatives with positive estimated
fair values. Joint venture investments accounted for on the
equity method and represent our investment in insurance
underwriting joint ventures in Japan, Chile and China. Tax
credit partnerships are established for the purpose of investing
in low-income housing and other social causes, where the primary
return on investment is in the form of tax credits, and which
are accounted for under the equity method. Funding agreements
represent arrangements where the Company has long-term interest
bearing amounts on deposit with third parties and are generally
stated at amortized cost. Funds withheld represent amounts
contractually withheld by ceding companies in accordance with
reinsurance agreements.
225
Leveraged
Leases
Investment in leveraged leases, included in other invested
assets, consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Rental receivables, net
|
|
$
|
1,486
|
|
|
$
|
1,491
|
|
Estimated residual values
|
|
|
1,913
|
|
|
|
1,881
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
3,399
|
|
|
|
3,372
|
|
Unearned income
|
|
|
(1,253
|
)
|
|
|
(1,313
|
)
|
|
|
|
|
|
|
|
|
|
Investment in leveraged leases
|
|
$
|
2,146
|
|
|
$
|
2,059
|
|
|
|
|
|
|
|
|
|
|
The Companys deferred income tax liability related to
leveraged leases was $1.2 billion and $1.0 billion at
December 31, 2008 and 2007, respectively. The rental
receivables set forth above are generally due in periodic
installments. The payment periods range from one to
15 years, but in certain circumstances are as long as
30 years.
The components of net income from investment in leveraged leases
are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Income from investment in leveraged leases (included in net
investment income)
|
|
$
|
116
|
|
|
$
|
68
|
|
|
$
|
55
|
|
Less: Income tax expense on leveraged leases
|
|
|
(40
|
)
|
|
|
(24
|
)
|
|
|
(18
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income from investment in leveraged leases
|
|
$
|
76
|
|
|
$
|
44
|
|
|
$
|
37
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage
Servicing Rights
The following table presents the changes in capitalized mortgage
servicing rights for the year ended December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
Carrying Value
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
Fair value on December 31, 2007
|
|
$
|
|
|
|
|
|
|
Acquisition of mortgage servicing rights
|
|
|
350
|
|
|
|
|
|
Reduction due to loan payments
|
|
|
(10
|
)
|
|
|
|
|
Reduction due to sales
|
|
|
|
|
|
|
|
|
Changes in fair value due to:
|
|
|
|
|
|
|
|
|
Changes in valuation model inputs or assumptions
|
|
|
(149
|
)
|
|
|
|
|
Other changes in fair value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value on December 31, 2008
|
|
$
|
191
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Company recognizes the rights to service residential
mortgage loans as mortgage servicing rights (MSRs).
MSRs are either acquired or are generated from the sale of
originated residential mortgage loans where the servicing rights
are retained by the Company. MSRs are carried at estimated fair
value and changes in estimated fair value, primarily due to
changes in valuation inputs and assumptions and to the
collection of expected cash flows, are reported in other
revenues in the period in which the change occurs. See also
Notes 1 and 18 of the Notes to the Consolidated Financial
Statements for further information about the how the estimated
fair value of mortgage servicing rights is determined and other
related information.
226
Short-term
Investments
The carrying value of short-term investments, which include
investments with remaining maturities of one year or less, but
greater than three months, at the time of acquisition and are
stated at amortized cost, which approximates estimated fair
value, was $13.9 billion and $2.5 billion at
December 31, 2008 and 2007, respectively.
Derivative
Financial Instruments
Derivatives. The Company uses a variety of
derivatives, including swaps, forwards, futures and option
contracts, to manage its various risks. Additionally, the
Company uses derivatives to synthetically create investments as
permitted by its insurance subsidiaries Derivatives Use
Plans approved by the applicable state insurance departments.
The following table presents the notional amount and current
market or estimated fair value of derivative financial
instruments, excluding embedded derivatives, held at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
December 31, 2007
|
|
|
|
|
|
|
Current Market
|
|
|
|
|
|
Current Market
|
|
|
|
Notional
|
|
|
or Fair Value
|
|
|
Notional
|
|
|
or Fair Value
|
|
|
|
Amount
|
|
|
Assets
|
|
|
Liabilities
|
|
|
Amount
|
|
|
Assets
|
|
|
Liabilities
|
|
|
|
(In millions)
|
|
|
Interest rate swaps
|
|
$
|
34,060
|
|
|
$
|
4,617
|
|
|
$
|
1,468
|
|
|
$
|
62,410
|
|
|
$
|
784
|
|
|
$
|
768
|
|
Interest rate floors
|
|
|
48,517
|
|
|
|
1,748
|
|
|
|
|
|
|
|
48,937
|
|
|
|
621
|
|
|
|
|
|
Interest rate caps
|
|
|
24,643
|
|
|
|
11
|
|
|
|
|
|
|
|
45,498
|
|
|
|
50
|
|
|
|
|
|
Financial futures
|
|
|
19,908
|
|
|
|
45
|
|
|
|
205
|
|
|
|
12,302
|
|
|
|
89
|
|
|
|
57
|
|
Foreign currency swaps
|
|
|
19,438
|
|
|
|
1,953
|
|
|
|
1,866
|
|
|
|
21,201
|
|
|
|
1,480
|
|
|
|
1,719
|
|
Foreign currency forwards
|
|
|
5,167
|
|
|
|
153
|
|
|
|
129
|
|
|
|
4,177
|
|
|
|
76
|
|
|
|
16
|
|
Options
|
|
|
8,450
|
|
|
|
3,162
|
|
|
|
35
|
|
|
|
6,565
|
|
|
|
713
|
|
|
|
1
|
|
Financial forwards
|
|
|
28,176
|
|
|
|
465
|
|
|
|
169
|
|
|
|
11,937
|
|
|
|
122
|
|
|
|
2
|
|
Credit default swaps
|
|
|
5,219
|
|
|
|
152
|
|
|
|
69
|
|
|
|
6,625
|
|
|
|
58
|
|
|
|
33
|
|
Synthetic GICs
|
|
|
4,260
|
|
|
|
|
|
|
|
|
|
|
|
3,670
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
250
|
|
|
|
|
|
|
|
101
|
|
|
|
250
|
|
|
|
43
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
198,088
|
|
|
$
|
12,306
|
|
|
$
|
4,042
|
|
|
$
|
223,572
|
|
|
$
|
4,036
|
|
|
$
|
2,596
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Hierarchy. Derivatives measured at
estimated fair value on a recurring basis and their
corresponding fair value hierarchy, are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
Derivative
|
|
|
Derivative
|
|
|
|
Assets
|
|
|
Liabilities
|
|
|
|
(In millions)
|
|
|
Quoted prices in active markets for identical assets and
liabilities (Level 1)
|
|
$
|
55
|
|
|
|
|
%
|
|
|
273
|
|
|
|
7
|
%
|
Significant other observable inputs (Level 2)
|
|
|
9,483
|
|
|
|
77
|
|
|
|
3,548
|
|
|
|
88
|
|
Significant unobservable inputs (Level 3)
|
|
|
2,768
|
|
|
|
23
|
|
|
|
221
|
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total estimated fair value
|
|
$
|
12,306
|
|
|
|
100
|
%
|
|
$
|
4,042
|
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The valuation of Level 3 derivatives involves the use of
significant unobservable inputs and generally requires a higher
degree of management judgment or estimation than the valuations
of Level 1 and Level 2 derivatives. Although
Level 3 inputs are based on assumptions deemed appropriate
given the circumstances and are consistent with what other
market participants would use when pricing such instruments, the
use of different inputs or methodologies could have a material
effect on the estimated fair value of Level 3 derivatives
and could materially affect net income.
Derivatives categorized as Level 3 at December 31,
2008 include: financial forwards including swap spread locks
with maturities which extend beyond observable periods; interest
rate lock commitments with certain
227
unobservable inputs, including pull-through rates; equity
variance swaps with unobservable volatility inputs or that are
priced via independent broker quotations; foreign currency swaps
which are cancelable and priced through independent broker
quotations; interest rate swaps with maturities which extend
beyond the observable portion of the yield curve; credit default
swaps based upon baskets of credits having unobservable credit
correlations as well as credit default swaps with maturities
which extend beyond the observable portion of the credit curves
and credit default swaps priced through independent broker
quotes; foreign currency forwards priced via independent broker
quotations or with liquidity adjustments; equity options with
unobservable volatility inputs; and interest rate caps and
floors referencing unobservable yield curves
and/or which
include liquidity and volatility adjustments.
At December 31, 2008 and 2007, 2.7% and 1.5% of the net
derivative estimated fair value was priced via independent
broker quotations.
A rollforward of the fair value measurements for derivatives
measured at estimated fair value on a recurring basis using
significant unobservable (Level 3) inputs for the year
ended December 31, 2008 is as follows:
|
|
|
|
|
|
|
Year Ended
|
|
|
|
December 31, 2008
|
|
|
|
(In millions)
|
|
|
Balance, December 31, 2007
|
|
$
|
789
|
|
Impact of SFAS 157 and SFAS 159 adoption
|
|
|
(1
|
)
|
|
|
|
|
|
Balance, beginning of period
|
|
|
788
|
|
Total realized/unrealized gains (losses) included in:
|
|
|
|
|
Earnings
|
|
|
1,729
|
|
Other comprehensive income (loss)
|
|
|
|
|
Purchases, sales, issuances and settlements
|
|
|
29
|
|
Transfer in and/or out of Level 3
|
|
|
1
|
|
|
|
|
|
|
Balance, end of period
|
|
$
|
2,547
|
|
|
|
|
|
|
See Summary of Critical Accounting
Estimates Derivative Financial Instruments for
further information on the estimates and assumptions that affect
the amounts reported above.
Credit Risk. The Company may be exposed to
credit-related losses in the event of nonperformance by
counterparties to derivative financial instruments. Generally,
the current credit exposure of the Companys derivative
contracts is limited to the net positive estimated fair value of
derivative contracts at the reporting date after taking into
consideration the existence of netting agreements and any
collateral received pursuant to credit support annexes.
The Company manages its credit risk related to over-the-counter
derivatives by entering into transactions with creditworthy
counterparties, maintaining collateral arrangements and through
the use of master agreements that provide for a single net
payment to be made by one counterparty to another at each due
date and upon termination. Because exchange-traded futures are
effected through regulated exchanges, and positions are marked
to market on a daily basis, the Company has minimal exposure to
credit-related losses in the event of nonperformance by
counterparties to such derivative instruments.
The Company enters into various collateral arrangements, which
require both the pledging and accepting of collateral in
connection with its derivative instruments. At December 31,
2008 and 2007, the Company was obligated to return cash
collateral under its control of $7,758 million and
$833 million, respectively. This unrestricted cash
collateral is included in cash and cash equivalents or in
short-term investments and the obligation to return it is
included in payables for collateral under securities loaned and
other transactions. At December 31, 2008 and 2007, the
Company had also accepted collateral consisting of various
securities with an estimated fair value of $1,249 million
and $678 million, respectively, which are held in separate
custodial accounts. The Company is permitted by contract to sell
or repledge this collateral, but at December 31, 2008 and
2007, none of the collateral had been sold or repledged.
228
At December 31, 2008 and 2007, the Company provided
securities collateral for various arrangements in connection
with derivative instruments of $776 million and
$162 million, respectively, which is included in fixed
maturity securities. The counterparties are permitted by
contract to sell or repledge this collateral. In addition, the
Company has exchange-traded futures, which require the pledging
of collateral. At December 31, 2008 and 2007, the Company
pledged securities collateral for exchange-traded futures of
$282 million and $167 million, respectively, which is
included in fixed maturity securities. The counterparties are
permitted by contract to sell or repledge this collateral. At
December 31, 2008 and 2007, the Company provided cash
collateral for exchange-traded futures of $686 million and
$102 million, respectively, which is included in premiums
and other receivables.
In connection with synthetically created investment transactions
and credit default swaps held in relation to the trading
portfolio, the Company writes credit default swaps for which it
receives a premium to insure credit risk. If a credit event, as
defined by the contract, occurs generally the contract will
require the Company to pay the counterparty the specified swap
notional amount in exchange for the delivery of par quantities
of the referenced credit obligation. The Companys maximum
amount at risk, assuming the value of all referenced credit
obligations is zero, was $1,875 million at
December 31, 2008. However, the Company believes that any
actual future losses will be significantly lower than this
amount. Additionally, the Company can terminate these contracts
at any time through cash settlement with the counterparty at an
amount equal to the then current estimated fair value of the
credit default swaps. At December 31, 2008, the Company
would have paid $37 million to terminate all of these
contracts.
Embedded Derivatives. The embedded derivatives
measured at estimated fair value on a recurring basis and their
corresponding fair value hierarchy, are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
|
|
|
Net Embedded Derivatives Within
|
|
|
|
|
|
|
Asset Host Contracts
|
|
|
Liability Host Contracts
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
Quoted prices in active markets for identical assets and
liabilities (Level 1)
|
|
$
|
|
|
|
|
|
%
|
|
$
|
|
|
|
|
|
%
|
|
|
|
|
Significant other observable inputs (Level 2)
|
|
|
|
|
|
|
|
|
|
|
(83
|
)
|
|
|
(3
|
)
|
|
|
|
|
Significant unobservable inputs (Level 3)
|
|
|
205
|
|
|
|
100
|
|
|
|
3,134
|
|
|
|
103
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total estimated fair value
|
|
$
|
205
|
|
|
|
100
|
%
|
|
$
|
3,051
|
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A rollforward of the fair value measurements for embedded
derivatives measured at estimated fair value on a recurring
basis using significant unobservable (Level 3) inputs
for the year ended December 31, 2008 is as follows:
|
|
|
|
|
|
|
Year Ended
|
|
|
|
December 31, 2008
|
|
|
|
(In millions)
|
|
|
Balance, December 31, 2007
|
|
$
|
(278
|
)
|
Impact of SFAS 157 and SFAS 159 adoption
|
|
|
24
|
|
|
|
|
|
|
Balance, beginning of period
|
|
|
(254
|
)
|
Total realized/unrealized gains (losses) included in:
|
|
|
|
|
Earnings
|
|
|
(2,500
|
)
|
Other comprehensive income (loss)
|
|
|
(81
|
)
|
Purchases, sales, issuances and settlements
|
|
|
(94
|
)
|
Transfer in and/or out of Level 3
|
|
|
|
|
|
|
|
|
|
Balance, end of period
|
|
$
|
(2,929
|
)
|
|
|
|
|
|
Effective January 1, 2008, upon adoption of SFAS 157,
the valuation of the Companys guaranteed minimum benefit
riders includes an adjustment for the Companys own credit.
For the year ended December 31, 2008, the Company
recognized net investment gains of $2,994 million in
connection with this adjustment.
See Summary of Critical Accounting
Estimates Embedded Derivatives for further
information on the estimates and assumptions that affect the
amounts reported above.
229
Variable
Interest Entities
The following table presents the total assets and total
liabilities relating to VIEs for which the Company has concluded
that it is the primary beneficiary and which are consolidated in
the Companys financial statements at December 31,
2008. Generally, creditors or beneficial interest holders of
VIEs where the Company is the primary beneficiary have no
recourse to the general credit of the Company.
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
Total Assets
|
|
|
Total Liabilities
|
|
|
|
(In millions)
|
|
|
MRSC collateral financing arrangement (1)
|
|
$
|
2,361
|
|
|
$
|
|
|
Real estate joint ventures (2)
|
|
|
26
|
|
|
|
15
|
|
Other limited partnership interests (3)
|
|
|
20
|
|
|
|
3
|
|
Other invested assets (4)
|
|
|
10
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
2,417
|
|
|
$
|
21
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
These assets are reflected at estimated fair value, and consist
of fixed maturity securities available-for-sale of
$2,137 million and cash and cash equivalents of
$224 million, of which $60 million is cash
held-in-trust.
Included within fixed maturity securities available-for-sale are
$948 million of U.S. corporate securities,
$561 million of residential mortgage-backed securities,
$409 million of asset-backed securities, $98 million
of commercial mortgage-backed securities, $95 million of
foreign corporate securities, $21 million of state and
political subdivision securities and $5 million of foreign
government securities. |
|
(2) |
|
Real estate joint ventures include partnerships and other
ventures which engage in the acquisition, development,
management and disposal of real estate investments. Upon
consolidation, the assets and liabilities are reflected at the
VIEs carrying amounts. The assets consist of
$20 million of real estate and real estate joint ventures
held-for-investment, $5 million of cash and cash
equivalents and $1 million of other assets. The liabilities
of $15 million are included within other liabilities. |
|
(3) |
|
Other limited partnership interests include partnerships
established for the purpose of investing in public and private
debt and equity securities. Upon consolidation, the assets and
liabilities are reflected at the VIEs carrying amounts.
The assets of $20 million are included within other limited
partnership interests, while the liabilities of $3 million
are included within other liabilities. |
|
(4) |
|
Other invested assets include tax-credit partnerships and other
investments established for the purpose of investing in
low-income housing and other social causes, where the primary
return on investment is in the form of tax credits. Upon
consolidation, the assets and liabilities are reflected at the
VIEs carrying amounts. The assets of $10 million are
included within other invested assets. The liabilities consist
of $2 million of long-term debt and $1 million of
other liabilities. |
The following table presents the carrying amount and maximum
exposure to loss relating to VIEs for which the Company holds
significant variable interests but is not the primary
beneficiary and which have not been consolidated at
December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
Carrying
|
|
|
Maximum
|
|
|
|
Amount (1)
|
|
|
Exposure to Loss (2)
|
|
|
|
(In millions)
|
|
|
Fixed maturity securities available-for-sale:
|
|
|
|
|
|
|
|
|
Foreign corporate securities
|
|
$
|
1,080
|
|
|
$
|
1,080
|
|
U.S. Treasury/agency securities
|
|
|
992
|
|
|
|
992
|
|
Real estate joint ventures
|
|
|
32
|
|
|
|
32
|
|
Other limited partnership interests
|
|
|
3,496
|
|
|
|
4,004
|
|
Other invested assets
|
|
|
318
|
|
|
|
108
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
5,918
|
|
|
$
|
6,216
|
|
|
|
|
|
|
|
|
|
|
230
|
|
|
(1) |
|
See Note 1 of the Notes to the Consolidated Financial
Statements for further discussion of the Companys
significant accounting policies with regards to the carrying
amounts of these investments. |
|
(2) |
|
The maximum exposure to loss relating to the fixed maturity
securities available-for-sale and equity securities
available-for-sale is equal to the carrying amounts or carrying
amounts of retained interests. The maximum exposure to loss
relating to the real estate joint ventures and other limited
partnership interests is equal to the carrying amounts plus any
unfunded commitments. Such a maximum loss would be expected to
occur only upon bankruptcy of the issuer or investee. For
certain of its investments in other invested assets, the
Companys return is in the form of tax credits which are
guaranteed by a creditworthy third party. For such investments,
the maximum exposure to loss is equal to the carrying amounts
plus any unfunded commitments, reduced by amounts guaranteed by
third parties. |
As discussed in Note 16 of the Notes to the Consolidated
Financial Statements, the Company makes commitments to fund
partnership investments in the normal course of business.
Excluding these commitments, MetLife did not provide financial
or other support to investees designated as VIEs during the
years ended December 31, 2008, 2007 and 2006.
Separate
Accounts
The Company had $120.8 billion and $160.1 billion held
in its separate accounts, for which the Company does not bear
investment risk, at December 31, 2008 and 2007,
respectively. The Company manages each separate accounts
assets in accordance with the prescribed investment policy that
applies to that specific separate account. The Company
establishes separate accounts on a single client and
multi-client commingled basis in compliance with insurance laws.
Effective with the adoption of
SOP 03-1,
Accounting and Reporting by Insurance Enterprises for Certain
Nontraditional Long-Duration Contracts and for Separate
Accounts, on January 1, 2004, the Company reported
separately, as assets and liabilities, investments held in
separate accounts and liabilities of the separate accounts if:
|
|
|
|
|
such separate accounts are legally recognized;
|
|
|
|
assets supporting the contract liabilities are legally insulated
from the Companys general account liabilities;
|
|
|
|
investments are directed by the contractholder; and
|
|
|
|
all investment performance, net of contract fees and
assessments, is passed through to the contractholder.
|
The Company reports separate account assets meeting such
criteria at their estimated fair value. Investment performance
(including net investment income, net investment gains (losses)
and changes in unrealized gains (losses)) and the corresponding
amounts credited to contractholders of such separate accounts
are offset within the same line in the consolidated statements
of income.
The Companys revenues reflect fees charged to the separate
accounts, including mortality charges, risk charges, policy
administration fees, investment management fees and surrender
charges. Separate accounts not meeting the above criteria are
combined on a
line-by-line
basis with the Companys general account assets,
liabilities, revenues and expenses.
The separate accounts measured at estimated fair value on a
recurring basis and their corresponding fair value hierarchy,
are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
(In millions)
|
|
|
Quoted prices in active markets for identical assets
(Level 1)
|
|
$
|
85,886
|
|
|
|
71.0
|
%
|
Significant other observable inputs (Level 2)
|
|
|
33,195
|
|
|
|
27.5
|
|
Significant unobservable inputs (Level 3)
|
|
|
1,758
|
|
|
|
1.5
|
|
|
|
|
|
|
|
|
|
|
Total estimated fair value
|
|
$
|
120,839
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
231
Policyholder
Liabilities
The Company establishes, and carries as liabilities, actuarially
determined amounts that are calculated to meet policy
obligations when a policy matures or is surrendered, an insured
dies or becomes disabled or upon the occurrence of other covered
events, or to provide for future annuity payments. Amounts for
actuarial liabilities are computed and reported in the
consolidated financial statements in conformity with GAAP. For
more details on Policyholder Liabilities see
Managements Discussion and Analysis of
Financial Condition and Results of Operations
Critical Accounting Estimates. Also see
Note 1 and Note 7 of the Notes to the Consolidated
Financial Statements.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Future Policy Benefits
|
|
|
Policyholder Account Balances
|
|
|
Other Policyholder Funds
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Institutional
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Group life
|
|
$
|
3,346
|
|
|
$
|
3,326
|
|
|
$
|
14,044
|
|
|
$
|
13,997
|
|
|
$
|
2,532
|
|
|
$
|
2,364
|
|
Retirement & savings
|
|
|
40,320
|
|
|
|
37,947
|
|
|
|
60,787
|
|
|
|
51,585
|
|
|
|
58
|
|
|
|
213
|
|
Non-medical health & other
|
|
|
11,619
|
|
|
|
10,617
|
|
|
|
501
|
|
|
|
501
|
|
|
|
609
|
|
|
|
597
|
|
Individual
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Traditional life
|
|
|
52,968
|
|
|
|
52,378
|
|
|
|
1
|
|
|
|
1
|
|
|
|
1,423
|
|
|
|
1,478
|
|
Variable & universal life
|
|
|
1,129
|
|
|
|
949
|
|
|
|
15,062
|
|
|
|
14,583
|
|
|
|
1,452
|
|
|
|
1,417
|
|
Annuities
|
|
|
3,655
|
|
|
|
3,055
|
|
|
|
44,282
|
|
|
|
37,785
|
|
|
|
88
|
|
|
|
76
|
|
Other
|
|
|
2
|
|
|
|
|
|
|
|
2,524
|
|
|
|
2,398
|
|
|
|
1
|
|
|
|
1
|
|
International
|
|
|
9,241
|
|
|
|
9,825
|
|
|
|
5,654
|
|
|
|
4,961
|
|
|
|
1,227
|
|
|
|
1,296
|
|
Auto & Home
|
|
|
3,083
|
|
|
|
3,273
|
|
|
|
|
|
|
|
|
|
|
|
43
|
|
|
|
51
|
|
Corporate & Other
|
|
|
5,192
|
|
|
|
4,646
|
|
|
|
6,950
|
|
|
|
4,531
|
|
|
|
329
|
|
|
|
345
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
130,555
|
|
|
$
|
126,016
|
|
|
$
|
149,805
|
|
|
$
|
130,342
|
|
|
$
|
7,762
|
|
|
$
|
7,838
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Due to the nature of the underlying risks and the high degree of
uncertainty associated with the determination of actuarial
liabilities, the Company cannot precisely determine the amounts
that will ultimately be paid with respect to these actuarial
liabilities, and the ultimate amounts may vary from the
estimated amounts, particularly when payments may not occur
until well into the future.
However, we believe our actuarial liabilities for future
benefits are adequate to cover the ultimate benefits required to
be paid to policyholders. We periodically review our estimates
of actuarial liabilities for future benefits and compare them
with our actual experience. We revise estimates, to the extent
permitted or required under GAAP, if we determine that future
expected experience differs from assumptions used in the
development of actuarial liabilities.
The Company has experienced, and will likely in the future
experience, catastrophe losses and possibly acts of terrorism,
and turbulent financial markets that may have an adverse impact
on our business, results of operations, and financial condition.
Catastrophes can be caused by various events, including
pandemics, hurricanes, windstorms, earthquakes, hail, tornadoes,
explosions, severe winter weather (including snow, freezing
water, ice storms and blizzards), fires and man-made events such
as terrorist attacks. Due to their nature, we cannot predict the
incidence, timing, severity or amount of losses from
catastrophes and acts of terrorism, but we make broad use of
catastrophic and non-catastrophic reinsurance to manage risk
from these perils.
Future
Policy Benefits
The Company establishes liabilities for amounts payable under
insurance policies. Generally, amounts are payable over an
extended period of time and related liabilities are calculated
as the present value of expected future benefits to be paid,
reduced by the present value of expected future net premiums.
Such liabilities are established
232
based on methods and underlying assumptions in accordance with
GAAP and applicable actuarial standards. Principal assumptions
used in the establishment of liabilities for future policy
benefits include mortality, morbidity, policy lapse, renewal,
retirement, investment returns, inflation, expenses and other
contingent events as appropriate to the respective product type.
These assumptions are established at the time the policy is
issued and are intended to estimate the experience for the
period the policy benefits are payable. Utilizing these
assumptions, liabilities are established on a block of business
basis. If experience is less favorable than assumed and future
losses are projected under loss recognition testing, then
additional liabilities may be required, resulting in a charge to
policyholder benefits and claims.
Group Life. Future policy benefits are
comprised mainly of liabilities for disabled lives under
disability waiver of premium policy provisions, liabilities for
survivor income benefit insurance, and premium stabilization and
other contingency liabilities held under participating group
life insurance contracts.
Retirement & Savings. Liabilities
are primarily related to retirement and structured settlement
annuities. There is no interest rate crediting flexibility on
these liabilities. A sustained low interest rate environment
could negatively impact earnings as a result. The Company has
various derivative positions, primarily interest rate floors and
interest rate swaps, to mitigate the risks associated with such
a scenario.
Non-Medical Health & Other. Future
policy benefits are comprised mainly of provisions for
liabilities for disabled lives under group long-term disability,
individual disability, and long-term care policies, active life
liabilities under long-term care and individual disability
policies. The Company entered into various derivative positions,
primarily interest rate swaps and swaptions, to mitigate the
risk that investment of premiums received and reinvestment of
maturing assets over the life of the policy will be at rates
below those assumed in the original pricing of these contracts.
Traditional Life. Future policy benefits
mostly relate to participating whole life policies and
endowments (including the closed block). The remainder support
liabilities for term life policies. The Company has often
reinsured a portion of the mortality risk on new individual life
insurance policies. The reinsurance programs are routinely
evaluated and this may result in increases or decreases to
existing coverage.
Variable & Universal Life. Future policy
benefits are comprised mainly of reserves for mortality and
SOP 03-1
liabilities related to universal life secondary guarantees. In
order to manage risk, the Company has often reinsured a portion
of the mortality risk on new individual life insurance policies.
The reinsurance programs are routinely evaluated and this may
result in increases or decreases to existing coverage.
Annuities. Future policy benefits are
comprised mainly of reserves for life-contingent income
annuities, supplemental contracts with and without life
contingencies, reserves for Guaranteed Minimum Death Benefits
(GMDBs) included in certain annuity contracts, and a
certain portion of guaranteed living benefits.
SeeVariable
Annuity Guarantees.
International. Future policy benefits are held
primarily for immediate annuities in Latin America, as well as
for total return pass-thru provisions included in certain
universal life and savings products in Latin America, and
traditional life, endowment and annuity contracts sold in
various countries in the Asia Pacific region. They also include
SOP 03-1
liabilities for variable annuity guarantees of minimum death
benefits, and longevity guarantees sold in the Asia Pacific
region. Finally, in the European region, they also include
unearned premium liabilities established for credit insurance
contracts covering death, disability and involuntary loss of
employment, as well as a small amount of traditional life and
endowment contracts. Factors impacting these liabilities include
sustained periods of lower yields than rates established at
issue, lower than expected asset reinvestment rates, asset
default and more rapid improvement of mortality levels than
anticipated for life contingent immediate annuities. The Company
mitigates its risks by implementing an asset/liability matching
policy and through the development of periodic experience
studies. See Variable Annuity Guarantees.
Auto & Home. Future policy benefits
include liabilities for unpaid claims and claim expenses for
property and casualty insurance and represent the amount
estimated for claims that have been reported but not settled and
claims incurred but not reported. Liabilities for unpaid claims
are estimated based upon assumptions such as rates of claim
frequencies, levels of severities, inflation, judicial trends,
legislative changes or regulatory decisions. Assumptions are
based upon the Companys historical experience and analyses
of historical development
233
patterns of the relationship of loss adjustment expenses to
losses for each line of business, and consider the effects of
current developments, anticipated trends and risk management
programs, reduced for anticipated salvage and subrogation.
Estimates for the liabilities for unpaid claims and claim
expenses are reset as actuarial indications change and these
changes in the liability are reflected in the current results of
operation as either favorable or unfavorable development of
prior year losses.
Corporate & Other. Future policy benefits
primarily include liabilities for quota-share reinsurance
agreements for certain long-term care and workers
compensation business written by MICC, a subsidiary of the
Company, prior to the acquisition of MICC. These run-off
businesses have been included within Corporate & Other
since the acquisition of MICC.
Policyholder
Account Balances
Policyholder account balances are generally equal to the account
value, which includes accrued interest credited, but exclude the
impact of any applicable surrender charge that may be incurred
upon surrender.
Group Life. Policyholder account balances are
held for death benefit disbursement retained asset accounts,
universal life policies, the fixed account of variable life
insurance policies, and specialized life insurance products for
benefit programs. Policyholder account balances are credited
interest at a rate set by the Company, which are influenced by
current market rates. The majority of the policyholder account
balances have a guaranteed minimum credited rate between 1.5%
and 4.0%. A sustained low interest rate environment could
negatively impact earnings as a result of the minimum credited
rate guarantees. The Company has various derivative positions,
primarily interest rate floors, to partially mitigate the risks
associated with such a scenario.
Retirement & Savings. Policyholder
account balances are comprised of funding agreements, GICs and
Global GICs (GGICs). Interest crediting rates vary
by type of contract, and can be fixed or variable. Variable
interest crediting rates are generally tied to an external
index, most commonly
1-month or
3-month
LIBOR. MetLife is exposed to interest rate risks, and foreign
exchange risk when guaranteeing payment of interest and return
of principal at the contractual maturity date. The Company may
invest in floating rate assets, or enter into floating rate
swaps, also tied to external indices, as well as caps to
mitigate the impact of changes in market interest rates. The
Company also mitigates its risks by implementing an
asset/liability matching policy and seeks to hedge all foreign
currency risk through the use of foreign currency hedges,
including cross currency swaps.
Variable & Universal
Life. Policyholder account balances are held for
general account universal life policies, and the fixed account
of variable life insurance policies. Policyholder account
balances are credited interest at a rate set by the Company, and
are influenced by current market rates. These contracts
generally have a guaranteed minimum credited rate. The majority
of the policyholder account balances have a minimum credited
rate between 3% and 5%.
Annuities. Policyholder account balances are
held for fixed deferred annuities and the fixed account portion
of variable annuities, for certain income annuities, and for
certain portions of guaranteed benefits. Policyholder account
balances are credited interest at a rate set by the Company,
which are influenced by current market rates, and generally have
a guaranteed minimum credited rate between 1.5% and 4.0%. See
Variable Annuity Guarantees.
International. Policyholder account balances
are held largely for fixed income retirement and savings plans
in Latin America and to a lesser degree, amounts for separate
account type funds in certain countries in the Latin America,
Europe, and Asia Pacific regions that do not meet the US GAAP
definition of separate accounts. Also included are certain
liabilities for retirement and savings products sold in certain
countries in the Asia Pacific region that generally are sold
with minimum credited rate guarantees. Liabilities for
guarantees on certain variable annuities in the Asia Pacific
region are established in accordance with SFAS 133 and are
also included within policyholder account balances. These
liabilities are generally impacted by sustained periods of low
interest rates, where there are interest rate guarantees. The
Company mitigates its risks by implementing an asset/liability
matching policy and by hedging its variable annuity guarantees.
See Variable Annuity Guarantees.
234
Variable
Annuity Guarantees
The Company issues certain variable annuity products with
guaranteed minimum benefit that provide the policyholder a
minimum return based on their initial deposit (i.e., the benefit
base) less withdrawals. In some cases the benefit base may be
increased by additional deposits, bonus amounts, accruals or
market value resets. These Guarantees are accounted for under
SOP 03-1
or as embedded derivatives under SFAS 133 depending on how
and when the benefit is paid. Specifically, a guarantee is
accounted for under SFAS 133 if a guarantee is paid without
requiring (i) the occurrence of specific insurable event or
(ii) the policyholder to annuitize. Alternatively, a
guarantee is accounted for under
SOP 03-1
if a guarantee is paid only upon either (i) the occurrence
of a specific insurable event or (ii) upon annuitization.
In certain cases, a guarantee may have elements of both
SFAS 133 and
SOP 03-1
and in such cases the guarantee is accounted for under a split
of the two models.
The net amount at risk (NAR) for guarantees can
change significantly during periods of sizable and sustained
shifts in equity market performance, increased equity
volatility, or changes in interest rates. The NAR disclosed in
Note 7 of the Notes to the Consolidated Financial
Statements, represents managements estimate of the current
value of the benefits under these guarantees if they were all
exercised simultaneously as of December 31, 2008 and 2007,
respectively. However, there are features, such as deferral
periods and benefits requiring annuitization or death, that
limit the amount of benefits that will be payable in the near
future. None of the GMIB guarantees are eligible for a
guaranteed annuitization prior to 2011.
Guarantees, including portions thereof, accounted for as
embedded derivatives under SFAS 133, are recorded at
estimated fair value and included in policyholder account
balances. Guarantees accounted for as embedded derivatives
include GMAB, the non life-contingent portion of GMWB and the
portion of certain GMIB that do not require annuitization. For
more detail on the determination of estimated fair value, see
Note 24 of the Notes to the Consolidated Financial
Statements.
The table below contains the carrying value for guarantees
included in policyholder account balances:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Individual:
|
|
|
|
|
|
|
|
|
Guaranteed minimum accumulation benefit
|
|
$
|
169
|
|
|
$
|
29
|
|
Guaranteed minimum withdrawal benefit
|
|
|
750
|
|
|
|
80
|
|
Guaranteed minimum income benefit
|
|
|
1,043
|
|
|
|
78
|
|
International:
|
|
|
|
|
|
|
|
|
Guaranteed minimum accumulation benefit
|
|
|
271
|
|
|
|
7
|
|
Guaranteed minimum withdrawal benefit
|
|
|
901
|
|
|
|
90
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
3,134
|
|
|
$
|
284
|
|
|
|
|
|
|
|
|
|
|
Included in net investment gains (losses) for the year ended
December 31, 2008 were losses of $2,677 million in
embedded derivatives related to the change in estimated fair
value of the above guarantees. Effective January 1, 2008,
the carrying amount of guarantees accounted for at estimated
fair value includes an adjustment for the Companys own
credit. In connection with this adjustment, gains of
$2,994 million are included in the loss of
$2,677 million in net investment gains (losses).
The estimated fair value of guarantees accounted for as embedded
derivatives can change significantly during periods of sizable
and sustained shifts in equity market performance, equity
volatility, interest rates or foreign exchange rates.
Additionally, because the estimated fair value for guarantees
accounted for at estimated fair value includes an adjustment for
the Companys own credit, a decrease in the Companys
credit spreads could cause the value of these liabilities to
increase. Conversely, a widening of the Companys credit
spreads could cause the value of these liabilities to decrease.
The Company uses derivative instruments to mitigate the
liability exposure, risk of loss and the volatility of net
income associated with these liabilities. The derivative
instruments used are primarily equity and treasury futures,
equity options and variance swaps, and interest rate swaps. The
change in valuation arising from the Companys own credit
is not hedged.
235
The table below contains the carrying value of the derivatives
hedging guarantees accounted for as embedded derivatives:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
Notional
|
|
|
Fair Value
|
|
|
Notional
|
|
|
Fair Value
|
|
|
|
Amount
|
|
|
Assets
|
|
|
Liabilities
|
|
|
Amount
|
|
|
Assets
|
|
|
Liabilities
|
|
|
|
(In millions)
|
|
|
Interest rate swaps
|
|
$
|
5,572
|
|
|
$
|
632
|
|
|
$
|
7
|
|
|
$
|
998
|
|
|
$
|
32
|
|
|
$
|
2
|
|
Financial futures
|
|
|
13,924
|
|
|
|
37
|
|
|
|
121
|
|
|
|
4,039
|
|
|
|
51
|
|
|
|
14
|
|
Foreign currency forwards
|
|
|
1,017
|
|
|
|
49
|
|
|
|
4
|
|
|
|
489
|
|
|
|
3
|
|
|
|
|
|
Options
|
|
|
5,424
|
|
|
|
2,065
|
|
|
|
|
|
|
|
4,906
|
|
|
|
554
|
|
|
|
1
|
|
Financial forwards
|
|
|
8,835
|
|
|
|
396
|
|
|
|
|
|
|
|
5,309
|
|
|
|
46
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
34,772
|
|
|
$
|
3,179
|
|
|
$
|
132
|
|
|
$
|
15,741
|
|
|
$
|
686
|
|
|
$
|
18
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Included in net investment gains (losses) for the year ended
December 31, 2008 were gains of $3,440 million related
to the change in estimated fair value of the above derivatives.
Guarantees, including portions thereof, accounted for under
SOP 03-1
have liabilities established that are included in future policy
benefits. Guarantees accounted for in this manner include GMDBs,
the life-contingent portion of certain GMWB, and the portion of
GMIB that require annuitization. These liabilities are accrued
over the life of the contract in proportion to actual and future
expected policy assessments based on the level of guaranteed
minimum benefits generated using multiple scenarios of separate
account returns. The scenarios use best estimate assumptions
consistent with those used to amortize deferred acquisition
costs. When current estimates of future benefits exceed those
previously projected or when current estimates of future
assessments are lower than those previously projected, the
SOP 03-1
reserves will increase, resulting in a current period charge to
net income. The opposite result occurs when the current
estimates of future benefits are lower than that previously
projected or when current estimates of future assessments exceed
those previously projected. At each reporting period, the
Company updates the actual amount of business remaining
in-force, which impacts expected future assessments and the
projection of estimated future benefits resulting in a current
period charge or increase to earnings.
The table below contains the carrying value for guarantees
included in Future Policy Benefits:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Individual:
|
|
|
|
|
|
|
|
|
Guaranteed minimum death benefit
|
|
$
|
204
|
|
|
$
|
72
|
|
Guaranteed minimum income benefit
|
|
|
403
|
|
|
|
74
|
|
International:
|
|
|
|
|
|
|
|
|
Guaranteed minimum death benefit
|
|
|
39
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
646
|
|
|
$
|
148
|
|
|
|
|
|
|
|
|
|
|
Included in policyholder benefits and claims for the year ended
December 31, 2008 is a charge of $502 million related
to the change in liabilities for the above guarantees.
The carrying amount of guarantees accounted for as
SOP 03-1
liabilities can change significantly during periods of sizable
and sustained shifts in equity market performance, increased
equity volatility, or changes in interest rates. The Company
uses reinsurance in combination with derivative instruments to
mitigate the liability exposure, risk of loss and the volatility
of net income associated with these liabilities. Derivative
instruments used are primarily equity and treasury futures.
Included in policyholder benefits and claims associated with the
hedging of the guarantees in future policy benefits for the year
ended December 31, 2008 were gains of $182 million
related to reinsurance treaties containing embedded derivatives
carried at estimated fair value and gains of $331 million
related to freestanding derivatives.
236
While the Company believes that the hedging strategies employed
for guarantees included in both policyholder account balances
and in future policy benefits, as well as other management
actions, have mitigated the risks related to these benefits, the
Company remains liable for the guaranteed benefits in the event
that reinsurers or derivative counterparties are unable or
unwilling to pay. Certain of the Companys reinsurance
agreements and derivative positions are collateralized and
derivatives positions are subject to master netting agreements,
both of which, significantly reduces the exposure to
counterparty risk. In addition, the Company is subject to the
risk that hedging and other management procedures prove
ineffective or that unanticipated policyholder behavior or
mortality, combined with adverse market events, produces
economic losses beyond the scope of the risk management
techniques employed. Lastly, because the valuation of the
guarantees accounted for as embedded derivatives includes an
adjustment for the Companys own credit that is not hedged,
changes in the Companys own credit may result in
significant volatility in net income.
Other
Policyholder Funds
Other policyholder funds include policy and contract claims,
unearned revenue liabilities, premiums received in advance,
policyholder dividends due and unpaid, and policyholder
dividends left on deposit.
The liability for policy and contract claims generally relates
to incurred but not reported death, disability, long-term care
(LTC) and dental claims as well as claims that have
been reported but not yet settled. The liability for these
claims is based on the Companys estimated ultimate cost of
settling all claims. The Company derives estimates for the
development of incurred but not reported claims principally from
actuarial analyses of historical patterns of claims and claims
development for each line of business. The methods used to
determine these estimates are continually reviewed. Adjustments
resulting from this continuous review process and differences
between estimates and payments for claims are recognized in
policyholder benefits and claims expense in the period in which
the estimates are changed or payments are made.
The unearned revenue liability relates to universal life-type
and investment-type products and represents policy charges for
services to be provided in future periods. The charges are
deferred as unearned revenue and amortized using the
products estimated gross profits and margins, similar to
deferred acquisition costs. Such amortization is recorded in
universal life and investment-type product policy fees.
Also included in other policyholder funds are policyholder
dividends due and unpaid on participating policies and
policyholder dividends left on deposit. Such liabilities are
presented at amounts contractually due to policyholders.
Policyholder
Dividends Payable
Policyholder dividends payable consists of liabilities related
to dividends payable in the following calendar year on
participating policies.
Policyholder
Dividend Obligation
For more detail on Policyholder Dividend Obligation
see Note 9 of the Notes to the Consolidated Financial
Statements.
|
|
Item 7A.
|
Quantitative
and Qualitative Disclosures About Market Risk
|
Risk
Management
The Company must effectively manage, measure and monitor the
market risk associated with its assets and liabilities. It has
developed an integrated process for managing risk, which it
conducts through its Enterprise Risk Management Department,
Asset/Liability Management Unit, Treasury Department and
Investment Department along with the management of the business
segments. The Company has established and implemented
comprehensive policies and procedures at both the corporate and
business segment level to minimize the effects of potential
market volatility.
237
The Company regularly analyzes its exposure to interest rate,
equity market price and foreign currency exchange rate risks. As
a result of that analysis, the Company has determined that the
estimated fair value of certain assets and liabilities are
materially exposed to changes in interest rates, foreign
currency exchange rates and changes in the equity markets.
Enterprise Risk Management. MetLife has
established several financial and non-financial senior
management committees as part of its risk management process.
These committees manage capital and risk positions, approve
asset/liability management strategies and establish appropriate
corporate business standards.
MetLife also has a separate Enterprise Risk Management
Department, which is responsible for risk throughout MetLife and
reports to MetLifes Chief Risk Officer. The Enterprise
Risk Management Departments primary responsibilities
consist of:
|
|
|
|
|
implementing a Board of Directors approved corporate risk
framework, which outlines the Companys approach for
managing risk on an enterprise-wide basis;
|
|
|
|
developing policies and procedures for managing, measuring,
monitoring and controlling those risks identified in the
corporate risk framework;
|
|
|
|
establishing appropriate corporate risk tolerance levels;
|
|
|
|
deploying capital on an economic capital basis; and
|
|
|
|
reporting on a periodic basis to the Finance and Risk Policy
Committee of the Companys Board of Directors, and with
respect to credit risk to the Investment Committee of the
Companys Board of Directors and various financial and
non-financial senior management committees.
|
MetLife does not expect to make any material changes to its risk
management practices in 2009.
Asset/Liability Management(ALM). The Company
actively manages its assets using an approach that balances
quality, diversification, asset/liability matching, liquidity,
concentration and investment return. The goals of the investment
process are to optimize, net of income tax, risk-adjusted
investment income and risk-adjusted total return while ensuring
that the assets and liabilities are reasonably managed on a cash
flow and duration basis. The asset/liability management process
is the shared responsibility of the Financial Risk Management
and Asset/Liability Management Unit, Enterprise Risk Management,
the Portfolio Management Unit, and the senior members of the
operating business segments and is governed by the ALM
Committee. The ALM Committees duties include reviewing and
approving target portfolios, establishing investment guidelines
and limits and providing oversight of the asset/liability
management process on a periodic basis. The directives of the
ALM Committee are carried out and monitored through ALM Working
Groups which are set up to manage by product type.
MetLife establishes target asset portfolios for each major
insurance product, which represent the investment strategies
used to profitably fund its liabilities within acceptable levels
of risk. These strategies are monitored through regular review
of portfolio metrics, such as effective duration, yield curve
sensitivity, convexity, liquidity, asset sector concentration
and credit quality by the ALM Working Groups. MetLife does not
expect to make any material changes to its asset/liability
management practices in 2009.
Market
Risk Exposures
The Company has exposure to market risk through its insurance
operations and investment activities. For purposes of this
disclosure, market risk is defined as the risk of
loss resulting from changes in interest rates, equity prices and
foreign currency exchange rates.
Interest Rates. The Companys exposure to
interest rate changes results most significantly from its
holdings of fixed maturity securities, as well as its interest
rate sensitive liabilities. The fixed maturity securities
include U.S. and foreign government bonds, securities
issued by government agencies, corporate bonds and
mortgage-backed securities, all of which are mainly exposed to
changes in medium- and long-term interest rates. The interest
rate sensitive liabilities for purposes of this disclosure
include debt, policyholder account balances related to certain
investment type contracts, and net embedded derivatives within
liability host contracts which have the same type of
238
interest rate exposure (medium- and long-term interest rates) as
fixed maturity securities. The Company employs product design,
pricing and asset/liability management strategies to reduce the
adverse effects of interest rate movements. Product design and
pricing strategies include the use of surrender charges or
restrictions on withdrawals in some products and the ability to
reset credited rates for certain products. Asset/liability
management strategies include the use of derivatives and
duration mismatch limits. See Risk Factors
Changes in Market Interest Rates May Significantly Affect Our
Profitability.
Foreign Currency Exchange Rates. The
Companys exposure to fluctuations in foreign currency
exchange rates against the U.S. dollar results from its
holdings in
non-U.S. dollar
denominated fixed maturity and equity securities, mortgage and
consumer loans, and certain liabilities, as well as through its
investments in foreign subsidiaries. The principal currencies
that create foreign currency exchange rate risk in the
Companys investment portfolios are the Euro, the Canadian
dollar and the British pound. The principal currencies that
create foreign currency exchange risk in the Companys
liabilities are the British pound, the Euro, the Canadian dollar
and the Swiss franc. Selectively, the Company uses
U.S. dollar assets to support certain long duration foreign
currency liabilities. Through its investments in foreign
subsidiaries and joint ventures, the Company is primarily
exposed to the Mexican peso, the Japanese yen, the South Korean
won, the Canadian dollar, the British pound, the Chilean peso,
the Australian dollar, the Argentine peso and the Hong Kong
dollar. In addition to hedging with foreign currency swaps,
forwards and options, in some countries, local surplus is held
entirely or in part in U.S. dollar assets which further
minimizes exposure to foreign currency exchange rate fluctuation
risk. The Company has matched much of its foreign currency
liabilities in its foreign subsidiaries with their respective
foreign currency assets, thereby reducing its risk to foreign
currency exchange rate fluctuation.
Equity Prices. The Company has exposure to
equity prices through certain liabilities that involve long-term
guarantees on equity performance such as variable annuities with
guaranteed minimum benefit riders, certain policyholder account
balances along with investments in equity securities. We manage
this risk on an integrated basis with other risks through our
asset/liability management strategies including the dynamic
hedging of certain variable annuity riders. The Company also
manages equity price risk incurred in its investment portfolio
through the use of derivatives. Equity exposures associated with
other limited partnership interests are excluded from this
section as they are not considered financial instruments under
generally accepted accounting principles.
Management
of Market Risk Exposures
The Company uses a variety of strategies to manage interest
rate, foreign currency exchange rate and equity price risk,
including the use of derivative instruments.
Interest Rate Risk Management. To manage
interest rate risk, the Company analyzes interest rate risk
using various models, including multi-scenario cash flow
projection models that forecast cash flows of the liabilities
and their supporting investments, including derivative
instruments. These projections involve evaluating the potential
gain or loss on most of the Companys in-force business
under various increasing and decreasing interest rate
environments. The New York State Insurance Department
regulations require that MetLife perform some of these analyses
annually as part of MetLifes review of the sufficiency of
its regulatory reserves. For several of its legal entities, the
Company maintains segmented operating and surplus asset
portfolios for the purpose of asset/liability management and the
allocation of investment income to product lines. For each
segment, invested assets greater than or equal to the GAAP
liabilities less the DAC asset and any non-invested assets
allocated to the segment are maintained, with any excess swept
to the surplus segment. The operating segments may reflect
differences in legal entity, statutory line of business and any
product market characteristic which may drive a distinct
investment strategy with respect to duration, liquidity or
credit quality of the invested assets. Certain smaller entities
make use of unsegmented general accounts for which the
investment strategy reflects the aggregate characteristics of
liabilities in those entities. The Company measures relative
sensitivities of the value of its assets and liabilities to
changes in key assumptions utilizing Company models. These
models reflect specific product characteristics and include
assumptions based on current and anticipated experience
regarding lapse, mortality and interest crediting rates. In
addition, these models include asset cash flow projections
reflecting interest payments, sinking fund payments, principal
payments, bond calls, mortgage prepayments and defaults.
239
Common industry metrics, such as duration and convexity, are
also used to measure the relative sensitivity of assets and
liability values to changes in interest rates. In computing the
duration of liabilities, consideration is given to all
policyholder guarantees and to how the Company intends to set
indeterminate policy elements such as interest credits or
dividends. Each asset portfolio has a duration target based on
the liability duration and the investment objectives of that
portfolio. Where a liability cash flow may exceed the maturity
of available assets, as is the case with certain retirement and
non-medical health products, the Company may support such
liabilities with equity investments, derivatives or curve
mismatch strategies.
Foreign Currency Exchange Rate Risk
Management. Foreign currency exchange rate risk
is assumed primarily in three ways: investments in foreign
subsidiaries, purchases of foreign currency denominated
investments in the investment portfolio and the sale of certain
insurance products.
|
|
|
|
|
The Companys Treasury Department is responsible for
managing the exposure to investments in foreign subsidiaries.
Limits to exposures are established and monitored by the
Treasury Department and managed by the Investment Department.
|
|
|
|
The Investment Department is responsible for managing the
exposure to foreign currency investments. Exposure limits to
unhedged foreign currency investments are incorporated into the
standing authorizations granted to management by the Board of
Directors and are reported to the Board of Directors on a
periodic basis.
|
|
|
|
The lines of business are responsible for establishing limits
and managing any foreign exchange rate exposure caused by the
sale or issuance of insurance products.
|
MetLife uses foreign currency swaps and forwards to hedge its
foreign currency denominated fixed income investments, its
equity exposure in subsidiaries and its foreign currency
exposures caused by the sale of insurance products.
Equity Price Risk Management. Equity price
risk incurred through the issuance of variable annuities is
managed by the Companys Asset/Liability Management Unit in
partnership with the Investment Department. Equity price risk is
also incurred through its investment in equity securities and is
managed by its Investment Department. MetLife uses derivatives
to hedge its equity exposure both in certain liability
guarantees such as variable annuities with guaranteed minimum
benefit riders and equity securities. These derivatives include
exchange-traded equity futures, equity index options contracts
and equity variance swaps. The Companys derivative hedges
performed effectively through the extreme movements in the
equity markets during the latter part of 2008. The Company also
employs reinsurance to manage these exposures.
Hedging Activities. MetLife uses derivative
contracts primarily to hedge a wide range of risks including
interest rate risk, foreign currency risk, and equity risk.
Derivative hedges are designed to reduce risk on an economic
basis while considering their impact on accounting results and
GAAP and Statutory capital. The construction of the
Companys derivative hedge programs vary depending on the
type of risk being hedged. Some hedge programs are asset or
liability specific while others are portfolio hedges that reduce
risk related to a group of liabilities or assets. The
Companys use of derivatives by major hedge programs is as
follows:
|
|
|
|
|
Risks Related to Living Benefit Riders The Company
uses a wide range of derivative contracts to hedge the risk
associated with variable annuity living benefit riders. These
hedges include equity and interest rate futures, interest rate
swaps, currency futures/forwards, equity indexed options and
interest rate option contracts and equity variance swaps.
|
|
|
|
Minimum Interest Rate Guarantees For certain Company
liability contracts, the Company provides the contractholder a
guaranteed minimum interest rate. These contracts include
certain fixed annuities and other insurance liabilities. The
Company purchases interest rate floors to reduce risk associated
with these liability guarantees.
|
|
|
|
Reinvestment Risk in Long Duration Liability
Contracts Derivatives are used to hedge interest
rate risk related to certain long duration liability contracts,
such as long term care. Hedges include zero coupon interest rate
swaps and swaptions.
|
240
|
|
|
|
|
Foreign Currency Risk The Company uses currency
swaps and forwards to hedge foreign currency risk. These hedges
primarily swap foreign denominated bonds or equity exposures to
US dollars.
|
|
|
|
General ALM Hedging Strategies In the ordinary
course of managing the Companys asset/liability risks, the
Company uses interest rate futures, interest rate swaps,
interest rate caps, interest rate floors and inflation swaps.
These hedges are designed to reduce interest rate risk or
inflation risk related to the existing assets or liabilities or
related to expected future cash flows.
|
Risk
Measurement: Sensitivity Analysis
The Company measures market risk related to its market sensitive
assets and liabilities based on changes in interest rates,
equity prices and foreign currency exchange rates utilizing a
sensitivity analysis. This analysis estimates the potential
changes in estimated fair value based on a hypothetical 10%
change (increase or decrease) in interest rates, equity market
prices and foreign currency exchange rates. The Company believes
that a 10% change (increase or decrease) in these market rates
and prices is reasonably possible in the near-term. In
performing the analysis summarized below, the Company used
market rates at December 31, 2008. The sensitivity analysis
separately calculates each of the Companys market risk
exposures (interest rate, equity price and foreign currency
exchange rate) relating to its trading and non trading assets
and liabilities. The Company modeled the impact of changes in
market rates and prices on the estimated fair values of its
market sensitive assets and liabilities as follows:
|
|
|
|
|
the net present values of its interest rate sensitive exposures
resulting from a 10% change (increase or decrease) in interest
rates;
|
|
|
|
the U.S. dollar equivalent estimated fair values of the
Companys foreign currency exposures due to a 10% change
(increase or decrease) in foreign currency exchange
rates; and
|
|
|
|
the estimated fair value of its equity positions due to a 10%
change (increase or decrease) in equity market prices.
|
The sensitivity analysis is an estimate and should not be viewed
as predictive of the Companys future financial
performance. The Company cannot ensure that its actual losses in
any particular year will not exceed the amounts indicated in the
table below. Limitations related to this sensitivity analysis
include:
|
|
|
|
|
the market risk information is limited by the assumptions and
parameters established in creating the related sensitivity
analysis, including the impact of prepayment rates on mortgages;
|
|
|
|
the derivatives that qualify as hedges, the impact on reported
earnings may be materially different from the change in market
values;
|
|
|
|
the analysis excludes other significant real estate holdings and
liabilities pursuant to insurance contracts; and
|
|
|
|
the model assumes that the composition of assets and liabilities
remains unchanged throughout the year.
|
Accordingly, the Company uses such models as tools and not as
substitutes for the experience and judgment of its management.
Based on its analysis of the impact of a 10% change (increase or
decrease) in market rates and prices, MetLife has determined
that such a change could have a material adverse effect on the
estimated fair value of certain assets and liabilities from
interest rate, foreign currency exchange rate and equity
exposures.
241
The table below illustrates the potential loss in estimated fair
value for each market risk exposure of the Companys market
sensitive assets and liabilities at December 31, 2008:
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
(In millions)
|
|
|
Non-trading:
|
|
|
|
|
Interest rate risk
|
|
$
|
4,695
|
|
Foreign currency exchange rate risk
|
|
$
|
522
|
|
Equity price risk
|
|
$
|
176
|
|
Trading:
|
|
|
|
|
Interest rate risk
|
|
$
|
4
|
|
Foreign currency exchange rate risk
|
|
$
|
4
|
|
242
Sensitivity Analysis; Interest Rates. The
table below provides additional detail regarding the potential
loss in fair value of the Companys trading and non-trading
interest sensitive financial instruments at December 31,
2008 by type of asset or liability:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
|
|
|
|
|
|
Assuming a
|
|
|
|
|
|
|
|
|
|
10% Increase
|
|
|
|
Notional
|
|
|
Estimated
|
|
|
in the Yield
|
|
|
|
Amount
|
|
|
Fair Value(3)
|
|
|
Curve
|
|
|
|
(In millions)
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities
|
|
|
|
|
|
$
|
188,251
|
|
|
$
|
(2,814
|
)
|
Equity securities
|
|
|
|
|
|
|
3,197
|
|
|
|
|
|
Trading securities
|
|
|
|
|
|
|
946
|
|
|
|
(4
|
)
|
Mortgage and consumer loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
Held-for-investment
|
|
|
|
|
|
|
48,133
|
|
|
|
(155
|
)
|
Held-for-sale
|
|
|
|
|
|
|
2,010
|
|
|
|
(6
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage and consumer loans, net
|
|
|
|
|
|
|
50,143
|
|
|
|
(161
|
)
|
Policy loans
|
|
|
|
|
|
|
11,952
|
|
|
|
(146
|
)
|
Real estate joint ventures (1)
|
|
|
|
|
|
|
176
|
|
|
|
|
|
Other limited partnership interests (1)
|
|
|
|
|
|
|
2,269
|
|
|
|
|
|
Short-term investments
|
|
|
|
|
|
|
13,878
|
|
|
|
(3
|
)
|
Other invested assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage servicing rights
|
|
|
|
|
|
|
191
|
|
|
|
(2
|
)
|
Other
|
|
|
|
|
|
|
900
|
|
|
|
(7
|
)
|
Cash and cash equivalents
|
|
|
|
|
|
|
24,207
|
|
|
|
|
|
Accrued investment income
|
|
|
|
|
|
|
3,061
|
|
|
|
|
|
Premiums and other receivables
|
|
|
|
|
|
|
3,473
|
|
|
|
(216
|
)
|
Other assets
|
|
|
|
|
|
|
629
|
|
|
|
(49
|
)
|
Assets of subsidiaries held-for-sale
|
|
|
|
|
|
|
649
|
|
|
|
(6
|
)
|
Net embedded derivatives within asset host contracts (2)
|
|
|
|
|
|
|
205
|
|
|
|
(19
|
)
|
Mortgage loan commitments
|
|
$
|
2,690
|
|
|
|
(129
|
)
|
|
|
(6
|
)
|
Commitments to fund bank credit facilities, bridge loans and
private corporate bond investments
|
|
|
979
|
|
|
|
(105
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
|
|
|
|
|
|
|
|
$
|
(3,433
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder account balances
|
|
|
|
|
|
$
|
102,902
|
|
|
$
|
878
|
|
Short-term debt
|
|
|
|
|
|
|
2,659
|
|
|
|
|
|
Long-term debt
|
|
|
|
|
|
|
8,155
|
|
|
|
143
|
|
Collateral financing arrangements
|
|
|
|
|
|
|
1,880
|
|
|
|
|
|
Junior subordinated debt securities
|
|
|
|
|
|
|
2,606
|
|
|
|
30
|
|
Payables for collateral under securities loaned and other
transactions
|
|
|
|
|
|
|
31,059
|
|
|
|
|
|
Other liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading liabilities
|
|
|
|
|
|
|
57
|
|
|
|
|
|
Other
|
|
|
|
|
|
|
638
|
|
|
|
|
|
Liabilities of subsidiaries held-for-sale
|
|
|
|
|
|
|
49
|
|
|
|
|
|
Net embedded derivatives within liability host contracts (2)
|
|
|
|
|
|
|
3,051
|
|
|
|
216
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
|
|
|
|
|
|
|
$
|
1,267
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative instruments (designated hedges or otherwise)
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate swaps
|
|
$
|
34,060
|
|
|
$
|
3,149
|
|
|
$
|
(550
|
)
|
Interest rate floors
|
|
|
48,517
|
|
|
|
1,748
|
|
|
|
(173
|
)
|
Interest rate caps
|
|
|
24,643
|
|
|
|
11
|
|
|
|
4
|
|
Financial futures
|
|
|
19,908
|
|
|
|
(160
|
)
|
|
|
(1,565
|
)
|
Foreign currency swaps
|
|
|
19,438
|
|
|
|
87
|
|
|
|
(46
|
)
|
Foreign currency forwards
|
|
|
5,167
|
|
|
|
24
|
|
|
|
1
|
|
Options
|
|
|
8,450
|
|
|
|
3,127
|
|
|
|
(199
|
)
|
Financial forwards
|
|
|
28,176
|
|
|
|
296
|
|
|
|
(5
|
)
|
Credit default swaps
|
|
|
5,219
|
|
|
|
83
|
|
|
|
|
|
Synthetic GICs
|
|
|
4,260
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
250
|
|
|
|
(101
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other
|
|
|
|
|
|
|
|
|
|
$
|
(2,533
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change
|
|
|
|
|
|
|
|
|
|
$
|
(4,699
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
243
|
|
|
(1) |
|
Represents only those investments accounted for using the cost
method. |
|
(2) |
|
Embedded derivatives are recognized in the consolidated balance
sheet in the same caption as the host contract. |
|
(3) |
|
Separate account assets and liabilities which are interest rate
sensitive are not included herein as any interest rate risk is
borne by the holder of the separate account. |
This quantitative measure of risk has decreased by
$489 million, or approximately 9%, to $4,699 million
at December 31, 2008 from $5,188 million at
December 31, 2007. From December 31, 2007 to
December 31, 2008 there was a decline in interest rates
across both the swaps and treasury curves which resulted in a
decrease in the interest rate risk by $2,860 million. In
addition, the interest rate risk declined by $755 million
due to a reduction in the asset base and by $414 million
due to the completion of the Companys split-off of its 52%
ownership in RGA. A change in the method of estimating the fair
value of liabilities in connection with the adoption of
SFAS 157 further reduced the interest rate risk by
$254 million. Partially offsetting the decline was an
increase in the interest rate risk from the use of derivatives
employed by the Company by $2,151 million, primarily
related to financial futures and interest rate swaps. Changes in
the duration of the Companys portfolio also attributed
$1,312 million to partially offset the decline in interest
rate risk. The inclusion of certain reinsurance recoverables
within premiums and other receivables also increased the
interest rate risk by $216 million. The remainder of the
fluctuation is attributable to numerous immaterial items.
In addition to the analysis above, as part of its asset
liability management program, the Company also performs an
analysis of the sensitivity to changes in interest rates,
including both insurance liabilities and financial instruments.
At December 31, 2008, a hypothetical instantaneous 10%
decrease in interest rates applied to the Companys
liabilities, insurance and associated asset portfolios would
reduce the estimated fair value of equity by $962 million.
244
Sensitivity Analysis; Foreign Currency Exchange
Rates. The table below provides additional detail
regarding the potential loss in estimated fair value of the
Companys portfolio due to a 10% change in foreign currency
exchange rates at December 31, 2008 by type of asset or
liability:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
|
|
|
|
|
|
Assuming a
|
|
|
|
|
|
|
|
|
|
10% Increase
|
|
|
|
Notional
|
|
|
Estimated
|
|
|
in the Foreign
|
|
|
|
Amount
|
|
|
Fair Value(1)
|
|
|
Exchange Rate
|
|
|
|
(In millions)
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities
|
|
|
|
|
|
$
|
188,251
|
|
|
$
|
(1,586
|
)
|
Trading securities
|
|
|
|
|
|
|
946
|
|
|
|
(4
|
)
|
Mortgage and consumer loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
Held-for-investment
|
|
|
|
|
|
|
48,133
|
|
|
|
(311
|
)
|
Held-for-sale
|
|
|
|
|
|
|
2,010
|
|
|
|
(13
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage and consumer loans, net
|
|
|
|
|
|
|
50,143
|
|
|
|
(324
|
)
|
Policy loans
|
|
|
|
|
|
|
11,952
|
|
|
|
(40
|
)
|
Short-term investments
|
|
|
|
|
|
|
13,878
|
|
|
|
(69
|
)
|
Cash and cash equivalents
|
|
|
|
|
|
|
24,207
|
|
|
|
(90
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
|
|
|
|
|
|
|
|
$
|
(2,113
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder account balances
|
|
|
|
|
|
$
|
102,902
|
|
|
$
|
1,426
|
|
Long-term debt
|
|
|
|
|
|
|
8,155
|
|
|
|
60
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
|
|
|
|
|
|
|
$
|
1,486
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative instruments (designated hedges or otherwise)
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate swaps
|
|
$
|
34,060
|
|
|
$
|
3,149
|
|
|
$
|
(18
|
)
|
Interest rate floors
|
|
|
48,517
|
|
|
|
1,748
|
|
|
|
|
|
Interest rate caps
|
|
|
24,643
|
|
|
|
11
|
|
|
|
|
|
Financial futures
|
|
|
19,908
|
|
|
|
(160
|
)
|
|
|
2
|
|
Foreign currency swaps
|
|
|
19,438
|
|
|
|
87
|
|
|
|
(26
|
)
|
Foreign currency forwards
|
|
|
5,167
|
|
|
|
24
|
|
|
|
239
|
|
Options
|
|
|
8,450
|
|
|
|
3,127
|
|
|
|
(90
|
)
|
Financial forwards
|
|
|
28,176
|
|
|
|
296
|
|
|
|
(6
|
)
|
Credit default swaps
|
|
|
5,219
|
|
|
|
83
|
|
|
|
|
|
Synthetic GICs
|
|
|
4,260
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
250
|
|
|
|
(101
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other
|
|
|
|
|
|
|
|
|
|
$
|
101
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change
|
|
|
|
|
|
|
|
|
|
$
|
(526
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Estimated fair value presented in the table above represents the
estimated fair value of all financial instruments within this
financial statement caption not necessarily those solely subject
to foreign exchange risk. |
Foreign currency exchange rate risk decreased by
$185 million, or 26%, to $526 million at
December 31, 2008 from $711 million at
December 31, 2007. From December 31, 2007 to
December 31, 2008 a decline in the exchange rate of the
Euro, British pound, the Mexican and Chilean pesos versus the
U.S. Dollar resulted in the decline of the foreign currency
exchange risk on fixed maturity securities by $446 million.
Partially offsetting the decline in
245
foreign currency exchange risk was the exclusion of certain
items due to the completion of the Companys split-off of
its 52% ownership in RGA which accounted for $296 million
reduction to the foreign currency risk. In addition, the foreign
currency exchange risk associated with long-term debt declined
by $80 million due the weakening of the British pound
against the U.S. dollar. The remainder of the fluctuation
is attributable to numerous immaterial items.
Sensitivity Analysis; Equity Prices. The table
below provides additional detail regarding the potential loss in
estimated fair value of the Companys portfolio due to a
10% change in equity at December 31, 2008 by type of asset
or liability:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
|
|
|
|
|
|
Assuming a
|
|
|
|
|
|
|
|
|
|
10% Increase
|
|
|
|
Notional
|
|
|
Estimated
|
|
|
in Equity
|
|
|
|
Amount
|
|
|
Fair Value(1)
|
|
|
Prices
|
|
|
|
(In millions)
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities
|
|
|
|
|
|
$
|
3,197
|
|
|
$
|
218
|
|
Net embedded derivatives within asset host contracts (2)
|
|
|
|
|
|
|
205
|
|
|
|
(15
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
|
|
|
|
|
|
|
|
$
|
203
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder account balances
|
|
|
|
|
|
$
|
102,902
|
|
|
$
|
121
|
|
Net embedded derivatives within liability host contracts (2)
|
|
|
|
|
|
|
3,051
|
|
|
|
240
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
|
|
|
|
|
|
|
$
|
361
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative instruments (designated hedges or otherwise)
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate swaps
|
|
$
|
34,060
|
|
|
$
|
3,149
|
|
|
|
|
|
Interest rate floors
|
|
|
48,517
|
|
|
|
1,748
|
|
|
|
|
|
Interest rate caps
|
|
|
24,643
|
|
|
|
11
|
|
|
|
|
|
Financial futures
|
|
|
19,908
|
|
|
|
(160
|
)
|
|
|
(626
|
)
|
Foreign currency swaps
|
|
|
19,438
|
|
|
|
87
|
|
|
|
|
|
Foreign currency forwards
|
|
|
5,167
|
|
|
|
24
|
|
|
|
|
|
Options
|
|
|
8,450
|
|
|
|
3,127
|
|
|
|
(137
|
)
|
Financial forwards
|
|
|
28,176
|
|
|
|
296
|
|
|
|
3
|
|
Credit default swaps
|
|
|
5,219
|
|
|
|
83
|
|
|
|
|
|
Synthetic GICs
|
|
|
4,260
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
250
|
|
|
|
(101
|
)
|
|
|
20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other
|
|
|
|
|
|
|
|
|
|
$
|
(740
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change
|
|
|
|
|
|
|
|
|
|
$
|
(176
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Estimated fair value presented in the table above represents the
estimated fair value of all financial instruments within this
financial statement caption not necessarily those solely subject
to equity price risk. |
|
(2) |
|
Embedded derivatives are recognized in the consolidated balance
sheet in the same caption as the host contract. |
Equity price risk increased by $80 million, or 83%, to
$176 million at December 31, 2008 from
$96 million at December 31, 2007. The increase was
primarily attributed to the increased use of equity derivatives
employed by the Company to hedge its equity exposures,
particularly the use of financial futures and options. An
increase in liabilities, particularly variable annuities with
guaranteed minimum benefit riders, during 2008 partially offset
the increase in equity price risk.
246
|
|
Item 8.
|
Financial
Statements and Supplementary Data
|
Index to
Consolidated Financial Statements and Schedules
|
|
|
|
|
|
|
Page
|
|
|
|
|
|
F-1
|
|
Financial Statements at December 31, 2008 and 2007 and for
the Years Ended December 31, 2008, 2007 and 2006:
|
|
|
|
|
|
|
|
F-2
|
|
|
|
|
F-3
|
|
|
|
|
F-4
|
|
|
|
|
F-5
|
|
|
|
|
F-7
|
|
Financial Statement Schedules at December 31, 2008 and 2007
and for the Years Ended December 31, 2008, 2007 and 2006:
|
|
|
|
|
|
|
|
F-165
|
|
|
|
|
F-166
|
|
|
|
|
F-181
|
|
|
|
|
F-183
|
|
247
Report of
Independent Registered Public Accounting Firm
To the Board of Directors and Stockholders of
MetLife, Inc.:
We have audited the accompanying consolidated balance sheets of
MetLife, Inc. and subsidiaries (the Company) as of
December 31, 2008 and 2007, and the related consolidated
statements of income, stockholders equity, and cash flows
for each of the three years in the period ended
December 31, 2008. Our audits also included the financial
statement schedules listed in the Index to Consolidated
Financial Statements and Schedules. These consolidated financial
statements and financial statement schedules are the
responsibility of the Companys management. Our
responsibility is to express an opinion on the consolidated
financial statements and financial statement schedules based on
our audits.
We conducted our audits in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the consolidated financial
statements are free of material misstatement. An audit includes
examining, on a test basis, evidence supporting the amounts and
disclosures in the consolidated financial statements. An audit
also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating
the overall financial statement presentation. We believe that
our audits provide a reasonable basis for our opinion.
In our opinion, such consolidated financial statements present
fairly, in all material respects, the financial position of
MetLife, Inc. and subsidiaries as of December 31, 2008 and
2007, and the results of their operations and their cash flows
for each of the three years in the period ended
December 31, 2008, in conformity with accounting principles
generally accepted in the United States of America. Also, in our
opinion, such financial statement schedules, when considered in
relation to the basic consolidated financial statements taken as
a whole, present fairly, in all material respects, the
information set forth therein.
As discussed in Note 1, the Company changed its method of
accounting for certain assets and liabilities to a fair value
measurement approach as required by accounting guidance adopted
on January 1, 2008, and changed its method of accounting
for deferred acquisition costs and for income taxes as required
by accounting guidance adopted on January 1, 2007.
We have also audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), the
Companys internal control over financial reporting as of
December 31, 2008, based on the criteria established in
Internal Control Integrated Framework issued
by the Committee of Sponsoring Organizations of the Treadway
Commission, and our report, dated February 26, 2009,
expressed an unqualified opinion on the Companys internal
control over financial reporting.
/s/ DELOITTE & TOUCHE LLP
DELOITTE & TOUCHE LLP
New York, New York
February 26, 2009
F-1
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
Assets
|
|
|
|
|
|
|
|
|
Investments:
|
|
|
|
|
|
|
|
|
Fixed maturity securities available-for-sale, at estimated fair
value (amortized cost: $209,508 and $229,354, respectively)
|
|
$
|
188,251
|
|
|
$
|
232,336
|
|
Equity securities available-for-sale, at estimated fair value
(cost: $4,131 and $5,732, respectively)
|
|
|
3,197
|
|
|
|
5,911
|
|
Trading securities, at estimated fair value (cost: $1,107 and
$768, respectively)
|
|
|
946
|
|
|
|
779
|
|
Mortgage and consumer loans:
|
|
|
|
|
|
|
|
|
Held-for-investment, at amortized cost (net of allowances for
loan losses of $304 and $197, respectively)
|
|
|
49,352
|
|
|
|
46,149
|
|
Held-for-sale, principally at estimated fair value
|
|
|
2,012
|
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
Mortgage and consumer loans, net
|
|
|
51,364
|
|
|
|
46,154
|
|
Policy loans
|
|
|
9,802
|
|
|
|
9,326
|
|
Real estate and real estate joint ventures held-for-investment
|
|
|
7,585
|
|
|
|
6,728
|
|
Real estate held-for-sale
|
|
|
1
|
|
|
|
39
|
|
Other limited partnership interests
|
|
|
6,039
|
|
|
|
6,155
|
|
Short-term investments
|
|
|
13,878
|
|
|
|
2,544
|
|
Other invested assets
|
|
|
17,248
|
|
|
|
8,076
|
|
|
|
|
|
|
|
|
|
|
Total investments
|
|
|
298,311
|
|
|
|
318,048
|
|
Cash and cash equivalents
|
|
|
24,207
|
|
|
|
9,961
|
|
Accrued investment income
|
|
|
3,061
|
|
|
|
3,545
|
|
Premiums and other receivables
|
|
|
16,973
|
|
|
|
13,373
|
|
Deferred policy acquisition costs and value of business acquired
|
|
|
20,144
|
|
|
|
17,810
|
|
Current income tax recoverable
|
|
|
|
|
|
|
334
|
|
Deferred income tax assets
|
|
|
4,927
|
|
|
|
|
|
Goodwill
|
|
|
5,008
|
|
|
|
4,814
|
|
Other assets
|
|
|
7,262
|
|
|
|
8,239
|
|
Assets of subsidiaries held-for-sale
|
|
|
946
|
|
|
|
22,883
|
|
Separate account assets
|
|
|
120,839
|
|
|
|
160,142
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
501,678
|
|
|
$
|
559,149
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and Stockholders Equity
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
Future policy benefits
|
|
$
|
130,555
|
|
|
$
|
126,016
|
|
Policyholder account balances
|
|
|
149,805
|
|
|
|
130,342
|
|
Other policyholder funds
|
|
|
7,762
|
|
|
|
7,838
|
|
Policyholder dividends payable
|
|
|
1,023
|
|
|
|
991
|
|
Policyholder dividend obligation
|
|
|
|
|
|
|
789
|
|
Short-term debt
|
|
|
2,659
|
|
|
|
667
|
|
Long-term debt
|
|
|
9,667
|
|
|
|
9,100
|
|
Collateral financing arrangements
|
|
|
5,192
|
|
|
|
4,882
|
|
Junior subordinated debt securities
|
|
|
3,758
|
|
|
|
4,075
|
|
Current income tax payable
|
|
|
342
|
|
|
|
|
|
Deferred income tax liability
|
|
|
|
|
|
|
1,502
|
|
Payables for collateral under securities loaned and other
transactions
|
|
|
31,059
|
|
|
|
44,136
|
|
Other liabilities
|
|
|
14,535
|
|
|
|
12,829
|
|
Liabilities of subsidiaries held-for-sale
|
|
|
748
|
|
|
|
20,661
|
|
Separate account liabilities
|
|
|
120,839
|
|
|
|
160,142
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
477,944
|
|
|
|
523,970
|
|
|
|
|
|
|
|
|
|
|
Contingencies, Commitments and Guarantees (Note 16)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity:
|
|
|
|
|
|
|
|
|
Preferred stock, par value $0.01 per share;
200,000,000 shares authorized; 84,000,000 shares
issued and outstanding; $2,100 aggregate liquidation preference
|
|
|
1
|
|
|
|
1
|
|
Common stock, par value $0.01 per share;
3,000,000,000 shares authorized; 798,016,664 and
786,766,664 shares issued at December 31, 2008 and
2007, respectively; 793,629,070 and 729,223,440 shares
outstanding at December 31, 2008 and 2007, respectively
|
|
|
8
|
|
|
|
8
|
|
Additional paid-in capital
|
|
|
15,811
|
|
|
|
17,098
|
|
Retained earnings
|
|
|
22,403
|
|
|
|
19,884
|
|
Treasury stock, at cost; 4,387,594 and 57,543,224 shares at
December 31, 2008 and 2007, respectively
|
|
|
(236
|
)
|
|
|
(2,890
|
)
|
Accumulated other comprehensive income (loss)
|
|
|
(14,253
|
)
|
|
|
1,078
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
23,734
|
|
|
|
35,179
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity
|
|
$
|
501,678
|
|
|
$
|
559,149
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to the consolidated financial statements.
F-2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
25,914
|
|
|
$
|
22,970
|
|
|
$
|
22,052
|
|
Universal life and investment-type product policy fees
|
|
|
5,381
|
|
|
|
5,238
|
|
|
|
4,711
|
|
Net investment income
|
|
|
16,296
|
|
|
|
18,063
|
|
|
|
16,247
|
|
Other revenues
|
|
|
1,586
|
|
|
|
1,465
|
|
|
|
1,301
|
|
Net investment gains (losses)
|
|
|
1,812
|
|
|
|
(578
|
)
|
|
|
(1,382
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
50,989
|
|
|
|
47,158
|
|
|
|
42,929
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims
|
|
|
27,437
|
|
|
|
23,783
|
|
|
|
22,869
|
|
Interest credited to policyholder account balances
|
|
|
4,787
|
|
|
|
5,461
|
|
|
|
4,899
|
|
Policyholder dividends
|
|
|
1,751
|
|
|
|
1,723
|
|
|
|
1,698
|
|
Other expenses
|
|
|
11,924
|
|
|
|
10,429
|
|
|
|
9,537
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
45,899
|
|
|
|
41,396
|
|
|
|
39,003
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before provision for income tax
|
|
|
5,090
|
|
|
|
5,762
|
|
|
|
3,926
|
|
Provision for income tax
|
|
|
1,580
|
|
|
|
1,660
|
|
|
|
1,016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
3,510
|
|
|
|
4,102
|
|
|
|
2,910
|
|
Income (loss) from discontinued operations, net of income tax
|
|
|
(301
|
)
|
|
|
215
|
|
|
|
3,383
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
3,209
|
|
|
|
4,317
|
|
|
|
6,293
|
|
Preferred stock dividends
|
|
|
125
|
|
|
|
137
|
|
|
|
134
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common shareholders
|
|
$
|
3,084
|
|
|
$
|
4,180
|
|
|
$
|
6,159
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations available to common
shareholders per common share
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
4.60
|
|
|
$
|
5.33
|
|
|
$
|
3.65
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
4.54
|
|
|
$
|
5.20
|
|
|
$
|
3.60
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common shareholders per common share
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
4.19
|
|
|
$
|
5.62
|
|
|
$
|
8.09
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
4.14
|
|
|
$
|
5.48
|
|
|
$
|
7.99
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash dividends per common share
|
|
$
|
0.74
|
|
|
$
|
0.74
|
|
|
$
|
0.59
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to the consolidated financial statements.
F-3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
|
|
|
Foreign
|
|
|
Defined
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional
|
|
|
|
|
|
Treasury
|
|
|
Unrealized
|
|
|
Currency
|
|
|
Benefit
|
|
|
|
|
|
|
Preferred
|
|
|
Common
|
|
|
Paid-in
|
|
|
Retained
|
|
|
Stock
|
|
|
Investment
|
|
|
Translation
|
|
|
Plans
|
|
|
|
|
|
|
Stock
|
|
|
Stock
|
|
|
Capital
|
|
|
Earnings
|
|
|
at Cost
|
|
|
Gains (Losses)
|
|
|
Adjustments
|
|
|
Adjustment
|
|
|
Total
|
|
|
Balance at January 1, 2006
|
|
$
|
1
|
|
|
$
|
8
|
|
|
$
|
17,274
|
|
|
$
|
10,865
|
|
|
$
|
(959
|
)
|
|
$
|
1,942
|
|
|
$
|
11
|
|
|
$
|
(41
|
)
|
|
$
|
29,101
|
|
Treasury stock transactions, net
|
|
|
|
|
|
|
|
|
|
|
180
|
|
|
|
|
|
|
|
(398
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(218
|
)
|
Dividends on preferred stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(134
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(134
|
)
|
Dividends on common stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(450
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(450
|
)
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,293
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,293
|
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized gains (losses) on derivative instruments, net of
income tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(43
|
)
|
|
|
|
|
|
|
|
|
|
|
(43
|
)
|
Unrealized investment gains (losses), net of related offsets and
income tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(35
|
)
|
|
|
|
|
|
|
|
|
|
|
(35
|
)
|
Foreign currency translation adjustments, net of income tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
46
|
|
|
|
|
|
|
|
46
|
|
Additional minimum pension liability adjustment, net of income
tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(18
|
)
|
|
|
(18
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(50
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,243
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adoption of SFAS 158, net of income tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(744
|
)
|
|
|
(744
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2006
|
|
|
1
|
|
|
|
8
|
|
|
|
17,454
|
|
|
|
16,574
|
|
|
|
(1,357
|
)
|
|
|
1,864
|
|
|
|
57
|
|
|
|
(803
|
)
|
|
|
33,798
|
|
Cumulative effect of changes in accounting principles, net of
income tax (Note 1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(329
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(329
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at January 1, 2007
|
|
|
1
|
|
|
|
8
|
|
|
|
17,454
|
|
|
|
16,245
|
|
|
|
(1,357
|
)
|
|
|
1,864
|
|
|
|
57
|
|
|
|
(803
|
)
|
|
|
33,469
|
|
Treasury stock transactions, net
|
|
|
|
|
|
|
|
|
|
|
94
|
|
|
|
|
|
|
|
(1,533
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,439
|
)
|
Obligation under accelerated common stock repurchase agreement
(Note 18)
|
|
|
|
|
|
|
|
|
|
|
(450
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(450
|
)
|
Dividends on preferred stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(137
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(137
|
)
|
Dividends on common stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(541
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(541
|
)
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,317
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,317
|
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized gains (losses) on derivative instruments, net of
income tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(40
|
)
|
|
|
|
|
|
|
|
|
|
|
(40
|
)
|
Unrealized investment gains (losses), net of related offsets and
income tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(853
|
)
|
|
|
|
|
|
|
|
|
|
|
(853
|
)
|
Foreign currency translation adjustments, net of income tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
290
|
|
|
|
|
|
|
|
290
|
|
Defined benefit plans adjustment, net of income tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
563
|
|
|
|
563
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(40
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,277
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2007
|
|
|
1
|
|
|
|
8
|
|
|
|
17,098
|
|
|
|
19,884
|
|
|
|
(2,890
|
)
|
|
|
971
|
|
|
|
347
|
|
|
|
(240
|
)
|
|
|
35,179
|
|
Cumulative effect of changes in accounting principles,
net of income tax (Note 1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27
|
|
|
|
|
|
|
|
(10
|
)
|
|
|
|
|
|
|
|
|
|
|
17
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at January 1, 2008
|
|
|
1
|
|
|
|
8
|
|
|
|
17,098
|
|
|
|
19,911
|
|
|
|
(2,890
|
)
|
|
|
961
|
|
|
|
347
|
|
|
|
(240
|
)
|
|
|
35,196
|
|
Common stock issuance newly issued shares
|
|
|
|
|
|
|
|
|
|
|
290
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
290
|
|
Treasury stock transactions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquired in connection with share repurchase agreements
(Note 18)
|
|
|
|
|
|
|
|
|
|
|
450
|
|
|
|
|
|
|
|
(1,250
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(800
|
)
|
Issued in connection with common stock issuance
|
|
|
|
|
|
|
|
|
|
|
(2,104
|
)
|
|
|
|
|
|
|
4,040
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,936
|
|
Issued to settle stock forward contracts
|
|
|
|
|
|
|
|
|
|
|
(29
|
)
|
|
|
|
|
|
|
1,064
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,035
|
|
Acquired in connection with split-off of subsidiary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,318
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,318
|
)
|
Other, net
|
|
|
|
|
|
|
|
|
|
|
(35
|
)
|
|
|
|
|
|
|
118
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
83
|
|
Deferral of stock-based compensation
|
|
|
|
|
|
|
|
|
|
|
141
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
141
|
|
Dividends on preferred stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(125
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(125
|
)
|
Dividends on common stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(592
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(592
|
)
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,209
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,209
|
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized gains (losses) on derivative instruments, net of
income tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
241
|
|
|
|
|
|
|
|
|
|
|
|
241
|
|
Unrealized investment gains (losses), net of related offsets and
income tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(13,766
|
)
|
|
|
|
|
|
|
|
|
|
|
(13,766
|
)
|
Foreign currency translation adjustments, net of income tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(593
|
)
|
|
|
|
|
|
|
(593
|
)
|
Defined benefit plans adjustment, net of income tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,203
|
)
|
|
|
(1,203
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(15,321
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(12,112
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2008
|
|
$
|
1
|
|
|
$
|
8
|
|
|
$
|
15,811
|
|
|
$
|
22,403
|
|
|
$
|
(236
|
)
|
|
$
|
(12,564
|
)
|
|
$
|
(246
|
)
|
|
$
|
(1,443
|
)
|
|
$
|
23,734
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to the consolidated financial statements.
F-4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Cash flows from operating activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
3,209
|
|
|
$
|
4,317
|
|
|
$
|
6,293
|
|
Adjustments to reconcile net income to net cash provided by
operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization expenses
|
|
|
375
|
|
|
|
457
|
|
|
|
394
|
|
Amortization of premiums and accretion of discounts associated
with investments, net
|
|
|
(939
|
)
|
|
|
(955
|
)
|
|
|
(618
|
)
|
(Gains) losses from sales of investments and businesses, net
|
|
|
(1,127
|
)
|
|
|
619
|
|
|
|
(3,492
|
)
|
Undistributed equity earnings of real estate joint ventures and
other limited partnership interests
|
|
|
679
|
|
|
|
(606
|
)
|
|
|
(459
|
)
|
Interest credited to policyholder account balances
|
|
|
4,912
|
|
|
|
5,790
|
|
|
|
5,246
|
|
Interest credited to bank deposits
|
|
|
166
|
|
|
|
200
|
|
|
|
193
|
|
Universal life and investment-type product policy fees
|
|
|
(5,462
|
)
|
|
|
(5,310
|
)
|
|
|
(4,779
|
)
|
Change in accrued investment income
|
|
|
428
|
|
|
|
(275
|
)
|
|
|
(315
|
)
|
Change in premiums and other receivables
|
|
|
(1,929
|
)
|
|
|
(283
|
)
|
|
|
(2,655
|
)
|
Change in deferred policy acquisition costs, net
|
|
|
545
|
|
|
|
(1,178
|
)
|
|
|
(1,317
|
)
|
Change in insurance-related liabilities
|
|
|
5,307
|
|
|
|
5,463
|
|
|
|
5,031
|
|
Change in trading securities
|
|
|
(418
|
)
|
|
|
200
|
|
|
|
(432
|
)
|
Change in residential mortgage loans held-for-sale, net
|
|
|
(1,946
|
)
|
|
|
|
|
|
|
|
|
Change in mortgage servicing rights
|
|
|
(185
|
)
|
|
|
|
|
|
|
|
|
Change in income tax payable
|
|
|
920
|
|
|
|
101
|
|
|
|
2,039
|
|
Change in other assets
|
|
|
5,737
|
|
|
|
582
|
|
|
|
1,665
|
|
Change in other liabilities
|
|
|
232
|
|
|
|
729
|
|
|
|
(202
|
)
|
Other, net
|
|
|
199
|
|
|
|
51
|
|
|
|
(38
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities
|
|
|
10,703
|
|
|
|
9,902
|
|
|
|
6,554
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales, maturities and repayments of:
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities
|
|
|
102,250
|
|
|
|
112,062
|
|
|
|
113,321
|
|
Equity securities
|
|
|
2,707
|
|
|
|
1,738
|
|
|
|
1,313
|
|
Mortgage and consumer loans
|
|
|
6,077
|
|
|
|
9,854
|
|
|
|
8,348
|
|
Real estate and real estate joint ventures
|
|
|
140
|
|
|
|
664
|
|
|
|
6,211
|
|
Other limited partnership interests
|
|
|
593
|
|
|
|
1,121
|
|
|
|
1,768
|
|
Purchases of:
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities
|
|
|
(86,874
|
)
|
|
|
(112,534
|
)
|
|
|
(129,644
|
)
|
Equity securities
|
|
|
(1,494
|
)
|
|
|
(2,883
|
)
|
|
|
(1,052
|
)
|
Mortgage and consumer loans
|
|
|
(10,096
|
)
|
|
|
(14,365
|
)
|
|
|
(13,472
|
)
|
Real estate and real estate joint ventures
|
|
|
(1,170
|
)
|
|
|
(2,228
|
)
|
|
|
(1,523
|
)
|
Other limited partnership interests
|
|
|
(1,643
|
)
|
|
|
(2,041
|
)
|
|
|
(1,915
|
)
|
Net change in short-term investments
|
|
|
(11,269
|
)
|
|
|
55
|
|
|
|
595
|
|
Additional consideration related to purchases of businesses
|
|
|
|
|
|
|
|
|
|
|
(115
|
)
|
Purchases of businesses, net of cash received of $314, $13 and
$0, respectively
|
|
|
(469
|
)
|
|
|
(43
|
)
|
|
|
|
|
(Payments) proceeds from sales of businesses, net of cash
disposed of $0, $763 and $0, respectively
|
|
|
(4
|
)
|
|
|
(694
|
)
|
|
|
48
|
|
Disposal of subsidiary
|
|
|
(313
|
)
|
|
|
|
|
|
|
|
|
Net change in other invested assets
|
|
|
(492
|
)
|
|
|
(1,020
|
)
|
|
|
(2,411
|
)
|
Net change in policy loans
|
|
|
(467
|
)
|
|
|
(190
|
)
|
|
|
(247
|
)
|
Other, net
|
|
|
(147
|
)
|
|
|
(140
|
)
|
|
|
(111
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
$
|
(2,671
|
)
|
|
$
|
(10,644
|
)
|
|
$
|
(18,886
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to the consolidated financial statements.
F-5
MetLife,
Inc.
Consolidated Statements of Cash Flows (Continued)
For the Years Ended December 31, 2008, 2007 and 2006
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Cash flows from financing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder account balances:
|
|
|
|
|
|
|
|
|
|
|
|
|
Deposits
|
|
$
|
76,963
|
|
|
$
|
58,025
|
|
|
$
|
53,946
|
|
Withdrawals
|
|
|
(61,134
|
)
|
|
|
(55,256
|
)
|
|
|
(50,574
|
)
|
Net change in short-term debt
|
|
|
1,992
|
|
|
|
(782
|
)
|
|
|
35
|
|
Long-term debt issued
|
|
|
339
|
|
|
|
726
|
|
|
|
284
|
|
Long-term debt repaid
|
|
|
(422
|
)
|
|
|
(286
|
)
|
|
|
(732
|
)
|
Collateral financing arrangements issued
|
|
|
310
|
|
|
|
4,882
|
|
|
|
850
|
|
Cash paid in connection with collateral financing arrangements
|
|
|
(800
|
)
|
|
|
|
|
|
|
|
|
Junior subordinated debt securities issued
|
|
|
750
|
|
|
|
694
|
|
|
|
1,248
|
|
Shares subject to mandatory redemption
|
|
|
|
|
|
|
(131
|
)
|
|
|
|
|
Debt issuance costs
|
|
|
(34
|
)
|
|
|
(14
|
)
|
|
|
(25
|
)
|
Net change in payables for collateral under securities loaned
and other transactions
|
|
|
(13,077
|
)
|
|
|
(1,710
|
)
|
|
|
11,331
|
|
Common stock issued, net of issuance costs
|
|
|
290
|
|
|
|
|
|
|
|
|
|
Stock options exercised
|
|
|
45
|
|
|
|
110
|
|
|
|
83
|
|
Treasury stock acquired in connection with share repurchase
agreements
|
|
|
(1,250
|
)
|
|
|
(1,705
|
)
|
|
|
(500
|
)
|
Treasury stock issued in connection with common stock issuance,
net of issuance costs
|
|
|
1,936
|
|
|
|
|
|
|
|
|
|
Treasury stock issued to settle stock forward contracts
|
|
|
1,035
|
|
|
|
|
|
|
|
|
|
Dividends on preferred stock
|
|
|
(125
|
)
|
|
|
(137
|
)
|
|
|
(134
|
)
|
Dividends on common stock
|
|
|
(592
|
)
|
|
|
(541
|
)
|
|
|
(450
|
)
|
Other, net
|
|
|
(38
|
)
|
|
|
67
|
|
|
|
12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by financing activities
|
|
|
6,188
|
|
|
|
3,942
|
|
|
|
15,374
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of change in foreign currency exchange rates on cash
balances
|
|
|
(349
|
)
|
|
|
61
|
|
|
|
47
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in cash and cash equivalents
|
|
|
13,871
|
|
|
|
3,261
|
|
|
|
3,089
|
|
Cash and cash equivalents, beginning of year
|
|
|
10,368
|
|
|
|
7,107
|
|
|
|
4,018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, end of year
|
|
$
|
24,239
|
|
|
$
|
10,368
|
|
|
$
|
7,107
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, subsidiaries held-for-sale, beginning
of year
|
|
$
|
407
|
|
|
$
|
170
|
|
|
$
|
133
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, subsidiaries held-for-sale, end of
year
|
|
$
|
32
|
|
|
$
|
407
|
|
|
$
|
170
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, from continuing operations, beginning
of year
|
|
$
|
9,961
|
|
|
$
|
6,937
|
|
|
$
|
3,885
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, from continuing operations, end of
year
|
|
$
|
24,207
|
|
|
$
|
9,961
|
|
|
$
|
6,937
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosures of cash flow information:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash paid during the year for:
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
|
|
$
|
1,107
|
|
|
$
|
1,011
|
|
|
$
|
819
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax
|
|
$
|
27
|
|
|
$
|
2,128
|
|
|
$
|
409
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-cash transactions during the year:
|
|
|
|
|
|
|
|
|
|
|
|
|
Business acquisitions:
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets acquired
|
|
$
|
2,083
|
|
|
$
|
|
|
|
$
|
|
|
Less: cash paid
|
|
|
(783
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities assumed
|
|
$
|
1,300
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disposal of subsidiary:
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets disposed
|
|
$
|
22,135
|
|
|
$
|
|
|
|
$
|
|
|
Less: liabilities disposed
|
|
|
(20,689
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net assets disposed
|
|
|
1,446
|
|
|
|
|
|
|
|
|
|
Add: cash disposed
|
|
|
270
|
|
|
|
|
|
|
|
|
|
Add: transaction costs, including cash paid of $43
|
|
|
60
|
|
|
|
|
|
|
|
|
|
Less: treasury stock received in common stock exchange
|
|
|
(1,318
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss on disposal of subsidiary
|
|
$
|
458
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Remarketing of debt securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities redeemed
|
|
$
|
32
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt issued
|
|
$
|
1,035
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Junior subordinated debt securities redeemed
|
|
$
|
1,067
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contribution of equity securities to MetLife Foundation
|
|
$
|
|
|
|
$
|
12
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities received in connection with insurance
contract commutation
|
|
$
|
115
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Real estate acquired in satisfaction of debt
|
|
$
|
1
|
|
|
$
|
1
|
|
|
$
|
6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to the consolidated financial statements.
F-6
MetLife,
Inc.
|
|
1.
|
Business,
Basis of Presentation, and Summary of Significant Accounting
Policies
|
Business
MetLife or the Company refers to
MetLife, Inc., a Delaware corporation incorporated in 1999 (the
Holding Company), and its subsidiaries, including
Metropolitan Life Insurance Company (MLIC). MetLife
is a leading provider of individual insurance, employee benefits
and financial services with operations throughout the United
States and the Latin America, Europe, and Asia Pacific regions.
Through its subsidiaries and affiliates, MetLife offers life
insurance, annuities, auto and home insurance, retail banking
and other financial services to individuals, as well as group
insurance and retirement & savings products and
services to corporations and other institutions.
Basis
of Presentation
The accompanying consolidated financial statements include the
accounts of the Holding Company and its subsidiaries as well as
partnerships and joint ventures in which the Company has
control. Closed block assets, liabilities, revenues and expenses
are combined on a
line-by-line
basis with the assets, liabilities, revenues and expenses
outside the closed block based on the nature of the particular
item. See Note 9. Intercompany accounts and transactions
have been eliminated.
In addition the Company has invested in certain structured
transactions that are variable interest entities
(VIEs) under Financial Accounting Standards Board
(FASB) Interpretation (FIN)
No. 46(r), Consolidation of Variable Interest
Entities An Interpretation of Accounting Research
Bulletin No. 51 (FIN 46(r)).
These structured transactions include reinsurance trusts,
asset-backed securitizations, trust preferred securities, joint
ventures, limited partnerships and limited liability companies.
The Company is required to consolidate those VIEs for which it
is deemed to be the primary beneficiary. The Company reconsiders
whether it is the primary beneficiary for investments designated
as VIEs on a quarterly basis.
The Company uses the equity method of accounting for investments
in equity securities in which it has more than a 20% interest
and for real estate joint ventures and other limited partnership
interests in which it has more than a minor equity interest or
more than a minor influence over the joint ventures or
partnerships operations, but does not have a controlling
interest and is not the primary beneficiary. The Company uses
the cost method of accounting for investments in real estate
joint ventures and other limited partnership interests in which
it has a minor equity investment and virtually no influence over
the joint ventures or the partnerships operations.
Minority interest related to consolidated entities included in
other liabilities was $251 million and $272 million at
December 31, 2008 and 2007, respectively. There was also
minority interest of $1.5 billion included in liabilities
of subsidiaries held-for-sale at December 31, 2007.
Certain amounts in the prior year periods consolidated
financial statements have been reclassified to conform with the
2008 presentation. Such reclassifications include
$61 million and $47 million for the years ended
December 31, 2007 and 2006, respectively, relating to the
effect of change in foreign currency exchange rates on cash
balances. These amounts were reclassified from cash flows from
operating activities in the consolidated statements of cash
flows for the years ended December 31, 2007 and 2006. See
also Note 23 for reclassifications related to discontinued
operations.
Summary
of Significant Accounting Policies and Critical Accounting
Estimates
The preparation of financial statements in conformity with
accounting principles generally accepted in the United States of
America (GAAP) requires management to adopt
accounting policies and make estimates and assumptions that
affect amounts reported in the consolidated financial
statements. The most critical estimates include those used in
determining:
|
|
|
|
(i)
|
the estimated fair value of investments in the absence of quoted
market values;
|
F-7
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
(ii)
|
investment impairments;
|
|
|
(iii)
|
the recognition of income on certain investment entities;
|
|
|
(iv)
|
the application of the consolidation rules to certain
investments;
|
|
|
(v)
|
the existence and estimated fair value of embedded derivatives
requiring bifurcation;
|
|
|
(vi)
|
the estimated fair value of and accounting for derivatives;
|
|
|
(vii)
|
the capitalization and amortization of deferred policy
acquisition costs (DAC) and the establishment and
amortization of value of business acquired (VOBA);
|
|
|
(viii)
|
the measurement of goodwill and related impairment, if any;
|
|
|
(ix)
|
the liability for future policyholder benefits;
|
|
|
(x)
|
accounting for income taxes and the valuation of deferred tax
assets;
|
|
|
(xi)
|
accounting for reinsurance transactions;
|
|
|
(xii)
|
accounting for employee benefit plans; and
|
|
|
(xiii)
|
the liability for litigation and regulatory matters.
|
A description of such critical estimates is incorporated within
the discussion of the related accounting policies which follow.
The application of purchase accounting requires the use of
estimation techniques in determining the fair values of assets
acquired and liabilities assumed the most
significant of which relate to the aforementioned critical
estimates. In applying these policies, management makes
subjective and complex judgments that frequently require
estimates about matters that are inherently uncertain. Many of
these policies, estimates and related judgments are common in
the insurance and financial services industries; others are
specific to the Companys businesses and operations. Actual
results could differ from these estimates.
Fair
Value
As described below, certain assets and liabilities are measured
at estimated fair value on the Companys consolidated
balance sheets. In addition, these footnotes to the consolidated
financial statements include disclosures of estimated fair
values. Effective January 1, 2008, the Company adopted
Statement of Financial Accounting Standards (SFAS)
No. 157, Fair Value Measurements
(SFAS 157). SFAS 157 defines fair value as
the price that would be received to sell an asset or paid to
transfer a liability (an exit price) in the principal or most
advantageous market for the asset or liability in an orderly
transaction between market participants on the measurement date.
In many cases, the exit price and the transaction (or entry)
price will be the same at initial recognition. However, in
certain cases, the transaction price may not represent fair
value. Under SFAS 157, fair value of a liability is based
on the amount that would be paid to transfer a liability to a
third party with the same credit standing. SFAS 157
requires that fair value be a market-based measurement in which
the fair value is determined based on a hypothetical transaction
at the measurement date, considered from the perspective of a
market participant. When quoted prices are not used to determine
fair value, SFAS 157 requires consideration of three broad
valuation techniques: (i) the market approach,
(ii) the income approach, and (iii) the cost approach.
The approaches are not new, but SFAS 157 requires that
entities determine the most appropriate valuation technique to
use, given what is being measured and the availability of
sufficient inputs. SFAS 157 prioritizes the inputs to fair
valuation techniques and allows for the use of unobservable
inputs to the extent that observable inputs are not available.
The Company has categorized its assets and liabilities measured
at estimated fair value into a three-level hierarchy, based on
the priority of the inputs to the respective valuation
technique. The fair value hierarchy gives the highest priority
to quoted prices in active markets for identical assets or
liabilities (Level 1) and the lowest priority to
unobservable inputs (Level 3). An asset
F-8
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
or liabilitys classification within the fair value
hierarchy is based on the lowest level of significant input to
its valuation. SFAS 157 defines the input levels as follows:
|
|
|
|
Level 1
|
Unadjusted quoted prices in active markets for identical assets
or liabilities. The Company defines active markets based on
average trading volume for equity securities. The size of the
bid/ask spread is used as an indicator of market activity for
fixed maturity securities.
|
|
|
Level 2
|
Quoted prices in markets that are not active or inputs that are
observable either directly or indirectly. Level 2 inputs
include quoted prices for similar assets or liabilities other
than quoted prices in Level 1; quoted prices in markets
that are not active; or other inputs that are observable or can
be derived principally from or corroborated by observable market
data for substantially the full term of the assets or
liabilities.
|
|
|
Level 3
|
Unobservable inputs that are supported by little or no market
activity and are significant to the estimated fair value of the
assets or liabilities. Unobservable inputs reflect the reporting
entitys own assumptions about the assumptions that market
participants would use in pricing the asset or liability.
Level 3 assets and liabilities include financial
instruments whose values are determined using pricing models,
discounted cash flow methodologies, or similar techniques, as
well as instruments for which the determination of estimated
fair value requires significant management judgment or
estimation.
|
The measurement and disclosures under SFAS 157 in the
accompanying financial statements and footnotes exclude certain
items such as nonfinancial assets and nonfinancial liabilities
initially measured at estimated fair value in a business
combination, reporting units measured at estimated fair value in
the first step of a goodwill impairment test and
indefinite-lived intangible assets measured at estimated fair
value for impairment assessment. The effective date for these
items was deferred to January 1, 2009.
Prior to adoption of SFAS 157, estimated fair value was
determined based solely upon the perspective of the reporting
entity. Therefore, methodologies used to determine the estimated
fair value of certain financial instruments prior to
January 1, 2008, while being deemed appropriate under
existing accounting guidance, may not have produced an exit
value as defined in SFAS 157.
Investments
The Companys principal investments are in fixed maturity
and equity securities, trading securities, mortgage and consumer
loans, policy loans, real estate, real estate joint ventures and
other limited partnership interests, short-term investments, and
other invested assets. The accounting policies related to each
are as follows:
Fixed Maturity and Equity Securities. The
Companys fixed maturity and equity securities are
classified as available-for-sale, except for trading securities,
and are reported at their estimated fair value.
Unrealized investment gains and losses on these securities are
recorded as a separate component of other comprehensive income
(loss), net of policyholder related amounts and deferred income
taxes. All security transactions are recorded on a trade date
basis. Investment gains and losses on sales of securities are
determined on a specific identification basis.
Interest income on fixed maturity securities is recorded when
earned using an effective yield method giving effect to
amortization of premiums and accretion of discounts. Dividends
on equity securities are recorded when declared. These dividends
and interest income are recorded in net investment income.
Included within fixed maturity securities are loan-backed
securities including mortgage-backed and asset-backed
securities. Amortization of the premium or discount from the
purchase of these securities considers the estimated timing and
amount of prepayments of the underlying loans. Actual prepayment
experience is periodically reviewed and effective yields are
recalculated when differences arise between the prepayments
originally anticipated and the actual prepayments received and
currently anticipated. Prepayment
F-9
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
assumptions for single class and multi-class mortgage-backed and
asset-backed securities are estimated by management using inputs
obtained from third party specialists, including broker-dealers,
and based on managements knowledge of the current market.
For credit-sensitive mortgage-backed and asset-backed securities
and certain prepayment-sensitive securities, the effective yield
is recalculated on a prospective basis. For all other
mortgage-backed and asset-backed securities, the effective yield
is recalculated on a retrospective basis.
The cost or amortized cost of fixed maturity and equity
securities is adjusted for impairments in value deemed to be
other-than-temporary in the period in which the determination is
made. These impairments are included within net investment gains
(losses) and the cost basis of the fixed maturity and equity
securities is reduced accordingly. The Company does not change
the revised cost basis for subsequent recoveries in value.
The assessment of whether impairments have occurred is based on
managements
case-by-case
evaluation of the underlying reasons for the decline in
estimated fair value. The Companys review of its fixed
maturity and equity securities for impairments includes an
analysis of the total gross unrealized losses by three
categories of securities: (i) securities where the
estimated fair value had declined and remained below cost or
amortized cost by less than 20%; (ii) securities where the
estimated fair value had declined and remained below cost or
amortized cost by 20% or more for less than six months; and
(iii) securities where the estimated fair value had
declined and remained below cost or amortized cost by 20% or
more for six months or greater. An extended and severe
unrealized loss position on a fixed maturity security may not
have any impact on the ability of the issuer to service all
scheduled interest and principal payments and the Companys
evaluation of recoverability of all contractual cash flows, as
well as the Companys ability and intent to hold the
security, including holding the security until the earlier of a
recovery in value, or until maturity. In contrast, for certain
equity securities, greater weight and consideration are given by
the Company to a decline in market value and the likelihood such
market value decline will recover. See also Note 3.
Additionally, management considers a wide range of factors about
the security issuer and uses its best judgment in evaluating the
cause of the decline in the estimated fair value of the security
and in assessing the prospects for near-term recovery. Inherent
in managements evaluation of the security are assumptions
and estimates about the operations of the issuer and its future
earnings potential. Considerations used by the Company in the
impairment evaluation process include, but are not limited to:
(i) the length of time and the extent to which the market
value has been below cost or amortized cost; (ii) the
potential for impairments of securities when the issuer is
experiencing significant financial difficulties; (iii) the
potential for impairments in an entire industry sector or
sub-sector; (iv) the potential for impairments in certain
economically depressed geographic locations; (v) the
potential for impairments of securities where the issuer, series
of issuers or industry has suffered a catastrophic type of loss
or has exhausted natural resources; (vi) the Companys
ability and intent to hold the security for a period of time
sufficient to allow for the recovery of its value to an amount
equal to or greater than cost or amortized cost (See also
Note 3); (vii) unfavorable changes in forecasted cash
flows on mortgage-backed and asset-backed securities; and
(viii) other subjective factors, including concentrations
and information obtained from regulators and rating agencies.
In periods subsequent to the recognition of an
other-than-temporary impairment on a debt security, the Company
accounts for the impaired security as if it had been purchased
on the measurement date of the impairment. Accordingly, the
discount (or reduced premium) based on the new cost basis is
accreted into net investment income over the remaining term of
the debt security in a prospective manner based on the amount
and timing of estimated future cash flows.
The Company purchases and receives beneficial interests in
special purpose entities (SPEs), which enhance the
Companys total return on its investment portfolio
principally by providing equity-based returns on debt
securities. These investments are generally made through
structured notes and similar instruments (collectively,
Structured Investment Transactions). The Company has
not guaranteed the performance, liquidity or obligations of the
SPEs and its exposure to loss is limited to its carrying value
of the beneficial
F-10
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
interests in the SPEs. The Company does not consolidate such
SPEs as it has determined it is not the primary beneficiary.
These Structured Investment Transactions are included in fixed
maturity securities and their income is generally recognized
using the retrospective interest method. Impairments of these
investments are included in net investment gains (losses).
Trading Securities. The Companys trading
securities portfolio, principally consisting of fixed maturity
and equity securities, supports investment strategies that
involve the active and frequent purchase and sale of securities
and the execution of short sale agreements, and supports asset
and liability matching strategies for certain insurance
products. Trading securities and short sale agreement
liabilities are recorded at estimated fair value with subsequent
changes in estimated fair value recognized in net investment
income. Related dividends and investment income are also
included in net investment income.
Securities Lending. Securities loaned
transactions, whereby blocks of securities, which are included
in fixed maturity and equity securities, are loaned to third
parties, are treated as financing arrangements and the
associated liability is recorded at the amount of cash received.
The Company generally obtains collateral in an amount equal to
102% of the estimated fair value of the securities loaned. The
Company monitors the estimated fair value of the securities
loaned on a daily basis with additional collateral obtained as
necessary. Substantially all of the Companys securities
loaned transactions are with large brokerage firms and
commercial banks. Income and expenses associated with securities
loaned transactions are reported as investment income and
investment expense, respectively, within net investment income.
Mortgage and Consumer Loans. Mortgage and
consumer loans held-for-investment are stated at unpaid
principal balance, adjusted for any unamortized premium or
discount, deferred fees or expenses, net of valuation
allowances. Interest income is accrued on the principal amount
of the loan based on the loans contractual interest rate.
Amortization of premiums and discounts is recorded using the
effective yield method. Interest income, amortization of
premiums and discounts, and prepayment fees are reported in net
investment income. Loans are considered to be impaired when it
is probable that, based upon current information and events, the
Company will be unable to collect all amounts due under the
contractual terms of the loan agreement. Based on the facts and
circumstances of the individual loans being impaired, valuation
allowances are established for the excess carrying value of the
loan over either (i) the present value of expected future
cash flows discounted at the loans original effective
interest rate, (ii) the estimated fair value of the
loans underlying collateral if the loan is in the process
of foreclosure or otherwise collateral dependent, or
(iii) the loans estimated fair value. The Company
also establishes allowances for loan losses when a loss
contingency exists for pools of loans with similar
characteristics, such as mortgage loans based on similar
property types or loan to value risk factors. A loss contingency
exists when the likelihood that a future event will occur is
probable based on past events. Interest income earned on
impaired loans is accrued on the principal amount of the loan
based on the loans contractual interest rate. However,
interest ceases to be accrued for loans on which interest is
generally more than 60 days past due
and/or when
the collection of interest is not considered probable. Cash
receipts on such impaired loans are recorded as a reduction of
the recorded investment. Gains and losses from the sale of loans
and changes in valuation allowances are reported in net
investment gains (losses).
Mortgage loans held-for-sale primarily include residential
mortgages which are originated with the intent to sell and for
which the fair value option was elected. These loans are stated
at estimated fair value with subsequent changes in estimated
fair value recognized in other revenue. Certain other mortgage
loans previously designated as held-for-investment have been
designated as held-for-sale to reflect a change in the
Companys intention as it relates to holding such loans. At
the time of transfer, such loans are recorded at the lower of
amortized cost or estimated fair value less expected disposition
costs determined on an individual loan basis. Amortized cost is
determined in the same manner as for mortgage loans
held-for-investment described above. The amount by which
amortized cost exceeds estimated fair value less expected
disposition costs is accounted for as a valuation allowance.
Changes in such valuation allowance are recognized in net
investment gains (losses).
F-11
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Policy Loans. Policy loans are stated at
unpaid principal balances. Interest income on such loans is
recorded as earned using the contractually agreed upon interest
rate. Generally, interest is capitalized on the policys
anniversary date.
Real Estate. Real estate held-for-investment,
including related improvements, is stated at cost less
accumulated depreciation. Depreciation is provided on a
straight-line basis over the estimated useful life of the asset
(typically 20 to 55 years). Rental income is recognized on
a straight-line basis over the term of the respective leases.
The Company classifies a property as held-for-sale if it commits
to a plan to sell a property within one year and actively
markets the property in its current condition for a price that
is reasonable in comparison to its estimated fair value. The
Company classifies the results of operations and the gain or
loss on sale of a property that either has been disposed of or
classified as held-for-sale as discontinued operations, if the
ongoing operations of the property will be eliminated from the
ongoing operations of the Company and if the Company will not
have any significant continuing involvement in the operations of
the property after the sale. Real estate held-for-sale is stated
at the lower of depreciated cost or estimated fair value less
expected disposition costs. Real estate is not depreciated while
it is classified as held-for-sale. The Company periodically
reviews its properties held-for-investment for impairment and
tests properties for recoverability whenever events or changes
in circumstances indicate the carrying amount of the asset may
not be recoverable and the carrying value of the property
exceeds its estimated fair value. Properties whose carrying
values are greater than their undiscounted cash flows are
written down to their estimated fair value, with the impairment
loss included in net investment gains (losses). Impairment
losses are based upon the estimated fair value of real estate,
which is generally computed using the present value of expected
future cash flows from the real estate discounted at a rate
commensurate with the underlying risks. Real estate acquired
upon foreclosure of commercial and agricultural mortgage loans
is recorded at the lower of estimated fair value or the carrying
value of the mortgage loan at the date of foreclosure.
Real Estate Joint Ventures and Other Limited Partnership
Interests. The Company uses the equity method of
accounting for investments in real estate joint ventures and
other limited partnership interests consisting of leveraged
buy-out funds, hedge funds and other private equity funds in
which it has more than a minor equity interest or more than a
minor influence over the joint ventures or partnerships
operations, but does not have a controlling interest and is not
the primary beneficiary. The Company uses the cost method of
accounting for investments in real estate joint ventures and
other limited partnership interests in which it has a minor
equity investment and virtually no influence over the joint
ventures or the partnerships operations. The Company
reports the distributions from real estate joint ventures and
other limited partnership interests accounted for under the cost
method and equity in earnings from real estate joint ventures
and other limited partnership interests accounted for under the
equity method in net investment income. In addition to the
investees performing regular evaluations for the impairment of
underlying investments, the Company routinely evaluates its
investments in real estate joint ventures and other limited
partnerships for impairments. The Company considers its cost
method investments for other-than-temporary impairment when the
carrying value of real estate joint ventures and other limited
partnership interests exceeds the net asset value. The Company
takes into consideration the severity and duration of this
excess when deciding if the cost method investment is
other-than-temporarily impaired. For equity method investees,
the Company considers financial and other information provided
by the investee, other known information and inherent risks in
the underlying investments, as well as future capital
commitments, in determining whether an impairment has occurred.
When an other-than-temporary impairment is deemed to have
occurred, the Company records a realized capital loss within net
investment gains (losses) to record the investment at its
estimated fair value.
Short-term Investments. Short-term investments
include investments with remaining maturities of one year or
less, but greater than three months, at the time of acquisition
and are stated at amortized cost, which approximates estimated
fair value, or stated at estimated fair value, if available.
F-12
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Other Invested Assets. Other invested assets
consist principally of freestanding derivatives with positive
estimated fair values, leveraged leases, joint venture
investments, tax credit partnerships, funding agreements,
mortgage servicing rights, and funds withheld at interest.
Freestanding derivatives with positive estimated fair values are
more fully described in the derivatives accounting policy which
follows.
Leveraged leases are recorded net of non-recourse debt. The
Company participates in lease transactions which are diversified
by industry, asset type and geographic area. The Company
recognizes income on the leveraged leases by applying the
leveraged leases estimated rate of return to the net
investment in the lease. The Company regularly reviews residual
values and impairs them to expected values as needed.
Joint venture investments represent the Companys
investments in entities that engage in insurance underwriting
activities and are accounted for on the equity method. Tax
credit partnerships are established for the purpose of investing
in low-income housing and other social causes, where the primary
return on investment is in the form of tax credits and are also
accounted for on equity method. The Company reports the equity
in earnings of joint venture investments and tax credit
partnerships in net investment income.
Funding agreements represent arrangements where the Company has
long-term interest bearing amounts on deposit with third parties
and are generally stated at amortized cost.
Mortgage servicing rights (MSRs) are measured at
estimated fair value and are either acquired or are generated
from the sale of originated residential mortgage loans where the
servicing rights are retained by the Company. Changes in
estimated fair value of MSRs are reported in other revenues in
the period in which the change occurs.
Funds withheld represent amounts contractually withheld by
ceding companies in accordance with reinsurance agreements. The
Company records a funds withheld receivable rather than the
underlying investments. The Company recognizes interest on funds
withheld at rates defined by the terms of the agreement which
may be contractually specified or directly related to the
investment portfolio and records it in net investment income.
Estimates and Uncertainties. The
Companys investments are exposed to four primary sources
of risk: credit, interest rate, liquidity risk, and market
valuation. The financial statement risks, stemming from such
investment risks, are those associated with the determination of
estimated fair values, the diminished ability to sell certain
investments in times of strained market conditions, the
recognition of impairments, the recognition of income on certain
investments, and the potential consolidation of VIEs. The use of
different methodologies, assumptions and inputs relating to
these financial statement risks may have a material effect on
the amounts presented within the consolidated financial
statements.
When available, the estimated fair value of the Companys
fixed maturity and equity securities are based on quoted prices
in active markets that are readily and regularly obtainable.
Generally, these are the most liquid of the Companys
securities holdings and valuation of these securities does not
involve management judgment.
When quoted prices in active markets are not available, the
determination of estimated fair value is based on market
standard valuation methodologies. The market standard valuation
methodologies utilized include: discounted cash flow
methodologies, matrix pricing or other similar techniques. The
assumptions and inputs in applying these market standard
valuation methodologies include, but are not limited to:
interest rates, credit standing of the issuer or counterparty,
industry sector of the issuer, coupon rate, call provisions,
sinking fund requirements, maturity, estimated duration and
managements assumptions regarding liquidity and estimated
future cash flows. Accordingly, the estimated fair values are
based on available market information and managements
judgments about financial instruments.
F-13
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The significant inputs to the market standard valuation
methodologies for certain types of securities with reasonable
levels of price transparency are inputs that are observable in
the market or can be derived principally from or corroborated by
observable market data. Such observable inputs include
benchmarking prices for similar assets in active, liquid
markets, quoted prices in markets that are not active and
observable yields and spreads in the market.
When observable inputs are not available, the market standard
valuation methodologies for determining the estimated fair value
of certain types of securities that trade infrequently, and
therefore have little or no price transparency, rely on inputs
that are significant to the estimated fair value that are not
observable in the market or cannot be derived principally from
or corroborated by observable market data. These unobservable
inputs can be based in large part on management judgment or
estimation, and cannot be supported by reference to market
activity. Even though unobservable, these inputs are based on
assumptions deemed appropriate given the circumstances and
consistent with what other market participants would use when
pricing such securities.
The estimated fair value of residential mortgage loans
held-for-sale are determined based on observable pricing of
residential mortgage loans held-for-sale with similar
characteristics, or observable pricing for securities backed by
similar types of loans, adjusted to convert the securities
prices to loan prices. Generally, quoted market prices are not
available. When observable pricing for similar loans or
securities that are backed by similar loans are not available,
the estimated fair values of residential mortgage loans
held-for-sale are determined using independent broker
quotations, which is intended to approximate the amounts that
would be received from third parties. Certain other mortgages
have also been designated as held-for-sale which are recorded at
the lower of amortized cost or estimated fair value less
expected disposition costs determined on an individual loan
basis. For these loans, estimated fair value is determined using
independent broker quotations or, when the loan is in
foreclosure or otherwise determined to be collateral dependent,
the estimated fair value of the underlying collateral estimated
using internal models.
The estimated fair value of MSRs is principally determined
through the use of internal discounted cash flow models which
utilize various assumptions as to discount rates,
loan-prepayments, and servicing costs. The use of different
valuation assumptions and inputs as well as assumptions relating
to the collection of expected cash flows may have a material
effect on MSRs estimated fair values.
Financial markets are susceptible to severe events evidenced by
rapid depreciation in asset values accompanied by a reduction in
asset liquidity. The Companys ability to sell securities,
or the price ultimately realized for these securities, depends
upon the demand and liquidity in the market and increases the
use of judgment in determining the estimated fair value of
certain securities.
The determination of the amount of allowances and impairments,
as applicable, is described previously by investment type. The
determination of such allowances and impairments is highly
subjective and is based upon the Companys periodic
evaluation and assessment of known and inherent risks associated
with the respective asset class. Such evaluations and
assessments are revised as conditions change and new information
becomes available. Management updates its evaluations regularly
and reflects changes in allowances and impairments in operations
as such evaluations are revised.
The recognition of income on certain investments (e.g.
loan-backed securities, including mortgage-backed and
asset-backed securities, certain structured investment
transactions, trading securities, etc.) is dependent upon market
conditions, which could result in prepayments and changes in
amounts to be earned.
The accounting rules under FIN 46(r) for the determination
of when an entity is a VIE and when to consolidate a VIE are
complex. The determination of the VIEs primary beneficiary
requires an evaluation of the contractual rights and obligations
associated with each party involved in the entity, an estimate
of the entitys expected losses and expected residual
returns and the allocation of such estimates to each party
involved in the entity. FIN 46(r) defines the primary
beneficiary as the entity that will absorb a majority of a
F-14
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
VIEs expected losses, receive a majority of a VIEs
expected residual returns if no single entity absorbs a majority
of expected losses, or both.
When determining the primary beneficiary for structured
investment products such as asset-backed securitizations and
collateralized debt obligations, the Company uses historical
default probabilities based on the credit rating of each issuer
and other inputs including maturity dates, industry
classifications and geographic location. Using computational
algorithms, the analysis simulates default scenarios resulting
in a range of expected losses and the probability associated
with each occurrence. For other investment structures such as
trust preferred securities, joint ventures, limited partnerships
and limited liability companies, the Company gains an
understanding of the design of the VIE and generally uses a
qualitative approach to determine if it is the primary
beneficiary. This approach includes an analysis of all
contractual rights and obligations held by all parties including
profit and loss allocations, repayment or residual value
guarantees, put and call options and other derivative
instruments. If the primary beneficiary of a VIE can not be
identified using this qualitative approach, the Company
calculates the expected losses and expected residual returns of
the VIE using a probability-weighted cash flow model. The use of
different methodologies, assumptions and inputs in the
determination of the primary beneficiary could have a material
effect on the amounts presented within the consolidated
financial statements.
Derivative
Financial Instruments
Derivatives are financial instruments whose values are derived
from interest rates, foreign currency exchange rates, or other
financial indices. Derivatives may be exchange-traded or
contracted in the over-the-counter market. The Company uses a
variety of derivatives, including swaps, forwards, futures and
option contracts, to manage the risk associated with variability
in cash flows or changes in estimated fair values related to the
Companys financial instruments. The Company also uses
derivative instruments to hedge its currency exposure associated
with net investments in certain foreign operations. To a lesser
extent, the Company uses credit derivatives, such as credit
default swaps, to synthetically replicate investment risks and
returns which are not readily available in the cash market. The
Company also purchases certain securities, issues certain
insurance policies and investment contracts and engages in
certain reinsurance contracts that have embedded derivatives.
Freestanding derivatives are carried on the Companys
consolidated balance sheet either as assets within other
invested assets or as liabilities within other liabilities at
estimated fair value as determined through the use of quoted
market prices for exchange-traded derivatives and financial
forwards to sell residential mortgage backed securities or
through the use of pricing models for over-the-counter
derivatives. The determination of estimated fair value, when
quoted market values are not available, is based on market
standard valuation methodologies and inputs that are assumed to
be consistent with what other market participants would use when
pricing the instruments. Derivative valuations can be affected
by changes in interest rates, foreign currency exchange rates,
financial indices, credit spreads, default risk (including the
counterparties to the contract), volatility, liquidity and
changes in estimates and assumptions used in the pricing models.
The significant inputs to the pricing models for most
over-the-counter derivatives are inputs that are observable in
the market or can be derived principally from or corroborated by
observable market data. Significant inputs that are observable
generally include: interest rates, foreign currency exchange
rates, interest rate curves, credit curves and volatility.
However, certain over-the-counter derivatives may rely on inputs
that are significant to the estimated fair value that are not
observable in the market or cannot be derived principally from
or corroborated by observable market data. Significant inputs
that are unobservable generally include: independent broker
quotes, credit correlation assumptions, references to emerging
market currencies and inputs that are outside the observable
portion of the interest rate curve, credit curve, volatility or
other relevant market measure. These unobservable inputs may
involve significant management judgment or estimation. Even
though unobservable, these inputs are based on assumptions
deemed appropriate given the circumstances and consistent with
what other market participants would use when pricing such
instruments. Most inputs for over-the-counter derivatives are
mid
F-15
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
market inputs but, in certain cases, bid level inputs are used
when they are deemed more representative of exit value. Market
liquidity as well as the use of different methodologies,
assumptions and inputs may have a material effect on the
estimated fair values of the Companys derivatives and
could materially affect net income.
The credit risk of both the counterparty and the Company are
considered in determining the estimated fair value for all
over-the-counter derivatives after taking into account the
effects of netting agreements and collateral arrangements.
Credit risk is monitored and consideration of any potential
credit adjustment is based on a net exposure by counterparty.
This is due to the existence of netting agreements and
collateral arrangements which effectively serve to mitigate
credit risk. The Company values its derivative positions using
the standard swap curve which includes a credit risk adjustment.
This credit risk adjustment is appropriate for those parties
that execute trades at pricing levels consistent with the
standard swap curve. As the Company and its significant
derivative counterparties consistently execute trades at such
pricing levels, additional credit risk adjustments are not
currently required in the valuation process. The need for such
additional credit risk adjustments is monitored by the Company.
The Companys ability to consistently execute at such
pricing levels is in part due to the netting agreements and
collateral arrangements that are in place with all of its
significant derivative counterparties. The evaluation of the
requirement to make an additional credit risk adjustments is
performed by the Company each reporting period.
If a derivative is not designated as an accounting hedge or its
use in managing risk does not qualify for hedge accounting,
changes in the estimated fair value of the derivative are
generally reported in net investment gains (losses) except for
those (i) in policyholder benefits and claims for economic
hedges of liabilities embedded in certain variable annuity
products offered by the Company, (ii) in net investment
income for economic hedges of equity method investments in joint
ventures, or for all derivatives held in relation to the trading
portfolios and (iii) in other revenues for derivatives held
in connection with the Companys mortgage banking
activities. The fluctuations in estimated fair value of
derivatives which have not been designated for hedge accounting
can result in significant volatility in net income.
To qualify for hedge accounting, at the inception of the hedging
relationship, the Company formally documents its risk management
objective and strategy for undertaking the hedging transaction,
as well as its designation of the hedge as either (i) a
hedge of the estimated fair value of a recognized asset or
liability or an unrecognized firm commitment (fair value
hedge); (ii) a hedge of a forecasted transaction or
of the variability of cash flows to be received or paid related
to a recognized asset or liability (cash flow
hedge); or (iii) a hedge of a net investment in a
foreign operation. In this documentation, the Company sets forth
how the hedging instrument is expected to hedge the designated
risks related to the hedged item and sets forth the method that
will be used to retrospectively and prospectively assess the
hedging instruments effectiveness and the method which
will be used to measure ineffectiveness. A derivative designated
as a hedging instrument must be assessed as being highly
effective in offsetting the designated risk of the hedged item.
Hedge effectiveness is formally assessed at inception and
periodically throughout the life of the designated hedging
relationship. Assessments of hedge effectiveness and
measurements of ineffectiveness are also subject to
interpretation and estimation and different interpretations or
estimates may have a material effect on the amount reported in
net income.
The accounting for derivatives is complex and interpretations of
the primary accounting standards continue to evolve in practice.
Judgment is applied in determining the availability and
application of hedge accounting designations and the appropriate
accounting treatment under these accounting standards. If it was
determined that hedge accounting designations were not
appropriately applied, reported net income could be materially
affected. Differences in judgment as to the availability and
application of hedge accounting designations and the appropriate
accounting treatment may result in a differing impact on the
consolidated financial statements of the Company from that
previously reported.
Under a fair value hedge, changes in the estimated fair value of
the hedging derivative, including amounts measured as
ineffectiveness, and changes in the estimated fair value of the
hedged item related to the designated risk being hedged, are
reported within net investment gains (losses). The estimated
fair values of the hedging derivatives are exclusive of any
accruals that are separately reported in the consolidated
statement of income within interest
F-16
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
income or interest expense to match the location of the hedged
item. However, balances that are not scheduled to settle until
maturity are included in the estimated fair value of derivatives.
Under a cash flow hedge, changes in the estimated fair value of
the hedging derivative measured as effective are reported within
other comprehensive income (loss), a separate component of
stockholders equity, and the deferred gains or losses on
the derivative are reclassified into the consolidated statement
of income when the Companys earnings are affected by the
variability in cash flows of the hedged item. Changes in the
estimated fair value of the hedging instrument measured as
ineffectiveness are reported within net investment gains
(losses). The estimated fair values of the hedging derivatives
are exclusive of any accruals that are separately reported in
the consolidated statement of income within interest income or
interest expense to match the location of the hedged item.
However, balances that are not scheduled to settle until
maturity are included in the estimated fair value of derivatives.
In a hedge of a net investment in a foreign operation, changes
in the estimated fair value of the hedging derivative that are
measured as effective are reported within other comprehensive
income (loss) consistent with the translation adjustment for the
hedged net investment in the foreign operation. Changes in the
estimated fair value of the hedging instrument measured as
ineffectiveness are reported within net investment gains
(losses).
The Company discontinues hedge accounting prospectively when:
(i) it is determined that the derivative is no longer
highly effective in offsetting changes in the estimated fair
value or cash flows of a hedged item; (ii) the derivative
expires, is sold, terminated, or exercised; (iii) it is no
longer probable that the hedged forecasted transaction will
occur; (iv) a hedged firm commitment no longer meets the
definition of a firm commitment; or (v) the derivative is
de-designated as a hedging instrument.
When hedge accounting is discontinued because it is determined
that the derivative is not highly effective in offsetting
changes in the estimate fair value or cash flows of a hedged
item, the derivative continues to be carried on the consolidated
balance sheet at its estimated fair value, with changes in
estimated fair value recognized currently in net investment
gains (losses). The carrying value of the hedged recognized
asset or liability under a fair value hedge is no longer
adjusted for changes in its estimated fair value due to the
hedged risk, and the cumulative adjustment to its carrying value
is amortized into income over the remaining life of the hedged
item. Provided the hedged forecasted transaction is still
probable of occurrence, the changes in estimated fair value of
derivatives recorded in other comprehensive income (loss)
related to discontinued cash flow hedges are released into the
consolidated statement of income when the Companys
earnings are affected by the variability in cash flows of the
hedged item.
When hedge accounting is discontinued because it is no longer
probable that the forecasted transactions will occur by the end
of the specified time period or the hedged item no longer meets
the definition of a firm commitment, the derivative continues to
be carried on the consolidated balance sheet at its estimated
fair value, with changes in estimated fair value recognized
currently in net investment gains (losses). Any asset or
liability associated with a recognized firm commitment is
derecognized from the consolidated balance sheet, and recorded
currently in net investment gains (losses). Deferred gains and
losses of a derivative recorded in other comprehensive income
(loss) pursuant to the cash flow hedge of a forecasted
transaction are recognized immediately in net investment gains
(losses).
In all other situations in which hedge accounting is
discontinued, the derivative is carried at its estimated fair
value on the consolidated balance sheet, with changes in its
estimated fair value recognized in the current period as net
investment gains (losses).
The Company is also a party to financial instruments that
contain terms which are deemed to be embedded derivatives. The
Company assesses each identified embedded derivative to
determine whether it is required to be bifurcated. If the
instrument would not be accounted for in its entirety at
estimated fair value and it is determined that the terms of the
embedded derivative are not clearly and closely related to the
economic characteristics of the host contract, and that a
separate instrument with the same terms would qualify as a
derivative instrument, the
F-17
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
embedded derivative is bifurcated from the host contract and
accounted for as a freestanding derivative. Such embedded
derivatives are carried on the consolidated balance sheet at
estimated fair value with the host contract and changes in their
estimated fair value are reported currently in net investment
gains (losses) or in policyholder benefits and claims. If the
Company is unable to properly identify and measure an embedded
derivative for separation from its host contract, the entire
contract is carried on the balance sheet at estimated fair
value, with changes in estimated fair value recognized in the
current period in net investment gains (losses) or in
policyholder benefits and claims. Additionally, the Company may
elect to carry an entire contract on the balance sheet at
estimated fair value, with changes in estimated fair value
recognized in the current period in net investment gains
(losses) or in policyholder benefits and claims if that contract
contains an embedded derivative that requires bifurcation. There
is a risk that embedded derivatives requiring bifurcation may
not be identified and reported at estimated fair value in the
consolidated financial statements and that their related changes
in estimated fair value could materially affect reported net
income.
Cash and
Cash Equivalents
The Company considers all highly liquid investments purchased
with an original or remaining maturity of three months or less
at the date of purchase to be cash equivalents.
Property,
Equipment, Leasehold Improvements and Computer
Software
Property, equipment and leasehold improvements, which are
included in other assets, are stated at cost, less accumulated
depreciation and amortization. Depreciation is determined using
either the straight-line or sum-of-the-years-digits method over
the estimated useful lives of the assets, as appropriate. The
estimated life for company occupied real estate property is
generally 40 years. Estimated lives generally range from
five to ten years for leasehold improvements and three to seven
years for all other property and equipment. The cost basis of
the property, equipment and leasehold improvements was
$1.8 billion and $1.6 billion at December 31,
2008 and 2007, respectively. Accumulated depreciation and
amortization of property, equipment and leasehold improvements
was $926 million and $810 million at December 31,
2008 and 2007, respectively. Related depreciation and
amortization expense was $150 million, $132 million
and $125 million for the years ended December 31,
2008, 2007 and 2006, respectively.
Computer software, which is included in other assets, is stated
at cost, less accumulated amortization. Purchased software
costs, as well as certain internal and external costs incurred
to develop internal-use computer software during the application
development stage, are capitalized. Such costs are amortized
generally over a four-year period using the straight-line
method. The cost basis of computer software was
$1.5 billion and $1.3 billion at December 31,
2008 and 2007, respectively. Accumulated amortization of
capitalized software was $1,002 million and
$858 million at December 31, 2008 and 2007,
respectively. Related amortization expense was
$153 million, $121 million and $109 million for
the years ended December 31, 2008, 2007 and 2006,
respectively.
Deferred
Policy Acquisition Costs and Value of Business
Acquired
The Company incurs significant costs in connection with
acquiring new and renewal insurance business. Costs that vary
with and relate to the production of new business are deferred
as DAC. Such costs consist principally of commissions and agency
and policy issuance expenses. VOBA is an intangible asset that
reflects the estimated fair value of in-force contracts in a
life insurance company acquisition and represents the portion of
the purchase price that is allocated to the value of the right
to receive future cash flows from the business in-force at the
acquisition date. VOBA is based on actuarially determined
projections, by each block of business, of future policy and
contract charges, premiums, mortality and morbidity, separate
account performance, surrenders, operating expenses, investment
returns and other factors. Actual experience on the purchased
business may vary from these projections. The recovery of DAC
and VOBA is dependent upon the future profitability of the
related business. DAC and VOBA are aggregated in the financial
statements for reporting purposes.
F-18
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
DAC for property and casualty insurance contracts, which is
primarily composed of commissions and certain underwriting
expenses, is amortized on a pro rata basis over the applicable
contract term or reinsurance treaty.
DAC and VOBA on life insurance or investment-type contracts are
amortized in proportion to gross premiums, gross margins or
gross profits, depending on the type of contract as described
below.
The Company amortizes DAC and VOBA related to non-participating
and non-dividend-paying traditional contracts (term insurance,
non-participating whole life insurance, non-medical health
insurance, and traditional group life insurance) over the entire
premium paying period in proportion to the present value of
actual historic and expected future gross premiums. The present
value of expected premiums is based upon the premium requirement
of each policy and assumptions for mortality, morbidity,
persistency, and investment returns at policy issuance, or
policy acquisition, as it relates to VOBA, that include
provisions for adverse deviation and are consistent with the
assumptions used to calculate future policyholder benefit
liabilities. These assumptions are not revised after policy
issuance or acquisition unless the DAC or VOBA balance is deemed
to be unrecoverable from future expected profits. Absent a
premium deficiency, variability in amortization after policy
issuance or acquisition is caused only by variability in premium
volumes.
The Company amortizes DAC and VOBA related to participating,
dividend-paying traditional contracts over the estimated lives
of the contracts in proportion to actual and expected future
gross margins. The amortization includes interest based on rates
in effect at inception or acquisition of the contracts. The
future gross margins are dependent principally on investment
returns, policyholder dividend scales, mortality, persistency,
expenses to administer the business, creditworthiness of
reinsurance counterparties, and certain economic variables, such
as inflation. For participating contracts (dividend paying
traditional contracts within the closed block) future gross
margins are also dependent upon changes in the policyholder
dividend obligation. Of these factors, the Company anticipates
that investment returns, expenses, persistency, and other factor
changes and policyholder dividend scales are reasonably likely
to impact significantly the rate of DAC and VOBA amortization.
Each reporting period, the Company updates the estimated gross
margins with the actual gross margins for that period. When the
actual gross margins change from previously estimated gross
margins, the cumulative DAC and VOBA amortization is re-
estimated and adjusted by a cumulative charge or credit to
current operations. When actual gross margins exceed those
previously estimated, the DAC and VOBA amortization will
increase, resulting in a current period charge to earnings. The
opposite result occurs when the actual gross margins are below
the previously estimated gross margins. Each reporting period,
the Company also updates the actual amount of business in-force,
which impacts expected future gross margins. When expected
future gross margins are below those previously estimated, the
DAC and VOBA amortization will increase, resulting in a current
period charge to earnings. The opposite result occurs when the
expected future gross margins are above the previously estimated
expected future gross margins. Total DAC and VOBA amortization
during a particular period may increase or decrease depending
upon the relative size of the amortization change resulting from
the adjustment to DAC and VOBA for the update of actual gross
margins and the re-estimation of expected future gross margins.
Each period, the Company also reviews the estimated gross
margins for each block of business to determine the
recoverability of DAC and VOBA balances.
The Company amortizes DAC and VOBA related to fixed and variable
universal life contracts and fixed and variable deferred annuity
contracts over the estimated lives of the contracts in
proportion to actual and expected future gross profits. The
amortization includes interest based on rates in effect at
inception or acquisition of the contracts. The amount of future
gross profits is dependent principally upon returns in excess of
the amounts credited to policyholders, mortality, persistency,
interest crediting rates, expenses to administer the business,
creditworthiness of reinsurance counterparties, the effect of
any hedges used, and certain economic variables, such as
inflation. Of these factors, the Company anticipates that
investment returns, expenses, and persistency are reasonably
likely to impact significantly the rate of DAC and VOBA
amortization. Each reporting period, the Company updates the
estimated gross profits with the actual gross profits for that
period. When the actual gross profits change from previously
estimated gross profits, the cumulative DAC and VOBA
amortization is re-estimated and adjusted by a cumulative charge
or credit to current operations. When actual gross profits
exceed those
F-19
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
previously estimated, the DAC and VOBA amortization will
increase, resulting in a current period charge to earnings. The
opposite result occurs when the actual gross profits are below
the previously estimated gross profits. Each reporting period,
the Company also updates the actual amount of business remaining
in-force, which impacts expected future gross profits. When
expected future gross profits are below those previously
estimated, the DAC and VOBA amortization will increase,
resulting in a current period charge to earnings. The opposite
result occurs when the expected future gross profits are above
the previously estimated expected future gross profits. Total
DAC and VOBA amortization during a particular period may
increase or decrease depending upon the relative size of the
amortization change resulting from the adjustment to DAC and
VOBA for the update of actual gross profits and the
re-estimation of expected future gross profits. Each period, the
Company also reviews the estimated gross profits for each block
of business to determine the recoverability of DAC and VOBA
balances.
Separate account rates of return on variable universal life
contracts and variable deferred annuity contracts affect
in-force account balances on such contracts each reporting
period which can result in significant fluctuations in
amortization of DAC and VOBA. Returns that are higher than the
Companys long-term expectation produce higher account
balances, which increases the Companys future fee
expectations and decreases future benefit payment expectations
on minimum death and living benefit guarantees, resulting in
higher expected future gross profits. The opposite result occurs
when returns are lower than the Companys long-term
expectation. The Companys practice to determine the impact
of gross profits resulting from returns on separate accounts
assumes that long-term appreciation in equity markets is not
changed by short-term market fluctuations, but is only changed
when sustained interim deviations are expected. The Company
monitors these changes and only changes the assumption when its
long-term expectation changes.
The Company also reviews periodically other long-term
assumptions underlying the projections of estimated gross
margins and profits. These include investment returns,
policyholder dividend scales, interest crediting rates,
mortality, persistency, and expenses to administer business.
Management annually updates assumptions used in the calculation
of estimated gross margins and profits which may have
significantly changed. If the update of assumptions causes
expected future gross margins and profits to increase, DAC and
VOBA amortization will decrease, resulting in a current period
increase to earnings. The opposite result occurs when the
assumption update causes expected future gross margins and
profits to decrease.
Prior to 2007, DAC related to any internally replaced contract
was generally expensed at the date of replacement. As described
more fully in Adoption of New Accounting
Pronouncements, effective January 1, 2007, the
Company adopted Statement of Position (SOP)
05-1,
Accounting by Insurance Enterprises for Deferred Acquisition
Costs in Connection with Modifications or Exchanges of Insurance
Contracts
(SOP 05-1).
Under
SOP 05-1,
an internal replacement is defined as a modification in product
benefits, features, rights or coverages that occur by the
exchange of a contract for a new contract, or by amendment,
endorsement, or rider to a contract, or by election or coverage
within a contract. If the modification substantially changes the
contract, the DAC is written off immediately through income and
any new deferrable costs associated with the replacement
contract are deferred. If the modification does not
substantially change the contract, the DAC amortization on the
original contract will continue and any acquisition costs
associated with the related modification are expensed.
Sales
Inducements
The Company has two different types of sales inducements which
are included in other assets: (i) the policyholder receives
a bonus whereby the policyholders initial account balance
is increased by an amount equal to a specified percentage of the
customers deposit; and (ii) the policyholder receives
a higher interest rate using a dollar cost averaging method than
would have been received based on the normal general account
interest rate credited. The Company defers sales inducements and
amortizes them over the life of the policy using the same
methodology and assumptions used to amortize DAC. The
amortization of sales inducements is included in interest
credited to policyholder account balances. Each year the Company
reviews the deferred sales inducements to determine the
recoverability of these balances.
F-20
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Value of
Distribution Agreements and Customer Relationships
Acquired
Value of distribution agreements (VODA) is reported
in other assets and represents the present value of future
profits associated with the expected future business derived
from the distribution agreements. Value of customer
relationships acquired (VOCRA) is also reported in
other assets and represents the present value of the expected
future profits associated with the expected future business
acquired through existing customers of the acquired company or
business. The VODA and VOCRA associated with past acquisitions
are amortized over useful life ranging from 10 to 30 years
and such amortization is included in other expenses. Each year
the Company reviews VODA and VOCRA to determine the
recoverability of these balances.
Goodwill
Goodwill is the excess of cost over the estimated fair value of
net assets acquired. Goodwill is not amortized but is tested for
impairment at least annually or more frequently if events or
circumstances, such as adverse changes in the business climate,
indicate that there may be justification for conducting an
interim test. The Company performs its annual goodwill
impairment testing during the third quarter of each year based
upon data as of the close of the second quarter.
Impairment testing is performed using the fair value approach,
which requires the use of estimates and judgment, at the
reporting unit level. A reporting unit is the
operating segment or a business one level below the operating
segment, if discrete financial information is prepared and
regularly reviewed by management at that level. For purposes of
goodwill impairment testing, a significant portion of goodwill
within Corporate & Other is allocated to reporting
units within the Companys business segments.
For purposes of goodwill impairment testing, if the carrying
value of a reporting units goodwill exceeds its estimated
fair value, there is an indication of impairment and the implied
fair value of the goodwill is determined in the same manner as
the amount of goodwill would be determined in a business
acquisition. The excess of the carrying value of goodwill over
the implied fair value of goodwill is recognized as an
impairment and recorded as a charge against net income.
In performing its goodwill impairment tests, when management
believes meaningful comparable market data are available, the
estimated fair values of the reporting units are determined
using a market multiple approach. When relevant comparables are
not available, the Company uses a discounted cash flow model.
For reporting units which are particularly sensitive to market
assumptions, such as the annuities and variable &
universal life reporting units within the Individual segment,
the Company may corroborate its estimated fair values by using
additional valuation methodologies.
The key inputs, judgments and assumptions necessary in
determining estimated fair value include projected earnings,
current book value (with and without accumulated other
comprehensive income), the level of economic capital required to
support the mix of business, long term growth rates, comparative
market multiples, the account value of in-force business,
projections of new and renewal business as well as margins on
such business, the level of interest rates, credit spreads,
equity market levels and the discount rate management believes
appropriate to the risk associated with the respective reporting
unit. The estimated fair value of the annuity and
variable & universal life reporting units are
particularly sensitive to the equity market levels.
When testing goodwill for impairment, management also considers
the Companys market capitalization in relation to its book
value. Management believes that the overall decrease in the
Companys current market capitalization is not
representative of a long-term decrease in the value of the
underlying reporting units.
Management applies significant judgment when determining the
estimated fair value of the Companys reporting units and
when assessing the relationship of market capitalization to the
estimated fair value of its reporting units and their book
value. The valuation methodologies utilized are subject to key
judgments and assumptions that are sensitive to change.
Estimates of fair value are inherently uncertain and represent
only
F-21
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
managements reasonable expectation regarding future
developments. These estimates and the judgments and assumptions
upon which the estimates are based will, in all likelihood,
differ in some respects from actual future results. Declines in
the estimated fair value of the Companys reporting units
could result in goodwill impairments in future periods which
could materially adversely affect the Companys results of
operations or financial position.
Management continues to evaluate current market conditions that
may affect the estimated fair value of the Companys
reporting units to assess whether any goodwill impairment
exists. Continued deteriorating or adverse market conditions for
certain reporting units may have a significant impact on the
estimated fair value of these reporting units and could result
in future impairments of goodwill.
See Note 6 for further consideration of goodwill impairment
testing during 2008.
Liability
for Future Policy Benefits and Policyholder Account
Balances
The Company establishes liabilities for amounts payable under
insurance policies, including traditional life insurance,
traditional annuities and non-medical health insurance.
Generally, amounts are payable over an extended period of time
and related liabilities are calculated as the present value of
future expected benefits to be paid reduced by the present value
of future expected premiums. Such liabilities are established
based on methods and underlying assumptions in accordance with
GAAP and applicable actuarial standards. Principal assumptions
used in the establishment of liabilities for future policy
benefits are mortality, morbidity, policy lapse, renewal,
retirement, disability incidence, disability terminations,
investment returns, inflation, expenses and other contingent
events as appropriate to the respective product type. Utilizing
these assumptions, liabilities are established on a block of
business basis.
Future policy benefit liabilities for participating traditional
life insurance policies are equal to the aggregate of
(i) net level premium reserves for death and endowment
policy benefits (calculated based upon the non-forfeiture
interest rate, ranging from 3% to 7% for domestic business and
3% to 10% for international business, and mortality rates
guaranteed in calculating the cash surrender values described in
such contracts); and (ii) the liability for terminal
dividends.
Future policy benefits for non-participating traditional life
insurance policies are equal to the aggregate of the present
value of expected future benefit payments and related expenses
less the present value of expected future net premiums.
Assumptions as to mortality and persistency are based upon the
Companys experience when the basis of the liability is
established. Interest rates assumptions for the aggregate future
policy benefit liabilities range from 2% to 8% for domestic
business and 2% to 12% for international business.
Participating business represented approximately 8% and 9% of
the Companys life insurance in-force, and 14% and 14% of
the number of life insurance policies in-force, at
December 31, 2008 and 2007, respectively. Participating
policies represented approximately 27% and 27%, 31% and 30%, and
30% and 29% of gross and net life insurance premiums for the
years ended December 31, 2008, 2007 and 2006, respectively.
The percentages indicated are calculated excluding the business
of the reinsurance segment.
Future policy benefit liabilities for individual and group
traditional fixed annuities after annuitization are equal to the
present value of expected future payments. Interest rates
assumptions used in establishing such liabilities range from 2%
to 11% for domestic business and 4% to 10% for international
business.
Future policy benefit liabilities for non-medical health
insurance are calculated using the net level premium method and
assumptions as to future morbidity, withdrawals and interest,
which provide a margin for adverse deviation. Interest rates
assumptions used in establishing such liabilities range from 4%
to 7% for domestic business and 2% to 10% for international
business.
Future policy benefit liabilities for disabled lives are
estimated using the present value of benefits method and
experience assumptions as to claim terminations, expenses and
interest. Interest rates assumptions used in establishing such
liabilities range from 3% to 8% for domestic business and 2% to
10% for international business.
F-22
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Liabilities for unpaid claims and claim expenses for property
and casualty insurance are included in future policyholder
benefits and represent the amount estimated for claims that have
been reported but not settled and claims incurred but not
reported. Liabilities for unpaid claims are estimated based upon
the Companys historical experience and other actuarial
assumptions that consider the effects of current developments,
anticipated trends and risk management programs, reduced for
anticipated salvage and subrogation. The effects of changes in
such estimated liabilities are included in the results of
operations in the period in which the changes occur.
The Company establishes future policy benefit liabilities for
minimum death and income benefit guarantees relating to certain
annuity contracts and secondary and
paid-up
guarantees relating to certain life policies as follows:
|
|
|
|
|
Guaranteed minimum death benefit (GMDB) liabilities
are determined by estimating the expected value of death
benefits in excess of the projected account balance and
recognizing the excess ratably over the accumulation period
based on total expected assessments. The Company regularly
evaluates estimates used and adjusts the additional liability
balance, with a related charge or credit to benefit expense, if
actual experience or other evidence suggests that earlier
assumptions should be revised. The assumptions used in
estimating the GMDB liabilities are consistent with those used
for amortizing DAC, and are thus subject to the same variability
and risk. The assumptions of investment performance and
volatility are consistent with the historical experience of the
Standard & Poors (S&P) 500
Index. The benefit assumptions used in calculating the
liabilities are based on the average benefits payable over a
range of scenarios.
|
|
|
|
Guaranteed minimum income benefit (GMIB) liabilities
are determined by estimating the expected value of the income
benefits in excess of the projected account balance at any
future date of annuitization and recognizing the excess ratably
over the accumulation period based on total expected
assessments. The Company regularly evaluates estimates used and
adjusts the additional liability balance, with a related charge
or credit to benefit expense, if actual experience or other
evidence suggests that earlier assumptions should be revised.
The assumptions used for estimating the GMIB liabilities are
consistent with those used for estimating the GMDB liabilities.
In addition, the calculation of guaranteed annuitization benefit
liabilities incorporates an assumption for the percentage of the
potential annuitizations that may be elected by the
contractholder. Certain GMIBs have settlement features that
result in a portion of that guarantee being accounted for as an
embedded derivative and are recorded in policyholder account
balances as described below.
|
Liabilities for universal and variable life secondary guarantees
and paid-up
guarantees are determined by estimating the expected value of
death benefits payable when the account balance is projected to
be zero and recognizing those benefits ratably over the
accumulation period based on total expected assessments. The
Company regularly evaluates estimates used and adjusts the
additional liability balances, with a related charge or credit
to benefit expense, if actual experience or other evidence
suggests that earlier assumptions should be revised. The
assumptions used in estimating the secondary and
paid-up
guarantee liabilities are consistent with those used for
amortizing DAC, and are thus subject to the same variability and
risk. The assumptions of investment performance and volatility
for variable products are consistent with historical S&P
experience. The benefits used in calculating the liabilities are
based on the average benefits payable over a range of scenarios.
The Company establishes policyholder account balances for
guaranteed minimum benefit riders relating to certain variable
annuity products as follows:
|
|
|
|
|
Guaranteed minimum withdrawal benefit riders (GMWB)
guarantee the contractholder a return of their purchase payment
via partial withdrawals, even if the account value is reduced to
zero, provided that the contractholders cumulative
withdrawals in a contract year do not exceed a certain limit.
The initial guaranteed withdrawal amount is equal to the initial
benefit base as defined in the contract (typically, the initial
purchase payments plus applicable bonus amounts). The GMWB is an
embedded derivative, which is measured at estimated fair value
separately from the host variable annuity product.
|
F-23
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
Guaranteed minimum accumulation benefit riders
(GMAB) provide the contractholder, after a specified
period of time determined at the time of issuance of the
variable annuity contract, with a minimum accumulation of their
purchase payments even if the account value is reduced to zero.
The initial guaranteed accumulation amount is equal to the
initial benefit base as defined in the contract (typically, the
initial purchase payments plus applicable bonus amounts). The
GMAB is an embedded derivative, which is measured at estimated
fair value separately from the host variable annuity product.
|
For GMWB, GMAB and certain GMIB, the initial benefit base is
increased by additional purchase payments made within a certain
time period and decreases by benefits paid
and/or
withdrawal amounts. After a specified period of time, the
benefit base may also increase as a result of an optional reset
as defined in the contract.
At the inception, the GMWB, GMAB and certain GMIB are accounted
for as embedded derivatives with changes in estimated fair value
reported in net investment gains (losses).
The Company attributes to the embedded derivative a portion of
the expected future rider fees to be collected from the
policyholder equal to the present value of expected future
guaranteed benefits. Any additional fees represent
excess fees and are reported in universal life and
investment-type product policy fees.
The fair value for these riders is estimated using the present
value of future benefits minus the present value of future fees
using actuarial and capital market assumptions related to the
projected cash flows over the expected lives of the contracts.
The projections of future benefits and future fees require
capital market and actuarial assumptions including expectations
concerning policyholder behavior. A risk neutral valuation
methodology is used under which the cash flows from the riders
are projected under multiple capital market scenarios using
observable risk free rates. Beginning in 2008, the valuation of
these embedded derivatives now includes an adjustment for the
Companys own credit and risk margins for non-capital
market inputs. The Companys own credit adjustment is
determined taking into consideration publicly available
information relating to the Companys debt as well as its
claims paying ability. Risk margins are established to capture
the non-capital market risks of the instrument which represent
the additional compensation a market participant would require
to assume the risks related to the uncertainties of such
actuarial assumptions as annuitization, premium persistency,
partial withdrawal and surrenders. The establishment of risk
margins requires the use of significant management judgment.
These riders may be more costly than expected in volatile or
declining equity markets. Market conditions including, but not
limited to, changes in interest rates, equity indices, market
volatility and foreign currency exchange rates; changes in the
Companys own credit standing; and variations in actuarial
assumptions regarding policyholder behavior, and risk margins
related to non-capital market inputs may result in significant
fluctuations in the estimated fair value of the riders that
could materially affect net income.
The Company periodically reviews its estimates of actuarial
liabilities for future policy benefits and compares them with
its actual experience. Differences between actual experience and
the assumptions used in pricing these policies, guarantees and
riders and in the establishment of the related liabilities
result in variances in profit and could result in losses. The
effects of changes in such estimated liabilities are included in
the results of operations in the period in which the changes
occur.
Policyholder account balances relate to investment-type
contracts, universal life-type policies and certain guaranteed
minimum benefit riders. Investment-type contracts principally
include traditional individual fixed annuities in the
accumulation phase and, non-variable group annuity contracts.
Policyholder account balances for these contracts are equal to
(i) policy account values, which consist of an accumulation
of gross premium payments; (ii) credited interest, ranging
from 1% to 17% for domestic business and 1% to 15% for
international business, less expenses, mortality charges, and
withdrawals; and (iii) fair value adjustments relating to
business combinations. Bank deposits related to the
Companys banking operations are also included in
policyholder account balances.
F-24
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Other
Policyholder Funds
Other policyholder funds include policy and contract claims,
unearned revenue liabilities, premiums received in advance,
policyholder dividends due and unpaid, and policyholder
dividends left on deposit.
The liability for policy and contract claims generally relates
to incurred but not reported death, disability, long-term care
and dental claims, as well as claims which have been reported
but not yet settled. The liability for these claims is based on
the Companys estimated ultimate cost of settling all
claims. The Company derives estimates for the development of
incurred but not reported claims principally from actuarial
analyses of historical patterns of claims and claims development
for each line of business. The methods used to determine these
estimates are continually reviewed. Adjustments resulting from
this continuous review process and differences between estimates
and payments for claims are recognized in policyholder benefits
and claims expense in the period in which the estimates are
changed or payments are made.
The unearned revenue liability relates to universal life-type
and investment-type products and represents policy charges for
services to be provided in future periods. The charges are
deferred as unearned revenue and amortized using the
products estimated gross profits and margins, similar to
DAC. Such amortization is recorded in universal life and
investment-type product policy fees.
The Company accounts for the prepayment of premiums on its
individual life, group life and health contracts as premium
received in advance and applies the cash received to premiums
when due.
Also included in other policyholder funds are policyholder
dividends due and unpaid on participating policies and
policyholder dividends left on deposit. Such liabilities are
presented at amounts contractually due to policyholders.
Recognition
of Insurance Revenue and Related Benefits
Premiums related to traditional life and annuity policies with
life contingencies are recognized as revenues when due from
policyholders. Policyholder benefits and expenses are provided
against such revenues to recognize profits over the estimated
lives of the policies. When premiums are due over a
significantly shorter period than the period over which benefits
are provided, any excess profit is deferred and recognized into
operations in a constant relationship to insurance in-force or,
for annuities, the amount of expected future policy benefit
payments.
Premiums related to non-medical health and disability contracts
are recognized on a pro rata basis over the applicable contract
term.
Deposits related to universal life-type and investment-type
products are credited to policyholder account balances. Revenues
from such contracts consist of amounts assessed against
policyholder account balances for mortality, policy
administration and surrender charges and are recorded in
universal life and investment-type product policy fees in the
period in which services are provided. Amounts that are charged
to operations include interest credited and benefit claims
incurred in excess of related policyholder account balances.
Premiums related to property and casualty contracts are
recognized as revenue on a pro rata basis over the applicable
contract term. Unearned premiums, representing the portion of
premium written relating to the unexpired coverage, are included
in future policy benefits.
Premiums, policy fees, policyholder benefits and expenses are
presented net of reinsurance.
The portion of fees allocated to embedded derivatives described
previously is recognized within net investment gains (losses) as
part of the estimated fair value of embedded derivative.
F-25
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Other
Revenues
Other revenues include, in addition to items described elsewhere
herein, advisory fees, broker-dealer commissions and fees, and
administrative service fees are also included in other revenues.
Such fees and commissions are recognized in the period in which
services are performed. Other revenues also include changes in
account value relating to corporate-owned life insurance
(COLI). Under certain COLI contracts, if the Company
reports certain unlikely adverse results in its consolidated
financial statements, withdrawals would not be immediately
available and would be subject to market value adjustment, which
could result in a reduction of the account value.
Policyholder
Dividends
Policyholder dividends are approved annually by the insurance
subsidiaries boards of directors. The aggregate amount of
policyholder dividends is related to actual interest, mortality,
morbidity and expense experience for the year, as well as
managements judgment as to the appropriate level of
statutory surplus to be retained by the insurance subsidiaries.
Income
Taxes
The Holding Company and its includable life insurance and
non-life insurance subsidiaries file a consolidated
U.S. federal income tax return in accordance with the
provisions of the Internal Revenue Code of 1986, as amended (the
Code). Non-includable subsidiaries file either
separate individual corporate tax returns or separate
consolidated tax returns.
The Companys accounting for income taxes represents
managements best estimate of various events and
transactions.
Deferred tax assets and liabilities resulting from temporary
differences between the financial reporting and tax bases of
assets and liabilities are measured at the balance sheet date
using enacted tax rates expected to apply to taxable income in
the years the temporary differences are expected to reverse.
The realization of deferred tax assets depends upon the
existence of sufficient taxable income within the carryback or
carryforward periods under the tax law in the applicable tax
jurisdiction. Valuation allowances are established when
management determines, based on available information, that it
is more likely than not that deferred income tax assets will not
be realized. Significant judgment is required in determining
whether valuation allowances should be established as well as
the amount of such allowances. When making such determination,
consideration is given to, among other things, the following:
|
|
|
|
(i)
|
future taxable income exclusive of reversing temporary
differences and carryforwards;
|
|
|
(ii)
|
future reversals of existing taxable temporary differences;
|
|
|
(iii)
|
taxable income in prior carryback years; and
|
|
|
(iv)
|
tax planning strategies.
|
The Company may be required to change its provision for income
taxes in certain circumstances. Examples of such circumstances
include when the ultimate deductibility of certain items is
challenged by taxing authorities (See also Note 15) or
when estimates used in determining valuation allowances on
deferred tax assets significantly change or when receipt of new
information indicates the need for adjustment in valuation
allowances. Additionally, future events, such as changes in tax
laws, tax regulations, or interpretations of such laws or
regulations, could have an impact on the provision for income
tax and the effective tax rate. Any such changes could
significantly affect the amounts reported in the consolidated
financial statements in the year these changes occur.
F-26
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
As described more fully in Adoption of New Accounting
Pronouncements, the Company adopted FIN No. 48,
Accounting for Uncertainty in Income Taxes An
Interpretation of FASB Statement No. 109
(FIN 48) effective January 1, 2007.
Under FIN 48, the Company determines whether it is
more-likely-than-not that a tax position will be sustained upon
examination by the appropriate taxing authorities before any
part of the benefit can be recorded in the financial statements.
A tax position is measured at the largest amount of benefit that
is greater than 50 percent likely of being realized upon
settlement. Unrecognized tax benefits due to tax uncertainties
that do not meet the threshold are included within other
liabilities and are charged to earnings in the period that such
determination is made.
The Company classifies interest recognized as interest expense
and penalties recognized as a component of income tax.
Reinsurance
The Company enters into reinsurance agreements primarily as a
purchaser of reinsurance for its various insurance products and
also as a provider of reinsurance for some insurance products
issued by third parties.
For each of its reinsurance agreements, the Company determines
if the agreement provides indemnification against loss or
liability relating to insurance risk in accordance with
applicable accounting standards. The Company reviews all
contractual features, particularly those that may limit the
amount of insurance risk to which the reinsurer is subject or
features that delay the timely reimbursement of claims.
For reinsurance of existing in-force blocks of long-duration
contracts that transfer significant insurance risk, the
difference, if any, between the amounts paid (received), and the
liabilities ceded (assumed) related to the underlying contracts
is considered the net cost of reinsurance at the inception of
the reinsurance agreement. The net cost of reinsurance is
recorded as an adjustment to DAC and recognized as a component
of other expenses on a basis consistent with the way the
acquisition costs on the underlying reinsured contracts would be
recognized. Subsequent amounts paid (received) on the
reinsurance of in-force blocks, as well as amounts paid
(received) related to new business, are recorded as ceded
(assumed) premiums and ceded (assumed) future policy benefit
liabilities are established.
For prospective reinsurance of short-duration contracts that
meet the criteria for reinsurance accounting, amounts paid
(received) are recorded as ceded (assumed) premiums and ceded
(assumed) unearned premiums and are reflected as a component of
premiums and other receivables (future policy benefits). Such
amounts are amortized through earned premiums over the remaining
contract period in proportion to the amount of protection
provided. For retroactive reinsurance of short-duration
contracts that meet the criteria of reinsurance accounting,
amounts paid (received) in excess of (which do not exceed) the
related insurance liabilities ceded (assumed) are recognized
immediately as a loss. Any gains on such retroactive agreements
are deferred and recorded in other liabilities. The gains are
amortized primarily using the recovery method.
The assumptions used to account for both long and short-duration
reinsurance agreements are consistent with those used for the
underlying contracts. Ceded policyholder and contract related
liabilities, other than those currently due, are reported gross
on the balance sheet.
Amounts currently recoverable under reinsurance agreements are
included in premiums and other receivables and amounts currently
payable are included in other liabilities. Such assets and
liabilities relating to reinsurance agreements with the same
reinsurer may be recorded net on the balance sheet, if a right
of offset exists within the reinsurance agreement.
Premiums, fees and policyholder benefits and claims include
amounts assumed under reinsurance agreements and are net of
reinsurance ceded. Amounts received from reinsurers for policy
administration are reported in other revenues.
F-27
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
If the Company determines that a reinsurance agreement does not
expose the reinsurer to a reasonable possibility of a
significant loss from insurance risk, the Company records the
agreement using the deposit method of accounting. Deposits
received are included in other liabilities and deposits made are
included within other assets. As amounts are paid or received,
consistent with the underlying contracts, the deposit assets or
liabilities are adjusted. Interest on such deposits is recorded
as other revenues or other expenses, as appropriate.
Periodically, the Company evaluates the adequacy of the expected
payments or recoveries and adjusts the deposit asset or
liability through other revenues or other expenses, as
appropriate.
Accounting for reinsurance requires extensive use of assumptions
and estimates, particularly related to the future performance of
the underlying business and the potential impact of counterparty
credit risks. The Company periodically reviews actual and
anticipated experience compared to the aforementioned
assumptions used to establish assets and liabilities relating to
ceded and assumed reinsurance and evaluates the financial
strength of counterparties to its reinsurance agreements using
criteria similar to that evaluated in the security impairment
process discussed previously.
Employee
Benefit Plans
Certain subsidiaries of the Holding Company (the
Subsidiaries) sponsor
and/or
administer various plans that provide defined benefit pension
and other postretirement benefits covering eligible employees
and sales representatives. A December 31 measurement date is
used for all of the Subsidiaries defined benefit pension
and other postretirement benefit plans.
Pension benefits are provided utilizing either a traditional
formula or cash balance formula. The traditional formula
provides benefits based upon years of credited service and
either final average or career average earnings. The cash
balance formula utilizes hypothetical or notional accounts which
credit participants with benefits equal to a percentage of
eligible pay, as well as earnings credits, determined annually
based upon the average annual rate of interest on
30-year
Treasury securities, for each account balance. At
December 31, 2008, virtually all the obligations are
calculated using the traditional formula.
The Subsidiaries also provide certain postemployment benefits
and certain postretirement medical and life insurance benefits
for retired employees. Employees of the Subsidiaries who were
hired prior to 2003 (or, in certain cases, rehired during or
after 2003) and meet age and service criteria while working
for one of the Subsidiaries, may become eligible for these other
postretirement benefits, at various levels, in accordance with
the applicable plans. Virtually all retirees, or their
beneficiaries, contribute a portion of the total cost of
postretirement medical benefits. Employees hired after 2003 are
not eligible for any employer subsidy for postretirement medical
benefits.
SFAS No. 87, Employers Accounting for
Pensions (SFAS 87), as amended, established
the accounting for pension plan obligations. Under SFAS 87,
the projected pension benefit obligation (PBO) is
defined as the actuarially calculated present value of vested
and non-vested pension benefits accrued based on future salary
levels. The accumulated pension benefit obligation
(ABO) is the actuarial present value of vested and
non-vested pension benefits accrued based on current salary
levels. Obligations, both PBO and ABO, of the defined benefit
pension plans are determined using a variety of actuarial
assumptions, from which actual results may vary, as described
below.
SFAS No. 106, Employers Accounting for
Postretirement Benefits Other than Pensions
(SFAS 106), as amended, established the
accounting for expected postretirement plan benefit obligations
(EPBO) which represents the actuarial present value
of all other postretirement benefits expected to be paid after
retirement to employees and their dependents. Unlike for
pensions, the EPBO is not recorded in the financial statements
but is used in measuring the periodic expense. The accumulated
postretirement plan benefit obligations (APBO)
represents the actuarial present value of future other
postretirement benefits attributed to employee services rendered
through a particular date and is the valuation basis upon which
liabilities are established. The APBO is determined using a
variety of actuarial assumptions, from which actual results may
vary, as described below.
F-28
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Prior to December 31, 2006, the funded status of the
pension and other postretirement plans, which is the difference
between the estimated fair value of plan assets and the PBO for
pension plans and the APBO for other postretirement plans
(collectively, the Benefit Obligations), were offset
by the unrecognized actuarial gains or losses, prior service
cost and transition obligations to determine prepaid or accrued
benefit cost, as applicable. The net amount was recorded as a
prepaid or accrued benefit cost, as applicable. Further, for
pension plans, if the ABO exceeded the estimated fair value of
the plan assets, that excess was recorded as an additional
minimum pension liability with a corresponding intangible asset.
Recognition of the intangible asset was limited to the amount of
any unrecognized prior service cost. Any additional minimum
pension liability in excess of the allowable intangible asset
was charged, net of income tax, to accumulated other
comprehensive income.
As described more fully in Adoption of New Accounting
Pronouncements, effective December 31, 2006, the
Company adopted SFAS No. 158, Employers
Accounting for Defined Benefit Pension and Other Postretirement
Plans an amendment of FASB Statements No. 87,
88, 106, and SFAS No. 132(r) (SFAS
158). Effective with the adoption of SFAS 158 on
December 31, 2006, the Company recognizes the funded status
of the Benefit Obligations for each of its plans on the
consolidated balance sheet. The actuarial gains or losses, prior
service costs and credits, and the remaining net transition
asset or obligation that had not yet been included in net
periodic benefit costs at December 31, 2006 are now
charged, net of income tax, to accumulated other comprehensive
income. Additionally, these changes eliminated the additional
minimum pension liability provisions of SFAS 87.
Net periodic benefit cost is determined using management
estimates and actuarial assumptions to derive service cost,
interest cost, and expected return on plan assets for a
particular year. Net periodic benefit cost also includes the
applicable amortization of any prior service cost (credit)
arising from the increase (decrease) in prior years
benefit costs due to plan amendments or initiation of new plans.
These costs are amortized into net periodic benefit cost over
the expected service years of employees whose benefits are
affected by such plan amendments. Actual experience related to
plan assets
and/or the
benefit obligations may differ from that originally assumed when
determining net periodic benefit cost for a particular period,
resulting in gains or losses. To the extent such aggregate gains
or losses exceed 10 percent of the greater of the benefit
obligations or the market-related asset value of the plans, they
are amortized into net periodic benefit cost over the expected
service years of employees expected to receive benefits under
the plans.
The obligations and expenses associated with these plans require
an extensive use of assumptions such as the discount rate,
expected rate of return on plan assets, rate of future
compensation increases, healthcare cost trend rates, as well as
assumptions regarding participant demographics such as rate and
age of retirements, withdrawal rates and mortality. Management,
in consultation with its external consulting actuarial firm,
determines these assumptions based upon a variety of factors
such as historical performance of the plan and its assets,
currently available market and industry data, and expected
benefit payout streams. The assumptions used may differ
materially from actual results due to, among other factors,
changing market and economic conditions and changes in
participant demographics. These differences may have a
significant effect on the Companys consolidated financial
statements and liquidity.
The Subsidiaries also sponsor defined contribution savings and
investment plans (SIP) for substantially all
employees under which a portion of employee contributions are
matched. Applicable matching contributions are made each payroll
period. Accordingly, the Company recognizes compensation cost
for current matching contributions. As all contributions are
transferred currently as earned to the SIP trust, no liability
for matching contributions is recognized in the consolidated
balance sheets.
Stock-Based
Compensation
Effective January 1, 2006, the Company adopted, using the
modified prospective transition method, SFAS No. 123
(revised 2004), Share-Based Payment
(SFAS 123(r)). In accordance with this
guidance the cost of all stock-based transactions is measured at
fair value and recognized over the period during which a grantee
is required to provide goods or services in exchange for the
award. Although the terms of the Companys stock-
F-29
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
based plans do not accelerate vesting upon retirement, or the
attainment of retirement eligibility, the requisite service
period subsequent to attaining such eligibility is considered
nonsubstantive. Accordingly, the Company recognizes compensation
expense related to stock-based awards over the shorter of the
requisite service period or the period to attainment of
retirement eligibility. Prior to January 1, 2006, the
Company recognized stock-based compensation over the vesting
period of the grant or award, including grants or awards to
retirement-eligible employees. An estimation of future
forfeitures of stock-based awards is incorporated into the
determination of compensation expense when recognizing expense
over the requisite service period. Prior to January 1,
2006, the Company recognized the corresponding reduction of
stock compensation in the period in which the forfeitures
occurred.
Stock-based awards granted after December 31, 2002 but
prior to January 1, 2006 were accounted for on a
prospective basis using the fair value accounting method
prescribed by SFAS No. 123, Accounting for
Stock-Based Compensation (SFAS 123), as
amended by SFAS No. 148, Accounting for Stock-Based
Compensation Transition and Disclosure
(SFAS 148). The fair value method
prescribed by SFAS 123 required compensation expense to be
measured based on the fair value of the equity instrument at the
grant or award date. Stock-based compensation was recognized
over the vesting period of the grant or award, including grants
or awards to retirement-eligible employees.
Foreign
Currency
Balance sheet accounts of foreign operations are translated at
the exchange rates in effect at each year-end and income and
expense accounts are translated at the average rates of exchange
prevailing during the year. The local currencies of foreign
operations generally are the functional currencies unless the
local economy is highly inflationary. Translation adjustments
are charged or credited directly to other comprehensive income
or loss. Gains and losses from foreign currency transactions are
reported as net investment gains (losses) in the period in which
they occur.
Discontinued
Operations
The results of operations of a component of the Company that
either has been disposed of or is classified as held-for-sale
are reported in discontinued operations if the operations and
cash flows of the component have been or will be eliminated from
the ongoing operations of the Company as a result of the
disposal transaction and the Company will not have any
significant continuing involvement in the operations of the
component after the disposal transaction.
Earnings
Per Common Share
Basic earnings per common share are computed based on the
weighted average number of common shares outstanding during the
period. The difference between the number of shares assumed
issued and number of shares assumed purchased represents the
dilutive shares. Diluted earnings per common share include the
dilutive effect of the assumed: (i) exercise or issuance of
stock-based awards using the treasury stock method;
(ii) settlement of stock purchase contracts underlying
common equity units using the treasury stock method; and
(iii) settlement of accelerated common stock repurchase
contract. Under the treasury stock method, exercise or issuance
of stock- based awards and settlement of the stock purchase
contracts underlying common equity units is assumed to occur
with the proceeds used to purchase common stock at the average
market price for the period. See Notes 13, 18 and 20.
The Company is a party to a number of legal actions and is
involved in a number of regulatory investigations. Given the
inherent unpredictability of these matters, it is difficult to
estimate the impact on the Companys financial position.
Liabilities are established when it is probable that a loss has
been incurred and the amount of the loss can
F-30
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
be reasonably estimated. On a quarterly and annual basis, the
Company reviews relevant information with respect to liabilities
for litigation, regulatory investigations and litigation-related
contingencies to be reflected in the Companys consolidated
financial statements. It is possible that an adverse outcome in
certain of the Companys litigation and regulatory
investigations, or the use of different assumptions in the
determination of amounts recorded could have a material effect
upon the Companys consolidated net income or cash flows in
particular quarterly or annual periods.
Separate accounts are established in conformity with insurance
laws and are generally not chargeable with liabilities that
arise from any other business of the Company. Separate account
assets are subject to general account claims only to the extent
the value of such assets exceeds the separate account
liabilities. Assets within the Companys separate accounts
primarily include: mutual funds, fixed maturity and equity
securities, mortgage loans, derivatives, hedge funds, other
limited partnership interests, short-term investments, and cash
and cash equivalents. The Company reports separately, as assets
and liabilities, investments held in separate accounts and
liabilities of the separate accounts if (i) such separate
accounts are legally recognized; (ii) assets supporting the
contract liabilities are legally insulated from the
Companys general account liabilities;
(iii) investments are directed by the contractholder; and
(iv) all investment performance, net of contract fees and
assessments, is passed through to the contractholder. The
Company reports separate account assets meeting such criteria at
their fair value which is based on the estimated fair values of
the underlying assets comprising the portfolios of an individual
separate account. Investment performance (including investment
income, net investment gains (losses) and changes in unrealized
gains (losses)) and the corresponding amounts credited to
contractholders of such separate accounts are offset within the
same line in the consolidated statements of income. Separate
accounts not meeting the above criteria are combined on a
line-by-line
basis with the Companys general account assets,
liabilities, revenues and expenses and the accounting for these
investments is consistent with the methodologies described
herein for similar financial instruments held within the general
account.
The Companys revenues reflect fees charged to the separate
accounts, including mortality charges, risk charges, policy
administration fees, investment management fees and surrender
charges.
Adoption
of New Accounting Pronouncements
Effective January 1, 2008, the Company adopted
SFAS 157 which defines fair value, establishes a consistent
framework for measuring fair value, establishes a fair value
hierarchy based on the observability of inputs used to measure
fair value, and requires enhanced disclosures about fair value
measurements and applied the provisions of the statement
prospectively to assets and liabilities measured at fair value.
The adoption of SFAS 157 changed the valuation of certain
freestanding derivatives by moving from a mid to bid pricing
convention as it relates to certain volatility inputs as well as
the addition of liquidity adjustments and adjustments for risks
inherent in a particular input or valuation technique. The
adoption of SFAS 157 also changed the valuation of the
Companys embedded derivatives, most significantly the
valuation of embedded derivatives associated with certain riders
on variable annuity contracts. The change in valuation of
embedded derivatives associated with riders on annuity contracts
resulted from the incorporation of risk margins associated with
non capital market inputs and the inclusion of the
Companys own credit standing in their valuation. At
January 1, 2008, the impact of adopting SFAS 157 on
assets and liabilities measured at estimated fair value was
$30 million ($19 million, net of income tax) and was
recognized as a change in estimate in the accompanying
consolidated statement of income where it was presented in the
respective income statement caption to which the item measured
at estimated fair value is presented. There were no significant
changes in estimated fair value of items measured at fair value
and reflected in accumulated other comprehensive income (loss).
The addition of risk margins and the Companys own credit
spread in the valuation of embedded derivatives associated with
annuity contracts may result in significant volatility in the
Companys
F-31
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
consolidated net income in future periods. Note 24 presents
the estimated fair value of all assets and liabilities required
to be measured at estimated fair value as well as the expanded
fair value disclosures required by SFAS 157.
In February 2007, the FASB issued SFAS No. 159, The
Fair Value Option for Financial Assets and Financial Liabilities
(SFAS 159). SFAS 159 permits entities
the option to measure most financial instruments and certain
other items at fair value at specified election dates and to
recognize related unrealized gains and losses in earnings. The
fair value option is applied on an
instrument-by-instrument
basis upon adoption of the standard, upon the acquisition of an
eligible financial asset, financial liability or firm commitment
or when certain specified reconsideration events occur. The fair
value election is an irrevocable election. Effective
January 1, 2008, the Company elected the fair value option
on fixed maturity and equity securities backing certain pension
products sold in Brazil. Such securities will now be presented
as trading securities in accordance with SFAS 115 on the
consolidated balance sheet with subsequent changes in estimated
fair value recognized in net investment income. Previously,
these securities were accounted for as available-for-sale
securities in accordance with SFAS 115 and unrealized gains
and losses on these securities were recorded as a separate
component of accumulated other comprehensive income (loss). The
Companys insurance joint venture in Japan also elected the
fair value option for certain of its existing single premium
deferred annuities and the assets supporting such liabilities.
The fair value option was elected to achieve improved reporting
of the asset/liability matching associated with these products.
Adoption of SFAS 159 by the Company and its Japanese joint
venture resulted in an increase in retained earnings of
$27 million, net of income tax, at January 1, 2008.
The election of the fair value option resulted in the
reclassification of $10 million, net of income tax, of net
unrealized gains from accumulated other comprehensive income
(loss) to retained earnings on January 1, 2008.
Effective January 1, 2008, the Company adopted FASB Staff
Position (FSP)
No. FAS 157-1,
Application of FASB Statement No. 157 to FASB Statement
No. 13 and Other Accounting Pronouncements That Address
Fair Value Measurements for Purposes of Lease Classification or
Measurement under Statement 13
(FSP 157-1).
FSP 157-1
amends SFAS 157 to provide a scope out exception for lease
classification and measurement under SFAS No. 13,
Accounting for Leases. The Company also adopted FSP
No. FAS 157-2,
Effective Date of FASB Statement No. 157 which
delays the effective date of SFAS 157 for certain
nonfinancial assets and liabilities that are recorded at fair
value on a nonrecurring basis. The effective date is delayed
until January 1, 2009 and impacts balance sheet items
including nonfinancial assets and liabilities in a business
combination and the impairment testing of goodwill and
long-lived assets.
Effective September 30, 2008, the Company adopted FSP
No. FAS 157-3,
Determining the Fair Value of a Financial Asset When the
Market for That Asset is Not Active
(FSP 157-3).
FSP 157-3
provides guidance on how a companys internal cash flow and
discount rate assumptions should be considered in the
measurement of fair value when relevant market data does not
exist, how observable market information in an inactive market
affects fair value measurement and how the use of market quotes
should be considered when assessing the relevance of observable
and unobservable data available to measure fair value. The
adoption of
FSP 157-3
did not have a material impact on the Companys
consolidated financial statements.
Effective December 31, 2008, the Company adopted FSP
No. FAS 140-4
and
FIN 46(r)-8,
Disclosures by Public Entities (Enterprises) about Transfers
of Financial Assets and Interests in Variable Interest Entities
(FSP 140-4
and
FIN 46(r)-8).
FSP 140-4
and
FIN 46(r)-8
requires additional qualitative and quantitative disclosures
about a transferors continuing involvement in transferred
financial assets and involvement in VIE. The exact nature of the
additional required VIE disclosures vary and depend on whether
or not the VIE is a qualifying special-purpose entity
(QSPE). For VIEs that are QSPEs, the additional
disclosures are only required for a non-transferor sponsor
holding a variable interest or a non-transferor servicer holding
a significant variable interest. For VIEs that are not QSPEs,
the additional disclosures are only required if the Company is
the primary beneficiary, and
F-32
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
if not the primary beneficiary, only if the Company holds a
significant variable interest or is the sponsor. The Company
provided all of the material required disclosures in its
consolidated financial statements.
Effective December 31, 2008, the Company adopted FSP
No. EITF 99-20-1,
Amendments to the Impairment Guidance of EITF Issue
No. 99-20
(FSP
EITF 99-20-1).
FSP
EITF 99-20-1
amends the guidance in EITF Issue
No. 99-20,
Recognition of Interest Income and Impairment on Purchased
Beneficial Interests and Beneficial Interests That Continue to
Be Held by a Transferor in Securitized Financial Assets, to
more closely align the guidance to determine whether an
other-than-temporary impairment has occurred for a beneficial
interest in a securitized financial asset with the guidance in
SFAS 115 for debt securities classified as
available-for-sale or held-to-maturity. The adoption of FSP
EITF 99-20-1
did not have an impact on the Companys consolidated
financial statements.
|
|
|
Derivative
Financial Instruments
|
Effective December 31, 2008, the Company adopted FSP
No. FAS 133-1
and
FIN 45-4,
Disclosures about Credit Derivatives and Certain
Guarantees An Amendment of FASB Statement
No. 133 and FASB Interpretation No. 45; and
Clarification of the Effective Date of FASB Statement
No. 161
(FSP 133-1
and
FIN 45-4).
FSP 133-1
and
FIN 45-4
amends SFAS No. 133, Accounting for Derivative
Instruments and Hedging Activities
(SFAS 133) to require certain enhanced
disclosures by sellers of credit derivatives by requiring
additional information about the potential adverse effects of
changes in their credit risk, financial performance, and cash
flows. It also amends FIN No. 45, Guarantors
Accounting and Disclosure Requirements for Guarantees, Including
Indirect Guarantees of Indebtedness of Others An
Interpretation of FASB Statements No. 5, 57, and 107 and
Rescission of FASB Interpretation No. 34
(FIN 45), to require an additional disclosure
about the current status of the payment/performance risk of a
guarantee. The Company provided all of the material required
disclosures in its consolidated financial statements.
Effective January 1, 2008, the Company adopted
SFAS 133 Implementation Issue No.
E-23,
Clarification of the Application of the Shortcut Method
(Issue
E-23).
Issue E-23
amended SFAS 133 by permitting interest rate swaps to have
a non-zero fair value at inception when applying the shortcut
method of assessing hedge effectiveness, as long as the
difference between the transaction price (zero) and the fair
value (exit price), as defined by SFAS 157, is solely
attributable to a bid-ask spread. In addition, entities are not
precluded from applying the shortcut method of assessing hedge
effectiveness in a hedging relationship of interest rate risk
involving an interest bearing asset or liability in situations
where the hedged item is not recognized for accounting purposes
until settlement date as long as the period between trade date
and settlement date of the hedged item is consistent with
generally established conventions in the marketplace. The
adoption of Issue
E-23 did not
have an impact on the Companys consolidated financial
statements.
Effective January 1, 2006, the Company adopted
prospectively SFAS No. 155, Accounting for Certain
Hybrid Instruments (SFAS 155).
SFAS 155 amends SFAS 133 and SFAS No. 140,
Accounting for Transfers and Servicing of Financial Assets
and Extinguishments of Liabilities
(SFAS 140). SFAS 155 allows financial
instruments that have embedded derivatives to be accounted for
as a whole, eliminating the need to bifurcate the derivative
from its host, if the holder elects to account for the whole
instrument on a fair value basis. In addition, among other
changes, SFAS 155:
|
|
|
|
(i)
|
clarifies which interest-only strips and principal-only strips
are not subject to the requirements of SFAS 133;
|
|
|
|
|
(ii)
|
establishes a requirement to evaluate interests in securitized
financial assets to identify interests that are freestanding
derivatives or that are hybrid financial instruments that
contain an embedded derivative requiring bifurcation;
|
|
|
|
|
(iii)
|
clarifies that concentrations of credit risk in the form of
subordination are not embedded derivatives; and
|
F-33
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
(iv)
|
amends SFAS 140 to eliminate the prohibition on a QSPE from
holding a derivative financial instrument that pertains to a
beneficial interest other than another derivative financial
interest.
|
The adoption of SFAS 155 did not have a material impact on
the Companys consolidated financial statements.
Effective October 1, 2006, the Company adopted
SFAS 133 Implementation Issue No. B40, Embedded
Derivatives: Application of Paragraph 13(b) to Securitized
Interests in Prepayable Financial Assets (Issue
B40). Issue B40 clarifies that a securitized interest in
prepayable financial assets is not subject to the conditions in
paragraph 13(b) of SFAS 133, if it meets both of the
following criteria: (i) the right to accelerate the
settlement if the securitized interest cannot be controlled by
the investor; and (ii) the securitized interest itself does
not contain an embedded derivative (including an interest
rate-related derivative) for which bifurcation would be required
other than an embedded derivative that results solely from the
embedded call options in the underlying financial assets. The
adoption of Issue B40 did not have a material impact on the
Companys consolidated financial statements.
Effective January 1, 2006, the Company adopted
prospectively SFAS 133 Implementation Issue No. B38,
Embedded Derivatives: Evaluation of Net Settlement with
Respect to the Settlement of a Debt Instrument through Exercise
of an Embedded Put Option or Call Option (Issue
B38) and SFAS 133 Implementation Issue No. B39,
Embedded Derivatives: Application of Paragraph 13(b) to
Call Options That Are Exercisable Only by the Debtor
(Issue B39). Issue B38 clarifies that the
potential settlement of a debtors obligation to a creditor
occurring upon exercise of a put or call option meets the net
settlement criteria of SFAS 133. Issue B39 clarifies that
an embedded call option, in which the underlying is an interest
rate or interest rate index, that can accelerate the settlement
of a debt host financial instrument should not be bifurcated and
fair valued if the right to accelerate the settlement can be
exercised only by the debtor (issuer/borrower) and the investor
will recover substantially all of its initial net investment.
The adoption of Issues B38 and B39 did not have a material
impact on the Companys consolidated financial statements.
Effective January 1, 2007, the Company adopted FIN 48.
FIN 48 clarifies the accounting for uncertainty in income
tax recognized in a companys financial statements.
FIN 48 requires companies to determine whether it is
more likely than not that a tax position will be
sustained upon examination by the appropriate taxing authorities
before any part of the benefit can be recorded in the financial
statements. It also provides guidance on the recognition,
measurement, and classification of income tax uncertainties,
along with any related interest and penalties. Previously
recorded income tax benefits that no longer meet this standard
are required to be charged to earnings in the period that such
determination is made.
As a result of the implementation of FIN 48, the Company
recognized a $35 million increase in the liability for
unrecognized tax benefits and a $9 million decrease in the
interest liability for unrecognized tax benefits, as well as a
$17 million increase in the liability for unrecognized tax
benefits and a $5 million increase in the interest
liability for unrecognized tax benefits which are included in
liabilities of subsidiaries held-for-sale. The corresponding
reduction to the January 1, 2007 balance of retained
earnings was $37 million, net of $11 million of
minority interest included in liabilities of subsidiaries
held-for-sale. See also Note 15.
Effective January 1, 2007, the Company adopted
SOP 05-1
which provides guidance on accounting by insurance enterprises
for DAC on internal replacements of insurance and investment
contracts other than those specifically described in
SFAS No. 97, Accounting and Reporting by Insurance
Enterprises for Certain Long-Duration Contracts and for Realized
Gains and Losses from the Sale of Investments.
SOP 05-1
defines an internal replacement and is effective for internal
replacements occurring in fiscal years beginning after
December 15, 2006. In addition, in February 2007, the
American Institute of Certified Public Accountants
(AICPA) issued related
F-34
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Technical Practice Aids (TPAs) to provide further
clarification of
SOP 05-1.
The TPAs became effective concurrently with the adoption of
SOP 05-1.
As a result of the adoption of
SOP 05-1
and the related TPAs, if an internal replacement modification
substantially changes a contract, then the DAC is written off
immediately through income and any new deferrable costs
associated with the new replacement are deferred. If a contract
modification does not substantially change the contract, the DAC
amortization on the original contract will continue and any
acquisition costs associated with the related modification are
immediately expensed.
The adoption of
SOP 05-1
and the related TPAs resulted in a reduction to DAC and VOBA on
January 1, 2007 and an acceleration of the amortization
period relating primarily to the Companys group life and
health insurance contracts that contain certain rate reset
provisions. Prior to the adoption of
SOP 05-1,
DAC on such contracts was amortized over the expected renewable
life of the contract. Upon adoption of
SOP 05-1,
DAC on such contracts is to be amortized over the rate reset
period. The impact as of January 1, 2007 was a cumulative
effect adjustment of $292 million, net of income tax of
$161 million, which was recorded as a reduction to retained
earnings.
|
|
|
Defined
Benefit and Other Postretirement Plans
|
Effective December 31, 2006, the Company adopted
SFAS 158. The pronouncement revises financial reporting
standards for defined benefit pension and other postretirement
benefit plans by requiring the:
|
|
|
|
(i)
|
recognition in the statement of financial position of the funded
status of defined benefit plans measured as the difference
between the estimated fair value of plan assets and the benefit
obligation, which is the projected benefit obligation for
pension plans and the accumulated postretirement benefit
obligation for other postretirement benefit plans;
|
|
|
|
|
(ii)
|
recognition as an adjustment to accumulated other comprehensive
income (loss), net of income tax, those amounts of actuarial
gains and losses, prior service costs and credits, and net asset
or obligation at transition that have not yet been included in
net periodic benefit costs as of the end of the year of adoption;
|
|
|
|
|
(iii)
|
recognition of subsequent changes in funded status as a
component of other comprehensive income;
|
|
|
|
|
(iv)
|
measurement of benefit plan assets and obligations as of the
date of the statement of financial position; and
|
|
|
|
|
(v)
|
disclosure of additional information about the effects on the
employers statement of financial position.
|
The adoption of SFAS 158 resulted in a reduction of
$744 million, net of income tax, to accumulated other
comprehensive income, which is included as a component of total
consolidated stockholders equity. As the Companys
measurement date for its pension and other postretirement
benefit plans is already December 31 there was no impact of
adoption due to changes in measurement date. See also
Summary of Significant Accounting Policies and Critical
Accounting Estimates and Note 17.
As described previously, effective January 1, 2006, the
Company adopted SFAS 123(r) including supplemental
application guidance issued by the U.S. Securities and Exchange
Commission in Staff Accounting Bulletin (SAB)
No. 107, Share Based Payment using the modified
prospective transition method. In accordance with the modified
prospective transition method, results for prior periods have
not been restated. SFAS 123(r) requires that the cost of
all stock-based transactions be measured at fair value and
recognized over the period during which a grantee is required to
provide goods or services in exchange for the award. The Company
had previously adopted the fair value method of accounting for
stock-based awards as prescribed by SFAS 123 on a
prospective basis effective January 1, 2003. The Company
did not modify the substantive terms of any existing awards
prior to adoption of SFAS 123(r).
F-35
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Under the modified prospective transition method, compensation
expense recognized during the year ended December 31, 2006
includes: (a) compensation expense for all stock-based
awards granted prior to, but not yet vested as of
January 1, 2006, based on the grant date fair value
estimated in accordance with the original provisions of
SFAS 123, and (b) compensation expense for all
stock-based awards granted beginning January 1, 2006, based
on the grant date fair value estimated in accordance with the
provisions of SFAS 123(r).
The adoption of SFAS 123(r) did not have a significant
impact on the Companys financial position or results of
operations as all stock-based awards accounted for under the
intrinsic value method prescribed by APB 25 had vested prior to
the adoption date and the Company had adopted the fair value
recognition provisions of SFAS 123 on January 1, 2003.
SFAS 123 allowed forfeitures of stock-based awards to be
recognized as a reduction of compensation expense in the period
in which the forfeiture occurred. Upon adoption of
SFAS 123(r), the Company changed its policy and now
incorporates an estimate of future forfeitures into the
determination of compensation expense when recognizing expense
over the requisite service period. The impact of this change in
accounting policy was not significant to the Companys
financial position or results of operations as of the date of
adoption.
Additionally, for awards granted after adoption, the Company
changed its policy from recognizing expense for stock-based
awards over the requisite service period to recognizing such
expense over the shorter of the requisite service period or the
period to attainment of retirement-eligibility. The pro forma
impact of this change in expense recognition policy for
stock-based compensation is detailed in Note 18.
Prior to the adoption of SFAS 123(r), the Company presented
tax benefits of deductions resulting from the exercise of stock
options within operating cash flows in the consolidated
statements of cash flows. SFAS 123(r) requires tax benefits
resulting from tax deductions in excess of the compensation cost
recognized for those options be classified and reported as a
financing cash inflow upon adoption of SFAS 123(r).
Effective January 1, 2008, the Company adopted FSP
No. FIN 39-1,
Amendment of FASB Interpretation No. 39
(FSP 39-1).
FSP 39-1
amends FASB Interpretation No. 39, Offsetting of Amounts
Related to Certain Contracts (FIN 39), to
permit a reporting entity to offset fair value amounts
recognized for the right to reclaim cash collateral (a
receivable) or the obligation to return cash collateral (a
payable) against fair value amounts recognized for derivative
instruments executed with the same counterparty under the same
master netting arrangement that have been offset in accordance
with FIN 39.
FSP 39-1
also amends FIN 39 for certain terminology modifications.
Upon adoption of
FSP 39-1,
the Company did not change its accounting policy of not
offsetting fair value amounts recognized for derivative
instruments under master netting arrangements. The adoption of
FSP 39-1
did not have an impact on the Companys consolidated
financial statements.
Effective January 1, 2008, the Company adopted
SAB No. 109, Written Loan Commitments Recorded at
Fair Value through Earnings (SAB 109),
which amends SAB No. 105, Application of Accounting
Principles to Loan Commitments. SAB 109 provides
guidance on (i) incorporating expected net future cash
flows when related to the associated servicing of a loan when
measuring fair value; and (ii) broadening the SEC
staffs view that internally-developed intangible assets
should not be recorded as part of the fair value of a derivative
loan commitment or to written loan commitments that are
accounted for at fair value through earnings.
Internally-developed intangible assets are not considered a
component of the related instruments. The adoption of
SAB 109 did not have an impact on the Companys
consolidated financial statements.
Effective January 1, 2008, the Company adopted Emerging
Issues Task Force (EITF) Issue
No. 07-6,
Accounting for the Sale of Real Estate When the Agreement
Includes a Buy-Sell Clause
(EITF 07-6)
prospectively.
EITF 07-6
addresses whether the existence of a buy-sell arrangement would
preclude partial sales treatment when real estate is sold to a
jointly owned entity.
EITF 07-6
concludes that the existence of a buy-sell
F-36
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
clause does not necessarily preclude partial sale treatment
under current guidance. The adoption of
EITF 07-6
did not have a material impact on the Companys
consolidated financial statements.
Effective January 1, 2007, the Company adopted FSP
No. EITF 00-19-2,
Accounting for Registration Payment Arrangements
(FSP
EITF 00-19-2).
FSP
EITF 00-19-2
specifies that the contingent obligation to make future payments
or otherwise transfer consideration under a registration payment
arrangement should be separately recognized and measured in
accordance with SFAS No. 5, Accounting for
Contingencies. The adoption of FSP
EITF 00-19-2
did not have an impact on the Companys consolidated
financial statements.
Effective January 1, 2007, the Company adopted FSP
No. FAS 13-2,
Accounting for a Change or Projected Change in the Timing of
Cash Flows Relating to Income Taxes Generated by a Leveraged
Lease Transaction
(FSP 13-2).
FSP 13-2
amends SFAS No. 13, Accounting for Leases, to
require that a lessor review the projected timing of income tax
cash flows generated by a leveraged lease annually or more
frequently if events or circumstances indicate that a change in
timing has occurred or is projected to occur. In addition,
FSP 13-2
requires that the change in the net investment balance resulting
from the recalculation be recognized as a gain or loss from
continuing operations in the same line item in which leveraged
lease income is recognized in the year in which the assumption
is changed. The adoption of
FSP 13-2
did not have a material impact on the Companys
consolidated financial statements.
Effective January 1, 2007, the Company adopted
SFAS No. 156, Accounting for Servicing of Financial
Assets an amendment of FASB Statement
No. 140 (SFAS 156). Among other
requirements, SFAS 156 requires an entity to recognize a
servicing asset or servicing liability each time it undertakes
an obligation to service a financial asset by entering into a
servicing contract in certain situations. The adoption of
SFAS 156 did not have an impact on the Companys
consolidated financial statements.
Effective November 15, 2006, the Company adopted
SAB No. 108, Considering the Effects of Prior Year
Misstatements when Quantifying Misstatements in Current Year
Financial Statements (SAB 108).
SAB 108 provides guidance on how prior year misstatements
should be considered when quantifying misstatements in current
year financial statements for purposes of assessing materiality.
SAB 108 requires that registrants quantify errors using
both a balance sheet and income statement approach and evaluate
whether either approach results in quantifying a misstatement
that, when relevant quantitative and qualitative factors are
considered, is material. SAB 108 permits companies to
initially apply its provisions by either restating prior
financial statements or recording a cumulative effect adjustment
to the carrying values of assets and liabilities as of
January 1, 2006 with an offsetting adjustment to retained
earnings for errors that were previously deemed immaterial but
are material under the guidance in SAB 108. The adoption of
SAB 108 did not have a material impact on the
Companys consolidated financial statements.
Effective January 1, 2006, the Company adopted
prospectively EITF Issue
No. 05-7,
Accounting for Modifications to Conversion Options Embedded
in Debt Instruments and Related Issues
(EITF 05-7).
EITF 05-7
provides guidance on whether a modification of conversion
options embedded in debt results in an extinguishment of that
debt. In certain situations, companies may change the terms of
an embedded conversion option as part of a debt modification.
The EITF concluded that the change in the fair value of an
embedded conversion option upon modification should be included
in the analysis of EITF Issue
No. 96-19,
Debtors Accounting for a Modification or Exchange of
Debt Instruments, to determine whether a modification or
extinguishment has occurred and that a change in the fair value
of a conversion option should be recognized upon the
modification as a discount (or premium) associated with the
debt, and an increase (or decrease) in additional paid-in
capital. The adoption of
EITF 05-7
did not have a material impact on the Companys
consolidated financial statements.
Effective January 1, 2006, the Company adopted EITF Issue
No. 05-8,
Income Tax Consequences of Issuing Convertible Debt with a
Beneficial Conversion Feature
(EITF 05-8).
EITF 05-8
concludes that: (i) the issuance of convertible debt with a
beneficial conversion feature results in a basis difference that
should be accounted for as a
F-37
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
temporary difference; and (ii) the establishment of the
deferred tax liability for the basis difference should result in
an adjustment to additional paid-in capital.
EITF 05-8
was applied retrospectively for all instruments with a
beneficial conversion feature accounted for in accordance with
EITF Issue
No. 98-5,
Accounting for Convertible Securities with Beneficial
Conversion Features or Contingently Adjustable Conversion
Ratios, and EITF Issue
No. 00-27,
Application of Issue
No. 98-5
to Certain Convertible Instruments. The adoption of
EITF 05-8
did not have a material impact on the Companys
consolidated financial statements.
Effective January 1, 2006, the Company adopted
SFAS No. 154, Accounting Changes and Error
Corrections, a replacement of APB Opinion No. 20 and FASB
Statement No. 3 (SFAS 154).
SFAS 154 requires retrospective application to prior
periods financial statements for a voluntary change in
accounting principle unless it is deemed impracticable. It also
requires that a change in the method of depreciation,
amortization, or depletion for long-lived, non-financial assets
be accounted for as a change in accounting estimate rather than
a change in accounting principle. The adoption of SFAS 154
did not have a material impact on the Companys
consolidated financial statements.
Future
Adoption of New Accounting Pronouncements
In December 2007, the FASB issued SFAS No. 141
(revised 2007), Business Combinations A
Replacement of FASB Statement No. 141
(SFAS 141(r)) and SFAS No. 160,
Noncontrolling Interests in Consolidated Financial
Statements An Amendment of ARB No. 51
(SFAS 160). Under SFAS 141(r) and
SFAS 160:
|
|
|
|
|
All business combinations (whether full, partial or
step acquisitions) result in all assets and
liabilities of an acquired business being recorded at fair
value, with limited exceptions.
|
|
|
|
Acquisition costs are generally expensed as incurred;
restructuring costs associated with a business combination are
generally expensed as incurred subsequent to the acquisition
date.
|
|
|
|
The fair value of the purchase price, including the issuance of
equity securities, is determined on the acquisition date.
|
|
|
|
Certain acquired contingent liabilities are recorded at fair
value at the acquisition date and subsequently measured at
either the higher of such amount or the amount determined under
existing guidance for non-acquired contingencies.
|
|
|
|
Changes in deferred tax asset valuation allowances and income
tax uncertainties after the acquisition date generally affect
income tax expense.
|
|
|
|
Noncontrolling interests (formerly known as minority
interests) are valued at fair value at the acquisition
date and are presented as equity rather than liabilities.
|
|
|
|
When control is attained on previously noncontrolling interests,
the previously held equity interests are remeasured at fair
value and a gain or loss is recognized.
|
|
|
|
Purchases or sales of equity interests that do not result in a
change in control are accounted for as equity transactions.
|
|
|
|
When control is lost in a partial disposition, realized gains or
losses are recorded on equity ownership sold and the remaining
ownership interest is remeasured and holding gains or losses are
recognized.
|
The pronouncements are effective for fiscal years beginning on
or after December 15, 2008 and apply prospectively to
business combinations after that date. Presentation and
disclosure requirements related to noncontrolling interests must
be retrospectively applied. The Company will apply the guidance
in SFAS 141(r) prospectively on its accounting for future
acquisitions and does not expect the adoption of SFAS 160
to have a material impact on the Companys consolidated
financial statements.
F-38
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
In November 2008, the FASB ratified the consensus on EITF Issue
No. 08-6,
Equity Method Investment Accounting Considerations
(EITF 08-6).
EITF 08-6
addresses a number of issues associated with the impact that
SFAS 141(r) and SFAS 160 might have on the accounting
for equity method investments, including how an equity method
investment should initially be measured, how it should be tested
for impairment, and how changes in classification from equity
method to cost method should be treated.
EITF 08-6
is effective prospectively for fiscal years beginning on or
after December 15, 2008. The Company does not expect the
adoption of
EITF 08-6
to have a material impact on the Companys consolidated
financial statements.
In November 2008, the FASB ratified the consensus on EITF Issue
No. 08-7,
Accounting for Defensive Intangible Assets
(EITF 08-7).
EITF 08-7
requires that an acquired defensive intangible asset (i.e., an
asset an entity does not intend to actively use, but rather,
intends to prevent others from using) be accounted for as a
separate unit of accounting at time of acquisition, not combined
with the acquirers existing intangible assets. In
addition, the EITF concludes that a defensive intangible asset
may not be considered immediately abandoned following its
acquisition or have indefinite life. The Company will apply the
guidance of
EITF 08-7
prospectively to its intangible assets acquired after fiscal
years beginning on or after December 15, 2008.
In April 2008, the FASB issued FSP
No. FAS 142-3,
Determination of the Useful Life of Intangible Assets
(FSP 142-3).
FSP 142-3
amends the factors that should be considered in developing
renewal or extension assumptions used to determine the useful
life of a recognized intangible asset under
SFAS No. 142, Goodwill and Other Intangible Assets
(SFAS 142). This change is intended to
improve the consistency between the useful life of a recognized
intangible asset under SFAS 142 and the period of expected
cash flows used to measure the fair value of the asset under
SFAS 141(r) and other GAAP.
FSP 142-3
is effective for financial statements issued for fiscal years
beginning after December 15, 2008, and interim periods
within those fiscal years. The requirement for determining
useful lives and related disclosures will be applied
prospectively to intangible assets acquired as of, and
subsequent to, the effective date.
|
|
|
Derivative
Financial Instruments
|
In March 2008, the FASB issued SFAS No. 161,
Disclosures about Derivative Instruments and Hedging
Activities An Amendment of FASB Statement
No. 133 (SFAS 161). SFAS 161
requires enhanced qualitative disclosures about objectives and
strategies for using derivatives, quantitative disclosures about
fair value amounts of and gains and losses on derivative
instruments, and disclosures about credit-risk-related
contingent features in derivative agreements. SFAS 161 is
effective for financial statements issued for fiscal years and
interim periods beginning after November 15, 2008. The
Company will provide all of the material required disclosures in
the appropriate future interim and annual periods.
In December 2008, the FASB issued FSP
No. FAS 132(r)-1,
Employers Disclosures about Postretirement Benefit Plan
Assets (FSP 132(r)-1). FSP 132(r)-1
amends SFAS No. 132(r), Employers Disclosures
about Pensions and Other Postretirement Benefits to enhance
the transparency surrounding the types of assets and associated
risks in an employers defined benefit pension or other
postretirement plan. The FSP requires an employer to disclose
information about the valuation of plan assets similar to that
required under SFAS 157. FSP 132(r)-1 is effective for
fiscal years ending after December 15, 2009. The Company
will provide all of the material required disclosures in the
appropriate future annual period.
In September 2008, the FASB ratified the consensus on EITF Issue
No. 08-5,
Issuers Accounting for Liabilities Measured at Fair
Value with a Third-Party Credit Enhancement
(EITF 08-5).
EITF 08-5
concludes that an issuer of a liability with a third-party
credit enhancement should not include the effect of the credit
enhancement in the fair value measurement of the liability. In
addition,
EITF 08-5
requires disclosures about the existence of any third-party
credit enhancement related to liabilities that are measured at
fair value.
EITF 08-5
is effective beginning in the first reporting period after
December 15, 2008 and will be applied prospectively, with
the effect of initial
F-39
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
application included in the change in fair value of the
liability in the period of adoption. The Company does not expect
the adoption of
EITF 08-5
to have a material impact on the Companys consolidated
financial statements.
In June 2008, the FASB ratified the consensus on EITF Issue
No. 07-5,
Determining Whether an Instrument (or Embedded Feature) Is
Indexed to an Entitys Own Stock
(EITF 07-5).
EITF 07-5
provides a framework for evaluating the terms of a particular
instrument and whether such terms qualify the instrument as
being indexed to an entitys own stock.
EITF 07-5
is effective for financial statements issued for fiscal years
beginning after December 15, 2008 and must be applied by
recording a cumulative effect adjustment to the opening balance
of retained earnings at the date of adoption. The Company does
not expect the adoption of
EITF 07-5
to have a material impact on its consolidated financial
statements.
In February 2008, the FASB issued FSP
No. FAS 140-3,
Accounting for Transfers of Financial Assets and Repurchase
Financing Transactions
(FSP 140-3).
FSP 140-3
provides guidance for evaluating whether to account for a
transfer of a financial asset and repurchase financing as a
single transaction or as two separate transactions.
FSP 140-3
is effective prospectively for financial statements issued for
fiscal years beginning after November 15, 2008. The Company
does not expect the adoption of
FSP 140-3
to have a material impact on its consolidated financial
statements.
|
|
2.
|
Acquisitions
and Dispositions
|
Disposition
of Reinsurance Group of America, Incorporated
On September 12, 2008, the Company completed a tax-free
split-off of its majority-owned subsidiary, Reinsurance Group of
America, Incorporated (RGA). The Company and RGA
entered into a recapitalization and distribution agreement,
pursuant to which the Company agreed to divest substantially all
of its 52% interest in RGA to the Companys stockholders.
The split-off was effected through the following:
|
|
|
|
|
A recapitalization of RGA common stock into two classes of
common stock RGA Class A common stock and RGA
Class B common stock. Pursuant to the terms of the
recapitalization, each outstanding share of RGA common stock,
including the 32,243,539 shares of RGA common stock
beneficially owned by the Company and its subsidiaries, was
reclassified as one share of RGA Class A common stock.
Immediately thereafter, the Company and its subsidiaries
exchanged 29,243,539 shares of its RGA Class A common
stock which represented all of the RGA Class A
common stock beneficially owned by the Company and its
subsidiaries other than 3,000,000 shares of RGA
Class A common stock with RGA for
29,243,539 shares of RGA Class B common stock.
|
|
|
|
An exchange offer, pursuant to which the Company offered to
acquire MetLife common stock from its stockholders in exchange
for all of its 29,243,539 shares of RGA Class B common
stock. The exchange ratio was determined based upon a
ratio as more specifically described in the exchange
offering document of the value of the MetLife and
RGA shares during the
three-day
period prior to the closing of the exchange offer. The
3,000,000 shares of the RGA Class A common stock were
not subject to the tax-free exchange.
|
As a result of completion of the recapitalization and exchange
offer, the Company received from MetLife stockholders
23,093,689 shares of the Companys common stock with a
market value of $1,318 million and, in exchange, delivered
29,243,539 shares of RGAs Class B common stock
with a net book value of $1,716 million. The resulting loss
on disposition, inclusive of transaction costs of
$60 million, was $458 million. The
3,000,000 shares of RGA Class A common stock retained
by the Company are marketable equity securities which do not
constitute significant continuing involvement in the operations
of RGA; accordingly, they have been classified within equity
securities in the consolidated financial statements of the
Company at a cost basis of $157 million which is equivalent
to the net book value of the shares. The cost basis will be
adjusted to fair value at each subsequent reporting date. The
Company has agreed to dispose of the remaining shares of RGA
within the next five years. In connection with the
Companys agreement to dispose of the remaining shares, the
Company also
F-40
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
recognized, in its provision for income tax on continuing
operations, a deferred tax liability of $16 million which
represents the difference between the book and taxable basis of
the remaining investment in RGA.
The impact of the disposition of the Companys investment
in RGA is reflected in the Companys consolidated financial
statements as discontinued operations. The disposition of RGA
results in the elimination of the Companys Reinsurance
segment. The Reinsurance segment was comprised of the results of
RGA, which at disposition became discontinued operations of
Corporate & Other, and the interest on economic
capital, which has been reclassified to the continuing
operations of Corporate & Other. See Note 23 for
reclassifications related to discontinued operations and
Note 22 for segment information.
Disposition
of Texas Life Insurance Company
MetLife, Inc. has entered into an agreement to sell Cova
Corporation (Cova), the parent company of Texas Life
Insurance Company, to a third party in the fourth quarter of
2008. The transaction is expected to close in early 2009. As a
result of the sale agreement, the Company recognized gains from
discontinued operations of $37 million, net of income tax,
in the fourth quarter of 2008. The gain was comprised of
recognition of tax benefits of $65 million relating to the
excess of outside tax basis of Cova over its financial reporting
basis, offset by other than temporary impairments of
$28 million, net of income tax, relating to Covas
investments. The Company has reclassified the assets and
liabilities of Cova as held-for-sale and its operations into
discontinued operations for all periods presented in the
consolidated financial statements. See also Note 23.
2008
Acquisitions
During 2008, the Company made five acquisitions for
$783 million. As a result of these acquisitions,
MetLifes Institutional segment increased its product
offering of dental and vision benefit plans, MetLife Bank within
Corporate & Other entered the mortgage origination and
servicing business and the International segment increased its
presence in Mexico and Brazil. The acquisitions were each
accounted for using the purchase method of accounting, and
accordingly, commenced being included in the operating results
of the Company upon their respective closing dates. Total
consideration paid by the Company for these acquisitions
consisted of $763 million in cash and $20 million in
transaction costs. The net fair value of assets acquired and
liabilities assumed totaled $527 million, resulting in
goodwill of $256 million. Goodwill increased by
$122 million, $73 million and $61 million in the
International segment, Institutional segment and
Corporate & Other, respectively. The goodwill is
deductible for tax purposes. VOCRA, VOBA and other intangibles
increased by $137 million, $7 million and
$6 million, respectively, as a result of these
acquisitions. Further information on VOBA, goodwill and VOCRA is
provided in Notes 5, 6 and 7, respectively.
2007
Acquisition and Disposition
On June 28, 2007, the Company acquired the remaining 50%
interest in a joint venture in Hong Kong, MetLife Fubon Limited
(MetLife Fubon), for $56 million in cash,
resulting in MetLife Fubon becoming a consolidated subsidiary of
the Company. The transaction was treated as a step acquisition,
and at June 30, 2007, total assets and liabilities of
MetLife Fubon of $839 million and $735 million,
respectively, were included in the Companys consolidated
balance sheet. The Companys investment for the initial 50%
interest in MetLife Fubon was $48 million. The Company used
the equity method of accounting for such investment in MetLife
Fubon. The Companys share of the joint ventures
results for the six months ended June 30, 2007, was a loss
of $3 million. The fair value of the assets acquired and
the liabilities assumed in the step acquisition at June 30,
2007, was $427 million and $371 million, respectively.
No additional goodwill was recorded as a part of the step
acquisition. As a result of this acquisition, additional VOBA
and VODA of $45 million and $5 million, respectively,
were recorded and both have a weighted average amortization
period of 16 years. In June 2008, the Company revised the
valuation of certain long-term liabilities, VOBA, and VODA based
on new information received. As a result, the fair value of
acquired insurance liabilities and VOBA were reduced by
$5 million and $12 million, respectively, offset by an
increase in
F-41
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
VODA of $7 million. The revised VOBA and VODA have a
weighted average amortization period of 11 years. Further
information on VOBA and VODA is described in Notes 5 and 7,
respectively.
On June 1, 2007, the Company completed the sale of its
Bermuda insurance subsidiary, MetLife International Insurance,
Ltd. (MLII), to a third party for $33 million
in cash consideration, resulting in a gain upon disposal of
$3 million, net of income tax. The net assets of MLII at
disposal were $27 million. A liability of $1 million
was recorded with respect to a guarantee provided in connection
with this disposition. Further information on guarantees is
described in Note 16.
Other
Acquisitions and Dispositions
On July 1, 2005, the Company completed the acquisition of
Travelers for $12.1 billion. The acquisition was accounted
for using the purchase method of accounting. The net fair value
of assets acquired and liabilities assumed totaled
$7.8 billion, resulting in goodwill of $4.3 billion.
The initial consideration paid by the Company in 2005 for the
acquisition consisted of $10.9 billion in cash and
22,436,617 shares of the Companys common stock with a
market value of $1.0 billion to Citigroup and
$100 million in other transaction costs. The Company
revised the purchase price as a result of the finalization by
both parties of their review of the June 30, 2005 financial
statements and final resolution as to the interpretation of the
provisions of the acquisition agreement which resulted in a
payment of additional consideration of $115 million by the
Company to Citigroup in 2006.
See Note 23 for information on the disposition of the
annuities and pension businesses of MetLife Insurance Limited
(MetLife Australia) and SSRM Holdings, Inc.
Fixed
Maturity and Equity Securities Available-for-Sale
The following tables present the cost or amortized cost, gross
unrealized gain and loss, estimated fair value of the
Companys fixed maturity and equity securities, and the
percentage that each sector represents by the respective total
holdings at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
Cost or
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortized
|
|
|
Gross Unrealized
|
|
|
Estimated
|
|
|
% of
|
|
|
|
Cost
|
|
|
Gain
|
|
|
Loss
|
|
|
Fair Value
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
|
|
|
U.S. corporate securities
|
|
$
|
72,211
|
|
|
$
|
994
|
|
|
$
|
9,902
|
|
|
$
|
63,303
|
|
|
|
33.6
|
%
|
Residential mortgage-backed securities
|
|
|
39,995
|
|
|
|
753
|
|
|
|
4,720
|
|
|
|
36,028
|
|
|
|
19.2
|
|
Foreign corporate securities
|
|
|
34,798
|
|
|
|
565
|
|
|
|
5,684
|
|
|
|
29,679
|
|
|
|
15.8
|
|
U.S. Treasury/agency securities
|
|
|
17,229
|
|
|
|
4,082
|
|
|
|
1
|
|
|
|
21,310
|
|
|
|
11.3
|
|
Commercial mortgage-backed securities
|
|
|
16,079
|
|
|
|
18
|
|
|
|
3,453
|
|
|
|
12,644
|
|
|
|
6.7
|
|
Asset-backed securities
|
|
|
14,246
|
|
|
|
16
|
|
|
|
3,739
|
|
|
|
10,523
|
|
|
|
5.6
|
|
Foreign government securities
|
|
|
9,474
|
|
|
|
1,056
|
|
|
|
377
|
|
|
|
10,153
|
|
|
|
5.4
|
|
State and political subdivision securities
|
|
|
5,419
|
|
|
|
80
|
|
|
|
942
|
|
|
|
4,557
|
|
|
|
2.4
|
|
Other fixed maturity securities
|
|
|
57
|
|
|
|
|
|
|
|
3
|
|
|
|
54
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities (1), (2)
|
|
$
|
209,508
|
|
|
$
|
7,564
|
|
|
$
|
28,821
|
|
|
$
|
188,251
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
$
|
1,778
|
|
|
$
|
40
|
|
|
$
|
133
|
|
|
$
|
1,685
|
|
|
|
52.7
|
%
|
Non-redeemable preferred stock (1)
|
|
|
2,353
|
|
|
|
4
|
|
|
|
845
|
|
|
|
1,512
|
|
|
|
47.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
$
|
4,131
|
|
|
$
|
44
|
|
|
$
|
978
|
|
|
$
|
3,197
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-42
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2007
|
|
|
|
Cost or
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortized
|
|
|
Gross Unrealized
|
|
|
Estimated
|
|
|
% of
|
|
|
|
Cost
|
|
|
Gain
|
|
|
Loss
|
|
|
Fair Value
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
|
|
|
U.S. corporate securities
|
|
$
|
74,310
|
|
|
$
|
1,685
|
|
|
$
|
2,076
|
|
|
$
|
73,919
|
|
|
|
31.8
|
%
|
Residential mortgage-backed securities
|
|
|
54,773
|
|
|
|
598
|
|
|
|
376
|
|
|
|
54,995
|
|
|
|
23.7
|
|
Foreign corporate securities
|
|
|
36,232
|
|
|
|
1,701
|
|
|
|
767
|
|
|
|
37,166
|
|
|
|
16.0
|
|
U.S. Treasury/agency securities
|
|
|
19,723
|
|
|
|
1,482
|
|
|
|
13
|
|
|
|
21,192
|
|
|
|
9.1
|
|
Commercial mortgage-backed securities
|
|
|
16,946
|
|
|
|
241
|
|
|
|
194
|
|
|
|
16,993
|
|
|
|
7.3
|
|
Asset-backed securities
|
|
|
11,048
|
|
|
|
40
|
|
|
|
516
|
|
|
|
10,572
|
|
|
|
4.6
|
|
Foreign government securities
|
|
|
11,645
|
|
|
|
1,350
|
|
|
|
182
|
|
|
|
12,813
|
|
|
|
5.5
|
|
State and political subdivision securities
|
|
|
4,342
|
|
|
|
140
|
|
|
|
114
|
|
|
|
4,368
|
|
|
|
1.9
|
|
Other fixed maturity securities
|
|
|
335
|
|
|
|
13
|
|
|
|
30
|
|
|
|
318
|
|
|
|
0.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities (1),(2)
|
|
$
|
229,354
|
|
|
$
|
7,250
|
|
|
$
|
4,268
|
|
|
$
|
232,336
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
$
|
2,477
|
|
|
$
|
568
|
|
|
$
|
108
|
|
|
$
|
2,937
|
|
|
|
49.7
|
%
|
Non-redeemable preferred stock (1)
|
|
|
3,255
|
|
|
|
60
|
|
|
|
341
|
|
|
|
2,974
|
|
|
|
50.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
$
|
5,732
|
|
|
$
|
628
|
|
|
$
|
449
|
|
|
$
|
5,911
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The Company classifies perpetual securities that have attributes
of both debt and equity as fixed maturity securities if the
security has a punitive interest rate
step-up
feature as it believes in most instances this feature will
compel the issuer to redeem the security at the specified call
date. Perpetual securities that do not have a punitive interest
rate step-up
feature are classified as non-redeemable preferred stock. Many
of such securities have been issued by
non-U.S.
financial institutions that are accorded Tier 1 and Upper
Tier 2 capital treatment by their respective regulatory
bodies and are commonly referred to as perpetual hybrid
securities. Perpetual hybrid securities classified as
non-redeemable preferred stock held by the Company at
December 31, 2008 and 2007 had an estimated fair value of
$1,224 million and $2,051 million, respectively. In
addition, the Company held $288 million and
$923 million at estimated fair value, respectively, at
December 31, 2008 and 2007 of other perpetual hybrid
securities, primarily U.S. financial institutions, also included
in non-redeemable preferred stock. Perpetual hybrid securities
held by the Company and included within fixed maturity
securities (primarily within foreign corporate securities) at
December 31, 2008 and 2007 had an estimated fair value of
$2,110 million and $3,896 million, respectively. In
addition, the Company held $46 million and $57 million
at estimated fair value, respectively, at December 31, 2008
and 2007 of other perpetual hybrid securities, primarily U.S.
financial institutions, included in fixed maturity securities. |
|
(2) |
|
At December 31, 2008 and 2007 the Company also held
$2,052 million and $3,432 million at estimated fair
value, respectively, of redeemable preferred stock which have
stated maturity dates which are included within fixed maturity
securities. These securities are primarily issued by U.S.
financial institutions, have cumulative interest deferral
features and are commonly referred to as capital
securities within U.S. corporate securities. |
The Company held foreign currency derivatives with notional
amounts of $9.1 billion and $9.2 billion to hedge the
exchange rate risk associated with foreign denominated fixed
maturity securities at December 31, 2008 and 2007,
respectively.
Below Investment Grade or Non Rated Fixed Maturity
Securities. The Company held fixed maturity securities at
estimated fair values that were below investment grade or not
rated by an independent rating agency that totaled
$12.4 billion and $17.4 billion at December 31,
2008 and 2007, respectively. These securities had net unrealized
losses of $5,094 million and $103 million at
December 31, 2008 and 2007, respectively.
F-43
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Non-Income Producing Fixed Maturity Securities.
Non-income producing fixed maturity securities at estimated
fair value were $75 million and $12 million at
December 31, 2008 and 2007, respectively. Net unrealized
gains (losses) associated with non-income producing fixed
maturity securities were ($19) million and $11 million
at December 31, 2008 and 2007, respectively.
Fixed Maturity Securities Credit Enhanced by Financial
Guarantee Insurers. At December 31, 2008,
$4.9 billion of the estimated fair value of the
Companys fixed maturity securities were credit enhanced by
financial guarantee insurers of which $2.0 billion,
$2.0 billion and $0.9 billion, are included within
state and political subdivision securities, U.S. corporate
securities, and asset-backed securities, respectively, and 15%
and 68% were guaranteed by financial guarantee insurers who were
Aa and Baa rated, respectively. As described below, all of the
asset-backed securities that are credit enhanced by financial
guarantee insurers are asset-backed securities which are backed
by sub-prime mortgage loans.
Concentrations of Credit Risk (Fixed Maturity Securities).
The following section contains a summary of the
concentrations of credit risk related to fixed maturity
securities holdings.
The Company is not exposed to any concentrations of credit risk
of any single issuer greater than 10% of the Companys
stockholders equity, other than securities of the
U.S. government and certain U.S. government agencies.
At December 31, 2008 and 2007, the Companys holdings
in U.S. Treasury and agency fixed maturity securities at
estimated fair value were $21.3 billion and
$21.2 billion, respectively. As shown in the sector table
above, at December 31, 2008 the Companys three
largest exposures in its fixed maturity security portfolio were
U.S. corporate fixed maturity securities (33.6%),
residential mortgage-backed securities (19.2%), and foreign
corporate securities (15.8%); and at December 31, 2007 were
U.S. corporate fixed maturity securities (31.8%),
residential mortgage-backed securities (23.7%), and foreign
corporate securities (16.0%).
Concentrations of Credit Risk (Fixed Maturity
Securities) U.S. and Foreign Corporate
Securities. At December 31, 2008 and 2007, the
Companys holdings in U.S. corporate and foreign
corporate fixed maturity securities at estimated fair value were
$93.0 billion and $111.1 billion, respectively. The
Company maintains a diversified portfolio of corporate
securities across industries and issuers. The portfolio does not
have exposure to any single issuer in excess of 1% of total
invested assets. The exposure to the largest single issuer of
corporate fixed maturity securities held at December 31,
2008 and 2007 was $1.5 billion and $1.2 billion,
respectively. At December 31, 2008 and 2007, the
Companys combined holdings in the ten issuers to which it
had the greatest exposure totaled $8.4 billion and
$7.8 billion, respectively, the total of these ten issuers
being less than 3% of the Companys total invested assets
at such dates. The table below shows the major industry types
that comprise the corporate fixed maturity holdings at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
Estimated
|
|
|
% of
|
|
|
Estimated
|
|
|
% of
|
|
|
|
Fair Value
|
|
|
Total
|
|
|
Fair Value
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Foreign (1)
|
|
$
|
29,679
|
|
|
|
32.0
|
%
|
|
$
|
37,166
|
|
|
|
33.4
|
%
|
Finance
|
|
|
14,996
|
|
|
|
16.1
|
|
|
|
20,639
|
|
|
|
18.6
|
|
Industrial
|
|
|
13,324
|
|
|
|
14.3
|
|
|
|
15,838
|
|
|
|
14.3
|
|
Consumer
|
|
|
13,122
|
|
|
|
14.1
|
|
|
|
15,793
|
|
|
|
14.2
|
|
Utility
|
|
|
12,434
|
|
|
|
13.4
|
|
|
|
13,206
|
|
|
|
11.9
|
|
Communications
|
|
|
5,714
|
|
|
|
6.1
|
|
|
|
7,679
|
|
|
|
6.9
|
|
Other
|
|
|
3,713
|
|
|
|
4.0
|
|
|
|
764
|
|
|
|
0.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
92,982
|
|
|
|
100.0
|
%
|
|
$
|
111,085
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-44
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
(1) |
|
Includes U.S. dollar-denominated debt obligations of foreign
obligors, and other fixed maturity foreign investments. |
Concentrations of Credit Risk (Fixed Maturity
Securities) Residential Mortgage-Backed Securities.
The Companys residential mortgage-backed securities
consist of the following holdings at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
Estimated
|
|
|
% of
|
|
|
Estimated
|
|
|
% of
|
|
|
|
Fair Value
|
|
|
Total
|
|
|
Fair Value
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Collateralized mortgage obligations
|
|
$
|
26,025
|
|
|
|
72.2
|
%
|
|
$
|
36,303
|
|
|
|
66.0
|
%
|
Pass-through securities
|
|
|
10,003
|
|
|
|
27.8
|
|
|
|
18,692
|
|
|
|
34.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total residential mortgage-backed securities
|
|
$
|
36,028
|
|
|
|
100.0
|
%
|
|
$
|
54,995
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Collateralized mortgage obligations are a type of
mortgage-backed security that creates separate pools or tranches
of pass-through cash flows for different classes of bondholders
with varying maturities. Pass-through mortgage-backed securities
are a type of asset-backed security that is secured by a
mortgage or collection of mortgages. The monthly mortgage
payments from homeowners pass from the originating bank through
an intermediary, such as a government agency or investment bank,
which collects the payments, and for fee, remits or passes these
payments through to the holders of the pass-through securities.
At December 31, 2008, the exposures in the Companys
residential mortgage-backed securities portfolio consist of
agency, prime, and alternative residential mortgage loans
(Alt-A) securities of 68%, 23%, and 9% of the total
holdings, respectively. At December 31, 2008 and 2007,
$33.3 billion and $54.7 billion, respectively, or 92%
and 99% respectively of the residential mortgage-backed
securities were rated Aaa/AAA by Moodys Investors Service
(Moodys), S&P, or Fitch Ratings
(Fitch). The majority of the agency residential
mortgage-backed securities are guaranteed or otherwise supported
by the Federal National Mortgage Association, the Federal Home
Loan Mortgage Corporation or the Government National Mortgage
Association. Prime residential mortgage lending includes the
origination of residential mortgage loans to the most
credit-worthy customers with high quality credit profiles. Alt-A
residential mortgage loans are a classification of mortgage
loans where the risk profile of the borrower falls between prime
and sub-prime. At December 31, 2008 and 2007, the
Companys Alt-A residential mortgage-backed securities
exposure was $3.4 billion and $6.3 billion,
respectively, with an unrealized loss of $1,963 million and
$139 million, respectively. At December 31, 2008 and
December 31, 2007, $2.1 billion and $6.3 billion,
respectively, or 63% and 99%, respectively, of the
Companys Alt-A residential mortgage-backed securities were
rated Aa/AA or better by Moodys, S&P or Fitch. In
December 2008, certain Alt-A residential mortgage-backed
securities experienced ratings downgrades from investment grade
to below investment grade, contributing to the decrease year
over year cited above in those securities rated Aa/AA or better.
At December 31, 2008 the Companys Alt-A holdings are
distributed as follows: 23% 2007 vintage year, 25% 2006 vintage
year; and 52% in the 2005 and prior vintage years. In January
2009, Moodys revised its loss projections for Alt-A
residential mortgage-backed securities, and the Company
anticipates that Moodys will be downgrading virtually all
2006 and 2007 vintage year Alt-A securities to below investment
grade, which will increase the percentage of our Alt-A
residential mortgage-backed securities portfolio that will be
rated below investment grade. Vintage year refers to the year of
origination and not to the year of purchase.
Concentrations of Credit Risk (Fixed Maturity
Securities) Commercial Mortgage-Backed Securities.
At December 31, 2008 and 2007, the Companys
holdings in commercial mortgage-backed securities was
$12.6 billion and $17.0 billion, respectively, at
estimated fair value. At December 31, 2008 and 2007,
$11.8 billion and $14.9 billion, respectively, of the
estimated fair value, or 93% and 88%, respectively, of the
commercial mortgage-backed securities were rated Aaa/AAA by
Moodys, S&P, or Fitch. At December 31, 2008, the
rating distribution of
F-45
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
the Companys commercial mortgage-backed securities
holdings was as follows: 93% Aaa, 4% Aa, 1% A, 1% Baa, and 1% Ba
or below. At December 31, 2008, 84% of the holdings are in
the 2005 and prior vintage years. At December 31, 2008, the
Company had no exposure to CMBX securities and its holdings of
commercial real estate collateralized debt obligations
(CRE-CDO) securities was $121 million at
estimated fair value.
Concentrations of Credit Risk (Fixed Maturity
Securities) Asset-Backed
Securities. At December 31, 2008 and 2007,
the Companys holdings in asset-backed securities was
$10.5 billion and $10.6 billion, respectively, at
estimated fair value. The Companys asset-backed securities
are diversified both by sector and by issuer. At
December 31, 2008 and 2007, $7.9 billion and
$5.7 billion, respectively, or 75% and 54%, respectively,
of total asset-backed securities were rated Aaa/AAA by
Moodys, S&P or Fitch. At December 31, 2008, the
largest exposures in the Companys asset-backed securities
portfolio were credit card receivables, residential
mortgage-backed securities backed by sub-prime mortgage loans,
automobile receivables and student loan receivables of 49%, 10%,
10% and 10% of the total holdings, respectively. Sub-prime
mortgage lending is the origination of residential mortgage
loans to customers with weak credit profiles. At
December 31, 2008 and 2007, the Company had exposure to
fixed maturity securities backed by sub-prime mortgage loans
with estimated fair values of $1.1 billion and
$2.0 billion, respectively, and unrealized losses of
$730 million and $198 million, respectively. At
December 31, 2008, 37% of the asset-backed securities
backed by sub-prime mortgage loans have been guaranteed by
financial guarantee insurers, of which 19% and 37% were
guaranteed by financial guarantee insurers who were Aa and Baa
rated, respectively.
Concentrations of Credit Risk (Equity
Securities). The Company is not exposed to any
concentrations of credit risk of any single issuer greater than
10% of the Companys stockholders equity in its
equity securities holdings.
The amortized cost and estimated fair value of fixed maturity
securities, by contractual maturity date (excluding scheduled
sinking funds), are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
Amortized
|
|
|
Estimated
|
|
|
Amortized
|
|
|
Estimated
|
|
|
|
Cost
|
|
|
Fair Value
|
|
|
Cost
|
|
|
Fair Value
|
|
|
|
(In millions)
|
|
|
Due in one year or less
|
|
$
|
5,556
|
|
|
$
|
5,491
|
|
|
$
|
4,362
|
|
|
$
|
4,453
|
|
Due after one year through five years
|
|
|
33,604
|
|
|
|
30,884
|
|
|
|
41,297
|
|
|
|
42,013
|
|
Due after five years through ten years
|
|
|
41,481
|
|
|
|
36,895
|
|
|
|
38,969
|
|
|
|
39,227
|
|
Due after ten years
|
|
|
58,547
|
|
|
|
55,786
|
|
|
|
61,959
|
|
|
|
64,083
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
139,188
|
|
|
|
129,056
|
|
|
|
146,587
|
|
|
|
149,776
|
|
Mortgage-backed and asset-backed securities
|
|
|
70,320
|
|
|
|
59,195
|
|
|
|
82,767
|
|
|
|
82,560
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
$
|
209,508
|
|
|
$
|
188,251
|
|
|
$
|
229,354
|
|
|
$
|
232,336
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities not due at a single maturity date have
been included in the above table in the year of final
contractual maturity. Actual maturities may differ from
contractual maturities due to the exercise of prepayment options.
F-46
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Net
Unrealized Investment Gains (Losses)
The components of net unrealized investment gains (losses),
included in accumulated other comprehensive income (loss), are
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Fixed maturity securities
|
|
$
|
(21,246
|
)
|
|
$
|
3,479
|
|
|
$
|
5,075
|
|
Equity securities
|
|
|
(934
|
)
|
|
|
159
|
|
|
|
541
|
|
Derivatives
|
|
|
(2
|
)
|
|
|
(373
|
)
|
|
|
(208
|
)
|
Minority interest
|
|
|
(10
|
)
|
|
|
(150
|
)
|
|
|
(159
|
)
|
Other
|
|
|
53
|
|
|
|
3
|
|
|
|
9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
(22,139
|
)
|
|
|
3,118
|
|
|
|
5,258
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts allocated from:
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance liability loss recognition
|
|
|
42
|
|
|
|
(608
|
)
|
|
|
(1,149
|
)
|
DAC and VOBA
|
|
|
3,025
|
|
|
|
(327
|
)
|
|
|
(189
|
)
|
Policyholder dividend obligation
|
|
|
|
|
|
|
(789
|
)
|
|
|
(1,062
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
3,067
|
|
|
|
(1,724
|
)
|
|
|
(2,400
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred income tax
|
|
|
6,508
|
|
|
|
(423
|
)
|
|
|
(994
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
9,575
|
|
|
|
(2,147
|
)
|
|
|
(3,394
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net unrealized investment gains (losses)
|
|
$
|
(12,564
|
)
|
|
$
|
971
|
|
|
$
|
1,864
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The changes in net unrealized investment gains (losses) are as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Balance, end of prior period
|
|
$
|
971
|
|
|
$
|
1,864
|
|
|
$
|
1,942
|
|
Cumulative effect of change in accounting principles, net of
income tax
|
|
|
(10
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, beginning of period
|
|
|
961
|
|
|
|
1,864
|
|
|
|
1,942
|
|
Unrealized investment gains (losses) during the year
|
|
|
(25,377
|
)
|
|
|
(2,140
|
)
|
|
|
(706
|
)
|
Unrealized investment losses of subsidiaries at the date of
disposal
|
|
|
130
|
|
|
|
|
|
|
|
|
|
Unrealized investment gains (losses) relating to:
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance liability gain (loss) recognition
|
|
|
650
|
|
|
|
541
|
|
|
|
261
|
|
DAC and VOBA
|
|
|
3,370
|
|
|
|
(138
|
)
|
|
|
(110
|
)
|
DAC and VOBA of subsidiaries at date of disposal
|
|
|
(18
|
)
|
|
|
|
|
|
|
|
|
Policyholder dividend obligation
|
|
|
789
|
|
|
|
273
|
|
|
|
430
|
|
Deferred income tax
|
|
|
6,991
|
|
|
|
571
|
|
|
|
47
|
|
Deferred income tax of subsidiaries at date of disposal
|
|
|
(60
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, end of period
|
|
$
|
(12,564
|
)
|
|
$
|
971
|
|
|
$
|
1,864
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in net unrealized investment gains (losses)
|
|
$
|
(13,525
|
)
|
|
$
|
(893
|
)
|
|
$
|
(78
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-47
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Unrealized
Loss for Fixed Maturity and Equity Securities
Available-for-Sale
The following tables present the estimated fair value and gross
unrealized loss of the Companys fixed maturity (aggregated
by sector) and equity securities in an unrealized loss position,
aggregated by length of time that the securities have been in a
continuous unrealized loss position at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
|
|
|
Equal to or Greater than
|
|
|
|
|
|
|
Less than 12 Months
|
|
|
12 Months
|
|
|
Total
|
|
|
|
Estimated
|
|
|
Gross
|
|
|
Estimated
|
|
|
Gross
|
|
|
Estimated
|
|
|
Gross
|
|
|
|
Fair Value
|
|
|
Unrealized Loss
|
|
|
Fair Value
|
|
|
Unrealized Loss
|
|
|
Fair Value
|
|
|
Unrealized Loss
|
|
|
|
(In millions, except number of securities)
|
|
|
U.S. corporate securities
|
|
$
|
30,076
|
|
|
$
|
4,479
|
|
|
$
|
18,011
|
|
|
$
|
5,423
|
|
|
$
|
48,087
|
|
|
$
|
9,902
|
|
Residential mortgage-backed securities
|
|
|
10,032
|
|
|
|
2,711
|
|
|
|
4,572
|
|
|
|
2,009
|
|
|
|
14,604
|
|
|
|
4,720
|
|
Foreign corporate securities
|
|
|
15,634
|
|
|
|
3,157
|
|
|
|
6,609
|
|
|
|
2,527
|
|
|
|
22,243
|
|
|
|
5,684
|
|
U.S. Treasury/agency securities
|
|
|
106
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
106
|
|
|
|
1
|
|
Commercial mortgage-backed securities
|
|
|
9,259
|
|
|
|
1,665
|
|
|
|
3,093
|
|
|
|
1,788
|
|
|
|
12,352
|
|
|
|
3,453
|
|
Asset-backed securities
|
|
|
6,412
|
|
|
|
1,325
|
|
|
|
3,777
|
|
|
|
2,414
|
|
|
|
10,189
|
|
|
|
3,739
|
|
Foreign government securities
|
|
|
2,030
|
|
|
|
316
|
|
|
|
403
|
|
|
|
61
|
|
|
|
2,433
|
|
|
|
377
|
|
State and political subdivision securities
|
|
|
2,035
|
|
|
|
405
|
|
|
|
948
|
|
|
|
537
|
|
|
|
2,983
|
|
|
|
942
|
|
Other fixed maturity securities
|
|
|
20
|
|
|
|
3
|
|
|
|
2
|
|
|
|
|
|
|
|
22
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
$
|
75,604
|
|
|
$
|
14,062
|
|
|
$
|
37,415
|
|
|
$
|
14,759
|
|
|
$
|
113,019
|
|
|
$
|
28,821
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities
|
|
$
|
727
|
|
|
$
|
306
|
|
|
$
|
978
|
|
|
$
|
672
|
|
|
$
|
1,705
|
|
|
$
|
978
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total number of securities in an unrealized loss position
|
|
|
9,066
|
|
|
|
|
|
|
|
3,539
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-48
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2007
|
|
|
|
|
|
|
Equal to or Greater than
|
|
|
|
|
|
|
Less than 12 Months
|
|
|
12 Months
|
|
|
Total
|
|
|
|
Estimated
|
|
|
Gross
|
|
|
Estimated
|
|
|
Gross
|
|
|
Estimated
|
|
|
Gross
|
|
|
|
Fair Value
|
|
|
Unrealized Loss
|
|
|
Fair Value
|
|
|
Unrealized Loss
|
|
|
Fair Value
|
|
|
Unrealized Loss
|
|
|
|
(In millions, except number of securities)
|
|
|
U.S. corporate securities
|
|
$
|
27,895
|
|
|
$
|
1,358
|
|
|
$
|
11,601
|
|
|
$
|
718
|
|
|
$
|
39,496
|
|
|
$
|
2,076
|
|
Residential mortgage-backed securities
|
|
|
14,077
|
|
|
|
272
|
|
|
|
5,841
|
|
|
|
104
|
|
|
|
19,918
|
|
|
|
376
|
|
Foreign corporate securities
|
|
|
10,860
|
|
|
|
464
|
|
|
|
6,155
|
|
|
|
303
|
|
|
|
17,015
|
|
|
|
767
|
|
U.S. Treasury/agency securities
|
|
|
431
|
|
|
|
3
|
|
|
|
622
|
|
|
|
10
|
|
|
|
1,053
|
|
|
|
13
|
|
Commercial mortgage-backed securities
|
|
|
2,406
|
|
|
|
98
|
|
|
|
3,728
|
|
|
|
96
|
|
|
|
6,134
|
|
|
|
194
|
|
Asset-backed securities
|
|
|
7,279
|
|
|
|
416
|
|
|
|
1,198
|
|
|
|
100
|
|
|
|
8,477
|
|
|
|
516
|
|
Foreign government securities
|
|
|
3,387
|
|
|
|
158
|
|
|
|
436
|
|
|
|
24
|
|
|
|
3,823
|
|
|
|
182
|
|
State and political subdivision securities
|
|
|
1,307
|
|
|
|
80
|
|
|
|
461
|
|
|
|
34
|
|
|
|
1,768
|
|
|
|
114
|
|
Other fixed maturity securities
|
|
|
91
|
|
|
|
30
|
|
|
|
1
|
|
|
|
|
|
|
|
92
|
|
|
|
30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
$
|
67,733
|
|
|
$
|
2,879
|
|
|
$
|
30,043
|
|
|
$
|
1,389
|
|
|
$
|
97,776
|
|
|
$
|
4,268
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities
|
|
$
|
2,678
|
|
|
$
|
378
|
|
|
$
|
531
|
|
|
$
|
71
|
|
|
$
|
3,209
|
|
|
$
|
449
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total number of securities in an unrealized loss position
|
|
|
7,476
|
|
|
|
|
|
|
|
2,650
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-49
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Aging
of Gross Unrealized Loss for Fixed Maturity and Equity
Securities Available-for-Sale
The following tables present the cost or amortized cost, gross
unrealized loss and number of securities for fixed maturity and
equity securities, where the estimated fair value had declined
and remained below cost or amortized cost by less than 20%, or
20% or more at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
Cost or Amortized Cost
|
|
|
Gross Unrealized Loss
|
|
|
Number of Securities
|
|
|
|
Less than
|
|
|
20% or
|
|
|
Less than
|
|
|
20% or
|
|
|
Less than
|
|
|
20% or
|
|
|
|
20%
|
|
|
more
|
|
|
20%
|
|
|
more
|
|
|
20%
|
|
|
more
|
|
|
|
(In millions, except number of securities)
|
|
|
Fixed Maturity Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less than six months
|
|
$
|
32,658
|
|
|
$
|
48,114
|
|
|
$
|
2,358
|
|
|
$
|
17,191
|
|
|
|
4,566
|
|
|
|
2,827
|
|
Six months or greater but less than nine months
|
|
|
14,975
|
|
|
|
2,180
|
|
|
|
1,313
|
|
|
|
1,109
|
|
|
|
1,314
|
|
|
|
157
|
|
Nine months or greater but less than twelve months
|
|
|
16,372
|
|
|
|
3,700
|
|
|
|
1,830
|
|
|
|
2,072
|
|
|
|
934
|
|
|
|
260
|
|
Twelve months or greater
|
|
|
23,191
|
|
|
|
650
|
|
|
|
2,533
|
|
|
|
415
|
|
|
|
1,809
|
|
|
|
102
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
87,196
|
|
|
$
|
54,644
|
|
|
$
|
8,034
|
|
|
$
|
20,787
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less than six months
|
|
$
|
386
|
|
|
$
|
1,190
|
|
|
$
|
58
|
|
|
$
|
519
|
|
|
|
351
|
|
|
|
551
|
|
Six months or greater but less than nine months
|
|
|
33
|
|
|
|
413
|
|
|
|
6
|
|
|
|
190
|
|
|
|
8
|
|
|
|
32
|
|
Nine months or greater but less than twelve months
|
|
|
3
|
|
|
|
487
|
|
|
|
|
|
|
|
194
|
|
|
|
5
|
|
|
|
15
|
|
Twelve months or greater
|
|
|
171
|
|
|
|
|
|
|
|
11
|
|
|
|
|
|
|
|
20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
593
|
|
|
$
|
2,090
|
|
|
$
|
75
|
|
|
$
|
903
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-50
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2007
|
|
|
|
Cost or Amortized Cost
|
|
|
Gross Unrealized Loss
|
|
|
Number of Securities
|
|
|
|
Less than
|
|
|
20% or
|
|
|
Less than
|
|
|
20% or
|
|
|
Less than
|
|
|
20% or
|
|
|
|
20%
|
|
|
more
|
|
|
20%
|
|
|
more
|
|
|
20%
|
|
|
more
|
|
|
|
(In millions, except number of securities)
|
|
|
Fixed Maturity Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less than six months
|
|
$
|
46,343
|
|
|
$
|
1,375
|
|
|
$
|
1,482
|
|
|
$
|
383
|
|
|
|
4,713
|
|
|
|
148
|
|
Six months or greater but less than nine months
|
|
|
15,833
|
|
|
|
14
|
|
|
|
730
|
|
|
|
4
|
|
|
|
1,028
|
|
|
|
24
|
|
Nine months or greater but less than twelve months
|
|
|
8,529
|
|
|
|
7
|
|
|
|
492
|
|
|
|
2
|
|
|
|
586
|
|
|
|
|
|
Twelve months or greater
|
|
|
29,893
|
|
|
|
50
|
|
|
|
1,162
|
|
|
|
13
|
|
|
|
2,692
|
|
|
|
32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
100,598
|
|
|
$
|
1,446
|
|
|
$
|
3,866
|
|
|
$
|
402
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less than six months
|
|
$
|
1,757
|
|
|
$
|
423
|
|
|
$
|
148
|
|
|
$
|
133
|
|
|
|
1,212
|
|
|
|
417
|
|
Six months or greater but less than nine months
|
|
|
528
|
|
|
|
|
|
|
|
62
|
|
|
|
|
|
|
|
154
|
|
|
|
|
|
Nine months or greater but less than twelve months
|
|
|
439
|
|
|
|
|
|
|
|
54
|
|
|
|
|
|
|
|
62
|
|
|
|
1
|
|
Twelve months or greater
|
|
|
511
|
|
|
|
|
|
|
|
52
|
|
|
|
|
|
|
|
90
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
3,235
|
|
|
$
|
423
|
|
|
$
|
316
|
|
|
$
|
133
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As described more fully in Note 1, the Company performs a
regular evaluation, on a
security-by-security
basis, of its investment holdings in accordance with its
impairment policy in order to evaluate whether such securities
are other-than-temporarily impaired. One of the criteria which
the Company considers in its other-than-temporary impairment
analysis is its intent and ability to hold securities for a
period of time sufficient to allow for the recovery of their
value to an amount equal to or greater than cost or amortized
cost. The Companys intent and ability to hold securities
considers broad portfolio management objectives such as
asset/liability duration management, issuer and industry segment
exposures, interest rate views and the overall total return
focus. In following these portfolio management objectives,
changes in facts and circumstances that were present in past
reporting periods may trigger a decision to sell securities that
were held in prior reporting periods. Decisions to sell are
based on current conditions or the Companys need to shift
the portfolio to maintain its portfolio management objectives
including liquidity needs or duration targets on asset/liability
managed portfolios. The Company attempts to anticipate these
types of changes and if a sale decision has been made on an
impaired security and that security is not expected to recover
prior to the expected time of sale, the security will be deemed
other-than-temporarily impaired in the period that the sale
decision was made and an other-than-temporary impairment loss
will be recognized.
At December 31, 2008 and 2007, $8.0 billion and
$3.9 billion, respectively, of unrealized losses related to
fixed maturity securities with an unrealized loss position of
less than 20% of cost or amortized cost, which represented 9%
and 4%, respectively, of the cost or amortized cost of such
securities. At December 31, 2008 and 2007, $75 million
and $316 million, respectively, of unrealized losses
related to equity securities with an unrealized loss position of
less than 20% of cost, which represented 13% and 10%,
respectively, of the cost of such securities.
At December 31, 2008, $20.8 billion and
$903 million of unrealized losses related to fixed maturity
securities and equity securities, respectively, with an
unrealized loss position of 20% or more of cost or amortized
cost, which represented 38% and 43% of the cost or amortized
cost of such fixed maturity securities and equity securities,
F-51
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
respectively. Of such unrealized losses of $20.8 billion
and $903 million, $17.2 billion and $519 million
related to fixed maturity securities and equity securities,
respectively, that were in an unrealized loss position for a
period of less than six months. At December 31, 2007,
$402 million and $133 million of unrealized losses
related to fixed maturity securities and equity securities,
respectively, with an unrealized loss position of 20% or more of
cost or amortized cost, which represented 28% and 31% of the
cost or amortized cost of such fixed maturity securities and
equity securities, respectively. Of such unrealized losses of
$402 million and $133 million, $383 million and
$133 million related to fixed maturity securities and
equity securities, respectively, that were in an unrealized loss
position for a period of less than six months.
The Company held 699 fixed maturity securities and 33 equity
securities, each with a gross unrealized loss at
December 31, 2008 of greater than $10 million. These
699 fixed maturity securities represented 50% or
$14.5 billion in the aggregate, of the gross unrealized
loss on fixed maturity securities. These 33 equity securities
represented 71% or $699 million in the aggregate, of the
gross unrealized loss on equity securities. The Company held 23
fixed maturity securities and six equity securities, each with a
gross unrealized loss at December 31, 2007 of greater than
$10 million. These 23 fixed maturity securities represented
8% or $357 million in the aggregate, of the gross
unrealized loss on fixed maturity securities. These six equity
securities represented 20% or $90 million in the aggregate,
of the gross unrealized loss on equity securities. The fixed
maturity and equity securities, each with a gross unrealized
loss greater than $10 million increased $14.7 billion
during the year ended December 31, 2008. These securities
were included in the regular evaluation of whether such
securities are other-than-temporarily impaired. Based upon the
Companys current evaluation of these securities in
accordance with its impairment policy, the cause of the decline
being primarily attributable to a rise in market yields caused
principally by an extensive widening of credit spreads which
resulted from a lack of market liquidity and a short-term market
dislocation versus a long-term deterioration in credit quality,
and the Companys current intent and ability to hold the
fixed maturity and equity securities with unrealized losses for
a period of time sufficient for them to recover, the Company has
concluded that these securities are not other-than-temporarily
impaired.
In the Companys impairment review process, the duration
of, and severity of, an unrealized loss position, such as
unrealized losses of 20% or more for equity securities, which
was $903 million and $133 million at December 31,
2008 and 2007, respectively, is given greater weight and
consideration, than for fixed maturity securities. An extended
and severe unrealized loss position on a fixed maturity security
may not have any impact on the ability of the issuer to service
all scheduled interest and principal payments and the
Companys evaluation of recoverability of all contractual
cash flows, as well as the Companys ability and intent to
hold the security, including holding the security until the
earlier of a recovery in value, or until maturity. In contrast,
for an equity security, greater weight and consideration is
given by the Company to a decline in market value and the
likelihood such market value decline will recover.
Equity securities with an unrealized loss of 20% or more for six
months or greater was $384 million at December 31,
2008, of which $382 million of the unrealized losses, or
99%, are for non-redeemable preferred securities, of which,
$377 million of the unrealized losses, or 99%, are for
investment grade non-redeemable preferred securities. Of the
$377 million of unrealized losses for investment grade
non-redeemable preferred securities, $372 million of the
unrealized losses, or 99%, was comprised of unrealized losses on
investment grade financial services industry non-redeemable
preferred securities, of which 85% are rated A or higher.
Equity securities with an unrealized loss of 20% or more for
less than six months was $519 million at December 31,
2008 of which $427 million of the unrealized losses, or
82%, are for non-redeemable preferred securities, of which
$421 million, of the unrealized losses, or 98% are for
investment grade non-redeemable preferred securities. Of the
$421 million of unrealized losses for investment grade
non-redeemable preferred securities, $417 million of the
unrealized losses, or 99%, was comprised of unrealized losses on
investment grade financial services industry non-redeemable
preferred securities, of which 81% are rated A or higher.
There were no equity securities with an unrealized loss of 20%
or more for twelve months or greater.
F-52
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
In connection with the equity securities impairment review
process during 2008, the Company evaluated its holdings in
non-redeemable preferred securities, particularly those of
financial services industry companies. The Company considered
several factors including whether there has been any
deterioration in credit of the issuer and the likelihood of
recovery in value of non-redeemable preferred securities with a
severe or an extended unrealized loss. With respect to common
stock holdings, the Company considered the duration and severity
of the securities in an unrealized loss position of 20% or more;
and the duration of securities in an unrealized loss position of
20% or less with in an extended unrealized loss position (i.e.,
12 months or more).
At December 31, 2008, there are $903 million of equity
securities with an unrealized loss of 20% or more, of which
$809 million of the unrealized losses, or 90%, were for
non-redeemable preferred securities. Through December 31,
2008, $798 million of the unrealized losses of 20% or more,
or 99%, of the non-redeemable preferred securities were
investment grade securities, of which, $789 million of the
unrealized losses of 20% or more, or 99%, are investment grade
financial services industry non-redeemable preferred securities;
and all non-redeemable preferred securities with unrealized
losses of 20% or more, regardless of rating, have not deferred
any dividend payments.
Also, the Company believes the unrealized loss position is not
necessarily predictive of the ultimate performance of these
securities, and with respect to fixed maturity securities, it
has the ability and intent to hold until the earlier of the
recovery in value, or until maturity, and with respect to equity
securities, it has the ability and intent to hold until the
recovery in value. Future other-than-temporary impairments will
depend primarily on economic fundamentals, issuer performance,
changes in collateral valuation, changes in interest rates, and
changes in credit spreads. If economic fundamentals and other of
the above factors continue to deteriorate, additional
other-than-temporary impairments may be incurred in upcoming
quarters.
F-53
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
At December 31, 2008 and 2007, the Companys gross
unrealized losses related to its fixed maturity and equity
securities of $29.8 billion and $4.7 billion,
respectively, were concentrated, calculated as a percentage of
gross unrealized loss, as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
Sector:
|
|
|
|
|
|
|
|
|
U.S. corporate securities
|
|
|
33
|
%
|
|
|
44
|
%
|
Foreign corporate securities
|
|
|
19
|
|
|
|
16
|
|
Residential mortgage-backed securities
|
|
|
16
|
|
|
|
8
|
|
Asset-backed securities
|
|
|
13
|
|
|
|
11
|
|
Commercial mortgage-backed securities
|
|
|
11
|
|
|
|
4
|
|
State and political subdivision securities
|
|
|
3
|
|
|
|
2
|
|
Foreign government securities
|
|
|
1
|
|
|
|
4
|
|
Other
|
|
|
4
|
|
|
|
11
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
Industry:
|
|
|
|
|
|
|
|
|
Mortgage-backed
|
|
|
27
|
%
|
|
|
12
|
%
|
Finance
|
|
|
24
|
|
|
|
33
|
|
Asset-backed
|
|
|
13
|
|
|
|
11
|
|
Consumer
|
|
|
11
|
|
|
|
3
|
|
Utility
|
|
|
8
|
|
|
|
8
|
|
Communication
|
|
|
5
|
|
|
|
2
|
|
Industrial
|
|
|
4
|
|
|
|
19
|
|
Foreign government
|
|
|
1
|
|
|
|
4
|
|
Other
|
|
|
7
|
|
|
|
8
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
F-54
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Net
Investment Gains (Losses)
The components of net investment gains (losses) are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Fixed maturity securities
|
|
$
|
(1,949
|
)
|
|
$
|
(615
|
)
|
|
$
|
(1,119
|
)
|
Equity securities
|
|
|
(257
|
)
|
|
|
164
|
|
|
|
84
|
|
Mortgage and consumer loans
|
|
|
(136
|
)
|
|
|
3
|
|
|
|
(8
|
)
|
Real estate and real estate joint ventures
|
|
|
(18
|
)
|
|
|
46
|
|
|
|
102
|
|
Other limited partnership interests
|
|
|
(140
|
)
|
|
|
16
|
|
|
|
1
|
|
Freestanding derivatives
|
|
|
6,560
|
|
|
|
61
|
|
|
|
(410
|
)
|
Embedded derivatives
|
|
|
(2,650
|
)
|
|
|
(321
|
)
|
|
|
202
|
|
Other
|
|
|
402
|
|
|
|
68
|
|
|
|
(234
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment gains (losses)
|
|
$
|
1,812
|
|
|
$
|
(578
|
)
|
|
$
|
(1,382
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from sales or disposals of fixed maturity and equity
securities and the components of fixed maturity and equity
securities net investment gains (losses) are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed Maturity Securities
|
|
|
Equity Securities
|
|
|
Total
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Proceeds
|
|
$
|
62,495
|
|
|
$
|
78,001
|
|
|
$
|
86,725
|
|
|
$
|
2,107
|
|
|
$
|
1,112
|
|
|
$
|
845
|
|
|
$
|
64,602
|
|
|
$
|
79,113
|
|
|
$
|
87,570
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross investment gains
|
|
|
858
|
|
|
|
554
|
|
|
|
421
|
|
|
|
436
|
|
|
|
226
|
|
|
|
130
|
|
|
|
1,294
|
|
|
|
780
|
|
|
|
551
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross investment losses
|
|
|
(1,511
|
)
|
|
|
(1,091
|
)
|
|
|
(1,484
|
)
|
|
|
(263
|
)
|
|
|
(43
|
)
|
|
|
(22
|
)
|
|
|
(1,774
|
)
|
|
|
(1,134
|
)
|
|
|
(1,506
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Writedowns
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit-related
|
|
|
(1,138
|
)
|
|
|
(58
|
)
|
|
|
(56
|
)
|
|
|
(90
|
)
|
|
|
(19
|
)
|
|
|
(24
|
)
|
|
|
(1,228
|
)
|
|
|
(77
|
)
|
|
|
(80
|
)
|
Other than credit-related (1)
|
|
|
(158
|
)
|
|
|
(20
|
)
|
|
|
|
|
|
|
(340
|
)
|
|
|
|
|
|
|
|
|
|
|
(498
|
)
|
|
|
(20
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total writedowns
|
|
|
(1,296
|
)
|
|
|
(78
|
)
|
|
|
(56
|
)
|
|
|
(430
|
)
|
|
|
(19
|
)
|
|
|
(24
|
)
|
|
|
(1,726
|
)
|
|
|
(97
|
)
|
|
|
(80
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment gains (losses)
|
|
$
|
(1,949
|
)
|
|
$
|
(615
|
)
|
|
$
|
(1,119
|
)
|
|
$
|
(257
|
)
|
|
$
|
164
|
|
|
$
|
84
|
|
|
$
|
(2,206
|
)
|
|
$
|
(451
|
)
|
|
$
|
(1,035
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Other-than credit-related writedowns include items such as
equity securities where the primary reason for the writedown was
the severity and/or the duration of an unrealized loss position
and fixed maturity securities where an interest-rate related
writedown was taken. |
The Company periodically disposes of fixed maturity and equity
securities at a loss. Generally, such losses are insignificant
in amount or in relation to the cost basis of the investment,
are attributable to declines in fair value occurring in the
period of the disposition or are as a result of
managements decision to sell securities based on current
conditions or the Companys need to shift the portfolio to
maintain its portfolio management objectives.
Losses from fixed maturity and equity securities deemed
other-than-temporarily impaired, included within net investment
gains (losses), were $1,726 million, $97 million and
$80 million for the years ended December 31, 2008,
2007 and 2006, respectively. The substantial increase in 2008
over 2007 was driven by writedowns totaling $1,014 million
of financial services industry securities holdings, comprised of
$673 million of fixed maturity securities and
$341 million of equity securities.
Overall, of the $1,296 million of fixed maturity security
writedowns in 2008, $673 million were on financial services
industry services holdings; $241 million were on
communication and consumer industries holdings;
F-55
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
$164 million on asset-backed (substantially all are backed
by or exposed to sub-prime mortgage loans) and below investment
grade commercial mortgage-backed holdings; and $218 million
in fixed maturity security holdings that the Company either
lacked the intent to hold, or due to extensive credit spread
widening, the Company was uncertain of its intent to hold these
fixed maturity securities for a period of time sufficient to
allow for recovery of the market value decline.
Included within the $430 million of writedowns on equity
securities in 2008 are $341 million related to the
financial services industry holdings, (of which,
$90 million related to the financial services industry
non-redeemable preferred securities) and $89 million across
several industries including consumer, communications,
industrial and utility.
Net
Investment Income
The components of net investment income are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Fixed maturity securities
|
|
$
|
13,577
|
|
|
$
|
14,576
|
|
|
$
|
13,523
|
|
Equity securities
|
|
|
258
|
|
|
|
265
|
|
|
|
106
|
|
Trading securities
|
|
|
(193
|
)
|
|
|
50
|
|
|
|
71
|
|
Mortgage and consumer loans
|
|
|
2,855
|
|
|
|
2,811
|
|
|
|
2,488
|
|
Policy loans
|
|
|
601
|
|
|
|
572
|
|
|
|
547
|
|
Real estate and real estate joint ventures
|
|
|
581
|
|
|
|
950
|
|
|
|
777
|
|
Other limited partnership interests
|
|
|
(170
|
)
|
|
|
1,309
|
|
|
|
945
|
|
Cash, cash equivalents and short-term investments
|
|
|
353
|
|
|
|
491
|
|
|
|
513
|
|
International joint ventures (1)
|
|
|
43
|
|
|
|
17
|
|
|
|
(9
|
)
|
Other
|
|
|
349
|
|
|
|
320
|
|
|
|
269
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total investment income
|
|
|
18,254
|
|
|
|
21,361
|
|
|
|
19,230
|
|
Less: Investment expenses
|
|
|
1,958
|
|
|
|
3,298
|
|
|
|
2,983
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment income
|
|
$
|
16,296
|
|
|
$
|
18,063
|
|
|
$
|
16,247
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Net of changes in estimated fair value of derivatives related to
economic hedges of these equity method investments that do not
qualify for hedge accounting of $178 million,
$12 million and ($40) million for the years ended
December 31, 2008, 2007 and 2006, respectively. |
Net investment income from other limited partnership interests,
including hedge funds, represents distributions from other
limited partnership interests accounted for under the cost
method and equity in earnings from other limited partnership
interests accounted for under the equity method. Overall for
2008, the net amount recognized by the Company was a loss of
($170) million resulting principally from losses on equity
method investments. Such earnings and losses recognized for
other limited partnership interests are impacted by volatility
in the equity and credit markets. Net investment income from
trading securities includes interest and dividends earned on
trading securities in addition to the net realized and
unrealized gains (losses) recognized on trading securities and
the short sale agreements liabilities. In 2008, unrealized
losses recognized on trading securities, due to the volatility
in the equity and credit markets, were in excess of interest and
dividends earned.
F-56
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Securities
Lending
The Company participates in securities lending programs whereby
blocks of securities, which are included in fixed maturity
securities and short-term investments are loaned to third
parties, primarily major brokerage firms and commercial banks.
The Company generally obtains collateral in an amount equal to
102% of the estimated fair value of the securities loaned.
Securities with a cost or amortized cost of $20.8 billion
and $41.1 billion and an estimated fair value of
$22.9 billion and $42.1 billion were on loan under the
program at December 31, 2008 and 2007, respectively.
Securities loaned under such transactions may be sold or
repledged by the transferee. The Company was liable for cash
collateral under its control of $23.3 billion and
$43.3 billion at December 31, 2008 and 2007,
respectively. Of this $23.3 billion of cash collateral at
December 31, 2008, $5.1 billion was on open terms,
meaning that the related loaned security could be returned to
the Company on the next business day requiring return of cash
collateral, and $14.7 billion and $3.5 billion,
respectively, were due within 30 days and 60 days. Of
the $5.0 billion of estimated fair value of the securities
related to the cash collateral on open at December 31,
2008, $4.4 billion were U.S. Treasury and agency
securities which, if put to the Company, can be immediately sold
to satisfy the cash requirements. The remainder of the
securities on loan are primarily U.S. Treasury and agency
securities, and very liquid residential mortgage-backed
securities. The estimated fair value of the reinvestment
portfolio acquired with the cash collateral was
$19.5 billion at December 31, 2008, and consisted
principally of fixed maturity securities (including residential
mortgage-backed, asset-backed, U.S. corporate and foreign
corporate securities).
Security collateral of $279 million and $40 million on
deposit from counterparties in connection with the securities
lending transactions at December 31, 2008 and 2007,
respectively may not be sold or repledged and is not reflected
in the consolidated financial statements.
Assets
on Deposit, Held in Trust and Pledged as
Collateral
The Company had investment assets on deposit with regulatory
agencies with an estimated fair value of $1.3 billion and
$1.8 billion at December 31, 2008 and 2007,
respectively, consisting primarily of fixed maturity and equity
securities. The Company also held in trust cash and securities,
primarily fixed maturity and equity securities with an estimated
fair value of $9.3 billion and $5.9 billion at
December 31, 2008 and 2007, respectively, to satisfy
collateral requirements. The Company has also pledged certain
fixed maturity securities in support of the collateral financing
arrangements described in Note 11.
The Company has pledged fixed maturity securities and mortgage
loans in support of its debt and funding agreements with the
Federal Home Loan Bank of New York (FHLB of NY) and
the Federal Home Loan Bank of Boston (FHLB of
Boston) of $22.2 billion and $7.0 billion at
December 31, 2008 and 2007, respectively. The Company has
also pledged certain agricultural real estate mortgage loans in
connection with funding agreements with the Federal Agricultural
Mortgage Corporation with a carrying value of $2.9 billion
at both December 31, 2008 and 2007. The Company has also
pledged qualifying mortgage loans and securities in connection
with collateralized borrowings from the Federal Reserve Bank of
New Yorks Term Auction Facility with an estimated fair
value of $1.6 billion at December 31, 2008. The nature
of these Federal Home Loan Bank, Federal Agricultural Mortgage
Corporation and Federal Reserve Bank of New York arrangements
are described in Notes 7 and 10.
Certain of the Companys invested assets are pledged as
collateral for various derivative transactions as described in
Note 4. Certain of the Companys trading securities
are pledged to secure liabilities associated with short sale
agreements in the trading securities portfolio as described in
the following section.
Trading
Securities
The Company has a trading securities portfolio to support
investment strategies that involve the active and frequent
purchase and sale of securities, the execution of short sale
agreements and asset and liability matching
F-57
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
strategies for certain insurance products. Trading securities
and short sale agreement liabilities are recorded at estimated
fair value with subsequent changes in estimated fair value
recognized in net investment income.
At December 31, 2008 and 2007, trading securities at
estimated fair value were $946 million and
$779 million, respectively, and liabilities associated with
the short sale agreements in the trading securities portfolio,
which were included in other liabilities, were $57 million
and $107 million, respectively. The Company had pledged
$346 million and $407 million of its assets, at
estimated fair value, primarily consisting of trading
securities, as collateral to secure the liabilities associated
with the short sale agreements in the trading securities
portfolio at December 31, 2008 and 2007, respectively.
Interest and dividends earned on trading securities in addition
to the net realized and unrealized gains (losses) recognized on
the trading securities and the related short sale agreement
liabilities included within net investment income totaled
($193) million, $50 million and $71 million for
the years ended December 31, 2008, 2007 and 2006,
respectively. Included within unrealized gains (losses) on such
trading securities and short sale agreement liabilities are
changes in estimated fair value of ($174) million,
($4) million and $26 million for the years ended
December 31, 2008, 2007 and 2006, respectively.
Mortgage
and Consumer Loans
Mortgage and consumer loans are categorized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
Amount
|
|
|
Percent
|
|
|
Amount
|
|
|
Percent
|
|
|
|
(In millions)
|
|
|
Commercial mortgage loans
|
|
$
|
36,197
|
|
|
|
72.9
|
%
|
|
$
|
34,824
|
|
|
|
75.1
|
%
|
Agricultural mortgage loans
|
|
|
12,295
|
|
|
|
24.8
|
|
|
|
10,476
|
|
|
|
22.6
|
|
Consumer loans
|
|
|
1,164
|
|
|
|
2.3
|
|
|
|
1,046
|
|
|
|
2.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
49,656
|
|
|
|
100.0
|
%
|
|
|
46,346
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Valuation allowances
|
|
|
304
|
|
|
|
|
|
|
|
197
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total mortgage and consumer loans held-for-investment
|
|
|
49,352
|
|
|
|
|
|
|
|
46,149
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage loans held-for-sale
|
|
|
2,012
|
|
|
|
|
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage and consumer loans, net
|
|
$
|
51,364
|
|
|
|
|
|
|
$
|
46,154
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At December 31, 2008, mortgage loans held-for-sale include
$1,975 million of residential mortgage loans held-for-sale
carried under the fair value option. At December 31, 2008
and 2007, mortgage loans held-for-sale also include
$37 million and $5 million, respectively, of
commercial and residential mortgage loans held-for-sale which
are carried at the lower of amortized cost or estimated fair
value.
Mortgage and Consumer Loans by Geographic Region and Property
Type The Company diversifies its mortgage loans
by both geographic region and property type to reduce risk of
concentration. Mortgage loans are collateralized by properties
primarily located in the United States. At December 31,
2008, 20%, 7% and 6% of the value of the Companys mortgage
and consumer loans were located in California, Texas and
Florida, respectively. Generally, the Company, as the lender,
only loans up to 75% of the purchase price of the underlying
real estate. As shown in the table above, commercial mortgage
loans at December 31, 2008 and 2007 were
$36,197 million and $34,824 million, respectively, or
72.9% and 75.1%, respectively, of total mortgage and consumer
loans prior to valuation allowances. Net of valuation allowances
commercial mortgage loans were $35,965 million and
F-58
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
$34,657 million, respectively, at December 31, 2008
and 2007 and there was diversity across geographic regions and
property types as shown below at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
December 31, 2007
|
|
|
|
Carrying
|
|
|
% of
|
|
|
Carrying
|
|
|
% of
|
|
|
|
Value
|
|
|
Total
|
|
|
Value
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Region
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pacific
|
|
$
|
8,837
|
|
|
|
24.6
|
%
|
|
$
|
8,436
|
|
|
|
24.4
|
%
|
South Atlantic
|
|
|
8,101
|
|
|
|
22.5
|
|
|
|
7,770
|
|
|
|
22.4
|
|
Middle Atlantic
|
|
|
5,931
|
|
|
|
16.5
|
|
|
|
5,042
|
|
|
|
14.5
|
|
International
|
|
|
3,414
|
|
|
|
9.5
|
|
|
|
3,642
|
|
|
|
10.5
|
|
West South Central
|
|
|
3,070
|
|
|
|
8.5
|
|
|
|
2,888
|
|
|
|
8.3
|
|
East North Central
|
|
|
2,591
|
|
|
|
7.2
|
|
|
|
2,866
|
|
|
|
8.3
|
|
New England
|
|
|
1,529
|
|
|
|
4.3
|
|
|
|
1,464
|
|
|
|
4.2
|
|
Mountain
|
|
|
1,052
|
|
|
|
2.9
|
|
|
|
1,002
|
|
|
|
2.9
|
|
West North Central
|
|
|
716
|
|
|
|
2.0
|
|
|
|
974
|
|
|
|
2.8
|
|
East South Central
|
|
|
468
|
|
|
|
1.3
|
|
|
|
481
|
|
|
|
1.4
|
|
Other
|
|
|
256
|
|
|
|
0.7
|
|
|
|
92
|
|
|
|
0.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
35,965
|
|
|
|
100.0
|
%
|
|
$
|
34,657
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property Type
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Office
|
|
$
|
15,307
|
|
|
|
42.6
|
%
|
|
$
|
15,216
|
|
|
|
43.9
|
%
|
Retail
|
|
|
8,038
|
|
|
|
22.3
|
|
|
|
7,334
|
|
|
|
21.1
|
|
Apartments
|
|
|
4,113
|
|
|
|
11.4
|
|
|
|
4,368
|
|
|
|
12.6
|
|
Hotel
|
|
|
3,078
|
|
|
|
8.6
|
|
|
|
3,258
|
|
|
|
9.4
|
|
Industrial
|
|
|
2,901
|
|
|
|
8.1
|
|
|
|
2,622
|
|
|
|
7.6
|
|
Other
|
|
|
2,528
|
|
|
|
7.0
|
|
|
|
1,859
|
|
|
|
5.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
35,965
|
|
|
|
100.0
|
%
|
|
$
|
34,657
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Certain of the Companys real estate joint ventures have
mortgage loans with the Company. The carrying values of such
mortgages were $372 million and $373 million at
December 31, 2008 and 2007, respectively.
Information regarding loan valuation allowances for mortgage and
consumer loans held-for-investment is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Balance at January 1,
|
|
$
|
197
|
|
|
$
|
182
|
|
|
$
|
172
|
|
Additions
|
|
|
200
|
|
|
|
76
|
|
|
|
36
|
|
Deductions
|
|
|
(93
|
)
|
|
|
(61
|
)
|
|
|
(26
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31,
|
|
$
|
304
|
|
|
$
|
197
|
|
|
$
|
182
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-59
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
A portion of the Companys mortgage and consumer loans
held-for-investment was impaired and consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Impaired loans with valuation allowances
|
|
$
|
259
|
|
|
$
|
622
|
|
Impaired loans without valuation allowances
|
|
|
52
|
|
|
|
44
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
311
|
|
|
|
666
|
|
Less: Valuation allowances on impaired loans
|
|
|
69
|
|
|
|
72
|
|
|
|
|
|
|
|
|
|
|
Impaired loans
|
|
$
|
242
|
|
|
$
|
594
|
|
|
|
|
|
|
|
|
|
|
The average investment in impaired loans was $389 million,
$453 million and $202 million for the years ended
December 31, 2008, 2007 and 2006, respectively. Interest
income on impaired loans was $10 million, $38 million
and $2 million for the years ended December 31, 2008,
2007 and 2006, respectively.
The investment in restructured loans was $1 million and
$2 million at December 31, 2008 and 2007,
respectively. Interest income recognized on restructured loans
was $1 million or less for each of the years ended
December 31, 2008, 2007 and 2006. Gross interest income
that would have been recorded in accordance with the original
terms of such loans also amounted to $1 million or less for
each of the years ended December 31, 2008, 2007 and 2006.
Mortgage and consumer loans with scheduled payments of
90 days or more past due on which interest is still
accruing, had an amortized cost of $2 million and
$4 million at December 31, 2008 and 2007,
respectively. Mortgage and consumer loans on which interest is
no longer accrued had an amortized cost of $11 million and
$28 million at December 31, 2008 and 2007,
respectively. Mortgage and consumer loans in foreclosure had an
amortized cost of $28 million and $12 million at
December 31, 2008 and 2007, respectively.
Real
Estate Holdings
Real estate holdings consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Real estate
|
|
$
|
5,441
|
|
|
$
|
5,167
|
|
Accumulated depreciation
|
|
|
(1,378
|
)
|
|
|
(1,210
|
)
|
|
|
|
|
|
|
|
|
|
Net real estate
|
|
|
4,063
|
|
|
|
3,957
|
|
Real estate joint ventures
|
|
|
3,522
|
|
|
|
2,771
|
|
|
|
|
|
|
|
|
|
|
Real estate and real estate joint ventures
|
|
|
7,585
|
|
|
|
6,728
|
|
Real estate held-for sale
|
|
|
1
|
|
|
|
39
|
|
|
|
|
|
|
|
|
|
|
Total real estate holdings
|
|
$
|
7,586
|
|
|
$
|
6,767
|
|
|
|
|
|
|
|
|
|
|
Related depreciation expense on real estate was
$136 million, $130 million and $131 million for
the years ended December 31, 2008, 2007 and 2006,
respectively. These amounts include less than $1 million,
$2 million and $27 million of depreciation expense
related to discontinued operations for the years ended
December 31, 2008, 2007 and 2006, respectively.
There were no impairments recognized on real estate
held-for-sale for the year ended December 31, 2008 and
2007. Impairment losses recognized on real estate held-for-sale
were $8 million for the year ended December 31,
F-60
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
2006. The carrying value of non-income producing real estate was
$28 million and $12 million at December 31, 2008
and 2007, respectively. The Company owned real estate acquired
in satisfaction of debt was $2 million and $3 million
at December 31, 2008 and 2007, respectively.
The Company diversifies its real estate holdings by both
geographic region and property type to reduce risk of
concentration. The Companys real estate holdings are
primarily located in the United States, and at December 31,
2008, 22%, 13%, 11% and 8% were located in California, Florida,
New York and Texas, respectively. Property type diversification
is shown in the table below.
Real estate holdings were categorized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
Amount
|
|
|
Percent
|
|
|
Amount
|
|
|
Percent
|
|
|
|
(In millions)
|
|
|
Office
|
|
$
|
3,489
|
|
|
|
46
|
%
|
|
$
|
3,480
|
|
|
|
51
|
%
|
Apartments
|
|
|
1,602
|
|
|
|
21
|
|
|
|
1,148
|
|
|
|
17
|
|
Real estate investment funds
|
|
|
1,080
|
|
|
|
14
|
|
|
|
950
|
|
|
|
14
|
|
Industrial
|
|
|
483
|
|
|
|
7
|
|
|
|
443
|
|
|
|
7
|
|
Retail
|
|
|
472
|
|
|
|
6
|
|
|
|
455
|
|
|
|
7
|
|
Hotel
|
|
|
180
|
|
|
|
3
|
|
|
|
60
|
|
|
|
1
|
|
Land
|
|
|
155
|
|
|
|
2
|
|
|
|
125
|
|
|
|
2
|
|
Agriculture
|
|
|
24
|
|
|
|
|
|
|
|
29
|
|
|
|
|
|
Other
|
|
|
101
|
|
|
|
1
|
|
|
|
77
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total real estate holdings
|
|
$
|
7,586
|
|
|
|
100
|
%
|
|
$
|
6,767
|
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
Limited Partnership Interests
The carrying value of other limited partnership interests (which
primarily represent ownership interests in pooled investment
funds that principally make private equity investments in
companies in the United States and overseas) was
$6.0 billion and $6.2 billion at December 31,
2008 and 2007, respectively. Included within other limited
partnership interests at December 31, 2008 and 2007 are
$1.3 billion and $1.6 billion, respectively, of hedge
funds.
For the years ended December 31, 2008, 2007 and 2006, net
investment income (loss) from other limited partnership
interests was ($170) million, $1,309 million and
$945 million, respectively. Net investment income (loss)
from other limited partnership interests, including hedge funds,
decreased by $1,479 million for the year ended 2008, due to
volatility in the equity and credit markets.
F-61
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Other
Invested Assets
The following table presents the carrying value of the
Companys other invested assets at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
Carrying
|
|
|
% of
|
|
|
Carrying
|
|
|
% of
|
|
Type
|
|
Value
|
|
|
Total
|
|
|
Value
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Freestanding derivatives with positive fair values
|
|
$
|
12,306
|
|
|
|
71.3
|
%
|
|
$
|
4,036
|
|
|
|
50.0
|
%
|
Leveraged leases, net of non-recourse debt
|
|
|
2,146
|
|
|
|
12.4
|
|
|
|
2,059
|
|
|
|
25.5
|
|
Joint venture investments
|
|
|
751
|
|
|
|
4.4
|
|
|
|
622
|
|
|
|
7.7
|
|
Tax credit partnerships
|
|
|
503
|
|
|
|
2.9
|
|
|
|
|
|
|
|
|
|
Funding agreements
|
|
|
394
|
|
|
|
2.3
|
|
|
|
383
|
|
|
|
4.7
|
|
Mortgage servicing rights
|
|
|
191
|
|
|
|
1.1
|
|
|
|
|
|
|
|
|
|
Funds withheld
|
|
|
62
|
|
|
|
0.4
|
|
|
|
80
|
|
|
|
1.0
|
|
Other
|
|
|
895
|
|
|
|
5.2
|
|
|
|
896
|
|
|
|
11.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
17,248
|
|
|
|
100.0
|
%
|
|
$
|
8,076
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See Note 4 regarding the freestanding derivatives with
positive estimated fair values. Joint venture investments are
accounted for on the equity method and represent our investment
in insurance underwriting joint ventures in Japan, Chile and
China. Tax credit partnerships are established for the purpose
of investing in low-income housing and other social causes,
where the primary return on investment is in the form of tax
credits, and are accounted for under the equity method. Funding
agreements represent arrangements where the Company has
long-term interest bearing amounts on deposit with third parties
and are generally stated at amortized cost. Funds withheld
represent amounts contractually withheld by ceding companies in
accordance with reinsurance agreements.
Leveraged
Leases
Investment in leveraged leases, included in other invested
assets, consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Rental receivables, net
|
|
$
|
1,486
|
|
|
$
|
1,491
|
|
Estimated residual values
|
|
|
1,913
|
|
|
|
1,881
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
3,399
|
|
|
|
3,372
|
|
Unearned income
|
|
|
(1,253
|
)
|
|
|
(1,313
|
)
|
|
|
|
|
|
|
|
|
|
Investment in leveraged leases
|
|
$
|
2,146
|
|
|
$
|
2,059
|
|
|
|
|
|
|
|
|
|
|
The Companys deferred income tax liability related to
leveraged leases was $1.2 billion and $1.0 billion at
December 31, 2008 and 2007, respectively. The rental
receivables set forth above are generally due in periodic
installments. The payment periods range from one to
15 years, but in certain circumstances are as long as
30 years.
F-62
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The components of net income from investment in leveraged leases
are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Income from investment in leveraged leases (included in net
investment income)
|
|
$
|
116
|
|
|
$
|
68
|
|
|
$
|
55
|
|
Less: Income tax expense on leveraged leases
|
|
|
(40
|
)
|
|
|
(24
|
)
|
|
|
(18
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income from investment in leveraged leases
|
|
$
|
76
|
|
|
$
|
44
|
|
|
$
|
37
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage
Servicing Rights
The following table presents the changes in capitalized mortgage
servicing rights for the year ended December 31, 2008:
|
|
|
|
|
|
|
Carrying Value
|
|
|
|
(In millions)
|
|
|
Fair value on December 31, 2007
|
|
$
|
|
|
Acquisition of mortgage servicing rights
|
|
|
350
|
|
Reduction due to loan payments
|
|
|
(10
|
)
|
Reduction due to sales
|
|
|
|
|
Changes in fair value due to:
|
|
|
|
|
Changes in valuation model inputs or assumptions
|
|
|
(149
|
)
|
Other changes in fair value
|
|
|
|
|
|
|
|
|
|
Fair value on December 31, 2008
|
|
$
|
191
|
|
|
|
|
|
|
The Company recognizes the rights to service residential
mortgage loans as mortgage servicing rights. MSRs are
either acquired or are generated from the sale of originated
residential mortgage loans where the servicing rights are
retained by the Company. MSRs are carried at estimated
fair value and changes in estimated fair value, primarily due to
changes in valuation inputs and assumptions and to the
collection of expected cash flows, are reported in other
revenues in the period in which the change occurs. See also
Note 24 for further information about the how the estimated
fair value of mortgage servicing rights is determined and other
related information.
F-63
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Variable
Interest Entities
The following table presents the total assets and total
liabilities relating to VIEs for which the Company has concluded
that it is the primary beneficiary and which are consolidated in
the Companys financial statements at December 31,
2008. Generally, creditors or beneficial interest holders of
VIEs where the Company is the primary beneficiary have no
recourse to the general credit of the Company.
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
Total Assets
|
|
|
Total Liabilities
|
|
|
|
(In millions)
|
|
|
MRSC collateral financing arrangement (1)
|
|
$
|
2,361
|
|
|
$
|
|
|
Real estate joint ventures (2)
|
|
|
26
|
|
|
|
15
|
|
Other limited partnership interests (3)
|
|
|
20
|
|
|
|
3
|
|
Other invested assets (4)
|
|
|
10
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
2,417
|
|
|
$
|
21
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
These assets are reflected at estimated fair value, and consist
of fixed maturity securities available-for-sale of
$2,137 million and cash and cash equivalents of
$224 million, of which $60 million is cash
held-in-trust.
Included within fixed maturity securities available-for-sale are
$948 million of U.S. corporate securities,
$561 million of residential mortgage-backed securities,
$409 million of asset-backed securities, $98 million
of commercial mortgage-backed securities, $95 million of
foreign corporate securities, $21 million of state and
political subdivision securities and $5 million of foreign
government securities. See Note 11. |
|
(2) |
|
Real estate joint ventures include partnerships and other
ventures which engage in the acquisition, development,
management and disposal of real estate investments. Upon
consolidation, the assets and liabilities are reflected at the
VIEs carrying amounts. The assets consist of
$20 million of real estate and real estate joint ventures
held-for-investment, $5 million of cash and cash
equivalents and $1 million of other assets. The liabilities
of $15 million are included within other liabilities. |
|
(3) |
|
Other limited partnership interests include partnerships
established for the purpose of investing in public and private
debt and equity securities. Upon consolidation, the assets and
liabilities are reflected at the VIEs carrying amounts.
The assets of $20 million are included within other limited
partnership interests while the liabilities of $3 million
are included within other liabilities. |
|
(4) |
|
Other invested assets include tax-credit partnerships and other
investments established for the purpose of investing in
low-income housing and other social causes, where the primary
return on investment is in the form of tax credits. Upon
consolidation, the assets and liabilities are reflected at the
VIEs carrying amounts. The assets of $10 million are
included within other invested assets. The liabilities consist
of $2 million of long-term debt and $1 million of
other liabilities. |
F-64
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The following table presents the carrying amount and maximum
exposure to loss relating to VIEs for which the Company holds
significant variable interests but is not the primary
beneficiary and which have not been consolidated at
December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
|
|
|
Maximum
|
|
|
|
Carrying
|
|
|
Exposure
|
|
|
|
Amount (1)
|
|
|
to Loss (2)
|
|
|
|
(In millions)
|
|
|
Fixed maturity securities available-for-sale:
|
|
|
|
|
|
|
|
|
Foreign corporate securities
|
|
$
|
1,080
|
|
|
$
|
1,080
|
|
U.S. Treasury/agency securities
|
|
|
992
|
|
|
|
992
|
|
Real estate joint ventures
|
|
|
32
|
|
|
|
32
|
|
Other limited partnership interests
|
|
|
3,496
|
|
|
|
4,004
|
|
Other invested assets
|
|
|
318
|
|
|
|
108
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
5,918
|
|
|
$
|
6,216
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
See Note 1 for further discussion of the Companys
significant accounting policies with regards to the carrying
amounts of these investments. |
|
(2) |
|
The maximum exposure to loss relating to the fixed maturity
securities available-for-sale and equity securities
available-for-sale is equal to the carrying amounts or carrying
amounts of retained interests. The maximum exposure to loss
relating to the real estate joint ventures and other limited
partnership interests is equal to the carrying amounts plus any
unfunded commitments. Such a maximum loss would be expected to
occur only upon bankruptcy of the issuer or investee. For
certain of its investments in other invested assets, the
Companys return is in the form of tax credits which are
guaranteed by a creditworthy third party. For such investments,
the maximum exposure to loss is equal to the carrying amounts
plus any unfunded commitments, reduced by amounts guaranteed by
third parties. |
As described in Note 16, the Company makes commitments to
fund partnership investments in the normal course of business.
Excluding these commitments, MetLife did not provide financial
or other support to investees designated as VIEs during the
years ended December 31, 2008, 2007 and 2006.
F-65
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
4.
|
Derivative
Financial Instruments
|
Types
of Derivative Financial Instruments
The following table presents the notional amount and current
market or estimated fair value of derivative financial
instruments, excluding embedded derivatives, held at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
December 31, 2007
|
|
|
|
|
|
|
Current Market
|
|
|
|
|
|
Current Market
|
|
|
|
Notional
|
|
|
or Fair Value
|
|
|
Notional
|
|
|
or Fair Value
|
|
|
|
Amount
|
|
|
Assets
|
|
|
Liabilities
|
|
|
Amount
|
|
|
Assets
|
|
|
Liabilities
|
|
|
|
(In millions)
|
|
|
Interest rate swaps
|
|
$
|
34,060
|
|
|
$
|
4,617
|
|
|
$
|
1,468
|
|
|
$
|
62,410
|
|
|
$
|
784
|
|
|
$
|
768
|
|
Interest rate floors
|
|
|
48,517
|
|
|
|
1,748
|
|
|
|
|
|
|
|
48,937
|
|
|
|
621
|
|
|
|
|
|
Interest rate caps
|
|
|
24,643
|
|
|
|
11
|
|
|
|
|
|
|
|
45,498
|
|
|
|
50
|
|
|
|
|
|
Financial futures
|
|
|
19,908
|
|
|
|
45
|
|
|
|
205
|
|
|
|
12,302
|
|
|
|
89
|
|
|
|
57
|
|
Foreign currency swaps
|
|
|
19,438
|
|
|
|
1,953
|
|
|
|
1,866
|
|
|
|
21,201
|
|
|
|
1,480
|
|
|
|
1,719
|
|
Foreign currency forwards
|
|
|
5,167
|
|
|
|
153
|
|
|
|
129
|
|
|
|
4,177
|
|
|
|
76
|
|
|
|
16
|
|
Options
|
|
|
8,450
|
|
|
|
3,162
|
|
|
|
35
|
|
|
|
6,565
|
|
|
|
713
|
|
|
|
1
|
|
Financial forwards
|
|
|
28,176
|
|
|
|
465
|
|
|
|
169
|
|
|
|
11,937
|
|
|
|
122
|
|
|
|
2
|
|
Credit default swaps
|
|
|
5,219
|
|
|
|
152
|
|
|
|
69
|
|
|
|
6,625
|
|
|
|
58
|
|
|
|
33
|
|
Synthetic GICs
|
|
|
4,260
|
|
|
|
|
|
|
|
|
|
|
|
3,670
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
250
|
|
|
|
|
|
|
|
101
|
|
|
|
250
|
|
|
|
43
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
198,088
|
|
|
$
|
12,306
|
|
|
$
|
4,042
|
|
|
$
|
223,572
|
|
|
$
|
4,036
|
|
|
$
|
2,596
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table presents the notional amount of derivative
financial instruments by maturity at December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Remaining Life
|
|
|
|
|
|
|
|
|
|
After Five
|
|
|
|
|
|
|
|
|
|
|
|
|
After One Year
|
|
|
Years
|
|
|
|
|
|
|
|
|
|
One Year or
|
|
|
Through Five
|
|
|
Through Ten
|
|
|
After Ten
|
|
|
|
|
|
|
Less
|
|
|
Years
|
|
|
Years
|
|
|
Years
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Interest rate swaps
|
|
$
|
2,295
|
|
|
$
|
12,632
|
|
|
$
|
12,809
|
|
|
$
|
6,324
|
|
|
$
|
34,060
|
|
Interest rate floors
|
|
|
15,294
|
|
|
|
325
|
|
|
|
32,898
|
|
|
|
|
|
|
|
48,517
|
|
Interest rate caps
|
|
|
590
|
|
|
|
24,053
|
|
|
|
|
|
|
|
|
|
|
|
24,643
|
|
Financial futures
|
|
|
19,908
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19,908
|
|
Foreign currency swaps
|
|
|
3,204
|
|
|
|
7,180
|
|
|
|
5,981
|
|
|
|
3,073
|
|
|
|
19,438
|
|
Foreign currency forwards
|
|
|
5,068
|
|
|
|
99
|
|
|
|
|
|
|
|
|
|
|
|
5,167
|
|
Options
|
|
|
128
|
|
|
|
2,239
|
|
|
|
5,419
|
|
|
|
664
|
|
|
|
8,450
|
|
Financial forwards
|
|
|
16,617
|
|
|
|
995
|
|
|
|
8,226
|
|
|
|
2,338
|
|
|
|
28,176
|
|
Credit default swaps
|
|
|
163
|
|
|
|
3,340
|
|
|
|
1,716
|
|
|
|
|
|
|
|
5,219
|
|
Synthetic GICs
|
|
|
4,260
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,260
|
|
Other
|
|
|
|
|
|
|
250
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
67,527
|
|
|
$
|
51,113
|
|
|
$
|
67,049
|
|
|
$
|
12,399
|
|
|
$
|
198,088
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate swaps are used by the Company primarily to reduce
market risks from changes in interest rates and to alter
interest rate exposure arising from mismatches between assets
and liabilities (duration mismatches). In an
F-66
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
interest rate swap, the Company agrees with another party to
exchange, at specified intervals, the difference between fixed
rate and floating rate interest amounts as calculated by
reference to an agreed notional principal amount. These
transactions are entered into pursuant to master agreements that
provide for a single net payment to be made by the counterparty
at each due date.
The Company commenced the use of inflation swaps during the
first quarter of 2008. Inflation swaps are used as an economic
hedge to reduce inflation risk generated from inflation-indexed
liabilities. Inflation swaps are included in interest rate swaps
in the preceding table.
The Company also enters into basis swaps to better match the
cash flows from assets and related liabilities. In a basis swap,
both legs of the swap are floating with each based on a
different index. Generally, no cash is exchanged at the outset
of the contract and no principal payments are made by either
party. A single net payment is usually made by one counterparty
at each due date. Basis swaps are included in interest rate
swaps in the preceding table.
Interest rate caps and floors are used by the Company primarily
to protect its floating rate liabilities against rises in
interest rates above a specified level, and against interest
rate exposure arising from mismatches between assets and
liabilities (duration mismatches), as well as to protect its
minimum rate guarantee liabilities against declines in interest
rates below a specified level, respectively.
In exchange-traded interest rate (Treasury and swap) and equity
futures transactions, the Company agrees to purchase or sell a
specified number of contracts, the value of which is determined
by the different classes of interest rate and equity securities,
and to post variation margin on a daily basis in an amount equal
to the difference in the daily market values of those contracts.
The Company enters into exchange-traded futures with regulated
futures commission merchants that are members of the exchange.
Exchange-traded interest rate (Treasury and swap) futures are
used primarily to hedge mismatches between the duration of
assets in a portfolio and the duration of liabilities supported
by those assets, to hedge against changes in value of securities
the Company owns or anticipates acquiring, and to hedge against
changes in interest rates on anticipated liability issuances by
replicating Treasury or swap curve performance. The value of
interest rate futures is substantially impacted by changes in
interest rates and they can be used to modify or hedge existing
interest rate risk.
Exchange-traded equity futures are used primarily to hedge
liabilities embedded in certain variable annuity products
offered by the Company.
Foreign currency derivatives, including foreign currency swaps,
foreign currency forwards and currency option contracts, are
used by the Company to reduce the risk from fluctuations in
foreign currency exchange rates associated with its assets and
liabilities denominated in foreign currencies. The Company also
uses foreign currency forwards and swaps to hedge the foreign
currency risk associated with certain of its net investments in
foreign operations.
In a foreign currency swap transaction, the Company agrees with
another party to exchange, at specified intervals, the
difference between one currency and another at a fixed exchange
rate, generally set at inception, calculated by reference to an
agreed upon principal amount. The principal amount of each
currency is exchanged at the inception and termination of the
currency swap by each party.
In a foreign currency forward transaction, the Company agrees
with another party to deliver a specified amount of an
identified currency at a specified future date. The price is
agreed upon at the time of the contract and payment for such a
contract is made in a different currency at the specified future
date.
The Company enters into currency option contracts that give it
the right, but not the obligation, to sell the foreign currency
amount in exchange for a functional currency amount within a
limited time at a contracted price. The contracts may also be
net settled in cash, based on differentials in the foreign
exchange rate and the strike price. Currency option contracts
are included in options in the preceding table.
F-67
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Swaptions are used by the Company to hedge interest rate risk
associated with the Companys long-term liabilities, as
well as to sell, or monetize, embedded call options in its fixed
rate liabilities. A swaption is an option to enter into a swap
with an effective date equal to the exercise date of the
embedded call and a maturity date equal to the maturity date of
the underlying liability. The Company receives a premium for
entering into the swaption. Swaptions are included in options in
the preceding table.
Equity index options are used by the Company primarily to hedge
minimum guarantees embedded in certain variable annuity products
offered by the Company. To hedge against adverse changes in
equity indices, the Company enters into contracts to sell the
equity index options within a limited time at a contracted
price. The contracts will be net settled in cash based on
differentials in the indices at the time of exercise and the
strike price. Equity index options are included in options in
the preceding table.
The Company enters into financial forwards to buy and sell
securities. The price is agreed upon at the time of the contract
and payment for such a contract is made at a specified future
date. In connection with the acquisition of a residential
mortgage origination and servicing business in the third quarter
of 2008, the Company acquired, as well as commenced issuing,
interest rate lock commitments and financial forwards to sell
residential mortgage-backed securities. The Company uses
financial forwards to sell securities as economic hedges against
the risk of changes in the estimated fair value of mortgage
loans held-for-sale and interest rate lock commitments. Interest
rate lock commitments are short-term commitments to fund
mortgage loan applications in process for a fixed term at a
fixed price. During the term of an interest rate lock
commitment, the Company is exposed to the risk that interest
rates will change from the rate quoted to the potential
borrower. Interest rate lock commitments to fund mortgage loans
that will be held-for-sale are considered derivatives pursuant
to SFAS 133. Interest rate lock commitments and financial
forwards to sell residential mortgage-backed securities are
included in financial forwards in the preceding table.
Equity variance swaps are used by the Company primarily to hedge
minimum guarantees embedded in certain variable annuity products
offered by the Company. In an equity variance swap, the Company
agrees with another party to exchange amounts in the future,
based on changes in equity volatility over a defined period.
Equity variance swaps are included in financial forwards in the
preceding table.
Swap spread locks are used by the Company to hedge invested
assets on an economic basis against the risk of changes in
credit spreads. Swap spread locks are forward transactions
between two parties whose underlying reference index is a
forward starting interest rate swap where the Company agrees to
pay a coupon based on a predetermined reference swap spread in
exchange for receiving a coupon based on a floating rate. The
Company has the option to cash settle with the counterparty in
lieu of maintaining the swap after the effective date. Swap
spread locks are included in financial forwards in the preceding
table.
Certain credit default swaps are used by the Company to hedge
against credit-related changes in the value of its investments
and to diversify its credit risk exposure in certain portfolios.
In a credit default swap transaction, the Company agrees with
another party, at specified intervals, to pay a premium to
insure credit risk. If a credit event, as defined by the
contract, occurs, generally the contract will require the swap
to be settled gross by the delivery of par quantities of the
referenced investment equal to the specified swap notional in
exchange for the payment of cash amounts by the counterparty
equal to the par value of the investment surrendered.
Credit default swaps are also used to synthetically create
investments that are either more expensive to acquire or
otherwise unavailable in the cash markets. These transactions
are a combination of a derivative and a cash instrument such as
a U.S. Treasury or Agency security. The Company also enters
into certain credit default swaps held in relation to trading
portfolios.
A synthetic guaranteed interest contract (GIC) is a
contract that simulates the performance of a traditional GIC
through the use of financial instruments. Under a synthetic GIC,
the policyholder owns the underlying assets. The Company
guarantees a rate return on those assets for a premium.
F-68
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Total rate of return swaps (TRRs) are swaps whereby
the Company agrees with another party to exchange, at specified
intervals, the difference between the economic risk and reward
of an asset or a market index and LIBOR, calculated by reference
to an agreed notional principal amount. No cash is exchanged at
the outset of the contract. Cash is paid and received over the
life of the contract based on the terms of the swap. These
transactions are entered into pursuant to master agreements that
provide for a single net payment to be made by the counterparty
at each due date. TRRs can be used as hedges or to synthetically
create investments and are included in the other classification
in the preceding table.
Hedging
The following table presents the notional amount and the
estimated fair value of derivatives by type of hedge designation
at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
December 31, 2007
|
|
|
|
Notional
|
|
|
Fair Value
|
|
|
Notional
|
|
|
Fair Value
|
|
|
|
Amount
|
|
|
Assets
|
|
|
Liabilities
|
|
|
Amount
|
|
|
Assets
|
|
|
Liabilities
|
|
|
|
(In millions)
|
|
|
Fair value
|
|
$
|
10,234
|
|
|
$
|
1,805
|
|
|
$
|
703
|
|
|
$
|
10,006
|
|
|
$
|
650
|
|
|
$
|
99
|
|
Cash flow
|
|
|
4,068
|
|
|
|
463
|
|
|
|
387
|
|
|
|
4,717
|
|
|
|
161
|
|
|
|
321
|
|
Foreign operations
|
|
|
1,834
|
|
|
|
33
|
|
|
|
50
|
|
|
|
1,674
|
|
|
|
11
|
|
|
|
114
|
|
Non-qualifying
|
|
|
181,952
|
|
|
|
10,005
|
|
|
|
2,902
|
|
|
|
207,175
|
|
|
|
3,214
|
|
|
|
2,062
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
198,088
|
|
|
$
|
12,306
|
|
|
$
|
4,042
|
|
|
$
|
223,572
|
|
|
$
|
4,036
|
|
|
$
|
2,596
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table presents the settlement payments recorded in
income for the:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Qualifying hedges:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment income
|
|
$
|
19
|
|
|
$
|
29
|
|
|
$
|
49
|
|
Interest credited to policyholder account balances
|
|
|
105
|
|
|
|
(34
|
)
|
|
|
(35
|
)
|
Other expenses
|
|
|
(9
|
)
|
|
|
1
|
|
|
|
3
|
|
Non-qualifying hedges:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment income
|
|
|
1
|
|
|
|
(5
|
)
|
|
|
|
|
Net investment gains (losses)
|
|
|
49
|
|
|
|
278
|
|
|
|
296
|
|
Other revenues
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
168
|
|
|
$
|
269
|
|
|
$
|
313
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair
Value Hedges
The Company designates and accounts for the following as fair
value hedges when they have met the requirements of
SFAS 133: (i) interest rate swaps to convert fixed
rate investments to floating rate investments;
(ii) interest rate swaps to convert fixed rate liabilities
to floating rate liabilities; and (iii) foreign currency
swaps to hedge the foreign currency fair value exposure of
foreign currency denominated investments and liabilities.
F-69
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The Company recognized net investment gains (losses)
representing the ineffective portion of all fair value hedges as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Changes in the fair value of derivatives
|
|
$
|
245
|
|
|
$
|
334
|
|
|
$
|
276
|
|
Changes in the fair value of the items hedged
|
|
|
(248
|
)
|
|
|
(326
|
)
|
|
|
(276
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net ineffectiveness of fair value hedging activities
|
|
$
|
(3
|
)
|
|
$
|
8
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All components of each derivatives gain or loss were
included in the assessment of hedge effectiveness. There were no
instances in which the Company discontinued fair value hedge
accounting due to a hedged firm commitment no longer qualifying
as a fair value hedge.
Cash
Flow Hedges
The Company designates and accounts for the following as cash
flow hedges when they have met the requirements of
SFAS 133: (i) interest rate swaps to convert floating
rate investments to fixed rate investments; (ii) interest
rate swaps to convert floating rate liabilities to fixed rate
liabilities; and (iii) foreign currency swaps to hedge the
foreign currency cash flow exposure of foreign currency
denominated investments and liabilities.
For the years ended December 31, 2008, 2007, and 2006, the
Company did not recognize any net investment gains (losses)
which represented the ineffective portion of all cash flow
hedges. All components of each derivatives gain or loss
were included in the assessment of hedge effectiveness. In
certain instances, the Company discontinued cash flow hedge
accounting because the forecasted transactions did not occur on
the anticipated date or in the additional time period permitted
by SFAS 133. The net amounts reclassified into net
investment losses for the years ended December 31, 2008,
2007 and 2006 related to such discontinued cash flow hedges were
$12 million, $3 million and $3 million,
respectively. There were no hedged forecasted transactions,
other than the receipt or payment of variable interest payments
for the years ended December 31, 2008, 2007, and 2006.
The following table presents the components of other
comprehensive income (loss), before income tax, related to cash
flow hedges:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Other comprehensive income (loss) balance at January 1,
|
|
$
|
(270
|
)
|
|
$
|
(208
|
)
|
|
$
|
(142
|
)
|
Gains (losses) deferred in other comprehensive income (loss) on
the effective portion of cash flow hedges
|
|
|
203
|
|
|
|
(168
|
)
|
|
|
80
|
|
Amounts reclassified to net investment gains (losses)
|
|
|
140
|
|
|
|
96
|
|
|
|
(158
|
)
|
Amounts reclassified to net investment income
|
|
|
9
|
|
|
|
13
|
|
|
|
15
|
|
Amortization of transition adjustment
|
|
|
1
|
|
|
|
(1
|
)
|
|
|
(1
|
)
|
Amounts reclassified to other expenses
|
|
|
(1
|
)
|
|
|
(2
|
)
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) balance at December 31,
|
|
$
|
82
|
|
|
$
|
(270
|
)
|
|
$
|
(208
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At December 31, 2008, $47 million of the deferred net
loss on derivatives accumulated in other comprehensive income
(loss) is expected to be reclassified to earnings during the
year ending December 31, 2009.
F-70
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Hedges
of Net Investments in Foreign Operations
The Company uses forward exchange contracts, foreign currency
swaps, options and non-derivative financial instruments to hedge
portions of its net investments in foreign operations against
adverse movements in exchange rates. The Company measures
ineffectiveness on the forward exchange contracts based upon the
change in forward rates. There was no ineffectiveness recorded
for the years ended December 31, 2008, 2007 and 2006.
The Companys consolidated statement of stockholders
equity for the years ended December 31, 2008, 2007 and 2006
include gains (losses) of $495 million, ($180) million
and ($17) million, respectively, related to foreign
currency contracts and non-derivative financial instruments used
to hedge its net investments in foreign operations. At
December 31, 2008 and 2007, the cumulative foreign currency
translation gain (loss) recorded in accumulated other
comprehensive income (loss) related to these hedges was
$126 million and ($369) million, respectively. When
net investments in foreign operations are sold or substantially
liquidated, the amounts in accumulated other comprehensive
income (loss) are reclassified to the consolidated statements of
income, while a pro rata portion will be reclassified upon
partial sale of the net investments in foreign operations.
Non-qualifying
Derivatives and Derivatives for Purposes Other Than
Hedging
The Company enters into the following derivatives that do not
qualify for hedge accounting under SFAS 133 or for purposes
other than hedging: (i) interest rate swaps, purchased caps
and floors, and interest rate futures to economically hedge its
exposure to interest rates; (ii) foreign currency forwards,
swaps and option contracts to economically hedge its exposure to
adverse movements in exchange rates; (iii) credit default
swaps to economically hedge exposure to adverse movements in
credit; (iv) equity futures, equity index options, interest
rate futures and equity variance swaps to economically hedge
liabilities embedded in certain variable annuity products;
(v) swap spread locks to economically hedge invested assets
against the risk of changes in credit spreads;
(vi) financial forwards to buy and sell securities to
economically hedge its exposure to interest rates;
(vii) synthetic guaranteed interest contracts;
(viii) credit default swaps and total rate of return swaps
to synthetically create investments; (ix) basis swaps to
better match the cash flows of assets and related liabilities;
(x) credit default swaps held in relation to trading
portfolios; (xi) swaptions to hedge interest rate risk;
(xii) inflation swaps to reduce risk generated from
inflation-indexed liabilities; and (xiii) interest rate
lock commitments.
The following table presents changes in estimated fair value
related to derivatives that do not qualify for hedge accounting:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Net investment gains (losses), excluding embedded derivatives
|
|
$
|
6,688
|
|
|
$
|
(227
|
)
|
|
$
|
(686
|
)
|
Policyholder benefits and claims (1)
|
|
|
331
|
|
|
|
7
|
|
|
|
(33
|
)
|
Net investment income (loss) (2)
|
|
|
240
|
|
|
|
31
|
|
|
|
(40
|
)
|
Other revenues (3)
|
|
|
146
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
7,405
|
|
|
$
|
(189
|
)
|
|
$
|
(759
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Changes in estimated fair value related to economic hedges of
liabilities embedded in certain variable annuity products
offered by the Company. |
|
(2) |
|
Changes in estimated fair value related to economic hedges of
equity method investments in joint ventures that do not qualify
for hedge accounting and changes in estimated fair value related
to derivatives held in relation to trading portfolios. |
|
(3) |
|
Changes in estimated fair value related to derivatives held in
connection with the Companys mortgage banking activities. |
F-71
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Embedded
Derivatives
The Company has certain embedded derivatives that are required
to be separated from their host contracts and accounted for as
derivatives. These host contracts principally include: variable
annuities with guaranteed minimum withdrawal, guaranteed minimum
accumulation and certain guaranteed minimum income riders; ceded
reinsurance contracts related to guaranteed minimum accumulation
and certain guaranteed minimum income riders; and guaranteed
investment contracts with equity or bond indexed crediting rates.
The following table presents the estimated fair value of the
Companys embedded derivatives at:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Net embedded derivatives within asset host contracts:
|
|
|
|
|
|
|
|
|
Ceded guaranteed minimum benefit riders
|
|
$
|
205
|
|
|
$
|
6
|
|
Call options in equity securities
|
|
|
(173
|
)
|
|
|
(16
|
)
|
|
|
|
|
|
|
|
|
|
Net embedded derivatives within asset host contracts
|
|
$
|
32
|
|
|
$
|
(10
|
)
|
|
|
|
|
|
|
|
|
|
Net embedded derivatives within liability host contracts:
|
|
|
|
|
|
|
|
|
Direct guaranteed minimum benefit riders
|
|
$
|
3,134
|
|
|
$
|
284
|
|
Other
|
|
|
(83
|
)
|
|
|
52
|
|
|
|
|
|
|
|
|
|
|
Net embedded derivatives within liability host contracts
|
|
$
|
3,051
|
|
|
$
|
336
|
|
|
|
|
|
|
|
|
|
|
The following table presents changes in the estimated fair value
related to embedded derivatives:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Net investment gains (losses) (1)
|
|
$
|
(2,650
|
)
|
|
$
|
(321
|
)
|
|
$
|
202
|
|
Policyholder benefits and claims
|
|
$
|
182
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
(1) |
|
Effective January 1, 2008, upon adoption of SFAS 157,
the valuation of the Companys guaranteed minimum benefit
riders includes an adjustment for the Companys own credit.
Included in net investment gains (losses) for the year ended
December 31, 2008 are gains of $2,994 million in
connection with this adjustment. |
Credit
Risk
The Company may be exposed to credit-related losses in the event
of nonperformance by counterparties to derivative financial
instruments. Generally, the current credit exposure of the
Companys derivative contracts is limited to the net
positive estimated fair value of derivative contracts at the
reporting date after taking into consideration the existence of
netting agreements and any collateral received pursuant to
credit support annexes.
The Company manages its credit risk related to over-the-counter
derivatives by entering into transactions with creditworthy
counterparties, maintaining collateral arrangements and through
the use of master agreements that provide for a single net
payment to be made by one counterparty to another at each due
date and upon termination. Because exchange traded futures are
effected through regulated exchanges, and positions are marked
to market on a daily basis, the Company has minimal exposure to
credit-related losses in the event of nonperformance by
counterparties to such derivative instruments. See Note 24
for a description of the impact of credit risk on the valuation
of derivative instruments.
The Company enters into various collateral arrangements, which
require both the pledging and accepting of collateral in
connection with its derivative instruments. At December 31,
2008 and 2007, the Company was
F-72
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
obligated to return cash collateral under its control of
$7,758 million and $833 million, respectively. This
unrestricted cash collateral is included in cash and cash
equivalents or in short-term investments and the obligation to
return it is included in payables for collateral under
securities loaned and other transactions in the consolidated
balance sheets. At December 31, 2008 and 2007, the Company
had also accepted collateral consisting of various securities
with a fair market value of $1,249 million and
$678 million, respectively, which are held in separate
custodial accounts. The Company is permitted by contract to sell
or repledge this collateral, but at December 31, 2008, none
of the collateral had been sold or repledged.
At December 31, 2008 and 2007, the Company provided
securities collateral for various arrangements in connection
with derivative instruments of $776 million and
$162 million, respectively, which is included in fixed
maturity securities. The counterparties are permitted by
contract to sell or repledge this collateral. In addition, the
Company has exchange-traded futures, which require the pledging
of collateral. At December 31, 2008 and 2007, the Company
pledged securities collateral for exchange-traded futures of
$282 million and $167 million, respectively, which is
included in fixed maturity securities. The counterparties are
permitted by contract to sell or repledge this collateral. At
December 31, 2008 and 2007, the Company provided cash
collateral for exchange-traded futures of $686 million and
$102 million, respectively, which is included in premiums
and other receivables.
In connection with synthetically created investment transactions
and credit default swaps held in relation to the trading
portfolio, the Company writes credit default swaps for which it
receives a premium to insure credit risk. If a credit event, as
defined by the contract, occurs generally the contract will
require the Company to pay the counterparty the specified swap
notional amount in exchange for the delivery of par quantities
of the referenced credit obligation. The Companys maximum
amount at risk, assuming the value of all referenced credit
obligations is zero, was $1,875 million at
December 31, 2008. The Company can terminate these
contracts at any time through cash settlement with the
counterparty at an amount equal to the then current fair value
of the credit default swaps. At December 31, 2008, the
Company would have paid $37 million to terminate all of
these contracts.
The Company has also entered into credit default swaps to
purchase credit protection on certain of the referenced credit
obligations in the table below. As a result, the maximum amount
of potential future recoveries available to offset the
$1,875 million from the table below was $13 million at
December 31, 2008.
F-73
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The following table presents the estimated fair value, maximum
amount of future payments and weighted average years to maturity
of written credit default swaps at December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
|
|
|
Maximum Amount of
|
|
|
|
|
|
|
Fair Value of
|
|
|
Future Payments
|
|
|
|
|
|
|
Credit Default
|
|
|
under Credit
|
|
|
Weighted Average
|
|
Rating Agency Designation of Referenced Credit
Obligations (1)
|
|
Swaps
|
|
|
Default Swaps (2)
|
|
|
Years to Maturity (3)
|
|
|
|
(In millions)
|
|
|
|
|
|
Aaa/Aa/A
|
|
|
|
|
|
|
|
|
|
|
|
|
Single name credit default swaps (corporate)
|
|
$
|
1
|
|
|
$
|
143
|
|
|
|
5.0
|
|
Credit default swaps referencing indices
|
|
|
(33
|
)
|
|
|
1,372
|
|
|
|
4.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
(32
|
)
|
|
|
1,515
|
|
|
|
4.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Baa
|
|
|
|
|
|
|
|
|
|
|
|
|
Single name credit default swaps (corporate)
|
|
|
2
|
|
|
|
110
|
|
|
|
2.6
|
|
Credit default swaps referencing indices
|
|
|
(5
|
)
|
|
|
215
|
|
|
|
4.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
(3
|
)
|
|
|
325
|
|
|
|
3.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ba
|
|
|
|
|
|
|
|
|
|
|
|
|
Single name credit default swaps (corporate)
|
|
|
|
|
|
|
25
|
|
|
|
1.6
|
|
Credit default swaps referencing indices
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
|
|
|
|
25
|
|
|
|
1.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
B
|
|
|
|
|
|
|
|
|
|
|
|
|
Single name credit default swaps (corporate)
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit default swaps referencing indices
|
|
|
(2
|
)
|
|
|
10
|
|
|
|
5.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
(2
|
)
|
|
|
10
|
|
|
|
5.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Caa and lower
|
|
|
|
|
|
|
|
|
|
|
|
|
Single name credit default swaps (corporate)
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit default swaps referencing indices
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In or near default
|
|
|
|
|
|
|
|
|
|
|
|
|
Single name credit default swaps (corporate)
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit default swaps referencing indices
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(37
|
)
|
|
$
|
1,875
|
|
|
|
4.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The rating agency designations are based on availability and the
midpoint of the applicable ratings among Moodys, S&P,
and Fitch. If no rating is available from a rating agency, then
the MetLife rating is used. |
|
(2) |
|
Assumes the value of the referenced credit obligations is zero. |
|
(3) |
|
The weighted average years to maturity of the credit default
swaps is calculated based on weighted average notional amounts. |
F-74
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
5.
|
Deferred
Policy Acquisition Costs and Value of Business
Acquired
|
Information regarding DAC and VOBA is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DAC
|
|
|
VOBA
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Balance at January 1, 2006
|
|
$
|
12,005
|
|
|
$
|
4,643
|
|
|
$
|
16,648
|
|
Capitalizations
|
|
|
2,825
|
|
|
|
|
|
|
|
2,825
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
14,830
|
|
|
|
4,643
|
|
|
|
19,473
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Amortization related to:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment gains (losses)
|
|
|
(160
|
)
|
|
|
(74
|
)
|
|
|
(234
|
)
|
Other expenses
|
|
|
1,747
|
|
|
|
391
|
|
|
|
2,138
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total amortization
|
|
|
1,587
|
|
|
|
317
|
|
|
|
1,904
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Unrealized investment gains (losses)
|
|
|
79
|
|
|
|
31
|
|
|
|
110
|
|
Less: Other
|
|
|
(48
|
)
|
|
|
3
|
|
|
|
(45
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2006
|
|
|
13,212
|
|
|
|
4,292
|
|
|
|
17,504
|
|
Effect of
SOP 05-1
adoption
|
|
|
(205
|
)
|
|
|
(248
|
)
|
|
|
(453
|
)
|
Capitalizations
|
|
|
3,064
|
|
|
|
|
|
|
|
3,064
|
|
Acquisitions
|
|
|
|
|
|
|
48
|
|
|
|
48
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
16,071
|
|
|
|
4,092
|
|
|
|
20,163
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Amortization related to:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment gains (losses)
|
|
|
(115
|
)
|
|
|
(11
|
)
|
|
|
(126
|
)
|
Other expenses
|
|
|
1,881
|
|
|
|
495
|
|
|
|
2,376
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total amortization
|
|
|
1,766
|
|
|
|
484
|
|
|
|
2,250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Unrealized investment gains (losses)
|
|
|
75
|
|
|
|
63
|
|
|
|
138
|
|
Less: Other
|
|
|
(30
|
)
|
|
|
(5
|
)
|
|
|
(35
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2007
|
|
|
14,260
|
|
|
|
3,550
|
|
|
|
17,810
|
|
Capitalizations
|
|
|
3,092
|
|
|
|
|
|
|
|
3,092
|
|
Acquisitions
|
|
|
|
|
|
|
(5
|
)
|
|
|
(5
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
17,352
|
|
|
|
3,545
|
|
|
|
20,897
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Amortization related to:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment gains (losses)
|
|
|
489
|
|
|
|
32
|
|
|
|
521
|
|
Other expenses
|
|
|
2,460
|
|
|
|
508
|
|
|
|
2,968
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total amortization
|
|
|
2,949
|
|
|
|
540
|
|
|
|
3,489
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Unrealized investment gains (losses)
|
|
|
(2,753
|
)
|
|
|
(599
|
)
|
|
|
(3,352
|
)
|
Less: Other
|
|
|
503
|
|
|
|
113
|
|
|
|
616
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2008
|
|
$
|
16,653
|
|
|
$
|
3,491
|
|
|
$
|
20,144
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See Note 2 for a description of acquisitions and
dispositions.
The estimated future amortization expense allocated to other
expenses for the next five years for VOBA is $375 million
in 2009, $353 million in 2010, $322 million in 2011,
$289 million in 2012, and $250 million in 2013.
F-75
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Amortization of VOBA and DAC is attributed to both investment
gains and losses and other expenses which are the amount of
gross margins or profits originating from transactions other
than investment gains and losses. Unrealized investment gains
and losses provide information regarding the amount of DAC and
VOBA that would have been amortized if such gains and losses had
been recognized.
Information regarding DAC and VOBA by segment and reporting unit
is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DAC
|
|
|
VOBA
|
|
|
Total
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Institutional:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Group life
|
|
$
|
74
|
|
|
$
|
79
|
|
|
$
|
9
|
|
|
$
|
17
|
|
|
$
|
83
|
|
|
$
|
96
|
|
Retirement & savings
|
|
|
31
|
|
|
|
33
|
|
|
|
1
|
|
|
|
1
|
|
|
|
32
|
|
|
|
34
|
|
Non-medical health & other
|
|
|
898
|
|
|
|
793
|
|
|
|
|
|
|
|
|
|
|
|
898
|
|
|
|
793
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
1,003
|
|
|
|
905
|
|
|
|
10
|
|
|
|
18
|
|
|
|
1,013
|
|
|
|
923
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Individual:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Traditional life
|
|
|
5,813
|
|
|
|
4,115
|
|
|
|
154
|
|
|
|
46
|
|
|
|
5,967
|
|
|
|
4,161
|
|
Variable & universal life
|
|
|
3,682
|
|
|
|
3,241
|
|
|
|
968
|
|
|
|
1,087
|
|
|
|
4,650
|
|
|
|
4,328
|
|
Annuities
|
|
|
3,971
|
|
|
|
3,724
|
|
|
|
1,917
|
|
|
|
1,825
|
|
|
|
5,888
|
|
|
|
5,549
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
13,466
|
|
|
|
11,080
|
|
|
|
3,039
|
|
|
|
2,958
|
|
|
|
16,505
|
|
|
|
14,038
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
International:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Latin America region
|
|
|
432
|
|
|
|
471
|
|
|
|
341
|
|
|
|
423
|
|
|
|
773
|
|
|
|
894
|
|
European region
|
|
|
303
|
|
|
|
216
|
|
|
|
22
|
|
|
|
35
|
|
|
|
325
|
|
|
|
251
|
|
Asia Pacific region
|
|
|
1,263
|
|
|
|
1,391
|
|
|
|
75
|
|
|
|
112
|
|
|
|
1,338
|
|
|
|
1,503
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
1,998
|
|
|
|
2,078
|
|
|
|
438
|
|
|
|
570
|
|
|
|
2,436
|
|
|
|
2,648
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Auto & Home
|
|
|
183
|
|
|
|
193
|
|
|
|
|
|
|
|
|
|
|
|
183
|
|
|
|
193
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate & Other
|
|
|
3
|
|
|
|
4
|
|
|
|
4
|
|
|
|
4
|
|
|
|
7
|
|
|
|
8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
16,653
|
|
|
$
|
14,260
|
|
|
$
|
3,491
|
|
|
$
|
3,550
|
|
|
$
|
20,144
|
|
|
$
|
17,810
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-76
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Goodwill is the excess of cost over the estimated fair value of
net assets acquired. Information regarding goodwill is as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Balance at beginning of the period
|
|
$
|
4,814
|
|
|
$
|
4,801
|
|
|
$
|
4,701
|
|
Acquisitions (1)
|
|
|
256
|
|
|
|
2
|
|
|
|
93
|
|
Other, net (2)
|
|
|
(62
|
)
|
|
|
11
|
|
|
|
7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at the end of the period
|
|
$
|
5,008
|
|
|
$
|
4,814
|
|
|
$
|
4,801
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
See Note 2 for a description of acquisitions and
dispositions. |
|
(2) |
|
Consisting principally of foreign currency translation
adjustments. |
Information regarding goodwill by segment and reporting unit is
as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Institutional:
|
|
|
|
|
|
|
|
|
Group life
|
|
$
|
15
|
|
|
$
|
15
|
|
Retirement & savings
|
|
|
887
|
|
|
|
887
|
|
Non-medical health & other
|
|
|
149
|
|
|
|
76
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
1,051
|
|
|
|
978
|
|
|
|
|
|
|
|
|
|
|
Individual:
|
|
|
|
|
|
|
|
|
Traditional life
|
|
|
73
|
|
|
|
73
|
|
Variable & universal life
|
|
|
1,174
|
|
|
|
1,174
|
|
Annuities
|
|
|
1,692
|
|
|
|
1,692
|
|
Other
|
|
|
18
|
|
|
|
18
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
2,957
|
|
|
|
2,957
|
|
|
|
|
|
|
|
|
|
|
International:
|
|
|
|
|
|
|
|
|
Latin America region
|
|
|
184
|
|
|
|
104
|
|
European region
|
|
|
37
|
|
|
|
50
|
|
Asia Pacific region
|
|
|
152
|
|
|
|
159
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
373
|
|
|
|
313
|
|
|
|
|
|
|
|
|
|
|
Auto & Home
|
|
|
157
|
|
|
|
157
|
|
|
|
|
|
|
|
|
|
|
Corporate & Other (1)
|
|
|
470
|
|
|
|
409
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
5,008
|
|
|
$
|
4,814
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The allocation of the goodwill to the reporting units was
performed at the time of the respective acquisition. The
$470 million of goodwill within Corporate & Other
relates to goodwill acquired as a part of the Travelers
acquisition of $405 million, as well as acquisitions by
MetLife Bank which resides within Corporate & Other.
For purposes of goodwill impairment testing at December 31,
2008 and 2007, the $405 million of Corporate & |
F-77
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
Other goodwill has been attributed to the Individual and
Institutional segment reporting units. The Individual segment
was attributed $210 million, (traditional life
$23 million, variable & universal
life $11 million and annuities
$176 million) and the Institutional segment was attributed
$195 million, (group life $2 million,
retirement & savings $186 million,
and non-medical health & other
$7 million) at both December 31, 2008 and 2007. |
As described in more detail in Note 1, the Company
performed its annual goodwill impairment tests during the third
quarter of 2008 based upon data as of June 30, 2008. Such
tests indicated that goodwill was not impaired as of
September 30, 2008. Current economic conditions, the
sustained low level of equity markets, declining market
capitalizations in the insurance industry and lower operating
earnings projections, particularly for the Individual segment,
required management of the Company to consider the impact of
these events on the recoverability of its assets, in particular
its goodwill. Management concluded it was appropriate to perform
an interim goodwill impairment test at December 31, 2008.
Based upon the tests performed management concluded no
impairment of goodwill had occurred for any of the
Companys reporting units at December 31, 2008.
Management continues to evaluate current market conditions that
may affect the estimated fair value of the Companys
reporting units to assess whether any goodwill impairment
exists. Continued deteriorating or adverse market conditions for
certain reporting units may have a significant impact on the
estimated fair value of these reporting units and could result
in future impairments of goodwill.
Insurance
Liabilities
Insurance liabilities are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Future Policy
|
|
|
Policyholder Account
|
|
|
Other Policyholder
|
|
|
|
Benefits
|
|
|
Balances
|
|
|
Funds
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Institutional
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Group life
|
|
$
|
3,346
|
|
|
$
|
3,326
|
|
|
$
|
14,044
|
|
|
$
|
13,997
|
|
|
$
|
2,532
|
|
|
$
|
2,364
|
|
Retirement & savings
|
|
|
40,320
|
|
|
|
37,947
|
|
|
|
60,787
|
|
|
|
51,585
|
|
|
|
58
|
|
|
|
213
|
|
Non-medical health & other
|
|
|
11,619
|
|
|
|
10,617
|
|
|
|
501
|
|
|
|
501
|
|
|
|
609
|
|
|
|
597
|
|
Individual
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Traditional life
|
|
|
52,968
|
|
|
|
52,378
|
|
|
|
1
|
|
|
|
1
|
|
|
|
1,423
|
|
|
|
1,478
|
|
Variable & universal life
|
|
|
1,129
|
|
|
|
949
|
|
|
|
15,062
|
|
|
|
14,583
|
|
|
|
1,452
|
|
|
|
1,417
|
|
Annuities
|
|
|
3,655
|
|
|
|
3,055
|
|
|
|
44,282
|
|
|
|
37,785
|
|
|
|
88
|
|
|
|
76
|
|
Other
|
|
|
2
|
|
|
|
|
|
|
|
2,524
|
|
|
|
2,398
|
|
|
|
1
|
|
|
|
1
|
|
International
|
|
|
9,241
|
|
|
|
9,825
|
|
|
|
5,654
|
|
|
|
4,961
|
|
|
|
1,227
|
|
|
|
1,296
|
|
Auto & Home
|
|
|
3,083
|
|
|
|
3,273
|
|
|
|
|
|
|
|
|
|
|
|
43
|
|
|
|
51
|
|
Corporate & Other
|
|
|
5,192
|
|
|
|
4,646
|
|
|
|
6,950
|
|
|
|
4,531
|
|
|
|
329
|
|
|
|
345
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
130,555
|
|
|
$
|
126,016
|
|
|
$
|
149,805
|
|
|
$
|
130,342
|
|
|
$
|
7,762
|
|
|
$
|
7,838
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-78
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Value
of Distribution Agreements and Customer Relationships
Acquired
Information regarding the VODA and VOCRA, which are reported in
other assets, is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
Balance at January 1,
|
|
$
|
706
|
|
|
$
|
708
|
|
|
$
|
715
|
|
Acquisitions
|
|
|
144
|
|
|
|
11
|
|
|
|
|
|
Amortization
|
|
|
(25
|
)
|
|
|
(16
|
)
|
|
|
(6
|
)
|
Other
|
|
|
(3
|
)
|
|
|
3
|
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31,
|
|
$
|
822
|
|
|
$
|
706
|
|
|
$
|
708
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The estimated future amortization expense allocated to other
expenses for the next five years for VODA and VOCRA is
$34 million in 2009, $40 million in 2010,
$44 million in 2011, $49 million in 2012 and
$52 million in 2013. See Note 2 for a description of
acquisitions and dispositions.
Sales
Inducements
Information regarding deferred sales inducements, which are
reported in other assets, is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
Balance at January 1,
|
|
$
|
677
|
|
|
$
|
578
|
|
|
$
|
414
|
|
Capitalization
|
|
|
176
|
|
|
|
181
|
|
|
|
194
|
|
Amortization
|
|
|
(142
|
)
|
|
|
(82
|
)
|
|
|
(30
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31,
|
|
$
|
711
|
|
|
$
|
677
|
|
|
$
|
578
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Separate
Accounts
Separate account assets and liabilities include two categories
of account types: pass-through separate accounts totaling
$96.6 billion and $141.7 billion at December 31,
2008 and 2007, respectively, for which the policyholder assumes
all investment risk, and separate accounts with a minimum return
or account value for which the Company contractually guarantees
either a minimum return or account value to the policyholder
which totaled $24.2 billion and $18.4 billion at
December 31, 2008 and 2007, respectively. The latter
category consisted primarily of Met Managed GICs and
participating close-out contracts. The average interest rate
credited on these contracts was 4.40% and 4.73% at
December 31, 2008 and 2007, respectively.
Fees charged to the separate accounts by the Company (including
mortality charges, policy administration fees and surrender
charges) are reflected in the Companys revenues as
universal life and investment-type product policy fees and
totaled $3.2 billion, $2.8 billion and
$2.4 billion for the years ended December 31, 2008,
2007 and 2006, respectively.
The Companys proportional interest in separate accounts is
included in the consolidated balance sheets as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Fixed maturity securities
|
|
$
|
21
|
|
|
$
|
35
|
|
Equity securities
|
|
$
|
19
|
|
|
$
|
41
|
|
Cash and cash equivalents
|
|
$
|
3
|
|
|
$
|
5
|
|
F-79
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
For the years ended December 31, 2008, 2007 and 2006, there
were no investment gains (losses) on transfers of assets from
the general account to the separate accounts.
Obligations
Under Guaranteed Interest Contract Program
The Company issues fixed and floating rate obligations under its
GIC program which are denominated in either U.S. dollars or
foreign currencies. During the years ended December 31,
2008, 2007 and 2006, the Company issued $5.8 billion,
$5.2 billion and $5.2 billion, respectively, and
repaid $8.3 billion, $4.3 billion and
$2.6 billion, respectively, of GICs under this program. At
December 31, 2008 and 2007, GICs outstanding, which are
included in policyholder account balances, were
$21.6 billion and $24.2 billion, respectively. During
the years ended December 31, 2008, 2007 and 2006, interest
credited on the contracts, which are included in interest
credited to policyholder account balances, was
$1.0 billion, $1.1 billion and $834 million,
respectively.
Obligations
Under Funding Agreements
MetLife Insurance Company of Connecticut is a member of the FHLB
of Boston and holds $70 million of common stock of the FHLB
of Boston at both December 31, 2008 and 2007, which is
included in equity securities. MICC has also entered into
funding agreements with the FHLB of Boston whereby MICC has
issued such funding agreements in exchange for cash and for
which the FHLB of Boston has been granted a blanket lien on
certain MICC assets, including residential mortgage-backed
securities, to collateralize MICCs obligations under the
funding agreements. MICC maintains control over these pledged
assets, and may use, commingle, encumber or dispose of any
portion of the collateral as long as there is no event of
default and the remaining qualified collateral is sufficient to
satisfy the collateral maintenance level. Upon any event of
default by MICC, the FHLB of Bostons recovery on the
collateral is limited to the amount of MICCs liability to
the FHLB of Boston. The amount of MICCs liability for
funding agreements with the FHLB of Boston was $526 million
and $726 million at December 31, 2008 and 2007,
respectively, which is included in policyholder account
balances. In addition, at December 31, 2008, MICC had
advances of $300 million from the FHLB of Boston with
original maturities of less than one year and therefore, such
advances are included in short-term debt. These advances and the
advances on these funding agreements are collateralized by
mortgage-backed securities with estimated fair values of
$1.3 billion and $901 million at December 31,
2008 and 2007, respectively.
Metropolitan Life Insurance Company is a member of the FHLB of
NY and holds $830 million and $339 million of common
stock of the FHLB of NY at December 31, 2008 and 2007,
respectively, which is included in equity securities. MLIC has
also entered into funding agreements with the FHLB of NY whereby
MLIC has issued such funding agreements in exchange for cash and
for which the FHLB of NY has been granted a lien on certain MLIC
assets, including residential mortgage-backed securities to
collateralize MLICs obligations under the funding
agreements. MLIC maintains control over these pledged assets,
and may use, commingle, encumber or dispose of any portion of
the collateral as long as there is no event of default and the
remaining qualified collateral is sufficient to satisfy the
collateral maintenance level. Upon any event of default by MLIC,
the FHLB of NYs recovery on the collateral is limited to
the amount of MLICs liability to the FHLB of NY. The
amount of the Companys liability for funding agreements
with the FHLB of NY was $15.2 billion and $4.6 billion
at December 31, 2008 and 2007, respectively, which is
included in policyholder account balances. The advances on these
agreements are collateralized by mortgage-backed securities with
estimated fair values of $17.8 billion and
$4.8 billion at December 31, 2008 and 2007,
respectively.
MLIC has issued funding agreements to certain trusts that have
issued securities guaranteed as to payment of interest and
principal by the Federal Agricultural Mortgage Corporation, a
federally chartered instrumentality of the United States. The
obligations under these funding agreements are secured by a
pledge of certain eligible agricultural real estate mortgage
loans and may, under certain circumstances, be secured by other
qualified collateral. The amount of the Companys liability
for funding agreements issued to such trusts was
$2.5 billion at both December 31, 2008 and 2007, which
is included in policyholder account balances. The obligations
under these
F-80
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
funding agreements are collateralized by designated agricultural
real estate mortgage loans with estimated fair values of
$2.9 billion at both December 31, 2008 and 2007.
Approximately $3.0 billion of the obligations outstanding
at MLIC at December 31, 2008 are subject to a temporary
contingent increase in MLICs borrowing capacity which is
scheduled to expire at December 31, 2009. The Company does
not expect to have any difficulties in meeting the contingencies
associated with the increased capacity.
Liabilities
for Unpaid Claims and Claim Expenses
Information regarding the liabilities for unpaid claims and
claim expenses relating to property and casualty, group accident
and non-medical health policies and contracts, which are
reported in future policy benefits and other policyholder funds,
is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Balance at January 1,
|
|
$
|
7,836
|
|
|
$
|
7,244
|
|
|
$
|
6,977
|
|
Less: Reinsurance recoverables
|
|
|
(955
|
)
|
|
|
(937
|
)
|
|
|
(940
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net balance at January 1,
|
|
|
6,881
|
|
|
|
6,307
|
|
|
|
6,037
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incurred related to:
|
|
|
|
|
|
|
|
|
|
|
|
|
Current year
|
|
|
6,263
|
|
|
|
5,796
|
|
|
|
5,064
|
|
Prior years
|
|
|
(353
|
)
|
|
|
(325
|
)
|
|
|
(329
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,910
|
|
|
|
5,471
|
|
|
|
4,735
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Paid related to:
|
|
|
|
|
|
|
|
|
|
|
|
|
Current year
|
|
|
(3,861
|
)
|
|
|
(3,297
|
)
|
|
|
(2,975
|
)
|
Prior years
|
|
|
(1,712
|
)
|
|
|
(1,600
|
)
|
|
|
(1,490
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5,573
|
)
|
|
|
(4,897
|
)
|
|
|
(4,465
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net balance at December 31,
|
|
|
7,218
|
|
|
|
6,881
|
|
|
|
6,307
|
|
Add: Reinsurance recoverables
|
|
|
1,042
|
|
|
|
955
|
|
|
|
937
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31,
|
|
$
|
8,260
|
|
|
$
|
7,836
|
|
|
$
|
7,244
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
During 2008, 2007 and 2006, as a result of changes in estimates
of insured events in the respective prior year, claims and claim
adjustment expenses associated with prior years decreased by
$353 million, $325 million and $329 million,
respectively, due to a reduction in prior year automobile bodily
injury and homeowners severity, reduced loss adjustment
expenses, improved loss ratio for non-medical health claim
liabilities and improved claim management.
Guarantees
The Company issues annuity contracts which may include
contractual guarantees to the contractholder for:
(i) return of no less than total deposits made to the
contract less any partial withdrawals (return of net
deposits); and (ii) the highest contract value on a
specified anniversary date minus any withdrawals following the
contract anniversary, or total deposits made to the contract
less any partial withdrawals plus a minimum return
(anniversary contract value or minimum
return). The Company also issues annuity contracts that
apply a lower rate of funds deposited if the contractholder
elects to surrender the contract for cash and a higher rate if
the contractholder elects to annuitize (two tier
annuities). These guarantees include benefits that are
payable in the event of death or at annuitization.
F-81
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The Company also issues universal and variable life contracts
where the Company contractually guarantees to the contractholder
a secondary guarantee or a guaranteed
paid-up
benefit.
Information regarding the types of guarantees relating to
annuity contracts and universal and variable life contracts is
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
In the
|
|
|
At
|
|
|
In the
|
|
|
At
|
|
|
|
Event of Death
|
|
|
Annuitization
|
|
|
Event of Death
|
|
|
Annuitization
|
|
|
|
(In millions)
|
|
|
Annuity Contracts (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return of Net Deposits
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Separate account value
|
|
$
|
15,882
|
|
|
|
N/A
|
|
|
$
|
18,573
|
|
|
|
N/A
|
|
Net amount at risk (2)
|
|
$
|
4,384
|
(3)
|
|
|
N/A
|
|
|
$
|
52
|
(3)
|
|
|
N/A
|
|
Average attained age of contractholders
|
|
|
62 years
|
|
|
|
N/A
|
|
|
|
61 years
|
|
|
|
N/A
|
|
Anniversary Contract Value or Minimum Return
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Separate account value
|
|
$
|
62,345
|
|
|
$
|
24,328
|
|
|
$
|
87,168
|
|
|
$
|
29,603
|
|
Net amount at risk (2)
|
|
$
|
18,637
|
(3)
|
|
$
|
11,312
|
(4)
|
|
$
|
2,331
|
(3)
|
|
$
|
441
|
(4)
|
Average attained age of contractholders
|
|
|
60 years
|
|
|
|
61 years
|
|
|
|
58 years
|
|
|
|
60 years
|
|
Two Tier Annuities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General account value
|
|
|
N/A
|
|
|
$
|
283
|
|
|
|
N/A
|
|
|
$
|
286
|
|
Net amount at risk (2)
|
|
|
N/A
|
|
|
$
|
50
|
(5)
|
|
|
N/A
|
|
|
$
|
51
|
(5)
|
Average attained age of contractholders
|
|
|
N/A
|
|
|
|
60 years
|
|
|
|
N/A
|
|
|
|
60 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
Secondary
|
|
|
Paid-Up
|
|
|
Secondary
|
|
|
Paid-Up
|
|
|
|
Guarantees
|
|
|
Guarantees
|
|
|
Guarantees
|
|
|
Guarantees
|
|
|
|
(In millions)
|
|
|
Universal and Variable Life Contracts (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Account value (general and separate account)
|
|
$
|
7,825
|
|
|
$
|
4,135
|
|
|
$
|
9,347
|
|
|
$
|
4,302
|
|
Net amount at risk (2)
|
|
$
|
145,927
|
(3)
|
|
$
|
31,274
|
(3)
|
|
$
|
141,840
|
(3)
|
|
$
|
33,855
|
(3)
|
Average attained age of policyholders
|
|
|
50 years
|
|
|
|
56 years
|
|
|
|
49 years
|
|
|
|
55 years
|
|
|
|
|
(1) |
|
The Companys annuity and life contracts with guarantees
may offer more than one type of guarantee in each contract.
Therefore, the amounts listed above may not be mutually
exclusive. |
|
(2) |
|
The net amount at risk is based on the direct amount at risk
(excluding reinsurance). |
|
(3) |
|
The net amount at risk for guarantees of amounts in the event of
death is defined as the current guaranteed minimum death benefit
in excess of the current account balance at the balance sheet
date. |
|
(4) |
|
The net amount at risk for guarantees of amounts at
annuitization is defined as the present value of the minimum
guaranteed annuity payments available to the contractholder
determined in accordance with the terms of the contract in
excess of the current account balance. |
|
(5) |
|
The net amount at risk for two tier annuities is based on the
excess of the upper tier, adjusted for a profit margin, less the
lower tier. |
F-82
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Information regarding the liabilities for guarantees (excluding
base policy liabilities) relating to annuity and universal and
variable life contracts is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Universal and Variable
|
|
|
|
|
|
|
Annuity Contracts
|
|
|
Life Contracts
|
|
|
|
|
|
|
Guaranteed
|
|
|
Guaranteed
|
|
|
|
|
|
Paid
|
|
|
|
|
|
|
Death
|
|
|
Annuitization
|
|
|
Secondary
|
|
|
Up
|
|
|
|
|
|
|
Benefits
|
|
|
Benefits
|
|
|
Guarantees
|
|
|
Guarantees
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Balance at January 1, 2006
|
|
$
|
41
|
|
|
$
|
29
|
|
|
$
|
15
|
|
|
$
|
39
|
|
|
$
|
124
|
|
Incurred guaranteed benefits
|
|
|
18
|
|
|
|
7
|
|
|
|
29
|
|
|
|
1
|
|
|
|
55
|
|
Paid guaranteed benefits
|
|
|
(6
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(6
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2006
|
|
|
53
|
|
|
|
36
|
|
|
|
44
|
|
|
|
40
|
|
|
|
173
|
|
Incurred guaranteed benefits
|
|
|
29
|
|
|
|
38
|
|
|
|
53
|
|
|
|
6
|
|
|
|
126
|
|
Paid guaranteed benefits
|
|
|
(8
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(8
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2007
|
|
|
74
|
|
|
|
74
|
|
|
|
97
|
|
|
|
46
|
|
|
|
291
|
|
Incurred guaranteed benefits
|
|
|
249
|
|
|
|
329
|
|
|
|
94
|
|
|
|
4
|
|
|
|
676
|
|
Paid guaranteed benefits
|
|
|
(80
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(80
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2008
|
|
$
|
243
|
|
|
$
|
403
|
|
|
$
|
191
|
|
|
$
|
50
|
|
|
$
|
887
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Account balances of contracts with insurance guarantees are
invested in separate account asset classes as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Mutual Fund Groupings
|
|
|
|
|
|
|
|
|
Equity
|
|
$
|
39,842
|
|
|
$
|
69,477
|
|
Balanced
|
|
|
14,548
|
|
|
|
15,977
|
|
Bond
|
|
|
5,671
|
|
|
|
6,284
|
|
Money Market
|
|
|
2,456
|
|
|
|
1,775
|
|
Specialty
|
|
|
488
|
|
|
|
870
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
63,005
|
|
|
$
|
94,383
|
|
|
|
|
|
|
|
|
|
|
The Companys Individual segment life insurance operations
participate in reinsurance activities in order to limit losses,
minimize exposure to large risks, and provide additional
capacity for future growth. The Company has historically
reinsured the mortality risk on new individual life insurance
policies primarily on an excess of retention basis or a quota
share basis. Until 2005, the Company reinsured up to 90% of the
mortality risk for all new individual life insurance policies
that it wrote through its various franchises. This practice was
initiated by the different franchises for different products
starting at various points in time between 1992 and 2000. During
2005, the Company changed its retention practices for certain
individual life insurance. Amounts reinsured in prior years
remain reinsured under the original reinsurance; however, under
the new retention guidelines, the Company reinsures up to 90% of
the mortality risk in excess of $1 million for most new
individual life insurance policies that it writes through its
various franchises and for certain individual life policies the
retention limits remained unchanged. On a case by case basis,
the Company may retain up to $20 million per life and
reinsure 100% of amounts in excess of the Companys
retention limits. The Company evaluates its reinsurance programs
routinely and may increase or decrease its retention at any
time. In addition, the Company reinsures a significant portion
of the mortality risk on its
F-83
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
individual universal life policies issued since 1983. Placement
of reinsurance is done primarily on an automatic basis and also
on a facultative basis for risks with specific characteristics.
The Companys Individual segment also reinsures a portion
of the living and death benefit riders issued in connection with
its variable annuities. Under these reinsurance agreements, the
Company pays a reinsurance premium generally based on rider fees
collected from policyholders and receives reimbursements for
benefits paid or accrued in excess of account values, subject to
certain limitations. The Company enters into similar agreements
for new or in-force business depending on market conditions.
The Institutional segment generally retains most of its risks
and does not significantly utilize reinsurance. The Company may,
on certain client arrangements, cede particular risks to
reinsurers.
The Auto & Home segment purchases reinsurance to
control its exposure to large losses (primarily catastrophe
losses) and to protect statutory surplus. Auto & Home
cedes to reinsurers a portion of losses and cedes premiums based
upon the risk and exposure of the policies subject to
reinsurance. To control exposure to large property and casualty
losses, Auto & Home utilizes property catastrophe,
casualty, and property per risk excess of loss agreements.
The Company also reinsures through 100% quota-share reinsurance
agreements certain long-term care and workers compensation
business written by MICC prior to the Companys acquisition
of MICC. These run-off businesses have been included within
Corporate & Other since the acquisition of MICC.
In addition to reinsuring mortality risk as described
previously, the Company reinsures other risks, as well as
specific coverages. The Company routinely reinsures certain
classes of risks in order to limit its exposure to particular
travel, avocation and lifestyle hazards. The Company has
exposure to catastrophes, which could contribute to significant
fluctuations in the Companys results of operations. The
Company uses excess of retention and quota share reinsurance
arrangements to provide greater diversification of risk and
minimize exposure to larger risks.
The Company reinsures its business through a diversified group
of reinsurers. In the event that reinsurers do not meet their
obligations to the Company under the terms of the reinsurance
agreements, reinsurance balances recoverable could become
uncollectible. Cessions under reinsurance arrangements do not
discharge the Companys obligations as the primary insurer.
F-84
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The amounts in the consolidated statements of income are
presented net of reinsurance ceded. Information regarding the
effect of reinsurance is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Premiums:
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct premiums
|
|
$
|
27,058
|
|
|
$
|
24,149
|
|
|
$
|
23,308
|
|
Reinsurance assumed
|
|
|
1,466
|
|
|
|
1,192
|
|
|
|
928
|
|
Reinsurance ceded
|
|
|
(2,610
|
)
|
|
|
(2,371
|
)
|
|
|
(2,184
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net premiums
|
|
$
|
25,914
|
|
|
$
|
22,970
|
|
|
$
|
22,052
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Universal life and investment-type product policy fees:
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct universal life and investment-type product policy fees
|
|
$
|
5,909
|
|
|
$
|
5,686
|
|
|
$
|
5,146
|
|
Reinsurance assumed
|
|
|
79
|
|
|
|
54
|
|
|
|
20
|
|
Reinsurance ceded
|
|
|
(607
|
)
|
|
|
(502
|
)
|
|
|
(455
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net universal life and investment-type product policy fees
|
|
$
|
5,381
|
|
|
$
|
5,238
|
|
|
$
|
4,711
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims:
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct policyholder benefits and claims
|
|
$
|
29,772
|
|
|
$
|
25,507
|
|
|
$
|
24,649
|
|
Reinsurance assumed
|
|
|
1,235
|
|
|
|
804
|
|
|
|
847
|
|
Reinsurance ceded
|
|
|
(3,570
|
)
|
|
|
(2,528
|
)
|
|
|
(2,627
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net policyholder benefits and claims
|
|
$
|
27,437
|
|
|
$
|
23,783
|
|
|
$
|
22,869
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Information regarding ceded reinsurance recoverable balances,
included in premiums and other receivables is as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Future policy benefit recoverables
|
|
$
|
8,258
|
|
|
$
|
6,842
|
|
Deposit recoverables
|
|
|
2,258
|
|
|
|
2,616
|
|
Claim recoverables
|
|
|
319
|
|
|
|
271
|
|
All other recoverables
|
|
|
232
|
|
|
|
48
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
11,067
|
|
|
$
|
9,777
|
|
|
|
|
|
|
|
|
|
|
Reinsurance recoverable balances are stated net of allowances
for uncollectible balances, which are immaterial. The Company
evaluates the financial strength of the Companys
reinsurers by monitoring their ratings and analyzing their
financial statements. The Company also analyzes recent trends in
arbitration and litigation outcomes in disputes, if any, with
its reinsurers. Recoverability of reinsurance recoverable
balances are evaluated based on these analyses.
Included in the reinsurance recoverables are, $1.2 billion
at both December 31, 2008 and 2007 related to reinsurance
of long-term GICs and structured settlement lump sum contracts
accounted for as a financing transaction; $3.9 billion and
$3.4 billion at December 31, 2008 and 2007,
respectively, related to reinsurance recoverable on the run-off
of long-term care business originally written by MICC;
$1.1 billion and $1.2 billion at December 31,
2008 and 2007, respectively, related to reinsurance recoverable
on the run-off of workers compensation business originally
written by MICC; and $0.6 billion and $1.1 billion at
December 31, 2008
F-85
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
and 2007, respectively, related to the reinsurance of
investment-type contracts held by small market defined benefit
contribution plans.
The Company has secured certain reinsurance recoverable balances
with various forms of collateral, including secured trusts,
funds withheld accounts and irrevocable letters of credit. At
December 31, 2008, the Company has $5,489 million of
reinsurance recoverable balances secured by funds held in trust
as collateral, $524 million of reinsurance recoverable
balances secured by funds withheld accounts and
$286 million of reinsurance recoverable balances secured
through irrevocable letters of credit issued by various
financial institutions.
At December 31, 2008, $7,651 million, or 69%, of the
Companys total reinsurance recoverable balances were due
from its five largest reinsurers. Of these reinsurance
recoverable balances, $5,194 million were secured by funds
held in trust as collateral and $209 million were secured
through irrevocable letters of credit issued by various
financial institutions.
Reinsurance balances payable, included in other liabilities,
were $1,405 million and $571 million at
December 31, 2008 and 2007, respectively.
On April 7, 2000, (the Demutualization Date),
MLIC converted from a mutual life insurance company to a stock
life insurance company and became a wholly-owned subsidiary of
MetLife, Inc. The conversion was pursuant to an order by the New
York Superintendent of Insurance (the
Superintendent) approving MLICs plan of
reorganization, as amended (the Plan). On the
Demutualization Date, MLIC established a closed block for the
benefit of holders of certain individual life insurance policies
of MLIC. Assets have been allocated to the closed block in an
amount that has been determined to produce cash flows which,
together with anticipated revenues from the policies included in
the closed block, are reasonably expected to be sufficient to
support obligations and liabilities relating to these policies,
including, but not limited to, provisions for the payment of
claims and certain expenses and taxes, and to provide for the
continuation of policyholder dividend scales in effect for 1999,
if the experience underlying such dividend scales continues, and
for appropriate adjustments in such scales if the experience
changes. At least annually, the Company compares actual and
projected experience against the experience assumed in the
then-current dividend scales. Dividend scales are adjusted
periodically to give effect to changes in experience.
The closed block assets, the cash flows generated by the closed
block assets and the anticipated revenues from the policies in
the closed block will benefit only the holders of the policies
in the closed block. To the extent that, over time, cash flows
from the assets allocated to the closed block and claims and
other experience related to the closed block are, in the
aggregate, more or less favorable than what was assumed when the
closed block was established, total dividends paid to closed
block policyholders in the future may be greater than or less
than the total dividends that would have been paid to these
policyholders if the policyholder dividend scales in effect for
1999 had been continued. Any cash flows in excess of amounts
assumed will be available for distribution over time to closed
block policyholders and will not be available to stockholders.
If the closed block has insufficient funds to make guaranteed
policy benefit payments, such payments will be made from assets
outside of the closed block. The closed block will continue in
effect as long as any policy in the closed block remains
in-force. The expected life of the closed block is over
100 years.
The Company uses the same accounting principles to account for
the participating policies included in the closed block as it
used prior to the Demutualization Date. However, the Company
establishes a policyholder dividend obligation for earnings that
will be paid to policyholders as additional dividends as
described below. The excess of closed block liabilities over
closed block assets at the effective date of the demutualization
(adjusted to eliminate the impact of related amounts in
accumulated other comprehensive income) represents the estimated
maximum future earnings from the closed block expected to result
from operations attributed to the closed block after income
taxes. Earnings of the closed block are recognized in income
over the period the policies and contracts
F-86
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
in the closed block remain in-force. Management believes that
over time the actual cumulative earnings of the closed block
will approximately equal the expected cumulative earnings due to
the effect of dividend changes. If, over the period the closed
block remains in existence, the actual cumulative earnings of
the closed block is greater than the expected cumulative
earnings of the closed block, the Company will pay the excess of
the actual cumulative earnings of the closed block over the
expected cumulative earnings to closed block policyholders as
additional policyholder dividends unless offset by future
unfavorable experience of the closed block and, accordingly,
will recognize only the expected cumulative earnings in income
with the excess recorded as a policyholder dividend obligation.
If over such period, the actual cumulative earnings of the
closed block is less than the expected cumulative earnings of
the closed block, the Company will recognize only the actual
earnings in income. However, the Company may change policyholder
dividend scales in the future, which would be intended to
increase future actual earnings until the actual cumulative
earnings equal the expected cumulative earnings.
Recent experience within the closed block, in particular
mortality and investment yields, as well as realized and
unrealized losses, has resulted in a reduction of the
policyholder dividend obligation to zero during the year ended
December 31, 2008. The reduction of the policyholder
dividend obligation to zero and the Companys decision to
revise the expected policyholder dividend scales, which are
based upon statutory results, has resulted in reduction to both
actual and expected cumulative earnings of the closed block.
This change in the timing of the expected cumulative earnings of
the closed block combined with a policyholder dividend
obligation of zero has resulted in a reduction in the DAC
associated with closed block, which resides outside of the
closed block, and a corresponding decrease in the Companys
net income of $127 million, net of income tax, for the year
ended December 31, 2008. Amortization of the closed block
DAC will be based upon actual cumulative earnings rather than
expected cumulative earnings of the closed block until such time
as the actual cumulative earnings of the closed block exceed the
expected cumulative earnings, at which time the policyholder
dividend obligation will be reestablished. Actual cumulative
earnings less than expected cumulative earnings will result in
future reductions to DAC and net income of the Company and
increase sensitivity of the Companys net income to
movements in closed block results. See also Note 5 for
further information regarding DAC.
F-87
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Information regarding the closed block liabilities and assets
designated to the closed block is as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Closed Block Liabilities
|
|
|
|
|
|
|
|
|
Future policy benefits
|
|
$
|
43,520
|
|
|
$
|
43,362
|
|
Other policyholder funds
|
|
|
315
|
|
|
|
323
|
|
Policyholder dividends payable
|
|
|
711
|
|
|
|
709
|
|
Policyholder dividend obligation
|
|
|
|
|
|
|
789
|
|
Payables for collateral under securities loaned and other
transactions
|
|
|
2,852
|
|
|
|
5,610
|
|
Other liabilities
|
|
|
254
|
|
|
|
290
|
|
|
|
|
|
|
|
|
|
|
Total closed block liabilities
|
|
|
47,652
|
|
|
|
51,083
|
|
|
|
|
|
|
|
|
|
|
Assets Designated to the Closed Block
|
|
|
|
|
|
|
|
|
Investments:
|
|
|
|
|
|
|
|
|
Fixed maturity securities available-for-sale, at estimated fair
value (amortized cost: $27,947 and $29,631, respectively)
|
|
|
26,205
|
|
|
|
30,481
|
|
Equity securities available-for-sale, at estimated fair value
(cost: $280 and $1,555, respectively)
|
|
|
210
|
|
|
|
1,875
|
|
Mortgage loans on real estate
|
|
|
7,243
|
|
|
|
7,472
|
|
Policy loans
|
|
|
4,426
|
|
|
|
4,290
|
|
Real estate and real estate joint ventures held-for-investment
|
|
|
381
|
|
|
|
297
|
|
Short-term investments
|
|
|
52
|
|
|
|
14
|
|
Other invested assets
|
|
|
952
|
|
|
|
829
|
|
|
|
|
|
|
|
|
|
|
Total investments
|
|
|
39,469
|
|
|
|
45,258
|
|
Cash and cash equivalents
|
|
|
262
|
|
|
|
333
|
|
Accrued investment income
|
|
|
484
|
|
|
|
485
|
|
Deferred income tax assets
|
|
|
1,632
|
|
|
|
640
|
|
Premiums and other receivables
|
|
|
98
|
|
|
|
151
|
|
|
|
|
|
|
|
|
|
|
Total assets designated to the closed block
|
|
|
41,945
|
|
|
|
46,867
|
|
|
|
|
|
|
|
|
|
|
Excess of closed block liabilities over assets designated to the
closed block
|
|
|
5,707
|
|
|
|
4,216
|
|
|
|
|
|
|
|
|
|
|
Amounts included in accumulated other comprehensive income
(loss):
|
|
|
|
|
|
|
|
|
Unrealized investment gains (losses), net of income tax of
($633) and $424, respectively
|
|
|
(1,174
|
)
|
|
|
751
|
|
Unrealized gains (losses) on derivative instruments, net of
income tax of ($8) and ($19), respectively
|
|
|
(15
|
)
|
|
|
(33
|
)
|
Allocated $284, net of income tax, to policyholder dividend
obligation at December 31, 2007
|
|
|
|
|
|
|
(505
|
)
|
|
|
|
|
|
|
|
|
|
Total amounts included in accumulated other comprehensive income
(loss)
|
|
|
(1,189
|
)
|
|
|
213
|
|
|
|
|
|
|
|
|
|
|
Maximum future earnings to be recognized from closed block
assets and liabilities
|
|
$
|
4,518
|
|
|
$
|
4,429
|
|
|
|
|
|
|
|
|
|
|
F-88
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Information regarding the closed block policyholder dividend
obligation is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Balance at January 1,
|
|
$
|
789
|
|
|
$
|
1,063
|
|
|
$
|
1,607
|
|
Impact on revenues, net of expenses and income tax
|
|
|
|
|
|
|
|
|
|
|
(114
|
)
|
Change in unrealized investment and derivative gains (losses)
|
|
|
(789
|
)
|
|
|
(274
|
)
|
|
|
(430
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31,
|
|
$
|
|
|
|
$
|
789
|
|
|
$
|
1,063
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Information regarding the closed block revenues and expenses is
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
2,787
|
|
|
$
|
2,870
|
|
|
$
|
2,959
|
|
Net investment income and other revenues
|
|
|
2,248
|
|
|
|
2,350
|
|
|
|
2,355
|
|
Net investment gains (losses)
|
|
|
(84
|
)
|
|
|
28
|
|
|
|
(130
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
4,951
|
|
|
|
5,248
|
|
|
|
5,184
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims
|
|
|
3,393
|
|
|
|
3,457
|
|
|
|
3,474
|
|
Policyholder dividends
|
|
|
1,498
|
|
|
|
1,492
|
|
|
|
1,479
|
|
Change in policyholder dividend obligation
|
|
|
|
|
|
|
|
|
|
|
(114
|
)
|
Other expenses
|
|
|
217
|
|
|
|
231
|
|
|
|
247
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
5,108
|
|
|
|
5,180
|
|
|
|
5,086
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues, net of expenses before income tax
|
|
|
(157
|
)
|
|
|
68
|
|
|
|
98
|
|
Income tax
|
|
|
(68
|
)
|
|
|
21
|
|
|
|
34
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues, net of expenses and income tax from continuing
operations
|
|
|
(89
|
)
|
|
|
47
|
|
|
|
64
|
|
Revenues, net of expenses and income tax from discontinued
operations
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues, net of expenses, income taxes and discontinued
operations
|
|
$
|
(89
|
)
|
|
$
|
47
|
|
|
$
|
65
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The change in the maximum future earnings of the closed block is
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Balance at December 31,
|
|
$
|
4,518
|
|
|
$
|
4,429
|
|
|
$
|
4,480
|
|
Less:
|
|
|
|
|
|
|
|
|
|
|
|
|
Cumulative effect of a change in accounting principle, net of
income tax
|
|
|
|
|
|
|
(4
|
)
|
|
|
|
|
Balance at January 1,
|
|
|
4,429
|
|
|
|
4,480
|
|
|
|
4,545
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change during year
|
|
$
|
89
|
|
|
$
|
(47
|
)
|
|
$
|
(65
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MLIC charges the closed block with federal income taxes, state
and local premium taxes, and other additive state or local
taxes, as well as investment management expenses relating to the
closed block as provided in the Plan. MLIC also charges the
closed block for expenses of maintaining the policies included
in the closed block.
F-89
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
10.
|
Long-term
and Short-term Debt
|
Long-term and short-term debt outstanding is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rates
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
December 31,
|
|
|
|
Range
|
|
|
Average
|
|
|
Maturity
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
|
Senior notes
|
|
|
5.00%-6.82%
|
|
|
|
6.04%
|
|
|
2011-2035
|
|
$
|
7,660
|
|
|
$
|
7,017
|
|
Repurchase agreements
|
|
|
2.54%-5.65%
|
|
|
|
3.76%
|
|
|
2009-2013
|
|
|
1,062
|
|
|
|
1,213
|
|
Surplus notes
|
|
|
7.63%-7.88%
|
|
|
|
7.86%
|
|
|
2015-2025
|
|
|
698
|
|
|
|
697
|
|
Fixed rate notes
|
|
|
5.50%-8.02%
|
|
|
|
8.02%
|
|
|
2010
|
|
|
65
|
|
|
|
43
|
|
Other notes with varying interest rates
|
|
|
3.44%-12.00%
|
|
|
|
3.65%
|
|
|
2009-2016
|
|
|
134
|
|
|
|
75
|
|
Capital lease obligations
|
|
|
|
|
|
|
|
|
|
|
|
|
48
|
|
|
|
55
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total long-term debt
|
|
|
|
|
|
|
|
|
|
|
|
|
9,667
|
|
|
|
9,100
|
|
Total short-term debt
|
|
|
|
|
|
|
|
|
|
|
|
|
2,659
|
|
|
|
667
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
$
|
12,326
|
|
|
$
|
9,767
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The aggregate maturities of long-term debt at December 31,
2008 for the next five years are $528 million in 2009,
$352 million in 2010, $850 million in 2011,
$597 million in 2012, $600 million in 2013 and
$6,740 million thereafter.
Repurchase agreements and capital lease obligations are
collateralized and rank highest in priority, followed by
unsecured senior debt which consists of senior notes, fixed rate
notes and other notes with varying interest rates, followed by
subordinated debt which consists of junior subordinated
debentures. Payments of interest and principal on the
Companys surplus notes, which are subordinate to all other
obligations at the operating company level and senior to
obligations at the Holding Company, may be made only with the
prior approval of the insurance department of the state of
domicile. Collateral financing arrangements are supported by
either surplus notes of subsidiaries or financing arrangements
with the Holding Company and accordingly have priority
consistent with other such obligations.
Long-term debt, credit facilities and letters of credit of the
Holding Company and its subsidiaries contain various covenants.
The Company has certain administrative, reporting, legal and
financial covenants, including one requiring the Company to
maintain a specified minimum consolidated net worth. The Company
amended certain of its credit facilities, including its
$2.85 billion, five-year revolving credit facilities, in
December 2008. The Company was in compliance with all covenants
at December 31, 2008 and 2007.
Senior
Notes
On August 15, 2008, the Holding Company remarketed its
existing $1,035 million 4.82% Series A junior
subordinated debentures as 6.817% senior debt securities,
Series A, due 2018 payable semi-annually. On
February 17, 2009, the Holding Company remarketed its
existing $1,035 million 4.91% Series B junior
subordinated debentures as 7.717% senior debt securities,
Series B, due 2019 payable semi-annually. The Series A
and Series B junior subordinated debentures were originally
issued in 2005 in connection with the common equity units. See
Notes 12, 13 and 25.
The Holding Company repaid a $500 million 5.25% senior
note which matured in December 2006.
Repurchase
Agreements with the Federal Home Loan Bank of New
York
MetLife Bank, National Association (MetLife Bank) is
a member of the FHLB of NY and holds $89 million and
$64 million of common stock of the FHLB of NY at
December 31, 2008 and 2007, respectively, which is
F-90
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
included in equity securities. MetLife Bank has also entered
into repurchase agreements with the FHLB of NY whereby MetLife
Bank has issued repurchase agreements in exchange for cash and
for which the FHLB of NY has been granted a blanket lien on
certain of MetLife Banks residential mortgages, mortgage
loans held-for-sale, commercial mortgages and mortgage-backed
securities to collateralize MetLife Banks obligations
under the repurchase agreements. MetLife Bank maintains control
over these pledged assets, and may use, commingle, encumber or
dispose of any portion of the collateral as long as there is no
event of default and the remaining qualified collateral is
sufficient to satisfy the collateral maintenance level. The
repurchase agreements and the related security agreement
represented by this blanket lien provide that upon any event of
default by MetLife Bank, the FHLB of NYs recovery is
limited to the amount of MetLife Banks liability under the
outstanding repurchase agreements. The amount of MetLife
Banks liability for repurchase agreements with the FHLB of
NY was $1.8 billion and $1.2 billion at
December 31, 2008 and 2007, respectively, which is included
in long-term debt and short-term debt depending upon the
original tenor of the advance. During the years ended
December 31, 2008, 2007 and 2006, MetLife Bank received
advances related to long-term borrowings totaling
$220 million, $390 million and $260 million,
respectively, from the FHLB of NY. MetLife Bank made repayments
to the FHLB of NY of $371 million, $175 million and
$117 million related to long-term borrowings for the years
ended December 31, 2008, 2007 and 2006, respectively. The
advances on these repurchase agreements related to both
long-term and short-term debt are collateralized by residential
mortgages, mortgage loans held-for-sale, commercial mortgages
and mortgage-backed securities with estimated fair values of
$3.1 billion and $1.3 billion at December 31,
2008 and 2007, respectively.
Collateralized
Borrowing from the Federal Reserve Bank of New
York
MetLife Bank is a depository institution that is approved to use
the Federal Reserve Bank of New York Discount Window borrowing
privileges and participate in the Federal Reserve Bank of New
York Term Auction Facility (TAF). In order to
utilize these facilities, since September 2008 MetLife Bank has
pledged qualifying loans and investment securities to the
Federal Reserve Bank of New York as collateral. Starting in
October 2008, MetLife Bank has participated in periodic TAF
auctions, which have a maximum maturity of 84 days. At
December 31, 2008, MetLife Banks liability for
advances from the Federal Reserve Bank of New York was
$950 million, which is included in short-term debt. The
estimated fair value of loan and investment security collateral
pledged by MetLife Bank to the Federal Reserve Bank of New York
at December 31, 2008 was $1.6 billion. For the year
ended December 31, 2008, the weighted average interest rate
on the TAF advances was 0.8% and the average daily balance was
$145 million. TAF advances were outstanding for an average
of 41 days during the year ended December 31, 2008.
Short-term
Debt
Short-term debt was $2,659 million and $667 million at
December 31, 2008 and 2007, respectively. At
December 31, 2008, short-term debt consisted of
$714 million of commercial paper, $950 million related
to the aforementioned collateralized borrowing from the Federal
Reserve Bank of New York, $695 million related to MetLife
Banks liability under the aforementioned repurchase
agreements with the FHLB of NY with original maturities of less
than one year and $300 million related to MICCs
liability for borrowings from the FHLB of Boston with original
maturities of less than one year. Short-term debt at
December 31, 2007 consisted entirely of commercial paper.
During the years ended December 31, 2008, 2007 and 2006,
the weighted average interest rate on short-term debt was 2.4%,
5.0% and 5.2%, respectively. During the years ended
December 31, 2008, 2007 and 2006, the average daily balance
of short-term debt was $1.3 billion, $1.6 billion and
$1.9 billion, respectively and short-term debt was
outstanding for an average of 25 days, 30 days and
39 days, respectively.
Interest
Expense
Interest expense related to the Companys indebtedness
included in other expenses was $554 million,
$600 million and $642 million for the years ended
December 31, 2008, 2007 and 2006, respectively, and does
F-91
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
not include interest expense on collateral financing
arrangements, junior subordinated debt securities, common equity
units or shares subject to mandatory redemption. See
Notes 11, 12, 13 and 14.
Credit
and Committed Facilities and Letters of Credit
Credit Facilities. The Company maintains
committed and unsecured credit facilities aggregating
$3.2 billion at December 31, 2008. When drawn upon,
these facilities bear interest at varying rates in accordance
with the respective agreements as specified below. The
facilities can be used for general corporate purposes and, at
December 31, 2008, $2.9 billion of the facilities also
served as
back-up
lines of credit for the Companys commercial paper
programs. These agreements contain various administrative,
reporting, legal and financial covenants, including one
requiring the Company to maintain a specified minimum
consolidated net worth. Management has no reason to believe that
its lending counterparties are unable to fulfill their
respective contractual obligations.
Total fees associated with these credit facilities were
$17 million, of which $11 million related to deferred
amendment fees, for the year ended December 31, 2008.
Information on these credit facilities at December 31, 2008
is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Letter of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit
|
|
|
|
|
|
Unused
|
|
Borrower(s)
|
|
Expiration
|
|
Capacity
|
|
|
Issuances
|
|
|
Drawdowns
|
|
|
Commitments
|
|
|
|
|
|
|
|
(In millions)
|
|
|
MetLife, Inc. and MetLife Funding, Inc.
|
|
June 2012
|
|
(1)
|
|
$
|
2,850
|
|
|
$
|
2,313
|
|
|
$
|
|
|
|
$
|
537
|
|
MetLife Bank, N.A
|
|
July 2009
|
|
(2)
|
|
|
300
|
|
|
|
|
|
|
|
100
|
|
|
|
200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
$
|
3,150
|
|
|
$
|
2,313
|
|
|
$
|
100
|
|
|
$
|
737
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
In December 2008, the Holding Company and MetLife Funding, Inc.
entered into an amended and restated $2.85 billion credit
agreement with various financial institutions. The agreement
amended and restated the $3.0 billion credit agreement
entered into in June 2007. Proceeds are available to be used for
general corporate purposes, to support their commercial paper
programs and for the issuance of letters of credit. All
borrowings under the credit agreement must be repaid by June
2012, except that letters of credit outstanding upon termination
may remain outstanding until June 2013. The borrowers and the
lenders under this facility may agree to extend the term of all
or part of the facility to no later than June 2014, except that
letters of credit outstanding upon termination may remain
outstanding until June 2015. Fees for this agreement include a
0.25% facility fee, 0.075% fronting fee, a letter of credit fee
between 1% and 5% based on certain market rates and a 0.05%
utilization fee, as applicable, and may vary based on MetLife,
Inc.s senior unsecured ratings. The Holding Company and
MetLife Funding, Inc. incurred amendment costs of
$11 million related to the $2,850 million amended and
restated credit agreement, which have been capitalized and
included in other assets. These costs will be amortized over the
term of the agreement. The Holding Company did not have any
deferred financing costs associated with the original June 2007
credit agreement. |
|
(2) |
|
In July 2008, the facility was increased by $100 million
and its maturity extended for one year to July 2009. Fees for
this agreement include a commitment fee of $10,000 and a margin
of Federal Funds plus 0.11%, as applicable. |
Committed Facilities. The Company maintains
committed facilities aggregating $11.5 billion at
December 31, 2008. When drawn upon, these facilities bear
interest at varying rates in accordance with the respective
agreements as specified below. The facilities are used for
collateral for certain of the Companys reinsurance
reserves. These facilities contain various administrative,
reporting, legal and financial covenants, including one
requiring the Company to maintain a specified minimum
consolidated net worth. Management has no reason to believe that
its lending counterparties are unable to fulfill their
respective contractual obligations.
F-92
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Total fees associated with these committed facilities were
$35 million, of which $13 million related to deferred
amendment fees, for the year ended December 31, 2008.
Information on committed facilities at December 31, 2008 is
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Letter of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit
|
|
|
Unused
|
|
|
Maturity
|
|
Account Party/Borrower(s)
|
|
Expiration
|
|
Capacity
|
|
|
Drawdowns
|
|
|
Issuances
|
|
|
Commitments
|
|
|
(Years)
|
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
MetLife, Inc.
|
|
August 2009
|
|
(1)
|
|
$
|
500
|
|
|
$
|
|
|
|
$
|
500
|
|
|
$
|
|
|
|
|
|
|
Exeter Reassurance Company Ltd., MetLife, Inc., & Missouri
Reinsurance (Barbados), Inc.
|
|
June 2016
|
|
(3)
|
|
|
500
|
|
|
|
|
|
|
|
490
|
|
|
|
10
|
|
|
|
7
|
|
Exeter Reassurance Company Ltd.
|
|
December 2027
|
|
(2), (4)
|
|
|
650
|
|
|
|
|
|
|
|
410
|
|
|
|
240
|
|
|
|
19
|
|
MetLife Reinsurance Company of South Carolina &
MetLife, Inc.
|
|
June 2037
|
|
(5)
|
|
|
3,500
|
|
|
|
2,692
|
|
|
|
|
|
|
|
808
|
|
|
|
29
|
|
MetLife Reinsurance Company of Vermont & MetLife,
Inc.
|
|
December 2037
|
|
(2), (6)
|
|
|
2,896
|
|
|
|
|
|
|
|
1,359
|
|
|
|
1,537
|
|
|
|
29
|
|
MetLife Reinsurance Company of Vermont & MetLife,
Inc.
|
|
September 2038
|
|
(2), (7)
|
|
|
3,500
|
|
|
|
|
|
|
|
1,500
|
|
|
|
2,000
|
|
|
|
29
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
$
|
11,546
|
|
|
$
|
2,692
|
|
|
$
|
4,259
|
|
|
$
|
4,595
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
In December 2008, the Holding Company entered into an amended
and restated one year $500 million letter of credit
facility (dated as of August 2008 and amended and restated at
December 31, 2008) with an unaffiliated financial
institution. Exeter Reassurance Company, Ltd.
(Exeter) is a co-applicant under this letter of
credit facility. This letter of credit facility matures in
August 2009, except that letters of credit outstanding upon
termination may remain outstanding until August 2010. Fees for
this agreement include a margin of 2.25% and a utilization fee
of 0.05%, as applicable. The Holding Company incurred amendment
costs of $1.3 million related to the $500 million
amended and restated letter of credit facility, which have been
capitalized and included in other assets. These costs will be
amortized over the term of the agreement. |
|
(2) |
|
The Holding Company is a guarantor under this agreement. |
|
(3) |
|
Letters of credit and replacements or renewals thereof issued
under this facility of $280 million, $10 million and
$200 million are set to expire no later than December 2015,
March 2016 and June 2016, respectively. |
|
(4) |
|
In December 2008, Exeter, as borrower, and the Holding Company,
as guarantor, entered into an amendment of an existing credit
agreement with an unaffiliated financial institution. Issuances
under this facility are set to expire in December 2027. Exeter
incurred amendment costs of $1.6 million related to the
amendment of the existing credit agreement, which have been
capitalized and included in other assets. These costs will be
amortized over the term of the agreement. |
|
(5) |
|
In May 2007, MetLife Reinsurance Company of South Carolina
(MRSC), a wholly-owned subsidiary of the Company,
terminated the $2.0 billion amended and restated five-year
letter of credit and reimbursement agreement entered into among
the Holding Company, MRSC and various financial institutions on
April 25, 2005. In its place, the Company entered into a
30-year
collateral financing arrangement as described in Note 11,
which may be extended by agreement of the Company and the
financial institution on each anniversary of the closing of the
facility for an additional one-year period. At December 31,
2008, $2.7 billion had been drawn upon under the collateral
financing arrangement. |
|
(6) |
|
In December 2007, Exeter Reassurance Company Ltd. terminated
four letters of credit, with expirations from March 2025 through
December 2026, which were issued under a letter of credit
facility with an unaffiliated financial institution in an
aggregate amount of $1.7 billion. The letters of credit had
served as collateral for Exeters obligations under a
reinsurance agreement that was recaptured by MLI-USA in December
2007. MLI-USA immediately thereafter entered into a new
reinsurance agreement with MetLife Reinsurance Company of |
F-93
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
Vermont (MRV). To collateralize its reinsurance
obligations, MRV and the Holding Company entered into a
30-year,
$2.9 billion letter of credit facility with an unaffiliated
financial institution. |
|
(7) |
|
In September 2008, MRV and the Holding Company entered into a
30-year,
$3.5 billion letter of credit facility with an unaffiliated
financial institution. These letters of credit serve as
collateral for MRVs obligations under a reinsurance
agreement. |
Letters of Credit. At December 31, 2008,
the Company had outstanding $6.6 billion in letters of
credit from various financial institutions of which
$4.3 billion and $2.3 billion, were part of committed
and credit facilities, respectively. As commitments associated
with letters of credit and financing arrangements may expire
unused, these amounts do not necessarily reflect the
Companys actual future cash funding requirements.
|
|
11.
|
Collateral
Financing Arrangements
|
Associated
with the Closed Block
In December 2007, MLIC reinsured a portion of its closed block
liabilities to MetLife Reinsurance Company of Charleston
(MRC), a wholly-owned subsidiary of the Company. In
connection with this transaction, MRC issued, to investors
placed by an unaffiliated financial institution,
$2.5 billion of
35-year
surplus notes to provide statutory reserve support for the
assumed closed block liabilities. Interest on the surplus notes
accrues at an annual rate of
3-month
LIBOR plus 0.55%, payable quarterly. The ability of MRC to make
interest and principal payments on the surplus notes is
contingent upon South Carolina regulatory approval. At both
December 31, 2008 and 2007, surplus notes outstanding were
$2.5 billion.
Simultaneous with the issuance of the surplus notes, the Holding
Company entered into an agreement with the unaffiliated
financial institution, under which the Holding Company is
entitled to the interest paid by MRC on the surplus notes of
3-month
LIBOR plus 0.55% in exchange for the payment of
3-month
LIBOR plus 1.12%, payable quarterly on such amount as adjusted,
as described below. Under this agreement, the Holding Company
may also be required to pledge collateral or make payments to
the unaffiliated financial institution related to any decline in
the estimated fair value of the surplus notes. Any such payments
would be accounted for as a receivable and included under other
assets on the Companys consolidated financial statements
and would not reduce the principal amount outstanding of the
surplus notes. In addition, the Holding Company may also be
required to make a payment to the unaffiliated financial
institution in connection with any early termination of this
agreement. During the year ended December 31, 2008, the
Holding Company paid $800 million to the unaffiliated
financial institution related to a decline in the estimated fair
value of the surplus notes. This payment reduced the amount
under the agreement on which the Holding Companys interest
payment is due but did not reduce the outstanding amount of the
surplus notes. In addition, the Holding Company had pledged
collateral of $230 million to the unaffiliated financial
institution at December 31, 2008. No collateral had been
pledged at December 31, 2007.
A majority of the proceeds from the offering of the surplus
notes were placed in trust, which is consolidated by the
Company, to support MRCs statutory obligations associated
with the assumed closed block liabilities.
During 2007 and 2008 the Company deposited $2.0 billion and
$314 million, respectively, into the trust, from the
proceeds of surplus notes issued in 2007. At December 31,
2008 and 2007, the estimated fair value of assets held in trust
by the Company was $2.1 billion and $2.0 billion,
respectively. The assets are principally invested in fixed
maturity securities and are presented as such within the
Companys consolidated balance sheet, with the related
income included within net investment income in the
Companys consolidated income statement. Interest on the
collateral financing arrangement is included as a component of
other expenses.
Total interest expense was $117 million and $5 million
for the years ended December 31, 2008 and 2007,
respectively.
F-94
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Associated
with Secondary Guarantees
In May 2007, the Holding Company and MetLife Reinsurance Company
of South Carolina, a wholly-owned subsidiary of the Company,
entered into a
30-year
collateral financing arrangement with an unaffiliated financial
institution that provides up to $3.5 billion of statutory
reserve support for MRSC associated with reinsurance obligations
under intercompany reinsurance agreements. Such statutory
reserves are associated with universal life secondary guarantees
and are required under U.S. Valuation of Life Policies
Model Regulation (commonly referred to as
Regulation A-XXX).
At December 31, 2008 and 2007, $2.7 billion and
$2.4 billion, respectively, had been drawn upon under the
collateral financing arrangement. The collateral financing
arrangement may be extended by agreement of the Holding Company
and the unaffiliated financial institution on each anniversary
of the closing.
Proceeds from the collateral financing arrangement were placed
in trust to support MRSCs statutory obligations associated
with the reinsurance of secondary guarantees. The trust is a VIE
which is consolidated by the Company. The unaffiliated financial
institution is entitled to the return on the investment
portfolio held by the trust.
In connection with the collateral financing arrangement, the
Holding Company entered into an agreement with the same
unaffiliated financial institution under which the Holding
Company is entitled to the return on the investment portfolio
held by the trust established in connection with this collateral
financing arrangement in exchange for the payment of a stated
rate of return to the unaffiliated financial institution of
3-month
LIBOR plus 0.70%, payable quarterly. The Holding Company may
also be required to make payments to the unaffiliated financial
institution, for deposit into the trust, related to any decline
in the estimated fair value of the assets held by the trust, as
well as amounts outstanding upon maturity or early termination
of the collateral financing arrangement. For the year ended
December 31, 2008, the Holding Company paid
$320 million to the unaffiliated financial institution as a
result of the decline in the estimated fair value of the assets
in the trust. All of the $320 million was deposited into
the trust. In January 2009, the Holding Company paid an
additional $360 million to the unaffiliated financial
institution as a result of the continued decline in the
estimated fair value of the assets in trust which was also
deposited into the trust.
In addition, the Holding Company may be required to pledge
collateral to the unaffiliated financial institution under this
agreement. At December 31, 2008, the Holding Company had
pledged $86 million under the agreement. No collateral had
been pledged under the agreement at December 31, 2007.
At December 31, 2008 and 2007, the Company held assets in
trust with a estimated fair value of $2.4 billion and
$2.3 billion, respectively, associated with this
transaction. The assets are principally invested in fixed
maturity securities and are presented as such within the
Companys consolidated balance sheet, with the related
income included within net investment income in the
Companys consolidated income statement. Interest on the
collateral financing arrangement is included as a component of
other expenses.
Transaction costs associated with the collateral financing
arrangement of $5 million have been capitalized, are
included in other assets, and are amortized using the effective
interest method over the period from the issuance of the
collateral financing arrangement to its expiration. Total
interest expense was $107 million and $84 million for
the years ended December 31, 2008 and 2007, respectively.
|
|
12.
|
Junior
Subordinated Debentures
|
Junior
Subordinated Debentures Underlying Common Equity
Units
In June 2005, the Holding Company issued $1,067 million
4.82% Series A and $1,067 million 4.91% Series B
junior subordinated debentures due no later than
February 15, 2039 and February 15, 2040, respectively,
for a total of $2,134 million, in exchange for
$64 million in trust common securities of MetLife Capital
Trust II (Series A Trust) and MetLife
Capital Trust III (Series B Trust and together
with the Series A Trust, the Capital Trusts),
both subsidiary trusts of MetLife, Inc., and $2,070 million
in aggregate cash proceeds from the sale by the subsidiary
trusts of trust preferred securities, constituting part of the
common equity units more fully described in
F-95
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Note 13. The subsidiary trusts each issued
$1,035 million of trust preferred securities and
$32 million of trust common securities. The trust common
securities were issued to the Holding Company.
On August 6, 2008, the Series A Trust was dissolved
and $32 million of the Series A junior subordinated
debentures were returned to the Holding Company concurrently
with the cancellation of the $32 million of trust common
securities of the Series A Trust held by MetLife, Inc. Upon
dissolution of the Series A Trust, the remaining
$1,035 million of Series A junior subordinated
debentures were distributed to the holders of the trust
preferred securities and such trust preferred securities were
cancelled. In connection with the remarketing transaction on
August 15, 2008, the remaining $1,035 million MetLife,
Inc. Series A junior subordinated debentures were modified,
as permitted by their terms, to be 6.817% senior debt
securities Series A, due August 15, 2018. The Company
did not receive any proceeds from the remarketing. See also
Notes 10 and 13.
On February 5, 2009, the Series B Trust was dissolved
and $32 million of the Series B junior subordinated
debentures were returned to the Holding Company concurrently
with the cancellation of the $32 million of trust common
securities of the Series B Trust held by MetLife, Inc. Upon
dissolution of the Series B Trust, the remaining
$1,035 million of Series B junior subordinated
debentures were distributed to the holders of the trust
preferred securities and such trust preferred securities were
cancelled. In connection with the remarketing transaction on
February 17, 2009, the remaining $1,035 million
MetLife, Inc. Series B junior subordinated debentures were
modified, as permitted by their terms, to be 7.717% senior
debt securities Series B, due February 15, 2019. The
Company did not receive any proceeds from the remarketing. See
also Notes 10, 13 and 25.
Interest expense on the junior subordinated debentures
underlying the common equity units was $84 million,
$104 million and $104 million for the years ended
December 31, 2008, 2007 and 2006, respectively.
Other
Junior Subordinated Debentures Issued by the Holding
Company
In April 2008, MetLife Capital Trust X, a VIE consolidated
by the Company, issued exchangeable surplus trust securities
(the 2008 Trust Securities) with a face amount
of $750 million. The 2008 Trust Securities will be
exchanged into a like amount of the Holding Companys
junior subordinated debentures on April 8, 2038, the
scheduled redemption date, mandatorily under certain
circumstances, and at any time upon the Holding Company
exercising its option to redeem the securities. The 2008 Trust
Securities will be exchanged for junior subordinated debentures
prior to repayment. The final maturity of the debentures is
April 8, 2068. The Holding Company may cause the redemption
of the 2008 Trust Securities or debentures (i) in whole or
in part, at any time on or after April 8, 2033 at their
principal amount plus accrued and unpaid interest to the date of
redemption, or (ii) in certain circumstances, in whole or
in part, prior to April 8, 2033 at their principal amount
plus accrued and unpaid interest to the date of redemption or,
if greater, a make-whole price. Interest on the 2008 Trust
Securities or debentures is payable semi-annually at a fixed
rate of 9.25% up to, but not including, April 8, 2038, the
scheduled redemption date. In the event the 2008 Trust
Securities or debentures are not redeemed on or before the
scheduled redemption date, interest will accrue at an annual
rate of
3-month
LIBOR plus a margin equal to 5.540%, payable quarterly in
arrears. The Holding Company has the right to, and in certain
circumstances the requirement to, defer interest payments on the
2008 Trust Securities or debentures for a period up to ten
years. Interest compounds during such periods of deferral. If
interest is deferred for more than five consecutive years, the
Holding Company may be required to use proceeds from the sale of
its common stock or warrants on common stock to satisfy its
obligation. In connection with the issuance of the 2008 Trust
Securities, the Holding Company entered into a replacement
capital covenant (RCC). As a part of the RCC, the
Holding Company agreed that it will not repay, redeem, or
purchase the debentures on or before April 8, 2058, unless,
subject to certain limitations, it has received proceeds from
the sale of specified capital securities. The RCC will terminate
upon the occurrence of certain events, including an acceleration
of the debentures due to the occurrence of an event of default.
The RCC is not intended for the benefit of holders of the
debentures and may not be enforced by them. The RCC is for the
benefit of holders of one or more other designated series of its
indebtedness (which will initially be its 5.70% senior
notes due June 15, 2035). The Holding Company also entered
into a replacement capital obligation which will commence in
2038 and under
F-96
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
which the Holding Company must use reasonable commercial efforts
to raise replacement capital through the issuance of certain
qualifying capital securities. Issuance costs associated with
the offering of the 2008 Trust Securities of $8 million
have been capitalized, are included in other assets, and are
amortized using the effective interest method over the period
from the issuance date of the 2008 Trust Securities until their
scheduled redemption. Interest expense on the 2008 Trust
Securities was $51 million for the year ended
December 31, 2008.
In December 2007, MetLife Capital Trust IV, a VIE
consolidated by the Company, issued exchangeable surplus trust
securities (the 2007 Trust Securities) with a face
amount of $700 million and a discount of $6 million
($694 million). The 2007 Trust Securities will be exchanged
into a like amount of Holding Company junior subordinated
debentures on December 15, 2037, the scheduled redemption
date; mandatorily under certain circumstances; and at any time
upon the Holding Company exercising its option to redeem the
securities. The 2007 Trust Securities will be exchanged for
junior subordinated debentures prior to repayment. The final
maturity of the debentures is December 15, 2067. The
Holding Company may cause the redemption of the 2007 Trust
Securities or debentures (i) in whole or in part, at any
time on or after December 15, 2032 at their principal
amount plus accrued and unpaid interest to the date of
redemption, or (ii) in certain circumstances, in whole or
in part, prior to December 15, 2032 at their principal
amount plus accrued and unpaid interest to the date of
redemption or, if greater, a make-whole price. Interest on the
2007 Trust Securities or debentures is payable semi-annually at
a fixed rate of 7.875% up to, but not including,
December 15, 2037, the scheduled redemption date. In the
event the 2007 Trust Securities or debentures are not redeemed
on or before the scheduled redemption date, interest will accrue
at an annual rate of
3-month
LIBOR plus a margin equal to 3.96%, payable quarterly in
arrears. The Holding Company has the right to, and in certain
circumstances the requirement to, defer interest payments on the
2007 Trust Securities or debentures for a period up to ten
years. Interest compounds during such periods of deferral. If
interest is deferred for more than five consecutive years, the
Holding Company may be required to use proceeds from the sale of
its common stock or warrants on common stock to satisfy its
obligation. In connection with the issuance of the 2007 Trust
Securities, the Holding Company entered into a RCC. As a part of
the RCC, the Holding Company agreed that it will not repay,
redeem, or purchase the debentures on or before
December 15, 2057, unless, subject to certain limitations,
it has received proceeds from the sale of specified capital
securities. The RCC will terminate upon the occurrence of
certain events, including an acceleration of the debentures due
to the occurrence of an event of default. The RCC is not
intended for the benefit of holders of the debentures and may
not be enforced by them. The RCC is for the benefit of holders
of one or more other designated series of its indebtedness
(which will initially be its 5.70% senior notes due
June 15, 2035). The Holding Company also entered into a
replacement capital obligation which will commence in 2037 and
under which the Holding Company must use reasonable commercial
efforts to raise replacement capital through the issuance of
certain qualifying capital securities. Issuance costs associated
with the offering of the 2007 Trust Securities of
$10 million have been capitalized, are included in other
assets, and are amortized using the effective interest method
over the period from the issuance date of the 2007 Trust
Securities until their scheduled redemption. Interest expense on
the 2007 Trust Securities was $55 million and
$3 million, for the years ended December 31, 2008 and
2007, respectively.
In December 2006, the Holding Company issued junior subordinated
debentures with a face amount of $1.25 billion. The
debentures are scheduled for redemption on December 15,
2036; the final maturity of the debentures is December 15,
2066. The Holding Company may redeem the debentures (i) in
whole or in part, at any time on or after December 15, 2031
at their principal amount plus accrued and unpaid interest to
the date of redemption, or (ii) in certain circumstances,
in whole or in part, prior to December 15, 2031 at their
principal amount plus accrued and unpaid interest to the date of
redemption or, if greater, a make-whole price. Interest is
payable semi-annually at a fixed rate of 6.40% up to, but not
including, December 15, 2036, the scheduled redemption
date. In the event the debentures are not redeemed on or before
the scheduled redemption date, interest will accrue at an annual
rate of
3-month
LIBOR plus a margin equal to 2.205%, payable quarterly in
arrears. The Holding Company has the right to, and in certain
circumstances the requirement to, defer interest payments on the
debentures for a period up to ten years. Interest compounds
during such periods of deferral. If interest is deferred for
more than five consecutive years, the Holding Company may be
required to use proceeds from the sale of its
F-97
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
common stock or warrants on common stock to satisfy its
obligation. In connection with the issuance of the debentures,
the Holding Company entered into a replacement capital covenant.
As part of the RCC, the Holding Company agreed that it will not
repay, redeem, or purchase the debentures on or before
December 15, 2056, unless, subject to certain limitations,
it has received proceeds from the sale of specified capital
securities. The RCC will terminate upon the occurrence of
certain events, including an acceleration of the debentures due
to the occurrence of an event of default. The RCC is not
intended for the benefit of holders of the debentures and may
not be enforced by them. The RCC is for the benefit of holders
of one or more other designated series of its indebtedness
(which will initially be its 5.70% senior notes due
June 15, 2035). The Holding Company also entered into a
replacement capital obligation which will commence in 2036 and
under which the Holding Company must use reasonable commercial
efforts to raise replacement capital through the issuance of
certain qualifying capital securities. Issuance costs associated
with the offering of the debentures of $13 million have
been capitalized, are included in other assets, and are
amortized using the effective interest method over the period
from the issuance date of the debentures until their scheduled
redemption. Interest expense on the debentures was
$80 million, $80 million and $2 million for the
years ended December 31, 2008, 2007 and 2006, respectively.
In connection with financing the acquisition of Travelers on
July 1, 2005, which is described in Note 2, the
Holding Company distributed and sold 82.8 million 6.375%
common equity units for $2,070 million in proceeds in a
registered public offering on June 21, 2005. As described
below, the common equity units consisted of interests in trust
preferred securities issued by MetLife Capital Trusts II
and III, and stock purchase contracts issued by the Holding
Company. The only assets of MetLife Capital Trusts II
and III were junior subordinated debentures issued by the
Holding Company. As described in Note 12 and in the
Remarketing of Junior Subordinated Debentures and
Settlement of Stock Purchase Contracts section which
follows, the common equity units ceased to exist upon the
closing of the remarketing of the underlying debt instruments
and the settlement of the stock purchase contracts in August
2008 and February 2009.
Common
Equity Units
Each common equity unit had an initial stated amount of $25 per
unit and consisted of: (i) a 1/80 or 1.25% ($12.50),
undivided beneficial ownership interest in a series A trust
preferred security of MetLife Capital Trust II
(Series A Trust), with an initial liquidation
amount of $1,000; (ii) a 1/80 or 1.25% ($12.50), undivided
beneficial ownership interest in a series B trust preferred
security of MetLife Capital Trust III (Series B
Trust and, together with the Series A Trust, the
Capital Trusts), with an initial liquidation amount
of $1,000; and (iii) a stock purchase contract under which
the holder of the common equity unit agreed to purchase, and the
Holding Company agreed to sell, on each of the initial stock
purchase date and the subsequent stock purchase date, a variable
number of shares of the Holding Companys common stock, par
value $0.01 per share, for a purchase price of $12.50. After the
closing of the first remarketing in August 2008, each common
equity unit had a stated value of $12.50, rather than the
initial stated amount of $25 per unit, and no longer included
any ownership interest in the Series A Trust.
Junior
Subordinated Debentures Issued to Support Trust Common and
Preferred Securities
The Holding Company issued $1,067 million 4.82%
Series A and $1,067 million 4.91% Series B junior
subordinated debentures due no later than February 15, 2039
and February 15, 2040, respectively, for a total of
$2,134 million, in exchange for $2,070 million in
aggregate proceeds from the sale of the trust preferred
securities by the Capital Trusts and $64 million in trust
common securities issued equally by the Capital Trusts. The
common and preferred securities of the Capital Trusts, totaling
$2,134 million, represented undivided beneficial ownership
interests in the assets of the Capital Trusts, had no stated
maturity and were required to be redeemed upon maturity of the
corresponding series of junior subordinated
debentures the sole assets of the respective Capital
Trusts. The Series A Trust and Series B Trust made
quarterly distributions on the common and preferred securities
when due at
F-98
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
an annual rate of 4.82% and 4.91%, respectively, until they were
dissolved in August 2008 and February 2009, respectively.
The trust common securities, which were held by the Holding
Company, represented a 3% interest in the Capital Trusts and
were reflected as fixed maturity securities in the consolidated
balance sheet of MetLife, Inc. The Capital Trusts were VIEs in
accordance with FIN 46(r), and the Company did not
consolidate its interest in MetLife Capital Trusts II
and III as it was not the primary beneficiary of either of
the Capital Trusts.
As described in Note 12, upon dissolution of MetLife
Capital Trusts II and III, $64 million of the junior
subordinated debentures were returned to the Holding Company
concurrently with the cancellation the $64 million of trust
common securities of MetLife Capital Trust II and III
held by the Holding Company and the remaining
$2,070 million of junior subordinated debentures were
distributed to the holders of the trust preferred securities and
such trust preferred securities were cancelled.
The Holding Company directly guaranteed the repayment of the
trust preferred securities to the holders thereof to the extent
that there were funds available in the Capital Trusts. The
guarantee remained in place until the full redemption of the
trust preferred securities. The trust preferred securities held
by the common equity unit holders were pledged to the Holding
Company to collateralize the obligation of the common equity
unit holders under the related stock purchase contracts. The
common equity unit holders were permitted to substitute certain
zero coupon treasury securities in place of the trust preferred
securities, or the junior subordinated debentures subsequent to
the dissolution of the Capital Trusts, as collateral under the
stock purchase contract.
The trust preferred securities, or the junior subordinated
debentures subsequent to the dissolution of the Capital Trusts,
had remarketing dates which corresponded with the initial and
subsequent stock purchase dates to provide the holders of the
common equity units with proceeds to settle the stock purchase
contracts. The initial stock purchase date was August 15,
2008, but could have been deferred for quarterly periods until
February 15, 2009 and the subsequent stock purchase date
was February 15, 2009 but could have been deferred for
quarterly periods until February 15, 2010. At the
respective remarketing dates, the remarketing agent had the
ability to reset the interest rate on the remarketed securities
to generate sufficient remarketing proceeds to satisfy the
common equity unit holders obligation under the stock
purchase contract, subject to a reset cap for each of the first
two attempted remarketings of each series , which reset cap was
waived by the Holding Company in connection with the remarketing
of the Series B debentures in February 2009. The interest
rate on the supporting junior subordinated debentures issued by
the Holding Company would have been reset at a commensurate
rate. If the initial remarketing had been unsuccessful, the
remarketing agent would have attempted to remarket the trust
preferred securities or junior subordinated debentures, as
necessary, in subsequent quarters through February 15, 2009
for the Series A trust preferred securities or junior
subordinated debentures and through February 15, 2010 for
the Series B trust preferred securities or junior
subordinated debentures. The final attempt at remarketing would
not have been subject to the reset cap. If all remarketing
attempts were unsuccessful, the Holding Company had the right,
as a secured party, to apply the liquidation amount on the trust
preferred securities to the common equity unit holders
obligation under the stock purchase contract and to deliver to
the common equity unit holder a junior subordinated debt
security payable on August 15, 2010 at an annual rate of
4.82% and 4.91% on the Series A and Series B trust
preferred securities or junior subordinated debentures,
respectively, in payment of any accrued and unpaid distributions.
Stock
Purchase Contracts
Each stock purchase contract required the holder of the common
equity unit to purchase, and the Holding Company to sell, for
$12.50, on each of the initial stock purchase date and the
subsequent stock purchase date, a number of newly issued or
treasury shares of the Holding Companys common stock, par
value $0.01 per share, equal to the applicable settlement rate.
The settlement rate at the respective stock purchase date was
calculated based on the closing price of the common stock during
a specified
20-day
period immediately preceding the applicable stock purchase date.
If the market value of the Holding Companys common stock
was less than the
F-99
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
threshold appreciation price of $53.10 but greater than $43.35,
the reference price, the settlement rate, as adjusted for
dividends in accordance with the terms of the stock purchase
contracts, was an amount of the Holding Companys common
stock equal to the stated amount of $12.50 divided by the market
value. If the market value was less than or equal to the
reference price, the settlement rate, as adjusted for dividends
in accordance with the terms of the stock purchase contracts,
was 0.28835 shares of the Holding Companys common
stock. If the market value was greater than or equal to the
threshold appreciation price, the settlement rate, as adjusted
for dividends in accordance with the terms of the stock purchase
contracts, was 0.23540 shares of the Holding Companys
common stock. Accordingly, upon settlement in the aggregate, the
Holding Company received proceeds of $2,070 million and
issued between 39.0 million and 47.8 million shares of
its common stock. The stock purchase contract could have been
exercised at the option of the holder at any time prior to the
settlement date. However, upon early settlement, the holder
would have received the minimum settlement rate. The Holding
Company delivered 44,587,703 shares of its common stock in
settlement of the stock purchase contracts.
The stock purchase contracts further required the Holding
Company to pay the holder of the common equity unit quarterly
contract payments on the stock purchase contracts at the annual
rate of 1.510% on the stated amount of $25 per stock purchase
contract until the initial stock purchase date and at the annual
rate of 1.465% on the remaining stated amount of $12.50 per
stock purchase contract thereafter.
The quarterly distributions on the Series A and
Series B trust preferred securities of 4.82% and 4.91%,
respectively, combined with the contract payments on the stock
purchase contract of 1.510%, (1.465% after the initial stock
purchase date) resulted in the 6.375% yield on the common equity
units.
If the Holding Company had exercised its right to defer any of
the contract payments on the stock purchase contract, then it
would have accrued additional amounts on the deferred amounts at
the annual rate of 6.375% until paid, to the extent permitted by
law.
The value of the stock purchase contracts at issuance,
$96.6 million, was calculated as the present value of the
future contract payments due under the stock purchase contract
of 1.510% through the initial stock purchase date, and 1.465% up
to the subsequent stock purchase date, discounted at the
interest rate on the supporting junior subordinated debentures
issued by the Holding Company, 4.82% or 4.91% on the
Series A and Series B trust preferred securities,
respectively. The value of the stock purchase contracts was
recorded in other liabilities with an offsetting decrease in
additional paid-in capital. The other liability balance related
to the stock purchase contracts accrued interest at the discount
rate of 4.82% or 4.91%, as applicable, with an offsetting
increase to interest expense. As the contract payments were made
under the stock purchase contracts they reduced the other
liability balance. During the years ended December 31,
2008, 2007 and 2006, the Holding Company increased the other
liability balance for the accretion of the discount on the
contract payment of $2 million, $2 million and
$3 million, respectively and made contract payments of
$26 million, $31 million and $31 million,
respectively.
Issuance
Costs
In connection with the offering of common equity units, the
Holding Company incurred $55.3 million of issuance costs of
which $5.8 million related to the issuance of the junior
subordinated debentures underlying common equity units which
funded the Series A and Series B trust preferred
securities and $49.5 million related to the expected
issuance of the common stock under the stock purchase contracts.
The $5.8 million in debt issuance costs were capitalized,
included in other assets, and amortized using the effective
interest method over the period from issuance date of the common
equity units to the initial and subsequent stock purchase date.
The remaining $49.5 million of costs related to the common
stock issuance under the stock purchase contracts and were
recorded as a reduction of additional paid-in capital.
F-100
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Earnings
Per Common Share
The stock purchase contracts are reflected in diluted earnings
per common share using the treasury stock method. The stock
purchase contracts were included in diluted earnings per common
share for the years ended December 31, 2008, 2007 and 2006
as shown in Note 20.
Remarketing
of Junior Subordinated Debentures and Settlement of Stock
Purchase Contracts
On August 15, 2008, the Holding Company closed the
successful remarketing of the Series A portion of the
junior subordinated debentures underlying the common equity
units. The Series A junior subordinated debentures were
modified as permitted by their terms to be 6.817% senior
debt securities Series A, due August 15, 2018. The
Holding Company did not receive any proceeds from the
remarketing. Most common equity unit holders chose to have their
junior subordinated debentures remarketed and used the
remarketing proceeds to settle their payment obligations under
the applicable stock purchase contract. For those common equity
unit holders that elected not to participate in the remarketing
and elected to use their own cash to satisfy the payment
obligations under the stock purchase contract, the terms of the
debt are the same as the remarketed debt. The initial settlement
of the stock purchase contracts occurred on August 15,
2008, providing proceeds to the Holding Company of
$1,035 million in exchange for shares of the Holding
Companys common stock. The Holding Company delivered
20,244,549 shares of its common stock held in treasury at a
value of $1,064 million to settle the stock purchase
contracts.
On February 17, 2009, the Holding Company closed the
successful remarketing of the Series B portion of the
junior subordinated debentures underlying the common equity
units. The Series B junior subordinated debentures were
modified as permitted by their terms to be 7.717% senior
debt securities Series B, due February 15, 2019. The
Holding Company did not receive any proceeds from the
remarketing. Most common equity unit holders chose to have their
junior subordinated debentures remarketed and used the
remarketing proceeds to settle their payment obligations under
the applicable stock purchase contract. For those common equity
unit holders that elected not to participate in the remarketing
and elected to use their own cash to satisfy the payment
obligations under the stock purchase contract, the terms of the
debt are the same as the remarketed debt. The subsequent
settlement of the stock purchase contracts occurred on
February 17, 2009, providing proceeds to the Holding
Company of $1,035 million in exchange for shares of the
Holding Companys common stock. The Holding Company
delivered 24,343,154 shares of its newly issued common
stock at a value of $1,035 million to settle the stock
purchase contracts. See also Notes 10, 12, 18 and 25.
|
|
14.
|
Shares
Subject to Mandatory Redemption and Company-Obligated
Mandatorily Redeemable Securities of Subsidiary Trusts
|
GenAmerica Capital I. In June 1997, GenAmerica
Corporation (GenAmerica) issued $125 million of
8.525% capital securities through a wholly-owned subsidiary
trust, GenAmerica Capital I. In October 2007, GenAmerica
redeemed these securities which were due to mature on
June 30, 2027. As a result of this redemption, the Company
recognized additional interest expense of $10 million.
Interest expense on these instruments is included in other
expenses and was $20 million and $11 million for the
years ended December 31, 2007 and 2006, respectively.
F-101
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The provision for income tax from continuing operations is as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Current:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
$
|
216
|
|
|
$
|
424
|
|
|
$
|
615
|
|
State and local
|
|
|
10
|
|
|
|
15
|
|
|
|
39
|
|
Foreign
|
|
|
372
|
|
|
|
200
|
|
|
|
144
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
598
|
|
|
|
639
|
|
|
|
798
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
|
1,078
|
|
|
|
1,015
|
|
|
|
164
|
|
State and local
|
|
|
(6
|
)
|
|
|
31
|
|
|
|
2
|
|
Foreign
|
|
|
(90
|
)
|
|
|
(25
|
)
|
|
|
52
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
982
|
|
|
|
1,021
|
|
|
|
218
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income tax
|
|
$
|
1,580
|
|
|
$
|
1,660
|
|
|
$
|
1,016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The reconciliation of the income tax provision at the
U.S. statutory rate to the provision for income tax as
reported for continuing operations is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Tax provision at U.S. statutory rate
|
|
$
|
1,781
|
|
|
$
|
2,017
|
|
|
$
|
1,374
|
|
Tax effect of:
|
|
|
|
|
|
|
|
|
|
|
|
|
Tax-exempt investment income
|
|
|
(254
|
)
|
|
|
(296
|
)
|
|
|
(296
|
)
|
State and local income tax
|
|
|
2
|
|
|
|
39
|
|
|
|
23
|
|
Prior year tax
|
|
|
53
|
|
|
|
70
|
|
|
|
(10
|
)
|
Foreign tax rate differential and change in valuation allowance
|
|
|
5
|
|
|
|
(116
|
)
|
|
|
(55
|
)
|
Other, net
|
|
|
(7
|
)
|
|
|
(54
|
)
|
|
|
(20
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income tax
|
|
$
|
1,580
|
|
|
$
|
1,660
|
|
|
$
|
1,016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-102
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Deferred income tax represents the tax effect of the differences
between the book and tax basis of assets and liabilities. Net
deferred income tax assets and liabilities consisted of the
following:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Deferred income tax assets:
|
|
|
|
|
|
|
|
|
Policyholder liabilities and receivables
|
|
$
|
5,553
|
|
|
$
|
4,092
|
|
Net operating loss carryforwards
|
|
|
741
|
|
|
|
595
|
|
Employee benefits
|
|
|
657
|
|
|
|
134
|
|
Capital loss carryforwards
|
|
|
273
|
|
|
|
158
|
|
Tax credit carryforwards
|
|
|
348
|
|
|
|
20
|
|
Net unrealized investment losses
|
|
|
6,590
|
|
|
|
|
|
Litigation-related and government mandated
|
|
|
284
|
|
|
|
113
|
|
Other
|
|
|
242
|
|
|
|
395
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,688
|
|
|
|
5,507
|
|
Less: Valuation allowance
|
|
|
272
|
|
|
|
127
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,416
|
|
|
|
5,380
|
|
|
|
|
|
|
|
|
|
|
Deferred income tax liabilities:
|
|
|
|
|
|
|
|
|
Investments, including derivatives
|
|
|
5,299
|
|
|
|
2,135
|
|
Intangibles
|
|
|
156
|
|
|
|
32
|
|
DAC
|
|
|
3,939
|
|
|
|
4,177
|
|
Net unrealized investment gains
|
|
|
|
|
|
|
423
|
|
Other
|
|
|
95
|
|
|
|
115
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,489
|
|
|
|
6,882
|
|
|
|
|
|
|
|
|
|
|
Net deferred income tax asset/(liability)
|
|
$
|
4,927
|
|
|
$
|
(1,502
|
)
|
|
|
|
|
|
|
|
|
|
Domestic net operating loss carryforwards amount to
$1,588 million at December 31, 2008 and will expire
beginning in 2020. Foreign net operating loss carryforwards
amount to $693 million at December 31, 2008 and were
generated in various foreign countries with expiration periods
of five years to indefinite expiration. Capital loss
carryforwards amount to $781 million at December 31,
2008 and will expire beginning in 2010. Tax credit carryforwards
amount to $348 million at December 31, 2008.
The Company has recorded a valuation allowance related to tax
benefits of certain foreign net operating loss carryforwards and
certain foreign unrealized losses. The valuation allowance
reflects managements assessment, based on available
information, that it is more likely than not that the deferred
income tax asset for certain foreign net operating loss
carryforwards and certain foreign unrealized losses will not be
realized. The tax benefit will be recognized when management
believes that it is more likely than not that these deferred
income tax assets are realizable. In 2008, the Company recorded
an increase to the deferred tax valuation allowance of
$145 million, of which $63 million related to certain
foreign net operating loss carryforwards and $82 million
related to certain foreign unrealized losses.
The Company has not established a valuation allowance against
the deferred tax asset of $6,590 million recognized in
connection with unrealized losses at December 31, 2008,
other than the $82 million of valuation allowance
recognized in connection with certain foreign unrealized losses.
A valuation allowance was not considered necessary based upon
the Companys intent and ability to hold such securities
until their recovery
F-103
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
or maturity and the existence of tax-planning strategies that
include sources of future taxable income against which such
losses could be offset.
The Company files income tax returns with the U.S. federal
government and various state and local jurisdictions, as well as
foreign jurisdictions. The Company is under continuous
examination by the Internal Revenue Service (IRS)
and other tax authorities in jurisdictions in which the Company
has significant business operations. The income tax years under
examination vary by jurisdiction. With a few exceptions, the
Company is no longer subject to U.S. federal, state and
local, or foreign income tax examinations by tax authorities for
years prior to 2000. In 2005, the IRS commenced an examination
of the Companys U.S. income tax returns for 2000
through 2002 that is anticipated to be completed in 2009.
As a result of the implementation of FIN 48 on
January 1, 2007, the Company recognized a $35 million
increase in the liability for unrecognized tax benefits and a
$9 million decrease in the interest liability for
unrecognized tax benefits, as well as a $17 million
increase in the liability for unrecognized tax benefits and a
$5 million increase in the interest liability for
unrecognized tax benefits which are included in liabilities of
subsidiaries held-for-sale. The corresponding reduction to the
January 1, 2007 balance of retained earnings was
$37 million, net of $11 million of minority interest
included in liabilities of subsidiaries held-for-sale. The
Companys total amount of unrecognized tax benefits upon
adoption of FIN 48 was $932 million. The Company
reclassified, at adoption, $602 million of current income
tax payables to the liability for unrecognized tax benefits
included within other liabilities. The Company also
reclassified, at adoption, $295 million of deferred income
tax liabilities, for which the ultimate deductibility is highly
certain but for which there is uncertainty about the timing of
such deductibility, to the liability for unrecognized tax
benefits. Because of the impact of deferred tax accounting,
other than interest and penalties, the disallowance of the
shorter deductibility period would not affect the annual
effective tax rate but would accelerate the payment of cash to
the taxing authority to an earlier period. The total amount of
unrecognized tax benefits as of January 1, 2007 that would
affect the effective tax rate, if recognized, was
$654 million. The Company also had $210 million of
accrued interest, included within other liabilities, as of
January 1, 2007. The Company classifies interest accrued
related to unrecognized tax benefits in interest expense, while
penalties are included within income tax expense.
At December 31, 2007, the Companys total amount of
unrecognized tax benefits was $840 million and the total
amount of unrecognized tax benefits that would affect the
effective tax rate, if recognized, was $565 million. The
total amount of unrecognized tax benefits decreased by
$92 million from the date of adoption primarily due to
settlements reached with the IRS with respect to certain
significant issues involving demutualization, post-sale purchase
price adjustments and reinsurance offset by additions for tax
positions of the current year. As a result of the settlements,
items within the liability for unrecognized tax benefits, in the
amount of $177 million, were reclassified to current and
deferred income taxes, as applicable, and a payment of
$156 million was made in December of 2007, with
$6 million to be paid in 2009 and the remaining
$15 million to be paid in future years.
At December 31, 2008, the Companys total amount of
unrecognized tax benefits was $766 million and the total
amount of unrecognized tax benefits that would affect the
effective tax rate, if recognized, was $567 million. The
total amount of unrecognized tax benefits decreased by
$74 million from December 31, 2007 primarily due to
settlements reached with the IRS with respect to certain
significant issues involving demutualization, leasing and tax
credits offset by additions for tax positions of the current
year. As a result of the settlements, items within the liability
for unrecognized tax benefits, in the amount of
$153 million, were reclassified to current and deferred
income taxes, as applicable. Of the $153 million
reclassified to current and deferred income taxes,
$20 million was paid in 2008 and $133 million will be
paid in 2009.
The Companys liability for unrecognized tax benefits will
change in the next 12 months pending the outcome of
remaining issues associated with the current IRS audit including
tax-exempt income and tax credits. Management is working to
resolve the remaining audit items directly with IRS auditors, as
well as through available accelerated IRS resolution programs
and may protest any unresolved issues through the IRS appeals
process and, possibly, litigation, the timing and extent of
which is uncertain. At this time, a reasonable estimate of
F-104
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
the range of a payment or change in the liability is between
$40 million and $50 million; however, the Company
continues to believe that the ultimate resolution of the issues
will not result in a material effect on its consolidated
financial statements, although the resolution of income tax
matters could impact the Companys effective tax rate for a
particular future period.
A reconciliation of the beginning and ending amount of
unrecognized tax benefits for the years ended December 31,
2008 and December 31, 2007, is as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Balance as of beginning of the period
|
|
$
|
840
|
|
|
$
|
932
|
|
Additions for tax positions of prior years
|
|
|
11
|
|
|
|
73
|
|
Reductions for tax positions of prior years
|
|
|
(51
|
)
|
|
|
(53
|
)
|
Additions for tax positions of current year
|
|
|
147
|
|
|
|
77
|
|
Reductions for tax positions of current year
|
|
|
(22
|
)
|
|
|
(8
|
)
|
Settlements with tax authorities
|
|
|
(153
|
)
|
|
|
(177
|
)
|
Lapses of statutes of limitations
|
|
|
(6
|
)
|
|
|
(4
|
)
|
|
|
|
|
|
|
|
|
|
Balance as of end of the period
|
|
$
|
766
|
|
|
$
|
840
|
|
|
|
|
|
|
|
|
|
|
During the year ended December 31, 2007, the Company
recognized $81 million in interest expense associated with
the liability for unrecognized tax benefits. At
December 31, 2007, the Company had $218 million of
accrued interest associated with the liability for unrecognized
tax benefits. The $8 million increase, from the date of
adoption, in accrued interest associated with the liability for
unrecognized tax benefits resulted from an increase of
$81 million of interest expense and a $73 million
decrease primarily resulting from the aforementioned IRS
settlements. During 2007, the $73 million resulting from
IRS settlements was reclassified to current income tax payable
and will be paid in 2009.
During the year ended December 31, 2008, the Company
recognized $37 million in interest expense associated with
the liability for unrecognized tax benefits. At
December 31, 2008, the Company had $176 million of
accrued interest associated with the liability for unrecognized
tax benefits. The $42 million decrease from
December 31, 2007 in accrued interest associated with the
liability for unrecognized tax benefits resulted from an
increase of $37 million of interest expense and a
$79 million decrease primarily resulting from the
aforementioned IRS settlements. Of the $79 million
decrease, $78 million has been reclassified to current
income tax payable and the remaining $1 million reduced
interest expense. Of the $78 million reclassified to
current income tax payable, $7 million was paid in 2008 and
the remainder of $71 million will be paid in 2009.
On September 25, 2007, the IRS issued Revenue Ruling
2007-61,
which announced its intention to issue regulations with respect
to certain computational aspects of the Dividends Received
Deduction (DRD) on separate account assets held in
connection with variable annuity contracts. Revenue Ruling
2007-61
suspended a revenue ruling issued in August 2007 that would have
changed accepted industry and IRS interpretations of the
statutes governing these computational questions. Any
regulations that the IRS ultimately proposes for issuance in
this area will be subject to public notice and comment, at which
time insurance companies and other interested parties will have
the opportunity to raise legal and practical questions about the
content, scope and application of such regulations. As a result,
the ultimate timing and substance of any such regulations are
unknown at this time. For the years ended December 31, 2008
and 2007, the Company recognized an income tax benefit of
$179 million and $188 million, respectively, related
to the separate account DRD.
F-105
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
16. Contingencies,
Commitments and Guarantees
Contingencies
Litigation
The Company is a defendant in a large number of litigation
matters. In some of the matters, very large
and/or
indeterminate amounts, including punitive and treble damages,
are sought. Modern pleading practice in the United States
permits considerable variation in the assertion of monetary
damages or other relief. Jurisdictions may permit claimants not
to specify the monetary damages sought or may permit claimants
to state only that the amount sought is sufficient to invoke the
jurisdiction of the trial court. In addition, jurisdictions may
permit plaintiffs to allege monetary damages in amounts well
exceeding reasonably possible verdicts in the jurisdiction for
similar matters. This variability in pleadings, together with
the actual experience of the Company in litigating or resolving
through settlement numerous claims over an extended period of
time, demonstrate to management that the monetary relief which
may be specified in a lawsuit or claim bears little relevance to
its merits or disposition value. Thus, unless stated below, the
specific monetary relief sought is not noted.
Due to the vagaries of litigation, the outcome of a litigation
matter and the amount or range of potential loss at particular
points in time may normally be inherently impossible to
ascertain with any degree of certainty. Inherent uncertainties
can include how fact finders will view individually and in their
totality documentary evidence, the credibility and effectiveness
of witnesses testimony, and how trial and appellate courts
will apply the law in the context of the pleadings or evidence
presented, whether by motion practice, or at trial or on appeal.
Disposition valuations are also subject to the uncertainty of
how opposing parties and their counsel will themselves view the
relevant evidence and applicable law.
On a quarterly and annual basis, the Company reviews relevant
information with respect to litigation and contingencies to be
reflected in the Companys consolidated financial
statements. In 2007, the Company received $39 million upon
the resolution of an indemnification claim associated with the
2000 acquisition of General American Life Insurance Company
(GALIC), and the Company reduced legal liabilities
by $38 million after the settlement of certain cases. The
review includes senior legal and financial personnel. Unless
stated below, estimates of possible losses or ranges of loss for
particular matters cannot in the ordinary course be made with a
reasonable degree of certainty. Liabilities are established when
it is probable that a loss has been incurred and the amount of
the loss can be reasonably estimated. Liabilities have been
established for a number of the matters noted below; in 2007 the
Company increased legal liabilities for pending sales practices,
employment, property and casualty and intellectual property
litigation matters against the Company. It is possible that some
of the matters could require the Company to pay damages or make
other expenditures or establish accruals in amounts that could
not be estimated at December 31, 2008.
Demutualization
Actions
Several lawsuits were brought in 2000 challenging the fairness
of the Plan and the adequacy and accuracy of MLICs
disclosure to policyholders regarding the Plan. The actions
discussed below name as defendants some or all of MLIC, the
Holding Company, and individual directors. MLIC, the Holding
Company, and the individual directors believe they have
meritorious defenses to the plaintiffs claims and are
contesting vigorously all of the plaintiffs claims in
these actions.
Fiala, et al. v. Metropolitan Life Ins. Co., et al. (Sup.
Ct., N.Y. County, filed March 17, 2000). The
plaintiffs in the consolidated state court class action seek
compensatory relief and punitive damages against MLIC, the
Holding Company, and individual directors. The court has
certified a litigation class of present and former policyholders
on plaintiffs claim that defendants violated
section 7312 of the New York Insurance Law. Pursuant to the
courts order, plaintiffs have given notice to the class of
the pendency of this action. Defendants motion for summary
judgment is pending.
F-106
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
In re MetLife Demutualization Litig. (E.D.N.Y., filed
April 18, 2000). In this class action
against MLIC and the Holding Company, plaintiffs served a second
consolidated amended complaint in 2004. Plaintiffs assert
violations of the Securities Act of 1933 and the Securities
Exchange Act of 1934 in connection with the Plan, claiming that
the Policyholder Information Booklets failed to disclose certain
material facts and contained certain material misstatements.
They seek rescission and compensatory damages. By orders dated
July 19, 2005 and August 29, 2006, the federal trial
court certified a litigation class of present and former
policyholders. The court has directed the manner and form of
notice to the class, but plaintiffs have not yet distributed the
notice. MLIC and the Holding Company have moved for summary
judgment, and plaintiffs have moved for partial summary
judgment. The court heard oral argument on the parties
motions for summary judgment on September 19, 2008.
Asbestos-Related
Claims
MLIC is and has been a defendant in a large number of
asbestos-related suits filed primarily in state courts. These
suits principally allege that the plaintiff or plaintiffs
suffered personal injury resulting from exposure to asbestos and
seek both actual and punitive damages. MLIC has never engaged in
the business of manufacturing, producing, distributing or
selling asbestos or asbestos-containing products nor has MLIC
issued liability or workers compensation insurance to
companies in the business of manufacturing, producing,
distributing or selling asbestos or asbestos-containing
products. The lawsuits principally have focused on allegations
with respect to certain research, publication and other
activities of one or more of MLICs employees during the
period from the 1920s through approximately the
1950s and allege that MLIC learned or should have learned
of certain health risks posed by asbestos and, among other
things, improperly publicized or failed to disclose those health
risks. MLIC believes that it should not have legal liability in
these cases. The outcome of most asbestos litigation matters,
however, is uncertain and can be impacted by numerous variables,
including differences in legal rulings in various jurisdictions,
the nature of the alleged injury, and factors unrelated to the
ultimate legal merit of the claims asserted against MLIC. MLIC
employs a number of resolution strategies to manage its asbestos
loss exposure, including seeking resolution of pending
litigation by judicial rulings and settling individual or groups
of claims or lawsuits under appropriate circumstances.
Claims asserted against MLIC have included negligence,
intentional tort and conspiracy concerning the health risks
associated with asbestos. MLICs defenses (beyond denial of
certain factual allegations) include that: (i) MLIC owed no
duty to the plaintiffs it had no special
relationship with the plaintiffs and did not manufacture,
produce, distribute or sell the asbestos products that allegedly
injured plaintiffs; (ii) plaintiffs did not rely on any
actions of MLIC; (iii) MLICs conduct was not the
cause of the plaintiffs injuries;
(iv) plaintiffs exposure occurred after the dangers
of asbestos were known; and (v) the applicable time with
respect to filing suit has expired. During the course of the
litigation, certain trial courts have granted motions dismissing
claims against MLIC, while other trial courts have denied
MLICs motions to dismiss. There can be no assurance that
MLIC will receive favorable decisions on motions in the future.
While most cases brought to date have settled, MLIC intends to
continue to defend aggressively against claims based on asbestos
exposure, including defending claims at trials.
The approximate total number of asbestos personal injury claims
pending against MLIC as of the dates indicated, the approximate
number of new claims during the years ended on those dates and
the approximate total settlement payments made to resolve
asbestos personal injury claims at or during those years are set
forth in the following table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions, except number of claims)
|
|
|
Asbestos personal injury claims at year end
|
|
|
74,027
|
|
|
|
79,717
|
|
|
|
87,070
|
|
Number of new claims during the year
|
|
|
5,063
|
|
|
|
7,161
|
|
|
|
7,870
|
|
Settlement payments during the year (1)
|
|
$
|
99.0
|
|
|
$
|
28.2
|
|
|
$
|
35.5
|
|
F-107
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
(1) |
|
Settlement payments represent payments made by MLIC during the
year in connection with settlements made in that year and in
prior years. Amounts do not include MLICs attorneys
fees and expenses and do not reflect amounts received from
insurance carriers. |
In 2005, MLIC received approximately 18,500 new claims, ending
the year with a total of approximately 100,250 claims, and paid
approximately $74.3 million for settlements reached in 2005
and prior years. In 2004, MLIC received approximately 23,900 new
claims, ending the year with a total of approximately 108,000
claims, and paid approximately $85.5 million for
settlements reached in 2004 and prior years. In 2003, MLIC
received approximately 58,750 new claims, ending the year with a
total of approximately 111,700 claims, and paid approximately
$84.2 million for settlements reached in 2003 and prior
years. The number of asbestos cases that may be brought, the
aggregate amount of any liability that MLIC may incur, and the
total amount paid in settlements in any given year are uncertain
and may vary significantly from year to year.
The ability of MLIC to estimate its ultimate asbestos exposure
is subject to considerable uncertainty, and the conditions
impacting its liability can be dynamic and subject to change.
The availability of reliable data is limited and it is difficult
to predict with any certainty the numerous variables that can
affect liability estimates, including the number of future
claims, the cost to resolve claims, the disease mix and severity
of disease in pending and future claims, the impact of the
number of new claims filed in a particular jurisdiction and
variations in the law in the jurisdictions in which claims are
filed, the possible impact of tort reform efforts, the
willingness of courts to allow plaintiffs to pursue claims
against MLIC when exposure to asbestos took place after the
dangers of asbestos exposure were well known, and the impact of
any possible future adverse verdicts and their amounts.
The ability to make estimates regarding ultimate asbestos
exposure declines significantly as the estimates relate to years
further in the future. In the Companys judgment, there is
a future point after which losses cease to be probable and
reasonably estimable. It is reasonably possible that the
Companys total exposure to asbestos claims may be
materially greater than the asbestos liability currently accrued
and that future charges to income may be necessary. While the
potential future charges could be material in the particular
quarterly or annual periods in which they are recorded, based on
information currently known by management, management does not
believe any such charges are likely to have a material adverse
effect on the Companys financial position.
During 1998, MLIC paid $878 million in premiums for excess
insurance policies for asbestos-related claims. The excess
insurance policies for asbestos-related claims provided for
recovery of losses up to $1.5 billion in excess of a
$400 million self-insured retention. The Companys
initial option to commute the excess insurance policies for
asbestos-related claims would have arisen at the end of 2008. On
September 29, 2008, MLIC entered into agreements commuting
the excess insurance policies as of September 30, 2008. As
a result of the commutation of the policies, MLIC received cash
and securities totaling $632 million. Of this total, MLIC
received $115 million in fixed maturity securities on
September 26, 2008, $200 million in cash on
October 29, 2008, and $317 million in cash on
January 29, 2009. MLIC recognized a loss on commutation of
the policies in the amount of $35.3 million during 2008.
In the years prior to commutation, the excess insurance policies
for asbestos-related claims were subject to annual and per claim
sublimits. Amounts exceeding the sublimits during 2007, 2006 and
2005 were approximately $16 million, $8 million and
$0, respectively. Amounts were recoverable under the policies
annually with respect to claims paid during the prior calendar
year. Each asbestos-related policy contained an experience fund
and a reference fund that provided for payments to MLIC at the
commutation date if the reference fund was greater than zero at
commutation or pro rata reductions from time to time in the loss
reimbursements to MLIC if the cumulative return on the reference
fund was less than the return specified in the experience fund.
The return in the reference fund was tied to performance of the
S&P 500 Index and the Lehman Brothers Aggregate Bond Index.
A claim with respect to the prior year was made under the excess
insurance policies in each year from 2003 through 2008 for the
amounts paid with respect to asbestos litigation in excess of
the retention. The foregone loss reimbursements were
approximately $62.2 million with respect to claims for the
period of 2002 through 2007. Because the policies were
F-108
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
commuted as of September 30, 2008, there will be no claims
under the policies or forgone loss reimbursements with respect
to payments made in 2008 and thereafter.
The Company believes adequate provision has been made in its
consolidated financial statements for all probable and
reasonably estimable losses for asbestos-related claims.
MLICs recorded asbestos liability is based on its
estimation of the following elements, as informed by the facts
presently known to it, its understanding of current law, and its
past experiences: (i) the probable and reasonably estimable
liability for asbestos claims already asserted against MLIC,
including claims settled but not yet paid; (ii) the
probable and reasonably estimable liability for asbestos claims
not yet asserted against MLIC, but which MLIC believes are
reasonably probable of assertion; and (iii) the legal
defense costs associated with the foregoing claims. Significant
assumptions underlying MLICs analysis of the adequacy of
its recorded liability with respect to asbestos litigation
include: (i) the number of future claims; (ii) the
cost to resolve claims; and (iii) the cost to defend claims.
MLIC reevaluates on a quarterly and annual basis its exposure
from asbestos litigation, including studying its claims
experience, reviewing external literature regarding asbestos
claims experience in the United States, assessing relevant
trends impacting asbestos liability and considering numerous
variables that can affect its asbestos liability exposure on an
overall or per claim basis. These variables include bankruptcies
of other companies involved in asbestos litigation, legislative
and judicial developments, the number of pending claims
involving serious disease, the number of new claims filed
against it and other defendants, and the jurisdictions in which
claims are pending. As previously disclosed, in 2002 MLIC
increased its recorded liability for asbestos-related claims by
$402 million from approximately $820 million to
$1,225 million. Based upon its regular reevaluation of its
exposure from asbestos litigation, MLIC has updated its
liability analysis for asbestos-related claims through
December 31, 2008.
Regulatory
Matters
The Company receives and responds to subpoenas or other
inquiries from state regulators, including state insurance
commissioners; state attorneys general or other state
governmental authorities; federal regulators, including the SEC;
federal governmental authorities, including congressional
committees; and the Financial Industry Regulatory Authority
seeking a broad range of information. The issues involved in
information requests and regulatory matters vary widely. Certain
regulators have requested information and documents regarding
contingent commission payments to brokers, the Companys
awareness of any sham bids for business, bids and
quotes that the Company submitted to potential customers,
incentive agreements entered into with brokers, or compensation
paid to intermediaries. Regulators also have requested
information relating to market timing and late trading of mutual
funds and variable insurance products and, generally, the
marketing of products. The Company has received a subpoena from
the Office of the U.S. Attorney for the Southern District
of California asking for documents regarding the insurance
broker Universal Life Resources. The Company has been
cooperating fully with these inquiries.
Regulatory authorities in a small number of states have had
investigations or inquiries relating to sales of individual life
insurance policies or annuities or other products by MLIC; New
England Mutual Life Insurance Company, New England Life
Insurance Company and New England Securities Corporation
(collectively New England); GALIC; Walnut Street
Securities, Inc. (Walnut Street Securities) and
MetLife Securities, Inc. (MSI). Over the past
several years, these and a number of investigations by other
regulatory authorities were resolved for monetary payments and
certain other relief. The Company may continue to resolve
investigations in a similar manner.
MSI is a defendant in two regulatory matters brought by the
Illinois Department of Securities. In 2005, MSI received a
notice from the Illinois Department of Securities asserting
possible violations of the Illinois Securities Act in connection
with sales of a former affiliates mutual funds. A response
has been submitted and in January 2008, MSI received notice of
the commencement of an administrative action by the Illinois
Department of Securities. In May 2008, MSIs motion to
dismiss the action was denied. In the second matter, in December
2008
F-109
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
MSI received a Notice of Hearing from the Illinois Department of
Securities based upon a complaint alleging that MSI failed to
reasonably supervise one of its former registered
representatives in connection with the sale of variable
annuities to Illinois investors. MSI intends to vigorously
defend against the claims in these matters.
In June 2008, the Environmental Protection Agency issued a
Notice of Violation (NOV) regarding the operations
of the Homer City Generating Station, an electrical generation
facility. The NOV alleges, among other things, that the
electrical generation facility is being operated in violation of
certain federal and state Clean Air Act requirements. Homer City
OL6 LLC, an entity owned by MLIC, is a passive investor with a
minority interest in the electrical generation facility, which
is solely operated by the lessee, EME Homer City Generation L.P.
(EME Homer). Homer City OL6 LLC and EME Homer are
among the respondents identified in the NOV. EME Homer has been
notified of its obligation to indemnify Homer City OL6 LLC and
MLIC for any claims resulting from the NOV and has expressly
acknowledged its obligation to indemnify Homer City OL6 LLC.
Other
Litigation
Jacynthe Evoy-Larouche v. Metropolitan Life Ins. Co.
(Que. Super. Ct., filed March 1998). This
putative class action lawsuit involving sales practices claims
is pending against MLIC in Canada. Plaintiff alleges
misrepresentations regarding dividends and future payments for
life insurance policies and seeks unspecified damages.
Travelers Ins. Co., et al. v. Banc of America Securities
LLC (S.D.N.Y., filed December 13, 2001). On
January 6, 2009, after a jury trial, the district
court entered a judgment in favor of The Travelers Insurance
Company, now known as MetLife Insurance Company of Connecticut,
in the amount of approximately $42 million in connection
with securities and common law claims against the defendant. The
defendant has filed a post judgment motion seeking a judgment in
its favor or, in the alternative, a new trial. If this motion is
denied, the defendant will likely file an appeal. As it is
possible that the judgment could be affected during the post
judgment motion practice or upon appeal, and the Company has not
collected any portion of the judgment, the Company has not
recognized any award amount in its consolidated financial
statements.
Shipley v. St. Paul Fire and Marine Ins. Co. and
Metropolitan Property and Casualty Ins. Co. (Ill. Cir. Ct.,
Madison County, filed February 26 and July 2,
2003). Two putative nationwide class actions have
been filed against Metropolitan Property and Casualty Insurance
Company in Illinois. One suit claims breach of contract and
fraud due to the alleged underpayment of medical claims arising
from the use of a purportedly biased provider fee pricing
system. The second suit currently alleges breach of contract
arising from the alleged use of preferred provider organizations
to reduce medical provider fees covered by the medical claims
portion of the insurance policy. Motions for class certification
have been filed and briefed in both cases. A third putative
nationwide class action relating to the payment of medical
providers, Innovative Physical Therapy, Inc. v. MetLife
Auto & Home, et ano (D. N.J., filed November 12,
2007), was filed against Metropolitan Property and Casualty
Insurance Company in federal court in New Jersey. The court
granted the defendants motion to dismiss, and plaintiff
appealed the dismissal. The Company is vigorously defending
against the claims in these matters.
The American Dental Association, et al. v. MetLife Inc., et
al. (S.D. Fla., filed May 19, 2003). The
American Dental Association and three individual providers have
sued the Holding Company, MLIC and other non-affiliated
insurance companies in a putative class action lawsuit. The
plaintiffs purport to represent a nationwide class of
in-network
providers who allege that their claims are being wrongfully
reduced by downcoding, bundling, and the improper use and
programming of software. The complaint alleges federal
racketeering and various state law theories of liability. On
February 10, 2009, the district court granted the
Companys motion to dismiss plaintiffs second amended
complaint, dismissing all of plaintiffs claims except for
breach of contract claims. Plaintiffs have been provided with an
opportunity to re-plead the dismissed claims by
February 26, 2009.
In Re Ins. Brokerage Antitrust Litig. (D. N.J., filed
February 24, 2005). In this multi-district
class action proceeding, plaintiffs complaint alleged that
the Holding Company, MLIC, several non-affiliated insurance
F-110
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
companies and several insurance brokers violated the Racketeer
Influenced and Corrupt Organizations Act (RICO), the
Employee Retirement Income Security Act of 1974
(ERISA), and antitrust laws and committed other
misconduct in the context of providing insurance to employee
benefit plans and to persons who participate in such employee
benefit plans. In August and September 2007 and January 2008,
the court issued orders granting defendants motions to
dismiss with prejudice the federal antitrust, the RICO, and the
ERISA claims. In February 2008, the court dismissed the
remaining state law claims on jurisdictional grounds.
Plaintiffs appeal from the orders dismissing their RICO
and federal antitrust claims is pending with the U.S. Court
of Appeals for the Third Circuit. A putative class action
alleging that the Holding Company and other non-affiliated
defendants violated state laws was transferred to the District
of New Jersey but was not consolidated with other related
actions. Plaintiffs motion to remand this action to state
court in Florida is pending.
MetLife v. Park Avenue Securities, et. al. (FINRA
Arbitration, filed May 2006). MetLife commenced
an action against Park Avenue Securities LLC., a registered
investment adviser and broker-dealer that is an indirect
wholly-owned subsidiary of The Guardian Life Insurance Company
of America, alleging misappropriation of confidential and
proprietary information and use of prohibited methods to solicit
MetLife customers and recruit MetLife financial services
representatives. On February 12, 2009, a Financial Industry
Regulatory Authority (FINRA) arbitration panel
awarded MetLife $21 million in damages, including punitive
damages and attorneys fees. Park Avenue Securities may appeal
the award.
Thomas, et al. v. Metropolitan Life Ins. Co., et al. (W.D.
Okla., filed January 31, 2007). A putative
class action complaint was filed against MLIC and MSI.
Plaintiffs assert legal theories of violations of the federal
securities laws and violations of state laws with respect to the
sale of certain proprietary products by the Companys
agency distribution group. Plaintiffs seek rescission,
compensatory damages, interest, punitive damages and
attorneys fees and expenses. In January and May 2008, the
court issued orders granting the defendants motion to
dismiss in part, dismissing all of plaintiffs claims
except for claims under the Investment Advisers Act.
Defendants motion to dismiss claims under the Investment
Advisers Act was denied. The Company will vigorously defend
against the remaining claims in this matter.
Sales Practices Claims. Over the past several
years, MLIC, New England, GALIC, Walnut Street Securities and
MSI have faced numerous claims, including class action lawsuits,
alleging improper marketing or sales of individual life
insurance policies, annuities, mutual funds or other products.
Some of the current cases seek substantial damages, including
punitive and treble damages and attorneys fees. At
December 31, 2008, there were approximately 125 sales
practices litigation matters pending against the Company. The
Company continues to vigorously defend against the claims in
these matters. The Company believes adequate provision has been
made in its consolidated financial statements for all probable
and reasonably estimable losses for sales practices claims
against MLIC, New England, GALIC, MSI and Walnut Street
Securities.
Summary
Putative or certified class action litigation and other
litigation and claims and assessments against the Company, in
addition to those discussed previously and those otherwise
provided for in the Companys consolidated financial
statements, have arisen in the course of the Companys
business, including, but not limited to, in connection with its
activities as an insurer, employer, investor, investment advisor
and taxpayer. Further, state insurance regulatory authorities
and other federal and state authorities regularly make inquiries
and conduct investigations concerning the Companys
compliance with applicable insurance and other laws and
regulations.
It is not possible to predict the ultimate outcome of all
pending investigations and legal proceedings or provide
reasonable ranges of potential losses, except as noted
previously in connection with specific matters. In some of the
matters referred to previously, very large
and/or
indeterminate amounts, including punitive and treble damages,
are sought. Although in light of these considerations it is
possible that an adverse outcome in certain cases could have a
material adverse effect upon the Companys financial
position, based on information currently known by the
Companys management, in its opinion, the outcomes of such
pending investigations and legal proceedings are not
F-111
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
likely to have such an effect. However, given the large
and/or
indeterminate amounts sought in certain of these matters and the
inherent unpredictability of litigation, it is possible that an
adverse outcome in certain matters could, from time to time,
have a material adverse effect on the Companys
consolidated net income or cash flows in particular quarterly or
annual periods.
Insolvency
Assessments
Most of the jurisdictions in which the Company is admitted to
transact business require insurers doing business within the
jurisdiction to participate in guaranty associations, which are
organized to pay contractual benefits owed pursuant to insurance
policies issued by impaired, insolvent or failed insurers. These
associations levy assessments, up to prescribed limits, on all
member insurers in a particular state on the basis of the
proportionate share of the premiums written by member insurers
in the lines of business in which the impaired, insolvent or
failed insurer engaged. Some states permit member insurers to
recover assessments paid through full or partial premium tax
offsets. Assets and liabilities held for insolvency assessments
are as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Other Assets:
|
|
|
|
|
|
|
|
|
Premium tax offset for future undiscounted assessments
|
|
$
|
50
|
|
|
$
|
40
|
|
Premium tax offsets currently available for paid assessments
|
|
|
7
|
|
|
|
6
|
|
Receivable for reimbursement of paid assessments (1)
|
|
|
7
|
|
|
|
7
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
64
|
|
|
$
|
53
|
|
|
|
|
|
|
|
|
|
|
Other Liabilities:
|
|
|
|
|
|
|
|
|
Insolvency assessments
|
|
$
|
83
|
|
|
$
|
74
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The Company holds a receivable from the seller of a prior
acquisition in accordance with the purchase agreement. |
Assessments levied against the Company were $2 million,
($1) million and $2 million for the years ended
December 31, 2008, 2007 and 2006, respectively.
Argentina
The Argentine economic, regulatory and legal environment,
including interpretations of laws and regulations by regulators
and courts, is uncertain. Potential legal or governmental
actions related to pension reform, fiduciary responsibilities,
performance guarantees and tax rulings could adversely affect
the results of the Company.
Upon acquisition of Citigroups insurance operations in
Argentina, the Company established insurance and contingent
liabilities, most significantly related to death and disability
policy coverages and to litigation against the governments
2002 Pesification Law. These liabilities were established based
upon the Companys interpretation of Argentine law at the
time and the Companys best estimate of its obligations
under laws applicable at the time.
In 2006, a decree was issued by the Argentine Government
regarding the taxability of pesification related gains resulting
in the $8 million, net of income tax, reduction of certain
tax liabilities during the year ended December 31, 2006.
In 2007, pension reform legislation in Argentina was enacted
which relieved the Company of its obligation to provide death
and disability policy coverages and resulted in the elimination
of related insurance liabilities. The reform reinstituted the
governments pension plan system and allowed for pension
participants to transfer their future contributions to the
government pension plan system.
F-112
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Although it no longer receives compensation, the Company
continued to be responsible for managing the funds of those
participants that transferred to the government system. This
change resulted in the establishment of a liability for future
servicing obligations and the elimination of the Companys
obligations under death and disability policy coverages. The
impact of the 2007 Argentine pension reform was an increase to
net income of $114 million, net of income tax, due to the
reduction of the insurance liabilities and other balances
associated with the death and disability coverages of
$197 million, net of income tax, which exceeded the
establishment of the liability for future service obligations of
$83 million, net of income tax, during the year ended
December 31, 2007. During the first quarter of 2008, the
future servicing obligation was reduced by $23 million, net
of income tax, when information regarding the level of
participation in the government pension plan became fully
available.
In October 2008, the Argentine government announced its
intention to nationalize private pensions and, in December 2008,
the Argentine government nationalized the private pension system
seizing the underlying investments of participants which were
being managed by the Company (Nationalization). With
this action, the Companys pension business in Argentina
ceased to exist and the Company eliminated certain assets and
liabilities held in connection with the pension business.
Deferred acquisition costs deferred tax assets, and
liabilities primarily the liability for future
servicing obligation referred to above were
eliminated and the Company incurred severance costs associated
with the termination of employees. The impact of the elimination
of assets and liabilities and the incurral of severance costs
was an increase to net income of $6 million, net of income
tax, during the year ended December 31, 2008.
In September 2008, the Argentine Supreme Court ruled against the
validity of the 2002 Pesification Law enacted by the Argentine
government. This ruling applied to certain social security
pension annuity contractholders that had filed a lawsuit against
the 2002 Pesification Law. The annuity contracts impacted by
this ruling, which were deemed peso denominated under the 2002
Pesification Law, are now considered to be U.S. dollar
denominated obligations of the Company. Contingent liabilities
that were established at acquisition in 2005 in connection with
the outstanding lawsuits have been adjusted and refined to be
consistent with the ruling. The impact of the refinements
resulting from the change in these contingent liabilities and
the associated future policyholder benefits was an increase to
net income of $34 million, net of income tax, during the
year ended December 31, 2008.
As part of Nationalization, the Company may receive compensation
from the Argentine government for the loss of the pension
business in the form of government bonds. The amount of any such
compensation, as well as the terms and value of the government
bonds to be received, cannot be determined at this time. The
compensation will only be reflected in the consolidated
financial statements of the Company if and when the fair value
of the compensation is received.
Further governmental or legal actions are possible in Argentina.
Such actions may impact the level of existing liabilities or may
create additional obligations or benefits to the Companys
operations in Argentina. Management has made its best estimate
of its obligations based upon information currently available;
however, further governmental or legal actions could result in
changes in obligations which could materially impact the amounts
presented within the consolidated financial statements.
Commitments
Leases
In accordance with industry practice, certain of the
Companys income from lease agreements with retail tenants
are contingent upon the level of the tenants sales
revenues. Additionally, the Company, as lessee, has entered into
various lease and sublease agreements for office space, data
processing and other equipment. Future
F-113
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
minimum rental and sublease income, and minimum gross rental
payments relating to these lease agreements are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross
|
|
|
|
Rental
|
|
|
Sublease
|
|
|
Rental
|
|
|
|
Income
|
|
|
Income
|
|
|
Payments
|
|
|
|
(In millions)
|
|
|
2009
|
|
$
|
431
|
|
|
$
|
15
|
|
|
$
|
278
|
|
2010
|
|
$
|
391
|
|
|
$
|
11
|
|
|
$
|
247
|
|
2011
|
|
$
|
314
|
|
|
$
|
11
|
|
|
$
|
213
|
|
2012
|
|
$
|
246
|
|
|
$
|
11
|
|
|
$
|
171
|
|
2013
|
|
$
|
206
|
|
|
$
|
11
|
|
|
$
|
152
|
|
Thereafter
|
|
$
|
724
|
|
|
$
|
34
|
|
|
$
|
1,080
|
|
During the fourth quarter of 2008, the Company moved certain of
its operations in New York from Long Island City to New York
City. As a result of this movement of operations and current
market conditions, which precluded the Companys immediate
and complete sublet of all unused space in both Long Island City
and New York City, the Company incurred a lease impairment
charge of $38 million which is included within other
expenses in Corporate & Other. The impairment charge
was determined based upon the present value of the gross rental
payments less sublease income discounted at a risk-adjusted rate
over the remaining lease terms which range from
15-20 years.
The Company has made assumptions with respect to the timing and
amount of future sublease income in the determination of this
impairment charge. Additional impairment charges could be
incurred should market conditions deteriorate further or last
for a period significantly longer than anticipated.
Commitments
to Fund Partnership Investments
The Company makes commitments to fund partnership investments in
the normal course of business. The amounts of these unfunded
commitments were $4.5 billion and $4.2 billion at
December 31, 2008 and 2007, respectively. The Company
anticipates that these amounts will be invested in partnerships
over the next five years.
Mortgage
Loan Commitments
The Company has issued interest rate lock commitments on certain
residential mortgage loan applications totaling
$8.0 billion at December 31, 2008. The Company intends
to sell the majority of these originated residential mortgage
loans. Interest rate lock commitments to fund mortgage loans
that will be held-for-sale are considered derivatives pursuant
to SFAS 133, and their estimated fair value and notional
amounts are included within financial forwards in Note 4.
The Company also commits to lend funds under certain other
mortgage loan commitments that will be held-for-investment. The
amounts of these mortgage loan commitments were
$2.7 billion and $4.0 billion at December 31,
2008 and 2007, respectively.
Commitments
to Fund Bank Credit Facilities, Bridge Loans and Private
Corporate Bond Investments
The Company commits to lend funds under bank credit facilities,
bridge loans and private corporate bond investments. The amounts
of these unfunded commitments were $1.0 billion and
$1.2 billion at December 31, 2008 and 2007,
respectively.
Guarantees
In the normal course of its business, the Company has provided
certain indemnities, guarantees and commitments to third parties
pursuant to which it may be required to make payments now or in
the future. In the context of acquisition, disposition,
investment and other transactions, the Company has provided
indemnities and guarantees, including those related to tax,
environmental and other specific liabilities, and other
indemnities
F-114
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
and guarantees that are triggered by, among other things,
breaches of representations, warranties or covenants provided by
the Company. In addition, in the normal course of business, the
Company provides indemnifications to counterparties in contracts
with triggers similar to the foregoing, as well as for certain
other liabilities, such as third party lawsuits. These
obligations are often subject to time limitations that vary in
duration, including contractual limitations and those that arise
by operation of law, such as applicable statutes of limitation.
In some cases, the maximum potential obligation under the
indemnities and guarantees is subject to a contractual
limitation ranging from less than $1 million to
$800 million, with a cumulative maximum of
$1.6 billion, while in other cases such limitations are not
specified or applicable. Since certain of these obligations are
not subject to limitations, the Company does not believe that it
is possible to determine the maximum potential amount that could
become due under these guarantees in the future. Management
believes that it is unlikely the Company will have to make any
material payments under these indemnities, guarantees, or
commitments.
In addition, the Company indemnifies its directors and officers
as provided in its charters and by-laws. Also, the Company
indemnifies its agents for liabilities incurred as a result of
their representation of the Companys interests. Since
these indemnities are generally not subject to limitation with
respect to duration or amount, the Company does not believe that
it is possible to determine the maximum potential amount that
could become due under these indemnities in the future.
The Company has also guaranteed minimum investment returns on
certain international retirement funds in accordance with local
laws. Since these guarantees are not subject to limitation with
respect to duration or amount, the Company does not believe that
it is possible to determine the maximum potential amount that
could become due under these guarantees in the future.
During the year ended December 31, 2008, the Company
recorded $7 million of additional liabilities for
guarantees related to certain investment transactions. The term
for these guarantees and their associated liabilities varies,
with a maximum of 18 years. The maximum potential amount of
future payments the Company could be required to pay under these
guarantees is $202 million. During the year ended
December 31, 2008, the Company reduced $7 million of
previously recorded liabilities related to indemnifications
provided in connection with the disposition of real estate
property and other investment transactions. The Companys
recorded liabilities were $6 million at both
December 31, 2008 and 2007 for indemnities, guarantees and
commitments.
In connection with synthetically created investment
transactions, the Company writes credit default swap obligations
that generally require payment of principal outstanding due in
exchange for the referenced credit obligation. If a credit
event, as defined by the contract, occurs the Companys
maximum amount at risk, assuming the value of all referenced
credits obligations is zero, was $1.9 billion at
December 31, 2008. The Company can terminate these
contracts at any time through cash settlement with the
counterparty at an amount equal to the then current fair value
of the credit default swaps. As of December 31, 2008, the
Company would have paid $37 million to terminate all of
these contracts.
See Note 4 for further disclosures related to credit
default swap obligations.
|
|
17.
|
Employee
Benefit Plans
|
Pension
and Other Postretirement Benefit Plans
The Subsidiaries sponsor
and/or
administer various qualified and non-qualified defined benefit
pension plans and other postretirement employee benefit plans
covering employees and sales representatives who meet specified
eligibility requirements. Pension benefits are provided
utilizing either a traditional formula or cash balance formula.
The traditional formula provides benefits based upon years of
credited service and either final average or career average
earnings. The cash balance formula utilizes hypothetical or
notional accounts which credit participants with benefits equal
to a percentage of eligible pay, as well as earnings credits,
determined annually based upon the average annual rate of
interest on
30-year
U.S. Treasury securities, for each account balance. At
December 31, 2008, the majority of active participants are
accruing benefits under the cash balance formula; however,
F-115
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
approximately 95% of the Subsidiaries obligations result
from benefits calculated with the traditional formula. The
non-qualified pension plans provide supplemental benefits, in
excess of amounts permitted by governmental agencies, to certain
executive level employees.
The Subsidiaries also provide certain postemployment benefits
and certain postretirement medical and life insurance benefits
for retired employees. Employees of the Subsidiaries who were
hired prior to 2003 (or, in certain cases, rehired during or
after 2003) and meet age and service criteria while working
for one of the Subsidiaries, may become eligible for these other
postretirement benefits, at various levels, in accordance with
the applicable plans. Virtually all retirees, or their
beneficiaries, contribute a portion of the total cost of
postretirement medical benefits. Employees hired after 2003 are
not eligible for any employer subsidy for postretirement medical
benefits.
As described more fully in Note 1, effective
December 31, 2006, the Company adopted SFAS 158. The
adoption of SFAS 158 required the recognition of the funded
status of defined benefit pension and other postretirement
benefit plans and eliminated the additional minimum pension
liability provision of SFAS 87. The Companys
additional minimum pension liability was $78 million, and
the intangible asset was $12 million, at December 31,
2005. The excess of the additional minimum pension liability
over the intangible asset of $66 million, $41 million
net of income tax, was recorded as a reduction of accumulated
other comprehensive income. At December 31, 2006,
immediately prior to adopting SFAS 158, the Companys
additional minimum pension liability was $92 million. The
additional minimum pension liability of $59 million, net of
income tax of $33 million, was recorded as a reduction of
accumulated other comprehensive income. The change in the
additional minimum pension liability of $18 million, net of
income tax, was reflected as a component of comprehensive income
for the year ended December 31, 2006. Upon adoption of
SFAS 158, the Company eliminated the additional minimum
pension liability and recognized as an adjustment to accumulated
other comprehensive income (loss), net of income tax, those
amounts of actuarial gains and losses, prior service costs and
credits, and the remaining net transition asset or obligation
that had not yet been included in net periodic benefit cost at
the date of adoption.
The following table summarizes the adjustments to the
December 31, 2006 consolidated balance sheet as a result of
recognizing the funded status of the defined benefit plans:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2006
|
|
|
|
|
|
|
Additional
|
|
|
|
|
|
|
|
|
|
|
|
|
Minimum
|
|
|
|
|
|
|
|
|
|
Pre
|
|
|
Pension
|
|
|
Adoption of
|
|
|
Post
|
|
|
|
SFAS 158
|
|
|
Liability
|
|
|
SFAS 158
|
|
|
SFAS 158
|
|
Balance Sheet Caption
|
|
Adjustments
|
|
|
Adjustment
|
|
|
Adjustment
|
|
|
Adjustments
|
|
|
|
(In millions)
|
|
|
Other assets: Prepaid pension benefit cost
|
|
$
|
1,938
|
|
|
$
|
|
|
|
$
|
(992
|
)
|
|
$
|
946
|
|
Other assets: Intangible asset
|
|
$
|
12
|
|
|
|
(12
|
)
|
|
|
|
|
|
$
|
|
|
Other liabilities: Accrued pension benefit cost
|
|
$
|
(497
|
)
|
|
|
(14
|
)
|
|
|
(66
|
)
|
|
$
|
(577
|
)
|
Other liabilities: Accrued other postretirement benefit plan cost
|
|
$
|
(794
|
)
|
|
|
|
|
|
|
(95
|
)
|
|
$
|
(889
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
|
|
|
|
(26
|
)
|
|
|
(1,153
|
)
|
|
|
|
|
Net liability of subsidiary held-for-sale
|
|
|
|
|
|
|
|
|
|
|
(18
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated other comprehensive income (loss), before income tax:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Defined benefit plans
|
|
$
|
(66
|
)
|
|
|
(26
|
)
|
|
|
(1,171
|
)
|
|
$
|
(1,263
|
)
|
Minority interest
|
|
|
|
|
|
|
|
|
|
|
8
|
|
|
|
|
|
Deferred income tax
|
|
|
|
|
|
|
8
|
|
|
|
419
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated other comprehensive income (loss), net of income tax:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Defined benefit plans
|
|
$
|
(41
|
)
|
|
$
|
(18
|
)
|
|
$
|
(744
|
)
|
|
$
|
(803
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A December 31 measurement date is used for all of the
Subsidiaries defined benefit pension and other
postretirement benefit plans.
F-116
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Obligations,
Funded Status and Net Periodic Benefit Costs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
|
|
|
Other
|
|
|
|
Pension
|
|
|
Postretirement
|
|
|
|
Benefits
|
|
|
Benefits
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Change in benefit obligation:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefit obligation at beginning of year
|
|
$
|
5,722
|
|
|
$
|
5,909
|
|
|
$
|
1,599
|
|
|
$
|
2,061
|
|
Service cost
|
|
|
164
|
|
|
|
162
|
|
|
|
21
|
|
|
|
27
|
|
Interest cost
|
|
|
379
|
|
|
|
351
|
|
|
|
103
|
|
|
|
103
|
|
Plan participants contributions
|
|
|
|
|
|
|
|
|
|
|
31
|
|
|
|
31
|
|
Net actuarial (gains) losses
|
|
|
129
|
|
|
|
(387
|
)
|
|
|
16
|
|
|
|
(463
|
)
|
Change in benefits
|
|
|
(1
|
)
|
|
|
39
|
|
|
|
1
|
|
|
|
|
|
Prescription drug subsidy
|
|
|
|
|
|
|
|
|
|
|
10
|
|
|
|
13
|
|
Benefits paid
|
|
|
(352
|
)
|
|
|
(352
|
)
|
|
|
(149
|
)
|
|
|
(173
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefit obligation at end of year
|
|
|
6,041
|
|
|
|
5,722
|
|
|
|
1,632
|
|
|
|
1,599
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in plan assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of plan assets at beginning of year
|
|
|
6,520
|
|
|
|
6,278
|
|
|
|
1,183
|
|
|
|
1,172
|
|
Actual return on plan assets
|
|
|
(952
|
)
|
|
|
546
|
|
|
|
(150
|
)
|
|
|
58
|
|
Employer contribution
|
|
|
343
|
|
|
|
48
|
|
|
|
2
|
|
|
|
1
|
|
Benefits paid
|
|
|
(352
|
)
|
|
|
(352
|
)
|
|
|
(24
|
)
|
|
|
(48
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of plan assets at end of year
|
|
|
5,559
|
|
|
|
6,520
|
|
|
|
1,011
|
|
|
|
1,183
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Funded status at end of year
|
|
$
|
(482
|
)
|
|
$
|
798
|
|
|
$
|
(621
|
)
|
|
$
|
(416
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts recognized in the consolidated balance sheet consist of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other assets
|
|
$
|
227
|
|
|
$
|
1,396
|
|
|
$
|
|
|
|
$
|
|
|
Other liabilities
|
|
|
(709
|
)
|
|
|
(598
|
)
|
|
|
(621
|
)
|
|
|
(416
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net amount recognized
|
|
$
|
(482
|
)
|
|
$
|
798
|
|
|
$
|
(621
|
)
|
|
$
|
(416
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated other comprehensive (income) loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net actuarial (gains) losses
|
|
$
|
2,184
|
|
|
$
|
623
|
|
|
$
|
147
|
|
|
$
|
(112
|
)
|
Prior service cost (credit)
|
|
|
45
|
|
|
|
64
|
|
|
|
(157
|
)
|
|
|
(193
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,229
|
|
|
|
687
|
|
|
|
(10
|
)
|
|
|
(305
|
)
|
Deferred income tax and minority interest
|
|
|
(780
|
)
|
|
|
(251
|
)
|
|
|
4
|
|
|
|
109
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,449
|
|
|
$
|
436
|
|
|
$
|
(6
|
)
|
|
$
|
(196
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-117
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The aggregate projected benefit obligation and aggregate fair
value of plan assets for the pension plans were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
Qualified Plan
|
|
|
Non-Qualified Plan
|
|
|
Total
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Aggregate fair value of plan assets (principally Company
contracts)
|
|
$
|
5,559
|
|
|
$
|
6,520
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
5,559
|
|
|
$
|
6,520
|
|
Aggregate projected benefit obligation
|
|
|
5,356
|
|
|
|
5,139
|
|
|
|
685
|
|
|
|
583
|
|
|
|
6,041
|
|
|
|
5,722
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Over (under) funded
|
|
$
|
203
|
|
|
$
|
1,381
|
|
|
$
|
(685
|
)
|
|
$
|
(583
|
)
|
|
$
|
(482
|
)
|
|
$
|
798
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accumulated benefit obligation for all defined benefit
pension plans was $5,620 million and $5,302 million at
December 31, 2008 and 2007, respectively.
Information for pension plans with an accumulated benefit
obligation in excess of plan assets is as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Projected benefit obligation
|
|
$
|
708
|
|
|
$
|
597
|
|
Accumulated benefit obligation
|
|
$
|
590
|
|
|
$
|
517
|
|
Fair value of plan assets
|
|
$
|
|
|
|
$
|
|
|
Information for pension and other postretirement benefit plans
with a projected benefit obligation in excess of plan assets is
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
|
|
|
Other
|
|
|
|
Pension
|
|
|
Postretirement
|
|
|
|
Benefits
|
|
|
Benefits
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
Projected benefit obligation
|
|
$
|
712
|
|
|
$
|
602
|
|
|
$
|
1,632
|
|
|
$
|
1,599
|
|
Fair value of plan assets
|
|
$
|
4
|
|
|
$
|
4
|
|
|
$
|
1,011
|
|
|
$
|
1,183
|
|
F-118
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The components of net periodic benefit cost and other changes in
plan assets and benefit obligations recognized in other
comprehensive income (loss) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
Pension
|
|
|
Other Postretirement
|
|
|
|
Benefits
|
|
|
Benefits
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Net Periodic Benefit Cost
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost
|
|
$
|
164
|
|
|
$
|
162
|
|
|
$
|
159
|
|
|
$
|
21
|
|
|
$
|
27
|
|
|
$
|
35
|
|
Interest cost
|
|
|
379
|
|
|
|
351
|
|
|
|
332
|
|
|
|
103
|
|
|
|
103
|
|
|
|
116
|
|
Expected return on plan assets
|
|
|
(517
|
)
|
|
|
(505
|
)
|
|
|
(452
|
)
|
|
|
(86
|
)
|
|
|
(86
|
)
|
|
|
(79
|
)
|
Amortization of net actuarial (gains) losses
|
|
|
24
|
|
|
|
68
|
|
|
|
128
|
|
|
|
(1
|
)
|
|
|
|
|
|
|
22
|
|
Amortization of prior service cost (credit)
|
|
|
15
|
|
|
|
17
|
|
|
|
8
|
|
|
|
(37
|
)
|
|
|
(36
|
)
|
|
|
(36
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic benefit cost
|
|
|
65
|
|
|
|
93
|
|
|
$
|
175
|
|
|
|
|
|
|
|
8
|
|
|
$
|
58
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic benefit cost of subsidiary held-for-sale
|
|
|
1
|
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
66
|
|
|
|
98
|
|
|
|
|
|
|
|
|
|
|
|
9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Changes in Plan Assets and Benefit Obligations
Recognized in Other Comprehensive Income (Loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net actuarial (gains) losses
|
|
|
1,561
|
|
|
|
(432
|
)
|
|
|
|
|
|
|
259
|
|
|
|
(440
|
)
|
|
|
|
|
Prior service cost (credit)
|
|
|
(19
|
)
|
|
|
40
|
|
|
|
|
|
|
|
36
|
|
|
|
|
|
|
|
|
|
Amortization of net actuarial (gains) losses
|
|
|
(24
|
)
|
|
|
(68
|
)
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
Amortization of prior service cost (credit)
|
|
|
(15
|
)
|
|
|
(17
|
)
|
|
|
|
|
|
|
37
|
|
|
|
36
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total recognized in other comprehensive income (loss)
|
|
|
1,503
|
|
|
|
(477
|
)
|
|
|
|
|
|
|
333
|
|
|
|
(404
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total recognized in net periodic benefit cost and other
comprehensive income (loss)
|
|
$
|
1,569
|
|
|
$
|
(379
|
)
|
|
|
|
|
|
$
|
333
|
|
|
$
|
(395
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Included within other comprehensive income (loss) are other
changes in plan assets and benefit obligations associated with
pension benefits of $1,503 million and other postretirement
benefits of $333 million for an aggregate reduction in
other comprehensive income (loss) of $1,836 million before
income tax and $1,203 million, net of income tax and
minority interest.
The estimated net actuarial losses and prior service cost for
the pension plans that will be amortized from accumulated other
comprehensive income (loss) into net periodic benefit cost over
the next year are $198 million and $9 million,
respectively.
The estimated net actuarial losses and prior service credit for
the defined benefit other postretirement benefit plans that will
be amortized from accumulated other comprehensive income (loss)
into net periodic benefit cost over the next year are
$10 million and ($36) million, respectively.
In 2004, the Company adopted the guidance in FSP
No. 106-2,
Accounting and Disclosure Requirements Related to the
Medicare Prescription Drug, Improvement and Modernization Act of
2003
(FSP 106-2),
to account for future subsidies to be received under the
Prescription Drug Act. The Company began receiving these
subsidies
F-119
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
during 2006. A summary of the reduction to the APBO and related
reduction to the components of net periodic other postretirement
benefit plan cost is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Cumulative reduction in benefit obligation:
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, beginning of year
|
|
$
|
299
|
|
|
$
|
328
|
|
|
$
|
298
|
|
Service cost
|
|
|
5
|
|
|
|
7
|
|
|
|
6
|
|
Interest cost
|
|
|
20
|
|
|
|
19
|
|
|
|
19
|
|
Net actuarial gains (losses)
|
|
|
3
|
|
|
|
(42
|
)
|
|
|
15
|
|
Prescription drug subsidy
|
|
|
(10
|
)
|
|
|
(13
|
)
|
|
|
(10
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, end of year
|
|
$
|
317
|
|
|
$
|
299
|
|
|
$
|
328
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Reduction in net periodic benefit cost:
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost
|
|
$
|
5
|
|
|
$
|
7
|
|
|
$
|
6
|
|
Interest cost
|
|
|
20
|
|
|
|
19
|
|
|
|
19
|
|
Amortization of net actuarial gains (losses)
|
|
|
|
|
|
|
5
|
|
|
|
30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total reduction in net periodic benefit cost
|
|
$
|
25
|
|
|
$
|
31
|
|
|
$
|
55
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Company received subsidies of $12 million and
$10 million for the years ended December 31, 2008 and
2007, respectively.
Assumptions
Assumptions used in determining benefit obligations were as
follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
Pension
|
|
Other Postretirement
|
|
|
Benefits
|
|
Benefits
|
|
|
2008
|
|
2007
|
|
2008
|
|
2007
|
|
Weighted average discount rate
|
|
6.60%
|
|
6.65%
|
|
6.62%
|
|
6.65%
|
Rate of compensation increase
|
|
3.5%-7.5%
|
|
3.5%-8%
|
|
N/A
|
|
N/A
|
Assumptions used in determining net periodic benefit cost were
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
Pension Benefits
|
|
Other Postretirement Benefits
|
|
|
2008
|
|
2007
|
|
2006
|
|
2008
|
|
2007
|
|
2006
|
|
Weighted average discount rate
|
|
6.65%
|
|
6.00%
|
|
5.82%
|
|
6.65%
|
|
6.00%
|
|
5.82%
|
Weighted average expected rate of return on plan assets
|
|
8.25%
|
|
8.25%
|
|
8.25%
|
|
7.33%
|
|
7.47%
|
|
7.42%
|
Rate of compensation increase
|
|
3.5%-8%
|
|
3.5%-8%
|
|
3%-8%
|
|
N/A
|
|
N/A
|
|
N/A
|
The discount rate is determined annually based on the yield,
measured on a yield to worst basis, of a hypothetical portfolio
constructed of high quality debt instruments available on the
valuation date, which would provide the necessary future cash
flows to pay the aggregate projected benefit obligation when due.
F-120
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The expected rate of return on plan assets is based on
anticipated performance of the various asset sectors in which
the plan invests, weighted by target allocation percentages.
Anticipated future performance is based on long-term historical
returns of the plan assets by sector, adjusted for the
Subsidiaries long-term expectations on the performance of
the markets. While the precise expected return derived using
this approach will fluctuate from year to year, the
Subsidiaries policy is to hold this long-term assumption
constant as long as it remains within reasonable tolerance from
the derived rate.
The weighted average expected return on plan assets for use in
that plans valuation in 2009 is currently anticipated to
be 8.25% for pension benefits and postretirement medical
benefits and 6.25% for postretirement life benefits.
The assumed healthcare cost trend rates used in measuring the
APBO and net periodic benefit cost were as follows:
|
|
|
|
|
|
|
December 31,
|
|
|
2008
|
|
2007
|
|
Pre-Medicare eligible claims
|
|
8.8% down to 5.8% in 2018 and
gradually decreasing until 2079
reaching the ultimate rate of 4.1%
|
|
8.5% down to 5% in 2014 and
remaining constant thereafter
|
Medicare eligible claims
|
|
8.8% down to 5.8% in 2018 and
gradually decreasing until 2079
reaching the ultimate rate of 4.1%
|
|
10.5% down to 5% in 2018 and
remaining constant thereafter
|
Assumed healthcare cost trend rates may have a significant
effect on the amounts reported for healthcare plans. A
one-percentage point change in assumed healthcare cost trend
rates would have the following effects:
|
|
|
|
|
|
|
|
|
|
|
One Percent
|
|
|
One Percent
|
|
|
|
Increase
|
|
|
Decrease
|
|
|
|
(In millions)
|
|
|
Effect on total of service and interest cost components
|
|
$
|
6
|
|
|
$
|
(6
|
)
|
Effect of accumulated postretirement benefit obligation
|
|
$
|
76
|
|
|
$
|
(86
|
)
|
Plan
Assets
The Subsidiaries have issued group annuity and life insurance
contracts supporting approximately 99% of all pension and other
postretirement benefit plans assets.
The account values of the group annuity and life insurance
contracts issued by the Subsidiaries and held as assets of the
pension and other postretirement benefit plans were
$6,451 million and $7,565 million at December 31,
2008 and 2007, respectively. The majority of such account values
are held in separate accounts established by the Subsidiaries.
Total revenue from these contracts recognized in the
consolidated statements of income was $42 million,
$47 million and $48 million for the years ended
December 31, 2008, 2007 and 2006, respectively, and
includes policy charges, net investment income from investments
backing the contracts and administrative fees. Total investment
income (loss), including realized and unrealized gains and
losses, credited to the account balances were
($1,090) million, $603 million and $818 million
for the years ended December 31, 2008, 2007 and 2006,
respectively. The terms of these contracts are consistent in all
material respects with those the Subsidiaries offer to
unaffiliated parties that are similarly situated.
F-121
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The weighted-average allocations of pension plan and other
postretirement benefit plan assets were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
|
Other
|
|
|
Pension
|
|
Postretirement
|
|
|
Benefits
|
|
Benefits
|
|
|
2008
|
|
2007
|
|
2008
|
|
2007
|
|
Asset Category
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities
|
|
|
28
|
%
|
|
|
38
|
%
|
|
|
27
|
%
|
|
|
37
|
%
|
Fixed maturity securities
|
|
|
51
|
|
|
|
44
|
|
|
|
71
|
|
|
|
58
|
|
Other (Real Estate and Alternative Investments)
|
|
|
21
|
|
|
|
18
|
|
|
|
2
|
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The weighted-average target allocations of pension plan and
other postretirement benefit plan assets for 2009 are as follows:
|
|
|
|
|
|
|
Pension
|
|
Other
|
|
Asset Category
|
|
|
|
|
Equity securities
|
|
25%-45%
|
|
30%-45%
|
Fixed maturity securities
|
|
35%-55%
|
|
55%-85%
|
Other (Real Estate and Alternative Investments)
|
|
5%-32%
|
|
0%-10%
|
Target allocations of assets are determined with the objective
of maximizing returns and minimizing volatility of net assets
through adequate asset diversification. Adjustments are made to
target allocations based on an assessment of the impact of
economic factors and market conditions.
Cash
Flows
It is the Subsidiaries practice to make contributions to
the qualified pension plans to comply with minimum funding
requirements of ERISA. In accordance with such practice, no
contributions were required for the years ended
December 31, 2008 or 2007. No contributions will be
required for 2009. The Subsidiaries made discretionary
contributions of $300 million to the qualified pension
plans during the year ended December 31, 2008 and did not
make discretionary contributions for the year ended
December 31, 2007. The Subsidiaries expect to make
additional discretionary contributions of $150 million in
2009.
Benefit payments due under the non-qualified pension plans are
funded from the Subsidiaries general assets as they become
due under the provision of the plans. These payments totaled
$43 million and $48 million for the years ended
December 31, 2008 and 2007, respectively. These payments
are expected to be at approximately the same level in 2009.
Other postretirement benefits represent a non-vested,
non-guaranteed obligation of the Subsidiaries and current
regulations do not require specific funding levels for these
benefits. While the Subsidiaries have partially funded such
plans in advance, it has been the Subsidiaries practice to
primarily use their general assets, net of participants
contributions, to pay postretirement medical claims as they come
due in lieu of utilizing plan assets. Total payments equaled
$149 million and $173 million for the years ended
December 31, 2008 and 2007, respectively.
The Subsidiaries expect to make contributions of
$120 million, net of participants contributions,
towards the other postretirement plan obligations in 2009. As
noted previously, the Subsidiaries expect to receive subsidies
under the Prescription Drug Act to partially offset such
payments.
F-122
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Gross benefit payments for the next ten years, which reflect
expected future service where appropriate, and gross subsidies
to be received under the Prescription Drug Act are expected to
be as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Postretirement Benefits
|
|
|
|
|
|
|
|
|
|
Prescription
|
|
|
|
|
|
|
Pension
|
|
|
|
|
|
Drug
|
|
|
|
|
|
|
Benefits
|
|
|
Gross
|
|
|
Subsidies
|
|
|
Net
|
|
|
|
(In millions)
|
|
|
2009
|
|
$
|
384
|
|
|
$
|
135
|
|
|
$
|
(15
|
)
|
|
$
|
120
|
|
2010
|
|
$
|
398
|
|
|
$
|
140
|
|
|
$
|
(16
|
)
|
|
$
|
124
|
|
2011
|
|
$
|
408
|
|
|
$
|
146
|
|
|
$
|
(16
|
)
|
|
$
|
130
|
|
2012
|
|
$
|
424
|
|
|
$
|
150
|
|
|
$
|
(17
|
)
|
|
$
|
133
|
|
2013
|
|
$
|
437
|
|
|
$
|
154
|
|
|
$
|
(18
|
)
|
|
$
|
136
|
|
2014-2018
|
|
$
|
2,416
|
|
|
$
|
847
|
|
|
$
|
(107
|
)
|
|
$
|
740
|
|
Savings
and Investment Plans
The Subsidiaries sponsor savings and investment plans for
substantially all employees under which a portion of employee
contributions are matched. The Subsidiaries contributed
$70 million, $76 million and $80 million for the
years ended December 31, 2008, 2007 and 2006, respectively.
Preferred
Stock
In September 1999, the Holding Company adopted a stockholder
rights plan (the rights plan) under which each
outstanding share of common stock issued between April 4,
2000 and the distribution date (as defined in the rights plan)
will be coupled with a stockholder right. Each right will
entitle the holder to purchase one one-hundredth of a share of
Series A Junior Participating Preferred Stock. Each one
one-hundredth of a share of Series A Junior Participating
Preferred Stock will have economic and voting terms equivalent
to one share of common stock. Until it is exercised, the right
itself will not entitle the holder thereof to any rights as a
stockholder, including the right to receive dividends or to vote
at stockholder meetings. Stockholder rights are not exercisable
until the distribution date, and will expire at the close of
business on April 4, 2010, unless earlier redeemed or
exchanged by the Holding Company. The rights plan is designed to
protect stockholders in the event of unsolicited offers to
acquire the Holding Company and other coercive takeover tactics.
The Holding Company has outstanding 24 million shares of
Floating Rate Non-Cumulative Preferred Stock, Series A (the
Series A preferred shares) with a
$0.01 par value per share, and a liquidation preference of
$25 per share, for aggregate proceeds of $600 million.
The Holding Company has outstanding 60 million shares of
6.50% Non-Cumulative Preferred Stock, Series B (the
Series B preferred shares), with a
$0.01 par value per share, and a liquidation preference of
$25 per share, for aggregate proceeds of $1.5 billion.
The Series A and Series B preferred shares (the
Preferred Shares) rank senior to the common stock
with respect to dividends and liquidation rights. Dividends on
the Preferred Shares are not cumulative. Holders of the
Preferred Shares will be entitled to receive dividend payments
only when, as and if declared by the Holding Companys
Board of Directors or a duly authorized committee of the board.
If dividends are declared on the Series A preferred shares,
they will be payable quarterly, in arrears, at an annual rate of
the greater of: (i) 1.00% above
3-month
LIBOR on the related LIBOR determination date; or
(ii) 4.00%. Any dividends declared on the Series B
preferred shares will be payable quarterly, in arrears, at an
annual fixed rate of 6.50%. Accordingly, in the event that
dividends are not declared on the Preferred Shares for payment
on any dividend payment date, then those dividends will cease to
accrue and be payable. If a dividend is not declared before the
dividend payment date, the
F-123
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Holding Company has no obligation to pay dividends accrued for
that dividend period whether or not dividends are declared and
paid in future periods. No dividends may, however, be paid or
declared on the Holding Companys common stock
or any other securities ranking junior to the Preferred
Shares unless the full dividends for the latest
completed dividend period on all Preferred Shares, and any
parity stock, have been declared and paid or provided for.
The Holding Company is prohibited from declaring dividends on
the Preferred Shares if it fails to meet specified capital
adequacy, net income and shareholders equity levels. In
addition, under Federal Reserve Bank of New York Board policy,
the Holding Company may not be able to pay dividends if it does
not earn sufficient operating income.
The Preferred Shares do not have voting rights except in certain
circumstances where the dividends have not been paid for an
equivalent of six or more dividend payment periods whether or
not those periods are consecutive. Under such circumstances, the
holders of the Preferred Shares have certain voting rights with
respect to members of the Board of Directors of the Holding
Company.
The Preferred Shares are not subject to any mandatory
redemption, sinking fund, retirement fund, purchase fund or
similar provisions. The Preferred Shares are redeemable, but not
prior to September 15, 2010. On and after that date,
subject to regulatory approval, the Preferred Shares will be
redeemable at the Holding Companys option in whole or in
part, at a redemption price of $25 per Preferred Share, plus
declared and unpaid dividends.
In December 2008, the Holding Company entered into an RCC
related to the Preferred Shares. As a part of the RCC, the
Holding Company agreed that it will not repay, redeem or
purchase the Preferred Shares on or before December 31,
2018, unless such repayment, redemption or purchase is made from
the proceeds of the issuance of certain capital securities. The
RCC is for the benefit of holders of one or more series of its
indebtedness as designated from time to time by the Company. The
RCC will terminate upon the occurrence of certain events,
including the date on which there are no series of outstanding
eligible debt securities.
In connection with the offering of the Preferred Shares, the
Holding Company incurred $56.8 million of issuance costs
which have been recorded as a reduction of additional paid-in
capital.
F-124
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Information on the declaration, record and payment dates, as
well as per share and aggregate dividend amounts, for the
Preferred Shares is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend
|
|
|
|
|
|
|
|
Series A
|
|
|
Series A
|
|
|
Series B
|
|
|
Series B
|
|
Declaration Date
|
|
Record Date
|
|
Payment Date
|
|
Per Share
|
|
|
Aggregate
|
|
|
Per Share
|
|
|
Aggregate
|
|
|
|
|
|
|
|
(In millions, except per share data)
|
|
|
November 17, 2008
|
|
November 30, 2008
|
|
December 15, 2008
|
|
$
|
0.2527777
|
|
|
$
|
7
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
August 15, 2008
|
|
August 31, 2008
|
|
September 15, 2008
|
|
$
|
0.2555555
|
|
|
$
|
6
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
May 15, 2008
|
|
May 31, 2008
|
|
June 16, 2008
|
|
$
|
0.2555555
|
|
|
$
|
7
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
March 5, 2008
|
|
February 29, 2008
|
|
March 17, 2008
|
|
$
|
0.3785745
|
|
|
$
|
9
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
29
|
|
|
|
|
|
|
$
|
96
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
November 15, 2007
|
|
November 30, 2007
|
|
December 17, 2007
|
|
$
|
0.4230476
|
|
|
$
|
11
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
August 15, 2007
|
|
August 31, 2007
|
|
September 17, 2007
|
|
$
|
0.4063333
|
|
|
$
|
10
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
May 15, 2007
|
|
May 31, 2007
|
|
June 15, 2007
|
|
$
|
0.4060062
|
|
|
$
|
10
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
March 5, 2007
|
|
February 28, 2007
|
|
March 15, 2007
|
|
$
|
0.3975000
|
|
|
$
|
10
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
41
|
|
|
|
|
|
|
$
|
96
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
November 15, 2006
|
|
November 30, 2006
|
|
December 15, 2006
|
|
$
|
0.4038125
|
|
|
$
|
10
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
August 15, 2006
|
|
August 31, 2006
|
|
September 15, 2006
|
|
$
|
0.4043771
|
|
|
$
|
10
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
May 16, 2006
|
|
May 31, 2006
|
|
June 15, 2006
|
|
$
|
0.3775833
|
|
|
$
|
9
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
March 6, 2006
|
|
February 28, 2006
|
|
March 15, 2006
|
|
$
|
0.3432031
|
|
|
$
|
9
|
|
|
$
|
0.4062500
|
|
|
$
|
24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
38
|
|
|
|
|
|
|
$
|
96
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See Note 25 for further information.
Common
Stock
At January 1, 2007, the Company had $216 million
remaining under its October 2004 stock repurchase program
authorization. In February 2007, the Companys Board of
Directors authorized an additional $1 billion common stock
repurchase program. In September 2007, the Companys Board
of Directors authorized an additional $1 billion common
stock repurchase program which began after the completion of the
$1 billion common stock repurchase program authorized in
February 2007. In January 2008, the Companys Board of
Directors authorized an additional $1 billion common stock
repurchase program, which began after the completion of the
September 2007 program. In April 2008, the Companys Board
of Directors authorized an additional $1 billion common
stock repurchase program, which will begin after the completion
of the January 2008 program. Under these authorizations, the
Company may purchase its common stock from the MetLife
Policyholder Trust, in the open market (including pursuant to
the terms of a pre-set trading plan meeting the requirements of
Rule 10b5-1
under the Exchange Act) and in privately negotiated transactions.
In February 2008, the Company entered into an accelerated common
stock repurchase agreement with a major bank. Under the
agreement, the Company paid the bank $711 million in cash
and the bank delivered an initial amount of
11,161,550 shares of the Companys outstanding common
stock that the bank borrowed from third parties. In May 2008,
the bank delivered an additional 864,646 shares of the
Companys common stock to the Company resulting in a total
of 12,026,196 shares being repurchased under the agreement.
The Company recorded the shares repurchased as treasury stock.
In December 2007, the Company entered into an accelerated common
stock repurchase agreement with a major bank. Under the terms of
the agreement, the Company paid the bank $450 million in
cash in January 2008 in
F-125
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
exchange for 6,646,692 shares of the Companys
outstanding common stock that the bank borrowed from third
parties. Also in January 2008, the bank delivered 1,043,530
additional shares of the Companys common stock to the
Company resulting in a total of 7,690,222 shares being
repurchased under the agreement. At December 31, 2007, the
Company recorded the obligation to pay $450 million to the
bank as a reduction of additional paid-in capital. Upon
settlement with the bank, the Company increased additional
paid-in capital and reduced treasury stock.
In November 2007, the Company repurchased 11,559,803 shares
of its outstanding common stock at an initial cost of
$750 million under an accelerated common stock repurchase
agreement with a major bank. The bank borrowed the stock sold to
the Company from third parties and purchased the common stock in
the open market to return to such third parties. Also, in
November 2007, the Company received a cash adjustment of
$19 million based on the trading prices of the common stock
during the repurchase period, for a final purchase price of
$731 million. The Company recorded the shares initially
repurchased as treasury stock and recorded the amount received
as an adjustment to the cost of the treasury stock.
In March 2007, the Company repurchased 11,895,321 shares of
its outstanding common stock at an aggregate cost of
$750 million under an accelerated common stock repurchase
agreement with a major bank. The bank borrowed the common stock
sold to the Company from third parties and purchased common
stock in the open market to return to such third parties. In
June 2007, the Company paid a cash adjustment of
$17 million for a final purchase price of
$767 million. The Company recorded the shares initially
repurchased as treasury stock and recorded the amount paid as an
adjustment to the cost of the treasury stock.
In December 2006, the Company repurchased 3,993,024 shares
of its outstanding common stock at an aggregate cost of
$232 million under an accelerated common stock repurchase
agreement with a major bank. The bank borrowed the common stock
sold to the Company from third parties and purchased the common
stock in the open market to return to such third parties. In
February 2007, the Company paid a cash adjustment of
$8 million for a final purchase price of $240 million.
The Company recorded the shares initially repurchased as
treasury stock and recorded the amount paid as an adjustment to
the cost of the treasury stock.
During the years ended December 31, 2008 and 2007, the
Company repurchased 1,550,000 shares and
3,171,700 shares, respectively, through open market
purchases for $88 million and $200 million,
respectively.
The Company repurchased 21,266,418 and 26,626,824 shares of
its common stock for $1,250 million and
$1,705 million, respectively, during the years ended
December 31, 2008 and 2007, respectively. At
December 31, 2008, an aggregate of $1,261 million
remains available under the Companys January 2008 and
April 2008 common stock repurchase programs. The Company does
not intend to make any purchases under the common stock
repurchase program in 2009.
In connection with the split-off of RGA as described in
Note 2, the Company received from MetLife stockholders
23,093,689 shares of the Companys common stock with a
market value of $1,318 million and, in exchange, delivered
29,243,539 shares of RGA Class B common stock with a
net book value of $1,716 million resulting in a loss on
disposition, including transaction costs, of $458 million.
Future common stock repurchases will be dependent upon several
factors, including the Companys capital position, its
financial strength and credit ratings, general market conditions
and the price of the Companys common stock.
As described in Note 13, in August 2008, the Company
delivered 20,244,549 shares of its common stock from
treasury stock for $1,035 million in connection with the
initial settlement of the stock purchase contracts issued as
part of the common equity units sold in June 2005. Also, as
described in Notes 13 and 25, the Company subsequently
delivered 24,343,154 shares of its newly issued common
stock on February 17, 2009 at a value of
$1,035 million to settle the remaining stock purchase
contracts issued as part of the common equity units sold in
F-126
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
June 2005. In the aggregate, the Company issued
44,587,703 shares of common stock to settle the stock
purchase contracts.
In October 2008, the Company issued 86,250,000 shares of
its common stock at a price of $26.50 per share for gross
proceeds of $2,286 million. Of the shares issued,
75,000,000 shares, with a value of $4,040 million were
issued from treasury stock for consideration of
$1,988 million. In connection with the offering of common
stock, the Company incurred $60.1 million of issuance costs
which have been recorded as a reduction of additional paid-in
capital.
During the years ended December 31, 2008 and 2007,
97,515,737 and 3,864,894 shares of common stock were issued
from treasury stock for $5,221 million and
$172 million, respectively.
The table below presents declaration, record and payment dates,
as well as per share and aggregate dividend amounts, for the
common stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend
|
|
Declaration Date
|
|
Record Date
|
|
Payment Date
|
|
Per Share
|
|
|
Aggregate
|
|
|
|
|
|
|
|
(In millions,
|
|
|
|
|
|
|
|
except per share data)
|
|
|
October 28, 2008
|
|
November 10, 2008
|
|
December 15, 2008
|
|
$
|
0.74
|
|
|
$
|
592
|
|
October 23, 2007
|
|
November 6, 2007
|
|
December 14, 2007
|
|
$
|
0.74
|
|
|
$
|
541
|
|
October 24, 2006
|
|
November 6, 2006
|
|
December 15, 2006
|
|
$
|
0.59
|
|
|
$
|
450
|
|
Stock-Based
Compensation Plans
As described more fully in Note 1, effective
January 1, 2006, the Company adopted SFAS 123(r),
using the modified prospective transition method. The adoption
of SFAS 123(r) did not have a significant impact on the
Companys financial position or results of operations.
The MetLife, Inc. 2000 Stock Incentive Plan, as amended (the
Stock Incentive Plan), authorized the granting of
awards in the form of options to buy shares of the
Companys common stock (Stock Options) that
either qualify as incentive Stock Options under
Section 422A of the Internal Revenue Code or are
non-qualified. The MetLife, Inc. 2000 Directors Stock Plan,
as amended (the Directors Stock Plan), authorized
the granting of awards in the form of the Companys common
stock, non-qualified Stock Options, or a combination of the
foregoing to outside Directors of the Company. Under the
MetLife, Inc. 2005 Stock and Incentive Compensation Plan, as
amended (the 2005 Stock Plan), awards granted may be
in the form of Stock Options, Stock Appreciation Rights,
Restricted Stock or Restricted Stock Units, Performance Shares
or Performance Share Units, Cash-Based Awards, and Stock-Based
Awards (each as defined in the 2005 Stock Plan). Under the
MetLife, Inc. 2005 Non-Management Director Stock Compensation
Plan (the 2005 Directors Stock Plan), awards
granted may be in the form of non-qualified Stock Options, Stock
Appreciation Rights, Restricted Stock or Restricted Stock Units,
or Stock-Based Awards (each as defined in the
2005 Directors Stock Plan). The Stock Incentive Plan,
Directors Stock Plan, 2005 Stock Plan, the 2005 Directors
Stock Plan and the LTPCP, as described below, are hereinafter
collectively referred to as the Incentive Plans.
The aggregate number of shares reserved for issuance under the
2005 Stock Plan and the LTPCP is 68,000,000, plus those shares
available but not utilized under the Stock Incentive Plan and
those shares utilized under the Stock Incentive Plan that are
recovered due to forfeiture of Stock Options. Additional shares
carried forward from the Stock Incentive Plan and available for
issuance under the 2005 Stock Plan were 12,584,119 at
December 31, 2008.
F-127
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
There were no shares carried forward from the Directors Stock
Plan. Each share issued under the 2005 Stock Plan in connection
with a Stock Option or Stock Appreciation Right reduces the
number of shares remaining for issuance under that plan by one,
and each share issued under the 2005 Stock Plan in connection
with awards other than Stock Options or Stock Appreciation
Rights reduces the number of shares remaining for issuance under
that plan by 1.179 shares. The number of shares reserved
for issuance under the 2005 Directors Stock Plan are
2,000,000. At December 31, 2008, the aggregate number of
shares remaining available for issuance pursuant to the 2005
Stock Plan and the 2005 Directors Stock Plan were
55,654,550 and 1,894,876, respectively.
Stock Option exercises and other stock-based awards to employees
settled in shares are satisfied through the issuance of shares
held in treasury by the Company. Under the current authorized
share repurchase program, as described previously, sufficient
treasury shares exist to satisfy foreseeable obligations under
the Incentive Plans.
Compensation expense related to awards under the Incentive Plans
is recognized based on the number of awards expected to vest,
which represents the awards granted less expected forfeitures
over the life of the award, as estimated at the date of grant.
Unless a material deviation from the assumed rate is observed
during the term in which the awards are expensed, any adjustment
necessary to reflect differences in actual experience is
recognized in the period the award becomes payable or
exercisable. Compensation expense of $121 million,
$145 million and $144 million, and income tax benefits
of $42 million, $51 million and $50 million,
related to the Incentive Plans was recognized for the years
ended December 31, 2008, 2007 and 2006, respectively.
Compensation expense is principally related to the issuance of
Stock Options, Performance Shares and LTPCP arrangements.
As described in Note 1, the Company changed its policy
prospectively for recognizing expense for stock-based awards to
retirement eligible employees. Had the Company continued to
recognize expense over the stated requisite service period,
compensation expense related to the Incentive Plans would have
been $100 million, $118 million and $116 million,
rather than $121 million, $145 million and
$144 million, for the years ended December 31, 2008,
2007 and 2006, respectively. Had the Company applied the policy
of recognizing expense related to stock-based compensation over
the shorter of the requisite service period or the period to
attainment of retirement eligibility for awards granted prior to
January 1, 2006, pro forma compensation expense would have
been $100 million, $118 million and $120 million
for the years ended December 31, 2008, 2007 and 2006,
respectively.
All Stock Options granted had an exercise price equal to the
closing price of the Companys common stock as reported on
the New York Stock Exchange on the date of grant, and have a
maximum term of ten years. Certain Stock Options granted under
the Stock Incentive Plan and the 2005 Stock Plan have or will
become exercisable over a three year period commencing with the
date of grant, while other Stock Options have or will become
exercisable three years after the date of grant. Stock Options
issued under the Directors Stock Plan were exercisable
immediately. The date at which any Stock Option issued under the
2005 Directors Stock Plan becomes exercisable would be
determined at the time such Stock Option is granted.
A summary of the activity related to Stock Options for the year
ended December 31, 2008 is presented below. The aggregate
intrinsic value was computed using the closing share price on
December 31, 2008 of $34.86 and December 31, 2007 of
$61.62, as applicable.
F-128
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
|
|
|
|
|
|
|
|
|
|
Remaining
|
|
|
Aggregate
|
|
|
|
Shares Under
|
|
|
Weighted Average
|
|
|
Contractual
|
|
|
Intrinsic
|
|
|
|
Option
|
|
|
Exercise Price
|
|
|
Term
|
|
|
Value
|
|
|
|
|
|
|
|
|
|
(Years)
|
|
|
(In millions)
|
|
|
Outstanding at January 1, 2008
|
|
|
24,430,547
|
|
|
$
|
38.83
|
|
|
|
6.17
|
|
|
$
|
557
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
3,464,075
|
|
|
$
|
59.48
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
(1,374,872
|
)
|
|
$
|
32.76
|
|
|
|
|
|
|
|
|
|
Cancelled/Expired
|
|
|
(142,145
|
)
|
|
$
|
44.62
|
|
|
|
|
|
|
|
|
|
Forfeited
|
|
|
(219,330
|
)
|
|
$
|
51.44
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2008
|
|
|
26,158,275
|
|
|
$
|
41.73
|
|
|
|
5.73
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate number of stock options expected to vest at
December 31, 2008
|
|
|
25,568,808
|
|
|
$
|
41.35
|
|
|
|
5.66
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at December 31, 2008
|
|
|
19,471,449
|
|
|
$
|
35.83
|
|
|
|
4.79
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The fair value of Stock Options is estimated on the date of
grant using a binomial lattice model. Significant assumptions
used in the Companys binomial lattice model, which are
further described below, include: expected volatility of the
price of the Holding Companys common stock; risk-free rate
of return; expected dividend yield on the Holding Companys
common stock; exercise multiple; and the post-vesting
termination rate.
Expected volatility is based upon an analysis of historical
prices of the Holding Companys common stock and call
options on that common stock traded on the open market. The
Company uses a weighted-average of the implied volatility for
publicly-traded call options with the longest remaining maturity
nearest to the money as of each valuation date and the
historical volatility, calculated using monthly closing prices
of the Holding Companys common stock. The Company chose a
monthly measurement interval for historical volatility as it
believes this better depicts the nature of employee option
exercise decisions being based on longer-term trends in the
price of the underlying shares rather than on daily price
movements.
The binomial lattice model used by the Company incorporates
different risk-free rates based on the imputed forward rates for
U.S. Treasury Strips for each year over the contractual
term of the option. The table below presents the full range of
rates that were used for options granted during the respective
periods.
Dividend yield is determined based on historical dividend
distributions compared to the price of the underlying common
stock as of the valuation date and held constant over the life
of the Stock Option.
The binomial model used by the Company incorporates the
contractual term of the Stock Options and then factors in
expected exercise behavior and a post-vesting termination rate,
or the rate at which vested options are exercised or expire
prematurely due to termination of employment, to derive an
expected life. Exercise behavior in the binomial lattice model
used by the Company is expressed using an exercise multiple,
which reflects the ratio of exercise price to the strike price
of Stock Options granted at which holders of the Stock Options
are expected to exercise. The exercise multiple is derived from
actual historical exercise activity. The post-vesting
termination rate is determined from actual historical exercise
experience and expiration activity under the Incentive Plans.
F-129
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The following weighted average assumptions, with the exception
of risk-free rate, which is expressed as a range, were used to
determine the fair value of Stock Options issued during the:
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
2008
|
|
2007
|
|
2006
|
|
Dividend yield
|
|
1.21%
|
|
0.94%
|
|
1.04%
|
Risk-free rate of return
|
|
1.91%-7.21%
|
|
4.30%-5.32%
|
|
4.17%-4.96%
|
Expected volatility
|
|
24.85%
|
|
19.54%
|
|
22.00%
|
Exercise multiple
|
|
1.73
|
|
1.66
|
|
1.52
|
Post-vesting termination rate
|
|
3.05%
|
|
3.66%
|
|
4.09%
|
Contractual term (years)
|
|
10
|
|
10
|
|
10
|
Expected life (years)
|
|
6
|
|
6
|
|
6
|
Weighted average exercise price of stock options granted
|
|
$59.48
|
|
$62.86
|
|
$50.21
|
Weighted average fair value of stock options granted
|
|
$17.51
|
|
$17.76
|
|
$13.84
|
Compensation expense related to Stock Option awards expected to
vest and granted prior to January 1, 2006 is recognized
ratably over the requisite service period, which equals the
vesting term. Compensation expense related to Stock Option
awards expected to vest and granted on or after January 1,
2006 is recognized ratably over the requisite service period or
the period to retirement eligibility, if shorter. Compensation
expense of $51 million, $55 million and
$56 million related to Stock Options was recognized for the
years ended December 31, 2008, 2007 and 2006, respectively.
At December 31, 2008, there were $43 million of total
unrecognized compensation costs related to Stock Options. It is
expected that these costs will be recognized over a weighted
average period of 1.81 years.
The following is a summary of Stock Option exercise activity for
the:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Total intrinsic value of stock options exercised
|
|
$
|
36
|
|
|
$
|
122
|
|
|
$
|
65
|
|
Cash received from exercise of stock options
|
|
$
|
45
|
|
|
$
|
110
|
|
|
$
|
83
|
|
Tax benefit realized from stock options exercised
|
|
$
|
13
|
|
|
$
|
43
|
|
|
$
|
23
|
|
Beginning in 2005, certain members of management were awarded
Performance Shares under (and as defined in) the 2005 Stock
Plan. Participants are awarded an initial target number of
Performance Shares with the final number of Performance Shares
payable being determined by the product of the initial target
multiplied by a factor of 0.0 to 2.0. The factor applied is
based on measurements of the Companys performance with
respect to: (i) the change in annual net operating earnings
per share, as defined; and (ii) the proportionate total
shareholder return, as defined, with reference to the three-year
performance period relative to other companies in the S&P
Insurance Index with reference to the same three-year period.
Performance Share awards will normally vest in their entirety at
the end of the three-year performance period (subject to certain
contingencies) and will be payable entirely in shares of the
Companys common stock.
F-130
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The following is a summary of Performance Share activity for the
year ended December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average
|
|
|
|
|
|
|
Grant Date
|
|
|
|
Performance Shares
|
|
|
Fair Value
|
|
|
Outstanding at January 1, 2008
|
|
|
2,690,125
|
|
|
$
|
48.39
|
|
Granted
|
|
|
954,075
|
|
|
$
|
57.17
|
|
Forfeited
|
|
|
(89,125
|
)
|
|
$
|
57.43
|
|
Paid
|
|
|
(968,425
|
)
|
|
$
|
36.87
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2008
|
|
|
2,586,650
|
|
|
$
|
55.63
|
|
|
|
|
|
|
|
|
|
|
Performance Shares expected to vest at December 31, 2008
|
|
|
2,535,784
|
|
|
$
|
55.56
|
|
|
|
|
|
|
|
|
|
|
Performance Share amounts above represent aggregate initial
target awards and do not reflect potential increases or
decreases resulting from the final performance factor to be
determined at the end of the respective performance period. At
December 31, 2008, the three year performance period for
the 2006 Performance Share grants was completed. Included in the
immediately preceding table are 812,975 outstanding Performance
Shares to which the final performance factor will be applied.
The calculation of the performance factor is expected to be
finalized during the second quarter of 2009 after all data
necessary to perform the calculation is publicly available.
Performance Share awards are accounted for as equity awards but
are not credited with dividend-equivalents for actual dividends
paid on the Holding Companys common stock during the
performance period. Accordingly, the estimated fair value of
Performance Shares is based upon the closing price of the
Holding Companys common stock on the date of grant,
reduced by the present value of estimated dividends to be paid
on that stock during the performance period.
Compensation expense related to initial Performance Shares
granted prior to January 1, 2006 and expected to vest is
recognized ratably during the performance period. Compensation
expense related to initial Performance Shares granted on or
after January 1, 2006 and expected to vest is recognized
ratably over the performance period or the period to retirement
eligibility, if shorter. Performance Shares expected to vest and
the related compensation expenses may be further adjusted by the
performance factor most likely to be achieved, as estimated by
management, at the end of the performance period. Compensation
expense of $70 million, $90 million and
$74 million, related to Performance Shares was recognized
for the years ended December 31, 2008, 2007 and 2006,
respectively.
At December 31, 2008, there were $57 million of total
unrecognized compensation costs related to Performance Share
awards. It is expected that these costs will be recognized over
a weighted average period of 1.65 years.
|
|
|
Long-Term
Performance Compensation Plan
|
Prior to January 1, 2005, the Company granted stock-based
compensation to certain members of management under the LTPCP.
Each participant was assigned a target compensation amount (an
Opportunity Award) at the inception of the
performance period with the final compensation amount determined
based on the total shareholder return on the Companys
common stock over the three-year performance period, subject to
limited further adjustment approved by the Companys Board
of Directors. Payments on the Opportunity Awards were normally
payable in their entirety (subject to certain contingencies) at
the end of the three-year performance period, and were paid in
whole or in part with shares of the Companys common stock,
as approved by the Companys Board of Directors. There were
no new grants under the LTPCP during the years ended
December 31, 2008, 2007 and 2006.
A portion of each Opportunity Award under the LTPCP was settled
in shares of the Holding Companys common stock while the
remainder was settled in cash. The portion of the Opportunity
Award settled in shares of the
F-131
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Holding Companys common stock was accounted for as an
equity award with the fair value of the award determined based
upon the closing price of the Holding Companys common
stock on the date of grant. The compensation expense associated
with the equity award, based upon the grant date fair value, was
recognized into expense ratably over the respective three-year
performance period. The portion of the Opportunity Award settled
in cash was accounted for as a liability and was remeasured
using the closing price of the Holding Companys common
stock on the final day of each subsequent reporting period
during the three-year performance period.
The final LTPCP performance period concluded during the six
months ended June 30, 2007. Final Opportunity Awards in the
amount of 618,375 shares of the Companys common stock
and $16 million in cash were paid on April 18, 2007.
No significant compensation expense related to LTPCP was
recognized during the year ended December 31, 2008 and
2007. Compensation expense of $14 million related to LTPCP
Opportunity Awards was recognized for the year ended
December 31, 2006.
Statutory
Equity and Income
Each insurance companys state of domicile imposes minimum
risk-based capital (RBC) requirements that were
developed by the National Association of Insurance Commissioners
(NAIC). The formulas for determining the amount of
RBC specify various weighting factors that are applied to
financial balances or various levels of activity based on the
perceived degree of risk. Regulatory compliance is determined by
a ratio of total adjusted capital, as defined by the NAIC, to
authorized control level RBC, as defined by the NAIC.
Companies below specific trigger points or ratios are classified
within certain levels, each of which requires specified
corrective action. Each of the Holding Companys
U.S. insurance subsidiaries exceeded the minimum RBC
requirements for all periods presented herein.
The NAIC has adopted the Codification of Statutory Accounting
Principles (Codification). Codification is intended
to standardize regulatory accounting and reporting to state
insurance departments. However, statutory accounting principles
continue to be established by individual state laws and
permitted practices. The New York Insurance Department has
adopted Codification with certain modifications for the
preparation of statutory financial statements of insurance
companies domiciled in New York. Modifications by the various
state insurance departments may impact the effect of
Codification on the statutory capital and surplus of the Holding
Companys insurance subsidiaries.
Statutory accounting principles differ from GAAP primarily by
charging policy acquisition costs to expense as incurred,
establishing future policy benefit liabilities using different
actuarial assumptions, reporting surplus notes as surplus
instead of debt and valuing securities on a different basis.
In addition, certain assets are not admitted under statutory
accounting principles and are charged directly to surplus. The
most significant assets not admitted by the Company are net
deferred income tax assets resulting from temporary differences
between statutory accounting principles basis and tax basis not
expected to reverse and become recoverable within a year.
Further, statutory accounting principles do not give recognition
to purchase accounting adjustments.
Statutory net income (loss) of Metropolitan Life Insurance
Company, a New York domiciled insurer, was ($338) million,
$2.1 billion and $1.0 billion for the years ended
December 31, 2008, 2007 and 2006, respectively. Statutory
capital and surplus, as filed with the Department, was
$11.6 billion and $13.0 billion at December 31,
2008 and 2007, respectively.
Statutory net income of MetLife Insurance Company of
Connecticut, a Connecticut domiciled insurer, was
$242 million, $1.1 billion, and $856 million for
the years ended December 31, 2008, 2007 and 2006,
respectively. Statutory capital and surplus, as filed with the
Connecticut Insurance Department, was $5.5 billion and
$4.2 billion at December 31, 2008 and 2007,
respectively.
F-132
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Statutory net income of Metropolitan Property and Casualty
Insurance Company (MPC), a Rhode Island domiciled
insurer, was $308 million, $400 million and
$385 million for the years ended December 31, 2008,
2007 and 2006, respectively. Statutory capital and surplus, as
filed with the Insurance Department of Rhode Island, was
$1.8 billion at both December 31, 2008 and 2007.
Statutory net income of Metropolitan Tower and Life Insurance
Company (MTL), a Delaware domiciled insurer, was
$212 million, $103 million and $2.8 billion for
the years ended December 31, 2008, 2007 and 2006,
respectively. Statutory capital and surplus, as filed with the
Delaware Insurance Department was $885 million and
$1.1 billion at December 31, 2008 and 2007,
respectively.
Dividend
Restrictions
The table below sets forth the dividends permitted to be paid by
the respective insurance subsidiary without insurance regulatory
approval and the respective dividends paid:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2009
|
|
|
2008
|
|
|
2007
|
|
|
|
Permitted w/o
|
|
|
|
|
|
Permitted w/o
|
|
|
|
|
|
Permitted w/o
|
|
Company
|
|
Approval (1)
|
|
|
Paid (2)
|
|
|
Approval (3)
|
|
|
Paid (2)
|
|
|
Approval (3)
|
|
|
|
(In millions)
|
|
|
Metropolitan Life Insurance Company
|
|
$
|
552
|
|
|
$
|
1,318
|
(4)
|
|
$
|
1,299
|
|
|
$
|
500
|
|
|
$
|
919
|
|
MetLife Insurance Company of Connecticut
|
|
$
|
714
|
|
|
$
|
500
|
|
|
$
|
1,026
|
|
|
$
|
690
|
(6)
|
|
$
|
690
|
|
Metropolitan Tower Life Insurance Company
|
|
$
|
88
|
|
|
$
|
277
|
(5)
|
|
$
|
113
|
|
|
$
|
|
|
|
$
|
104
|
|
Metropolitan Property and Casualty Insurance Company
|
|
$
|
9
|
|
|
$
|
300
|
|
|
$
|
|
|
|
$
|
400
|
|
|
$
|
16
|
|
|
|
|
(1) |
|
Reflects dividend amounts that may be paid during 2009 without
prior regulatory approval. However, if paid before a specified
date during 2009, some or all of such dividends may require
regulatory approval. |
|
(2) |
|
All amounts paid, including those requiring regulatory approval. |
|
(3) |
|
Reflects dividend amounts that could have been paid during the
relevant year without prior regulatory approval. |
|
(4) |
|
As described in Note 2, consists of shares of RGA stock
distributed by MLIC to the Holding Company as an in-kind
dividend of $1,318 million. |
|
(5) |
|
Includes shares of an affiliate distributed to the Holding
Company as an in-kind dividend in the amount of
$164 million. |
|
(6) |
|
Includes a return of capital of $404 million as approved by
the applicable insurance department, of which $350 million
was paid to the Holding Company. |
Under New York State Insurance Law, MLIC is permitted, without
prior insurance regulatory clearance, to pay stockholder
dividends to the Holding Company as long as the aggregate amount
of all such dividends in any calendar year does not exceed the
lesser of: (i) 10% of its surplus to policyholders as of
the end of the immediately preceding calendar year; or
(ii) its statutory net gain from operations for the
immediately preceding calendar year (excluding realized capital
gains). MLIC will be permitted to pay a cash dividend to the
Holding Company in excess of the lesser of such two amounts only
if it files notice of its intention to declare such a dividend
and the amount thereof with the Superintendent and the
Superintendent does not disapprove the distribution within
30 days of its filing. Under New York State Insurance Law,
the Superintendent has broad discretion in determining whether
the financial condition of a stock life insurance company would
support the payment of such dividends to its shareholders. The
New York State Department of Insurance (the
Department) has established informal guidelines for
such determinations. The guidelines, among other things, focus
on the insurers overall financial condition and
profitability under statutory accounting practices.
F-133
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Under Connecticut State Insurance Law, MICC is permitted,
without prior insurance regulatory clearance, to pay shareholder
dividends to its parent as long as the amount of such dividends,
when aggregated with all other dividends in the preceding
12 months, does not exceed the greater of: (i) 10% of
its surplus to policyholders as of the end of the immediately
preceding calendar year; or (ii) its statutory net gain
from operations for the immediately preceding calendar year.
MICC will be permitted to pay a cash dividend in excess of the
greater of such two amounts only if it files notice of its
declaration of such a dividend and the amount thereof with the
Connecticut Commissioner of Insurance (the Connecticut
Commissioner) and the Connecticut Commissioner does not
disapprove the payment within 30 days after notice. In
addition, any dividend that exceeds earned surplus (unassigned
funds, reduced by 25% of unrealized appreciation in value or
revaluation of assets or unrealized profits on investments) as
of the last filed annual statutory statement requires insurance
regulatory approval. Under Connecticut State Insurance Law, the
Connecticut Commissioner has broad discretion in determining
whether the financial condition of a stock life insurance
company would support the payment of such dividends to its
shareholders. The Connecticut State Insurance Law requires prior
approval for any dividends for a period of two years following a
change in control. As a result of the acquisition of MICC by the
Holding Company on July 1, 2005, under Connecticut State
Insurance Law, all dividend payments by MICC through
June 30, 2007 required prior approval of the Connecticut
Commissioner.
Under Delaware State Insurance Law, Metropolitan Tower Life
Insurance Company is permitted, without prior insurance
regulatory clearance, to pay a stockholder dividend to the
Holding Company as long as the amount of the dividend when
aggregated with all other dividends in the preceding
12 months does not exceed the greater of: (i) 10% of
its surplus to policyholders as of the end of the immediately
preceding calendar year; or (ii) its statutory net gain
from operations for the immediately preceding calendar year
(excluding realized capital gains). MTL will be permitted to pay
a cash dividend to the Holding Company in excess of the greater
of such two amounts only if it files notice of the declaration
of such a dividend and the amount thereof with the Delaware
Commissioner of Insurance (the Delaware
Commissioner) and the Delaware Commissioner does not
disapprove the distribution within 30 days of its filing.
In addition, any dividend that exceeds earned surplus (defined
as unassigned funds) as of the last filed annual statutory
statement requires insurance regulatory approval. Under Delaware
State Insurance Law, the Delaware Commissioner has broad
discretion in determining whether the financial condition of a
stock life insurance company would support the payment of such
dividends to its shareholders.
Under Rhode Island State Insurance Law, MPC is permitted,
without prior insurance regulatory clearance, to pay a
stockholder dividend to the Holding Company as long as the
aggregate amount of all such dividends in any twelve-month
period does not exceed the lesser of: (i) 10% of its
surplus to policyholders as of the end of the immediately
preceding calendar year; or (ii) net income, not including
realized capital gains, for the immediately preceding calendar
year, which may include carry forward net income from the second
and third preceding calendar years excluding realized capital
gains and less dividends paid in the second and immediately
preceding calendar years. MPC will be permitted to pay a cash
dividend to the Holding Company in excess of the lesser of such
two amounts only if it files notice of its intention to declare
such a dividend and the amount thereof with the Rhode Island
Commissioner of Insurance (the Rhode Island
Commissioner) and the Rhode Island Commissioner does not
disapprove the distribution within 30 days of its filing.
Under Rhode Island State Insurance Code, the Rhode Island
Commissioner has broad discretion in determining whether the
financial condition of a stock property and casualty insurance
company would support the payment of such dividends to its
shareholders. MPC may not pay any dividends in 2009 without
prior regulatory approval for dividend payments with payment
dates prior to December 12, 2009. Subsequent to
December 12, 2009, MPC can pay dividends totaling
$9 million without requiring regulatory approval from the
Rhode Island Commissioner.
F-134
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Other
Comprehensive Income (Loss)
The following table sets forth the reclassification adjustments
required for the years ended December 31, 2008, 2007 and
2006 in other comprehensive income (loss) that are included as
part of net income for the current year that have been reported
as a part of other comprehensive income (loss) in the current or
prior year:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Holding gains (losses) on investments arising during the year
|
|
$
|
(26,491
|
)
|
|
$
|
(1,485
|
)
|
|
$
|
(1,022
|
)
|
Income tax effect of holding gains (losses)
|
|
|
8,989
|
|
|
|
581
|
|
|
|
379
|
|
Reclassification adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
Recognized holding (gains) losses included in current year income
|
|
|
2,040
|
|
|
|
176
|
|
|
|
916
|
|
Amortization of premiums and accretion of discounts associated
with investments
|
|
|
(926
|
)
|
|
|
(831
|
)
|
|
|
(600
|
)
|
Income tax effect
|
|
|
(377
|
)
|
|
|
254
|
|
|
|
(117
|
)
|
Allocation of holding losses on investments relating to other
policyholder amounts
|
|
|
4,809
|
|
|
|
676
|
|
|
|
581
|
|
Income tax effect of allocation of holding losses to other
policyholder amounts
|
|
|
(1,621
|
)
|
|
|
(264
|
)
|
|
|
(215
|
)
|
Unrealized investment loss of subsidiary at date of sale
|
|
|
112
|
|
|
|
|
|
|
|
|
|
Deferred income tax on unrealized investment loss of subsidiary
at date of sale
|
|
|
(60
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net unrealized investment gains (losses), net of income tax
|
|
|
(13,525
|
)
|
|
|
(893
|
)
|
|
|
(78
|
)
|
Foreign currency translation adjustment
|
|
|
(593
|
)
|
|
|
290
|
|
|
|
46
|
|
Minimum pension liability adjustment, net of income tax
|
|
|
|
|
|
|
|
|
|
|
(18
|
)
|
Defined benefit plan adjustment, net of income tax
|
|
|
(1,203
|
)
|
|
|
563
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss)
|
|
$
|
(15,321
|
)
|
|
$
|
(40
|
)
|
|
$
|
(50
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Information on other expenses is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Compensation
|
|
$
|
3,549
|
|
|
$
|
3,548
|
|
|
$
|
3,422
|
|
Commissions
|
|
|
3,384
|
|
|
|
3,207
|
|
|
|
2,866
|
|
Interest and debt issue costs
|
|
|
1,086
|
|
|
|
987
|
|
|
|
812
|
|
Amortization of DAC and VOBA
|
|
|
3,489
|
|
|
|
2,250
|
|
|
|
1,904
|
|
Capitalization of DAC
|
|
|
(3,092
|
)
|
|
|
(3,064
|
)
|
|
|
(2,825
|
)
|
Rent, net of sublease income
|
|
|
477
|
|
|
|
373
|
|
|
|
345
|
|
Minority interest
|
|
|
(23
|
)
|
|
|
23
|
|
|
|
23
|
|
Insurance tax
|
|
|
497
|
|
|
|
503
|
|
|
|
488
|
|
Other
|
|
|
2,557
|
|
|
|
2,602
|
|
|
|
2,502
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other expenses
|
|
$
|
11,924
|
|
|
$
|
10,429
|
|
|
$
|
9,537
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-135
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
Amortization
and Capitalization of DAC and VOBA
|
See Note 5 for deferred acquisition costs by segment and a
rollforward of deferred acquisition costs including impacts of
amortization and capitalization. See also Note 9 for a
description of the DAC amortization impact associated with the
closed block.
|
|
|
Interest
and Debt Issue Costs
|
See Notes 10, 11, 12, 13 and 14 for attribution of interest
expense by debt issuance.
See Note 16 for description of lease impairments included
within other expenses.
The Company has initiated an enterprise-wide cost reduction and
revenue enhancement initiative. This initiative is focused on
reducing complexity, leveraging scale, increasing productivity,
and improving the effectiveness of the Companys
operations, as well as providing a foundation for future growth.
During the third quarter of 2008, the Company recognized a
severance-related restructuring charge of $73 million
associated with the termination of certain employees in
connection with this enterprise-wide initiative. During the
fourth quarter of 2008, the Company recorded further severance
related restructuring costs of $36 million offset by an
$8 million reduction to its third quarter restructuring
charge attributable to lower than anticipated costs for variable
incentive compensation and for employees whose severance status
changed. Severance costs of $15 million were paid during
the fourth quarter of 2008. Total restructuring charges incurred
in connection with this enterprise-wide initiative during the
year ended December 31, 2008 were $101 million and
were reflected within Corporate & Other. Estimated
restructuring costs may change as management continues to
execute its restructuring plans. Restructuring charges
associated with this enterprise-wide initiative were as follows:
|
|
|
|
|
|
|
Year Ended
|
|
|
|
December 31, 2008
|
|
|
|
(In millions)
|
|
|
Balance as of beginning of the period
|
|
$
|
|
|
Severance charges
|
|
|
109
|
|
Change in severance charge estimates
|
|
|
(8
|
)
|
Cash payments
|
|
|
(15
|
)
|
|
|
|
|
|
Balance as of end of the period
|
|
$
|
86
|
|
|
|
|
|
|
Total restructuring charges incurred
|
|
$
|
101
|
|
|
|
|
|
|
Management anticipates further restructuring charges including
severance, lease and asset impairments will be incurred during
the years ended December 31, 2009 and 2010. However, such
restructuring plans are not sufficiently developed to enable the
Company to make an estimate of such restructuring charges at
December 31, 2008.
In addition to the restructuring charges incurred in connection
with the aforementioned enterprise-wide initiative, the Company
also incurred severance costs in connection with the Argentine
governments nationalization of the its private pension
business. The Company recognized a restructuring charge of
$15 million within the International segment during the
fourth quarter of 2008 and made payments of $12 million
resulting in a restructuring liability of $3 million at
December 31, 2008.
F-136
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
20.
|
Earnings
Per Common Share
|
The following table presents the weighted average shares used in
calculating basic earnings per common share and those used in
calculating diluted earnings per common share for each income
category presented below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions, except share and per share data)
|
|
|
Weighted average common stock outstanding for basic earnings per
common share
|
|
|
735,184,337
|
|
|
|
744,153,514
|
|
|
|
761,105,024
|
|
Incremental common shares from assumed:
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock purchase contracts underlying common equity units (1)
|
|
|
2,043,553
|
|
|
|
7,138,900
|
|
|
|
1,416,134
|
|
Exercise or issuance of stock-based awards
|
|
|
7,557,540
|
|
|
|
10,971,585
|
|
|
|
8,182,938
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common stock outstanding for diluted earnings
per common share
|
|
|
744,785,430
|
|
|
|
762,263,999
|
|
|
|
770,704,096
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
3,510
|
|
|
$
|
4,102
|
|
|
$
|
2,910
|
|
Preferred stock dividends
|
|
|
125
|
|
|
|
137
|
|
|
|
134
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations available to common
shareholders
|
|
$
|
3,385
|
|
|
$
|
3,965
|
|
|
$
|
2,776
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
4.60
|
|
|
$
|
5.33
|
|
|
$
|
3.65
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
4.54
|
|
|
$
|
5.20
|
|
|
$
|
3.60
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from discontinued operations, net of income
tax
|
|
$
|
(301
|
)
|
|
$
|
215
|
|
|
$
|
3,383
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
(0.41
|
)
|
|
$
|
0.29
|
|
|
$
|
4.44
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
(0.40
|
)
|
|
$
|
0.28
|
|
|
$
|
4.39
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
3,209
|
|
|
$
|
4,317
|
|
|
$
|
6,293
|
|
Preferred stock dividends
|
|
|
125
|
|
|
|
137
|
|
|
|
134
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common shareholders
|
|
$
|
3,084
|
|
|
$
|
4,180
|
|
|
$
|
6,159
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
4.19
|
|
|
$
|
5.62
|
|
|
$
|
8.09
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
4.14
|
|
|
$
|
5.48
|
|
|
$
|
7.99
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
See Note 13 for a description of the Companys common
equity units. |
F-137
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
21.
|
Quarterly
Results of Operations (Unaudited)
|
The unaudited quarterly results of operations for 2008 and 2007
are summarized in the table below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
June 30,
|
|
|
September 30,
|
|
|
December 31,
|
|
|
|
(In millions, except per share data)
|
|
|
2008 (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
$
|
11,626
|
|
|
$
|
12,048
|
|
|
$
|
13,353
|
|
|
$
|
13,962
|
|
Total expenses
|
|
$
|
10,788
|
|
|
$
|
10,824
|
|
|
$
|
11,763
|
|
|
$
|
12,524
|
|
Income from continuing operations
|
|
$
|
628
|
|
|
$
|
883
|
|
|
$
|
1,058
|
|
|
$
|
941
|
|
Income (loss) from discontinued operations, net of income tax
|
|
$
|
20
|
|
|
$
|
63
|
|
|
$
|
(428
|
)
|
|
$
|
44
|
|
Net income
|
|
$
|
648
|
|
|
$
|
946
|
|
|
$
|
630
|
|
|
$
|
985
|
|
Net income available to common shareholders
|
|
$
|
615
|
|
|
$
|
915
|
|
|
$
|
600
|
|
|
$
|
954
|
|
Basic earnings per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations available to common
shareholders
|
|
$
|
0.82
|
|
|
$
|
1.19
|
|
|
$
|
1.44
|
|
|
$
|
1.15
|
|
Income (loss) from discontinued operations, net of income tax
|
|
$
|
0.03
|
|
|
$
|
0.09
|
|
|
$
|
(0.60
|
)
|
|
$
|
0.06
|
|
Net income
|
|
$
|
0.90
|
|
|
$
|
1.33
|
|
|
$
|
0.88
|
|
|
$
|
1.25
|
|
Net income available to common shareholders
|
|
$
|
0.85
|
|
|
$
|
1.28
|
|
|
$
|
0.84
|
|
|
$
|
1.21
|
|
Diluted earnings per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations available to common
shareholders
|
|
$
|
0.81
|
|
|
$
|
1.17
|
|
|
$
|
1.42
|
|
|
$
|
1.14
|
|
Income (loss) from discontinued operations, net of income tax
|
|
$
|
0.03
|
|
|
$
|
0.09
|
|
|
$
|
(0.59
|
)
|
|
$
|
0.06
|
|
Net income
|
|
$
|
0.88
|
|
|
$
|
1.30
|
|
|
$
|
0.88
|
|
|
$
|
1.25
|
|
Net income available to common shareholders
|
|
$
|
0.84
|
|
|
$
|
1.26
|
|
|
$
|
0.83
|
|
|
$
|
1.20
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
$
|
11,505
|
|
|
$
|
11,699
|
|
|
$
|
11,646
|
|
|
$
|
12,308
|
|
Total expenses
|
|
$
|
10,149
|
|
|
$
|
10,141
|
|
|
$
|
10,328
|
|
|
$
|
10,778
|
|
Income from continuing operations
|
|
$
|
970
|
|
|
$
|
1,109
|
|
|
$
|
940
|
|
|
$
|
1,083
|
|
Income from discontinued operations, net of income tax
|
|
$
|
47
|
|
|
$
|
54
|
|
|
$
|
79
|
|
|
$
|
35
|
|
Net income
|
|
$
|
1,017
|
|
|
$
|
1,163
|
|
|
$
|
1,019
|
|
|
$
|
1,118
|
|
Net income available to common shareholders
|
|
$
|
983
|
|
|
$
|
1,129
|
|
|
$
|
985
|
|
|
$
|
1,083
|
|
Basic earnings per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations available to common
shareholders
|
|
$
|
1.24
|
|
|
$
|
1.44
|
|
|
$
|
1.22
|
|
|
$
|
1.42
|
|
Income from discontinued operations, net of income tax
|
|
$
|
0.07
|
|
|
$
|
0.08
|
|
|
$
|
0.10
|
|
|
$
|
0.05
|
|
Net income
|
|
$
|
1.35
|
|
|
$
|
1.56
|
|
|
$
|
1.37
|
|
|
$
|
1.52
|
|
Net income available to common shareholders
|
|
$
|
1.31
|
|
|
$
|
1.52
|
|
|
$
|
1.32
|
|
|
$
|
1.47
|
|
Diluted earnings per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations available to common
shareholders
|
|
$
|
1.22
|
|
|
$
|
1.41
|
|
|
$
|
1.19
|
|
|
$
|
1.39
|
|
Income from discontinued operations, net of income tax
|
|
$
|
0.06
|
|
|
$
|
0.07
|
|
|
$
|
0.10
|
|
|
$
|
0.05
|
|
Net income
|
|
$
|
1.32
|
|
|
$
|
1.52
|
|
|
$
|
1.34
|
|
|
$
|
1.48
|
|
Net income available to common shareholders
|
|
$
|
1.28
|
|
|
$
|
1.48
|
|
|
$
|
1.29
|
|
|
$
|
1.44
|
|
|
|
|
(1) |
|
During the fourth quarter of 2008, the Company recorded a
cumulative out-of-period adjustment in connection with the
exclusion of certain derivative gains from the estimation of
cumulative gross profits used in the determination of DAC
amortization. The adjustment decreased deferred policy
acquisition costs and increased DAC amortization by
$124 million and decreased net income by $80 million
in the fourth quarter of 2008. Had the amounts been reflected
during the first, second and third quarters of 2008
in the periods in which they arose DAC amortization
would have increased (decreased) by $100 million,
($61) million, and $85 million, respectively,
resulting in an increase (decrease) of net income by
($65) million, $40 million and ($55) million,
respectively. Net income available to common shareholders per
diluted common share would have been higher (lower) by ($0.09),
$0.06, ($0.08) and $0.10 during the first, second, third and
fourth quarters, respectively, of 2008 had the amounts been
reflected in the periods in which they arose. Based upon an
evaluation of all relevant quantitative and qualitative factors,
and after considering the provisions of APB Opinion No. 28,
Interim Financial Reporting, paragraph 29,
SAB No. 99, Materiality, and SAB 108,
management believes this correcting adjustment was not material
to the Companys full year results for 2008 or the trend of
earnings. |
F-138
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
22.
|
Business
Segment Information
|
The Company is a leading provider of individual insurance,
employee benefits and financial services with operations
throughout the United States and the regions of Latin America,
Asia Pacific, and Europe. Subsequent to the disposition of RGA
and the elimination of the Reinsurance segment as described in
Notes 2 and 23, the Companys business is divided into
four operating segments: Institutional, Individual,
International, and Auto & Home, as well as
Corporate & Other. These segments are managed
separately because they either provide different products and
services, require different strategies or have different
technology requirements.
Institutional offers a broad range of group insurance and
retirement & savings products and services, including
group life insurance, non-medical health insurance, such as
short and long-term disability, long-term care, and dental
insurance, and other insurance products and services. Individual
offers a wide variety of protection and asset accumulation
products, including life insurance, annuities and mutual funds.
International provides life insurance, accident and health
insurance, annuities and retirement & savings products
to both individuals and groups. Auto & Home provides
personal lines property and casualty insurance, including
private passenger automobile, homeowners and personal excess
liability insurance.
Corporate & Other contains the excess capital not
allocated to the business segments, various
start-up
entities, MetLife Bank and run-off entities, as well as interest
expense related to the majority of the Companys
outstanding debt and expenses associated with certain legal
proceedings and income tax audit issues. Corporate &
Other also includes the elimination of all intersegment amounts,
which generally relate to intersegment loans, which bear
interest rates commensurate with related borrowings, as well as
intersegment transactions. The operations of RGA are also
reported in Corporate & Other as discontinued
operations. Additionally, the Companys asset management
business, including amounts reported as discontinued operations,
is included in the results of operations for
Corporate & Other. See Note 23 for disclosures
regarding discontinued operations, including real estate.
Economic capital is an internally developed risk capital model,
the purpose of which is to measure the risk in the business and
to provide a basis upon which capital is deployed. The economic
capital model accounts for the unique and specific nature of the
risks inherent in MetLifes businesses. As a part of the
economic capital process, a portion of net investment income is
credited to the segments based on the level of allocated equity.
F-139
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Set forth in the tables below is certain financial information
with respect to the Companys segments, as well as
Corporate & Other, for the years ended
December 31, 2008, 2007 and 2006. The accounting policies
of the segments are the same as those of the Company, except for
the method of capital allocation and the accounting for gains
(losses) from intercompany sales, which are eliminated in
consolidation. The Company allocates equity to each segment
based upon the economic capital model that allows the Company to
effectively manage its capital. The Company evaluates the
performance of each segment based upon net income excluding net
investment gains (losses), net of income tax, adjustments
related to net investment gains (losses), net of income tax, the
impact from the cumulative effect of changes in accounting, net
of income tax and discontinued operations, other than
discontinued real estate, net of income tax, less preferred
stock dividends. The Company allocates certain non-recurring
items, such as expenses associated with certain legal
proceedings, to Corporate & Other.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended
|
|
|
|
|
|
|
|
|
|
|
Auto &
|
|
|
Corporate &
|
|
|
|
|
December 31, 2008
|
|
Institutional
|
|
|
Individual
|
|
|
International
|
|
|
Home
|
|
|
Other
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Statement of Income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
14,964
|
|
|
$
|
4,481
|
|
|
$
|
3,470
|
|
|
$
|
2,971
|
|
|
$
|
28
|
|
|
$
|
25,914
|
|
Universal life and investment-type product policy fees
|
|
|
886
|
|
|
|
3,400
|
|
|
|
1,095
|
|
|
|
|
|
|
|
|
|
|
|
5,381
|
|
Net investment income
|
|
|
7,535
|
|
|
|
6,509
|
|
|
|
1,249
|
|
|
|
186
|
|
|
|
817
|
|
|
|
16,296
|
|
Other revenues
|
|
|
775
|
|
|
|
571
|
|
|
|
18
|
|
|
|
38
|
|
|
|
184
|
|
|
|
1,586
|
|
Net investment gains (losses)
|
|
|
168
|
|
|
|
665
|
|
|
|
167
|
|
|
|
(135
|
)
|
|
|
947
|
|
|
|
1,812
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
24,328
|
|
|
|
15,626
|
|
|
|
5,999
|
|
|
|
3,060
|
|
|
|
1,976
|
|
|
|
50,989
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims
|
|
|
16,525
|
|
|
|
5,779
|
|
|
|
3,166
|
|
|
|
1,919
|
|
|
|
48
|
|
|
|
27,437
|
|
Interest credited to policyholder account balances
|
|
|
2,581
|
|
|
|
2,028
|
|
|
|
171
|
|
|
|
|
|
|
|
7
|
|
|
|
4,787
|
|
Policyholder dividends
|
|
|
|
|
|
|
1,739
|
|
|
|
7
|
|
|
|
5
|
|
|
|
|
|
|
|
1,751
|
|
Other expenses
|
|
|
2,408
|
|
|
|
5,143
|
|
|
|
1,671
|
|
|
|
804
|
|
|
|
1,898
|
|
|
|
11,924
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
21,514
|
|
|
|
14,689
|
|
|
|
5,015
|
|
|
|
2,728
|
|
|
|
1,953
|
|
|
|
45,899
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before provision for income tax
|
|
|
2,814
|
|
|
|
937
|
|
|
|
984
|
|
|
|
332
|
|
|
|
23
|
|
|
|
5,090
|
|
Provision for income tax
|
|
|
955
|
|
|
|
307
|
|
|
|
404
|
|
|
|
57
|
|
|
|
(143
|
)
|
|
|
1,580
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
1,859
|
|
|
|
630
|
|
|
|
580
|
|
|
|
275
|
|
|
|
166
|
|
|
|
3,510
|
|
Income (loss) from discontinued operations, net of income tax
|
|
|
3
|
|
|
|
(11
|
)
|
|
|
|
|
|
|
|
|
|
|
(293
|
)
|
|
|
(301
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
1,862
|
|
|
|
619
|
|
|
|
580
|
|
|
|
275
|
|
|
|
(127
|
)
|
|
|
3,209
|
|
Preferred stock dividends
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
125
|
|
|
|
125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common shareholders
|
|
$
|
1,862
|
|
|
$
|
619
|
|
|
$
|
580
|
|
|
$
|
275
|
|
|
$
|
(252
|
)
|
|
$
|
3,084
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance Sheet:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
195,191
|
|
|
$
|
214,476
|
|
|
$
|
25,891
|
|
|
$
|
5,232
|
|
|
$
|
60,888
|
|
|
$
|
501,678
|
|
DAC and VOBA
|
|
$
|
1,013
|
|
|
$
|
16,505
|
|
|
$
|
2,436
|
|
|
$
|
183
|
|
|
$
|
7
|
|
|
$
|
20,144
|
|
Goodwill
|
|
$
|
1,051
|
|
|
$
|
2,957
|
|
|
$
|
373
|
|
|
$
|
157
|
|
|
$
|
470
|
|
|
$
|
5,008
|
|
Separate account assets
|
|
$
|
46,912
|
|
|
$
|
69,456
|
|
|
$
|
4,471
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
120,839
|
|
Policyholder liabilities
|
|
$
|
133,816
|
|
|
$
|
123,610
|
|
|
$
|
16,122
|
|
|
$
|
3,126
|
|
|
$
|
12,471
|
|
|
$
|
289,145
|
|
Separate account liabilities
|
|
$
|
46,912
|
|
|
$
|
69,456
|
|
|
$
|
4,471
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
120,839
|
|
F-140
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended
|
|
|
|
|
|
|
|
|
|
|
Auto &
|
|
|
Corporate &
|
|
|
|
|
December 31, 2007
|
|
Institutional
|
|
|
Individual
|
|
|
International
|
|
|
Home
|
|
|
Other
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Statement of Income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
12,392
|
|
|
$
|
4,481
|
|
|
$
|
3,096
|
|
|
$
|
2,966
|
|
|
$
|
35
|
|
|
$
|
22,970
|
|
Universal life and investment-type product policy fees
|
|
|
802
|
|
|
|
3,441
|
|
|
|
995
|
|
|
|
|
|
|
|
|
|
|
|
5,238
|
|
Net investment income
|
|
|
8,176
|
|
|
|
7,025
|
|
|
|
1,247
|
|
|
|
196
|
|
|
|
1,419
|
|
|
|
18,063
|
|
Other revenues
|
|
|
726
|
|
|
|
600
|
|
|
|
24
|
|
|
|
43
|
|
|
|
72
|
|
|
|
1,465
|
|
Net investment gains (losses)
|
|
|
(582
|
)
|
|
|
(112
|
)
|
|
|
56
|
|
|
|
15
|
|
|
|
45
|
|
|
|
(578
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
21,514
|
|
|
|
15,435
|
|
|
|
5,418
|
|
|
|
3,220
|
|
|
|
1,571
|
|
|
|
47,158
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims
|
|
|
13,805
|
|
|
|
5,665
|
|
|
|
2,460
|
|
|
|
1,807
|
|
|
|
46
|
|
|
|
23,783
|
|
Interest credited to policyholder account balances
|
|
|
3,094
|
|
|
|
2,013
|
|
|
|
354
|
|
|
|
|
|
|
|
|
|
|
|
5,461
|
|
Policyholder dividends
|
|
|
|
|
|
|
1,715
|
|
|
|
4
|
|
|
|
4
|
|
|
|
|
|
|
|
1,723
|
|
Other expenses
|
|
|
2,439
|
|
|
|
4,003
|
|
|
|
1,749
|
|
|
|
829
|
|
|
|
1,409
|
|
|
|
10,429
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
19,338
|
|
|
|
13,396
|
|
|
|
4,567
|
|
|
|
2,640
|
|
|
|
1,455
|
|
|
|
41,396
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before provision for income tax
|
|
|
2,176
|
|
|
|
2,039
|
|
|
|
851
|
|
|
|
580
|
|
|
|
116
|
|
|
|
5,762
|
|
Provision for income tax
|
|
|
740
|
|
|
|
698
|
|
|
|
207
|
|
|
|
144
|
|
|
|
(129
|
)
|
|
|
1,660
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
1,436
|
|
|
|
1,341
|
|
|
|
644
|
|
|
|
436
|
|
|
|
245
|
|
|
|
4,102
|
|
Income (loss) from discontinued operations, net of income tax
|
|
|
13
|
|
|
|
16
|
|
|
|
(9
|
)
|
|
|
|
|
|
|
195
|
|
|
|
215
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
1,449
|
|
|
|
1,357
|
|
|
|
635
|
|
|
|
436
|
|
|
|
440
|
|
|
|
4,317
|
|
Preferred stock dividends
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
137
|
|
|
|
137
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common shareholders
|
|
$
|
1,449
|
|
|
$
|
1,357
|
|
|
$
|
635
|
|
|
$
|
436
|
|
|
$
|
303
|
|
|
$
|
4,180
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance Sheet:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
204,005
|
|
|
$
|
250,691
|
|
|
$
|
26,357
|
|
|
$
|
5,672
|
|
|
$
|
72,424
|
|
|
$
|
559,149
|
|
DAC and VOBA
|
|
$
|
923
|
|
|
$
|
14,038
|
|
|
$
|
2,648
|
|
|
$
|
193
|
|
|
$
|
8
|
|
|
$
|
17,810
|
|
Goodwill
|
|
$
|
978
|
|
|
$
|
2,957
|
|
|
$
|
313
|
|
|
$
|
157
|
|
|
$
|
409
|
|
|
$
|
4,814
|
|
Separate account assets
|
|
$
|
52,046
|
|
|
$
|
102,918
|
|
|
$
|
5,195
|
|
|
$
|
|
|
|
$
|
(17
|
)
|
|
$
|
160,142
|
|
Policyholder liabilities
|
|
$
|
121,147
|
|
|
$
|
115,901
|
|
|
$
|
16,082
|
|
|
$
|
3,324
|
|
|
$
|
9,522
|
|
|
$
|
265,976
|
|
Separate account liabilities
|
|
$
|
52,046
|
|
|
$
|
102,918
|
|
|
$
|
5,195
|
|
|
$
|
|
|
|
$
|
(17
|
)
|
|
$
|
160,142
|
|
F-141
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended
|
|
|
|
|
|
|
|
|
|
|
Auto &
|
|
|
Corporate &
|
|
|
|
|
December 31, 2006
|
|
Institutional
|
|
|
Individual
|
|
|
International
|
|
|
Home
|
|
|
Other
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Statement of Income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
11,867
|
|
|
$
|
4,502
|
|
|
$
|
2,722
|
|
|
$
|
2,924
|
|
|
$
|
37
|
|
|
$
|
22,052
|
|
Universal life and investment-type product policy fees
|
|
|
775
|
|
|
|
3,131
|
|
|
|
805
|
|
|
|
|
|
|
|
|
|
|
|
4,711
|
|
Net investment income
|
|
|
7,260
|
|
|
|
6,863
|
|
|
|
949
|
|
|
|
177
|
|
|
|
998
|
|
|
|
16,247
|
|
Other revenues
|
|
|
684
|
|
|
|
524
|
|
|
|
28
|
|
|
|
22
|
|
|
|
43
|
|
|
|
1,301
|
|
Net investment gains (losses)
|
|
|
(630
|
)
|
|
|
(591
|
)
|
|
|
(10
|
)
|
|
|
3
|
|
|
|
(154
|
)
|
|
|
(1,382
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
19,956
|
|
|
|
14,429
|
|
|
|
4,494
|
|
|
|
3,126
|
|
|
|
924
|
|
|
|
42,929
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims
|
|
|
13,368
|
|
|
|
5,335
|
|
|
|
2,411
|
|
|
|
1,717
|
|
|
|
38
|
|
|
|
22,869
|
|
Interest credited to policyholder account balances
|
|
|
2,593
|
|
|
|
2,018
|
|
|
|
288
|
|
|
|
|
|
|
|
|
|
|
|
4,899
|
|
Policyholder dividends
|
|
|
|
|
|
|
1,696
|
|
|
|
(3
|
)
|
|
|
5
|
|
|
|
|
|
|
|
1,698
|
|
Other expenses
|
|
|
2,313
|
|
|
|
3,485
|
|
|
|
1,531
|
|
|
|
846
|
|
|
|
1,362
|
|
|
|
9,537
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
18,274
|
|
|
|
12,534
|
|
|
|
4,227
|
|
|
|
2,568
|
|
|
|
1,400
|
|
|
|
39,003
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations before provision
(benefit) for income tax
|
|
|
1,682
|
|
|
|
1,895
|
|
|
|
267
|
|
|
|
558
|
|
|
|
(476
|
)
|
|
|
3,926
|
|
Provision (benefit) for income tax
|
|
|
563
|
|
|
|
653
|
|
|
|
95
|
|
|
|
142
|
|
|
|
(437
|
)
|
|
|
1,016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations
|
|
|
1,119
|
|
|
|
1,242
|
|
|
|
172
|
|
|
|
416
|
|
|
|
(39
|
)
|
|
|
2,910
|
|
Income from discontinued operations, net of income tax
|
|
|
48
|
|
|
|
22
|
|
|
|
28
|
|
|
|
|
|
|
|
3,285
|
|
|
|
3,383
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
1,167
|
|
|
|
1,264
|
|
|
|
200
|
|
|
|
416
|
|
|
|
3,246
|
|
|
|
6,293
|
|
Preferred stock dividends
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
134
|
|
|
|
134
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common shareholders
|
|
$
|
1,167
|
|
|
$
|
1,264
|
|
|
$
|
200
|
|
|
$
|
416
|
|
|
$
|
3,112
|
|
|
$
|
6,159
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment income and net investment gains (losses) are
based upon the actual results of each segments
specifically identifiable asset portfolio adjusted for allocated
equity. Other costs are allocated to each of the segments based
upon: (i) a review of the nature of such costs;
(ii) time studies analyzing the amount of employee
compensation costs incurred by each segment; and (iii) cost
estimates included in the Companys product pricing.
Revenues derived from any customer did not exceed 10% of
consolidated revenues for the years ended December 31,
2008, 2007 and 2006. Revenues from U.S. operations were
$44.6 billion, $41.7 billion and $38.4 billion
for the years ended December 31, 2008, 2007 and 2006,
respectively, which represented 87%, 88% and 90%, respectively,
of consolidated revenues.
|
|
23.
|
Discontinued
Operations
|
Real
Estate
The Company actively manages its real estate portfolio with the
objective of maximizing earnings through selective acquisitions
and dispositions. Income related to real estate classified as
held-for-sale or sold is presented in discontinued operations.
These assets are carried at the lower of depreciated cost or
estimated fair value less expected disposition costs.
F-142
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The following information presents the components of income from
discontinued real estate operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Investment income
|
|
$
|
6
|
|
|
$
|
21
|
|
|
$
|
243
|
|
Investment expense
|
|
|
(3
|
)
|
|
|
(9
|
)
|
|
|
(151
|
)
|
Net investment gains (losses)
|
|
|
8
|
|
|
|
13
|
|
|
|
4,795
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
11
|
|
|
|
25
|
|
|
|
4,887
|
|
Provision for income tax
|
|
|
4
|
|
|
|
11
|
|
|
|
1,725
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued operations, net of income tax
|
|
$
|
7
|
|
|
$
|
14
|
|
|
$
|
3,162
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The carrying value of real estate related to discontinued
operations was $1 million and $39 million at
December 31, 2008 and 2007, respectively.
The following table presents the discontinued real estate
operations by segment:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Net investment income
|
|
|
|
|
|
|
|
|
|
|
|
|
Institutional
|
|
$
|
4
|
|
|
$
|
9
|
|
|
$
|
15
|
|
Individual
|
|
|
(1
|
)
|
|
|
1
|
|
|
|
4
|
|
Corporate & Other
|
|
|
|
|
|
|
2
|
|
|
|
73
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total net investment income
|
|
$
|
3
|
|
|
$
|
12
|
|
|
$
|
92
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment gains (losses)
|
|
|
|
|
|
|
|
|
|
|
|
|
Institutional
|
|
$
|
2
|
|
|
$
|
12
|
|
|
$
|
58
|
|
Individual
|
|
|
6
|
|
|
|
|
|
|
|
23
|
|
Corporate & Other
|
|
|
|
|
|
|
1
|
|
|
|
4,714
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total net investment gains (losses)
|
|
$
|
8
|
|
|
$
|
13
|
|
|
$
|
4,795
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In the fourth quarter of 2006, the Company sold its Peter Cooper
Village and Stuyvesant Town properties located in Manhattan, New
York for $5.4 billion. The Peter Cooper Village and
Stuyvesant Town properties together make up the largest
apartment complex in Manhattan, New York totaling over
11,000 units, spread over 80 contiguous acres. The
properties were owned by the Companys subsidiary, MTL. Net
investment income on these properties was $73 million for
the year ended December 31, 2006. The sale resulted in a
gain of $3 billion, net of income tax.
Operations
As more fully described in Note 2, on September 12,
2008, the Company completed a tax-free split-off of its
majority-owned subsidiary, RGA. As a result of the disposition,
the Reinsurance segment was eliminated. (See also Note 22).
RGAs assets and liabilities were reclassified to assets
and liabilities of subsidiaries held-for-sale and its operating
results were reclassified to discontinued operations for all
periods presented. Interest on economic capital associated with
the Reinsurance segment has been reclassified to the continuing
operations of Corporate & Other.
F-143
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The following tables present the amounts related to the
operations and financial position of RGA that have been
reflected as discontinued operations in the consolidated
statements of income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Premiums
|
|
$
|
3,535
|
|
|
$
|
4,910
|
|
|
$
|
4,348
|
|
Net investment income
|
|
|
597
|
|
|
|
908
|
|
|
|
781
|
|
Other revenues
|
|
|
69
|
|
|
|
77
|
|
|
|
66
|
|
Net investment gains (losses)
|
|
|
(249
|
)
|
|
|
(177
|
)
|
|
|
7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
3,952
|
|
|
|
5,718
|
|
|
|
5,202
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims
|
|
|
2,989
|
|
|
|
3,989
|
|
|
|
3,490
|
|
Interest credited to policyholder account balances
|
|
|
108
|
|
|
|
262
|
|
|
|
254
|
|
Other expenses
|
|
|
699
|
|
|
|
1,226
|
|
|
|
1,227
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
3,796
|
|
|
|
5,477
|
|
|
|
4,971
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before provision for income tax
|
|
|
156
|
|
|
|
241
|
|
|
|
231
|
|
Provision for income tax
|
|
|
53
|
|
|
|
84
|
|
|
|
81
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued operations, net of income tax
|
|
|
103
|
|
|
|
157
|
|
|
|
150
|
|
Loss on disposal, net of income tax
|
|
|
(458
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from discontinued operations, net of income tax
|
|
$
|
(355
|
)
|
|
$
|
157
|
|
|
$
|
150
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-144
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
|
|
December 31, 2007
|
|
|
|
(In millions)
|
|
|
Fixed maturity securities
|
|
$
|
9,398
|
|
Equity securities
|
|
|
137
|
|
Mortgage and consumer loans
|
|
|
832
|
|
Policy loans
|
|
|
1,059
|
|
Short-term investments
|
|
|
75
|
|
Other invested assets
|
|
|
4,897
|
|
|
|
|
|
|
Total investments
|
|
|
16,398
|
|
Cash and cash equivalents
|
|
|
404
|
|
Accrued investment income
|
|
|
78
|
|
Premiums and other receivables
|
|
|
1,440
|
|
Deferred policy acquisition costs and VOBA
|
|
|
3,513
|
|
Goodwill
|
|
|
96
|
|
Other assets
|
|
|
91
|
|
Separate account assets
|
|
|
17
|
|
|
|
|
|
|
Total assets held-for-sale
|
|
$
|
22,037
|
|
|
|
|
|
|
Future policy benefits
|
|
$
|
6,159
|
|
Policyholder account balances
|
|
|
6,657
|
|
Other policyholder funds
|
|
|
2,297
|
|
Long-term debt
|
|
|
528
|
|
Collateral financing arrangements
|
|
|
850
|
|
Junior subordinated debt securities
|
|
|
399
|
|
Shares subject to mandatory redemption
|
|
|
159
|
|
Current income tax payable
|
|
|
33
|
|
Deferred income tax liability
|
|
|
941
|
|
Other liabilities
|
|
|
1,918
|
|
Separate account liabilities
|
|
|
17
|
|
|
|
|
|
|
Total liabilities held-for-sale
|
|
$
|
19,958
|
|
|
|
|
|
|
The operations of RGA include direct policies and reinsurance
agreements with MetLife and some of its subsidiaries. These
agreements are generally terminable by either party upon
90 days written notice with respect to future new business.
Agreements related to existing business generally are not
terminable, unless the underlying policies terminate or are
recaptured. These direct policies and reinsurance agreements do
not constitute significant continuing involvement by the Company
with RGA. Included in continuing operations in the
Companys consolidated statements of operations are amounts
related to these transactions, including ceded amounts that
reduced premiums and fees by $158 million,
$251 million and $228 million and ceded amounts that
reduced policyholder benefits and claims by $136 million,
$290 million and $207 million for the years ended
December 31, 2008, 2007 and 2006, respectively that have
not been eliminated as these transactions are expected to
continue after the RGA disposition. Related amounts included in
the Companys consolidated balance sheets include assets
totaling $805 million, and liabilities totaling
$542 million at December 31, 2007.
During the fourth quarter of 2008, the Holding Company entered
into an agreement to sell its wholly-owned subsidiary, Cova, the
parent company of Texas Life Insurance Company, to a third party
in the fourth quarter of
F-145
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
2008. The transaction is expected to close in early 2009. (See
also Note 2). Accordingly, the Company has reclassified the
assets and liabilities of Cova as held-for-sale and its
operations into discontinued operations for all periods
presented in the consolidated financial statements. The
following tables present the amounts related to the operations
and financial position of Cova that have been reflected as
discontinued operations in the consolidated statements of income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Premiums
|
|
$
|
17
|
|
|
$
|
15
|
|
|
$
|
14
|
|
Universal life and investment-type product policy fees
|
|
|
81
|
|
|
|
72
|
|
|
|
68
|
|
Net investment income
|
|
|
38
|
|
|
|
39
|
|
|
|
55
|
|
Other revenues
|
|
|
|
|
|
|
1
|
|
|
|
1
|
|
Net investment gains (losses)
|
|
|
(2
|
)
|
|
|
16
|
|
|
|
(5
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
134
|
|
|
|
143
|
|
|
|
133
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims
|
|
|
70
|
|
|
|
56
|
|
|
|
72
|
|
Interest credited to policyholder account balances
|
|
|
17
|
|
|
|
17
|
|
|
|
17
|
|
Policyholder dividends
|
|
|
3
|
|
|
|
3
|
|
|
|
2
|
|
Other expenses
|
|
|
29
|
|
|
|
29
|
|
|
|
28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
119
|
|
|
|
105
|
|
|
|
119
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before provision for income tax
|
|
|
15
|
|
|
|
38
|
|
|
|
14
|
|
Provision for income tax
|
|
|
4
|
|
|
|
13
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued operations, net of income tax
|
|
|
11
|
|
|
|
25
|
|
|
|
11
|
|
Gain on disposal, net of income tax
|
|
|
37
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued operations, net of income tax
|
|
$
|
48
|
|
|
$
|
25
|
|
|
$
|
11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-146
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Fixed maturity securities
|
|
$
|
514
|
|
|
$
|
508
|
|
Equity securities
|
|
|
1
|
|
|
|
2
|
|
Mortgage and consumer loans
|
|
|
41
|
|
|
|
44
|
|
Policy loans
|
|
|
35
|
|
|
|
34
|
|
Real estate and real estate joint ventures held-for-investment
|
|
|
2
|
|
|
|
2
|
|
Short-term investments
|
|
|
|
|
|
|
29
|
|
Other invested assets
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
Total investments
|
|
|
593
|
|
|
|
620
|
|
Cash and cash equivalents
|
|
|
32
|
|
|
|
3
|
|
Accrued investment income
|
|
|
7
|
|
|
|
6
|
|
Premiums and other receivables
|
|
|
19
|
|
|
|
17
|
|
Deferred policy acquisition costs and VOBA
|
|
|
232
|
|
|
|
198
|
|
Deferred income tax asset
|
|
|
61
|
|
|
|
|
|
Other assets
|
|
|
2
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
Total assets held-for-sale
|
|
$
|
946
|
|
|
$
|
846
|
|
|
|
|
|
|
|
|
|
|
Future policy benefits
|
|
$
|
180
|
|
|
$
|
158
|
|
Policyholder account balances
|
|
|
356
|
|
|
|
350
|
|
Other policyholder funds
|
|
|
181
|
|
|
|
156
|
|
Policyholder dividends payable
|
|
|
4
|
|
|
|
3
|
|
Current income tax payable
|
|
|
1
|
|
|
|
|
|
Deferred income tax liability
|
|
|
|
|
|
|
14
|
|
Other liabilities
|
|
|
26
|
|
|
|
22
|
|
|
|
|
|
|
|
|
|
|
Total liabilities held-for-sale
|
|
$
|
748
|
|
|
$
|
703
|
|
|
|
|
|
|
|
|
|
|
On August 31, 2007, MetLife Insurance Limited
(MetLife Australia) completed the sale of its
annuities and pension businesses to a third party for
$25 million in cash consideration resulting in a gain upon
disposal of $41 million, net of income tax, which was
adjusted in the fourth quarter of 2007 for additional
transaction costs. The Company reclassified the assets and
liabilities of the annuities and pension businesses within
MetLife Australia, which is reported in the International
segment, to assets and liabilities of subsidiaries held-for-sale
and the operations of the business to discontinued operations
for all periods presented. Included within the assets to be sold
were certain fixed maturity securities in a loss position for
which the Company recognized a net investment loss on a
consolidated basis of $59 million, net of income tax, for
the year ended December 31, 2007, because the Company no
longer had the intent to hold such securities.
F-147
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The following table presents the amounts related to the
operations of MetLife Australias annuities and pension
businesses:
|
|
|
|
|
|
|
|
|
|
|
Years Ended
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Revenues
|
|
$
|
71
|
|
|
$
|
132
|
|
Expenses
|
|
|
58
|
|
|
|
89
|
|
|
|
|
|
|
|
|
|
|
Income before provision for income tax
|
|
|
13
|
|
|
|
43
|
|
Provision for income tax
|
|
|
4
|
|
|
|
15
|
|
Net investment gain (loss), net of income tax
|
|
|
(4
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued operations, net of income tax
|
|
$
|
5
|
|
|
$
|
28
|
|
|
|
|
|
|
|
|
|
|
On January 31, 2005, the Company completed the sale of SSRM
Holdings, Inc. to a third party for $328 million in cash
and stock. The Company reported the operations of SSRM in
discontinued operations. Under the terms of the sale agreement,
MetLife had an opportunity to receive additional payments based
on, among other things, certain revenue retention and growth
measures. The purchase price was also subject to reduction over
five years, depending on retention of certain MetLife-related
business. In the second quarter of 2008, the Company paid
$3 million, net of income tax, of which $2 million was
accrued in the fourth quarter of 2007, related to the
termination of certain MetLife-related business. Also under the
terms of such agreement, MetLife had the opportunity to receive
additional consideration for the retention of certain customers
for a specific period in 2005. Upon finalization of the
computation, the Company received a payment of $30 million,
net of income tax, in the second quarter of 2006 due to the
retention of these specific customer accounts. In the first
quarter of 2007, the Company received a payment of
$16 million, net of income tax, as a result of the revenue
retention and growth measure provision in the sales agreement.
In the fourth quarter of 2006, the Company eliminated
$4 million of a liability that was previously recorded with
respect to the indemnities provided in connection with the sale
of SSRM, resulting in a benefit to the Company of
$2 million, net of income tax. The Company believes that
future payments relating to these indemnities are not probable.
The following table presents the amounts related to operations
of SSRM that have been reflected as discontinued operations in
the consolidated statements of income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Revenues
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued operations before provision for income
tax
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income tax
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment gain (loss), net of income tax
|
|
|
(1
|
)
|
|
|
14
|
|
|
|
32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued operations, net of income tax
|
|
$
|
(1
|
)
|
|
$
|
14
|
|
|
$
|
32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair
Value of Financial Instruments
As described in Note 1, the Company prospectively adopted
the provisions of SFAS 157 effective January 1, 2008.
As a result, the methodologies used to determine the estimated
fair value for certain financial instruments at
December 31, 2008 may have been modified from those
utilized at December 31, 2007, which, while being deemed
appropriate under existing accounting guidance, may not have
produced an exit value as defined in SFAS 157.
F-148
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Accordingly, the estimated fair value of financial instruments,
and the description of the methodologies used to derive those
estimated fair values, are presented separately at
December 31, 2007 and December 31, 2008. Considerable
judgment is often required in interpreting market data to
develop estimates of fair value and the use of different
assumptions or valuation methodologies may have a material
effect on the estimated fair value amounts.
Amounts related to the Companys financial instruments are
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notional
|
|
|
Carrying
|
|
|
Estimated
|
|
December 31, 2007
|
|
Amount
|
|
|
Value
|
|
|
Fair Value
|
|
|
|
(In millions)
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities
|
|
|
|
|
|
$
|
232,336
|
|
|
$
|
232,336
|
|
Equity securities
|
|
|
|
|
|
$
|
5,911
|
|
|
$
|
5,911
|
|
Trading securities
|
|
|
|
|
|
$
|
779
|
|
|
$
|
779
|
|
Mortgage and consumer loans
|
|
|
|
|
|
$
|
46,154
|
|
|
$
|
46,714
|
|
Policy loans
|
|
|
|
|
|
$
|
9,326
|
|
|
$
|
9,326
|
|
Short-term investments
|
|
|
|
|
|
$
|
2,544
|
|
|
$
|
2,544
|
|
Cash and cash equivalents
|
|
|
|
|
|
$
|
9,961
|
|
|
$
|
9,961
|
|
Accrued investment income
|
|
|
|
|
|
$
|
3,545
|
|
|
$
|
3,545
|
|
Assets of subsidiaries held-for-sale
|
|
|
|
|
|
$
|
12,609
|
|
|
$
|
12,618
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder account balances
|
|
|
|
|
|
$
|
110,371
|
|
|
$
|
110,199
|
|
Short-term debt
|
|
|
|
|
|
$
|
667
|
|
|
$
|
667
|
|
Long-term debt
|
|
|
|
|
|
$
|
9,100
|
|
|
$
|
9,015
|
|
Collateral financing arrangements
|
|
|
|
|
|
$
|
4,882
|
|
|
$
|
4,604
|
|
Junior subordinated debt securities
|
|
|
|
|
|
$
|
4,075
|
|
|
$
|
3,982
|
|
Payables for collateral under securities loaned and other
transactions
|
|
|
|
|
|
$
|
44,136
|
|
|
$
|
44,136
|
|
Liabilities of subsidiaries held-for-sale
|
|
|
|
|
|
$
|
6,963
|
|
|
$
|
6,092
|
|
Commitments: (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage loan commitments
|
|
$
|
4,030
|
|
|
$
|
|
|
|
$
|
(43
|
)
|
Commitments to fund bank credit facilities, bridge loans and
private corporate bond investments
|
|
$
|
1,196
|
|
|
$
|
|
|
|
$
|
(59
|
)
|
|
|
|
(1) |
|
Commitments are off-balance sheet obligations. Negative
estimated fair values represent off-balance sheet liabilities. |
The methods and assumptions used to estimate the fair value of
financial instruments are summarized as follows:
Fixed Maturity Securities, Equity Securities and Trading
Securities The estimated fair values of publicly
held fixed maturity securities and publicly held equity
securities are based on quoted market prices or estimates from
independent pricing services. However, in cases where quoted
market prices are not available, such as for private fixed
maturity securities, fair values are estimated using present
value or valuation techniques. The determination of estimated
fair values is based on: (i) market standard valuation
methodologies; (ii) securities the Company deems to be
comparable; and (iii) assumptions deemed appropriate given
the circumstances. The value estimates based on available market
information and judgments about financial instruments, including
estimates of the timing and amounts of expected future cash
flows and the credit standing of the issuer or counterparty.
Factors considered in estimating fair value include; coupon
rate, maturity, estimated duration, call provisions, sinking
fund requirements, credit rating, industry sector of the issuer,
and quoted market prices of comparable securities.
F-149
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Mortgage and Consumer Loans, Mortgage Loan Commitments and
Commitments to Fund Bank Credit Facilities, Bridge Loans,
and Private Corporate Bond Investments Fair
values for mortgage and consumer loans are estimated by
discounting expected future cash flows, using current interest
rates for similar loans with similar credit risk. For mortgage
loan commitments and commitments to fund bank credit facilities,
bridge loans, and private corporate bond investments the
estimated fair value is the net premium or discount of the
commitments.
Policy Loans The estimated fair values for
policy loans approximate carrying values.
Cash and Cash Equivalents and Short-term
Investments The estimated fair values for cash
and cash equivalents and short-term investments approximate
carrying values due to the short-term maturities of these
instruments.
Accrued Investment Income The estimated fair
value for accrued investment income approximates carrying value.
Policyholder Account Balances The fair value
of policyholder account balances which have final contractual
maturities are estimated by discounting expected future cash
flows based upon interest rates currently being offered for
similar contracts with maturities consistent with those
remaining for the agreements being valued. The estimated fair
value of policyholder account balances without final contractual
maturities are assumed to equal their current net surrender
value.
Short-term and Long-term Debt, Collateral Financing
Arrangements, Junior Subordinated Debt
Securities The estimated fair values of
short-term and long-term debt, collateral financing arrangements
and junior subordinated debt securities are determined by
discounting expected future cash flows using risk rates
currently available for debt with similar terms and remaining
maturities.
Payables for Collateral Under Securities Loaned and Other
Transactions The estimated fair value for
payables for collateral under securities loaned and other
transactions approximates carrying value.
Assets and Liabilities of Subsidiaries
Held-For-Sale The carrying values of assets and
liabilities of subsidiaries held-for-sale reflect those assets
and liabilities which were previously determined to be financial
instruments and which were reflected in other financial
statement captions in the table above in previous periods but
have been reclassified to this caption to reflect the
discontinued nature of the operations. The estimated fair value
of the assets and liabilities of subsidiaries held-for-sale have
been determined on a basis consistent with similar instruments
as described herein.
Derivative Financial Instruments The
estimated fair value of derivative financial instruments,
including financial futures, financial forwards, interest rate,
credit default and foreign currency swaps, foreign currency
forwards, caps, floors, and options are based upon quotations
obtained from dealers or other reliable sources. See Note 4
for derivative fair value disclosures.
F-150
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notional
|
|
|
Carrying
|
|
|
Estimated
|
|
December 31, 2008
|
|
Amount
|
|
|
Value
|
|
|
Fair Value
|
|
|
|
(In millions)
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities
|
|
|
|
|
|
$
|
188,251
|
|
|
$
|
188,251
|
|
Equity securities
|
|
|
|
|
|
$
|
3,197
|
|
|
$
|
3,197
|
|
Trading securities
|
|
|
|
|
|
$
|
946
|
|
|
$
|
946
|
|
Mortgage and consumer loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
Held-for-investment
|
|
|
|
|
|
$
|
49,352
|
|
|
$
|
48,133
|
|
Held-for-sale
|
|
|
|
|
|
$
|
2,012
|
|
|
$
|
2,010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage and consumer loans, net
|
|
|
|
|
|
$
|
51,364
|
|
|
$
|
50,143
|
|
Policy loans
|
|
|
|
|
|
$
|
9,802
|
|
|
$
|
11,952
|
|
Real estate joint ventures (1)
|
|
|
|
|
|
$
|
163
|
|
|
$
|
176
|
|
Other limited partnership interests (1)
|
|
|
|
|
|
$
|
1,900
|
|
|
$
|
2,269
|
|
Short-term investments
|
|
|
|
|
|
$
|
13,878
|
|
|
$
|
13,878
|
|
Other invested assets: (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative assets
|
|
$
|
133,565
|
|
|
$
|
12,306
|
|
|
$
|
12,306
|
|
Mortgage servicing rights
|
|
|
|
|
|
$
|
191
|
|
|
$
|
191
|
|
Other
|
|
|
|
|
|
$
|
801
|
|
|
$
|
900
|
|
Cash and cash equivalents
|
|
|
|
|
|
$
|
24,207
|
|
|
$
|
24,207
|
|
Accrued investment income
|
|
|
|
|
|
$
|
3,061
|
|
|
$
|
3,061
|
|
Premiums and other receivables (1)
|
|
|
|
|
|
$
|
2,995
|
|
|
$
|
3,473
|
|
Other assets (1)
|
|
|
|
|
|
$
|
800
|
|
|
$
|
629
|
|
Assets of subsidiaries held-for-sale (1)
|
|
|
|
|
|
$
|
630
|
|
|
$
|
649
|
|
Separate account assets
|
|
|
|
|
|
$
|
120,839
|
|
|
$
|
120,839
|
|
Net embedded derivatives within asset host contracts (2)
|
|
|
|
|
|
$
|
205
|
|
|
$
|
205
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder account balances (1)
|
|
|
|
|
|
$
|
110,174
|
|
|
$
|
102,902
|
|
Short-term debt
|
|
|
|
|
|
$
|
2,659
|
|
|
$
|
2,659
|
|
Long-term debt (1)
|
|
|
|
|
|
$
|
9,619
|
|
|
$
|
8,155
|
|
Collateral financing arrangements
|
|
|
|
|
|
$
|
5,192
|
|
|
$
|
1,880
|
|
Junior subordinated debt securities
|
|
|
|
|
|
$
|
3,758
|
|
|
$
|
2,606
|
|
Payables for collateral under securities loaned and other
transactions
|
|
|
|
|
|
$
|
31,059
|
|
|
$
|
31,059
|
|
Other liabilities: (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative liabilities
|
|
$
|
64,523
|
|
|
$
|
4,042
|
|
|
$
|
4,042
|
|
Trading liabilities
|
|
|
|
|
|
$
|
57
|
|
|
$
|
57
|
|
Other
|
|
|
|
|
|
$
|
638
|
|
|
$
|
638
|
|
Liabilities of subsidiaries held-for-sale (1)
|
|
|
|
|
|
$
|
50
|
|
|
$
|
49
|
|
Separate account liabilities (1)
|
|
|
|
|
|
$
|
28,862
|
|
|
$
|
28,862
|
|
Net embedded derivatives within liability host contracts (2)
|
|
|
|
|
|
$
|
3,051
|
|
|
$
|
3,051
|
|
Commitments: (3)
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage loan commitments
|
|
$
|
2,690
|
|
|
$
|
|
|
|
$
|
(129
|
)
|
Commitments to fund bank credit facilities, bridge loans and
private corporate bond investments
|
|
$
|
979
|
|
|
$
|
|
|
|
$
|
(105
|
)
|
F-151
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
(1) |
|
Carrying values presented herein differ from those presented on
the consolidated balance sheet because certain items within the
respective financial statement caption are not considered
financial instruments. Financial statement captions omitted from
the table above are not considered financial instruments. |
|
(2) |
|
Net embedded derivatives within asset host contracts are
presented within premiums and other receivables. Net embedded
derivatives within liability host contracts are presented within
policyholder account balances. Equity securities also include
embedded derivatives of ($173) million. |
|
(3) |
|
Commitments are off-balance sheet obligations. Negative
estimated fair values represent off-balance sheet liabilities. |
The methods and assumptions used to estimate the fair value of
financial instruments are summarized as follows:
Fixed Maturity Securities, Equity Securities and Trading
Securities When available, the estimated fair
value of the Companys fixed maturity, equity and trading
securities are based on quoted prices in active markets that are
readily and regularly obtainable. Generally, these are the most
liquid of the Companys securities holdings and valuation
of these securities does not involve management judgment.
When quoted prices in active markets are not available, the
determination of estimated fair value is based on market
standard valuation methodologies. The market standard valuation
methodologies utilized include: discounted cash flow
methodologies, matrix pricing or other similar techniques. The
assumptions and inputs in applying these market standard
valuation methodologies include, but are not limited to:
interest rates, credit standing of the issuer or counterparty,
industry sector of the issuer, coupon rate, call provisions,
sinking fund requirements, maturity, estimated duration and
managements assumptions regarding liquidity and estimated
future cash flows. Accordingly, the estimated fair values are
based on available market information and managements
judgments about financial instruments.
The significant inputs to the market standard valuation
methodologies for certain types of securities with reasonable
levels of price transparency are inputs that are observable in
the market or can be derived principally from or corroborated by
observable market data. Such observable inputs include
benchmarking prices for similar assets in active, liquid
markets, quoted prices in markets that are not active and
observable yields and spreads in the market.
When observable inputs are not available, the market standard
valuation methodologies for determining the estimated fair value
of certain types of securities that trade infrequently, and
therefore have little or no price transparency, rely on inputs
that are significant to the estimated fair value that are not
observable in the market or cannot be derived principally from
or corroborated by observable market data. These unobservable
inputs can be based in large part on management judgment or
estimation, and cannot be supported by reference to market
activity. Even though unobservable, these inputs are based on
assumptions deemed appropriate given the circumstances and
consistent with what other market participants would use when
pricing such securities.
The use of different methodologies, assumptions and inputs may
have a material effect on the estimated fair values of the
Companys securities holdings.
Mortgage and Consumer Loans The Company
originates mortgage and consumer loans for both investment
purposes and with the intention to sell them to third parties.
Commercial and agricultural loans are originated for investment
purposes and are primarily carried at amortized cost within the
consolidated financial statements. Loans classified as consumer
loans are generally purchased from third parties for investment
purposes and are primarily carried at amortized cost. Mortgage
loans held-for-sale consist principally of residential mortgage
loans for which the Company has elected the fair value option
and which are carried at estimated fair value in the
consolidated financial statements and to a significantly lesser
degree certain loans which were previously held-for-investment
but
F-152
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
where the Company has changed its intention as it relates to
holding them for investment. The estimated fair values of these
loans are determined as follows:
|
|
|
|
|
Mortgage and Consumer Loans
Held-for-Investment For mortgage and consumer
loans held-for-investment and carried at amortized cost, fair
value is primarily determined by estimating expected future cash
flows and discounting them using current interest rates for
similar loans with similar credit risk.
|
|
|
|
Mortgage Loans Held-for-Sale Mortgage loans
held-for-sale principally includes residential mortgages for
which the fair value option was elected and which are carried at
estimated fair value. Generally, quoted market prices are not
available for residential mortgage loans held-for-sale;
accordingly, the estimated fair values of such assets are
determined based on observable pricing of residential mortgage
loans held-for-sale with similar characteristics, or observable
pricing for securities backed by similar types of loans,
adjusted to convert the securities prices to loan prices. When
observable pricing for similar loans or securities that are
backed by similar loans are not available, the estimated fair
values of residential mortgage loans held-for-sale are
determined using independent broker quotations, which is
intended to approximate the amounts that would be received from
third parties. Certain other mortgages previously classified as
held-for-investment have also been designated as held-for-sale.
For these loans, estimated fair value is determined using
independent broker quotations or, when the loan is in
foreclosure or otherwise determined to be collateral dependent,
the fair value of the underlying collateral estimated using
internal models.
|
Policy Loans For policy loans with fixed
interest rates, estimated fair values are determined using a
discounted cash flow model applied to groups of similar policy
loans determined by the nature of the underlying insurance
liabilities. Cash flow estimates are developed applying a
weighted-average interest rate to the outstanding principal
balance of the respective group of loans and an estimated
average maturity determined through experience studies of the
past performance of policyholder repayment behavior for similar
loans. These cash flows are discounted using current risk-free
interest rates with no adjustment for borrower credit risk as
these loans are fully collateralized by the cash surrender value
of the underlying insurance policy. The estimated fair value for
policy loans with variable interest rates approximates carrying
value due to the absence of borrower credit risk and the short
time period between interest rate resets, which presents minimal
risk of a material change in estimated fair value due to changes
in market interest rates.
Real Estate Joint Ventures and Other Limited Partnership
Interests Other limited partnerships and real
estate joint ventures included in the preceding table consist of
those investments accounted for using the cost method. The
remaining carrying value recognized in the consolidated balance
sheet represents investments in real estate or real estate joint
ventures and other limited partnerships accounted for using the
equity method, which do not satisfy the definition of financial
instruments for which fair value is required to be disclosed.
The estimated fair values for other limited partnership
interests and real estate joint ventures accounted for under the
cost method are generally based on the Companys share of
the net asset value (NAV) as provided in the
financial statements of the investees. In certain circumstances,
management may adjust the net asset value by a premium or
discount when it has sufficient evidence to support applying
such adjustments.
Short-term Investments Certain short-term
investments do not qualify as securities and are recognized at
amortized cost in the consolidated balance sheet. For these
instruments, the Company believes that there is minimal risk of
material changes in interest rates or credit of the issuer such
that estimated fair value approximates carrying value. In light
of recent market conditions, short-term investments have been
monitored to ensure there is sufficient demand and maintenance
of issuer credit quality and the Company has determined
additional adjustment is not required. Short-term investments
that meet the definition of a security are recognized at
estimated fair value in the consolidated balance sheet in the
same manner described above for similar instruments that are
classified within captions of other major investment classes.
Other Invested Assets Other invested assets
in the consolidated balance sheet is principally comprised of
freestanding derivatives with positive estimated fair values,
leveraged leases, investments in tax credit partnerships,
F-153
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
joint venture investments, mortgage servicing rights, investment
in a funding agreement, funds withheld at interest and various
interest-bearing assets held in foreign subsidiaries. Leveraged
leases and investments in tax credit partnerships and joint
ventures, which are accounted for under the equity method, are
not financial instruments subject to fair value disclosure.
Accordingly, they have been excluded from the preceding table.
The estimated fair value of derivatives with
positive and negative estimated fair values is
described in the respectively labeled section which follows.
Although mortgage servicing rights are not financial
instruments, the Company has included them in the preceding
table as a result of its election to carry mortgage servicing
rights at fair value pursuant to SFAS No. 140,
Accounting for Transfers and Servicing of Financial Assets
and Extinguishments of Liabilities, as amended by
SFAS No. 156, Accounting for Servicing of Financial
Assets. As sales of mortgage servicing rights tend to occur
in private transactions where the precise terms and conditions
of the sales are typically not readily available, observable
market valuations are limited. As such, the Company relies
primarily on a discounted cash flow model to estimate the fair
value of the mortgage servicing rights. The model requires
inputs such as type of loan (fixed vs. variable and agency vs.
other), age of loan, loan interest rates and current market
interest rates that are generally observable. The model also
requires the use of unobservable inputs including assumptions
regarding estimates of discount rates, loan pre-payment, and
servicing costs.
The fair value of the investment in a funding agreement is
estimated discounting the expected future cash flows using
current market rates and the credit risk of the note issuer.
For funds withheld at interest and the various interest-bearing
assets held in foreign subsidiaries, the Company evaluates the
specific facts and circumstances of each instrument to determine
the appropriate estimated fair values. These estimated fair
values were not materially different from the recognized
carrying values.
Cash and Cash Equivalents Due to the
short-term maturities of cash and cash equivalents, the Company
believes there is minimal risk of material changes in interest
rates or credit of the issuer such that estimated fair value
generally approximates carrying value. In light of recent market
conditions, cash and cash equivalent instruments have been
monitored to ensure there is sufficient demand and maintenance
of issuer credit quality, or sufficient solvency in the case of
depository institutions, and the Company has determined
additional adjustment is not required.
Accrued Investment Income Due to the
short-term until settlement of accrued investment income, the
Company believes there is minimal risk of material changes in
interest rates or credit of the issuer such that estimated fair
value approximates carrying value. In light of recent market
conditions, the Company has monitored the credit quality of the
issuers and has determined additional adjustment is not required.
Premiums and Other Receivables Premiums and
other receivables in the consolidated balance sheet is
principally comprised of premiums due and unpaid for insurance
contracts, amounts recoverable under reinsurance contracts,
amounts on deposit with financial institutions to facilitate
daily settlements related to certain derivative positions,
amounts receivable for securities sold but not yet settled, fees
and general operating receivables, and embedded derivatives
related to the ceded reinsurance of certain variable annuity
riders.
Premiums receivable and those amounts recoverable under
reinsurance treaties determined to transfer sufficient risk are
not financial instruments subject to disclosure and thus have
been excluded from the amounts presented in the preceding table.
Amounts recoverable under ceded reinsurance contracts which the
Company has determined do not transfer sufficient risk such that
they are accounted for using the deposit method of accounting
have been included in the preceding table with the estimated
fair value determined as the present value of expected future
cash flows under the related contracts discounted using an
interest rate determined to reflect the appropriate credit
standing of the assuming counterparty.
The amounts on deposit for derivative settlements essentially
represent the equivalent of demand deposit balances such that
the estimated fair value approximates carrying value. In light
of recent market conditions, the
F-154
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Company has monitored the solvency position of the financial
institutions and has determined additional adjustments are not
required.
Embedded derivatives recognized in connection with ceded
reinsurance of certain variable annuity riders are included in
this caption in the consolidated financial statements but
excluded from this caption in the preceding table as they are
separately presented.
Other Assets Other assets in the consolidated
balance sheet is principally comprised of prepaid expenses,
amounts held under corporate owned life insurance, fixed assets,
capitalized software, deferred sales inducements, VODA, VOCRA,
and a receivable for cash collateral pledged under the MRC
collateral financing arrangement as described in Note 11.
With the exception of the receivable for collateral pledged,
other assets are not considered financial instruments subject to
disclosure. Accordingly, the amount presented in the preceding
table represent the receivable for collateral pledged for which
the estimated fair value was determined by discounting the
expected future cash flows using a discount rate that reflects
the credit of the financial institution.
Separate Account Assets Separate account
assets are carried at estimated fair value and reported as a
summarized total on the consolidated balance sheet in accordance
with Statement of Position (SOP)
03-1,
Accounting and Reporting by Insurance Enterprises for Certain
Nontraditional Long-Duration Contracts and for Separate Accounts
(SOP 03-1).
The estimated fair values of separate account assets are based
on the estimated fair value of the underlying assets owned by
the separate account. Assets within the Companys separate
accounts include: mutual funds, fixed maturity securities,
equity securities, mortgage loans, derivatives, hedge funds,
other limited partnership interests, short-term investments and
cash and cash equivalents. The estimated fair value of mutual
funds is based upon quoted prices or reported net assets values
provided by the fund manager and are reviewed by management to
determine whether such values require adjustment to represent
exit value. The estimated fair values of fixed maturity
securities, equity securities, derivatives, short-term
investments and cash and cash equivalents held by separate
accounts are determined on a basis consistent with the
methodologies described herein for similar financial instruments
held within the general account. The estimated fair value of
hedge funds is based upon NAVs provided by the fund manager and
are reviewed by management to determine whether such values
require adjustment to represent exit value. The estimated fair
value of mortgage loans is determined by discounting expected
future cash flows, using current interest rates for similar
loans with similar credit risk. Other limited partnership
interests are valued giving consideration to the value of the
underlying holdings of the partnerships and by applying a
premium or discount, if appropriate, for factors such as
liquidity, bid/ask spreads, the performance record of the fund
manager or other relevant variables which may impact the exit
value of the particular partnership interest.
Policyholder Account Balances Policyholder
account balances in the table above include investment contracts
and customer bank deposits. Embedded derivatives on investment
contracts and certain variable annuity riders accounted for as
embedded derivatives are included in this caption in the
consolidated financial statements but excluded from this caption
in the table above as they are separately presented therein. The
remaining difference between the amounts reflected as
policyholder account balances in the preceding table and those
recognized in the consolidated balance sheet represents those
amounts due under contracts that satisfy the definition of
insurance contracts and are not considered financial instruments.
The investment contracts primarily include guaranteed investment
contracts, certain funding arrangements, fixed deferred
annuities, modified guaranteed annuities, fixed term payout
annuities, and total control accounts. The fair values for these
investment contracts are estimated by discounting best estimate
future cash flows using current market risk-free interest rates
and adding a spread for the Companys own credit determined
using market standard swap valuation models and observable
market inputs that take into consideration publicly available
information relating to the Companys debt as well as its
claims paying ability.
Due to frequency of interest rate resets on customer bank
deposits held in money market accounts, the Company believes
that there is minimal risk of a material change in interest
rates such that the estimated fair value
F-155
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
approximates carrying value. For time deposits, estimated fair
values are estimated by discounting the expected cash flows to
maturity using a discount rate based on an average market rate
for certificates of deposit being offered by a representative
group of large financial institutions as of the date of the
valuation.
Short-term and Long-term Debt, Collateral Financing
Arrangements, and Junior Subordinated Debt The
estimated fair value for short-term debt approximates carrying
value due to the short-term nature of these obligations. The
estimated fair values of long-term debt, collateral financing
arrangements, and junior subordinated debt securities are
generally determined by discounting expected future cash flows
using market rates currently available for debt with similar,
remaining maturities and reflecting the credit risk of the
Company including inputs, when available, from actively traded
debt of the Company or other companies with similar types of
borrowing arrangements. Risk-adjusted discount rates applied to
the expected future cash flows can vary significantly based upon
the specific terms of each individual arrangement, including,
but not limited to: subordinated rights; contractual interest
rates in relation to current market rates; the structuring of
the arrangement; and the nature and observability of the
applicable valuation inputs. Use of different risk-adjusted
discount rates could result in different estimated fair values.
The carrying value of long-term debt presented in the table
above differs from the amounts presented in the consolidated
balance sheet as it does not include capital leases which are
not required to be disclosed at estimated fair value.
Payables for Collateral Under Securities Loaned and Other
Transactions The estimated fair value for
payables for collateral under securities loaned and other
transactions approximates carrying value. The related agreements
to loan securities are short-term in nature such that Company
believes there is limited risk of a material change in market
interest rates. Additionally, because borrowers are
cross-collateralized by the borrowed securities, the Company
believes no additional consideration for changes in its own
credit are necessary.
Other Liabilities Other liabilities in the
consolidated balance sheet is principally comprised of
freestanding derivatives with negative estimated fair values;
securities trading liabilities; tax and litigation contingency
liabilities; obligations for employee-related benefits; interest
due on the Companys debt obligations and on cash
collateral held in relation to securities lending; dividends
payable; amounts due for securities purchased but not yet
settled; amounts due under assumed reinsurance contracts;
minority interests in consolidated subsidiaries; and general
operating accruals and payables.
The estimated fair value of derivatives with
positive and negative estimated fair values is
described in the respectively labeled section which follows.
The amounts included in the table above reflect those other
liabilities that satisfy the definition of financial instruments
subject to disclosure. These items consist primarily of
securities trading liabilities; interest and dividends payable;
amounts due for securities purchased but not yet settled; and
amounts payable under certain assumed reinsurance contracts
recognized using the deposit method of accounting. The Company
evaluates the specific terms, facts and circumstances of each
arrangement to determine the appropriate estimated fair values,
which were not materially different from the recognized carrying
values.
Separate Account Liabilities Separate account
liabilities included in the table above represent those balances
due to policyholders under contracts that are classified as
investment contracts. The difference between the separate
account liabilities reflected above and the amounts presented in
the consolidated balance sheet represents those contracts
classified as insurance contracts which do not satisfy the
criteria of financial instruments for which fair value is to be
disclosed.
Separate account liabilities classified as investment contracts
primarily represent variable annuities with no significant
mortality risk to the Company such that the death benefit is
equal to the account balance; funding arrangements related to
institutional group life contracts; and certain contracts that
provide for benefit funding under Institutional retirement
& savings products.
F-156
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Separate account liabilities, whether related to investment or
insurance contracts, are recognized in the consolidated balance
sheet at an equivalent summary total of the separate account
assets as prescribed by
SOP 03-1.
Separate account assets, which equal net deposits, net
investment income and realized and unrealized capital gains and
losses, are fully offset by corresponding amounts credited to
the contractholders liability which is reflected in
separate account liabilities. Since separate account liabilities
are fully funded by cash flows from the separate account assets
which are recognized at estimated fair value as described above,
the Company believes the value of those assets approximates the
estimated fair value of the related separate account liabilities.
Derivatives The estimated fair value of
derivatives is determined through the use of quoted market
prices for exchange-traded derivatives and financial forwards to
sell residential mortgage-backed securities or through the use
of pricing models for over-the-counter derivatives. The
determination of estimated fair value, when quoted market values
are not available, is based on market standard valuation
methodologies and inputs that are assumed to be consistent with
what other market participants would use when pricing the
instruments. Derivative valuations can be affected by changes in
interest rates, foreign currency exchange rates, financial
indices, credit spreads, default risk (including the
counterparties to the contract), volatility, liquidity and
changes in estimates and assumptions used in the pricing models.
The significant inputs to the pricing models for most
over-the-counter derivatives are inputs that are observable in
the market or can be derived principally from or corroborated by
observable market data. Significant inputs that are observable
generally include: interest rates, foreign currency exchange
rates, interest rate curves, credit curves and volatility.
However, certain over-the-counter derivatives may rely on inputs
that are significant to the estimated fair value that are not
observable in the market or cannot be derived principally from
or corroborated by observable market data. Significant inputs
that are unobservable generally include: independent broker
quotes, credit correlation assumptions, references to emerging
market currencies and inputs that are outside the observable
portion of the interest rate curve, credit curve, volatility or
other relevant market measure. These unobservable inputs may
involve significant management judgment or estimation. Even
though unobservable, these inputs are based on assumptions
deemed appropriate given the circumstances and consistent with
what other market participants would use when pricing such
instruments.
The credit risk of both the counterparty and the Company are
considered in determining the estimated fair value for all
over-the-counter derivatives after taking into account the
effects of netting agreements and collateral arrangements.
Credit risk is monitored and consideration of any potential
credit adjustment is based on net exposure by counterparty. This
is due to the existence of netting agreements and collateral
arrangements which effectively serve to mitigate risk. The
Company values its derivative positions using the standard swap
curve which includes a credit risk adjustment. This credit risk
adjustment is appropriate for those parties that execute trades
at pricing levels consistent with the standard swap curve. As
the Company and its significant derivative counterparties
consistently execute trades at such pricing levels, additional
credit risk adjustments are not currently required in the
valuation process. The need for such additional credit risk
adjustments is monitored by the Company. The Companys
ability to consistently execute at such pricing levels is in
part due to the netting agreements and collateral arrangements
that are in place with all of its significant derivative
counterparties.
Most inputs for over-the-counter derivatives are mid market
inputs but, in certain cases, bid level inputs are used when
they are deemed more representative of exit value. Market
liquidity as well as the use of different methodologies,
assumptions and inputs, may have a material effect on the
estimated fair values of the Companys derivatives and
could materially affect net income.
Embedded Derivatives within Asset and Liability Host
Contracts Embedded derivatives principally
include certain direct, assumed and ceded variable annuity
riders and certain guaranteed investment contracts with equity
or bond indexed crediting rates. Embedded derivatives are
recorded in the financial statements at estimated fair value
with changes in estimated fair value adjusted through net income.
The Company issues certain variable annuity products with
guaranteed minimum benefit riders. GMWB, GMAB and certain GMIB
riders are embedded derivatives, which are measured at estimated
fair value separately
F-157
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
from the host variable annuity contract, with changes in
estimated fair value reported in net investment gains (losses).
These embedded derivatives are classified within policyholder
account balances. The fair value for these riders is estimated
using the present value of future benefits minus the present
value of future fees using actuarial and capital market
assumptions related to the projected cash flows over the
expected lives of the contracts. A risk neutral valuation
methodology is used under which the cash flows from the riders
are projected under multiple capital market scenarios using
observable risk free rates. Effective January 1, 2008, upon
adoption of SFAS 157, the valuation of these riders now
includes an adjustment for the Companys own credit and
risk margins for non-capital market inputs. The Companys
own credit adjustment is determined taking into consideration
publicly available information relating to the Companys
debt as well as its claims paying ability. Risk margins are
established to capture the non-capital market risks of the
instrument which represent the additional compensation a market
participant would require to assume the risks related to the
uncertainties of such actuarial assumptions as annuitization,
premium persistency, partial withdrawal and surrenders. The
establishment of risk margins requires the use of significant
management judgment. These riders may be more costly than
expected in volatile or declining equity markets. Market
conditions including, but not limited to, changes in interest
rates, equity indices, market volatility and foreign currency
exchange rates; changes in the Companys own credit
standing; and variations in actuarial assumptions regarding
policyholder behavior and risk margins related to non-capital
market inputs may result in significant fluctuations in the
estimated fair value of the riders that could materially affect
net income.
The Company ceded the risk associated with certain of the GMIB
and GMAB riders described in the preceding paragraph. These
reinsurance contracts contain embedded derivatives which are
included in premiums and other receivables with changes in
estimated fair value reported in net investments gains (losses)
or policyholder benefit and claims depending on the income
statement classification of the direct risk. The value of the
embedded derivatives on the ceded risk is determined using a
methodology consistent with that described previously for the
riders directly written by the Company.
The estimated fair value of the embedded equity and bond indexed
derivatives contained in certain guaranteed investment contracts
is determined using market standard swap valuation models and
observable market inputs, including an adjustment for the
Companys own credit that takes into consideration publicly
available information relating to the Companys debt as
well as its claims paying ability. The estimated fair value of
these embedded derivatives are included, along with their
guaranteed investment contract host, within policyholder account
balances with changes in estimated fair value recorded in net
investment gains (losses). Changes in equity and bond indices,
interest rates and the Companys credit standing may result
in significant fluctuations in the estimated fair value of these
embedded derivatives that could materially affect net income.
The accounting for embedded derivatives is complex and
interpretations of the primary accounting standards continue to
evolve in practice. If interpretations change, there is a risk
that features previously not bifurcated may require bifurcation
and reporting at estimated fair value in the consolidated
financial statements and respective changes in estimated fair
value could materially affect net income.
Assets and Liabilities of Subsidiaries
Held-For-Sale The carrying value of the assets
and liabilities of subsidiaries held-for-sale reflects those
assets and liabilities which were previously determined to be
financial instruments and which were reflected in other
financial statement captions in the table above in previous
periods but have been reclassified to this caption to reflect
the discontinued nature of the operations. The estimated fair
value of the assets and liabilities of subsidiaries
held-for-sale have been determined on a basis consistent with
the asset type as described herein.
Mortgage Loan Commitments and Commitments to Fund Bank
Credit Facilities, Bridge Loans, and Private Corporate Bond
Investments The estimated fair values for
mortgage loan commitments and commitments to fund bank credit
facilities, bridge loans and private corporate bond investments
reflected in the above table represent the difference between
the discounted expected future cash flows using interest rates
that incorporate current credit risk for similar instruments on
the reporting date and the principal amounts of the original
commitments.
F-158
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Assets
and Liabilities Measured at Fair Value
Recurring
Fair Value Measurements
The assets and liabilities measured at estimated fair value on a
recurring basis, including those items for which the Company has
elected the fair value option, are determined as described in
the preceding section. These estimated fair values and their
corresponding fair value hierarchy are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
Fair Value Measurements at
|
|
|
|
|
|
|
Reporting Date Using
|
|
|
|
|
|
|
Quoted Prices in
|
|
|
Significant
|
|
|
|
|
|
|
|
|
|
Active Markets for
|
|
|
Other
|
|
|
Significant
|
|
|
|
|
|
|
Identical Assets
|
|
|
Observable
|
|
|
Unobservable
|
|
|
Total
|
|
|
|
and Liabilities
|
|
|
Inputs
|
|
|
Inputs
|
|
|
Estimated
|
|
|
|
(Level 1)
|
|
|
(Level 2)
|
|
|
(Level 3)
|
|
|
Fair Value
|
|
|
|
(In millions)
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. corporate securities
|
|
$
|
|
|
|
$
|
55,805
|
|
|
$
|
7,498
|
|
|
$
|
63,303
|
|
Residential mortgage-backed securities
|
|
|
|
|
|
|
35,433
|
|
|
|
595
|
|
|
|
36,028
|
|
Foreign corporate securities
|
|
|
|
|
|
|
23,735
|
|
|
|
5,944
|
|
|
|
29,679
|
|
U.S. Treasury/agency securities
|
|
|
10,132
|
|
|
|
11,090
|
|
|
|
88
|
|
|
|
21,310
|
|
Commercial mortgage-backed securities
|
|
|
|
|
|
|
12,384
|
|
|
|
260
|
|
|
|
12,644
|
|
Asset-backed securities
|
|
|
|
|
|
|
8,071
|
|
|
|
2,452
|
|
|
|
10,523
|
|
Foreign government securities
|
|
|
282
|
|
|
|
9,463
|
|
|
|
408
|
|
|
|
10,153
|
|
State and political subdivision securities
|
|
|
|
|
|
|
4,434
|
|
|
|
123
|
|
|
|
4,557
|
|
Other fixed maturity securities
|
|
|
|
|
|
|
14
|
|
|
|
40
|
|
|
|
54
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
|
10,414
|
|
|
|
160,429
|
|
|
|
17,408
|
|
|
|
188,251
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
|
413
|
|
|
|
1,167
|
|
|
|
105
|
|
|
|
1,685
|
|
Non-redeemable preferred stock
|
|
|
|
|
|
|
238
|
|
|
|
1,274
|
|
|
|
1,512
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
|
413
|
|
|
|
1,405
|
|
|
|
1,379
|
|
|
|
3,197
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading securities
|
|
|
587
|
|
|
|
184
|
|
|
|
175
|
|
|
|
946
|
|
Short-term investments (1)
|
|
|
10,549
|
|
|
|
2,913
|
|
|
|
100
|
|
|
|
13,562
|
|
Mortgage and consumer loans (2)
|
|
|
|
|
|
|
1,798
|
|
|
|
177
|
|
|
|
1,975
|
|
Derivative assets (3)
|
|
|
55
|
|
|
|
9,483
|
|
|
|
2,768
|
|
|
|
12,306
|
|
Net embedded derivatives within asset host contracts (4)
|
|
|
|
|
|
|
|
|
|
|
205
|
|
|
|
205
|
|
Mortgage servicing rights (5)
|
|
|
|
|
|
|
|
|
|
|
191
|
|
|
|
191
|
|
Separate account assets (6)
|
|
|
85,886
|
|
|
|
33,195
|
|
|
|
1,758
|
|
|
|
120,839
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
107,904
|
|
|
$
|
209,407
|
|
|
$
|
24,161
|
|
|
$
|
341,472
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative liabilities (3)
|
|
$
|
273
|
|
|
$
|
3,548
|
|
|
$
|
221
|
|
|
$
|
4,042
|
|
Net embedded derivatives within liability host contracts (4)
|
|
|
|
|
|
|
(83
|
)
|
|
|
3,134
|
|
|
|
3,051
|
|
Trading liabilities (7)
|
|
|
57
|
|
|
|
|
|
|
|
|
|
|
|
57
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
$
|
330
|
|
|
$
|
3,465
|
|
|
$
|
3,355
|
|
|
$
|
7,150
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-159
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
(1) |
|
Short-term investments as presented in the table above differ
from the amounts presented in the consolidated balance sheet
because certain short-term investments are not measured at
estimated fair value (e.g. time deposits, money market funds,
etc.). |
|
(2) |
|
Mortgage and consumer loans as presented in the table above
differ from the amount presented in the consolidated balance
sheet as this table only includes residential mortgage loans
held-for-sale measured at estimated fair value on a recurring
basis. |
|
(3) |
|
Derivative assets are presented within other invested assets and
derivatives liabilities are presented within other liabilities.
The amounts are presented gross in the table above to reflect
the presentation in the consolidated balance sheet, but are
presented net for purposes of the rollforward in the following
tables. |
|
(4) |
|
Net embedded derivatives within asset host contracts are
presented within premiums and other receivables. Net embedded
derivatives within liability host contracts are presented within
policyholder account balances. Equity securities also includes
embedded derivatives of ($173) million. |
|
(5) |
|
Mortgage servicing rights are presented within other invested
assets. |
|
(6) |
|
Separate account assets are measured at estimated fair value.
Investment performance related to separate account assets is
fully offset by corresponding amounts credited to
contractholders whose liability is reflected within separate
account liabilities. Separate account liabilities are set equal
to the estimated fair value of separate account assets as
prescribed by
SOP 03-1. |
|
(7) |
|
Trading liabilities are presented within other liabilities. |
The Company has categorized its assets and liabilities into the
three-level fair value hierarchy, as defined in Note 1,
based upon the priority of the inputs to the respective
valuation technique. The following summarizes the types of
assets and liabilities included within the three-level fair
value hierarchy presented in the preceding table.
|
|
|
|
Level 1
|
This category includes certain U.S. Treasury and agency
fixed maturity securities, certain foreign government fixed
maturity securities; exchange-traded common stock; and certain
short-term money market securities. As it relates to
derivatives, this level includes financial futures including
exchange-traded equity and interest rate futures, as well as
financial forwards to sell residential mortgage-backed
securities. Separate account assets classified within this level
principally include mutual funds. Also included are assets held
within separate accounts which are similar in nature to those
classified in this level for the general account.
|
|
|
Level 2
|
This category includes fixed maturity and equity securities
priced principally by independent pricing services using
observable inputs. These fixed maturity securities include most
U.S. Treasury and agency securities as well as the majority
of U.S. and foreign corporate securities, residential
mortgage-backed securities, commercial mortgage-backed
securities, state and political subdivision securities, foreign
government securities, and asset-backed securities. Equity
securities classified as Level 2 securities consist
principally of non-redeemable preferred stock and certain equity
securities where market quotes are available but are not
considered actively traded. Short-term investments and trading
securities included within Level 2 are of a similar nature
to these fixed maturity and equity securities. Mortgage and
consumer loans included in Level 2 include residential
mortgage loans held-for-sale for which there is readily
available observable pricing for similar loans or securities
backed by similar loans and the unobservable adjustments to such
prices are insignificant. As it relates to derivatives, this
level includes all types of derivative instruments utilized by
the Company with the exception of exchange-traded futures and
financial forwards to sell residential mortgage-backed
securities included within Level 1 and those derivative
instruments with unobservable inputs as described in
Level 3. Separate account assets classified within this
level are generally similar to those classified within this
level for the general account. Hedge funds owned by separate
accounts are also included within this level. Embedded
derivatives classified within this level include embedded equity
derivatives contained in certain guaranteed investment contracts.
|
F-160
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
|
Level 3
|
This category includes fixed maturity securities priced
principally through independent broker quotations or market
standard valuation methodologies using inputs that are not
market observable or cannot be derived principally from or
corroborated by observable market data. This level consists of
less liquid fixed maturity securities with very limited trading
activity or where less price transparency exists around the
inputs to the valuation methodologies including: U.S. and
foreign corporate securities including below
investment grade private placements; residential mortgage-backed
securities; asset-backed securities including all of
those supported by sub-prime mortgage loans; and other fixed
maturity securities such as structured securities. Equity
securities classified as Level 3 securities consist
principally of common stock of privately held companies and
non-redeemable preferred stock where there has been very limited
trading activity or where less price transparency exists around
the inputs to the valuation. Short-term investments and trading
securities included within Level 3 are of a similar nature
to these fixed maturity and equity securities. Mortgage and
consumer loans included in Level 3 include residential
mortgage loans held-for-sale for which pricing for similar loans
or securities backed by similar loans is not observable and the
estimate of fair value is determined using unobservable broker
quotes. As it relates to derivatives this category includes:
financial forwards including swap spread locks with maturities
which extend beyond observable periods; interest rate lock
commitments with certain unobservable inputs, including
pull-through rates; equity variance swaps with unobservable
volatility inputs or that are priced via independent broker
quotations; foreign currency swaps which are cancelable and
priced through independent broker quotations; interest rate
swaps with maturities which extend beyond the observable portion
of the yield curve; credit default swaps based upon baskets of
credits having unobservable credit correlations as well as
credit default swaps with maturities which extend beyond the
observable portion of the credit curves and credit default swaps
priced through independent broker quotes; foreign currency
forwards priced via independent broker quotations or with
liquidity adjustments; equity options with unobservable
volatility inputs; and interest rate caps and floors referencing
unobservable yield curves
and/or which
include liquidity and volatility adjustments. Separate account
assets classified within this level are generally similar to
those classified within this level for the general account;
however, they also include mortgage loans, and other limited
partnership interests. Embedded derivatives classified within
this level include embedded derivatives associated with certain
variable annuity riders. This category also includes mortgage
servicing rights which are carried at estimated fair value and
have multiple significant unobservable inputs including discount
rates, estimates of loan prepayments and servicing costs.
|
A rollforward of all assets and liabilities measured at
estimated fair value on a recurring basis using significant
unobservable (Level 3) inputs for year ended
December 31, 2008 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements Using Significant Unobservable Inputs
(Level 3)
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Realized/Unrealized
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impact of
|
|
|
|
|
|
Gains (Losses) included in:
|
|
|
Purchases,
|
|
|
|
|
|
|
|
|
|
Balance,
|
|
|
SFAS 157 and
|
|
|
Balance,
|
|
|
|
|
|
Other
|
|
|
Sales,
|
|
|
Transfer In
|
|
|
Balance,
|
|
|
|
December 31,
|
|
|
SFAS 159
|
|
|
Beginning
|
|
|
|
|
|
Comprehensive
|
|
|
Issuances and
|
|
|
and/or Out
|
|
|
End of
|
|
|
|
2007
|
|
|
Adoption (1)
|
|
|
of Period
|
|
|
Earnings (2, 3)
|
|
|
Income (Loss)
|
|
|
Settlements (4)
|
|
|
of Level 3 (5)
|
|
|
Period
|
|
|
|
(In millions)
|
|
|
Fixed maturity securities
|
|
$
|
23,326
|
|
|
$
|
(8
|
)
|
|
$
|
23,318
|
|
|
$
|
(881
|
)
|
|
$
|
(6,272
|
)
|
|
$
|
(596
|
)
|
|
$
|
1,839
|
|
|
$
|
17,408
|
|
Equity securities
|
|
|
2,371
|
|
|
|
|
|
|
|
2,371
|
|
|
|
(197
|
)
|
|
|
(478
|
)
|
|
|
(288
|
)
|
|
|
(29
|
)
|
|
|
1,379
|
|
Trading securities
|
|
|
183
|
|
|
|
8
|
|
|
|
191
|
|
|
|
(26
|
)
|
|
|
|
|
|
|
18
|
|
|
|
(8
|
)
|
|
|
175
|
|
Short-term investments
|
|
|
179
|
|
|
|
|
|
|
|
179
|
|
|
|
|
|
|
|
|
|
|
|
(79
|
)
|
|
|
|
|
|
|
100
|
|
Mortgage and consumer loans
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4
|
|
|
|
|
|
|
|
171
|
|
|
|
2
|
|
|
|
177
|
|
Net derivatives (6)
|
|
|
789
|
|
|
|
(1
|
)
|
|
|
788
|
|
|
|
1,729
|
|
|
|
|
|
|
|
29
|
|
|
|
1
|
|
|
|
2,547
|
|
Mortgage servicing rights (7),(8)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(149
|
)
|
|
|
|
|
|
|
340
|
|
|
|
|
|
|
|
191
|
|
Separate account assets (9)
|
|
|
1,464
|
|
|
|
|
|
|
|
1,464
|
|
|
|
(129
|
)
|
|
|
|
|
|
|
90
|
|
|
|
333
|
|
|
|
1,758
|
|
Net embedded derivatives (10)
|
|
|
(278
|
)
|
|
|
24
|
|
|
|
(254
|
)
|
|
|
(2,500
|
)
|
|
|
(81
|
)
|
|
|
(94
|
)
|
|
|
|
|
|
|
(2,929
|
)
|
F-161
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
|
|
|
(1) |
|
Impact of SFAS 157 adoption represents the amount
recognized in earnings as a change in estimate upon the adoption
of SFAS 157 associated with Level 3 financial
instruments held at January 1, 2008. The net impact of
adoption on Level 3 assets and liabilities presented in the
table above was a $23 million increase to net assets. Such
amount was also impacted by an increase to DAC of
$17 million. The impact of adoption of SFAS 157 on
RGA not reflected in the table above as a result of
the reflection of RGA in discontinued operations was
a net increase of $2 million (i.e., a decrease in
Level 3 net embedded derivative liabilities of
$17 million offset by a DAC decrease of $15 million)
for a total impact of $42 million on Level 3 assets
and liabilities. This impact of $42 million along with a
$12 million reduction in the estimated fair value of
Level 2 freestanding derivatives, results in a total net
impact of adoption of SFAS 157 of $30 million as
described in Note 1. |
|
(2) |
|
Amortization of premium/discount is included within net
investment income which is reported within the earnings caption
of total gains/losses. Impairments are included within net
investment gains (losses) which is reported within the earnings
caption of total gains/losses. Lapses associated with embedded
derivatives are included with the earnings caption of total
gains/losses. |
|
(3) |
|
Interest and dividend accruals, as well as cash interest coupons
and dividends received, are excluded from the rollforward. |
|
(4) |
|
The amount reported within purchases, sales, issuances and
settlements is the purchase/issuance price (for purchases and
issuances) and the sales/settlement proceeds (for sales and
settlements) based upon the actual date purchased/issued or
sold/settled. Items purchased/issued and sold/settled in the
same period are excluded from the rollforward. For embedded
derivatives, attributed fees are included within this caption
along with settlements, if any. |
|
(5) |
|
Total gains and losses (in earnings and other comprehensive
income (loss)) are calculated assuming transfers in (out) of
Level 3 occurred at the beginning of the period. Items
transferred in and out in the same period are excluded from the
rollforward. |
|
(6) |
|
Freestanding derivative assets and liabilities are presented net
for purposes of the rollforward. |
|
(7) |
|
The additions and reductions (due to loan payments) affecting
mortgage servicing rights were $350 million and
($10) million respectively, for the year ended
December 31, 2008. |
|
(8) |
|
The changes in estimated fair value due to changes in valuation
model inputs or assumptions, and other changes in estimated fair
value affecting mortgage servicing rights were
($149) million and $0, respectively, for the year ended
December 31, 2008. |
|
(9) |
|
Investment performance related to separate account assets is
fully offset by corresponding amounts credited to
contractholders whose liability is reflected within separate
account liabilities. |
|
(10) |
|
Embedded derivative assets and liabilities are presented net for
purposes of the rollforward. |
|
(11) |
|
Amounts presented do not reflect any associated hedging
activities. Actual earnings associated with Level 3,
inclusive of hedging activities, could differ materially. |
F-162
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
The table below summarizes both realized and unrealized gains
and losses for the year ended December 31, 2008 due to
changes in estimated fair value recorded in earnings for
Level 3 assets and liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Gains and Losses
|
|
|
|
Classification of Realized/Unrealized Gains
|
|
|
|
(Losses) included in Earnings
|
|
|
|
Net
|
|
|
Net
|
|
|
|
|
|
Policyholder
|
|
|
|
|
|
|
Investment
|
|
|
Investment
|
|
|
Other
|
|
|
Benefits and
|
|
|
|
|
|
|
Income
|
|
|
Gains (Losses)
|
|
|
Revenues
|
|
|
Claims
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Fixed maturity securities
|
|
$
|
176
|
|
|
$
|
(1,057
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(881
|
)
|
Equity securities
|
|
|
|
|
|
|
(197
|
)
|
|
|
|
|
|
|
|
|
|
|
(197
|
)
|
Trading securities
|
|
|
(26
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(26
|
)
|
Short-term investments
|
|
|
1
|
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage and consumer loans
|
|
|
|
|
|
|
|
|
|
|
4
|
|
|
|
|
|
|
|
4
|
|
Net derivatives
|
|
|
103
|
|
|
|
1,587
|
|
|
|
39
|
|
|
|
|
|
|
|
1,729
|
|
Mortgage servicing rights
|
|
|
|
|
|
|
|
|
|
|
(149
|
)
|
|
|
|
|
|
|
(149
|
)
|
Net embedded derivatives
|
|
|
|
|
|
|
(2,682
|
)
|
|
|
|
|
|
|
182
|
|
|
|
(2,500
|
)
|
The table below summarizes the portion of unrealized gains and
losses recorded in earnings for the year ended December 31,
2008 for Level 3 assets and liabilities that are still held
at December 31, 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes in Unrealized Gains (Losses)
|
|
|
|
Relating to Assets and Liabilities Held at December 31,
2008
|
|
|
|
Net
|
|
|
Net
|
|
|
|
|
|
Policyholder
|
|
|
|
|
|
|
Investment
|
|
|
Investment
|
|
|
Other
|
|
|
Benefits and
|
|
|
|
|
|
|
Income
|
|
|
Gains (Losses)
|
|
|
Revenues
|
|
|
Claims
|
|
|
Total
|
|
|
|
(In millions)
|
|
|
Fixed maturity securities
|
|
$
|
163
|
|
|
$
|
(793
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(630
|
)
|
Equity securities
|
|
|
|
|
|
|
(164
|
)
|
|
|
|
|
|
|
|
|
|
|
(164
|
)
|
Trading securities
|
|
|
(17
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(17
|
)
|
Short-term investments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage and consumer loans
|
|
|
|
|
|
|
|
|
|
|
3
|
|
|
|
|
|
|
|
3
|
|
Net derivatives
|
|
|
114
|
|
|
|
1,504
|
|
|
|
38
|
|
|
|
|
|
|
|
1,656
|
|
Mortgage servicing rights
|
|
|
|
|
|
|
|
|
|
|
(150
|
)
|
|
|
|
|
|
|
(150
|
)
|
Net embedded derivatives
|
|
|
|
|
|
|
(2,779
|
)
|
|
|
|
|
|
|
182
|
|
|
|
(2,597
|
)
|
Fair
Value Option Mortgage and Consumer
Loans
The Company has elected fair value accounting for certain
residential mortgage loans held-for-sale. At December 31,
2008, the estimated fair value carrying amount of
$1,975 million is greater than the aggregate unpaid
principal amount of $1,920 million by $55 million.
None of the loans where the fair value option has been elected
are more than 90 days past due or in non-accrual status at
December 31, 2008.
Residential mortgage loans held-for-sale accounted for under
SFAS 159 are initially measured at estimated fair value.
Gains and losses from initial measurement, subsequent changes in
estimated fair value, and gains or losses on sales are
recognized in other revenues. Interest income on residential
mortgage loans held-for-sale is recorded based on the stated
rate of the loan and is recorded in net investment income.
Changes in estimated fair value of $55 million have been
included in the statement of income for residential mortgage
loans held-for-sale for the year ended December 31, 2008.
F-163
MetLife,
Inc.
Notes to
the Consolidated Financial
Statements (Continued)
Changes in estimated fair value due to instrument-specific
credit risk are estimated based on changes in credit spreads for
non-agency loans and adjustments in individual loan quality, of
which there were none for the year ended December 31, 2008.
Non-Recurring
Fair Value Measurements
At December 31, 2008, the Company held $220 million in
mortgage loans which are carried at estimated fair value based
on independent broker quotations or, if the loans were in
foreclosure or are otherwise determined to be collateral
dependent, on the value of the underlying collateral of which
$188 million was related to impaired mortgage loans
held-for-investment and $32 million to certain mortgage
loans held-for-sale. These impaired mortgage loans were recorded
at estimated fair value and represent a nonrecurring fair value
measurement. The estimated fair value was categorized as
Level 3. Included within net investment gains (losses) for
such impaired mortgage loans are net impairments of
$79 million for the year ended December 31, 2008.
At December 31, 2008, the Company held $137 million in
cost basis other limited partnership interests which were
impaired during the year ended December 31, 2008 based on
the underlying limited partnership financial statements. These
other limited partnership interests were recorded at estimated
fair value and represent a nonrecurring fair value measurement.
The estimated fair value was categorized as Level 3.
Included within net investment gains (losses) for such other
limited partnerships are impairments of $105 million for
the year ended December 31, 2008.
Dividends
On February 18, 2009, the Companys Board of Directors
announced dividends of $0.25 per share, for a total of
$6 million, on its Series A preferred shares, and
$0.40625 per share, for a total of $24 million, on its
Series B preferred shares, subject to the final
confirmation that it has met the financial tests specified in
the Series A and Series B preferred shares, which the
Company anticipates will be made on or about March 5, 2009,
the earliest date permitted in accordance with the terms of the
securities. Both dividends will be payable March 16, 2009
to shareholders of record as of February 28, 2009.
Remarketing
of Securities and Settlement of Stock Purchase Contracts
Underlying Common Equity Units
On February 17, 2009, the Holding Company closed the
successful remarketing of the Series B portion of the
junior subordinated debentures underlying the common equity
units. The junior subordinated debentures were modified as
permitted by their terms to be 7.717% senior debt
securities Series B, due February 15, 2019. The
Holding Company did not receive any proceeds from the
remarketing. Most common equity unit holders chose to have their
junior subordinated debentures remarketed and used the
remarketing proceeds to settle their payment obligations under
the applicable stock purchase contract. For those common equity
unit holders that elected not to participate in the remarketing
and elected to use their own cash to satisfy the payment
obligations under the stock purchase contract, the terms of the
debt are the same as the remarketed debt.
The subsequent settlement of the stock purchase contracts
occurred on February 17, 2009, providing proceeds to the
Holding Company of $1,035 million in exchange for shares of
the Holding Companys common stock. The Holding Company
delivered 24,343,154 shares of its newly issued common
stock to settle the remaining stock purchase contracts issued as
part of the common equity units sold in June 2005.
See also Notes 10, 12, 13 and 18.
F-164
MetLife,
Inc.
Schedule I
Consolidated
Summary of Investments
Other Than Investments in Related Parties
December 31, 2008
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount at
|
|
|
|
Cost or
|
|
|
Estimated
|
|
|
Which Shown on
|
|
Type of Investments
|
|
Amortized Cost(1)
|
|
|
Fair Value
|
|
|
Balance Sheet
|
|
|
Fixed Maturity Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Bonds:
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasury/agency securities
|
|
$
|
17,229
|
|
|
$
|
21,310
|
|
|
$
|
21,310
|
|
Foreign government securities
|
|
|
9,474
|
|
|
|
10,153
|
|
|
|
10,153
|
|
Public utilities
|
|
|
9,906
|
|
|
|
9,058
|
|
|
|
9,058
|
|
State and political subdivision securities
|
|
|
5,419
|
|
|
|
4,557
|
|
|
|
4,557
|
|
All other corporate bonds
|
|
|
89,783
|
|
|
|
79,716
|
|
|
|
79,716
|
|
Mortgage-backed and asset-backed securities
|
|
|
70,320
|
|
|
|
59,195
|
|
|
|
59,195
|
|
Redeemable preferred stock
|
|
|
7,320
|
|
|
|
4,208
|
|
|
|
4,208
|
|
Other fixed maturity securities
|
|
|
57
|
|
|
|
54
|
|
|
|
54
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
|
209,508
|
|
|
|
188,251
|
|
|
|
188,251
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading Securities
|
|
|
1,107
|
|
|
|
946
|
|
|
|
946
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-redeemable preferred stock
|
|
|
2,353
|
|
|
|
1,512
|
|
|
|
1,512
|
|
Common stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
Public utilities
|
|
|
966
|
|
|
|
957
|
|
|
|
957
|
|
Industrial, miscellaneous and all other
|
|
|
640
|
|
|
|
590
|
|
|
|
590
|
|
Banks, trust and insurance companies
|
|
|
172
|
|
|
|
138
|
|
|
|
138
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
|
4,131
|
|
|
|
3,197
|
|
|
|
3,197
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage and consumer loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
Held-for-sale
|
|
|
2,012
|
|
|
|
|
|
|
|
2,012
|
|
Held-for-investment
|
|
|
49,352
|
|
|
|
|
|
|
|
49,352
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage and consumer loans, net
|
|
|
51,364
|
|
|
|
|
|
|
|
51,364
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policy loans
|
|
|
9,802
|
|
|
|
|
|
|
|
9,802
|
|
Real estate and real estate joint ventures
|
|
|
7,584
|
|
|
|
|
|
|
|
7,584
|
|
Real estate acquired in satisfaction of debt
|
|
|
2
|
|
|
|
|
|
|
|
2
|
|
Other limited partnership interests
|
|
|
6,039
|
|
|
|
|
|
|
|
6,039
|
|
Short-term investments
|
|
|
13,878
|
|
|
|
|
|
|
|
13,878
|
|
Other invested assets
|
|
|
17,248
|
|
|
|
|
|
|
|
17,248
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total investments
|
|
$
|
320,663
|
|
|
|
|
|
|
$
|
298,311
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The Companys trading securities portfolio is mainly
comprised of fixed maturity and equity securities. Cost or
amortized cost for fixed maturity securities and mortgage and
consumer loans represents original cost reduced by repayments,
net valuation allowances and writedowns from
other-than-temporary declines in value and adjusted for
amortization of premiums or discounts; for equity securities,
cost represents original cost reduced by writedowns from
other-than-temporary declines in value; for real estate, cost
represents original cost reduced by writedowns and adjusted for
valuation allowances and depreciation; cost for real estate
joint ventures and other limited partnership interests
represents original cost reduced for other-than-temporary
impairments or original cost adjusted for equity in earnings and
distributions. |
F-165
MetLife,
Inc.
Schedule II
Condensed
Financial Information
(Parent Company Only)
December 31, 2008 and 2007
(In millions, except share and per share data)
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
Condensed Balance Sheets
|
|
|
|
|
|
|
|
|
Assets
|
|
|
|
|
|
|
|
|
Investments:
|
|
|
|
|
|
|
|
|
Fixed maturity securities available-for-sale, at estimated fair
value (amortized cost: $1,504 and $2,567, respectively)
|
|
$
|
1,391
|
|
|
$
|
2,540
|
|
Equity securities available-for-sale, at estimated fair value
(cost: $20 and $32, respectively)
|
|
|
8
|
|
|
|
24
|
|
Short-term investments
|
|
|
1,073
|
|
|
|
|
|
Other invested assets
|
|
|
39
|
|
|
|
65
|
|
|
|
|
|
|
|
|
|
|
Total investments
|
|
|
2,511
|
|
|
|
2,629
|
|
Cash and cash equivalents
|
|
|
678
|
|
|
|
587
|
|
Accrued investment income
|
|
|
29
|
|
|
|
62
|
|
Investment in subsidiaries
|
|
|
33,203
|
|
|
|
45,611
|
|
Loans to subsidiaries
|
|
|
1,200
|
|
|
|
1,600
|
|
Receivables from subsidiaries
|
|
|
1
|
|
|
|
20
|
|
Other assets
|
|
|
974
|
|
|
|
82
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
38,596
|
|
|
$
|
50,591
|
|
|
|
|
|
|
|
|
|
|
Liabilities and Stockholders Equity Liabilities:
|
|
|
|
|
|
|
|
|
Short-term debt
|
|
$
|
300
|
|
|
$
|
310
|
|
Long-term debt unaffiliated
|
|
|
7,660
|
|
|
|
7,017
|
|
Long-term debt affiliated
|
|
|
500
|
|
|
|
500
|
|
Collateral financing arrangements
|
|
|
2,692
|
|
|
|
2,382
|
|
Junior subordinated debt securities
|
|
|
2,315
|
|
|
|
3,382
|
|
Payables for collateral under securities loaned and other
transactions
|
|
|
343
|
|
|
|
814
|
|
Other liabilities
|
|
|
1,052
|
|
|
|
1,007
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
14,862
|
|
|
|
15,412
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity:
|
|
|
|
|
|
|
|
|
Preferred stock, par value $0.01 per share;
200,000,000 shares authorized; 84,000,000 shares
issued and outstanding; $2,100 aggregate liquidation preference
|
|
|
1
|
|
|
|
1
|
|
Common stock, par value $0.01 per share;
3,000,000,000 shares authorized; 798,016,664 and
786,766,664 shares issued at December 31, 2008 and
2007, respectively; 793,629,070 and 729,223,440 shares
outstanding at December 31, 2008 and 2007, respectively
|
|
|
8
|
|
|
|
8
|
|
Additional paid-in capital
|
|
|
15,811
|
|
|
|
17,098
|
|
Retained earnings
|
|
|
22,403
|
|
|
|
19,884
|
|
Treasury stock, at cost; 4,387,594 and 57,543,224 shares at
December 31, 2008 and 2007, respectively
|
|
|
(236
|
)
|
|
|
(2,890
|
)
|
Accumulated other comprehensive income (loss)
|
|
|
(14,253
|
)
|
|
|
1,078
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
23,734
|
|
|
|
35,179
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity
|
|
$
|
38,596
|
|
|
$
|
50,591
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to condensed financial information.
F-166
MetLife,
Inc.
Schedule II
Condensed
Financial Information (Continued)
(Parent Company Only)
For the Years Ended December 31, 2008, 2007 and 2006
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Condensed Statements of Income
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity in earnings of subsidiaries
|
|
$
|
3,666
|
|
|
$
|
4,632
|
|
|
$
|
6,675
|
|
Net investment income
|
|
|
167
|
|
|
|
274
|
|
|
|
140
|
|
Net investment gains (losses)
|
|
|
(272
|
)
|
|
|
(41
|
)
|
|
|
(6
|
)
|
Other income
|
|
|
149
|
|
|
|
84
|
|
|
|
|
|
Interest expense
|
|
|
(736
|
)
|
|
|
(733
|
)
|
|
|
(618
|
)
|
Other expenses
|
|
|
(89
|
)
|
|
|
(62
|
)
|
|
|
(88
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before provision for income tax
|
|
|
2,885
|
|
|
|
4,154
|
|
|
|
6,103
|
|
Income tax expense (benefit)
|
|
|
(324
|
)
|
|
|
(163
|
)
|
|
|
(190
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
3,209
|
|
|
|
4,317
|
|
|
|
6,293
|
|
Preferred stock dividends
|
|
|
125
|
|
|
|
137
|
|
|
|
134
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common shareholders
|
|
$
|
3,084
|
|
|
$
|
4,180
|
|
|
$
|
6,159
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to condensed financial information.
F-167
MetLife,
Inc.
Schedule II
Condensed
Financial Information (Continued)
(Parent Company Only)
For the Years Ended December 31, 2008, 2007 and 2006
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Condensed Statements of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from operating activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
3,209
|
|
|
$
|
4,317
|
|
|
$
|
6,293
|
|
Earnings of subsidiaries
|
|
|
(3,666
|
)
|
|
|
(4,632
|
)
|
|
|
(6,675
|
)
|
Dividends from subsidiaries
|
|
|
1,148
|
|
|
|
1,254
|
|
|
|
4,237
|
|
Other, net
|
|
|
509
|
|
|
|
248
|
|
|
|
60
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities
|
|
|
1,200
|
|
|
|
1,187
|
|
|
|
3,915
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales of fixed maturity securities
|
|
|
3,970
|
|
|
|
5,203
|
|
|
|
1,123
|
|
Purchases of fixed maturity securities
|
|
|
(2,983
|
)
|
|
|
(4,586
|
)
|
|
|
(3,575
|
)
|
Sales of equity securities
|
|
|
|
|
|
|
13
|
|
|
|
|
|
Purchases of equity securities
|
|
|
(1
|
)
|
|
|
(32
|
)
|
|
|
|
|
Net change in short-term investments
|
|
|
(1,073
|
)
|
|
|
|
|
|
|
38
|
|
Purchase of businesses
|
|
|
(202
|
)
|
|
|
|
|
|
|
(115
|
)
|
Capital contribution to subsidiaries
|
|
|
(1,284
|
)
|
|
|
(422
|
)
|
|
|
(690
|
)
|
Return of capital from subsidiaries
|
|
|
|
|
|
|
526
|
|
|
|
413
|
|
Repayment of loans to subsidiaries
|
|
|
400
|
|
|
|
800
|
|
|
|
|
|
Issuance of loans to subsidiaries
|
|
|
|
|
|
|
(700
|
)
|
|
|
|
|
Disposal of subsidiary
|
|
|
(43
|
)
|
|
|
|
|
|
|
|
|
Other, net
|
|
|
57
|
|
|
|
(60
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by investing activities
|
|
|
(1,159
|
)
|
|
|
742
|
|
|
|
(2,806
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in short-term debt
|
|
|
(10
|
)
|
|
|
(306
|
)
|
|
|
(345
|
)
|
Long-term debt repaid
|
|
|
|
|
|
|
|
|
|
|
(500
|
)
|
Cash paid in connection with collateral financing arrangements
|
|
|
(800
|
)
|
|
|
|
|
|
|
|
|
Junior subordinated debt securities issued
|
|
|
|
|
|
|
|
|
|
|
1,248
|
|
Debt issuance costs
|
|
|
(8
|
)
|
|
|
(7
|
)
|
|
|
(12
|
)
|
Net change in payable for collateral under securities loaned and
other transactions
|
|
|
(471
|
)
|
|
|
(282
|
)
|
|
|
850
|
|
Common stock issued, net of issuance costs
|
|
|
290
|
|
|
|
|
|
|
|
|
|
Stock options exercised
|
|
|
45
|
|
|
|
110
|
|
|
|
83
|
|
Treasury stock acquired in connection with share repurchase
agreements
|
|
|
(1,250
|
)
|
|
|
(1,705
|
)
|
|
|
(500
|
)
|
Treasury stock issued in connection with common stock issuance,
net of issuance costs
|
|
|
1,936
|
|
|
|
|
|
|
|
|
|
Treasury stock issued to settle stock forward contracts
|
|
|
1,035
|
|
|
|
|
|
|
|
|
|
Dividends on preferred stock
|
|
|
(125
|
)
|
|
|
(137
|
)
|
|
|
(134
|
)
|
Dividends on common stock
|
|
|
(592
|
)
|
|
|
(541
|
)
|
|
|
(450
|
)
|
Other, net
|
|
|
|
|
|
|
|
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) financing activities
|
|
|
50
|
|
|
|
(2,868
|
)
|
|
|
239
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in cash and cash equivalents
|
|
|
91
|
|
|
|
(939
|
)
|
|
|
1,348
|
|
Cash and cash equivalents, beginning of year
|
|
|
587
|
|
|
|
1,526
|
|
|
|
178
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, end of year
|
|
$
|
678
|
|
|
$
|
587
|
|
|
$
|
1,526
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosures of cash flow information:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash paid (received) during the year for:
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
|
|
$
|
696
|
|
|
$
|
711
|
|
|
$
|
596
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax
|
|
$
|
(249
|
)
|
|
$
|
(241
|
)
|
|
$
|
(136
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-cash transactions during the year:
|
|
|
|
|
|
|
|
|
|
|
|
|
Disposal of subsidiary:
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment in subsidiary disposed
|
|
$
|
1,716
|
|
|
$
|
|
|
|
$
|
|
|
Add: transaction costs, including cash paid of $43
|
|
|
60
|
|
|
|
|
|
|
|
|
|
Less: treasury stock received in common stock exchange
|
|
|
(1,318
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss on disposal of subsidiary
|
|
$
|
458
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Remarketing of debt securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities redeemed
|
|
$
|
32
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt issued
|
|
$
|
1,035
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Junior subordinated debt securities redeemed
|
|
$
|
1,067
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of exchange bond to an affiliate
|
|
$
|
|
|
|
$
|
|
|
|
$
|
214
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contribution of goodwill to subsidiaries
|
|
$
|
22
|
|
|
$
|
|
|
|
$
|
32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contribution of other intangible assets to subsidiaries, net of
deferred income tax
|
|
$
|
97
|
|
|
$
|
|
|
|
$
|
558
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of collateral financing arrangement
|
|
$
|
310
|
|
|
$
|
2,382
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital contribution to subsidiary
|
|
$
|
310
|
|
|
$
|
2,382
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocation of interest expense to subsidiary
|
|
$
|
107
|
|
|
$
|
84
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocation of interest income to subsidiary
|
|
$
|
110
|
|
|
$
|
72
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to condensed financial information.
F-168
MetLife,
Inc.
Schedule II
Notes to
the Condensed Financial Information
(Parent
Company Only)
|
|
1.
|
Summary
of Accounting Policies
|
Business
MetLife or the Company refers to
MetLife, Inc., a Delaware corporation incorporated in 1999 (the
Holding Company), and its subsidiaries, including
Metropolitan Life Insurance Company (MLIC). MetLife,
Inc. is a leading provider of individual insurance, employee
benefits and financial services with operations throughout the
United States and the Latin America, Europe and Asia Pacific
regions. Through its subsidiaries and affiliates, MetLife offers
life insurance, annuities, auto and home insurance, retail
banking and other financial services to individuals, as well as
group insurance and retirement & savings products and
services to corporations and other institutions.
Basis
of Presentation
The condensed financial information of the Holding Company
(Parent Company Only) should be read in conjunction
with the Consolidated Financial Statements of MetLife, Inc. and
subsidiaries and the notes thereto (the Consolidated
Financial Statements). These condensed nonconsolidated
financial statements reflect the results of operations,
financial position and cash flows for the parent company only.
Investments in subsidiaries are accounted for using the equity
method of accounting prescribed by Accounting Principles Board
(APB) Opinion No. 18, The Equity Method of
Accounting for Investments in Common Stock.
The condensed unconsolidated financial statements are prepared
in conformity with accounting principles generally accepted in
the United States of America (GAAP) except as stated
previously which also requires management to make certain
estimates and assumptions. The most important of these estimates
and assumptions relate to the fair value measurements, the
accounting for goodwill and identifiable intangible assets and
the provision for potential losses that may arise from
litigation and regulatory proceedings and tax audits, which may
affect the amounts reported in the condensed financial
statements and accompanying notes. Actual results could differ
materially from these estimates.
For information on the following, refer to the indicated Notes
to the Consolidated Financial Statements of MetLife, Inc.:
|
|
|
|
|
Business, Basis of Presentation and Summary of Significant
Accounting Policies (Note 1)
|
|
|
|
Long-term and Short-term Debt (Note 10)
|
|
|
|
Collateral Financing Arrangements (Note 11)
|
|
|
|
Junior Subordinated Debentures (Note 12)
|
|
|
|
Common Equity Units (Note 13)
|
|
|
|
Contingencies, Commitments and Guarantees (Note 16)
|
|
|
|
Equity (Note 18)
|
|
|
|
Earnings per Common Share (Note 20)
|
|
|
|
Subsequent Events (Note 25)
|
F-169
MetLife,
Inc.
Schedule II
Notes to
the Condensed Financial
Information (Continued)
(Parent
Company Only)
|
|
2.
|
Dispositions
and Acquisition
|
Disposition
of Reinsurance Group of America, Incorporated
As more fully described in Note 2 of the Notes to the
Consolidated Financial Statements, on September 12, 2008,
the Holding Company completed a tax-free split-off of its
majority-owned subsidiary, Reinsurance Group of America,
Incorporated (RGA). The Holding Company and RGA
entered into a recapitalization and distribution agreement,
pursuant to which the Holding Company agreed to divest
substantially all of its 52% interest in RGA to the Holding
Companys stockholders. As a result of completion of the
recapitalization and exchange offer, the Holding Company
received from its stockholders 23,093,689 shares of
the Holding Companys common stock with a market value of
$1,318 million and, in exchange, delivered
29,243,539 shares of RGAs Class B common stock
with a net book value of $1,716 million. The transaction
resulted in a loss of $398 million, which is included in
equity in earnings of subsidiaries, and transaction costs of
$60 million, which is included in other expenses.
Disposition
of Texas Life Insurance Company
As more fully described in Note 2 of the Notes to the
Consolidated Financial Statements, the Holding Company
anticipates completing the sale of Cova Corporation
(Cova), the parent company of Texas Life Insurance
Company in early 2009. As a result of the sale agreement, the
Holding Company recognized a tax benefit of $65 million
relating to the excess of outside tax basis of Cova over its
financial reporting basis.
2008
Acquisition
During 2008, the Holding Company made an acquisition for
$202 million. Total consideration paid by the Holding
Company for this acquisition consisted of $190 million in
cash and $12 million in transaction costs. At
December 31, 2008 the Holding Company held a receivable
related to the settlement of this transaction of
$3 million. The net fair value of assets acquired and
liabilities assumed totaled $129 million which is included
in investment in subsidiaries, resulting in goodwill of
$70 million of which $22 million was contributed to a
subsidiary of the Holding Company. The goodwill is deductible
for tax purposes. During 2008, the Holding Company made a
capital contribution of $97 million to its subsidiaries in
the form of other intangible assets of $143 million, net of
deferred taxes of $46 million, for which the subsidiaries
receive the benefit of such assets.
The Holding Company lends funds, as necessary, to its
subsidiaries, some of which are regulated, to meet their capital
requirements. Such loans are included in loans to subsidiaries
and consisted of the following at:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
|
|
Maturity
|
|
December 31,
|
|
Subsidiaries
|
|
Rate
|
|
Date
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
(In millions)
|
|
|
Metropolitan Life Insurance Company
|
|
3-month LIBOR + 1.15%
|
|
December 31, 2009
|
|
$
|
700
|
|
|
$
|
700
|
|
Metropolitan Life Insurance Company
|
|
7.13%
|
|
December 15, 2032
|
|
|
400
|
|
|
|
400
|
|
Metropolitan Life Insurance Company
|
|
7.13%
|
|
January 15, 2033
|
|
|
100
|
|
|
|
100
|
|
MetLife Investors USA Insurance Company
|
|
7.35%
|
|
April 1, 2035
|
|
|
|
|
|
|
400
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
$
|
1,200
|
|
|
$
|
1,600
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In June 2008, MetLife Investors USA Insurance Company
(MLI-USA) repaid the $400 million surplus note
with an interest rate of 7.35% to the Holding Company.
F-170
MetLife,
Inc.
Schedule II
Notes to
the Condensed Financial
Information (Continued)
(Parent
Company Only)
In December 2007, MLIC repaid the $800 million surplus note
with an interest rate of 5.00% to the Holding Company and then
issued to the Holding Company a $700 million surplus note
with an interest rate of
3-month
LIBOR plus 1.15%.
Interest income earned on loans to subsidiaries of
$81 million, $105 million and $105 million for
the years ended December 31, 2008, 2007 and 2006,
respectively, is included within net investment income.
Payments of interest and principal on surplus notes, which are
subordinate to all other obligations of the issuing company, may
be made only with the prior approval of the insurance department
of the state of domicile.
|
|
4.
|
Long-term
and Short-term Debt
|
Long-term
Debt
Long-term debt outstanding is as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Senior notes:
|
|
|
|
|
|
|
|
|
6.13% due 2011
|
|
$
|
750
|
|
|
$
|
750
|
|
5.38% due 2012
|
|
|
399
|
|
|
|
398
|
|
5.00% due 2013
|
|
|
498
|
|
|
|
497
|
|
5.50% due 2014
|
|
|
351
|
|
|
|
352
|
|
5.00% due 2015
|
|
|
998
|
|
|
|
998
|
|
6.82% due 2018
|
|
|
1,035
|
|
|
|
|
|
5.25% due 2020
|
|
|
578
|
|
|
|
787
|
|
5.38% due 2024
|
|
|
503
|
|
|
|
687
|
|
6.50% due 2032
|
|
|
596
|
|
|
|
596
|
|
5.88% due 2033
|
|
|
200
|
|
|
|
200
|
|
6.38% due 2034
|
|
|
754
|
|
|
|
754
|
|
5.70% due 2035
|
|
|
998
|
|
|
|
998
|
|
|
|
|
|
|
|
|
|
|
Total long-term debt unaffiliated
|
|
|
7,660
|
|
|
|
7,017
|
|
Total long-term debt affiliated
|
|
|
500
|
|
|
|
500
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
8,160
|
|
|
$
|
7,517
|
|
|
|
|
|
|
|
|
|
|
Issuances
In August 2008, the Holding Company issued $1,035 million
of long-term debt with an interest rate of 6.82% maturing in
2018. See also Notes 10, 12 and 13 of the Notes to the
Consolidated Financial Statements.
In September 2006, the Holding Company issued $204 million
of affiliated long-term debt with an interest rate of 6.07%
maturing in 2016.
In March 2006, the Holding Company issued $10 million of
affiliated long-term debt with an interest rate of 5.70%
maturing in 2016.
F-171
MetLife,
Inc.
Schedule II
Notes to
the Condensed Financial
Information (Continued)
(Parent
Company Only)
Repayments
The Holding Company repaid a $500 million 5.25% senior
note which matured in December 2006.
Short-term
Debt
At December 31, 2008 and 2007, the Holding Companys
short-term debt of $300 million and $310 million,
respectively, consisted of commercial paper. During the years
ended December 31, 2008, 2007 and 2006, the commercial
papers average daily balance was $352 million,
$634 million and $1.1 billion, respectively, and was
outstanding for an average of 26 days, 41 days and
32 days, respectively, with a weighted average interest
rate of 2.5%, 4.9% and 5.2%, respectively.
Interest
Expense
Interest expense is comprised of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Short-term debt
|
|
$
|
10
|
|
|
$
|
33
|
|
|
$
|
59
|
|
Long-term debt unaffiliated
|
|
|
412
|
|
|
|
401
|
|
|
|
430
|
|
Long-term debt affiliated
|
|
|
28
|
|
|
|
30
|
|
|
|
20
|
|
Collateral financing arrangements
|
|
|
121
|
|
|
|
84
|
|
|
|
|
|
Junior subordinated debt securities
|
|
|
164
|
|
|
|
183
|
|
|
|
106
|
|
Stock purchase contracts
|
|
|
1
|
|
|
|
2
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total interest expense
|
|
$
|
736
|
|
|
$
|
733
|
|
|
$
|
618
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit
and Committed Facilities and Letters of Credit
Credit Facilities. In December 2008, the
Holding Company and MetLife Funding, Inc. entered into an
amended and restated $2,850 million credit agreement (dated
as of June 2007 and amended and restated at December 23,
2008) with various financial institutions, the proceeds of
which are available to be used for general corporate purposes,
to support their commercial paper programs and for the issuance
of letters of credit. All borrowings under the credit agreement
must be repaid by June 2012, except that letters of credit
outstanding upon termination may remain outstanding until June
2013. The borrowers and the lenders under this facility may
agree to extend the term of all or part of the facility to no
later than June 2014, except that letters of credit outstanding
upon termination may remain outstanding until June 2015. The
Holding Company and MetLife Funding, Inc. incurred amendment
costs of $11 million related to the $2,850 million
amended and restated credit agreement, which have been
capitalized and included in other assets. These costs will be
amortized over the term of the agreement. The Holding Company
did not have any deferred financing costs associated with the
original June 2007 credit agreement.
At December 31, 2008, $2.3 billion of letters of
credit have been issued under these unsecured credit facilities
on behalf of the Holding Company.
These agreements contain various administrative, reporting,
legal and financial covenants, including a consolidated net
worth covenant. Management has no reason to believe that its
lending counterparties are unable to fulfill their respective
contractual obligations.
F-172
MetLife,
Inc.
Schedule II
Notes to
the Condensed Financial
Information (Continued)
(Parent
Company Only)
Committed Facilities. The Holding Company
maintains committed facilities aggregating $11.5 billion at
December 31, 2008. When drawn upon, these facilities bear
interest at varying rates in accordance with the respective
agreements as specified below. The facilities are used for
collateral for certain of the Companys insurance
liabilities. These agreements contain various administrative,
reporting, legal and financial covenants, including a
consolidated net worth covenant.
Total fees associated with these committed facilities were
$35 million, of which $13 million related to deferred
amendment fees, for the year ended December 31, 2008.
Information on committed facilities at December 31, 2008 is
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Letter of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit
|
|
|
Unused
|
|
|
Maturity
|
|
Account Party/Borrower(s)
|
|
Expiration
|
|
Capacity
|
|
|
Drawdowns
|
|
|
Issuances
|
|
|
Commitments
|
|
|
(Years)
|
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
MetLife, Inc.
|
|
August 2009
|
|
(1)
|
|
$
|
500
|
|
|
$
|
|
|
|
$
|
500
|
|
|
$
|
|
|
|
|
|
|
Exeter Reassurance Company Ltd., MetLife, Inc., & Missouri
Reinsurance (Barbados), Inc.
|
|
June 2016
|
|
(3)
|
|
|
500
|
|
|
|
|
|
|
|
490
|
|
|
|
10
|
|
|
|
7
|
|
Exeter Reassurance Company Ltd.
|
|
December 2027
|
|
(2), (4)
|
|
|
650
|
|
|
|
|
|
|
|
410
|
|
|
|
240
|
|
|
|
19
|
|
MetLife Reinsurance Company of South Carolina &
MetLife, Inc.
|
|
June 2037
|
|
(5)
|
|
|
3,500
|
|
|
|
2,692
|
|
|
|
|
|
|
|
808
|
|
|
|
29
|
|
MetLife Reinsurance Company of Vermont & MetLife,
Inc.
|
|
December 2037
|
|
(2), (6)
|
|
|
2,896
|
|
|
|
|
|
|
|
1,359
|
|
|
|
1,537
|
|
|
|
29
|
|
MetLife Reinsurance Company of Vermont & MetLife,
Inc.
|
|
September 2038
|
|
(2), (7)
|
|
|
3,500
|
|
|
|
|
|
|
|
1,500
|
|
|
|
2,000
|
|
|
|
29
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
$
|
11,546
|
|
|
$
|
2,692
|
|
|
$
|
4,259
|
|
|
$
|
4,595
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
In December 2008, the Holding Company entered into an amended
and restated one year $500 million letter of credit
facility (dated as of August 2008 and amended and restated at
December 31, 2008 with an unaffiliated financial
institution. Exeter Reassurance Company, Ltd. is a co-applicant
under this letter of credit facility. This letter of credit
facility matures in August 2009, except that letters of credit
outstanding upon termination may remain outstanding until August
2010. Fees for this agreement include a margin of 2.25% and a
utilization fee of 0.05%, as applicable. The Holding Company
incurred amendment costs of $1.3 million related to the
$500 million amended and restated letter of credit
facility, which have been capitalized and included in other
assets. These costs will be amortized over the term of the
agreement. |
|
(2) |
|
The Holding Company is a guarantor under this agreement. |
|
(3) |
|
Letters of credit and replacements or renewals thereof issued
under this facility of $280 million, $10 million and
$200 million are set to expire no later than December 2015,
March 2016 and June 2016, respectively. |
|
(4) |
|
In December 2008, Exeter as borrower and the Holding Company as
guarantor entered into an amendment of an existing credit
agreement with an unaffiliated financial institution. Issuances
under this facility are set to expire in December 2027. Exeter
incurred amendment costs of $1.6 million related to the
amendment of the existing credit agreement, which have been
capitalized and included in other assets. These costs will be
amortized over the term of the agreement. |
|
(5) |
|
In May 2007, MetLife Reinsurance Company of South Carolina
(MRSC), a wholly-owned subsidiary of the Holding
Company, terminated the $2.0 billion amended and restated
five-year letter of credit and reimbursement agreement entered
into among the Holding Company, MRSC and various financial
institutions on April 25, 2005. In its place, the Holding
Company entered into a
30-year
collateral |
F-173
MetLife,
Inc.
Schedule II
Notes to
the Condensed Financial
Information (Continued)
(Parent
Company Only)
|
|
|
|
|
financing arrangement as described in Note 11 of the Notes
to the Consolidated Financial Statements, which may be extended
by agreement of the Holding Company and the financial
institution on each anniversary of the closing of the facility
for an additional one-year period. At December 31, 2008,
$2.7 billion had been drawn upon under the collateral
financing arrangement. |
|
(6) |
|
In December 2007, Exeter terminated four letters of credit, with
expirations from March 2025 through December 2026, which were
issued under a letter of credit facility with an unaffiliated
financial institution in an aggregate amount of
$1.7 billion. The letters of credit had served as
collateral for Exeters obligations under a reinsurance
agreement that was recaptured by MLI-USA in December 2007.
MLI-USA immediately thereafter entered into a new reinsurance
agreement with MetLife Reinsurance Company of Vermont
(MRV). To collateralize its reinsurance obligations,
MRV and the Holding Company entered into a
30-year,
$2.9 billion letter of credit facility with an unaffiliated
financial institution. |
|
(7) |
|
In September 2008, MRV and the Holding Company entered into a
30-year,
$3.5 billion letter of credit facility with an unaffiliated
financial institution. These letters of credit serve as
collateral for MRVs obligations under a reinsurance
agreement. |
Letters of Credit. At December 31, 2008,
the Holding Company had outstanding $2.8 billion in letters
of credit, substantially all of which are associated with the
aforementioned credit facilities, from various financial
institutions, of which $500 million and $2.3 billion
were part of committed and credit facilities, respectively. As
commitments associated with letters of credit and financing
arrangements may expire unused, these amounts do not necessarily
reflect the Holding Companys actual future cash funding
requirements.
|
|
5.
|
Related
Party Transactions
|
Dividends
The primary source of the Holding Companys liquidity is
dividends it receives from its insurance subsidiaries. The
Holding Companys insurance subsidiaries are subject to
regulatory restrictions on the payment of dividends imposed by
the regulators of their respective domiciles. The dividend
limitation for U.S. insurance subsidiaries is based on the
surplus to policyholders as of the immediately preceding
calendar year and statutory net gain from operations for the
immediately preceding calendar year. The maximum aggregate
amount of dividends which the Holding Company subsidiaries may
pay to the Holding Company in 2009 without insurance regulatory
approval is $1,363 million.
Financing
Arrangements Related to Subsidiaries
As described more fully in Note 11 of the Notes to the
Consolidated Financial Statements:
|
|
|
|
|
In December 2007, the Holding Company, in connection with the
collateral financing arrangement associated with MetLife
Reinsurance Company of Charlestons (MRC)
reinsurance of the closed block liabilities, entered into an
agreement with an unaffiliated financial institution under which
the Holding Company is entitled to the interest paid by MRC on
the surplus notes of
3-month
LIBOR plus 0.55% in exchange for the payment of
3-month
LIBOR plus 1.12%, payable quarterly. Under this agreement, the
Holding Company may also be required to pledge collateral or
make payments to the unaffiliated financial institution related
to any decline in the estimated fair value of the surplus notes
and in connection with any early termination of this agreement.
During the year ended December 31, 2008, the Holding
Company paid $800 million to the unaffiliated financial
institution related to a decline in the estimated fair value of
the surplus notes. This payment reduced the amount under the
agreement on which the Holding Companys interest payment
is due but did not reduce the outstanding amount of the surplus
notes. In addition, the Holding Company had pledged collateral
of $230 million to the unaffiliated financial institution
at
|
F-174
MetLife,
Inc.
Schedule II
Notes to
the Condensed Financial
Information (Continued)
(Parent
Company Only)
|
|
|
|
|
December 31, 2008. No collateral had been pledged at
December 31, 2007. The Holding Companys net cost of
0.57% has been allocated to MRC. For the year ended
December 31, 2008, this amount was $14 million. For
the year ended December 31, 2007, this amount was
immaterial.
|
|
|
|
|
|
In May 2007, the Holding Company, in connection with the
collateral financing arrangement associated with MRSC
reinsurance of universal life secondary guarantees, entered into
an agreement with an unaffiliated financial institution under
which the Holding Company is entitled to the return on the
investment portfolio held by the trust established in connection
with this collateral financing arrangement in exchange for the
payment of a stated rate of return to the unaffiliated financial
institution of
3-month
LIBOR plus 0.70%, payable quarterly. The Holding Company may
also be required to make payments to the unaffiliated financial
institution, for deposit into the trust, related to any decline
in the estimated fair value of the assets held by the trust, as
well as amounts outstanding upon maturity or early termination
of the collateral financing arrangement. As a result of this
agreement, the Holding Company effectively assumed the
$2.4 billion liability under the collateral financing
arrangement along with a beneficial interest in the trust
holding the associated assets. The Holding Company
simultaneously contributed to MRSC its beneficial interest in
the trust, along with any return to be received on the
investment portfolio held by the trust. For the year ended
December 31, 2008, the Holding Company paid
$320 million to the unaffiliated financial institution as a
result of the decline in the estimated fair value of the assets
in the trust. All of the $320 million was deposited into
the trust. In January 2009, the Holding Company paid an
additional $360 million to the unaffiliated financial
institution as a result of the continued decline in the
estimated fair value of the assets in trust which was also
deposited into the trust. In addition, the Holding Company may
be required to pledge collateral to the unaffiliated financial
institution under this agreement. At December 31, 2008, the
Holding Company had pledged $86 million under the
agreement. No collateral had been pledged under the agreement as
December 31, 2007. Interest expense incurred by the Holding
Company under the collateral financing arrangement for the years
ended December 31, 2008 and 2007 was $107 million and
$84 million, respectively. The allocation of these
financing costs to MRSC is included in other revenues and
recorded as an additional investment in MRSC.
|
Support
Agreements
In October 2007, the Holding Company, in connection with
MRVs reinsurance of certain universal life and term life
insurance risks, committed to the Vermont Department of Banking,
Insurance, Securities and Health Care Administration to take
necessary action to cause each of the two initial protected
cells of MRV to maintain total adjusted capital equal to or
greater than 200% of such protected cells authorized
control level risk-based capital (RBC), as defined
in state insurance statutes. This transaction is more fully
described in Note 10 of the Notes to the Consolidated
Financial Statements.
In December 2007, the Holding Company, in connection with the
collateral financing arrangement associated with MRCs
reinsurance of a portion of the liabilities associated with the
closed block, committed to the South Carolina Department of
Insurance to make capital contributions, if necessary, to MRC so
that MRC may at all times maintain its total adjusted capital at
a level of not less than 200% of the company action
level RBC, as defined in state insurance statutes as in
effect on the date of determination or December 31, 2007,
whichever calculation produces the greater capital requirement,
or as otherwise required by the South Carolina Department of
Insurance. This collateral financing arrangement is more fully
described in Note 11 of the Notes to the Consolidated
Financial Statements.
In May 2007, the Holding Company, in connection with the
collateral financing arrangement associated with MRSCs
reinsurance of universal life secondary guarantees, committed to
the South Carolina Department of Insurance to take necessary
action to cause MRSC to maintain total adjusted capital equal to
the greater of $250,000
F-175
MetLife,
Inc.
Schedule II
Notes to
the Condensed Financial
Information (Continued)
(Parent
Company Only)
or 100% of MRSCs authorized control level RBC, as
defined in state insurance statutes. This collateral financing
arrangement is more fully described in Note 11 of the Notes
to the Consolidated Financial Statements.
The Holding Company has net worth maintenance agreements with
two of its insurance subsidiaries, MetLife Investors Insurance
Company and First MetLife Investors Insurance Company. Under
these agreements, as subsequently amended, the Holding Company
agreed, without limitation as to the amount, to cause each of
these subsidiaries to have a minimum capital and surplus of
$10 million, total adjusted capital at a level not less
than 150% of the company action level RBC, as defined by
state insurance statutes, and liquidity necessary to enable it
to meet its current obligations on a timely basis.
The Holding Company entered into a net worth maintenance
agreement with Mitsui Sumitomo MetLife Insurance Company Limited
(MSMIC), an investment in Japan of which the Holding
Company owns 50% of the equity. Under the agreement, the Holding
Company agreed, without limitation as to amount, to cause MSMIC
to have the amount of capital and surplus necessary for MSMIC to
maintain a solvency ratio of at least 400%, as calculated in
accordance with the Insurance Business Law of Japan, and to make
such loans to MSMIC as may be necessary to ensure that MSMIC has
sufficient cash or other liquid assets to meet its payment
obligations as they fall due.
The Holding Company has guaranteed the obligations of its
subsidiary, Exeter, under a reinsurance agreement with MSMIC
under which Exeter reinsures variable annuities written by MSMIC.
Management anticipates that to the extent that these
arrangements place significant demands upon the Holding Company,
there will be sufficient liquidity and capital to enable the
Holding Company to meet these demands.
Other
See Note 3 for description of loans to subsidiaries.
See Note 4 for description of the Holding Companys
debt with subsidiaries.
Fair
Value of Financial Instruments
The Holding Company prospectively adopted the provisions of
SFAS 157 effective January 1, 2008. As a result, the
methodologies used to determine the estimated fair value for
certain financial instruments at December 31, 2008 may
have been modified from those utilized at December 31,
2007, which, while being deemed appropriate under existing
accounting guidance, may not have produced an exit value as
defined in SFAS 157. Accordingly, the estimated fair value
of financial instruments, and the description of the
methodologies used to derive those estimated fair values, are
presented separately at December 31, 2007 and
December 31, 2008. Considerable judgment is often required
in interpreting market data to develop estimates of fair value
and the use of different assumptions or valuation methodologies
may have a material effect on the estimated fair value amounts.
F-176
MetLife,
Inc.
Schedule II
Notes to
the Condensed Financial
Information (Continued)
(Parent
Company Only)
Amounts related to the Holding Companys financial
instruments are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notional
|
|
Carrying
|
|
Estimated
|
December 31, 2007
|
|
Amount
|
|
Value
|
|
Fair Value
|
|
|
(In millions)
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities
|
|
|
|
|
|
$
|
2,540
|
|
|
$
|
2,540
|
|
Equity securities
|
|
|
|
|
|
$
|
24
|
|
|
$
|
24
|
|
Cash and cash equivalents
|
|
|
|
|
|
$
|
587
|
|
|
$
|
587
|
|
Accrued investment income
|
|
|
|
|
|
$
|
62
|
|
|
$
|
62
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term debt
|
|
|
|
|
|
$
|
310
|
|
|
$
|
310
|
|
Long-term debt unaffiliated
|
|
|
|
|
|
$
|
7,017
|
|
|
$
|
6,814
|
|
Long-term debt affiliated
|
|
|
|
|
|
$
|
500
|
|
|
$
|
413
|
|
Collateral financing arrangements
|
|
|
|
|
|
$
|
2,382
|
|
|
$
|
2,164
|
|
Junior subordinated debt securities
|
|
|
|
|
|
$
|
3,382
|
|
|
$
|
3,268
|
|
Payables for collateral under securities loaned and other
transactions
|
|
|
|
|
|
$
|
814
|
|
|
$
|
814
|
|
For a summary of the methods and assumptions used to estimate
the fair value of financial instruments, including long-term
debt-affiliated which is valued in the same manner as long-term
debt-unaffiliated, see Fair Value of Financial
Instruments 2007 in Note 24 of the Notes
to the Consolidated Financial Statements.
F-177
MetLife,
Inc.
Schedule II
Notes to
the Condensed Financial
Information (Continued)
(Parent
Company Only)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notional
|
|
Carrying
|
|
Estimated
|
December 31, 2008
|
|
Amount
|
|
Value
|
|
Fair Value
|
|
|
(In millions)
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities
|
|
|
|
|
|
$
|
1,391
|
|
|
$
|
1,391
|
|
Equity securities
|
|
|
|
|
|
$
|
8
|
|
|
$
|
8
|
|
Short-term investments
|
|
|
|
|
|
$
|
1,073
|
|
|
$
|
1,073
|
|
Other invested assets (3)
|
|
$
|
1,332
|
|
|
$
|
39
|
|
|
$
|
39
|
|
Cash and cash equivalents
|
|
|
|
|
|
$
|
678
|
|
|
$
|
678
|
|
Accrued investment income
|
|
|
|
|
|
$
|
29
|
|
|
$
|
29
|
|
Loans to and receivables from subsidiaries
|
|
|
|
|
|
$
|
1,201
|
|
|
$
|
984
|
|
Other assets (1)
|
|
|
|
|
|
$
|
863
|
|
|
$
|
692
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term debt
|
|
|
|
|
|
$
|
300
|
|
|
$
|
300
|
|
Long-term debt unaffiliated
|
|
|
|
|
|
$
|
7,660
|
|
|
$
|
6,348
|
|
Long-term debt affiliated
|
|
|
|
|
|
$
|
500
|
|
|
$
|
351
|
|
Collateral financing arrangements
|
|
|
|
|
|
$
|
2,692
|
|
|
$
|
946
|
|
Junior subordinated debt securities
|
|
|
|
|
|
$
|
2,315
|
|
|
$
|
1,720
|
|
Payables for collateral under securities loaned and other
transactions
|
|
|
|
|
|
$
|
343
|
|
|
$
|
343
|
|
Other liabilities: (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative liabilities
|
|
$
|
2,318
|
|
|
$
|
634
|
|
|
$
|
634
|
|
Other
|
|
|
|
|
|
$
|
176
|
|
|
$
|
176
|
|
Commitments:
|
|
|
|
|
|
|
|
|
|
|
|
|
Commitment under collateral financing arrangement (2)
|
|
$
|
1,700
|
|
|
$
|
|
|
|
$
|
(502
|
)
|
|
|
|
(1) |
|
Carrying values presented herein differ from those presented in
the condensed financial information because certain items within
the respective balance sheet caption are not considered
financial instruments. Balance sheet captions omitted from the
table above are not considered financial instruments. |
|
(2) |
|
Commitment under collateral financing arrangement is an
off-balance sheet liability and is not recognized in the
condensed financial information. |
|
(3) |
|
Other invested assets is comprised of freestanding derivatives
with positive estimated fair values. |
For a summary of the methods and assumptions used to estimate
the fair value of financial instruments, including long-term
debt-affiliated which is valued in the same manner as long-term
debt-unaffiliated, see Fair Value of Financial
Instruments 2008 under Note 24 of the
Notes to the Consolidated Financial Statements. The methods and
assumptions used to estimate the fair value of certain other
financial instruments are summarized as follows:
Loans to and Receivables from Subsidiaries
The Holding Company lends funds, as necessary, to its
subsidiaries, some of which are regulated, to meet their capital
requirements. The estimated fair values are determined by
discounting expected future cash flows using current market
interest rates currently available for instruments with similar
terms issued to companies of comparable credit quality of the
respective subsidiaries.
F-178
MetLife,
Inc.
Schedule II
Notes to
the Condensed Financial
Information (Continued)
(Parent
Company Only)
Commitment Under Collateral Financing
Arrangement The commitment under collateral
financing arrangement is an off-balance sheet liability that
represents the Holding Companys obligation to potentially
make additional payments to the unaffiliated financial
institution under the terms of the agreement entered into
simultaneously with the issuance of surplus notes by MRC as
discussed in Note 11 of the Notes to the Consolidated
Financial Statements. The fair value of this commitment was
estimated based on a valuation model similar to that used to
value a credit default swap using inputs based on market data
for issuers with credit ratings similar to MRC.
Assets
and Liabilities Measured at Fair Value
Recurring
Fair Value Measurements
The assets and liabilities measured at estimated fair value on a
recurring basis are estimated as described in the preceding
section. These estimated fair values and their corresponding
fair value hierarchy are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
Fair Value Measurements at Reporting Date Using
|
|
|
|
|
Quoted Prices in
|
|
|
|
|
|
|
|
|
Active Markets for
|
|
|
|
Significant
|
|
|
|
|
Identical Assets
|
|
Significant Other
|
|
Unobservable
|
|
Total
|
|
|
and Liabilities
|
|
Observable Inputs
|
|
Inputs
|
|
Estimated
|
|
|
(Level 1)
|
|
(Level 2)
|
|
(Level 3)
|
|
Fair Value
|
|
|
|
|
(In millions)
|
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. corporate securities
|
|
$
|
|
|
|
$
|
167
|
|
|
$
|
3
|
|
|
$
|
170
|
|
Residential mortgage-backed securities
|
|
|
|
|
|
|
859
|
|
|
|
|
|
|
|
859
|
|
Foreign corporate securities
|
|
|
|
|
|
|
11
|
|
|
|
22
|
|
|
|
33
|
|
U.S. Treasury/agency securities
|
|
|
108
|
|
|
|
72
|
|
|
|
|
|
|
|
180
|
|
Commercial mortgage-backed securities
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
1
|
|
Asset-backed securities
|
|
|
|
|
|
|
96
|
|
|
|
20
|
|
|
|
116
|
|
Other fixed maturity securities
|
|
|
|
|
|
|
|
|
|
|
32
|
|
|
|
32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity securities
|
|
|
108
|
|
|
|
1,206
|
|
|
|
77
|
|
|
|
1,391
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-redeemable preferred stock
|
|
|
|
|
|
|
1
|
|
|
|
7
|
|
|
|
8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
|
|
|
|
|
1
|
|
|
|
7
|
|
|
|
8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term investments
|
|
|
886
|
|
|
|
187
|
|
|
|
|
|
|
|
1,073
|
|
Derivative assets
|
|
|
|
|
|
|
39
|
|
|
|
|
|
|
|
39
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
994
|
|
|
$
|
1,433
|
|
|
$
|
84
|
|
|
$
|
2,511
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative liabilities
|
|
$
|
|
|
|
$
|
634
|
|
|
$
|
|
|
|
$
|
634
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Holding Company has categorized its assets and liabilities
into the three-level fair value hierarchy, as defined in
Note 1 of the Notes to the Consolidated Financial
Statements, based upon the priority of the inputs to the
respective valuation technique. Assets and liabilities
recognized at the Holding Company are of the same types as those
reported on a consolidated basis for MetLife, Inc. and are
included within the fair value hierarchy in the same
F-179
MetLife,
Inc.
Schedule II
Notes to
the Condensed Financial
Information (Continued)
(Parent
Company Only)
manner as described in Assets and Liabilities Measured at
Fair Value under Note 24 of the Notes to the
Consolidated Financial Statements.
A rollforward of the fair value measurements for all assets and
liabilities measured at estimated fair value on a recurring
basis using significant unobservable (Level 3) inputs
for year ended December 31, 2008 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements Using Significant Unobservable Inputs
(Level 3)
|
|
|
|
|
|
|
|
|
Total Realized/Unrealized
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gains (Losses) included in:
|
|
Purchases,
|
|
|
|
|
|
|
Balance,
|
|
Impact of
|
|
Balance,
|
|
|
|
Other
|
|
Sales,
|
|
Transfer In
|
|
|
|
|
December 31,
|
|
SFAS 157
|
|
Beginning
|
|
|
|
Comprehensive
|
|
Issuances and
|
|
and/or Out
|
|
Balance,
|
|
|
2007
|
|
Adoption (1)
|
|
of Period
|
|
Earnings (2, 3)
|
|
Income (Loss)
|
|
Settlements (4)
|
|
of Level 3 (5)
|
|
End of Period
|
|
|
(In millions)
|
|
Fixed maturity securities
|
|
$
|
197
|
|
|
$
|
|
|
|
$
|
197
|
|
|
$
|
(21
|
)
|
|
$
|
(32
|
)
|
|
$
|
(79
|
)
|
|
$
|
12
|
|
|
$
|
77
|
|
Equity securities
|
|
|
21
|
|
|
|
|
|
|
|
21
|
|
|
|
(12
|
)
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
|
|
|
7
|
|
See Assets and Liabilities Measured at Fair Value
under Note 24 of the Notes to the Consolidated Financial
Statements for an explanation of the footnotes in the preceding
table.
The Holding Company had realized and unrealized gains and losses
recorded in earnings for the year ended December 31, 2008
due to changes in estimated fair value recorded in net
investment gains (losses) for Level 3 assets and
liabilities of ($21) million and ($12) million for
fixed maturity and equity securities respectively. The Holding
Company had no unrealized gains and losses recorded in earnings
for the year ended December 31, 2008 for Level 3
assets and liabilities that were still held at December 31,
2008.
In February 2009, the Holding Company contributed a total of
$74 million to two of its insurance subsidiaries.
On January 28, 2009, the Holding Company made a
$360 million payment to the unaffiliated financial
institution related to the collateral financing arrangement for
MRSC. Under the terms of this arrangement, the Holding Company
may be required to make payments to the unaffiliated financial
institution, for deposit into the trust, related to any decline
in the estimated fair value of the assets held by the trust.
F-180
MetLife,
Inc.
Schedule III
Consolidated
Supplementary Insurance Information
December 31, 2008, 2007 and 2006
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Future Policy
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits, Other
|
|
|
|
|
|
|
|
|
|
|
|
DAC
|
|
|
Policyholder Funds
|
|
|
Policyholder
|
|
|
Policyholder
|
|
|
|
|
|
and
|
|
|
and Policyholder
|
|
|
Account
|
|
|
Dividends
|
|
|
Unearned
|
Segment
|
|
VOBA
|
|
|
Dividend Obligation
|
|
|
Balances
|
|
|
Payable
|
|
|
Revenue (1)
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Institutional
|
|
$
|
1,013
|
|
|
$
|
58,484
|
|
|
$
|
75,332
|
|
|
$
|
|
|
|
$
|
73
|
Individual
|
|
|
16,505
|
|
|
|
60,718
|
|
|
|
61,869
|
|
|
|
1,023
|
|
|
|
1,267
|
International
|
|
|
2,436
|
|
|
|
10,468
|
|
|
|
5,654
|
|
|
|
|
|
|
|
583
|
Auto & Home
|
|
|
183
|
|
|
|
3,126
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate & Other
|
|
|
7
|
|
|
|
5,521
|
|
|
|
6,950
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
20,144
|
|
|
$
|
138,317
|
|
|
$
|
149,805
|
|
|
$
|
1,023
|
|
|
$
|
1,923
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Institutional
|
|
$
|
923
|
|
|
$
|
55,064
|
|
|
$
|
66,083
|
|
|
$
|
|
|
|
$
|
56
|
Individual
|
|
|
14,038
|
|
|
|
60,143
|
|
|
|
54,767
|
|
|
|
991
|
|
|
|
1,238
|
International
|
|
|
2,648
|
|
|
|
11,121
|
|
|
|
4,961
|
|
|
|
|
|
|
|
544
|
Auto & Home
|
|
|
193
|
|
|
|
3,324
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate & Other
|
|
|
8
|
|
|
|
4,991
|
|
|
|
4,531
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
17,810
|
|
|
$
|
134,643
|
|
|
$
|
130,342
|
|
|
$
|
991
|
|
|
$
|
1,838
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Institutional
|
|
$
|
1,370
|
|
|
$
|
53,511
|
|
|
$
|
59,694
|
|
|
$
|
|
|
|
$
|
37
|
Individual
|
|
|
13,814
|
|
|
|
59,421
|
|
|
|
56,857
|
|
|
|
957
|
|
|
|
1,078
|
International
|
|
|
2,117
|
|
|
|
9,346
|
|
|
|
4,198
|
|
|
|
|
|
|
|
373
|
Auto & Home
|
|
|
190
|
|
|
|
3,453
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate & Other
|
|
|
13
|
|
|
|
4,664
|
|
|
|
4,636
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
17,504
|
|
|
$
|
130,395
|
|
|
$
|
125,385
|
|
|
$
|
957
|
|
|
$
|
1,488
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Amounts are included within the future policy benefits, other
policyholder funds and policyholder dividend obligation column. |
F-181
MetLife,
Inc.
Schedule III (Continued)
Consolidated Supplementary Insurance Information
December 31, 2008, 2007 and 2006
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of
|
|
|
|
|
|
|
|
|
|
Premium
|
|
|
Net
|
|
|
Policyholder
|
|
|
DAC and VOBA
|
|
|
Other
|
|
|
|
|
|
|
Revenue and
|
|
|
Investment
|
|
|
Benefits and
|
|
|
Charged to
|
|
|
Operating
|
|
|
Premiums Written
|
|
Segment
|
|
Policy Charges
|
|
|
Income
|
|
|
Interest Credited
|
|
|
Other Expenses
|
|
|
Expenses (1)
|
|
|
(Excluding Life)
|
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Institutional
|
|
$
|
15,850
|
|
|
$
|
7,535
|
|
|
$
|
19,106
|
|
|
$
|
151
|
|
|
$
|
2,257
|
|
|
$
|
5,594
|
|
Individual
|
|
|
7,881
|
|
|
|
6,509
|
|
|
|
7,807
|
|
|
|
2,498
|
|
|
|
4,384
|
|
|
|
|
|
International
|
|
|
4,565
|
|
|
|
1,249
|
|
|
|
3,337
|
|
|
|
381
|
|
|
|
1,297
|
|
|
|
846
|
|
Auto & Home
|
|
|
2,971
|
|
|
|
186
|
|
|
|
1,919
|
|
|
|
454
|
|
|
|
355
|
|
|
|
2,949
|
|
Corporate & Other
|
|
|
28
|
|
|
|
817
|
|
|
|
55
|
|
|
|
5
|
|
|
|
1,893
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
31,295
|
|
|
$
|
16,296
|
|
|
$
|
32,224
|
|
|
$
|
3,489
|
|
|
$
|
10,186
|
|
|
$
|
9,389
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Institutional
|
|
$
|
13,194
|
|
|
$
|
8,176
|
|
|
$
|
16,899
|
|
|
$
|
251
|
|
|
$
|
2,188
|
|
|
$
|
4,972
|
|
Individual
|
|
|
7,922
|
|
|
|
7,025
|
|
|
|
7,678
|
|
|
|
1,211
|
|
|
|
4,507
|
|
|
|
|
|
International
|
|
|
4,091
|
|
|
|
1,247
|
|
|
|
2,814
|
|
|
|
309
|
|
|
|
1,444
|
|
|
|
669
|
|
Auto & Home
|
|
|
2,966
|
|
|
|
196
|
|
|
|
1,807
|
|
|
|
468
|
|
|
|
365
|
|
|
|
2,982
|
|
Corporate & Other
|
|
|
35
|
|
|
|
1,419
|
|
|
|
46
|
|
|
|
11
|
|
|
|
1,398
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
28,208
|
|
|
$
|
18,063
|
|
|
$
|
29,244
|
|
|
$
|
2,250
|
|
|
$
|
9,902
|
|
|
$
|
8,623
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Institutional
|
|
$
|
12,642
|
|
|
$
|
7,260
|
|
|
$
|
15,961
|
|
|
$
|
182
|
|
|
$
|
2,131
|
|
|
$
|
4,575
|
|
Individual
|
|
|
7,633
|
|
|
|
6,863
|
|
|
|
7,353
|
|
|
|
896
|
|
|
|
4,285
|
|
|
|
|
|
International
|
|
|
3,527
|
|
|
|
949
|
|
|
|
2,699
|
|
|
|
362
|
|
|
|
1,166
|
|
|
|
623
|
|
Auto & Home
|
|
|
2,924
|
|
|
|
177
|
|
|
|
1,717
|
|
|
|
459
|
|
|
|
392
|
|
|
|
2,946
|
|
Corporate & Other
|
|
|
37
|
|
|
|
998
|
|
|
|
38
|
|
|
|
5
|
|
|
|
1,357
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
26,763
|
|
|
$
|
16,247
|
|
|
$
|
27,768
|
|
|
$
|
1,904
|
|
|
$
|
9,331
|
|
|
$
|
8,144
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Includes other expenses and policyholder dividends, excluding
amortization of DAC and VOBA charged to other expenses. |
F-182
MetLife,
Inc.
Schedule IV
Consolidated
Reinsurance
December 31, 2008, 2007 and 2006
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% Amount
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assumed
|
|
|
|
Gross Amount
|
|
|
Ceded
|
|
|
Assumed
|
|
|
Net Amount
|
|
|
to Net
|
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance in-force
|
|
$
|
3,697,999
|
|
|
$
|
715,741
|
|
|
$
|
684,281
|
|
|
$
|
3,666,539
|
|
|
|
18.7
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance premium
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance
|
|
$
|
17,252
|
|
|
$
|
2,066
|
|
|
$
|
1,224
|
|
|
$
|
16,410
|
|
|
|
7.5
|
%
|
Accident and health
|
|
|
6,741
|
|
|
|
444
|
|
|
|
226
|
|
|
|
6,523
|
|
|
|
3.5
|
%
|
Property and casualty insurance
|
|
|
3,065
|
|
|
|
100
|
|
|
|
16
|
|
|
|
2,981
|
|
|
|
0.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total insurance premium
|
|
$
|
27,058
|
|
|
$
|
2,610
|
|
|
$
|
1,466
|
|
|
$
|
25,914
|
|
|
|
5.7
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% Amount
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assumed
|
|
|
|
Gross Amount
|
|
|
Ceded
|
|
|
Assumed
|
|
|
Net Amount
|
|
|
to Net
|
|
|
Life insurance in-force
|
|
$
|
3,368,637
|
|
|
$
|
566,998
|
|
|
$
|
489,340
|
|
|
$
|
3,290,979
|
|
|
|
14.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance premium
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance
|
|
$
|
15,184
|
|
|
$
|
1,819
|
|
|
$
|
965
|
|
|
$
|
14,330
|
|
|
|
6.7
|
%
|
Accident and health
|
|
|
5,900
|
|
|
|
436
|
|
|
|
201
|
|
|
|
5,665
|
|
|
|
3.5
|
%
|
Property and casualty insurance
|
|
|
3,065
|
|
|
|
116
|
|
|
|
26
|
|
|
|
2,975
|
|
|
|
0.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total insurance premium
|
|
$
|
24,149
|
|
|
$
|
2,371
|
|
|
$
|
1,192
|
|
|
$
|
22,970
|
|
|
|
5.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% Amount
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assumed
|
|
|
|
Gross Amount
|
|
|
Ceded
|
|
|
Assumed
|
|
|
Net Amount
|
|
|
to Net
|
|
|
Life insurance in-force
|
|
$
|
3,588,979
|
|
|
$
|
635,470
|
|
|
$
|
67,599
|
|
|
$
|
3,021,108
|
|
|
|
2.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance premium
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance
|
|
$
|
14,926
|
|
|
$
|
1,621
|
|
|
$
|
705
|
|
|
$
|
14,010
|
|
|
|
5.0
|
%
|
Accident and health
|
|
|
5,305
|
|
|
|
449
|
|
|
|
133
|
|
|
|
4,989
|
|
|
|
2.7
|
%
|
Property and casualty insurance
|
|
|
3,077
|
|
|
|
114
|
|
|
|
90
|
|
|
|
3,053
|
|
|
|
2.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total insurance premium
|
|
$
|
23,308
|
|
|
$
|
2,184
|
|
|
$
|
928
|
|
|
$
|
22,052
|
|
|
|
4.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-183
|
|
Item 9.
|
Changes
in and Disagreements With Accountants on Accounting and
Financial Disclosure
|
None.
|
|
Item 9A.
|
Controls
and Procedures
|
Management, with the participation of the Chief Executive
Officer and Chief Financial Officer, has evaluated the
effectiveness of the design and operation of the Companys
disclosure controls and procedures as defined in Exchange Act
Rule 13a-15(e)
as of the end of the period covered by this report. Based on
that evaluation, the Chief Executive Officer and Chief Financial
Officer have concluded that these disclosure controls and
procedures are effective.
There were no changes to the Companys internal control
over financial reporting as defined in Exchange Act
Rule 13a-15(f)
during the quarter ended December 31, 2008 that have
materially affected, or are reasonably likely to materially
affect, the Companys internal control over financial
reporting.
Managements
Annual Report on Internal Control Over Financial
Reporting
Management of MetLife, Inc. and subsidiaries is responsible for
establishing and maintaining adequate internal control over
financial reporting. In fulfilling this responsibility,
estimates and judgments by management are required to assess the
expected benefits and related costs of control procedures. The
objectives of internal control include providing management with
reasonable, but not absolute, assurance that assets are
safeguarded against loss from unauthorized use or disposition,
and that transactions are executed in accordance with
managements authorization and recorded properly to permit
the preparation of consolidated financial statements in
conformity with GAAP.
Financial management has documented and evaluated the
effectiveness of the internal control of the Company at
December 31, 2008 pertaining to financial reporting in
accordance with the criteria established in Internal
Control Integrated Framework issued by the
Committee of Sponsoring Organizations of the Treadway Commission.
In the opinion of management, MetLife, Inc. maintained effective
internal control over financial reporting at December 31,
2008.
Deloitte & Touche LLP, an independent registered
public accounting firm, has audited the consolidated financial
statements and consolidated financial statement schedules
included in the Annual Report on
Form 10-K
for the year ended December 31, 2008. The Report of the
Independent Registered Public Accounting Firm on their audit of
the consolidated financial statements and consolidated financial
statement schedules is included at
page F-1.
Attestation
Report of the Companys Registered Public Accounting
Firm
The Companys independent registered public accounting
firm, Deloitte & Touche LLP, has issued their
attestation report on managements internal control over
financial reporting which is set forth below.
248
Report of
Independent Registered Public Accounting Firm
To the Board of Directors and Stockholders of
MetLife, Inc.:
We have audited the internal control over financial reporting of
MetLife, Inc. and subsidiaries (the Company) as of
December 31, 2008, based on criteria established in
Internal Control Integrated Framework issued
by the Committee of Sponsoring Organizations of the Treadway
Commission. The Companys management is responsible for
maintaining effective internal control over financial reporting
and for its assessment of the effectiveness of internal control
over financial reporting, included in the accompanying
Managements Annual Report on Internal Control Over
Financial Reporting. Our responsibility is to express an opinion
on the Companys internal control over financial reporting
based on our audit.
We conducted our audit in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether effective internal control
over financial reporting was maintained in all material
respects. Our audit included obtaining an understanding of
internal control over financial reporting, assessing the risk
that a material weakness exists, testing and evaluating the
design and operating effectiveness of internal control based on
the assessed risk, and performing such other procedures as we
considered necessary in the circumstances. We believe that our
audit provides a reasonable basis for our opinion.
A companys internal control over financial reporting is a
process designed by, or under the supervision of, the
companys principal executive and principal financial
officers, or persons performing similar functions, and effected
by the companys board of directors, management, and other
personnel to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with
generally accepted accounting principles. A companys
internal control over financial reporting includes those
policies and procedures that (1) pertain to the maintenance
of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the
company; (2) provide reasonable assurance that transactions
are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting
principles, and that receipts and expenditures of the company
are being made only in accordance with authorizations of
management and directors of the company; and (3) provide
reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use, or disposition of the
companys assets that could have a material effect on the
financial statements.
Because of the inherent limitations of internal control over
financial reporting, including the possibility of collusion or
improper management override of controls, material misstatements
due to error or fraud may not be prevented or detected on a
timely basis. Also, projections of any evaluation of the
effectiveness of the internal control over financial reporting
to future periods are subject to the risk that the controls may
become inadequate because of changes in conditions, or that the
degree of compliance with the policies or procedures may
deteriorate.
In our opinion, the Company maintained, in all material
respects, effective internal control over financial reporting as
of December 31, 2008, based on the criteria established in
Internal Control Integrated Framework issued
by the Committee of Sponsoring Organizations of the Treadway
Commission.
We have also audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), the
consolidated financial statements and financial statement
schedules as of and for the year ended December 31, 2008,
of the Company, and our report dated February 26, 2009,
expressed an unqualified opinion on those consolidated financial
statements and financial statement schedules and included an
explanatory paragraph regarding changes in the Companys
method of accounting for certain assets and liabilities to a
fair value measurement approach as required by accounting
guidance adopted on January 1, 2008.
/s/ DELOITTE &
TOUCHE LLP
DELOITTE &
TOUCHE LLP
New York, New York
February 26, 2009
249
|
|
Item 9B.
|
Other
Information
|
On February 24, 2009, the Compensation Committee of the
Board of Directors of MetLife, Inc. approved special
compensation grants (Special Grants) to William J.
Wheeler, the Companys Executive Vice President and Chief
Financial Officer and Steven A. Kandarian, the Companys
Executive Vice President and Chief Investment Officer. The
Special Grants were approved in recognition of the critical
nature of their roles at the Company, these executives
sustained high performance, and to encourage them to continue to
provide a high level of performance that will create value for
Company shareholders. The grants were in addition to grants
determined under the Companys general executive
compensation practices. The Special Grants consisted of 130,000
stock options and 64,000 performance shares for Mr. Wheeler
and 120,000 stock options and 64,000 performance shares for
Mr. Kandarian. The grants the Committee determined under
the Companys general executive compensation practices
included 65,000 stock options and 32,000 performance shares for
Mr. Wheeler, and 60,000 stock options and 32,000
performance shares for Mr. Kandarian. The Special Grant
stock options will normally become exercisable on the third
anniversary of their grant date, rather than at a rate of
one-third on each of the first three anniversaries of their
grant date as do the stock options determined under the
Companys general executive compensation practices.
250
Part III
|
|
Item 10.
|
Directors,
Executive Officers and Corporate Governance
|
The information called for by this Item pertaining to Directors
is incorporated herein by reference to the sections entitled
Proposal One Election of Directors,
Corporate Governance Information About the
Board of Directors, Corporate Governance
Board Committees, Corporate Governance
Membership on Board Committees and
Security Ownership of Directors and Executive
Officers Section 16(a) Beneficial Ownership
Reporting Compliance in MetLife, Inc.s definitive
proxy statement for the Annual Meeting of Shareholders to be
held on April 28, 2009, to be filed by MetLife, Inc. with
the U.S. Securities and Exchange Commission
(SEC) pursuant to Regulation 14A within
120 days after the year ended December 31, 2008 (the
2009 Proxy Statement).
The information called for by this Item pertaining to Executive
Officers appears in Part I Item 1.
Business Executive Officers of the Registrant
and Security Ownership of Directors and Executive
Officers Section 16(a) Beneficial Ownership
Reporting Compliance in the 2009 Proxy Statement.
The Company has adopted the MetLife Financial Management Code of
Professional Conduct (the Financial Management
Code), a code of ethics as defined under the
rules of the SEC, that applies to the Holding Companys
Chief Executive Officer, Chief Financial Officer, Chief
Accounting Officer, Corporate Controller and all professionals
in finance and finance-related departments. In addition, the
Company has adopted the Directors Code of Business Conduct
and Ethics (the Directors Code) which applies
to all members of the Holding Companys Board of Directors,
including the Chief Executive Officer, and the Employee Code of
Business Conduct and Ethics (together with the Financial
Management Code and the Directors Code, collectively, the
Ethics Codes), which applies to all employees of the
Company, including the Holding Companys Chief Executive
Officer, Chief Financial Officer, Chief Accounting Officer, and
Corporate Controller. The Ethics Codes are available on the
Companys website at
http://www.metlife.com/corporategovernance.
The Company intends to satisfy its disclosure obligations under
Item 5.05 of
Form 8-K
by posting information about amendments to, or waivers from a
provision of, the Ethics Codes that apply to the Holding
Companys Chief Executive Officer, Chief Financial Officer,
Chief Accounting Officer, and Corporate Controller on the
Companys website at the address given above.
|
|
Item 11.
|
Executive
Compensation
|
The information called for by this Item is incorporated herein
by reference to the sections entitled Corporate
Governance Board Committees, Corporate
Governance Compensation of Non-Management
Directors, Compensation Committee Report,
Compensation Discussion and Analysis, Summary
Compensation Table, Grants of Plan-Based Awards in
2008, Outstanding Equity Awards at 2008 Fiscal-Year
End, Option Exercises and Stock Vested in
2008, Pension Benefits, Nonqualified
Deferred Compensation and Potential Payments Upon
Termination or
Change-in-Control
in the 2009 Proxy Statement.
|
|
Item 12.
|
Security
Ownership of Certain Beneficial Owners and Management and
Related Stockholder Matters
|
The information called for by this Item pertaining to ownership
of the Holding Companys common stock is incorporated
herein by reference to the sections entitled Security
Ownership of Directors and Executive Officers and
Security Ownership of Certain Beneficial Owners and
Proposal Two Reapproval of the MetLife,
Inc. 2005 Stock and Incentive Compensation Plan
Equity Compensation Plan Information in the 2009 Proxy
Statement.
251
|
|
Item 13.
|
Certain
Relationships and Related Transactions, and Director
Independence
|
The information called for by this Item is incorporated herein
by reference to the sections entitled Corporate
Governance Procedures for Reviewing Related Person
Transactions and Corporate Governance
Information About the Board of Directors
Responsibilities, Independence and Composition of the Board of
Directors in the 2009 Proxy Statement.
|
|
Item 14.
|
Principal
Accountant Fees and Services
|
The information called for by this item is incorporated herein
by reference to the section entitled
Proposal Three Ratification of
Appointment of the Independent Auditor in the 2009 Proxy
Statement.
252
Part IV
|
|
Item 15.
|
Exhibits
and Financial Statement Schedules
|
The following documents are filed as part of this report:
1. Financial Statements
The financial statements are listed in the Index to Consolidated
Financial Statements and Schedules on page 247.
2. Financial Statement Schedules
The financial statement schedules are listed in the Index to
Consolidated Financial Statements and Schedules on page 247.
3. Exhibits
The exhibits are listed in the Exhibit Index which begins
on
page E-1.
253
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
February 27, 2009
METLIFE, INC.
|
|
|
|
By
|
/s/ C.
Robert Henrikson
|
Name: C. Robert Henrikson
|
|
|
|
Title:
|
Chairman of the Board, President
|
and Chief Executive Officer
Pursuant to the requirements of the Securities Exchange Act of
1934, this report has been signed below by the following persons
on behalf of the registrant and in the capacities and on the
dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Sylvia
Mathews Burwell
Sylvia
Mathews Burwell
|
|
Director
|
|
February 27, 2009
|
|
|
|
|
|
/s/ Eduardo
Castro-Wright
Eduardo
Castro-Wright
|
|
Director
|
|
February 27, 2009
|
|
|
|
|
|
/s/ Burton
A. Dole, Jr.
Burton
A. Dole, Jr.
|
|
Director
|
|
February 27, 2009
|
|
|
|
|
|
/s/ Cheryl
W. Grisé
Cheryl
W. Grisé
|
|
Director
|
|
February 27, 2009
|
|
|
|
|
|
/s/ R.
Glenn Hubbard
R.
Glenn Hubbard
|
|
Director
|
|
February 27, 2009
|
|
|
|
|
|
/s/ John
M. Keane
John
M. Keane
|
|
Director
|
|
February 27, 2009
|
|
|
|
|
|
/s/ James
M. Kilts
James
M. Kilts
|
|
Director
|
|
February 27, 2009
|
|
|
|
|
|
/s/ Hugh
B. Price
Hugh
B. Price
|
|
Director
|
|
February 27, 2009
|
|
|
|
|
|
/s/ David
Satcher, M.D.
David
Satcher, M.D.
|
|
Director
|
|
February 27, 2009
|
|
|
|
|
|
/s/ Kenton
J. Sicchitano
Kenton
J. Sicchitano
|
|
Director
|
|
February 27, 2009
|
254
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ William
C. Steere, Jr.
William
C. Steere, Jr.
|
|
Director
|
|
February 27, 2009
|
|
|
|
|
|
/s/ Lulu
C. Wang
Lulu
C. Wang
|
|
Director
|
|
February 27, 2009
|
|
|
|
|
|
/s/ C.
Robert Henrikson
C.
Robert Henrikson
|
|
Chairman of the Board, President and Chief Executive Officer
(Principal Executive Officer)
|
|
February 27, 2009
|
|
|
|
|
|
/s/ William
J. Wheeler
William
J. Wheeler
|
|
Executive Vice President and Chief Financial Officer (Principal
Financial Officer)
|
|
February 27, 2009
|
|
|
|
|
|
/s/ Joseph
J. Prochaska, Jr.
Joseph
J. Prochaska, Jr.
|
|
Executive Vice President, Finance Operations and Chief
Accounting Officer (Principal Accounting Officer)
|
|
February 27, 2009
|
255
Exhibit Index
(Note Regarding Reliance on Statements in Our
Contracts: In reviewing the agreements included
as exhibits to this Annual Report on
Form 10-K,
please remember that they are included to provide you with
information regarding their terms and are not intended to
provide any other factual or disclosure information about
MetLife, Inc., its subsidiaries or the other parties to the
agreements. The agreements contain representations and
warranties by each of the parties to the applicable agreement.
These representations and warranties have been made solely for
the benefit of the other parties to the applicable agreement and
(i) should not in all instances be treated as categorical
statements of fact, but rather as a way of allocating the risk
to one of the parties if those statements prove to be
inaccurate; (ii) have been qualified by disclosures that
were made to the other party in connection with the negotiation
of the applicable agreement, which disclosures are not
necessarily reflected in the agreement; (iii) may apply
standards of materiality in a way that is different from what
may be viewed as material to investors; and (iv) were made
only as of the date of the applicable agreement or such other
date or dates as may be specified in the agreement and are
subject to more recent developments. Accordingly, these
representations and warranties may not describe the actual state
of affairs as of the date they were made or at any other time.
Additional information about MetLife, Inc. and its subsidiaries
may be found elsewhere in this Annual Report on
Form 10-K
and MetLife, Inc.s other public filings, which are
available without charge through the SECs website at
www.sec.gov.)
|
|
|
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
|
|
|
2
|
.1
|
|
|
Plan of Reorganization (Incorporated by reference to
Exhibit 2.1 to MetLife, Inc.s Registration Statement
on
Form S-1
(No. 333-91517)
(the
S-1
Registration Statement)).
|
|
|
|
2
|
.2
|
|
|
Amendment to Plan of Reorganization dated as of March 9,
2000 (Incorporated by reference to Exhibit 2.2 to the
S-1
Registration Statement).
|
|
|
|
2
|
.3
|
|
|
Acquisition Agreement between MetLife, Inc. and Citigroup Inc.,
dated as of January 31, 2005 (Incorporated by reference to
Exhibit 2.1 to MetLife, Inc.s Current Report on
Form 8-K
dated February 4, 2005).
|
|
|
|
3
|
.1
|
|
|
Amended and Restated Certificate of Incorporation of MetLife,
Inc. (Incorporated by reference to Exhibit 3.1 to MetLife,
Inc.s Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006 (the 2006
Annual Report)).
|
|
|
|
3
|
.2
|
|
|
Certificate of Designation, Preferences and Rights of
Series A Junior Participating Preferred Stock of MetLife,
Inc., filed with the Secretary of State of Delaware on
April 7, 2000 (Incorporated by reference to
Exhibit 3.2 to the 2006 Annual Report).
|
|
|
|
3
|
.3
|
|
|
Certificate of Designations of Floating Rate Non-Cumulative
Preferred Stock, Series A, of MetLife, Inc., filed with the
Secretary of State of Delaware on June 10, 2005
(Incorporated by reference to Exhibit 99.5 to MetLife,
Inc.s Registration Statement on
Form 8-A
filed on June 10, 2005).
|
|
|
|
3
|
.4
|
|
|
Certificate of Designations of 6.50% Non-Cumulative Preferred
Stock, Series B, of MetLife, Inc., filed with the Secretary
of State of Delaware on June 14, 2005 (Incorporated by
reference to Exhibit 99.5 to MetLife, Inc.s
Registration Statement on
Form 8-A
filed on June 15, 2005).
|
|
|
|
3
|
.5
|
|
|
MetLife, Inc. Amended and Restated By-Laws effective
June 19, 2007 (Incorporated by reference to
Exhibit 3.1 to MetLife, Inc.s Current Report on
Form 8-K
dated June 25, 2007 (the June 2007
Form 8-K)).
|
|
|
|
4
|
.1(a)
|
|
|
Indenture dated as of November 9, 2001 between MetLife,
Inc. and Bank One Trust Company, N.A. (predecessor to The
Bank of New York Trust Company, N.A.) relating to Senior
Debt Securities (Incorporated by reference to
Exhibit 4.1(a) to the 2006 Annual Report).
|
|
|
|
4
|
.1(b)
|
|
|
Form of Indenture for Senior Debt Securities between MetLife,
Inc. and one or more banking institutions to be qualified as
Trustee pursuant to Section 305(b)(2) of the
Trust Indenture Act of 1939 (Included in
Exhibit 4.1(a) incorporated by reference to
Exhibit 4.1(a) to the 2006 Annual Report, except for the
name of the trustee).
|
|
|
E-1
|
|
|
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
|
|
|
4
|
.2
|
|
|
Second Supplemental Indenture dated as of November 27, 2001
between MetLife, Inc. and Bank One Trust Company, N.A.
(predecessor to The Bank of New York Trust Company, N.A.)
relating to the 6.125% Senior Notes due December 1,
2011 (Incorporated by reference to Exhibit 4.3 to the 2006
Annual Report).
|
|
|
|
4
|
.3
|
|
|
Third Supplemental Indenture dated as of December 10, 2002
between MetLife, Inc. and Bank One Trust Company, N.A.
(predecessor to The Bank of New York Trust Company, N.A.)
relating to the 5.375% Senior Notes due December 15,
2012 (Incorporated by reference to Exhibit 4.3 to MetLife,
Inc.s Annual Report on
Form 10-K
for the fiscal year ended December 31, 2007 (the 2007
Annual Report).
|
|
|
|
4
|
.4
|
|
|
Fourth Supplemental Indenture dated as of December 10, 2002
between MetLife, Inc. and Bank One Trust Company, N.A.
(predecessor to The Bank of New York Trust Company, N.A.)
relating to the 6.50% Senior Notes due December 15,
2032 (Incorporated by reference to Exhibit 4.4 to the 2007
Annual Report).
|
|
|
|
4
|
.5
|
|
|
Fifth Supplemental Indenture dated as of November 21, 2003
between MetLife, Inc. and J.P. Morgan Trust Company,
National Association (predecessor to The Bank of New York
Trust Company, N.A.) relating to the 5.875% Senior
Notes due November 21, 2033.
|
|
|
|
4
|
.6
|
|
|
Sixth Supplemental Indenture dated as of November 24, 2003
between MetLife, Inc. and J.P. Morgan Trust Company,
National Association (predecessor to The Bank of New York
Trust Company, N.A.) relating to the 5.00% Senior
Notes due November 24, 2013.
|
|
|
|
4
|
.7
|
|
|
Seventh Supplemental Indenture dated as of June 3, 2004
between MetLife, Inc. and J.P. Morgan Trust Company,
National Association (predecessor to The Bank of New York
Trust Company, N.A.), as trustee, relating to the
5.50% Senior Notes due June 15, 2014 (Incorporated by
reference to Exhibit 4.1 to MetLife, Inc.s Current
Report on
Form 8-K
dated June 3, 2004 (the June 2004
Form 8-K)).
|
|
|
|
4
|
.8
|
|
|
Eighth Supplemental Indenture dated as of June 3, 2004
between MetLife, Inc. and J.P. Morgan Trust Company,
National Association (predecessor to The Bank of New York
Trust Company, N.A.), as trustee, relating to the
6.375% Senior Notes due June 15, 2034 (Incorporated by
reference to Exhibit 4.3 to the June 2004
Form 8-K).
|
|
|
|
4
|
.9
|
|
|
Ninth Supplemental Indenture dated as of July 23, 2004
between MetLife, Inc. and J.P. Morgan Trust Company,
National Association (predecessor to The Bank of New York
Trust Company, N.A.), as trustee, relating to the
5.50% Senior Notes due June 15, 2014 (Incorporated by
reference to Exhibit 4.1 to MetLife, Inc.s Current
Report on
Form 8-K
dated July 23, 2004 (the July 2004
Form 8-K)).
|
|
|
|
4
|
.10
|
|
|
Tenth Supplemental Indenture dated as of July 23, 2004
between MetLife, Inc. and J.P. Morgan Trust Company,
National Association (predecessor to The Bank of New York
Trust Company, N.A.), as trustee, relating to the
6.375% Senior Notes due June 15, 2034 (Incorporated by
reference to Exhibit 4.3 to the July 2004
Form 8-K).
|
|
|
|
4
|
.11
|
|
|
Eleventh Supplemental Indenture dated as of December 9,
2004 between MetLife, Inc. and J.P. Morgan
Trust Company, National Association (predecessor to The
Bank of New York Trust Company, N.A.), as trustee, relating
to the 5.375% Senior Notes due December 9, 2024
(Incorporated by reference to Exhibit 4.1 to MetLife,
Inc.s Current Report on
Form 8-K
dated December 9, 2004 (the December 2004
Form 8-K)).
|
|
|
|
4
|
.12
|
|
|
Twelfth Supplemental Indenture dated as of June 23, 2005
between MetLife, Inc. and J.P. Morgan Trust Company,
National Association (predecessor to The Bank of New York
Trust Company, N.A.), as trustee, relating to the
5.00% Senior Notes due June 15, 2015 (Incorporated by
reference to Exhibit 4.1 to MetLife, Inc.s Current
Report on
Form 8-K
dated June 23, 2005 (the June 23, 2005
Form 8-K)).
|
|
|
|
4
|
.13
|
|
|
Thirteenth Supplemental Indenture dated as of June 23, 2005
between MetLife, Inc. and J.P. Morgan Trust Company,
National Association (predecessor to The Bank of New York
Trust Company, N.A.), as trustee, relating to the
5.70% Senior Notes due June 15, 2035 (Incorporated by
reference to Exhibit 4.3 to the June 23, 2005
Form 8-K).
|
|
|
E-2
|
|
|
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
|
|
|
4
|
.14
|
|
|
Fourteenth Supplemental Indenture dated as of June 29, 2005
between MetLife, Inc. and J.P. Morgan Trust Company,
National Association (predecessor to The Bank of New York
Trust Company, N.A.), as trustee, relating to the
5.25% Senior Notes due June 29, 2020 (Incorporated by
reference to Exhibit 4.1 to MetLife, Inc.s Current
Report on
Form 8-K
dated June 29, 2005 (the June 29, 2005
Form 8-K)).
|
|
|
|
4
|
.15
|
|
|
Form of 6.125% Senior Note due December 1, 2011
(Included in Exhibit 4.2 incorporated by reference to
Exhibit 4.3 to the 2006 Annual Report).
|
|
|
|
4
|
.16
|
|
|
Form of 5.375% Senior Note due December 15, 2012
(Included in Exhibit 4.3 incorporated by reference to
Exhibit 4.3 to the 2007 Annual Report).
|
|
|
|
4
|
.17
|
|
|
Form of 6.50% Senior Note due December 15, 2032
(Included in Exhibit 4.4 incorporated by reference to
Exhibit 4.4 to the 2007 Annual Report).
|
|
|
|
4
|
.18
|
|
|
Form of 5.875% Senior Note due November 21, 2033
(Included in Exhibit 4.5).
|
|
|
|
4
|
.19
|
|
|
Form of 5.00% Senior Note due November 24, 2013
(Included in Exhibit 4.6).
|
|
|
|
4
|
.20
|
|
|
Form of 5.50% Senior Note due June 15, 2014 (Included
in Exhibit 4.7 incorporated by reference to
Exhibit 4.1 to the June 2004
Form 8-K).
|
|
|
|
4
|
.21
|
|
|
Form of 6.375% Senior Note due June 15, 2034 (Included
in Exhibit 4.8 incorporated by reference to
Exhibit 4.3 to the June 2004
Form 8-K).
|
|
|
|
4
|
.22
|
|
|
Form of 5.50% Senior Note due June 15, 2014 (Included
in Exhibit 4.9 incorporated by reference to
Exhibit 4.1 to the July 2004
Form 8-K).
|
|
|
|
4
|
.23
|
|
|
Form of 6.375% Senior Note due June 15, 2034 (Included
in Exhibit 4.10 incorporated by reference to
Exhibit 4.3 to the July 2004
Form 8-K).
|
|
|
|
4
|
.24
|
|
|
Form of 5.375% Senior Note due December 9, 2024
(Included in Exhibit 4.11 incorporated by reference to
Exhibit 4.1 to the December 2004
Form 8-K).
|
|
|
|
4
|
.25
|
|
|
Form of 5.00% Senior Note due June 15, 2015 (Included
in Exhibit 4.12 incorporated by reference to
Exhibit 4.1 to the June 23, 2005
Form 8-K).
|
|
|
|
4
|
.26
|
|
|
Form of 5.70% Senior Note due June 15, 2035 (Included
in Exhibit 4.13 incorporated by reference to
Exhibit 4.3 to the June 23, 2005
Form 8-K).
|
|
|
|
4
|
.27
|
|
|
Form of 5.25% Senior Note due June 29, 2020 (Included
in Exhibit 4.14 incorporated by reference to
Exhibit 4.1 to the June 29, 2005
Form 8-K).
|
|
|
|
4
|
.28(a)
|
|
|
Indenture dated as of June 21, 2005 between MetLife, Inc.
and J.P. Morgan Trust Company, National Association
(predecessor to The Bank of New York Trust Company, N.A.)
relating to Subordinated Debt Securities (the Subordinated
Indenture) (Incorporated by reference to Exhibit 4.5
to MetLife, Inc.s Current Report on
Form 8-K
dated June 22, 2005 (the June 22, 2005
Form 8-K)).
|
|
|
|
4
|
.28(b)
|
|
|
Form of Indenture for Subordinated Debt Securities between
MetLife, Inc. and one or more banking institutions to be
qualified as Trustee pursuant to Section 305(b)(2) of the
Trust Indenture Act of 1939 (Incorporated by reference to
Exhibit 4.28(a), except for the name of the trustee).
|
|
|
|
4
|
.29
|
|
|
First Supplemental Indenture dated as of June 21, 2005 to
the Subordinated Indenture between MetLife, Inc. and
J.P. Morgan Trust Company, National Association
(predecessor to The Bank of New York Trust Company, N.A.)
(Incorporated by reference to Exhibit 4.6 to the
June 22, 2005
Form 8-K).
|
|
|
|
4
|
.30
|
|
|
Second Supplemental Indenture dated as of June 21, 2005 to
the Subordinated Indenture between MetLife, Inc. and
J.P. Morgan Trust Company, National Association
(predecessor to The Bank of New York Trust Company, N.A.)
(Incorporated by reference to Exhibit 4.8 to the
June 22, 2005
Form 8-K).
|
|
|
E-3
|
|
|
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
|
|
|
4
|
.31
|
|
|
Third Supplemental Indenture dated as of December 21, 2006
to the Subordinated Indenture between MetLife, Inc. and The Bank
of New York Trust Company, N.A. (as successor to
J.P. Morgan Trust Company, National Association)
(Incorporated by reference to Exhibit 4.1 to MetLife,
Inc.s Current Report on
Form 8-K
dated December 22, 2006 (the December 2006
Form 8-K)).
|
|
|
|
4
|
.32
|
|
|
Sixth Supplemental Indenture dated as of August 7, 2008 to
the Subordinated Indenture between MetLife, Inc. and The Bank of
New York Mellon Trust Company, N.A. (as successor in
interest to J.P. Morgan Trust Company, National
Association), as trustee (Incorporated by reference to
Exhibit 4.1 to MetLife, Inc.s Current Report on
Form 8-K
dated August 8, 2008).
|
|
|
|
4
|
.33
|
|
|
Seventh Supplemental Indenture dated February 6, 2009 for
the Subordinated Indenture between MetLife, Inc. and The Bank of
New York Mellon Trust Company, N.A. (as successor in interest to
J.P. Morgan Trust Company, National Association), as trustee
(Incorporated by reference to Exhibit 4.1 to MetLife,
Inc.s Current Report on
Form 8-K
dated February 9, 2009).
|
|
|
|
4
|
.34
|
|
|
Form of Series A Debenture (Incorporated by reference to
Exhibit 4.7 to the June 22, 2005
Form 8-K).
|
|
|
|
4
|
.35
|
|
|
Form of Series B Debenture (Incorporated by reference to
Exhibit 4.9 to the June 22, 2005
Form 8-K).
|
|
|
|
4
|
.36
|
|
|
Form of junior subordinated debenture (Included in
Exhibit 4.31 incorporated by reference to Exhibit 4.3
to the December 2006
Form 8-K).
|
|
|
|
4
|
.37
|
|
|
Form of security certificate representing MetLife, Inc.s
6.817% Senior Debt Securities, Series A, due 2018
(Incorporated by reference to Exhibit 4.1 to MetLife,
Inc.s Current Report on
Form 8-K
dated August 15, 2008).
|
|
|
|
4
|
.38
|
|
|
Form of security certificate representing MetLife, Inc.s
7.717% Senior Debt Securities, Series B, due 2019
(Incorporated by reference to Exhibit 4.1 to MetLife
Inc.s Current Report on
Form 8-K
dated February 18, 2009).
|
|
|
|
4
|
.39
|
|
|
Certificate of Trust of MetLife Capital Trust III
(Incorporated by reference to Exhibit 4.7 to MetLife,
Inc.s, MetLife Capital Trust IIs and MetLife
Capital Trust IIIs Registration Statement on
Form S-3
(Nos.
333-61282,
333-61282-01
and
333-61282-02)
(the 2001
S-3
Registration Statement)).
|
|
|
|
4
|
.40
|
|
|
Certificate of Amendment to Certificate of Trust of MetLife
Capital Trust III (Incorporated by reference to
Exhibit 4.6 to MetLife, Inc.s., MetLife Capital
Trust IIs and MetLife Capital Trust IIIs
Registration Statement on
Form S-3
(Nos.
333-112073,
333-112073-01
and
333-112073-02)
(the 2004
S-3
Registration Statement)).
|
|
|
|
4
|
.41
|
|
|
Certificate of Trust of MetLife Capital Trust V
(Incorporated by reference to Exhibit 4.3 to MetLife,
Inc.s, MetLife Capital Trust Vs, MetLife
Capital Trust VIs, MetLife Capital
Trust VIIs, MetLife Capital Trust VIIIs
and MetLife Capital Trust IXs Registration Statement
on
Form S-3
(Nos.
333-147180,
333-147180-01,
333-147180-02,
333-147180-03,
333-147180-04
and
333-147180-05)
(the 2007
S-3
Registration Statement)).
|
|
|
|
4
|
.42
|
|
|
Certificate of Trust of MetLife Capital Trust VI
(Incorporated by reference to Exhibit 4.4 to the 2007
S-3
Registration Statement).
|
|
|
|
4
|
.43
|
|
|
Certificate of Trust of MetLife Capital Trust VII
(Incorporated by reference to Exhibit 4.5 to the 2007
S-3
Registration Statement).
|
|
|
|
4
|
.44
|
|
|
Certificate of Trust of MetLife Capital Trust VIII
(Incorporated by reference to Exhibit 4.6 to the 2007
S-3
Registration Statement).
|
|
|
|
4
|
.45
|
|
|
Certificate of Trust of MetLife Capital Trust IX
(Incorporated by reference to Exhibit 4.7 to the 2007
S-3
Registration Statement).
|
|
|
|
4
|
.46
|
|
|
Amended and Restated Declaration of Trust of MetLife Capital
Trust III dated as of June 21, 2005 (Incorporated by
reference to Exhibit 4.17 to the June 22, 2005
Form 8-K).
|
|
|
|
4
|
.47
|
|
|
Declaration of Trust of MetLife Capital Trust V
(Incorporated by reference to Exhibit 4.8 to the 2007
S-3
Registration Statement).
|
|
|
E-4
|
|
|
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
|
|
|
4
|
.48
|
|
|
Declaration of Trust of MetLife Capital Trust VI
(Incorporated by reference to Exhibit 4.9 to the 2007
S-3
Registration Statement).
|
|
|
|
4
|
.49
|
|
|
Declaration of Trust of MetLife Capital Trust VII
(Incorporated by reference to Exhibit 4.10 to the 2007
S-3
Registration Statement).
|
|
|
|
4
|
.50
|
|
|
Declaration of Trust of MetLife Capital Trust VIII
(Incorporated by reference to Exhibit 4.11 to the 2007
S-3
Registration Statement).
|
|
|
|
4
|
.51
|
|
|
Declaration of Trust of MetLife Capital Trust IX
(Incorporated by reference to Exhibit 4.12 to the 2007
S-3
Registration Statement).
|
|
|
|
4
|
.52
|
|
|
Form of Amended and Restated Declaration of Trust (substantially
identical, except for names and dates, for MetLife Capital
Trust V, MetLife Capital Trust VI, MetLife Capital
Trust VII, MetLife Capital Trust VIII and MetLife
Capital Trust IX) (Incorporated by reference to
Exhibit 4.13 to the 2007
S-3
Registration Statement).
|
|
|
|
4
|
.53
|
|
|
Form of Trust Preferred Security Certificate (substantially
identical, except for names and dates, for MetLife Capital
Trust V, MetLife Capital Trust VI, MetLife Capital
Trust VII, MetLife Capital Trust VIII and MetLife
Capital Trust IX) (Included in Exhibit 4.53
incorporated by reference to Exhibit 4.13 to the 2007
S-3
Registration Statement).
|
|
|
|
4
|
.54
|
|
|
Guarantee Agreement dated June 21, 2005 by and between
MetLife, Inc., as Guarantor, and J.P. Morgan
Trust Company, National Association (predecessor to The
Bank of New York Trust Company, N.A.), as Guarantee
Trustee, relating to MetLife Capital Trust III
(Incorporated by reference to Exhibit 4.19 to the
June 22, 2005
Form 8-K).
|
|
|
|
4
|
.55
|
|
|
Form of Trust Preferred Securities Guarantee Agreement
(substantially identical, except for names and dates, for
MetLife Capital Trust V, MetLife Capital Trust VI,
MetLife Capital Trust VII, MetLife Capital Trust VIII
and MetLife Capital Trust IX) (Incorporated by reference to
Exhibit 4.15 to the 2007
S-3
Registration Statement).
|
|
|
|
4
|
.56
|
|
|
Form of Common Securities Guarantee Agreement (substantially
identical, except for names and dates, for MetLife Capital
Trust V, MetLife Capital Trust VI, MetLife Capital
Trust VII, MetLife Capital Trust VIII and MetLife
Capital Trust IX) (Incorporated by reference to
Exhibit 4.16 to the 2007
S-3
Registration Statement).
|
|
|
|
4
|
.57
|
|
|
Removal and Appointment of Trustees of MetLife Capital
Trust III (Incorporated by reference to Exhibit 4.10
to the 2004
S-3
Registration Statement).
|
|
|
|
4
|
.58
|
|
|
Form of Certificate for Common Stock, par value $0.01 per share
(Incorporated by reference to Exhibit 4.1 to the
S-1
Registration Statement).
|
|
|
|
4
|
.59
|
|
|
Rights Agreement dated as of April 4, 2000 between MetLife,
Inc. and ChaseMellon Shareholder Services, L.L.C. (predecessor
to Mellon Investor Services LLC) (Incorporated by reference to
Exhibit 4.48 to the 2006 Annual Report).
|
|
|
|
4
|
.60
|
|
|
Certificate of Designation, Preferences and Rights of
Series A Junior Participating Preferred Stock of MetLife,
Inc., filed with the Secretary of State of Delaware on
April 7, 2000 (See Exhibit 3.2 above).
|
|
|
|
4
|
.61
|
|
|
Form of Right Certificate (Included as Exhibit B of
Exhibit 4.59 incorporated by reference to Exhibit 4.48
to the 2006 Annual Report).
|
|
|
|
4
|
.62
|
|
|
Form of Warrant Agreement (Incorporated by reference to
Exhibit 4.21 to the 2007
S-3
Registration Statement)**.
|
|
|
|
4
|
.63
|
|
|
Form of Deposit Agreement (Incorporated by reference to
Exhibit 4.22 to the 2007
S-3
Registration Statement)**.
|
|
|
|
4
|
.64
|
|
|
Form of Depositary Receipt (Included in Exhibit 4.63)**.
|
|
|
|
4
|
.65
|
|
|
Form of Purchase Contract Agreement (Incorporated by reference
to Exhibit 4.24 to the 2007
S-3
Registration Statement)**.
|
|
|
|
4
|
.66
|
|
|
Form of Pledge Agreement (Incorporated by reference to
Exhibit 4.25 to the 2007
S-3
Registration Statement)**.
|
|
|
E-5
|
|
|
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
|
|
|
4
|
.67
|
|
|
Form of Unit Agreement (Incorporated by reference to
Exhibit 4.26 to the 2007
S-3
Registration Statement)**.
|
|
|
|
4
|
.68
|
|
|
Stock Purchase Contract Agreement dated June 21, 2005
between MetLife, Inc. and J.P. Morgan Trust Company,
National Association (predecessor to The Bank of New York
Trust Company, N.A.), as Stock Purchase Contract Agent
(Incorporated by reference to Exhibit 4.1 to the
June 22, 2005
Form 8-K).
|
|
|
|
4
|
.69
|
|
|
Form of Normal Common Equity Unit Certificate (Incorporated by
reference to Exhibit 4.2 to the June 22, 2005
Form 8-K).
|
|
|
|
4
|
.70
|
|
|
Form of Stripped Common Equity Unit Certificate (Incorporated by
reference to Exhibit 4.3 to the June 22, 2005
Form 8-K).
|
|
|
|
4
|
.71
|
|
|
Pledge Agreement dated as of June 21, 2005 among MetLife,
Inc., JP Morgan Chase Bank, National Association (predecessor to
The Bank of New York Trust Company, N.A.), as Collateral
Agent, Custodial Agent and Securities Intermediary, and J.P
Morgan Trust Company, National Association (predecessor to
The Bank of New York Trust Company, N.A.), as Stock
Purchase Contract Agent (Incorporated by reference to
Exhibit 4.4 to the June 22, 2005
Form 8-K).
|
|
|
|
4
|
.72
|
|
|
Certificate of Designations of Floating Rate Non-Cumulative
Preferred Stock, Series A, of MetLife, Inc., filed with the
Secretary of State of Delaware on June 10, 2005 (See
Exhibit 3.3 above).
|
|
|
|
4
|
.73
|
|
|
Form of Stock Certificate, Floating Rate Non-Cumulative
Preferred Stock, Series A, of MetLife, Inc. (Incorporated
by reference of Exhibit 99.6 to MetLife, Inc.s
Registration Statement on
Form 8-A
filed on June 10, 2005).
|
|
|
|
4
|
.74
|
|
|
Certificate of Designations of 6.50% Non-Cumulative Preferred
Stock, Series B, of MetLife, Inc., filed with the Secretary
of State of Delaware on June 14, 2005 (See Exhibit 3.4
above).
|
|
|
|
4
|
.75
|
|
|
Form of Stock Certificate, 6.50% Non-Cumulative Preferred Stock,
Series B, of MetLife, Inc. (Incorporated by reference to
Exhibit 99.6 to MetLife, Inc.s Registration Statement
on
Form 8-A
filed on June 15, 2005).
|
|
|
|
4
|
.76
|
|
|
Replacement Capital Covenant, dated as of December 21, 2006
(Incorporated by reference to Exhibit 4.2 to the December
2006
Form 8-K).
|
|
|
|
4
|
.77
|
|
|
Replacement Capital Covenant, dated as of December 12, 2007
(Incorporated by reference to Exhibit 4.2 to MetLife,
Inc.s Current Report on
Form 8-K
dated December 12, 2007).
|
|
|
|
4
|
.78
|
|
|
Replacement Capital Covenant, dated as of April 8, 2008
(Incorporated by reference to Exhibit 4.2 to MetLife,
Inc.s Current Report on
Form 8-K
dated April 8, 2008).
|
|
|
|
4
|
.79
|
|
|
Replacement Capital Covenant, dated as of December 30, 2008
(Incorporated by reference to Exhibit 4.1 to MetLife,
Inc.s Current Report on
Form 8-K
dated December 30, 2008 (the December 2008
Form 8-K)).
|
|
|
|
10
|
.1
|
|
|
MetLife Executive Severance Plan (effective as of
December 17, 2007) (Incorporated by reference to
Exhibit 10.2 to MetLife, Inc.s Current Report on
Form 8-K
dated December 13, 2007)*.
|
|
|
|
10
|
.2
|
|
|
MetLife, Inc. 2000 Stock Incentive Plan, as amended and restated
March 28, 2000 (Incorporated by reference to
Exhibit 10.7 to the
S-1
Registration Statement)*.
|
|
|
|
10
|
.3
|
|
|
MetLife, Inc. 2000 Stock Incentive Plan, as amended, effective
February 8, 2002 (Incorporated by reference to
Exhibit 10.13 to the 2007 Annual Report)*.
|
|
|
|
10
|
.4
|
|
|
Form of Management Stock Option Agreement under the MetLife,
Inc. 2000 Stock Incentive Plan*.
|
|
|
|
10
|
.5
|
|
|
MetLife, Inc. 2000 Directors Stock Plan, as amended and
restated March 28, 2000 (Incorporated by reference to
Exhibit 10.8 to the
S-1
Registration Statement)*.
|
|
|
|
10
|
.6
|
|
|
MetLife, Inc. 2000 Directors Stock Plan, as amended
effective February 8, 2002 (Incorporated by reference to
Exhibit 10.17 to the 2007 Annual Report)*.
|
|
|
|
10
|
.7
|
|
|
Form of Director Stock Option Agreement under the MetLife, Inc.
2000 Directors Stock Plan*.
|
|
|
E-6
|
|
|
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
|
|
|
10
|
.8
|
|
|
MetLife, Inc. 2005 Stock and Incentive Compensation Plan,
effective April 15, 2005 (the 2005 SIC Plan)
(Incorporated by reference to Exhibit 10.2 to MetLife,
Inc.s Quarterly Report on
Form 10-Q
for the quarter ended March 31, 2004 (the First
Quarter 2004
10-Q))*.
|
|
|
|
10
|
.9
|
|
|
MetLife, Inc. 2005 Non-Management Director Stock Compensation
Plan, effective April 15, 2005 (Incorporated by reference
to Exhibit 10.3 to the First Quarter 2004
10-Q)*.
|
|
|
|
10
|
.10
|
|
|
Form of Management Stock Option Agreement under the 2005 SIC
Plan (Incorporated by reference to Exhibit 10.1 to MetLife,
Inc.s Current Report on
Form 8-K
dated February 28, 2005 (the February 28, 2005
Form 8-K))*.
|
|
|
|
10
|
.11
|
|
|
Form of Management Stock Option Agreement under the 2005 SIC
Plan (effective as of April 25, 2007) (Incorporated by
reference to Exhibit 10.4 to MetLife, Inc.s Quarterly
Report on
Form 10-Q
for the quarter ended March 31, 2007 (the First
Quarter 2007
10-Q))*.
|
|
|
|
10
|
.12
|
|
|
Amendment to Stock Option Agreements under the 2005 SIC Plan
(effective as of April 25, 2007) (Incorporated by reference
to Exhibit 10.1 to the First Quarter 2007
10-Q)*.
|
|
|
|
10
|
.13
|
|
|
Form of Management Restricted Stock Unit Agreement under the
2005 SIC Plan (Incorporated by reference to Exhibit 10.19
to MetLife, Inc.s Annual Report on
Form 10-K
for the fiscal year ended December 31, 2004)*.
|
|
|
|
10
|
.14
|
|
|
Amendment to Management Restricted Stock Unit Agreement under
the 2005 SIC Plan (effective December 31, 2005)
(Incorporated by reference to Exhibit 10.2 to MetLife,
Inc.s Current Report on
Form 8-K
dated January 10, 2006 (the January 10, 2006
Form 8-K))*.
|
|
|
|
10
|
.15
|
|
|
Form of Management Restricted Stock Unit Agreement under the
2005 SIC Plan (effective December 31, 2005) (Incorporated
by reference to Exhibit 10.4 to the January 10, 2006
Form 8-K)*.
|
|
|
|
10
|
.16
|
|
|
Form of Management Restricted Stock Unit Agreement under the
2005 SIC Plan (effective as of April 25, 2007)
(Incorporated by reference to Exhibit 10.6 to the First
Quarter 2007
10-Q)*.
|
|
|
|
10
|
.17
|
|
|
Amendment to Restricted Stock Unit Agreements under the 2005 SIC
Plan (effective as of April 25, 2007) (Incorporated by
reference to Exhibit 10.3 to the First Quarter 2007
10-Q)*.
|
|
|
|
10
|
.18
|
|
|
Form of Management Restricted Stock Unit Agreement under the
2005 SIC Plan (effective December 11, 2007) (Incorporated
by reference to Exhibit 10.5 to MetLife, Inc.s
Current Report on
Form 8-K
dated December 13, 2007 (the December 13, 2007
Form 8-K))*.
|
|
|
|
10
|
.19
|
|
|
Amendment to Restricted Stock Unit Agreements under the 2005 SIC
Plan (effective as of December 31, 2007) (Incorporated by
reference to Exhibit 10.29 to the 2007 Annual Report)*.
|
|
|
|
10
|
.20
|
|
|
Form of Management Performance Share Agreement under the 2005
SIC Plan (Incorporated by reference to Exhibit 10.2 to the
February 28, 2005
Form 8-K)*.
|
|
|
|
10
|
.21
|
|
|
Clarification of Management Performance Share Agreement under
the 2005 SIC Plan (Incorporated by reference to
Exhibit 10.3 to MetLife, Inc.s Current Report on
Form 8-K
dated December 19, 2005 (the December 2005
Form 8-K))*.
|
|
|
|
10
|
.22
|
|
|
Amendment to Management Performance Share Agreement under the
2005 SIC Plan (effective December 31, 2005) (Incorporated
by reference to Exhibit 10.1 to the January 10, 2006
Form 8-K))*.
|
|
|
|
10
|
.23
|
|
|
Form of Management Performance Share Agreement under the 2005
SIC Plan (effective December 31, 2005) (Incorporated by
reference to Exhibit 10.3 to the January 10, 2006
Form 8-K)*.
|
|
|
|
10
|
.24
|
|
|
Form of Management Performance Share Agreement under the 2005
SIC Plan (effective February 27, 2007) (Incorporated by
reference to Exhibit 10.27 to the 2006 Annual Report)*.
|
|
|
|
10
|
.25
|
|
|
Form of Management Performance Share Agreement under the 2005
SIC Plan (effective as of April 25, 2007) (Incorporated by
reference to Exhibit 10.5 to the First Quarter 2007
10-Q)*.
|
|
|
|
10
|
.26
|
|
|
Amendment to Management Performance Share Agreements under the
2005 SIC Plan (effective as of April 25, 2007)
(Incorporated by reference to Exhibit 10.2 to the First
Quarter 2007
10-Q)*.
|
|
|
E-7
|
|
|
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
|
|
|
10
|
.27
|
|
|
Form of Management Performance Share Agreement under the 2005
SIC Plan (effective December 11, 2007) (Incorporated by
reference to Exhibit 10.4 to the December 13, 2007
Form 8-K)*.
|
|
|
|
10
|
.28
|
|
|
Amendment to Management Performance Share Agreements under the
2005 SIC Plan (effective as of December 31, 2007)
(Incorporated by reference to Exhibit 10.3 to the
December 13, 2007
Form 8-K)*.
|
|
|
|
10
|
.29
|
|
|
Form of Management Performance Share Agreement under the 2005
SIC Plan (effective as of January 27, 2009) (Incorporated
by reference to Exhibit 10.1 to MetLife, Inc.s
Current Report on
Form 8-K
dated January 30, 2009)*.
|
|
|
|
10
|
.30
|
|
|
MetLife Policyholder Trust Agreement (Incorporated by
reference to Exhibit 10.12 to the
S-1
Registration Statement).
|
|
|
|
10
|
.31
|
|
|
Amendment to MetLife Policyholder Trust Agreement (Incorporated
by reference to Exhibit 3.2 to the MetLife Policyholder
Trusts Annual Report on
Form 10-K
for the fiscal year ended December 31, 2007).
|
|
|
|
10
|
.32
|
|
|
Five-Year $3,000,000,000 Credit Agreement, dated as of
June 20, 2007, among MetLife, Inc. and MetLife Funding,
Inc., as borrowers, and other parties signatory thereto
(Incorporated by reference to Exhibit 10.1 to the June 2007
Form 8-K).
|
|
|
|
10
|
.33
|
|
|
Amended and Restated $2,850,000 Five-Year Credit Agreement,
dated as of June 20, 2007 and amended and restated as of
December 23, 2008, among MetLife, Inc. and MetLife Funding,
Inc., as borrowers, and other parties signatory thereto
(Incorporated by reference to Exhibit 10.1 to the December
2008
Form 8-K).
|
|
|
|
10
|
.34
|
|
|
MetLife Annual Variable Incentive Plan (AVIP)
(Incorporated by reference to Exhibit 10.1 to the First
Quarter 2004
10-Q)*.
|
|
|
|
10
|
.35
|
|
|
Amendment Number One to the AVIP (Incorporated by reference to
Exhibit 10.2 to the December 2005
Form 8-K)*.
|
|
|
|
10
|
.36
|
|
|
Resolutions of the MetLife, Inc. Board of Directors (adopted
December 12, 2006) regarding the selection of
performance measures for 2007 awards under the AVIP
(Incorporated by reference to Exhibit 10.42 to the 2006
Annual Report)*.
|
|
|
|
10
|
.37
|
|
|
Resolutions of the MetLife, Inc. Board of Directors (adopted
December 11, 2007) regarding the selection of
performance measures for 2008 awards under the AVIP
(Incorporated by reference to Exhibit 10.54 to the 2007
Annual Report)*.
|
|
|
|
10
|
.38
|
|
|
Metropolitan Life Auxiliary Savings and Investment Plan (as
amended and restated, effective May 4, 2005) (Incorporated
by reference to Exhibit 10.2 to MetLife, Inc.s
Quarterly Report on
Form 10-Q
for the quarter ended March 31, 2005 (the First
Quarter 2005
10-Q))*.
|
|
|
|
10
|
.39
|
|
|
Amendment, dated as of August 1, 2005, to the Metropolitan
Life Auxiliary Savings and Investment Plan (effective as of
July 1, 2005) (Incorporated by reference to
Exhibit 10.7 to MetLife, Inc.s Quarterly Report on
Form 10-Q
for the quarter ended June 30, 2005)*.
|
|
|
|
10
|
.40
|
|
|
Metropolitan Life Auxiliary Savings and Investment Plan (as
amended and restated, effective January 1, 2008)
(Incorporated by reference to Exhibit 10.57 to the 2007
Annual Report)*.
|
|
|
|
10
|
.41
|
|
|
MetLife Deferred Compensation Plan for Officers, as amended and
restated, effective November 1, 2003*.
|
|
|
|
10
|
.42
|
|
|
Amendment Number One to the MetLife Deferred Compensation Plan
for Officers, dated May 4, 2005 (Incorporated by reference
to Exhibit 10.1 to the First Quarter 2005
10-Q)*.
|
|
|
|
10
|
.43
|
|
|
Amendment Number Two to The MetLife Deferred Compensation Plan
for Officers, effective December 14, 2005 (Incorporated by
reference to Exhibit 10.7 to the December 2005
Form 8-K)*.
|
|
|
|
10
|
.44
|
|
|
Amendment Number Three to The MetLife Deferred Compensation Plan
for Officers (as amended and restated as of November 1,
2003, effective February 26, 2007) (Incorporated by
reference to Exhibit 10.48 to the 2006 Annual Report)*.
|
|
|
E-8
|
|
|
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
|
|
|
10
|
.45
|
|
|
MetLife Leadership Deferred Compensation Plan, dated
November 2, 2006 (as amended and restated effective with
respect to salary and cash incentive compensation,
January 1, 2005, and with respect to stock compensation,
April 15, 2005) (Incorporated by reference to
Exhibit 10.3 to MetLife, Inc.s Quarterly Report on
Form 10-Q
for the quarter ended September 30, 2006 (the Third
Quarter 2006
10-Q))*.
|
|
|
|
10
|
.46
|
|
|
Amendment Number One to The MetLife Leadership Deferred
Compensation Plan, dated December 13, 2007 (effective as of
December 31, 2007) (Incorporated by reference to
Exhibit 10.63 to the 2007 Annual Report)*.
|
|
|
|
10
|
.47
|
|
|
Amendment Number Two to The MetLife Leadership Deferred
Compensation Plan, dated December 11, 2008 (effective
December 31, 2008)*.
|
|
|
|
10
|
.48
|
|
|
MetLife Deferred Compensation Plan for Outside Directors
(effective December 9, 2003)*.
|
|
|
|
10
|
.49
|
|
|
Amendment Number One to The MetLife Deferred Compensation Plan
for Outside Directors (as amended and restated as of December,
2003, effective February 26, 2007) (Incorporated by
reference to Exhibit 10.51 to the 2006 Annual Report)*.
|
|
|
|
10
|
.50
|
|
|
MetLife Non-Management Director Deferred Compensation Plan,
dated November 2, 2006 (as amended and restated, effective
January 1, 2005) (Incorporated by reference to
Exhibit 10.4 to the Third Quarter 2006
10-Q)*.
|
|
|
|
10
|
.51
|
|
|
Amendment Number One to The MetLife Non-Management Director
Deferred Compensation Plan (as amended and restated as of
December, 2006, effective February 26, 2007) (Incorporated
by reference to Exhibit 10.53 to the 2006 Annual Report)*.
|
|
|
|
10
|
.52
|
|
|
MetLife Non-Management Director Deferred Compensation Plan,
dated December 5, 2007 (as amended and restated, effective
January 1, 2005) (Incorporated by reference to
Exhibit 10.68 to the 2007 Annual Report)*.
|
|
|
|
10
|
.53
|
|
|
The MetLife Non-Management Director Deferred Compensation Plan,
dated December 9, 2008 (as amended and restated effective
January 1, 2005)*.
|
|
|
|
10
|
.54
|
|
|
MetLife, Inc. Director Indemnity Plan (dated and effective
July 22, 2008) (Incorporated by reference to
Exhibit 10.1 to MetLife, Inc.s Current Report on
Form 8-K
dated July 25, 2008)*.
|
|
|
|
10
|
.55
|
|
|
MetLife Auxiliary Pension Plan dated August 7, 2006 (as
amended and restated, effective June 30, 2006)
(Incorporated by reference to Exhibit 10.3 to MetLife,
Inc.s Quarterly Report on
Form 10-Q
for the quarter ended June 30, 2006 (the Second
Quarter 2006
10-Q))*.
|
|
|
|
10
|
.56
|
|
|
MetLife Auxiliary Pension Plan dated December 21, 2006
(amending and restating Part I thereof, effective
January 1, 2007) (Incorporated by reference to
Exhibit 10.57 to the 2006 Annual Report)*.
|
|
|
|
10
|
.57
|
|
|
MetLife Auxiliary Pension Plan dated December 21, 2007
(amending and restating Part I thereof, effective
January 1, 2008) (Incorporated by reference to
Exhibit 10.1 to MetLife, Inc.s Current Report on
Form 8-K
dated December 28, 2007)*.
|
|
|
|
10
|
.58
|
|
|
Amendment #1 to the MetLife Auxiliary Pension Plan (as amended
and restated effective January 1, 2008) dated
October 24, 2008 (effective October 1, 2008)*.
|
|
|
|
10
|
.59
|
|
|
Amendment Number Two to the MetLife Auxiliary Pension Plan (as
amended and restated effective January 1, 2008) dated
December 12, 2008 (effective December 31, 2008)*.
|
|
|
|
10
|
.60
|
|
|
MetLife Plan for Transition Assistance for Officers, dated
January 7, 2000, as amended (the MPTA)
(Incorporated by reference to Exhibit 10.4 to MetLife,
Inc.s Quarterly Report on
Form 10-Q
for the quarter ended September 30, 2004)*.
|
|
|
|
10
|
.61
|
|
|
Amendment Number Ten to the MPTA, dated January 26, 2005*
(Incorporated by reference to Exhibit 10.55 to MetLife,
Inc.s Annual Report on
Form 10-K
for the fiscal year ended December 31, 2005 (the 2005
Annual Report))*.
|
|
|
|
10
|
.62
|
|
|
Amendment Number Eleven to the MPTA, dated February 28,
2006 (Incorporated by reference to Exhibit 10.56 to the
2005 Annual Report)*.
|
|
|
|
10
|
.63
|
|
|
Amendment Number Twelve to the MPTA, dated August 7, 2006
(Incorporated by reference to Exhibit 10.1 to the Second
Quarter 2006
10-Q)*.
|
|
|
E-9
|
|
|
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
|
|
|
10
|
.64
|
|
|
Amendment Number Thirteen to the MPTA, dated August 7, 2006
(Incorporated by reference to Exhibit 10.2 to the Second
Quarter 2006
10-Q)*.
|
|
|
|
10
|
.65
|
|
|
Amendment Number Fourteen to the MPTA, dated January 26,
2007 (Incorporated by reference to Exhibit 10.63 to the
2006 Annual Report)*.
|
|
|
|
10
|
.66
|
|
|
Amendment Number Fifteen to the MPTA, dated June 1, 2007
(Incorporated by reference to Exhibit 10.2 to MetLife,
Inc.s Quarterly Report on
Form 10-Q
for the quarter ended June 30, 2007)*.
|
|
|
|
10
|
.67
|
|
|
Amendment Number Sixteen to the MPTA, dated December 12,
2007 (Incorporated by reference to Exhibit 10.81 to the
2007 Annual Report)*.
|
|
|
|
10
|
.68
|
|
|
Amendment Number Seventeen to the MPTA, dated June 3, 2008
(Incorporated by reference to Exhibit 10.1 to MetLife,
Inc.s Quarterly Report on
Form 10-Q
for the quarter ended June 30, 2008)*.
|
|
|
|
10
|
.69
|
|
|
Amendment Number Eighteen to the MPTA, dated August 13,
2008*.
|
|
|
|
10
|
.70
|
|
|
Amendment Number Nineteen to the MPTA, dated December 8,
2008*.
|
|
|
|
10
|
.71
|
|
|
Amendment Number Twenty to the MPTA, dated December 16,
2008*.
|
|
|
|
10
|
.72
|
|
|
Amendment Number Twenty-One to the MPTA, dated December 18,
2008*.
|
|
|
|
10
|
.73
|
|
|
One Madison Avenue Purchase and Sale Agreement, dated as of
March 29, 2005, between Metropolitan Life Insurance
Company, as Seller, and 1 Madison Venture LLC and Column
Financial, Inc., collectively, as Purchaser (Incorporated by
reference to Exhibit 10.1 to MetLife, Inc.s Current
Report on
Form 8-K
dated April 4, 2005 (the April 4, 2005
Form 8-K)).
|
|
|
|
10
|
.74
|
|
|
MetLife Building, 200 Park Avenue, New York, NY Purchase and
Sale Agreement, dated as of April 1, 2005, between
Metropolitan Tower Life Insurance Company, as Seller, and
Tishman Speyer Development, L.L.C., as Purchaser (Incorporated
by reference to Exhibit 10.2 to the April 4, 2005
Form 8-K).
|
|
|
|
10
|
.75
|
|
|
Stuyvesant Town, New York, New York, Purchase and Sale Agreement
between Metropolitan Tower Life Insurance Company, as Seller,
and Tishman Speyer Development Corp., as Purchaser, dated as of
October 17, 2006 (Incorporated by reference to
Exhibit 10.1 to the Third Quarter 2006
10-Q).
|
|
|
|
10
|
.76
|
|
|
Peter Cooper Village, New York, New York, Purchase and Sale
Agreement between Metropolitan Tower Life Insurance Company, as
Seller, and Tishman Speyer Development Corp., as Purchaser,
dated as of October 17, 2006 (Incorporated by reference to
Exhibit 10.2 to the Third Quarter 2006
10-Q).
|
|
|
|
10
|
.77
|
|
|
International Distribution Agreement dated as of July 1,
2005 between MetLife, Inc. and Citigroup Inc. (Incorporated by
reference to Exhibit 10.1 to MetLife, Inc.s Current
Report on
Form 8-K
dated July 8, 2005 (the July 8, 2005
Form 8-K)).
|
|
|
|
10
|
.78
|
|
|
Domestic Distribution Agreement dated as of July 1, 2005
between MetLife, Inc. and Citigroup Inc. (Incorporated by
reference to Exhibit 10.2 to the July 8, 2005
Form 8-K).
|
|
|
|
12
|
.1
|
|
|
Statement re: Computation of Ratios of Earnings to Fixed Charges.
|
|
|
|
21
|
.1
|
|
|
Subsidiaries of the Registrant.
|
|
|
|
23
|
.1
|
|
|
Consent of Deloitte & Touche LLP.
|
|
|
|
31
|
.1
|
|
|
Certification of Chief Executive Officer pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
31
|
.2
|
|
|
Certification of Chief Financial Officer pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
32
|
.1
|
|
|
Certification of Chief Executive Officer pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
32
|
.2
|
|
|
Certification of Chief Financial Officer pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
E-10
|
|
|
* |
|
Indicates management contracts or compensatory plans or
arrangements. |
|
** |
|
Indicates document to be filed as an exhibit to a Current Report
on
Form 8-K
or Quarterly Report on
Form 10-Q
pursuant to Item 601 of
Regulation S-K
and incorporated herein by reference. |
E-11